Anti-microbial peptides

ABSTRACT

Described herein are anti-microbial peptides having enhanced activity and transport.

TECHNICAL FIELD

Described herein are anti-microbial peptides having enhanced activity and transport.

BACKGROUND

The evolution of new strains of multi drug resistant bacteria is an emerging problem. Currently, there is a lack of a concerted effort among major pharmaceutical companies for addressing this problem. Highlighting this aspect is the small number of U.S. Food and Drug Administration (FDA) approved antibiotics. For example, only Teflaro® (ceftaroline fosamil) has been approved by the FDA since 2010. Moreover, anti-biotic resistant gram-negative bacteria in hospital acquired infections are increasingly becoming problematic with dwindling supplies of antibiotics that are efficacious against these pathogens. These antibiotic resistant bacterial infections in immunocompromised/sick patients further complicate the therapy of other underlying diseases. Thus, new strategies for the development of anti-bacterial drugs and methods of treatment are needed.

Accordingly, a paradigm shift in how the scientific community thinks about developing new anti-bacterial therapeutics may be underway. Fox, Nature Biotechnology 31(5): 379-382 (2013). This shift is into the potential use and therapeutic potential of anti-microbial peptides (AMPs). AMPs are molecules naturally found in microorganisms to mammals that comprise short peptides of about 15 amino acids to about 50 amino acids. The product is ribosomally synthesized and often post-translationally modified. This synthesis is in contrast to other natural peptide based antibiotics, such as vancomycin, which are formed by enzymatic cleavage. Fox, Nature Biotechnology 31(5): 379-382 (2013).

Anti-microbial peptides serve as a major component of the innate immunity and complement cell-mediated immune responses. The mechanism of action of most anti-microbial peptides depends on the target cellular surface. The principle anti-microbial activity of most AMPs has been proposed by the so called “carpet model,” wherein the amino acid composition, amphipathicity, and positive charge allow the peptides to electrostatically interact and insert into the mostly negatively charged microbial cell membranes, resulting in pore formation and cell death. Other modes of action include the inhibition of cell wall synthesis, autolysin activation, and the inhibition of DNA, RNA, and protein synthesis. The specificity of AMPs to microbes is due to mammalian and plant cell membranes having no net charge, which limits AMP interaction. Furthermore, acquired resistence to AMPs appears to be low as only a moderate increase in AMP resistance was observed after more than ten passages. Hancock, The Lancet Infectious Diseases 1(3): 156-164 (2001).

Additional problems emerging in the treatment of infectious diseases is biofilms. Sanchez et al., BMC Infectious Diseases 13: 47 (2013); Dean et al., BMC Microbiology 11: 114 (2011). Bacteria and fungi can assume a planktonic or free swimming phenotype, or they can exist as part of a colony (i.e., attached to a surface) or a biofilm. A colony of bacteria in a biofilm are surrounded by an exopolysaccharide matrix for protection, making them notoriously difficult to eradicate. Biofilms are found in 60-80% of chronic hospital-associated infections. Van Acker et al., Trends in Microbiology 22(6): 326-333 (2014). There are endogenous anti-biofilm peptides, Dean et al., BMC Microbiology 11: 114 (2011); de la Fuente-Nunez et al., PLoS Pathogens 10(5): e1004152 (2014), and while these peptides are similar to AMPs, not all of them are anti-microbial. These anti-biofilm peptides are potentially useful as topical agents for bacterial infections with a biofilm component, but in their natural form, they are not amenable for the treatment of systemic infections. Dean et al., BMC Microbiology 11: 114 (2011).

AMPs have principally been generated or discovered from naturally occuring AMPs. For example, U.S. Pat. No. 7,550,558 describes a method of using phage display to identify new anti-microbial peptides. Using the methods of this invention, the identified and most efficacious peptide had a high level of similarity to naturally occuring indolicidin and tritrpticin AMPs, which are known to have high levels of in vivo toxicity. While this AMP is potentially useful, no in vivo safety testing or efficacy was provided. U.S. Pat. No. 7,452,864 describes the use of a natural peptide cathelicidin LL-37 for topical wound regeneration promoted by its anti-microbial activity. Further examples of naturally derived peptides that have promising in vitro results are described by U.S. Pat. Nos. 7,531,509 and 7,504,380. However, anti-microbial peptides based on native peptide sequences are often subject to in vivo proteolysis or degradation, preventing in vivo efficacy. Fox, Nature Biotechnology 31(5): 379-382 (2013).

Thus, despite the promise of AMPs, many concerns remain, including toxicity, oral availability, and in vivo stability. Many peptides lack activity against gram-negative bacterial pathogens. Fox, Nature Biotechnology 31(5): 379-382 (2013). AMPs can have toxic effects from their hemolytic activity. Furthermore, naturally occuring small AMP-like melanocortin peptides have been shown to have potent cardiovascular side-effects from the presence of “RFamide” sequences (Arg-Phe or conservative substitutions) near the C-terminus of these peptides. Thiemermann et al., Biochem Biophys Res Commun. 175(1): 318-324 (1991); Gruber et al., Am J Physiol. 257(4 Pt 2): R681-694 (1989). U.S. Pat. No. 8,541,545 describes the elimination of RFamide effects in a similar class of small melanocortin peptides leading to decreased cardiovascular side effects. However, no concerted effort has been made in the prior art to eliminate potential RFamide effects in AMPs.

Thus, described herein, are rationally designed AMPs with efficacy against both gram negative and gram positive bacteria. The AMPs described herein further have modifications to overcome previous limitations of AMPs, which include decreased proteolysis, reduced hemolysis, and increased in vivo safety. Further, described herein are AMPs having both anti-biofilm and anti-microbial activity in a single molecule. Additionally, contemplated herein, are methods of use of the described AMPs.

SUMMARY

Described herein are anti-microbial peptide having enhanced anti-microbial activity and transport. Some anti-microbial peptides described herein have a metabolically stable C-terminal extension to minimize or abolish side effects, and potentiate therapeutic activity for use in the treatment of various pathological conditions. Also described herein are structural modifications to anti-microbial peptides that enhance the therapeutic activity of overlapping pharmacophores for use in the treatment of various pathological conditions, and allow regulation of drug active transport through the gastrointestinal tract (oral activity) and drug access or the prevention of access to the central nervous system (transport through the blood-brain-barrier).

One embodiment described herein is a non-naturally occuring anti-microbial peptide comprising at least three or more amino acid or amino acid analog residues, wherein at least one of the three or more residues comprises: (a) at least one or more natural, synthetic, or chemically modified cationic amino acid residues; (b) at least one, synthetic, or chemically modified anionic amino acid residue; (c) at least one or more natural, synthetic, or chemically modified aromatic residues; or (d) a combination of natural, synthetic, or chemically modified amino acid residues thereof. In one aspect, the length of the peptide is from about 3 residues to about 17 residues. In another aspect, the peptide is stabilized. In another aspect, the N-terminus of the non-naturally occuring anti-microbial peptide is stabilized. In another aspect, stabilization comprises the addition of between 1 and 3 natural or artificial stabilizing residues. In another aspect, the N-terminal stabilizing residues comprise: D-threonine, L-threonine, D-proline, L-proline, β-homo proline, D-alanine, L-alanine, β-alanine, D-valine, L-valine, β-valine, 3-methyl-β-valine, D-leucine, L-leucine, β-leucine, D-norleucine, L-norleucine, D-isoleucine, L-isoleucine, β-isoleucine, or a piperazin-2-one ring. In another aspect, the N-terminus is acylated. In another aspect, the C-terminus of the non-naturally occuring anti-microbial peptide is stabilized. In another aspect, the stabilization comprises the addition of between 1 and 3 natural or artificial stabilizing residues. In one aspect, the C-terminal stabilizing residues comprise: D-threonine, L-threonine, D-proline, L-proline, β-homo proline, D-alanine, L-alanine, D-valine, L-valine, β-valine, 3-methyl-β-valine, D-leucine, L-leucine, β-leucine, D-norleucine, L-norleucine, D-norleucine, L-norleucine, D-isoleucine, L-isoleucine, β-isoleucine, D-phenylalanine, L-phenylalanine, or a piperazin-2-one ring. In another aspect, the C-terminus is amidated. In another aspect, the C-terminal stabilization also increases the specificity of the anti-microbial peptide to target gram-negative bacteria. In another aspect, the C-terminal stabilization increases the specificity of the anti-microbial peptide to target gram-positive bacteria. In one aspect, the C-terminal stabilizing residues comprise: D-Pro-D-Val; D-Val-D-Pro; β-Val-β-Pro; β-Pro-β-Val; 3-methyl-β-Val-β-Pro; D-Pro-D-Ala; D-Ala-D-Pro; β-Pro-β-Ala; β-Ala-β-Pro; D-Pro-D-Leu; D-Leu-D-Pro; β-Pro-β-Leu; β-Leu-β-Pro; D-Val-D-Ala; D-Ala-D-Val; β-Val-β-Ala; β-Ala-β-Val; 3-methyl-β-Val-β-Ala; D-Val-D-Leu; D-Leu-D-Val; β-Val-β-Leu; β-Leu-β-Val; 3-methyl-β-Val-β-Leu; D-Phe-D-Val; or D-Val-D-Phe. In another aspect, the C-terminus is amidated. In another aspect, the non-naturally occuring anti-microbial peptide is cyclized. In another aspect, the non-naturally occuring anti-microbial peptide is cyclized through a lactam linkage. In another aspect, the non-naturally occuring anti-microbial peptide is cyclized between a positive and negative residue.

In another embodiment described herein, an anti-biofilm peptide is covalently linked to the anti-microbial peptide. In one aspect, the anti-biofilm peptide is covalently linked to the N-terminus of the anti-microbial peptide. In another aspect, the anti-biofilm peptide is covalently linked to the C-terminus of the anti-microbial peptide. In another aspect, the anti-biofilm peptide is covalently linked to the anti-microbial peptide through at least one linker. In another aspect, the anti-biofilm peptide comprises between 1 and 12 natural, synthetic, or chemically modified residues.

In another embodiment described herein, the anti-biofilm peptide comprises the sequence according to Formula IV: B¹-B²-B³-B⁴-B⁵-B⁶-B⁷-B⁸-B⁹-B¹⁰-B¹¹-B¹², wherein: each residue corresponding to positions B¹, B³, B⁴, B⁵, B⁶, B⁷, or B⁹ comprises any hydrophobic non-aromatic natural, synthetic, or chemically modified amino acid; each residue corresponding to positions B², B⁸, B¹¹, or B¹² comprises any natural, synthetic, or chemically modified positive amino acid; and each residue corresponding to position B¹⁰ comprises any natural, synthetic, or chemically modified aromatic amino acid. In one aspect, the anti-biofilm peptide comprises the sequence B¹-B²-B³-B⁴-B⁵-B⁶-B⁷-B⁸. In another aspect, the anti-biofilm peptide comprises the sequence B⁷-B⁸-B⁹-B¹⁰-B¹¹-B¹². In another aspect, the anti-biofilm peptide comprises the sequence B¹-B²-B³-B⁴-B⁵-B⁶. In another aspect, the anti-biofilm peptide comprises the sequence B¹-B²-B³-B⁴-B⁵-B⁶-B⁷.

In another embodiment described herein, the anti-biofilm peptide comprises the sequence according to Formula IV: B¹-B²-B³-B⁴-B⁵-B⁶-B⁷-B⁸-B⁹-B¹⁰-B¹¹, wherein: each residue corresponding to positions B¹, B², B⁴, B⁵, B⁸, B⁹, or B¹¹ comprises any natural, synthetic, or chemically modified positive amino acid; each residue corresponding to positions B³, B⁶, or B⁷ comprises any natural, synthetic, or chemically modified aromatic amino acid; and each residue corresponding to position B¹⁰ comprises any hydrophobic non-aromatic natural, synthetic, or chemically modified amino acid. In one aspect, the anti-biofilm peptide comprises the sequence B¹-B²-B³-B⁴-B⁵-B⁶-B⁷. In another aspect, the anti-biofilm peptide comprises the sequence B⁶-B⁷-B⁸-B⁹-B¹⁰-B¹¹. In another aspect, the anti-biofilm peptide comprises the sequence B¹-B²-B³-B⁴-B⁵-B⁶-B⁷-B⁸-B⁹. In another aspect, the anti-biofilm peptide comprises the sequence B⁴-B⁵-B⁶-B⁷-B⁸-B⁹-B¹⁰. In another aspect, the anti-biofilm peptide is covalently linked to the N-terminus or C-terminus of the anti-microbial peptide. In another aspect, the anti-microbial peptide is stabilized by the addition of between 1 and 3 natural or artificial stabilizing residues to the anti-biofilm peptide. In another aspect, the stabilizing residues comprise: D-threonine, L-threonine, D-proline, L-proline, β-homo proline, D-alanine, L-alanine, β-alanine, D-valine, L-valine, β-valine, 3-methyl-β-valine, D-leucine, L-leucine, β-leucine, D-norleucine, L-norleucine, D-norleucine, L-norleucine, D-isoleucine, L-isoleucine, β-isoleucine, or a piperazin-2-one ring. In another aspect, the anti-biofilm peptide is methylated.

Another embodiment described herein is a non-naturally occurring anti-microbial peptide comprising the sequence according to Formula I: X¹-X²-X³-R¹-R²-[R³-R⁴-R⁵-R⁶-R⁷-R⁸-R⁹-R¹⁰-R¹¹-R¹²-R¹³-R¹⁴-R¹⁵-R¹⁶-R¹⁷]Y¹-Y²-Y³, wherein: X¹, X², and X³ represent optional N-terminal residues; R¹ to R¹⁷ represent residues of the anti-microbial peptide; Y¹, Y², and Y³ represent optional degradation-resistant C-terminal residues. In one aspect, R¹ to R¹⁷ is further represented by formula II: P₀₋₂−|−[N−|−(U)₀₋₁−|−(P|A)₁₋₃−|−(U)₀₋₁−|−(P|A)₀₋₃−|−(U)₀₋₁−|−(P|A)₀₋₃−|−(U)₀₋₁−|−(P|A)₀₋₃−P], wherein: “N” is any natural, synthetic, or chemically modified negative residue; “U” is any natural, synthetic, or chemically modified polar uncharged residue or a hydrophobic non-aromatic natural, synthetic, or chemically modified residue; “P” is any natural, synthetic, or chemically modified proline residue or any natural, synthetic, or chemically modified positive residue; “A” is any natural, synthetic, or chemically modified aromatic residue. In another aspect, the length of the peptide is from about 3 residues to about 17 residues. In another aspect, the peptide is stabilized. In another aspect, the N-terminus of the non-naturally occuring anti-microbial peptide is stabilized. In another aspect, the stabilization comprises the addition of between 1 and 3 natural or artificial stabilizing residues. In another aspect, the N-terminal stabilizing residues comprise: D-threonine, L-threonine, D-proline, L-proline, β-homo proline, D-alanine, L-alanine, β-alanine, D-valine, L-valine, β-valine, 3-methyl-β-valine, D-leucine, L-leucine, β-leucine, D-norleucine, L-norleucine, D-isoleucine, L-isoleucine, β-isoleucine, or a piperazin-2-one ring. In another aspect, the N-terminus is acylated. In another aspect, the C-terminus of the non-naturally occuring anti-microbial peptide is stabilized. In another aspect, the stabilization comprises the addition of between 1 and 3 natural or artificial stabilizing residues. In another aspect, the C-terminal stabilizing residues comprise: D-threonine, L-threonine, D-proline, L-proline, β-homo proline, D-alanine, L-alanine, D-valine, L-valine, β-valine, 3-methyl-β-valine, D-leucine, L-leucine, β-leucine, D-norleucine, L-norleucine, D-isoleucine, L-isoleucine, β-isoleucine, D-phenylalanine, L-phenylalanine, or a piperazin-2-one ring. In another aspect, the C-terminus is amidated. In another aspect, the C-terminal stabilization also increases the specificity of the anti-microbial peptide to target gram-negative bacteria. In another aspect, the C-terminal stabilization increases the specificity of the anti-microbial peptide to target gram-positive bacteria. In another aspect, the C-terminal stabilizing residues comprise: D-Pro-D-Val; D-Val-D-Pro; β-Val-β-Pro; β-Pro-β-Val; 3-methyl-β-Val-β-Pro; D-Pro-D-Ala; D-Ala-D-Pro; β-Pro-β-Ala; β-Ala-β-Pro; D-Pro-D-Leu; D-Leu-D-Pro; β-Pro-β-Leu; β-Leu-β-Pro; D-Val-D-Ala; D-Ala-D-Val; β-Val-β-Ala; β-Ala-β-Val; 3-methyl-β-Val-β-Ala; D-Val-D-Leu; D-Leu-D-Val; β-Val-β-Leu; β-Leu-β-Val; 3-methyl-β-Val-β-Leu; D-Phe-D-Val; or D-Val-D-Phe. In another aspect, the C-terminus is amidated. In another aspect, the non-naturally occuring anti-microbial peptide is cyclized. In another aspect, the non-naturally occuring anti-microbial peptide is cyclized through a lactam linkage. In another aspect, the non-naturally occuring anti-microbial peptide is cyclized between a positive and negative residue.

Another embodiment described herein is a non-naturally occuring anti-microbial peptide, wherein an anti-biofilm peptide is covalently linked to the anti-microbial peptide. In one aspect, the anti-biofilm peptide is covalently linked to the N-terminus of the anti-microbial peptide. In another aspect, the anti-biofilm peptide is covalently linked to the C-terminus of the anti-microbial peptide. In another aspect, the anti-biofilm peptide is covalently linked to the anti-microbial peptide through at least one linker. In another aspect, the anti-biofilm peptide comprises between 1 and 12 natural, synthetic, or chemically modified residues.

In another embodiment described herein, the anti-biofilm peptide comprises the sequence according to Formula IV: B¹-B²-B³-B⁴-B⁵-B⁶-B⁷-B⁸-B⁹-B¹⁰-B¹¹-B¹², wherein: each residue corresponding to positions B¹, B³, B⁴, B⁵, B⁶, B⁷, or B⁹ comprises any hydrophobic non-aromatic natural, synthetic, or chemically modified amino acid; each residue corresponding to positions B², B⁸, B¹¹, or B¹² comprises any natural, synthetic, or chemically modified positive amino acid; and each residue corresponding to position B¹⁰ comprises any natural, synthetic, or chemically modified aromatic amino acid. In one aspect, the anti-biofilm peptide comprises the sequence B¹-B²-B³-B⁴-B⁵-B⁶-B⁷-B⁸. In another aspect, the anti-biofilm peptide comprises the sequence B⁷-B⁸-B⁹-B¹⁰-B¹¹-B¹². In another aspect, the anti-biofilm peptide comprises the sequence B¹-B²-B³-B⁴-B⁵-B⁶. In another aspect, the anti-biofilm peptide comprises the sequence B¹-B²-B³-B⁴-B⁵-B⁶-B⁷. In another aspect, the anti-biofilm peptide comprises the sequence according to Formula IV: B¹-B²-B³-B⁴-B⁵-B⁶-B⁷-B⁸-B⁹-B¹⁰-B¹¹, wherein: each residue corresponding to positions B¹, B², B⁴, B⁵, B⁸, B⁹, or B¹¹ comprises any natural, synthetic, or chemically modified positive amino acid; each residue corresponding to positions B³, B⁶, or B⁷ comprises any natural, synthetic, or chemically modified aromatic amino acid; and each residue corresponding to position B¹⁰ comprises any hydrophobic non-aromatic natural, synthetic, or chemically modified amino acid. In another aspect, the anti-biofilm peptide comprises the sequence B¹-B²-B³-B⁴-B⁵-B⁶-B⁷. In another aspect, the anti-biofilm peptide comprises the sequence B⁶-B⁷-B⁸-B⁹-B¹⁰-B¹¹. In another aspect, the anti-biofilm peptide comprises the sequence B¹-B²-B³-B⁴-B⁵-B⁶-B⁷-B⁸-B⁹. In another aspect, the anti-biofilm peptide comprises the sequence B⁴-B⁵-B⁶-B⁷-B⁸-B⁹-B¹⁰. In another aspect, the anti-biofilm peptide is covalently linked to the N-terminus or C-terminus of the anti-microbial peptide. In another aspect, the anti-microbial peptide is stabilized by the addition of between 1 and 3 natural or artificial stabilizing residues to the anti-biofilm peptide. In another aspect, the stabilizing residues comprise: D-threonine, L-threonine, D-proline, L-proline, β-homo proline, D-alanine, L-alanine, β-alanine, D-valine, L-valine, β-valine, 3-methyl-β-valine, D-leucine, L-leucine, β-leucine, D-norleucine, L-norleucine, D-isoleucine, L-isoleucine, β-isoleucine, or a piperazin-2-one ring. In another aspect, the anti-biofilm peptide is methylated.

Another embodiment described herein is a non-naturally occurring anti-microbial peptide comprising the sequence according to Formula I: X¹ R¹ R² [R³ R⁴ R⁵ R⁶ R⁷ R⁸ R⁹ R¹⁰ R¹¹ R¹² R¹³ R¹⁴ R¹⁵ R¹⁶ R¹⁷]Y¹ Y², wherein: wherein: X¹ is norleucine and Y¹ Y² is D-Pro-D-Val, D-Val-D-Pro, D-Phe-D-Val or D-Val-D-Phe, wherein R¹ to R¹⁷ represent residues of the anti-microbial peptide and R¹ to R¹⁷ is further represented by formula II: P₀₋₂−|−[N−|−(U)₀₋₁−|−(P|A)₁₋₃−|−(U)₀₋₁−|−(P|A)₀₋₃−|−(U)₀₋₁−|−(P|A)₀₋₃−|−(U)₀₋₁−|−(P|A)₀₋₃−P], wherein: “N” is aspartic acid; “U” glutamine or leucine; “P” is proline, histidine, lysine, or arginine; “A” is noralanine, 2′-naphthylalanine, tryptophan, tyrosine, or phenylalanine; and wherein an anti-biofilm peptide is optionally covalently attached to the N-terminus of the antimicrobial peptide of formula I and formula II. In one aspect, the length of the peptide is from about 3 residues to about 17 residues. In another aspect, X¹ and Y¹ Y² increase the stability of the non-naturally occuring anti-microbial peptide. In another aspect, the N-terminus is acylated. In another aspect, the C-terminus is amidated. In another aspect, Y¹ Y² increases the specificity of the anti-microbial peptide to target gram-negative bacteria. In another aspect, Y¹ Y² increases the specificity of the anti-microbial peptide to target gram-positive bacteria. In another aspect, the non-naturally occuring anti-microbial peptide is cyclized through a lactam linkage between a positive and negative residue. In another aspect, an anti-biofilm peptide comprising between 1 and 12 natural, synthetic, or chemically modified residues is covalently linked to the anti-microbial peptide.

In another embodiment described herein, an anti-biofilm peptide comprises the sequence according to Formula IV: B¹-B²-B³-B⁴-B⁵-B⁶-B⁷-B⁸-B⁹-B¹⁰-B¹¹-B¹², wherein: each residue corresponding to positions B¹, B³, B⁴, B⁵, B⁶, B⁷, or B⁹ is alanine, valine, or isoleucine; each residue corresponding to positions B², B⁸, B¹¹, or B¹² is arginine, histidine, or lysine; and each residue corresponding to position B¹⁰ is noralanine, 2′-naphthylalanine, tryptophan, tyrosine, or phenylalanine. In one aspect, the anti-biofilm peptide comprises the sequence B¹-B²-B³-B⁴-B⁵-B⁶-B⁷-B⁸. In another aspect, the anti-biofilm peptide comprises the sequence B⁷-B⁸-B⁹-B¹⁰-B¹¹-B¹². In another aspect, the anti-biofilm peptide comprises the sequence B₁-B²-B³-B⁴-B⁵-B⁶. In another aspect, the anti-biofilm peptide comprises the sequence B₁-B²-B³-B⁴-B⁵-B⁶-B⁷. In another aspect, the anti-biofilm peptide comprises the sequence according to Formula IV: B¹-B²-B³-B⁴-B⁵-B⁶-B⁷-B⁸-B⁹-B¹⁰-B¹¹, wherein: each residue corresponding to positions B¹, B², B⁴, B⁵, B⁸, B⁹, or B¹¹ is arginine, histidine, or lysine; each residue corresponding to positions B³, B⁶, or B⁷ is noralanine, 2′-naphthylalanine, tryptophan, tyrosine, or phenylalanine; and each residue corresponding to position B¹⁰ is alanine, valine, or isoleucine. In another aspect, the anti-biofilm peptide comprises the sequence B¹-B²-B³-B⁴-B⁵-B⁶-B⁷. In another aspect, the anti-biofilm peptide comprises the sequence B⁶-B⁷-B⁸-B⁹-B¹⁰-B¹¹. In another aspect, the anti-biofilm peptide comprises the sequence B¹-B²-B³-B⁴-B⁵-B⁶-B⁷-B⁸-B⁹. In another aspect, the anti-biofilm peptide comprises the sequence B⁴-B⁵-B⁶-B⁷-B⁸-B⁹-B¹⁰. In another aspect, the anti-biofilm peptide is methylated.

Another embodiment described herein is a non-naturally occuring anti-microbial peptide comprising any one of SEQ NOs: 1-4296. In one aspect, the length of the peptide is from about 3 residues to about 17 residues. In another aspect, the peptide is stabilized.

The non-naturally occuring anti-microbial peptide of claim 98, wherein the N-terminus of the non-naturally occuring anti-microbial peptide is stabilized. In another aspect, the stabilization comprises the addition of between 1 and 3 natural or artificial stabilizing residues. In another aspect, the N-terminal stabilizing residues comprise: D-threonine, L-threonine, D-proline, L-proline, β-homo proline, D-alanine, L-alanine, β-alanine, D-valine, L-valine, β-valine, 3-methyl-β-valine, D-leucine, L-leucine, β-leucine, D-norleucine, L-norleucine, D-isoleucine, L-isoleucine, β-isoleucine, or a piperazin-2-one ring. In another aspect, the N-terminus is acylated. In another aspect, the C-terminus of the non-naturally occuring anti-microbial peptide is stabilized. In another aspect, the stabilization comprises the addition of between 1 and 3 natural or artificial stabilizing residues. In another aspect, the C-terminal stabilizing residues comprise: D-threonine, L-threonine, D-proline, L-proline, β-homo proline, D-alanine, L-alanine, D-valine, L-valine, β-valine, 3-methyl-β-valine, D-leucine, L-leucine, β-leucine, D-norleucine, L-norleucine, D-isoleucine, L-isoleucine, β-isoleucine, D-phenylalanine, L-phenylalanine, or a piperazin-2-one ring. In another aspect, the C-terminus is amidated. In another aspect, the C-terminal stabilization also increases the specificity of the anti-microbial peptide to target gram-negative bacteria. In another aspect, the C-terminal stabilization increases the specificity of the anti-microbial peptide to target gram-positive bacteria. In another aspect, the C-terminal stabilizing residues comprise: D-Pro-D-Val; D-Val-D-Pro; β-Val-β-Pro; β-Pro-β-Val; 3-methyl-β-Val-β-Pro; D-Pro-D-Ala; D-Ala-D-Pro; β-Pro-β-Ala; β-Ala-β-Pro; D-Pro-D-Leu; D-Leu-D-Pro; β-Pro-β-Leu; β-Leu-β-Pro; D-Val-D-Ala; D-Ala-D-Val; β-Val-β-Ala; β-Ala-β-Val; 3-methyl-β-Val-β-Ala; D-Val-D-Leu; D-Leu-D-Val; β-Val-β-Leu; β-Leu-β-Val; 3-methyl-β-Val-β-Leu; D-Phe-D-Val; or D-Val-D-Phe. In another aspect, the C-terminus is amidated. In another aspect, the non-naturally occuring anti-microbial peptide is cyclized. In another aspect, the non-naturally occuring anti-microbial peptide is cyclized through a lactam linkage. In another aspect, the non-naturally occuring anti-microbial peptide is cyclized between a positive and negative residue. In another aspect, an anti-biofilm peptide is covalently linked to the anti-microbial peptide. In another aspect, the anti-biofilm peptide is covalently linked to the N-terminus of the anti-microbial peptide. In another aspect, the anti-biofilm peptide is covalently linked to the C-terminus of the anti-microbial peptide. In another aspect, the anti-biofilm peptide is covalently linked to the anti-microbial peptide through at least one linker. In another aspect, the anti-biofilm peptide comprises between 1 and 12 natural, synthetic, or chemically modified residues.

In one embodiment described herein, the anti-biofilm peptide comprises the sequence according to Formula IV: B¹-B²-B³-B⁴-B⁵-B⁶-B⁷-B⁸-B⁹-B¹⁰-B¹¹-B¹², wherein: each residue corresponding to positions B¹, B³, B⁴, B⁵, B⁶, B⁷, or B⁹ comprises any hydrophobic non-aromatic natural, synthetic, or chemically modified amino acid; each residue corresponding to positions B², B⁸, B¹¹, or B¹² comprises any natural, synthetic, or chemically modified positive amino acid; and each residue corresponding to position B¹⁰ comprises any natural, synthetic, or chemically modified aromatic amino acid. In one aspect, the anti-biofilm peptide comprises the sequence B¹-B²-B³-B⁴-B⁵-B⁶-B⁷-B⁸. In another aspect, the anti-biofilm peptide comprises the sequence B⁷-B⁸-B⁹-B¹⁰-B¹¹-B¹². In another aspect, the anti-biofilm peptide comprises the sequence B¹-B²-B³-B⁴-B⁵-B⁶. In another aspect, the anti-biofilm peptide comprises the sequence B¹-B²-B³-B⁴-B⁵-B⁶-B⁷.

In another embodiment described herein, the anti-biofilm peptide comprises the sequence according to Formula IV: B¹-B²-B³-B⁴-B⁵-B⁶-B⁷-B⁸-B⁹-B¹⁰-B¹¹, wherein: each residue corresponding to positions B¹, B², B⁴, B⁵, B⁸, B⁹, or B¹¹ comprises any natural, synthetic, or chemically modified positive amino acid; each residue corresponding to positions B³, B⁶, or B⁷ comprises any natural, synthetic, or chemically modified aromatic amino acid; and each residue corresponding to position B¹⁰ comprises any hydrophobic non-aromatic natural, synthetic, or chemically modified amino acid. In another aspect, the anti-biofilm peptide comprises residues B¹ B² B³ B⁴ B⁵ B⁶ B⁷. In another aspect, the anti-biofilm peptide comprises residues B⁶ B⁷ B⁸ B⁹ B¹⁰ B¹¹. In another aspect, the anti-biofilm peptide comprises residues B¹ B² B³ B⁴ B⁵ B⁶ B⁷ B⁸ B⁹. In another aspect, the anti-biofilm peptide comprises residues B⁴ B⁵ B⁶ B⁷ B⁸ B⁹ B¹⁰. In another aspect, the anti-biofilm peptide is covalently linked to the N-terminus or C-terminus of the anti-microbial peptide. In another aspect, the anti-microbial peptide is stabilized by the addition of between 1 and 3 natural or artificial stabilizing residues to the anti-biofilm peptide. In another aspect, the stabilizing residues comprise: D-threonine, L-threonine, D-proline, L-proline, β-homo proline, D-alanine, L-alanine, β-alanine, D-valine, L-valine, β-valine, 3-methyl-β-valine, D-leucine, L-leucine, β-leucine, D-norleucine, L-norleucine, D-isoleucine, L-isoleucine, β-isoleucine, or a piperazin-2-one ring. In another aspect, the anti-biofilm peptide is methylated.

Another embodiment described herein is a method for changing the physiology of a microbe using any of the non-naturally occuring anti-microbial peptide described herein. In another aspect, the changing the physiology of a microbe comprises reducing the growth rate, inhibiting DNA synthesis, inhibiting protein synthesis, inhibiting structural stability, reducing cell-membrane integrity, inhibiting cell wall synthesis, reducing viability, or causing death. In another aspect, the microbe comprises a pathogenic organism. In another aspect, the pathogenic organism comprises a fungi, bacteria, virus, unicellular organism, bacterial colony, or biofilm. In another aspect, the anti-microbial peptides are used in a laboratory setting. In another aspect, the anti-microbial peptide is used as a scientific tool. In another aspect, the anti-microbial peptides are used in a hospital setting. In another aspect, the anti-microbial peptides are used as an animal feed additive.

Another embodiment described herein is a method for treating, ameliorating the symptoms of, or delaying the onset of a medical condition by administering to a subject in need thereof any of the anti-microbial peptides described herein. In one aspect, the medical condition comprises a microbial infection. In another aspect, the anti-microbial peptide reduces the growth rate, reduces the viability, or causes death of a microbe, thereby treating, ameliorating the symptoms of, or delaying the onset of a microbial infection. In another aspect, the anti-microbial peptide is administered to a subject comprising: intravenous (IV), subcutaneous (SC), intramuscular (IM), intraperitoneal (IP), intracerebroventricular (ICV), oral, topical, or nasal or a combination thereof the routes of administration.

BRIEF DESCRIPTION OF THE DRAWINGS

FIG. 1. Representative schematic of anti-microbial peptides described herein.

FIG. 2. NMR Imaging of anti-microbial peptide TCAM207 (SEQ NO: 209) (also referenced as TCMCB07).

FIG. 3. In vivo safety profiling of anti-microbial peptide TCAM207 (SEQ NO: 209) in a large animal canine model.

FIG. 4. Blood plasma concentration of orally administered anti-microbial peptide TCAM207 (SEQ NO: 209) in canines.

FIG. 5. Graphic representation of AMP reduction of M. Smegmatis adhesion in a 2-day old biofilm.

DETAILED DESCRIPTION

Short therapeutic peptides often need to be stabilized against enzymatic degradation, necessitating protective groups, modifications, or additional residues. These therapeutic peptides must also be able to exhibit trans-epithelial transport, in order to have oral activity (gastrointestinal transport) and in some applications blood-brain barrier transport. According to the “Rule of Five,” a molecular mass greater than 500 g/mol is one of the “violations” that prevent drug paracellular transport. Lipinski et al., Adv. Drug Deliv. Rev. 46(1-3): 3-26 (2001). Thus according to Lipinski's Rule, most, if not all, peptide or peptide mimetic pharmacophores would be unable to exhibit paracellular movement through the gastrointestinal tract or blood-brain-barrier. A potential way to surmount this problem is to use an active transport mechanism for trans-epithelial movement of a peptide drug. Active transport carriers for di- and tri-peptides have been described, and these transported peptides could serve as carriers for small cyclic peptides or non-peptide drugs. Brandsch, Amino Acids 31(2): 119-136 (2006); Brandsch et al., J. Pharm. Pharmacol. 60(5): 543-58 (2008). Alternatively, organic anionic transport polypeptides have been implicated in transporting cyclic cationic peptides. International Transporter Consortium, Nat. Rev. Drug Discov. 9(3): 215-236 (2010).

In one aspect described herein, non-naturally occurring short peptides are provided that comprise an anti-microbial peptide coupled to a degradation resistant N- and/or C-terminal di or tri-peptide extension and in some aspects further coupled to an anti-biofilm peptide. One or both of the extensions contain a pharmacophore that enables active transport by di- or tri-peptide transport systems, conferring oral activity and/or blood-brain-barrier transport.

One aspect described herein, is a non-naturally occurring anti-microbial peptide that comprises an anti-microbial peptide coupled to a degradation resistant N- and/or C-terminal di or tri-peptide extension. The stabilizing effects of the extension(s) are designed to maximize the activity of the pharmacophores with therapeutically desirable activity.

Another aspect described herein is a non-naturally occurring anti-microbial peptide that comprises an anti-microbial peptide coupled to a degradation resistant N- and/or C-terminal di- or tri-peptide extension. The structure of the anti-microbial peptide and the peptide extension are designed to prevent a specific type of trans-epithelial transport. This analog would have utility when an orally active (i.e., having gastrointestinal transport) or when active only at peripheral sites of action (e.g., not within the central nervous system).

Another aspect described herein is a composition comprising a non-naturally occurring anti-microbial peptide coupled to a degradation-resistant N- and/or C-terminal extension to suppress exposure and effects of overlapping pharmacophores, and potentiate therapeutic activity. The degradation-resistant extension is at least one amino acid, at least one modified amino acid, a peptide mimetic (non-amino acid small molecule), or combinations thereof. A degradation-resistant N- and/or C-terminal extension is one selected to resist degradation under physiological conditions, thereby allowing the anti-microbial peptide to enhance at least one anti-microbial effect while exhibiting minimized or abolished side effects and potentiated therapeutic activity when acutely or chronically administered to a human or mammal.

Described herein are peptides comprising non-naturally occurring anti-microbial peptide comprising degradation-resistant N-terminal and/or C-terminal extensions.

A naturally occuring “anti-microbial peptide” is a small naturally occuring peptide that has a naturally occuring genomically-encoded peptide sequence that is ribosomally synthesized, which forms a secondary structure and acts on or targets microbes. Often, this targeting reduces microbial growth rate; inhibits DNA, RNA, or protein synthesis; reduces structural or membrane stability, inhibits cell wall synthesis, reduces viability, or causes microbial death.

A “non-naturally occuring anti-microbial peptide” is a non-naturally occuring man-made peptide, peptide mimetic, or pharmacophore that is not derived from any natural genomic sequences or any other natural source, which forms a secondar structure and acts on or targets microbes. In some aspects, non-naturally occuring anti-microbial peptides can be synthesized using peptide synthesis technology known in the art; or it can be artifically expressed as a recombinant protein encoded by an expression vector and purified from a host through methods known in the art.

A peptide or amino acid “mimetic” is a non-amino acid molecule that mimics a peptide (a chain of amino acids) or one amino acid residue.

A “pharmacophore” is the minimum set of amino acid residues necessary to achieve a physiological effect. An anti-microbial physiological effect comprises any change to the normal functions of any microbe.

A “microbe” is a microscopic organism that can be a single cell or a multicellular organism. As used herein, a microbe comprises all classes of bacteria, archaea, protozoa, and fungi.

“Side effects” refer to any unwanted biological activity that occurs in conjunction with a therapeutic anti-microbial effect.

“Substantial degradation” refers to the degradation of the N-terminal extension, the C-terminal extension, both N- and C-terminal degradation or degradation to other regions of the anti-microbial peptide by physiological enzymes and other factors, in such a manner or to a degree that side effects appear. According to one aspect, an anti-microbial peptide having a C-terminal extension that resists substantial degradation is one where no more than 50% of the administered peptide causes side effects and/or displays a low half-life. In some aspects, no more than 25% of the administered peptide causes side effects and/or displays a low half-life. More preferably, in some aspects, less than 10% of the administered peptide causes side effects and/or displays a low half-life, as compared to an anti-microbial peptide that lacks a C-terminal extension.

A “pharmaceutical composition” includes anti-microbial peptides described herein, or a pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable carrier. The carrier may be a liquid formulation, for example, a buffered, isotonic, aqueous solution. Pharmaceutically acceptable carriers also can include excipients, such as diluents, carriers and the like, and additives, such as stabilizing agents, preservatives, solubilizing agents, buffers and the like.

The terms “bind,” “binding,” “complex,” and “complexing,” refer to all types of physical and chemical binding, reactions, complexing, attraction, chelating and the like.

The symbol between residues in the peptide formulas described herein represented by a “-”symbol (hypen) corresponds to contiguously linked amino acid residues. In some aspects, this linkage is through an amide bond between the contigous residues.

The “peptides” described herein can be (a) naturally-occurring, (b) produced by chemical synthesis, (c) produced by recombinant DNA technology, (d) produced by biochemical or enzymatic fragmentation of larger molecules, (e) produced by methods resulting from a combination of methods (a) through (d) listed above, or (f) produced by any other means for producing peptides.

By employing chemical synthesis, a useful means of production, it is possible to introduce various amino acids which do not naturally occur along the chain, modify the N- or C-terminus, and the like, thereby providing for improved stability and formulation, resistance to protease degradation, and the like.

The term “peptide” as used herein includes any structure comprised of two or more amino acids, including chemical modifications and derivatives of amino acids. The amino acids forming all or a part of a peptide may be naturally occurring amino acids, stereoisomers and modifications of such amino acids, non-protein amino acids, post-translationally modified amino acids, enzymatically modified amino acids, constructs or structures designed to mimic amino acids, and the like, so that the term “peptide” includes pseudopeptides and peptidomimetics, including structures which have a non-peptidic backbone. The term “peptide” also includes dimers or multimers of peptides. A “manufactured” peptide includes a peptide produced by chemical synthesis, recombinant DNA technology, biochemical, or enzymatic fragmentation of larger molecules, combinations of the foregoing or, in general, made by any other method. The term “peptide” includes peptides containing a variable number of amino acid residues, optionally with non-amino acid residue groups at the N- and C-termini, such groups including acyl, acetyl, alkenyl, alkyl, N-alkyl, amine, or amide groups, among others.

“Amino acids” are molecules containing an amine group, a carboxylic acid group, and a side-chain that is specific to each amino acid. The key elements of an amino acid are carbon, hydrogen, oxygen, and nitrogen and have the generic formula H₂N—CHR—COOH, wherein R represents a side chain group. The various a-amino acids differ in the side-chain moiety that is attached to the a-carbon.

The phrase “amino acid side chain moiety” used herein, including as used in the specification and claims, includes any side chain of any amino acid, as the term “amino acid” is defined herein. This thus includes the side chain moiety present in naturally occurring amino acids. It further includes side chain moieties in modified naturally occurring amino acids, such as glycosylated amino acids. It further includes side chain moieties in stereoisomers and modifications of naturally occurring protein amino acids, non-protein amino acids, post-translationally modified amino acids, enzymatically synthesized amino acids, derivatized amino acids, constructs, or structures designed to mimic amino acids, and the like. For example, the side chain moiety of any amino acid disclosed herein is included within the definition. A “derivative” of an amino acid side chain moiety is included within the definition of an amino acid side chain moiety.

The “derivative” of an amino acid side chain moiety includes any modification to or variation in any amino acid side chain moieties, including a modification of naturally occurring amino acid side chain moieties. By way of example, derivatives of amino acid side chain moieties include straight chain or branched, cyclic or noncyclic, substituted or unsubstituted, saturated or unsaturated, alkyl, aryl or aralkyl moieties.

The “amino acids” used herein, and the term as used in the specification and claims, include the known naturally occurring protein amino acids, which are referred to by both their common three letter abbreviation and single letter abbreviation. See generally Synthetic Peptides: A User's Guide, G. A. Grant, editor, W.H. Freeman & Co., New York (1992), the teachings of which are incorporated herein by reference, including the text and table set forth at pages 11-24. As set forth above, the term “amino acid” also includes stereoisomers and modifications of naturally occurring protein amino acids, non-protein amino acids, post-translationally modified amino acids, enzymatically synthesized amino acids, derivatized amino acids, constructs or structures designed to mimic amino acids, and the like. Modified and unusual amino acids are described generally in Synthetic Peptides: A User's Guide, supra; Hruby et al., Biochem. J. 268(2): 49-262 (1990); and Toniolo, Int. J. Peptide Protein Res. 35: 287-300 (1990); the teachings of all of which are incorporated herein by reference.

In the peptides described herein, conventional amino acid residues have their conventional meaning as given in Chapter 2400, of the USPTO Manual of Patent Examining Procedure, (MPEP) 9^(th) Ed. Thus, “Ala” is alanine; “Arg” is arginine; “Asn” is asparagine; “Asp” is aspartic acid; “Cys” is cysteine; “Gln” is glutamine; “Glu” is glutamic acid; “His” is histidine; “Ile” is isoleucine; “Leu” is leucine; “Lys” is lysine; “Met” is methionine; “Phe” is phenylalanine; “Pro” is proline; “Ser” is serine; Thr is threonine; “Trp” is tryptophan; “Tyr” is tryosine; and “Val” is valine. Unless otherwise indicated, all amino acids abbreviations represent either isomer, i.e., the L-isomer or the D-isomer. Thus, for example, “L-Phe” is L-phenylalanine; “D-Phe” is D-phenylalanine; “D-/L-Phe” is either D-phenylalanine or L-phenylalanine; “Phe” is also either D-phenylalanine or L-phenylalanine, and so on. Non-standard amino acids are “Nle” is norleucine; “NaI” is noralanine; “D-NaI” is D-noralanine; D-NaI(2′) is D-2′-naphthylalanine; and so on.

An alpha (α)-amino acid has the generic formula H₂N—C_(α)HR—COOH, where R is a side chain moiety and the amino group is attached to the carbon atom immediately adjacent to the carboxylate group (i.e., the α-carbon). Other types of amino acid exist when the amino group is attached to a different carbon atom. For example, beta (β)-amino acids, the carbon atom to which the amino group is attached is separated from the carboxylate group by one carbon atom, C_(β). For example, α-alanine has the formula H₂N—C_(α)H(CH₃)—COOH. In contrast, β-alanine has the general formula H₂N—C_(β)H₂—C_(α)H₂—COON (i.e., 3-aminopropanoic acid).

When β-amino acids are incorporated into peptides, two main types of β-peptides exist: those with the side chain residue, R, on the carbon next to the amine are called β³ peptides and those with the side chain residue on the carbon next to the carbonyl group are called β² amino acids. As a non-limiting example, “β-valine” can refer to:

-   -   —NH—C_(β)H₂—C_(α)H(CH₃)₂—CO—, i.e., β²-valine (R on carboxy         side);     -   —NH—C_(β)H(CH₃)₂—C_(α)H₂—CO—, i.e., β³-valine (R on amino side);         or     -   —NH—C_(β)H(CH₃)₂—C_(α)H(CH₃)₂—CO—, i.e., β^(2,3)-valine (R at         both positions).

Gamma (γ)-amino acids are amino acids with the carbon atom to which the amino group attaches is separated from the carboxylate moiety by two carbon atoms. For example, γ-amino butyric acid has the formula, H₂N—C_(γ)H₂—C_(β)H₂—C_(α)H₂—COOH.

For additional modified and unusual amino acids, see MPEP §2422, particularly Table 4 at 2400-24. Additionally, “Ac” indicates N-acetyl and “cyclo” refers to a cyclic structure, which is also shown in the literature as “c” or referred to as a “lactam.” “NH₂” indicates an amine group, typically added on the C-terminus of a polypeptide. Accordingly, as used herein, an —NH₂ moiety on the C-terminus of a peptide indicates an amide, i.e., —CO—NH₂. In addition, the following abbreviations are used herein: Harg is Homo arginine; Hlys is Homo lysine; NaI(2′) is D-(2′-naphthyl)alanine.

Additional abbreviations are used as follows: tBu is tert-butyl; Hyp(Bzl) is benzyl-L-hydroxy-proline; Mamb is 3-aminomethyl-benzoic acid; glutaric acid linker is CO—(CH₂)₃—CO; Pen is L-Penicillamine; Aib is 2-Aminoisobutyric acid; Tic is 1,2,3,4-Tetrahydroisoquinoline-3-carboxylic Acid; Aba is 4-amino-1,2,4,5-tetra-hydro-2-benzazepin-3-one; Pip is piperidine-2-carboxylic acid; Nip is piperidine-3-carboxylic acid; Tic is tetrahydroquinoline-3-carboxylic acid; Bipisbiphenylalanine; Phg is α-Phenyl-glycine; Sar is Sarcosine; Azt is 3′-azido-3′-deoxythymidine; Oic is Octohydroindole-2-carboxylic acid.

The term “alkene” includes unsaturated hydrocarbons that contain one or more double carbon-carbon bonds. Examples of such alkene groups include ethylene, propene, and the like.

The term “alkenyl” includes a linear monovalent hydrocarbon radical of two to six carbon atoms or a branched monovalent hydrocarbon radical of three to six carbon atoms containing at least one double bond; examples thereof include ethenyl, 2-propenyl, and the like.

The “alkyl” groups specified herein include those alkyl radicals of the designated length in either a straight or branched configuration. Examples of such alkyl radicals include methyl, ethyl, propyl, isopropyl, butyl, sec-butyl, tertiary butyl, pentyl, isopentyl, hexyl, isohexyl, and the like.

The term “alkynal” includes a linear monovalent hydrocarbon radical of two to six carbon atoms or a branched monovalent hydrocarbon radical of three to six carbon atoms containing at least one triple bond; examples thereof include ethynyl, propynal, butynyl, and the like.

The term “aryl” includes a monovalent or bicyclic aromatic hydrocarbon radical of 6-to-12 ring atoms, and optionally substituted independently with one or more substituents selected from alkyl, haloalkyl, cycloalkyl, alkoxy, alkythio, halo, nitro, acyl, cyano, amino, monosubstituted amino, disubstituted amino, hydroxy, carboxy, or alkoxy-carbonyl. Examples of an aryl group include phenyl, biphenyl, naphthyl, 1-naphthyl, and 2-naphthyl, derivatives thereof, and the like.

The term “aliphatic” includes compounds with hydrocarbon chains, such as for example alkanes, alkenes, alkynes, and derivatives thereof.

The term “acyl” includes a group RCO—, where R is an organic group. An example is the acetyl group CH₃CO—, referred to herein as “Ac.”

A peptide or aliphatic moiety is “acylated” when an alkyl or substituted alkyl group as defined above is bonded through one or more carbonyl {—(C═O)—} groups. A peptide is most usually acylated at the N-terminus.

An “omega amino derivative” includes an aliphatic moiety with a terminal amino group. Examples of omega amino derivatives include aminoheptanoyl and the amino acid side chain moieties of ornithine and lysine.

The term “heteroaryl” includes mono- and bicyclic aromatic rings containing from 1 to 4 heteroatoms selected from nitrogen, oxygen, and sulfur. Five- or six-membered heteroaryl are monocyclic heteroaromatic rings; examples thereof include thiazole, oxazole, thiophene, furan, pyrrole, imidazole, isoxazole, pyrazole, triazole, thiadiazole, tetrazole, oxadiazole, pyridine, pyridazine, pyrimidine, pyrazine, and the like. Bicyclic heteroaromatic rings include, but are not limited to, benzothiadiazole, indole, benzothiophene, benzofuran, benzimidazole, benzisoxazole, benzothiazole, quinoline, benzotriazole, benzoxazole, isoquinoline, purine, furopyridine, and thienopyridine.

An “amine” includes compounds that contain an amine group (—NH₂).

An “amide” includes compounds that have a trivalent nitrogen attached to a carbonyl group (i.e., —CO—NH₂), such as for example methylamide, ethylamide, propylamide, and the like. A peptide is most usually amidated at the C-terminus by the addition of an amine (—NH₂) moiety to the C-terminal carboxyl group.

An “imine” includes compounds that have a carbon-nitrogen double bond, with the nitrogen also attached to a hydrogen (NH═CH—R).

An “imide” includes compounds containing an imido group (—OC—NH—CO—).

A “nitrile” includes compounds that are carboxylic acid derivatives and contain a (—CN) group bound to an organic group.

The term “halogen” is intended to include the halogen atoms fluorine, chlorine, bromine and iodine, and groups including one or more halogen atoms, such as —CF₃ and the like.

The term “composition,” as in pharmaceutical composition, is intended to encompass a product comprising the active ingredient(s), and the inert ingredient(s) that make up the carrier, as well as any product which results, directly or indirectly, from combination, complexation or aggregation of any two or more of the ingredients, or from dissociation of one or more of the ingredients, or from other types of reactions or interactions of one or more of the ingredients. Accordingly, the pharmaceutical compositions encompass any composition made by admixing a peptide and a pharmaceutically acceptable carrier.

Amino acids, including stereoisomers and modifications of naturally occurring amino acids, protein amino acids, non-protein amino acids, post-translationally modified amino acids, enzymatically synthesized amino acids, derivatized amino acids, constructs, or structures designed to mimic amino acids (peptide mimetics), and the like, including all of the foregoing, are sometimes referred to herein as “residues.”

“Cachexia” refers to a state of general ill health and malnutrition. It is often associated with and induced by malignant cancer, cystic fibrosis, or AIDS, and is characterized by loss of appetite, loss of body mass, especially lean body mass, and muscle wasting.

“Anorexia” refers simply to a loss of appetite, whether brought on by medical, physiological, or psychological factors. Anorexia is often closely associated with, and generally contributes to, cachexia seen in patients with advanced cancers and other conditions.

Anti-Microbial Peptides

Non-naturally occuring peptide having a melanocortin pharmacophore (SEQ NOs: 205-212) were suprisingly found to have anti-microbial activity. Thus, described further herein are non-naturally occuring peptides having anti-microbial activity represented by the formulas, and amino acid sequences described herein.

A non-naturally occurring anti-microbial peptide sequence is represented by Formula I, as shown, and comprises an anti-microbial peptide coupled to a degradation-resistant C-terminal extension and an optional N-terminal extension:

X¹-X²-X³-R¹-R²-[R³-R⁴-R⁵-R⁶-R⁷-R⁸-R⁹-R¹⁰-R¹¹-R¹²-R¹³-R¹⁴-R¹⁵-R¹⁶-R¹⁷]Y¹-Y²-Y³   (Formula I),

wherein X¹, X², and X³ represent optional stabilizing N-terminal residues or an amino acid residue mimetic; R¹ to R¹⁷ represent residues of the anti-microbial peptide; and Y¹, Y², and Y³ represent degradation-resistant C-terminal residues or an amino acid residue mimetic; brackets indicate residues that are cyclized in some aspects.

In one aspect, the anti-microbial peptide is represented by Formula I above, and residues R¹ to R¹⁷ represent the anti-microbial peptide comprising synthetic amino acid residues, chemically modified amino acid residues, or amino acid residues in natural form as either an L or D isomer. In one aspect, the anti-microbial peptide is represented by Formula I above, and residues R¹ to R¹⁷ represent the anti-microbial peptide comprising but not limited to (o-Phe)Phe R5, 3-diamino-propionic acid, Aba, acetylated cysteine, acetylated norleucine, alanine, arginine, aspartic acid, Azt, Bip, CO-cis-CH═CH—CO, cysteine, D-NaI(2′), D-phenylalanine, D-proline, D-tryptophan, glutamic acid, glutaric acid, glycine, histidine, histidine methylated at positions 1 or 3, homoarginine, Hyp(Bzl), I-NaI(2′), 1-phenylalanine, 1-proline, 1-tryptophan, lysine, Mamb, methylated D-phenylalanine, n-hexanoyl group, Nip, norleucine, n-pentanoyl group, Oic, o-pthalic acid, ornithine, pCl-D-Phe, Phg, Pip, proline, Sar, succinic acid, tButGly, Tic, tyrosine, and β-alanine.

Collectively, residues R¹ to R¹⁷ (i.e., R¹ R² R³ R⁴ R⁵ R⁶ R⁷ R⁸ R⁹ R¹⁰ R¹¹ R¹² R¹³ R¹⁴ R¹⁵ R¹⁶ R¹²) can be one of many known anti-microbial peptides, wherein each of the residues is independently an amino acid or peptide mimetic. In some aspects, the anti-microbial peptides have between 3 and 15 residues (e.g., R¹ to R³ and R¹ to R¹⁵). In some aspects, the anti-microbial peptides have 3, or 4, or 5, or 6, or 7, or 8, or 9, or 10, or 11, or 12, or 13, or 14, or 15 residues (e.g., R¹ to R³, R¹ to R⁴, R¹ to R⁵, R¹ to R⁶, R¹ to R⁷, R¹ to R⁸, R¹ to R⁹, R¹ to R¹⁰, R¹ to R¹¹, R¹ to R¹², R¹ to R¹³, R¹ to R¹⁴, or R¹ to R¹⁵). The individual anti-microbial peptide residues R¹ to R¹⁷ (e.g., R¹ to R³, R¹ to R⁴, R¹ to R⁵, R¹ to R⁶, R¹ to R⁷, R¹ to R⁸, R¹ to R⁹, R¹ to R¹⁰, R¹ to R¹¹, R¹ to R¹², R¹ to R¹³, R¹ to R¹⁴, or R¹ to R¹⁵, R¹ to R¹⁶, or R¹ to R¹⁷) are further represented by Formula II below:

P ₀₋₂ −|−[N _(c)−|−(U)₀₋₁−|−(P|A)₁₋₃−|−(U)₀₋₁−|−(P|A)₀₋₃−|−(U)₀₋₁−|−(P|A)₀₋₃−|−(U)₀₋₁−|−(P|A)₀₋₃ −P _(c)]   (Formula II)

wherein R¹-R¹⁷ are represented by “P”, “U”, “N”, and “A”; and “N” represents any negative residue; the “c” indicates cyclization between “c” labelled residues; “U” represents any polar uncharged residue (e.g., glutamine; Gln) or a hydrophobic non-aromatic residue (e.g., leucine; Leu); “P” represents any positive residue (e.g., histidine; His, lysine; Lys or arginine; Arg) or proline (Pro), “A” represents any aromatic residue (e.g., noralanine; NaI, 2′-naphthylalanine; NaI(2′), tryptophan; Trp, tyrosine; Tyr, or Phe; F); the symbol “|” indicates the presence of amide bond between an alternative residue or residues; the number of sequential residues is indicated in the adjacent numerical subscript (a 0 indicates no residue is present, a 1 indicates one residue is present with an amide bond with the adjacent residues, a 2 indicates two residues present with an amide bond with the adjacent residues, a 3 indicates three residues present with an amide bond with the adjacent residues). The alternative residues (number 0-3 or 1-3) according to Formula II can further be in any order or number (1-3 residues) as specified (e.g., P-P-P, P-P, P, A-A-A, A-A, A, P-A-A, P-P-A, P-A, A-P-P, A-A-P, A-P, P-A-P, OR A-P-A)

In another aspect, the anti-microbial peptide is represented by Formula III comprising an anti-microbial peptide coupled to a degradation-resistant C-terminal extension and an optional N-terminal extension:

X ₁₋₃ −|−P ₀₋₂ −|−[N _(c)−|−(U)₀₋₁−|−(P|A)₁₋₃−|−(U)₀₋₁−|−(P|A)₀₋₃−|−(U)₀₋₁−|−(P|A)₀₋₃−|−(U)₀₋₁−|−(P|A)₀₋₃ −P _(c)]−|−   (Formula III)

wherein X₁₋₃ represents optional stabilizing N-terminal residues or an amino acid residue mimetic; wherein the individual residues of the antimicrobial peptide are represented by “P”, “U”, “N”, and “A” and “N” and “N” represents any negative residue; the “c” indicates cyclization between “c” labelled residues; “U” represents any polar uncharged residue (e.g., glutamine; Gln) or a hydrophobic non-aromatic residue (e.g., leucine; Leu); “P” represents any positive residue (e.g., histidine; His, lysine; Lys or arginine; Arg) or proline (Pro), “A” represents any aromatic residue (e.g., noralanine; NaI, 2′-naphthylalanine; NaI(2′), tryptophan; Trp, tyrosine; Tyr, or Phe; F); the symbol “|” indicates the presence of amide bond between an alternative residue or residues; the number of sequential residues is indicated in the adjacent numerical subscript (a 0 indicates no residue is present, a 1 indicates one residue is present with an amide bond with the adjacent residues, a 2 indicates two residues present with an amide bond with the adjacent residues, a 3 indicates three residues present with an amide bond with the adjacent residues). The alternative residues (number 0-3 or 1-3) according to Formula II can further be in any order or number (1-3 residues) as specified (e.g., P-P-P, P-P, P, A-A-A, A-A, A, P-A-A, P-P-A, P-A, A-P-P, A-A-P, A-P, P-A-P, OR A-P-A); and Y₁₋₃ represent degradation-resistant C-terminal residues or an amino acid residue mimetic.

In another aspect, the anti-microbial peptide represented by Formula I, Formula II, or Formula III is provided, wherein at least one D-phenylalanine residue, or all D-phenylalanine residues are halogenated (e.g., fluorine or chlorine).

N-Terminal Extensions

In one aspect, an N-terminal extension is coupled to the anti-microbial peptide. The N-terminal extension is represented as X¹ X² X³ in Formula I, wherein:

-   -   X¹ is selected from the group consisting of D-threonine,         L-threonine, D-proline, L-proline, β-homo proline, D-alanine,         L-alanine, β-alanine, D-valine, L-valine, β-valine,         3-methyl-β-valine, D-leucine, L-leucine, β-leucine,         D-norleucine, L-norleucine, D-isoleucine, L-isoleucine,         β-isoleucine, and a piperazin-2-one ring;     -   X² is absent or is selected from the group consisting of         D-threonine, L-threonine, D-proline, L-proline, β-homo proline,         D-alanine, L-alanine, β-alanine, D-valine, L-valine, β-valine,         3-methyl-β-valine, D-leucine, L-leucine, β-leucine,         D-norleucine, L-norleucine, D-isoleucine, L-isoleucine,         β-isoleucine, and a piperazin-2-one ring; and     -   X³ is absent or is selected from the group consisting of         D-threonine, L-threonine, D-proline, L-proline, β-homo proline,         D-alanine, L-alanine, β-alanine, D-valine, L-valine, β-valine,         3-methyl-β-valine, D-leucine, L-leucine, β-leucine,         D-norleucine, L-norleucine, D-isoleucine, L-isoleucine,         β-isoleucine, and a piperazin-2-one ring.

In another aspect, an N-terminal extension is represented as X₁₋₃ in Formula III, wherein:

-   -   X₁₋₃ is between 1 and 3 residues selected from the group         consisting of D-threonine, L-threonine, D-proline, L-proline,         β-homo proline, D-alanine, L-alanine, β-alanine, D-valine,         L-valine, β-valine, 3-methyl-β-valine, D-leucine, L-leucine,         β-leucine, D-norleucine, L-norleucine, D-isoleucine,         L-isoleucine, β-isoleucine, and a piperazin-2-one ring;

In another aspect, an anti-microbial peptide represented by Formula I or Formula II containing any of the above N-terminal Extensions, X¹, X², or X³ may be modified on the N-terminus by acylation (CH₃—CO—).

C-Terminal Extensions

To the anti-microbial peptide of Formula I, or to the anti-microbial peptide of Formula III, a C-terminal extension is provided in order to confer degradation-resistance of the C-terminal extension to prevent exposure of the RFamide sequence, and to potentially confer trans-epithelial transport. International Patent Application Nos. WO 2013/138340 A1 and WO 2011/026015 A3 are incorporated by reference herein for their teachings thereof.

In one aspect the C-terminal extension is represented by Y¹ Y² Y³ of Formula I, wherein

-   -   Y¹ is absent or is selected from the group consisting of         D-threonine, L-threonine, D-proline, L-proline, β-homo proline,         D-alanine, L-alanine, D-valine, L-valine, β-valine,         3-methyl-β-valine, D-leucine, L-leucine, β-leucine,         D-isoleucine, L-isoleucine, β-isoleucine, D-phenylalanine,         L-phenylalanine, or a piperazin-2-one ring;     -   Y² is absent or is D-threonine, L-threonine, D-proline,         L-proline, β-homo proline, D-alanine, L-alanine, D-valine,         L-valine, β-valine, 3-methyl-β-valine, D-leucine, L-leucine,         β-leucine, D-isoleucine, L-isoleucine, β-isoleucine,         D-phenylalanine, L-phenylalanine, or a piperazin-2-one ring; and     -   Y³ is absent or is D-cysteine, L-cysteine, D-threonine,         L-threonine, D-proline, L-proline, β-homo proline, D-alanine,         L-alanine, D-valine, L-valine, β-valine, 3-methyl-β-valine,         D-leucine, L-leucine, β-leucine, D-isoleucine, L-isoleucine,         β-isoleucine, D-phenylalanine, L-phenylalanine, or a         piperazin-2-one ring.

In another aspect, the C-terminal extension is represented by Y₁₋₃ of Formula III, wherein

-   -   Y₁₋₃ is between 1 and 3 residues selected from the group         consisting of D-threonine, L-threonine, D-proline, L-proline,         β-homo proline, D-alanine, L-alanine, D-valine, L-valine,         β-valine, 3-methyl-β-valine, D-leucine, L-leucine, β-leucine,         D-isoleucine, L-isoleucine, β-isoleucine, D-phenylalanine,         L-phenylalanine, or a piperazin-2-one ring.

In one aspect, the C-terminal extension has a conformation that chronically inhibits degradation from carboxy peptidases. Examples of a C-terminal extension that chronically inhibit degradation include the di- and tri-peptides: D-Pro-D-Pro; D-Thr-D-Pro; and D-Thr-D-Pro-D-Thr as described in Tugyi et al., Proc. Natl. Acad. Sci USA 102(2): 413-418 (2005). Other examples of C-terminal extensions that inhibit C-terminal degradation are D-Pro-D-Val; D-Val-D-Pro; β-Val-β-Pro; β-Pro-β-Val; 3-methyl-β-Val-β-Pro; D-Pro-D-Ala; D-Ala-D-Pro; β-Pro-β-Ala; β-Ala-β-Pro; D-Pro-D-Leu; D-Leu-D-Pro; β-Pro-β-Leu; β-Leu-β-Pro; D-Val-D-Ala; D-Ala-D-Val; β-Val-β-Ala; β-Ala-β-Val; 3-methyl-β-Val-β-Ala; D-Val-D-Leu; D-Leu-D-Val; β-Val-β-Leu; β-Leu-β-Val; 3-methyl-β-Val-β-Leu; D-Phe-D-Val; D-Val-D-Phe; and others.

In one aspect, the C-terminal extension unexpectedly changes the specificity of the anti-microbial peptide to invert its specificity between gram-positive and gram-negative bacteria. In another aspect, the C-terminal extension changes the specificity of the anti-microbial peptide to increase its anti-microbial activity against gram-negative bacteria, wherein there is a concomitant decrease in anti-microbial activity to gram-positive bacteria. In another aspect, the C-terminal extension changes the specificity of the anti-microbial peptide to increase its anti-microbial activity against gram-positive bacteria, wherein there is a concomitant decrease in anti-microbial activity to gram-negative bacteria.

In one aspect, the presence of D-Phe-D-Val or D-Val-D-Phe in the C-terminal extension of the anti-microbial peptide increases its specificity for gram-negative bacteria. In another aspect, the presence of D-Pro-D-Val or D-Val-D-Pro in the C-terminal extension of the anti-microbial peptide increases its specificity for gram-positive bacteria.

In some aspects, the anti-microbial activity is detectable by bacterial cell agglutination (cell-clumping). Agglutination is a common mode of action for the natural anti-microbial peptides which leads to increased phagocytosis and bacterial cell clearance by macrophages. Torrent et al., PLoS Pathogens 8(11): e1003005 (2012). In other aspects, the anti-microbial peptides described herein have anti-microbial activity ascribed to other intracellular modes of action, and many have been reported to transverse the cytoplasmic membrane. Accordingly, the anti-microbial peptides are capable of interfering with numerous bacterial processes by inhibiting DNA synthesis, RNA synthesis, protein synthesis, and cell wall synthesis In addition, the anti-microbial peptides described herein can inhibit septum formation process during bacterial cell division, leading to elongation and filamentation of bacterial cells. Brogden, Nature Reviews Microbiology 3(3): 238-250 (2005).

In another aspect, an anti-microbial peptide represented by Formula I or Formula III containing any of the above C-terminal Extensions, Y¹, Y², or Y³ may be modified on the C-terminus by adding an amine group (—NH₂) to form an amide (i.e., —CO—NH₂).

In another aspect, a proline mimetic (piperazin-2-one ring) is substituted for D-Pro. In one approach, a proline mimetic is synthesized as described in Teixido et al., Brain Res Bull, 2007, 73(1-3): 103-107. The piperazin-2-one ring is also discussed in Bhatt and Just, Helvetica Chimica Acta 83: 722-727 (2000). For the replacement of proline with a piperazin-2-one ring, an ethylene bridge is incorporated between the nitrogen molecules of two adjacent a-amino groups. This produces a six-membered ring, containing two nitrogen and four carbon atoms, a structure that is similar to a proline ring (albeit six-membered) between the two adjacent amino acid residue functional groups.

The C-terminal extension of the anti-microbial peptide is resistant to substantial degradation prior to the peptide being cleared from the bloodstream in the human or animal body. A C-terminal extension is of sufficient stability such that the anti-microbial peptide does not cause cardiovascular effects, or has minimized cardiovascular effects when administered to a human or animal. As stability of peptides, amino acids, and small molecules varies widely, anti-microbial peptide described herein have variable length C-terminal extensions in the extracellular physiological environment. The C-terminal extension is of sufficient stability (e.g., length, steric structure) such that any degradation in the body prior to clearance from the bloodstream will not re-expose the cardiovascular (RFamide) pharmacophore to achieve the effect.

Cyclization of the Anti-Microbial Peptide Comprising Formula I

Cyclized anti-microbial peptides have shown improved efficacy and stability. See Balse-Srinivasan et al., J. Med. Chem. 46(17): 3728-3733 (2003) and Bednarek et al., Biochem. Biophys. Res. Corn. 286(3): 641-645 (2001); Kavarana et al., J. Med. Chem. 45(12): 2644-2650 (2002). In one aspect, the non-naturally occurring anti-microbial peptide represented by Formula I is cyclized. The following represents a non-limiting list of examples of how the anti-microbial peptide represented by Formula I can be cyclized:

In Formula I, disulfide bond between an amino terminal anti-microbial peptide residue (R_(n); e.g., R¹ R² R³ R⁴) and a carboxy terminal anti-microbial peptide residue (R_(c), e.g., R⁹, R¹⁰ R¹¹ R¹² R¹³ R¹⁴ R¹⁵ R¹⁶ R¹⁷), the exact number and location of which is dependent upon the number of residues of the anti-microbial peptide; or Y¹, when a R_(n) is cysteine and R_(c) or Y¹ is cysteine as described in Balse-Srinivasan et al., J. Med. Chem. 46(23): 4965-4973 (2003). When Y¹ is cysteine, Y² is not absent, but is selected from the group consisting of D-threonine, L-threonine, D-proline, L-proline and a piperazin-2-one ring.

A lactam bridge between an amino terminal anti-microbial peptide residue (R_(n); e.g., R¹ R² R³ R⁴) and a carboxy terminal anti-microbial peptide residue (R_(c), e.g., R⁹, R¹⁰ R¹¹ R¹² R¹³ R¹⁴ R¹⁵ R¹⁶ R¹⁷), the exact number and location of which is dependent upon the number of residues of the anti-microbial peptide, when R_(n) is norleucine and R_(c) is glutamic acid, as described in Mayorov et al. J. Med. Chem. 49: 1946-1952 (2006) and Bednarek et al., Biochem. Biophys. Res. Corn. 286(3): 641-645 (2001).

A side-chain lactam bridge between an amino terminal anti-microbial peptide residue (R_(n); e.g., R¹ R² R³ R⁴) and a carboxy terminal anti-microbial peptide residue (R_(c), e.g., R⁹, R¹⁰ R¹¹ R¹² R¹³ R¹⁴ R¹⁵ R¹⁶ R¹⁷), the exact number and location of which is dependent upon the number of residues of the anti-microbial peptide, when R_(n) is glutamic acid or aspartic acid and R_(c) is lysine, as described in Bednarek et al., Biochem. Biophys. Res. Corn. 286(3): 641-645 (2001).

A lactam bridge between an amino terminal anti-microbial peptide residue (R_(n); e.g., R¹ R² R³ R⁴) and a carboxy terminal anti-microbial peptide residue (R_(c), e.g., R⁹, R¹⁰ R¹¹ R¹² R¹³ R¹⁴ R¹⁵ R¹⁶ R¹⁷), the exact number and location of which is dependent upon the number of residues of the anti-microbial peptide, when R_(n) is succinic acid or o-pthalic acid and R_(c) is lysine, as described in Bednarek et al., Biochem. Biophys. Res. Corn. 286(3): 641-645 (2001) and Kavarana et al., J. Med. Chem. 45(12): 2644-2650 (2002).

A lactam bridge between an amino terminal anti-microbial peptide residue (R_(n); e.g., R¹ R² R³ R⁴) and a carboxy terminal anti-microbial peptide residue (R_(c), e.g., R⁹, R¹⁰ R¹¹ R¹² R¹³ R¹⁴ R¹⁵ R¹⁶ R¹⁷), the exact number and location of which is dependent upon the number of residues of the anti-microbial peptide R² or R³ and R⁷, when R_(n) is succinic acid and R_(c) is 2,3-diamino-propionic acid as described in Bednarek et al., Biochem. Biophys. Res. Corn. 286(3): 641-645 (2001).

A “backbone” cyclized peptide is formed by covalent bond formation between the C- andor N-terminus of a linear peptide of interest. An example of this is described in the bonding of two amide nitrogens via a bridge consisting of alkyl groups and an amide, as described by Hess et al., J. Med. Chem. 50: 6201-6211 (2007).

Amino Acids—Isomers and Non-Standard Amino Acids

In one aspect, the amino acid residues, as provided herein for the non-naturally occurring anti-microbial peptide described herein, can be either D- or L-amino acids or can be substituted with their non-standard, isomeric counterparts. For example, α-amino acids can be substituted with β-amino acids, and L-amino acids can be substituted with D-amino acids. An amino acid disclosed herein that is not designated as a D- or L-isomer, can be either isomer. All amino acids are α-amino acids, unless specifically indicated as β-amino acids. A β-amino acid can be either a β²-amino acid or a β³-amino acid, or both β² and β³ in some cases, unless a specific designation is provided. In other aspects, the amino acid can be an amino acid analog, or a synthetic, or chemically modified amino acid.

Cyclization of the Anti-Microbial Peptide of Formula II or Formula III

In one aspect, the non-naturally occurring anti-microbial peptide represented by Formula II is cyclized. The anti-microbial peptide represented by Formula II or III can be cyclized through a lactam side chain between an amino terminal anti-microbial peptide residue (R_(n); e.g., R¹ R² R³ R⁴) and a carboxy terminal anti-microbial peptide residue (R_(c), e.g., R⁹, R¹⁰ R¹¹ R¹² R¹³ R¹⁴ R¹⁵ R¹⁶ R¹⁷), the exact number and location of which is dependent upon the number of residues of the anti-microbial peptide, when R_(n) is aspartic acid and R_(c) is lysine, as described. See Bednarek et al., Biochem. Biophys. Res. Com. 286(3): 641-645 (2001) and Mayorov et al., J. Med. Chem. 49: 1946-1952 (2006).

Anti-Biofilm Peptide Extensions

In some embodiments, the anti-microbial peptides described herein are used in conjunction with a peptide having anti-biofilm activity. In some aspects, the anti-microbial peptides described herein are covalently linked to an anti-biofilm peptide. Biofilms are growths of microorganisms on a surface embedded in an extracellular polymeric substance. Typically, biofilms are formed through quorum sensing and cell-cell communication in response to a myriad of extracellular cues, including nutrient stress and exposure to low doses of antibiotics. These aspects of biofilm formation make them particularly problematic in hospitals resulting in the generation of antibiotic resistent bacterial strains.

Suitable anti-biofilm peptides described herein are cationic peptides that are able to disrupt, reduce, or reverse biofilm formation and growth. In some aspects, the anti-biofilm peptides described herein also possess anti-microbial activity. This secondary anti-microbial activity of the anti-biofilm peptides stems from the presence of duplicate and triplet cationic residues with in the primary peptide sequence. In some aspects, the anti-biofilm peptides described herein only possess anti-biofilm activity and no anti-microbial activity.

In some aspects, the anti-biofilm peptide is represented by Formula IV, as shown below:

B¹-B²-B³-B⁴-B⁵-B⁶-B⁷-B⁸-B⁹-B¹⁰-B¹¹-B¹²   (Formula IV),

wherein each residue corresponding to positions B¹, B³, B⁴, B⁵, B⁶, B⁷, or B⁹ is any hydrophobic non-aromatic natural or synthetic amino acid (e.g., alanine (Ala), valine (Val), isoleucine (Ile); each residue corresponding to positions B², B⁸, B¹¹, or B¹² is any positive natural or synthetic amino acid (e.g., arginine (Arg), histidine (His), lysine (Lys); residue corresponding to position B¹⁰ is any natural or synthetic aromatic amino acid (e.g., noralanine, 2′-naphthylalanine, tryptophan (Trp), tyrosine (Tyr), or phenylalanine (F). In some aspects, the positive residue for the anti-biofilm peptide described herein is selected to be arginine (Arg). In some aspects, the anti-biofilm peptide described herein comprises the sequence corresponding to positions B¹-B²-B³-B⁴-B⁵-B⁶-B⁷-B⁸ according to Formula IV. In some aspects, the anti-biofilm peptide described herein comprises the sequence corresponding to positions B⁷-B⁸-B⁹-B¹⁰-B¹¹-B¹² according to Formula IV. In some aspects, the anti-biofilm peptide described herein comprises the sequence corresponding to positions B B¹-B²-B³-B⁴-B⁵-B⁶ according to Formula IV. In some aspects, the anti-biofilm peptide described herein comprises the sequence corresponding to positions B¹-B²-B³-B⁴-B⁵-B⁶-B⁷ according to Formula IV.

In some aspects, the anti-biofilm peptide is represented by Formula V, as shown below:

B¹-B²-B³-B⁴-B⁵-B⁶-B⁷-B⁸-B⁹-B¹⁰-B¹¹   (Formula V),

wherein residue corresponding to position B¹⁰ is any hydrophobic non-aromatic natural or synthetic amino acid (e.g., alanine (Ala), valine (Val), isoleucine (Ile); each residue corresponding to positions B¹ B² B³ B⁴ B⁵ B⁸ B⁹ B¹¹ is any positive natural or synthetic amino acid (e.g., arginine (Arg), histidine (His), lysine (Lys); each residue corresponding to positions B³ B⁶ B⁷ is any natural or synthetic aromatic amino acid (e.g., noralanine, 2′-naphthylalanine, tryptophan (Trp), tyrosine (Tyr), or phenylalanine (F). In some aspects, the positive residue for the anti-biofilm peptide described herein is selected to be arginine (Arg). In some aspects, the anti-biofilm peptide described herein comprises the sequence B¹-B²-B³-B⁴-B⁵-B⁶-B⁷ according to Formula V. In some aspects, the anti-biofilm peptide described herein comprises the sequence B⁶-B⁷-B⁸-B⁹-B¹⁰-B¹¹ according to Formula V. In some aspects, the anti-biofilm peptide described herein comprises the sequence B¹-B²-B³-B⁴-B⁵-B⁶-B⁷-B⁸-B⁹ according to Formula V. In some aspects, the anti-biofilm peptide described herein comprises residues B⁴-B⁵-B⁶-B⁷-B⁸-B⁹-B¹⁰ according to Formula V.

In some aspects, the anti-biofilm peptides described herein are linked to an anti-microbial peptide described herein to generate a fusion protein of consisting of an anti-microbial peptide fused to an antimicrobial peptide. In some aspects, the linkage is directly to the amino terminal amino acid of the anti-microbial peptides described herein. In some aspects, the linkage is directly to the carboxy terminal amino acid of the anti-microbial peptides described herein. In some aspects, the linkage is indirectly coupled through linking amino acids between the anti-microbial peptide and anti-biofilm peptides. The anti-biofilm can be on the carboxy terminus or amino terminus of the anti-microbial peptide through indirect coupling with linking amino acids.

In some aspects, the amino acids of the anti-biofilm are modified to prevent cyclization with the anti-microbial peptide during cyclization methods described herein. In some aspects, cyclization of the anti-biofilm peptides described herein with the anti-microbial peptides described herein is prevented by substituting residues that do not form a lactam bridge (e.g., substitution of Arg for Lys). In some aspects, the cyclization of the anti-biofilm peptides described herein with the anti-microbial peptides described herein is prevented by chemically modifying one or more amino terminal amino acids of the anti-microbial peptides described herein. In some aspects, the cyclization of the anti-biofilm peptides described herein with the anti-microbial peptides described herein is prevented by chemically methylating (e.g., adding a CH3 moiety) to one of the amino terminal amino acids of the anti-microbial peptides described herein.

In some aspects, the fusion of the anti-biofilm peptide to an anti-microbial peptide is represented by Formula VI, as shown below:

(B ¹⁻¹² |B ¹⁻¹¹)−|−(P)₀₋₂ −|−[N _(c)−|−(U)₀₋₁−|−(P|A)₁₋₃−|−(U)₀₋₁−|−(P|A)₀₋₃−|−(U)₀₋₁−|−(P−A)₀₋₃−|−(U)₀₋₁−|−(P|A)₀₋₃ −P _(c)]  (formula VI)

wherein B¹⁻¹² and B¹⁻¹¹ correspond to the anti-biofilm peptide residues of Formula IV and Formula V, respectively; and “P”, “U”, “N”, and “A” represent residues R¹ to R¹⁷ (of Formula I) of the anti-microbial peptide; wherein “N” represents any negative residue; the “c” indicates cyclization between “c” labelled residues; “U” represents any polar uncharged residue (e.g., glutamine; Gln) or a hydrophobic non-aromatic residue (e.g., leucine; Leu); “P” represents any positive residue (e.g., histidine; His, lysine; Lys or arginine; Arg) or proline (Pro), “A” represents any aromatic residue (e.g., noralanine; NaI, 2′-naphthylalanine; NaI(2′), tryptophan; Trp, tyrosine; Tyr, or Phe; F); the symbol “|” indicates the presence of amide bond between an alternative residue or residues; the number of sequential residues is indicated in the adjacent numerical subscript (a 0 indicates no residue is present, a 1 indicates one residue is present with an amide bond with the adjacent residues, a 2 indicates two residues present with an amide bond with the adjacent residues, a 3 indicates three residues present with an amide bond with the adjacent residues). The alternative residues (number 0-3 or 1-3) according to Formula II can further be in any order or number (1-3 residues) as specified (e.g., P-P-P, P-P, P, A-A-A, A-A, A, P-A-A, P-P-A, P-A, A-P-P, A-A-P, A-P, P-A-P, OR A-P-A).

One of ordinary skill in the art would recognize that modifications can be made to the fusion proteins without diminishing their biological activity. Some modifications may be made to facilitate the cloning, expression, or incorporation of the targeting molecule into a fusion protein. Such modifications are well known to those of skill in the art and include, for example, a methionine added at the amino terminus to provide an initiation site, or additional amino acids placed on either terminus to create conveniently located restriction sites or termination codons.

As indicated above, in various embodiments a peptide linker/spacer is used to join the one or more targeting moieties to one or more effector(s). In various embodiments the peptide linker is relatively short, typically less than about 10 amino acids, preferably less than about 8 amino acids and more preferably about 3 to about 5 amino acids. Suitable illustrative linkers include, but are not limited to comprise: Ala-Ala-Ala, Gly-Gly-Gly, Ser-Gly-Gly, Gly-Gly-Ser-Gly-Gly-Ser, Ser-Ala-Thr, Pro-Trp-Pro, Pro-Ser-Pro-Ser-Pro, Ala-Ser-Ala, Ala-Ser-Ala-Ser-Ala, Pro-Ser-Pro-Ser-Pro, Lys-Lys-Lys-Lys-, Arg-Arg-Arg-Arg, (Gly4-Ser)₃, Gly-Gly-Gly-Gly, Gly-Gly-Gly-Gly-Ser, (Gly-Gly-Gly-Gly-Ser)₂, (Gly-Gly-Gly-Gly-Ser)₄, (Gly-Gly-Gly-Gly-Ser)₅, (Gly-Gly-Gly-Gly-Ser)₆, 2-nitrobenzene or O-nitrobenzyl, Nitropyridyl disulfide, Dioleoylphosphatidylethanolamine (DOPE), S-acetylmercaptosuccinic acid, 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetracetic acid (DOTA), β-glucuronide and β-glucuronide variants, Poly(alkylacrylic acid), Benzene-based linkers (for example: 2,5-Bis(hexyloxy)-1,4-bis[2,5-bis(hexyloxy)-4-formyl-phenylenevinylene]benzene) and like molecules, Disulfide linkages, Carbon nanotubes, Hydrazone and hydrazone variant linkers, alkane or alkene groups of any chain length, One or more DNA or RNA nucleotides, including polyamine and polycarboxyl-containing variants, Inulin, sucrose, glucose, or other single, di or polysaccharides, Linoleic acid or other polyunsaturated fatty acids, variants of any of the above linkers containing halogen or thiol groups, or any combination thereof.

In some aspects described herein, the anti-microbial peptides have a structure as indicated in FIG. 1. In one aspect, the anti-microbial peptide (100) is depicted by FIG. 1A. An amino-terminal protective group, as described herein (102) is covalently linked by an amide bond (104) to a cyclized anti-microbial pharmacophore (101) as described herein, which is further linked by an amide bond (104) to a carboxy-terminal protective group, as described herein (103). In another aspect, the anti-microbial peptide structure (200) is depicted by FIG. 1B. An amino terminal anti-biofilm peptide as described herein (105) is covalently linked by an amide (104) bond to a cyclized anti-microbial pharmacophore (101) as described herein, which is further linked by an amide bond (104) to a carboxy-terminal protective group, as described herein (103). In another aspect, the anti-microbial peptide structure (300) is depicted by FIG. 1C. An amino-terminal protective group, as described herein (102) is covalently linked by an amide bond (104) to a cyclized anti-microbial pharmacophore (101) as described herein, which is further linked by an amide bond (104) to a carboxy-terminal anti-biofilm peptide as described herein (105), which is further linked to a carboxy-terminal protective group, as described herein (103). In another aspect, the anti-microbial peptide structure (400) is depicted by FIG. 1D. An amino terminal anti-biofilm peptide as described herein (105) is covalently linked by an amide (104) bond to amino acid linkers as described herein, which are covalently linked by an amide bond (104) both to each adjacent linking amino acid and to a cyclized anti-microbial pharmacophore (101) as described herein, which is further linked by an amide bond (104) to a carboxy-terminal protective group, as described herein (103). In another aspect, the anti-microbial peptide structure (500) is depicted by FIG. 1E. An amino-terminal protective group, as described herein (102) is covalently linked by an amide bond (104) to anti-biofilm peptide as described herein (105), which is covalently linked by an amide (104) bond to a cyclized anti-microbial pharmacophore (101) as described herein, which is further linked by an amide bond (104) to a carboxy-terminal protective group, as described herein (103).

Peptide Synthesis

The anti-microbial peptides, anti-biofilm peptides and fusion proteins thereof, described herein may be readily synthesized by any known conventional procedure for the formation of a peptide linkage between amino acids. Such conventional procedures include, for example, any solution phase procedure permitting a condensation between the free alpha amino group of an amino acid or residue thereof having the carboxyl group or other reactive groups protected and the free primary carboxyl group of another amino acid or residue thereof having the amino group or other reactive groups protected. In an exemplary procedure, the peptides described herein may be synthesized by solid-phase synthesis and purified according to methods known in the art. Any of a number of well-known procedures utilizing a variety of resins and reagents may be used to prepare the peptides described herein.

The process for synthesizing the peptides may be carried out by a procedure whereby each amino acid in the desired sequence is added one at a time in succession to another amino acid or residue thereof or by a procedure whereby peptide fragments with the desired amino acid sequence are first synthesized conventionally and then condensed to provide the desired peptide. The resulting peptide is then cyclized to yield a cyclic peptide.

Solid phase peptide synthesis methods are well known and practiced in the art. In such methods, the synthesis of peptides can be carried out by sequentially incorporating the desired amino acid residues one at a time into the growing peptide chain according to the general principles of solid phase methods. These methods are disclosed in numerous references, including Merrifield, Angew Chem. 24: 799-810 (1985) and Barany et al., The Peptides, Analysis, Synthesis and Biology, Vol. 2, Gross E. and Meienhofer J., Eds. Academic Press, 1-284 (1980).

In chemical syntheses of peptides, reactive side chain groups of the various amino acid residues are protected with suitable protecting groups, which prevent a chemical reaction from occurring at that site until the protecting group is removed. Also common is the protection of the alpha amino group of an amino acid residue or fragment while that entity reacts at the carboxyl group, followed by the selective removal of the alpha amino protecting group to allow a subsequent reaction to take place at that site. Specific protecting for solid phase synthesis methods and solution phase synthesis methods groups are known to those having ordinary skill in the art.

Alpha amino groups may be protected by a suitable protecting group, including a urethane-type protecting group, such as benzyloxycarbonyl (Z) and substituted benzyloxycarbonyl, such as p-chlorobenzyloxycarbonyl, p-nitrobenzyloxycarbonyl, p-bromobenzyloxycarbonyl, p-biphenyl-isopropoxycarbonyl, 9-fluorenylmethoxycarbonyl (Fmoc) and p-methoxybenzyloxycarbonyl (Moz); aliphatic urethane-type protecting groups, such as t-butyloxycarbonyl (Boc), diisopropylmethoxycarbonyl, isopropoxycarbonyl, and allyloxycarbonyl. Fmoc is useful for alpha amino protection.

Guanidino groups may be protected by a suitable protecting group, such as nitro, p-toluenesulfonyl (Tos), Z, pentamethylchromanesulfonyl (Pmc), adamantyloxycarbonyl, pentamethyldihydrobenzofuran-5-sulfonyl (Pbf) and Boc. Pmc is a useful protecting group for Arg.

Solid phase synthesis is commenced from the C-terminal end of the peptide by coupling a protected alpha amino acid to a suitable resin. Such starting material is prepared by attaching an alpha amino-protected amino acid by an ester linkage to a p-benzyloxybenzyl alcohol (Wang) resin or a 2-chlorotrityl chloride resin, by an amide bond between an Fmoc-Linker, such as p-[(R, S)-α-[1-(9H-fluor-en-9-yl)-methoxyformamido]-2,4-dimethyloxybenzyl]-phenoxyacetic acid (Rink linker) to a benzhydrylamine (BHA) resin, or by other means well known in the art. Fmoc-Linker-BHA resin supports are commercially available and generally used when feasible. The resins are carried through repetitive cycles as necessary to add amino acids sequentially. The alpha amino Fmoc protecting groups are removed under basic conditions. Piperidine, piperazine, diethylamine, or morpholine (20-40% v/v) in N,N-dimethylformamide (DMF) may be used for this purpose.

Following removal of the alpha amino protecting group, the subsequent protected amino acids are coupled stepwise in the desired order to obtain an intermediate, protected peptide-resin. The activating reagents used for coupling of the amino acids in the solid phase synthesis of the peptides are well known in the art. After the peptide is synthesized, if desired, the orthogonally protected side chain protecting groups may be removed using methods well known in the art for further derivatization of the peptide.

Reactive groups in a peptide can be selectively modified, either during solid phase synthesis or after removal from the resin. For example, peptides can be modified to obtain N-terminus modifications, such as acetylation, while on resin, or may be removed from the resin by use of a cleaving reagent and then modified. Methods for N-terminus modification, such as acetylation, and for C-terminus modification, such as amidation, are known in the art. Similarly, methods for modifying side chains of amino acids are well known to those skilled in the art of peptide synthesis. The choice of modifications made to reactive groups present on the peptide will be determined, in part, by the characteristics that are desired in the peptide.

The peptide can be cyclized prior to cleavage from the peptide resin. For cyclization through reactive side chain moieties, the desired side chains are deprotected, and the peptide suspended in a suitable solvent and a cyclic coupling agent added. Suitable solvents include, for example DMF, dichloromethane (DCM) or 1-methyl-2-pyrrolidone (NMP). Suitable cyclic coupling reagents include, for example, 2-(1H-benzotriazol-1-yl)-1,1,3,3-tetramethyluronium tetrafluoroborate (TBTU), 2-(1H-benzotriazol-1-yl)-1,1,3,3-tetra methyluronium hexafluorophosphate (HBTU), benzotriazole-1-yl-oxy-tris(dimethylamino)phosphoniumhexafluorophosphate (BOP), be nzotriazole-1-yl-oxy-tris(pyrrolidino)phosphoniumhexafluorophosp-hate (PyBOP), 2-(7-aza-1H-benzotriazol-1-yl)-1,1,3,3-tetramethyluronium tetrafluoroborate (TATU), 2-(2-oxo-1(2H)-pyridyl)-1,1,3,3-tetramethyluronium tetrafluoroborate (TPTU) or N,N′-dicyclohexylcarbodiimide/1-hydroxybenzotriazole (DCCl/HOBt). Coupling is convention initiated by use of a suitable base, such as N,N-diispropylethylamine (DIPEA), sym-collidine or N-methylmorpholine (NMM).

Following cleavage of peptides from the solid phase following their synthesis, the peptide can be purified by any number of methods, such as reverse phase high performance liquid chromatography (RP-HPLC), using a suitable column, such as a C₁₈ column. Other methods of separation or purification, such as methods based on the size or charge of the peptide, can also be employed. Once purified, the peptide can be characterized by any number of methods, such as high performance liquid chromatograph (HPLC), amino acid analysis, mass spectrometry, and the like.

Formulation

The anti-microbial peptides disclosed herein can be used for both medical applications, animal husbandry, veterinary applications, or used in research laboratory settings as a research tool or a diagnostic tool. Typically, the product is used in humans, but may also be used in other mammals. The term “patient” is intended to denote a mammalian individual, and is so used throughout the specification and in the claims. The primary application can involve human patients, but may be applied to laboratory, farm, zoo, wildlife, pet, sport, or other animals.

In general, the anti-microbial peptide described herein may be synthesized by solid-phase synthesis and purified according to methods known in the art. Any of a number of procedures utilizing a variety of resins and reagents may be used to prepare the peptides described herein.

Salt Forms of Peptides

The anti-microbial peptide peptides described herein may be in the form of any pharmaceutically acceptable salt. The term “pharmaceutically acceptable salts” refers to salts prepared from pharmaceutically acceptable non-toxic bases or acids including inorganic or organic bases and inorganic or organic acids. Salts derived from inorganic bases include aluminum, ammonium, calcium, copper, ferric, ferrous, lithium, magnesium, manganic salts, manganous, potassium, sodium, zinc, and the like. Exemplary salts are the ammonium, calcium, lithium, magnesium, potassium, and sodium salts. Salts derived from pharmaceutically acceptable organic non-toxic bases include salts of primary, secondary, and tertiary amines, substituted amines including naturally occurring substituted amines, cyclic amines, and basic ion exchange resins, such as arginine, betaine, caffeine, choline, N,N′-dibenzylethylenediamine, diethylamine, 2-diethylaminoethanol, 2-dimethylaminoethanol, ethanolamine, ethylenediamine, N-ethyl-morpholine, N-ethylpiperidine, glucamine, glucosamine, histidine, hydrabamine, isopropylamine, lysine, methylglucamine, morpholine, piperazine, piperidine, polyamine resins, procaine, purines, theobromine, triethylamine, trimethylamine, tripropylamine, tromethamine, and the like.

When the peptides described herein are basic, acid addition salts may be prepared from pharmaceutically acceptable non-toxic acids, including inorganic and organic acids. Such acids include acetic, benzenesulfonic, benzoic, camphorsulfonic, carboxylic, citric, ethanesulfonic, formic, fumaric, gluconic, glutamic, hydrobromic, hydrochloric, isethionic, lactic, maleic, malic, mandelic, methanesulfonic, malonic, mucic, nitric, pamoic, pantothenic, phosphoric, propionic, succinic, sulfuric, tartaric, p-toluenesulfonic acid, trifluoroacetic acid, and the like. Acid addition salts of the peptides described herein are prepared in a suitable solvent from the peptide and an excess of an acid, such as hydrochloric, hydrobromic, sulfuric, phosphoric, acetic, trifluoroacetic, citric, tartaric, maleic, succinic or methanesulfonic acid. The acetate salt form is especially useful. Where the peptides described herein include an acidic moiety, suitable pharmaceutically acceptable salts may include alkali metal salts, such as sodium or potassium salts, or alkaline earth metal salts, such as calcium or magnesium salts.

Pharmaceutical Compositions

Also described herein are pharmaceutical composition that includes an anti-microbial peptide analog peptide and a pharmaceutically acceptable carrier. The carrier may be a liquid formulation, and can be a buffered, isotonic, aqueous solution. Pharmaceutically acceptable carriers also include excipients, such as diluents, carriers and the like, and additives, such as stabilizing agents, preservatives, solubilizing agents, buffers and the like, as hereafter described.

The peptides described herein may be formulated or compounded into pharmaceutical compositions that include at least one peptide together with one or more pharmaceutically acceptable carriers, including excipients, such as diluents, carriers and the like, and additives, such as stabilizing agents, preservatives, solubilizing agents, buffers and the like, as may be desired. Formulation excipients may include polyvinylpyrrolidone, gelatin, hydroxy cellulose, acacia, polyethylene glycol, mannitol, sodium chloride, and sodium citrate. For injection or other liquid administration formulations, water containing at least one or more buffering constituents is useful, and stabilizing agents, preservatives and solubilizing agents may also be employed. For solid administration formulations, any of a variety of thickening, filler, bulking and carrier additives may be employed, such as starches, sugars, fatty acids and the like. For topical administration formulations, any of a variety of creams, ointments, gels, lotions and the like may be employed. For most pharmaceutical formulations, non-active ingredients will constitute the greater part, by weight or volume, of the preparation. For pharmaceutical formulations, it is also contemplated that any of a variety of measured-release, slow-release or time-release formulations and additives may be employed, so that the dosage may be formulated so as to effect delivery of a peptide described herein over a period of time.

In general, the actual quantity of peptides administered to a patient will vary between fairly wide ranges depending on the mode of administration, the formulation used, and the response desired.

In practical use, the peptides as disclosed herein can be combined as the active ingredient in an admixture with a pharmaceutical carrier according to conventional pharmaceutical compounding techniques. The carrier may take a wide variety of forms depending on the form of preparation desired for administration, for example, oral, parenteral (including intravenous), urethral, vaginal, nasal, buccal, sublingual, ophthalmic, or the like. In preparing the compositions for oral dosage form, any of the usual pharmaceutical media may be employed, such as, for example, water, glycols, oils, alcohols, flavoring agents, preservatives, coloring agents and the like in the case of oral liquid preparations, such as, for example, suspensions, elixirs and solutions; or carriers such as starches, sugars, microcrystalline cellulose, diluents, granulating agents, lubricants, binders, disintegrating agents and the like in the case of oral solid preparations such as, for example, powders, hard and soft capsules and tablets.

Because of their ease of administration, tablets and capsules represent an advantageous oral dosage unit form. If desired, tablets may be coated by standard aqueous or nonaqueous techniques. The amount of active peptide in such therapeutically useful compositions is such that an effective dosage will be obtained. In another advantageous dosage unit form, sublingual constructs may be employed, such as sheets, wafers, tablets or the like. The active peptides can also be administered intranasally as, for example, by liquid drops or spray.

The tablets, pills, capsules, and the like may also contain a binder such as gum tragacanth, acacia, cornstarch, or gelatin; excipients such as dicalcium phosphate; a disintegrating agent such as cornstarch, potato starch, or alginic acid; a lubricant such as magnesium stearate; and a sweetening agent such as sucrose, lactose, or saccharin. When a dosage unit form is a capsule, it may contain, in addition to materials of the above type, a liquid carrier such as a polyethylene glycol, a lipid or lipophilic oil, or combination thereof.

Various other materials may be utilized as coatings or to modify the physical form of the dosage unit. For instance, tablets may be coated with shellac, sugar or both. A syrup or elixir may contain, in addition to the active ingredient, sucrose as a sweetening agent, methyl, and propylparabens as preservatives, dyes, and flavorings such as cherry or orange flavor.

Peptides may also be administered parenterally. Solutions or suspensions of these active peptides can be prepared in water suitably mixed with a surfactant such as hydroxy-propylcellulose. Dispersions can also be prepared in glycerol, liquid polyethylene glycols and mixtures thereof in oils. These preparations may optionally contain a preservative to prevent the growth of microorganisms.

The pharmaceutical peptides suitable for injectable use include sterile aqueous solutions or dispersions and sterile powders for the extemporaneous preparation of sterile injectable solutions or dispersions. In all cases, the form must be sterile and must be fluid to the extent that it may be administered by syringe. The form must be stable under the conditions of manufacture and storage and must be preserved against the contaminating action of microorganisms such as bacteria and fungi. The carrier can be a solvent or dispersion medium containing, for example, water, ethanol, a polyol, for example glycerol, propylene glycol or liquid polyethylene glycol, suitable mixtures thereof, and vegetable oils.

Peptides as disclosed herein may be therapeutically applied by means of nasal administration. “Nasal administration” indicates any form of intranasal administration of any of the peptides described herein. The peptides may be in an aqueous solution, such as a solution including saline, citrate or other common excipients or preservatives. The peptides may also be in a dry or powder formulation.

Alternatively, peptides may be administered directly into the lung. Intrapulmonary administration may be performed by means of a metered dose inhaler, a device allowing self-administration of a metered bolus of a peptide when actuated by a patient during inspiration.

The peptides may be formulated with any of a variety of agents that increase effective nasal or ocular absorption of drugs. These agents should increase nasal absorption without unacceptable damage to the mucosal membrane. U.S. Pat. Nos. 5,693,608; 5,977,070; and 5,908,825, among others, teach a number of pharmaceutical compositions that may be employed, and are incorporated by reference for these teachings.

If in an aqueous solution, peptides may be appropriately buffered by means of saline, acetate, phosphate, citrate, acetate or other buffering agents, which may be at any physiologically acceptable pH, generally from about pH 4 to about pH 7. A combination of buffering agents may also be employed, such as phosphate buffered saline, a saline and acetate buffer, and the like. In the case of saline, a 0.9% saline solution may be employed. In the case of acetate, phosphate, citrate, acetate and the like, a 50 mM solution may be employed. In addition to buffering agents, a suitable preservative may be employed, to prevent or limit bacteria and other microbial growth. One such preservative that may be employed is 0.05% benzalkonium chloride.

It is also possible and contemplated that the peptide may be in a dried and particulate form. For example, the particles can be between about 0.5 and 6.0 μm, such that the particles have sufficient mass to settle on the lung surface, and not be exhaled, but are small enough that they are not deposited on surfaces of the air passages prior to reaching the lung. Any of a variety of different techniques may be used to make dry powder microparticles, including but not limited to micro milling, spray drying and a quick freeze aerosol followed by lyophilization. With micro-particles, the peptides may be deposited to the deep lung, thereby providing quick and efficient absorption into the bloodstream. Further, with such approach penetration enhancers are not required, as is sometimes the case in transdermal, nasal or oral mucosal delivery routes. Any of a variety of inhalers can be employed, including propellant-based aerosols, nebulizers, single dose dry powder inhalers and multidose dry powder inhalers. Common devices in current use include metered dose inhalers, which are used to deliver medications for the treatment of asthma, chronic obstructive pulmonary disease and the like. Exemplary devices include dry powder inhalers, designed to form a cloud or aerosol of fine powder with a particle size that is typically less than about 6.0 μm.

Microparticle size, including mean size distribution, may be controlled by means of the method of making. For micro milling, the size of the milling head, speed of the rotor, time of processing and the like control the microparticle size. For spray drying, the nozzle size, flow rate, dryer heat, and the like control the microparticle size. For making by means of quick freeze aerosol followed by lyophilization, the nozzle size, flow rate, concentration of aerosolized solution and the like control the microparticle size. These parameters and others may be employed to control the microparticle size.

The peptides described herein may be therapeutically administered by means of an injection, typically a deep intramuscular injection, such as in the gluteal or deltoid muscle, of a time-release injectable formulation. A peptide may be formulated with a polyethylene glycol, such as polyethylene glycol 3350, and optionally one or more additional excipients and preservatives, including but not limited to excipients such as salts, polysorbate 80, sodium hydroxide, or hydrochloric acid to adjust pH, and the like. A peptide may also be formulated with a poly(ortho ester), which may be an auto-catalyzed poly(ortho ester) with any of a variable percentage of lactic acid in the polymeric backbone, and optionally one or more additional excipients. A poly(D,L-lactide-co-glycolide) polymer (PLGA polymer) may be employed, such as a PLGA polymer with a hydrophilic end group, such as PLGA RG502H from Boehringer Ingelheim, Inc. (Ingelheim, Germany). Such formulations may be made, for example, by combining a peptide in a suitable solvent, such as methanol, with a solution of PLGA in methylene chloride, and adding thereto a continuous phase solution of polyvinyl alcohol under suitable mixing conditions in a reactor. In general, any of a number of injectable and biodegradable polymers, which may also be adhesive polymers, may be employed in a time-release injectable formulation. The teachings of U.S. Pat. Nos. 4,938,763; 6,432,438; and 6,673,767, and the biodegradable polymers and methods of formulation disclosed therein, are incorporated here by reference. The formulation may be such that an injection is required on a weekly, monthly, or other periodic basis, depending on the concentration and amount of cyclic peptide, the biodegradation rate of the polymer, and other factors known to those of skill in the art.

Routes of Administration

In various aspects, the anti-microbial peptides described herein can be administered using any means known in the art, including orally, rectally, vaginally, ocularly, intranasally, topically, parenterally, or by injection. If administered by injection, the peptide injection may be intravenous (IV), subcutaneous (SC), intramuscular (IM), intraperitoneal (IP), intracerebroventricular (ICV), or other means known in the art. The peptides described herein may be formulated by any means known in the art, including but not limited to formulation as tablets, capsules, caplets, suspensions, powders, lyophilized preparations, suppositories, pessaries, ocular drops, skin patches, orally soluble formulations, enteric formulations, solutions sprays, aerosols and the like, and may be mixed and formulated with buffers, binders, excipients, stabilizers, lubricants, oils, adjuvants, anti-oxidants and other agents known in the art. In general, any route of administration by which the peptides are introduced across an epidermal layer of cells may be employed. Administration includes topical delivery. Administration includes delivery across the blood brain barrier. Administration includes delivery through mucous membranes, buccal administration, ophthalmic administration, oral administration, dermal administration, inhalation administration, nasal administration, urethral administration, vaginal administration, rectal administration, and the like.

Therapeutically Effective Amount

In general, the actual quantity of an anti-microbial peptide administered to a patient will vary between fairly wide ranges depending upon the mode of administration, the formulation used, and the response desired. The dosage for treatment is administration, by any of the foregoing means or any other means known in the art, of an amount sufficient to bring about the desired therapeutic effect. Thus a therapeutically effective amount includes an amount of a peptide or pharmaceutical composition that is sufficient to therapeutically alleviate feeding disorder in a patient, or to prevent or delay onset or recurrence of the feeding disorder, or for the management of the feeding disorder in patients with diseases or syndromes associated with cachexia, including secondary to immune disorders and cancer.

In general, the anti-microbial peptides described herein are highly active. For example, the anti-microbial peptide can be administered at about 0.001 nmol, 0.005 nmol, 0.01 nmol, 0.02 nmol, 0.05 nmol, 0.1 nmol, 0.25 nmol, 0.5 nmol, 1 nmol, 2.5 nmol, 5 nmol, 10 nmol, 20 nmol, 25 nmol, 50 nmol, 100 nmol, 250 nmol, 500 nmol, or 1000 nmol, or even more, depending on the specific peptide selected, the desired therapeutic response, the route of administration, the formulation and other factors known to those of skill in the art.

In other aspects, the compositions are useful for topical administration can be, e.g., creams, lotions, mouthwashes, nasal or ocular drops or aerosol.

In some aspects, an effective dose of the peptide is at least about 0.001 nmol, 0.005 nmol, 0.01 nmol, 0.02 nmol, 0.03 nmol, 0.04 nmol, 0.05 nmol, 0.06 nmol, 0.07 nmol, 0.08 nmol, 0.09 nmol, 0.1 nmol, 0.2 nmol, 0.3 nmol, 0.4 nmol, 0.5 nmol, 0.6 nmol, 0.7 nmol, 0.8 nmol, 0.9 nmol, 1.0 nmol, 1.1 nmol, 1.2 nmol, 1.3 nmol, 1.4 nmol, 1.5 nmol, 1.6 nmol, 1.7 nmol, 1.8 nmol, 1.9 nmol, 2 nmol, 3 nmol, 4 nmol, 5 nmol, 6 nmol, 7 nmol, 8 nmol, 9 nmol, 10 nmol, 11 nmol, 12 nmol, 13 nmol, 14 nmol, 15 nmol, 16 nmol, 17 nmol, 18 nmol, 19 nmol, 20 nmol, 21 nmol, 22 nmol, 23 nmol, 24 nmol, 25 nmol, 26 nmol, 27 nmol, 28 nmol, 29 nmol, 30 nmol, 31 nmol, 32 nmol, 33 nmol, 34 nmol, 35 nmol, 36 nmol, 37 nmol, 38 nmol, 39 nmol, 40 nmol, 41 nmol, 42 nmol, 43 nmol, 44 nmol, 45 nmol, 46 nmol, 47 nmol, 48 nmol, 49 nmol, 50 nmol, 51 nmol, 52 nmol, 53 nmol, 54 nmol, 55 nmol, 56 nmol, 57 nmol, 58 nmol, 59 nmol, 60 nmol, 61 nmol, 62 nmol, 63 nmol, 64 nmol, 65 nmol, 66 nmol, 67 nmol, 68 nmol, 69 nmol, 70 nmol, 61 nmol, 72 nmol, 73 nmol, 74 nmol, 75 nmol, 76 nmol, 77 nmol, 78 nmol, 79 nmol, 80 nmol, 81 nmol, 82 nmol, 83 nmol, 84 nmol, 85 nmol, 86 nmol, 87 nmol, 88 nmol, 89 nmol, 90 nmol, 91 nmol, 92 nmol, 93 nmol, 94 nmol, 95 nmol, 96 nmol, 97 nmol, 98 nmol, 99 nmol, 100 nmol, 110 nmol, 120 nmol, 130 nmol, 140 nmol, 150 nmol, 160 nmol, 170 nmol, 180 nmol, 190 nmol, 200 nmol, 210 nmol, 220 nmol, 230 nmol, 240 nmol, 250 nmol, 260 nmol, 270 nmol, 280 nmol, 290 nmol, 300 nmol, 310 nmol, 320 nmol, 330 nmol, 340 nmol, 350 nmol, 360 nmol, 370 nmol, 380 nmol, 390 nmol, 400 nmol, 410 nmol, 420 nmol, 430 nmol, 440 nmol, 450 nmol, 460 nmol, 470 nmol, 480 nmol, 490 nmol, 500 nmol, 510 nmol, 520 nmol, 530 nmol, 540 nmol, 550 nmol, 660 nmol, 770 nmol, 880 nmol, 990 nmol, 600 nmol, 610 nmol, 620 nmol, 630 nmol, 640 nmol, 650 nmol, 660 nmol, 670 nmol, 680 nmol, 690 nmol, 700 nmol, 710 nmol, 720 nmol, 730 nmol, 740 nmol, 750 nmol, 760 nmol, 770 nmol, 780 nmol, 790 nmol, 800 nmol, 810 nmol, 820 nmol, 830 nmol, 840 nmol, 850 nmol, 860 nmol, 870 nmol, 880 nmol, 890 nmol, 900 nmol, 910 nmol, 920 nmol, 930 nmol, 940 nmol, 950 nmol, 960 nmol, 970 nmol, 980 nmol, 990 nmol, 1000 nmol, or in some aspects, even more.

In some aspects an effective dose of the peptide is at least about 0.001 mg, 0.005 mg, 0.1 mg, 0.2 mg, 0.3 mg, 0.4 mg, 0.5 mg, 6 mg, 0.7 mg, 0.8 mg, 0.9 mg, 1 mg, 2 mg, 3 mg, 4 mg, 5 mg, 6 mg, 7 mg, 8 mg, 9 mg, 10 mg, 11 mg, 12 mg, 13 mg, 14 mg, 15 mg, 16 mg, 17 mg, 18 mg, 19 mg, 20 mg, 21 mg, 22 mg, 23 mg, 24 mg, 25 mg, 26 mg, 27 mg, 28 mg, 29 mg, 30 mg, 31 mg, 32 mg, 33 mg, 34 mg, 35 mg, 36 mg, 37 mg, 38 mg, 39 mg, 40 mg, 41 mg, 42 mg, 43 mg, 44 mg, 45 mg, 46 mg, 47 mg, 48 mg, 49 mg, 50 mg, 51 mg, 52 mg, 53 mg, 54 mg, 55 mg, 56 mg, 57 mg, 58 mg, 59 mg, 60 mg, 61 mg, 62 mg, 63 mg, 64 mg, 65 mg, 66 mg, 67 mg, 68 mg, 69 mg, 70 mg, 61 mg, 72 mg, 73 mg, 74 mg, 75 mg, 76 mg, 77 mg, 78 mg, 79 mg, 80 mg, 81 mg, 82 mg, 83 mg, 84 mg, 85 mg, 86 mg, 87 mg, 88 mg, 89 mg, 90 mg, 91 mg, 92 mg, 93 mg, 94 mg, 95 mg, 96 mg, 97 mg, 98 mg, 99 mg, 100 mg, 110 mg, 120 mg, 130 mg, 140 mg, 150 mg, 160 mg, 170 mg, 180 mg, 190 mg, 200 mg, 210 mg, 220 mg, 230 mg, 240 mg, 250 mg, 260 mg, 270 mg, 280 mg, 290 mg, 300 mg, 310 mg, 320 mg, 330 mg, 340 mg, 350 mg, 360 mg, 370 mg, 380 mg, 390 mg, 400 mg, 410 mg, 420 mg, 430 mg, 440 mg, 450 mg, 460 mg, 470 mg, 480 mg, 490 mg, 500 mg, 510 mg, 520 mg, 530 mg, 540 mg, 550 mg, 560 mg, 570 mg, 580 mg, 590 mg, 600 mg, 610 mg, 620 mg, 630 mg, 640 mg, 650 mg, 660 mg, 670 mg, 680 mg, 690 mg, 700 mg, 710 mg, 720 mg, 730 mg, 740 mg, 750 mg, 760 mg, 770 mg, 780 mg, 790 mg, 800 mg, 810 mg, 820 mg, 830 mg, 840 mg, 850 mg, 860 mg, 870 mg, 880 mg, 890 mg, 900 mg, 910 mg, 920 mg, 930 mg, 940 mg, 950 mg, 960 mg, 970 mg, 980 mg, 990 mg, 1000 mg, or in some aspects, even more.

In some aspects of the methods described herein, at least one individual dose of the peptide is no more than about 1000 nmol, 990 nmol, 980 nmol, 970 nmol, 960 nmol, 950 nmol, 940 nmol, 930 nmol, 920 nmol, 910 nmol, 900 nmol, 890 nmol, 880 nmol, 870 nmol, 860 nmol, 850 nmol, 840 nmol, 830 nmol, 820 nmol, 810 nmol, 800 nmol, 790 nmol, 780 nmol, 770 nmol, 760 nmol, 750 nmol, 740 nmol, 730 nmol, 720 nmol, 710 nmol, 700 nmol, 690 nmol, 680 nmol, 670 nmol, 660 nmol, 650 nmol, 640 nmol, 630 nmol, 620 nmol, 610 nmol, 600 nmol, 590 nmol, 580 nmol, 570 nmol, 560 nmol, 550 nmol, 540 nmol, 530 nmol, 520 nmol, 510 nmol, 500 nmol, 490 nmol, 480 nmol, 470 nmol, 460 nmol, 450 nmol, 440 nmol, 430 nmol, 420 nmol, 410 nmol, 400 nmol, 390 nmol, 380 nmol, 370 nmol, 360 nmol, 350 nmol, 340 nmol, 330 nmol, 320 nmol, 310 nmol, 300 nmol, 290 nmol, 280 nmol, 270 nmol, 260 nmol, 250 nmol, 240 nmol, 230 nmol, 220 nmol, 210 nmol, 200 nmol, 190 nmol, 180 nmol, 170 nmol, 160 nmol, 150 nmol, 140 nmol, 130 nmol, 120 nmol, 110 nmol, 100 nmol, 99 nmol, 98 nmol, 97 nmol, 96 nmol, 95 nmol, 94 nmol, 93 nmol, 92 nmol, 91 nmol, 90 nmol, 89 nmol, 88 nmol, 87 nmol, 86 nmol, 85 nmol, 84 nmol, 83 nmol, 82 nmol, 81 nmol, 80 nmol, 79 nmol, 78 nmol, 77 nmol, 76 nmol, 75 nmol, 74 nmol, 73 nmol, 72 nmol, 71 nmol, 70 nmol, 69 nmol, 68 nmol, 67 nmol, 66 nmol, 65 nmol, 64 nmol, 63 nmol, 62 nmol, 61 nmol, 60 nmol, 59 nmol, 58 nmol, 57 nmol, 56 nmol, 95 nmol, 54 nmol, 53 nmol, 52 nmol, 51 nmol, 50 nmol, 49 nmol, 48 nmol, 47 nmol, 46 nmol, 45 nmol, 44 nmol, 43 nmol, 42 nmol, 41 nmol, 40 nmol, 39 nmol, 38 nmol, 37 nmol, 36 nmol, 35 nmol, 34 nmol, 33 nmol, 32 nmol, 31 nmol, 30 nmol, 29 nmol, 28 nmol, 27 nmol, 26 nmol, 25 nmol, 24 nmol, 23 nmol, 22 nmol, 21 nmol, 20 nmol, 19 nmol, 18 nmol, 17 nmol, 16 nmol, 15 nmol, 94 nmol, 13 nmol, 12 nmol, 11 nmol, 10 nmol, 9 nmol, 8 nmol, 7 nmol, 6, nmol, 5 nmol, 4 nmol, 3 nmol, 2 nmol, 1 nmol, 0.9 nmol, 0.8 nmol, 0.7 nmol, 0.6 nmol, 0.5 nmol, 0.4 nmol, 0.3 nmol, 0.2 nmol, 0.1 nmol, 0.05 nmol, 0.01 nmol, 0.005 nmol, 0.001 nmol, and even, in some aspects, less than about 0.001 nmol.

In some aspects of the methods described herein, at least one individual dose of the peptide is no more than about 1000 mg, 990 mg, 980 mg, 970 mg, 960 mg, 950 mg, 940 mg, 930 mg, 920 mg, 910 mg, 900 mg, 890 mg, 880 mg, 870 mg, 860 mg, 850 mg, 840 mg, 830 mg, 820 mg, 810 mg, 800 mg, 790 mg, 780 mg, 770 mg, 760 mg, 750 mg, 740 mg, 730 mg, 720 mg, 710 mg, 700 mg, 690 mg, 680 mg, 670 mg, 660 mg, 650 mg, 640 mg, 630 mg, 620 mg, 610 mg, 600 mg, 590 mg, 580 mg, 570 mg, 560 mg, 550 mg, 540 mg, 530 mg, 520 mg, 510 mg, 500 mg, 490 mg, 480 mg, 470 mg, 460 mg, 450 mg, 440 mg, 430 mg, 420 mg, 410 mg, 400 mg, 390 mg, 380 mg, 370 mg, 360 mg, 350 mg, 340 mg, 330 mg, 320 mg, 310 mg, 300 mg, 290 mg, 280 mg, 270 mg, 260 mg, 250 mg, 240 mg, 230 mg, 220 mg, 210 mg, 200 mg, 190 mg, 180 mg, 170 mg, 160 mg, 150 mg, 140 mg, 130 mg, 120 mg, 110 mg, 100 mg, 99 mg, 98 mg, 97 mg, 96 mg, 95 mg, 94 mg, 93 mg, 92 mg, 91 mg, 90 mg, 89 mg, 88 mg, 87 mg, 86 mg, 85 mg, 84 mg, 83 mg, 82 mg, 81 mg, 80 mg, 79 mg, 78 mg, 77 mg, 76 mg, 75 mg, 74 mg, 73 mg, 72 mg, 71 mg, 70 mg, 69 mg, 68 mg, 67 mg, 66 mg, 65 mg, 64 mg, 63 mg, 62 mg, 61 mg, 60 mg, 59 mg, 58 mg, 57 mg, 56 mg, 95 mg, 54 mg, 53 mg, 52 mg, 51 mg, 50 mg, 49 mg, 48 mg, 47 mg, 46 mg, 45 mg, 44 mg, 43 mg, 42 mg, 41 mg, 40 mg, 39 mg, 38 mg, 37 mg, 36 mg, 35 mg, 34 mg, 33 mg, 32 mg, 31 mg, 30 mg, 29 mg, 28 mg, 27 mg, 26 mg, 25 mg, 24 mg, 23 mg, 22 mg, 21 mg, 20 mg, 19 mg, 18 mg, 17 mg, 16 mg, 15 mg, 94 mg, 13 mg, 12 mg, 11 mg, 10 mg, 9 mg, 8 mg, 7 mg, 6, mg, 5 mg, 4 mg, 3 mg, 2 mg, 1 mg, 0.9 mg, 0.8 mg, 0.7 mg, 0.6 mg, 0.5 mg, 0.4 mg, 0.3 mg, 0.2 mg, 0.1 mg, 0.05 mg, 0.01 mg, 0.005 mg, 0.001 mg, and in some aspects, even less.

In some aspects of the methods described herein, an effective dose of the peptide is at least about 0.001 mg/kg body weight to about 10 mg/kg body weight per day.

In some aspects described herein, an effective dose of the peptide is at least about 0.001 mg/kg, 0.005 mg/kg, 0.01 mg/kg, 0.02 mg/kg, 0.03 mg/kg, 0.04 mg/kg, 0.05 mg/kg, 0.06 mg/kg, 0.07 mg/kg, 0.08 mg/kg, 0.09 mg/kg, 0.1 mg/kg, 0.2 mg/kg, 0.3 mg/kg, 0.4 mg/kg, 0.5 mg/kg, 0.6 mg/kg, 0.7 mg/kg, 0.8 mg/kg, 0.9 mg/kg, 1.0 mg/kg, 1.1 mg/kg, 1.2 mg/kg, 1.3 mg/kg, 1.4 mg/kg, 1.5 mg/kg, 1.6 mg/kg, 1.7 mg/kg, 1.8 mg/kg, 1.9 mg/kg, 2.0 mg/kg, 2.1 mg/kg, 2.2 mg/kg, 2.3 mg/kg, 2.4 mg/kg, 2.5 mg/kg, 2.6 mg/kg, 2.7 mg/kg, 2.8 mg/kg, 2.9 mg/kg, 3.0 mg/kg, 3.1 mg/kg, 3.2 mg/kg, 3.3 mg/kg, 3.4 mg/kg, 3.5 mg/kg, 3.6 mg/kg, 3.7 mg/kg, 3.8 mg/kg, 3.9 mg/kg, 4.0 mg/kg, 4.1 mg/kg, 4.2 mg/kg, 4.3 mg/kg, 4.4 mg/kg, 4.5 mg/kg, 4.6 mg/kg, 4.7 mg/kg, 4.8 mg/kg, 4.9 mg/kg, 5.0 mg/kg, 5.1 mg/kg, 5.2 mg/kg, 5.3 mg/kg, 5.4 mg/kg, 5.5 mg/kg, 5.6 mg/kg, 5.7 mg/kg, 5.8 mg/kg, 5.9 mg/kg, 6.0 mg/kg, 6.1 mg/kg, 6.2 mg/kg, 6.3 mg/kg, 6.4 mg/kg, 6.5 mg/kg, 6.6 mg/kg, 6.7 mg/kg, 6.8 mg/kg, 6.9 mg/kg, 2.0 mg/kg, 7.1 mg/kg, 7.2 mg/kg, 7.3 mg/kg, 7.4 mg/kg, 7.5 mg/kg, 7.6 mg/kg, 7.7 mg/kg, 7.8 mg/kg, 7.9 mg/kg, 8.0 mg/kg, 8.1 mg/kg, 8.2 mg/kg, 8.3 mg/kg, 8.4 mg/kg, 8.5 mg/kg, 8.6 mg/kg, 8.7 mg/kg, 8.8 mg/kg, 8.9 mg/kg, 9.0 mg/kg, 9.1 mg/kg, 9.2 mg/kg, 9.3 mg/kg, 9.4 mg/kg, 9.5 mg/kg, 9.6 mg/kg, 9.7 mg/kg, 9.8 mg/kg, 9.9 mg/kg, 10.0 mg/kg of body weight per day, or in some aspects, even more.

In some aspects, the peptide is administered by a clinician. In other aspects, the peptide is self-administered. For example, the peptide may be administered in the morning, in the afternoon, or periodically throughout the day. The dose size may be adjusted to account for the frequency and timing of administration of the peptide, and that the daily dosage may, to some degree, be determined by the subject or a clinician based on estimated need, on the delivery system used, and on the presence or absence of other risk factors (e.g., hereditary risk factors or other environmental risk factors such as occupational risk factors and/or exposure to air pollution).

In some aspects, it may be desirable to place an upper limit on single doses and/or daily dosage. Administration devices that limit or modulate self-administration of pulmonary administered pharmaceuticals and other substances in order to prevent possible overdose by the subject are known in the art.

In some aspects of the methods described herein, the peptide may be administered several times a month, several times a week, once each day, or even several times a day. Typically, a therapeutically effective dose is administered once each day. As a non-limiting example, an effective dose may be administered in one or more sessions, such as one portion of a dose is administered in the morning and the remaining portion of a dose is administered in the afternoon.

Dose frequency may be from once daily, twice daily, three times daily, or four times daily, to twice daily, four times daily, six times daily, eight times daily, ten times daily or more than ten times per day. In some aspects, the dose frequency is from once daily to ten times daily, once daily to five times daily, twice daily, or once daily. Frequency of administration may be determined and adjusted over the course of care, and is generally, but not necessarily, based on symptoms and clinical findings.

Therapeutic Uses of Anti-Microbial Peptides

In some aspects, described herein, the anti-microbial peptides described herein useful for preventing weight loss (e.g., through anti-cachexia activity), while further inhibiting infection.

In some aspects, the anti-microbial peptides are useful for the treatment, prophylaxis, or amelioration of any disease or condition, wherein an individual or subject has an altered immune response (e.g., any immunodeficiency, microbial infection, immunosuppresive therapy, or a reduced immune system), or needs to gain body mass or weight from Cachexia. In one aspect, the anti-microbial peptides are useful for the treatment, prophylaxis, or amelioration opportunistic infections stemming from the presence of a primary humoral immune deficiency, multiple myeloma, chronic lymphoid leukemia, human immunodeficiency virus infection (HIV), acquired immunodeficiency syndrome (AIDS), bone marrow transplantation, any solid organ allograft/transplantation, the chronic use of steroids, the chronic or acute use of immunosuppressive regimens (e.g., from a solid organ allograft/transplantation), cancer chemotherapy, lymphoma, glucocorticoid therapy, chronic granulomatous disease, a splenectomy, trauma, sickle cell anema, a congenital deficiency in the complement system.

In some aspects, the anti-microbial peptides are useful for the treatment, prophylaxis, or amelioration of a hospital acquired infection. In one aspect, the anti-microbial peptides are useful in emergency and severe situations and are suitable for the I.V. administration of a patient or subject (e.g., a human) in need thereof.

In some aspects, the anti-microbial peptides described herein are useful for the treatment of a bacterial infection. In some aspects, the anti-microbial peptides described herein are useful for the treatment of a fungal infection. In some aspects, the anti-microbial peptides described herein are useful for the treatment of sepsis stemming from a bacterial infection. In some aspects, the anti-microbial peptides described herein, are useful for the treatment of a gram-negative bacterial infection. In some aspects, the anti-microbial peptides described herein are useful for the treatment of a gram positive bacterial infection. Exemplary non-limiting examples of sepsis-causing microorganisms that can be treated in accordance with the present invention include, but are not limited to, those that cause infections in the lung, abdomen, bloodstream, skin, soft tissue, infections associated with intravascular devices, and respiratory infections. Examples of other pathogenic microorganisms that can be treated include, but are not limited to, Gram-negative bacteria such as Bacteroides, Fusobacterium, Escherichia, Klebsiella, Salmonella, Shigella, Proteus, Pseudomonas, Vibrio, Legionella, Haemophilus, Bordetella, Brucella, Campylobacter, Neisseria, Branhamella; Gram-positive bacteria such as Streptococcus, Staphylococcus, Peptococcus, Bacillus, Listeria, Clostridium, Propionibacteria; organisms that stain poorly or not at all with Gram's stain such as Mycobacteria, Treponema, Leptospira, Borrelia, Mycoplasma, Chlamydia, Rickettsia and Coxiella; and fungi such as Candida, Aspergillosis, Blastomycosis, Coccidioidomycosis, Cryptococcosis, Histoplasmosis, Paracoccidioidomycosis, Sporotrichosis, Zygomycosis.

Combination Therapies

In some aspects, the peptides described herein may be used in combination with other drugs or agents, particularly in the treatment of cachexia. These other drugs and agents may include agents that induce weight gain, including corticosteroids and progestational agents. Peptides may be used in combination with a therapeutically effective amount of a second weight gain pharmaceutical agent.

Methods for the treatment of cachexia are described herein. The methods include the step of administering to the patient having or at risk of having cachexia a therapeutically effective amount of a peptide in combination with a therapeutically effective amount of another compound that is useful in the treatment of cachexia. The second compound useful for the treatment of cachexia are selected from but not limited to the group consisting of ADP-ribose-polymerase inhibitors, ADP-ribose-transferase inhibitors, NADase inhibitors, nicotinamide benzamide, theophylline, thymine and analogs thereof; omega-3 fatty acids such as alpha-linolenic acid, stearidonic acid, eicosapentaenoic acid (EPA), docosapentaenoic acid, docosahexaenoic acid or mixtures thereof; branched-chain amino acids valine, leucine, isoleucine or mixtures thereof, with or without reduced levels of tryptophan and 5-hydroxytryptophan; antioxidants selected from the group comprising beta-carotene, vitamin C, vitamin E, selenium, or mixtures thereof; L-glutamine, vitamin A, vitamin C, vitamin E, and selenium; quinine derivatives including 3,5,6-trimethyl-2-β-pyridyl)methyl-1,4-benzoquinone hydrochloride; interleukin 2; benzaldehyde; 4,6-O-benzylidene-D-glucose; friedelan-3-one; hydrazine sulfate; medroxyprogesterone acetate; beta 2-adrenoceptor agonists; corticosteroids such as dexamethasone; Vitor™; Pro-Stat™; megestrol acetate (Megace™); dronabinol (Marinol™); magestrol acetate (Megace™); thalidomide (Thalidomid™); fluoxymesterone (Halotestin™); pentoxifylline (Trental™); cyproheptadine (Periactin™); metoclopramide (Reglan™); total parenteral nutrition; or other MC4-R antagonists. A second compound useful for the treatment of cachexia is somatropin (Serostim™), an injectable form of human growth hormone.

In some aspects, the anti-microbial peptides described herein are used alone or in combination with another agent for treating, reducing the symptoms of, or onset of an infection in a subject. In some aspects, the anti-microbial peptides described herein are used alone or in combination with another agent for treating, reducing the symptoms of, or onset of an opportunistic infection a subject. In some aspects, the anti-microbial peptides described herein are used alone or in combination with another agent for treating, reducing the symptoms of, or onset of a hospital acquired infection. In some aspects, the anti-microbial peptides described herein are used alone or in combination with another agent that decreases the efficiency of the immune system (e.g., immunosuppressive therapy, steroids, or anti-cancer therapeutics). In some aspects, the anti-microbial peptides described herein are used alone or in combination with another agent for the treatment of a symptom of an underlying condition or ailment (e.g., pain medications, anti-tussives, expectorants, anti-proliferatives, or a combination thereof).

In some aspects, the anti-microbial agents used in combination with the anti-microbial peptides described herein include other anti-microbial agents. Exemplary non-limiting examples of other anti-microbial agents include antibacterial drugs including beta-lactam compounds, such as penicillin, methicillin, nafcillin, oxacillin, cloxacillin, dicloxacillin, ampicillin, ticarcillin, amoxicillin, carbenicillin, and piperacillin; cephalosporins and cephamycins such as cefadroxil, cefazolin, cephalexin, cephalothin, cephapirin, cephradine, cefaclor, cefamandole, cefonicid, cefuroxime, cefprozil, loracarbef, ceforanide, cefoxitin, cefmetazole, cefotetan, cefoperazone, cefotaxime, ceftazidine, ceftizoxine, ceftriaxone, cefixime, cefpodoxime, proxetil, cefdinir, cefditoren, pivoxil, ceftibuten, moxalactam, and cefepime; other beta-lactam drugs such as aztreonam, clavulanic acid, sulbactam, tazobactam, ertapenem, imipenem, and meropenem; other cell wall membrane active agents such as vancomycin, teicoplanin, daptomycin, fosfomycin, bacitracin, and cycloserine; tetracyclines such as tetracycline, chlortetracycline, oxytetracycline, demeclocycline, methacycline, doxycycline, minocycline, and tigecycline; macrolides such as erythromycin, clarithromycin, azithromycin, and telithromycin; aminoglycosides such as streptomycin, neomycin, kanamycin, amikacin, gentamicin, tobramycin, sisomicin, and netilmicin; sulfonamides such as sulfacytine, sulfisoxazole, sulfamethizole, sulfadiazine, sulfamethoxazole, sulfapyridine, and sulfadoxine; fluoroquinolones such as ciprofloxacin, enoxacin, gatifloxacin, gemifloxacin, levofloxacin, lomefloxacin, moxifloxacin, norfloxacin, and ofloxacin; antimycobacterial drugs such as isoniazid, rifampin, rifabutin, rifapentine, pyrazinamide, ethambutol, ethionamide, capreomycin, clofazimine, and dapsone; and miscellaneous antimicrobials such as colistimethate sodium, methenamine hippurate, methenamine mandelate, metronidazole, mupirocin, nitrofurantoin, polymyxin B, clindamycin, chloramphenicol, quinupristin-dalfopristin, linezolid, spectinomycin, trimethoprim, pyrimethamine, and trimethoprim-sulfamethoxazole.

In some aspects, the anti-microbial agents used in combination with the anti-microbial peptides described herein include antifungal agents. Non-limiting examples of antifungal agents include anidulafungin, amphotericin B, butoconazole, butenafine, caspofungin, clotrimazole, econazole, fluconazole, flucytosine griseofulvin, itraconazole, ketoconazole, miconazole, micafungin, naftifine, natamycin, nystatin, oxiconazole, sulconazole, terbinafine, terconazole, tioconazole, tolnaftate, and/or voriconazole.

In some aspects, the anti-microbial agents used in combination with the anti-microbial peptides described herein include oxidizing chemicals suitable to disrupt or destroy cell membranes. For example, some oxidizing chemicals may withdraw electrons from a cell membrane causing it to, for example, become destabilized. Destroying the integrity of cell membranes of, for example, a pathogen may lead to cell death.

In some aspects, the anti-microbial agents used in combination with the anti-microbial peptides described herein include antiseptics and disinfectants. Non-limiting examples of antiseptics and disinfectants include acetic acid, acrisorcin, aluminum acetate, alcohols (e.g., ethanol, isopropanol, benzyl alcohol, phenylethyl alcohol), aldehydes (e.g., formaldehyde, glutaraldehyde), benzoic acid, boric acid, butylparaben, chlorhexidine gluconate, chlorine sodium hypochlorite, hexachlorophene, iodine, povidone-iodine, phenols, oxidizing agents (e.g., hydrogen peroxide), parabens (e.g., butylparaben, ethylparaben, methylparaben, propylparaben), phenylmercuric acetate, phenylmercuric nitrate, potassium permanganate, propylene oxide, pyrithione zinc, and quaternary ammonium (e.g., benzalkonium chloride, cetylpyridinum chloride, benzethonium chloride), nitrofurazone, selenium sulfide, silver nitrate, and silver sulfadiazine.

In some aspects, the anti-microbial agents used in combination with the anti-microbial peptides described herein include antiseptics and disinfectants incorporated into a substrate, or non-fouling polymer at a surface (e.g., a coating of a medical device or catheter) to enhance antimicrobial activity at the surface or be released to provide antimicrobial activity in a desired location. Suitable agents include silver metals, silver salts such as silver sulfadiazine, silver oxide, silver carbonate, silver acetate, silver alginate, silver azide, silver citrate, silver lactate, silver nitrate, silver sulfate, silver chloride, silver thiocyanate, silver-sodium-hydrogen-zirconium phosphate, silver sulfadiazine, silver cyclohexanediacetic acid and disilver 2,5-dichloro-3,6-dihydroxy-2,5-cyclohexadiene-1,4-dione, among others, a bismuth salt such as bismuth nitrate, bismuth citrate or bismuth salicylate among others, a zinc salt, a cerium salt, triclosan, combinations of chlorhexidine free base and chlorhexidine acetate, benzalkonium chloride, citrate, povidoneiodine, parachlorometaxylene, gramicidin, polymixin, norfloxacin, tobramycin, sulfamylon, polyhexamethylene biguanide, alexidine, iodine, rifampicin, miconazole, bacitracin, and minocycline, ciprofloxacin, clindamycin, erythromycin, gentamycin, tetracycline and vancomycin. Additional biguanide compounds which may be used and include poly(hexamethylene biguanide) hydrochloride and chlorhexidine compounds. Chlorhexidine is the term denoting the chemical compound 1,6 bis(N-5-p-chlorophenyl-N1-biguanido)hexane). Chlorhexidine compounds include chlorhexidine free base (“CHX”) as well as chlorhexidine salts, such as chlorhexidine diphosphanilate, chlorhexidine digluconate (“CHG”), chlorhexidine diacetate (“CHA”), chlorhexidine dihydrochloride, chlorhexidine dichloride, chlorhexidine dihydroiodide, chlorhexidine diperchlorate, chlorhexidine dinitrate, chlorhexidine sulfate, chlorhexidine sulfite, chlorhexidine thiosulfate, chlorhexidine di-acid phosphate, chlorhexidine difluorophosphate, chlorhexidine diformate, chlorhexidine dipropionate, chlorhexidine di-iodobutyrate, chlorhexidine di-n-valerate, chlorhexidine dicaproate, chlorhexidine malonate, chlorhexidine succinate, chlorhexidine malate, chlorhexidine tartrate, chlorhexidine dimonoglycolate, chlorhexidine mono-diglycolate, chlorhexidine dilactate, chlorhexidine di-α-hydroxyisobutyrate, chlorhexidine diglucoheptonate, chlorhexidine di-isothionate, chlorhexidine dibenzoate, chlorhexidine dicinnamate, chlorhexidine dimandelate, chlorhexidine di-isophthalate, chlorhexidine di-2-hydroxy-napthoate, and chlorhexidine embonate.

In some aspects, the anti-microbial agents used in combination with the anti-microbial peptides described herein can be further combined with antipyretics, analgesics and antiphlogistics (such as indometacin, acetylsalicylic acid, diclofenac sodium, ketoprofen, ibuprofen, mefenamic acid, azulene, phenacetin, isopropyl antipyrine, acetaminophen, bendazac, phenylbutazone, flufenamic acid, acetylsalicylic acid (aspirin), paracetamol, phenazone, sodium salicylate, salicylamide, sazapyrine, and etodolac) opioid analgesics (such as buprenorphine, dextromoramide, dextropropoxyphene, fentanyl, alfentanil, sufentanil, hydromorphone, methadone, morphine, oxycodone, papavereturn, pentazocine, pethidine, phenoperidine, codeine dihydrocodeine) non-selective COX inhibitors such as salicylic acid derivatives, aspirin, sodium salicylate, choline magnesium trisalicylate, salsalate, diflunisal, sulfasalazine and olsalazine). Para-aminophenol derivatives such as acetaminophen. Indole and indene acetic acids such as indomethacin and sulindac. Heteroaryl acetic acids such as tolmetin, diclofenac and ketorolac. Arylpropionic acids such as ibuprofen, naproxen, flurbiprofen, ketoprofen, fenoprofen and oxaprozin. Anthranilic acids (fenamates) such as mefenamic acid and meloxicam. Enolic acids such as the oxicams (piroxicam, meloxicam). Alkanones such as nabumetone. Selective COX-2 Inhibitors (such as diaryl-substituted furanones such as rofecoxib; diaryl-substituted pyrazoles such as celecoxib; indole acetic acids such as etodolac and sulfonanilides such as nimesulide).

In some aspects, the anti-microbial agents used in combination with the anti-microbial peptides described herein can be further combined with examples of anti-inflammatory steroids (such as cortisone, hydrocortisone, prednisone, dexamethasone, methylprednisolone, triamcinolone, beclomethasone, flunisolide, fluticasone proprionate, triamcinolone acetonide, budesonide, loteprednol etabonate, mometasone, aclometasone, desonide, hydrocortisone, betamethasone, clocortolone, desoximetasone, fluocinolone, flurandrenolide, mometasone, prednicarbate; amcinonide, desoximetasone, diflorasone, fluocinolone, fluocinonide, halcinonide, clobetasol, augmented betamethasone, diflorasone, halobetasol, prednisone, dexamethasone and methylprednisolone and their derivatives); antiulcer drugs (such as ecabet sodium, enprostil, sulpiride, cetraxate hydrochloride, gefarnate, irsogladine maleate, cimetidine, ranitidine hydrochloride, famotidine, nizatidine and roxatidine acetate hydrochloride); coronary vasodilators (such as nifedipine, isosorbide dinitrate, diltiazem hydrochloride, trapidil, dipyridamole, dilazep hydrochloride, verapamil, nicardipine, nicardipine hydrochloride and verapamil hydrochloride); or peripheral vasodilators (such as ifenprodil tartrate, cinepazide maleate, cyclandelate, cinnarizine and pentoxyphylline).

In some aspects, the anti-microbial agents used in combination with the anti-microbial peptides described herein can be further combined with synthetic antimicrobials (such as nalidixic acid, piromidic acid, pipemidic acid trihydrate, enoxacin, cinoxacin, of loxacin, norfloxacin, ciprofloxacin hydrochloride and sulfamethoxazole-trimethoprim); antiviral agents (such as acyclovir, ganciclovir, acyclovir prodrugs, famciclovir, zidovudine, didanosine, stavudine, lamivudine, zalcitabine, saquinavir, indinavir, ritonavir, n-docosanol, tromantadine and idoxuridine).

In some aspects, the anti-microbial agents used in combination with the anti-microbial peptides described herein can be further combined with antitussives (such as tipepidine hibenzate, methylephedrine hydrochloride, codeine phosphate, tranilast, dextromethorphan hydrobromide, dimemorfan phosphate, clobutinol hydrochloride, fominoben hydrochloride, benproperine phosphate, eprazinone hydrochloride, clofedanol hydrochloride, ephedrine hydrochloride, noscapine, pentoxyverine citrate, oxeladin citrate and isoaminyl citrate); expectorants (such as bromhexine hydrochloride, carbocysteine, ethyl cysteine hydrochloride and methylcysteine hydrochloride); bronchodilators (such as theophylline, aminophylline, sodium cromoglicate, procaterol hydrochloride, trimetoquinol hydrochloride, diprophylline, salbutamol sulfate, clorprenaline hydrochloride, formoterol fumarate, orciprenaline sulfate, pirbuterol hydrochloride, hexoprenaline sulfate, bitolterol mesilate, clenbuterol hydrochloride, terbutaline sulfate, malbuterol hydrochloride, fenoterol hydrobromide and methoxyphenamine hydrochloride), cardiotonics (such as dopamine hydrochloride, dobutamine hydrochloride, docarpamine, denopamine, caffeine, digoxin, digitoxin and ubidecarenone); antihistamines (such as chlorpheniramine maleate, clemastine fumarate, mequitazine, alimemazine tartrate, cyproheptadine hydrochloride and bepotastine besilate).

In some aspects, the anti-microbial agents used in combination with the anti-microbial peptides described herein can be further combined with antineoplastic/antiangiogenic (such as acivicin, aclarubicin, acodazole, acronycine, adozelesin, alanosine, aldesleukin, allopurinol sodium, altretamine, aminoglutethimide, amonafide, ampligen, amsacrine, androgens, anguidine, aphidicolin glycinate, asaley, asparaginase, 5-azacitidine, azathioprine, Bacillus calmette-guerin (BCG), Baker's Antifol (soluble), beta-2′-deoxythioguanosine, bisantrene hcl, bleomycin sulfate, busulfan, buthionine sulfoximine, BWA 773U82, BW 502U83.HCI, BW 7U85 mesylate, caracemide, carbetimer, carboplatin, carmustine, chlorambucil, chloroquinoxaline-sulfonamide, chlorozotocin, chromomycin A3, cisplatin, cladribine, corticosteroids, Corynebacterium parvum, CPT-11, crisnatol, cyclocytidine, cyclophosphamide, cytarabine, cytembena, dabis maleate, dacarbazine, dactinomycin, daunorubicin HCl, deazauridine, dexrazoxane, dianhydrogalactitol, diaziquone, dibromodulcitol, didemnin B, diethyldithiocarbamate, diglycoaldehyde, dihydro-5-azacytidine, doxorubicin, echinomycin, edatrexate, edelfosine, eflornithine, Elliott's solution, elsamitrucin, epirubicin, esorubicin, estramustine phosphate, estrogens, etanidazole, ethiofos, etoposide, fadrozole, fazarabine, fenretinide, filgrastim, finasteride, flavone acetic acid, floxuridine, fludarabine phosphate, 5-fluorouracil, Fluosol®, flutamide, gallium nitrate, gemcitabine, goserelin acetate, hepsulfam, hexamethylene bisacetamide, homoharringtonine, hydrazine sulfate, 4-hydroxyandrostenedione, hydroxyurea, idarubicin HCl, ifosfamide, interferon alfa, interferon beta, interferon gamma, interleukin-1 alpha and beta, interleukin-3, interleukin-4, interleukin-6,4-ipomeanol, iproplatin, isotretinoin, leucovorin calcium, leuprolide acetate, levamisole, liposomal daunorubicin, liposome encapsulated doxorubicin, lomustine, lonidamine, maytansine, mechlorethamine hydrochloride, melphalan, menogaril, merbarone, 6-mercaptopurine, mesna, methanol extraction residue of Bacillus calmette-guerin, methotrexate, N-methylformamide, mifepristone, mitoguazone, mitomycin-C, mitotane, mitoxantrone hydrochloride, monocyte/macrophage colony-stimulating factor, nabilone, nafoxidine, neocarzinostatin, octreotide acetate, ormaplatin, oxaliplatin, paclitaxel, pala, pentostatin, piperazinedione, pipobroman, pirarubicin, piritrexim, piroxantrone hydrochloride, PIXY-321, plicamycin, porfimer sodium, prednimustine, procarbazine, progestins, pyrazofurin, razoxane, sargramostim, semustine, spirogermanium, spiromustine, streptonigrin, streptozocin, sulofenur, suramin sodium, tamoxifen, taxotere, tegafur, teniposide, terephthalamidine, teroxirone, thioguanine, thiotepa, thymidine injection, tiazofurin, topotecan, toremifene, tretinoin, trifluoperazine hydrochloride, trifluridine, trimetrexate, tumor necrosis factor, uracil mustard, vinblastine sulfate, vincristine sulfate, vindesine, vinorelbine, vinzolidine, Yoshi 864, zorubicin, and mixtures thereof.

In some aspects, the anti-microbial agents used in combination with the anti-microbial peptides described herein can be further combined with immunosuppressant agents (such as cyclosporine A, mycophenolic acid, tacrolimus, rapamycin, rapamycin analogues, azathioprine, recombinant or monoclonal antibodies to interleukins, T-cells, B-cells and/or their receptors).

In some aspects, the anti-microbial agents used in combination with the anti-microbial peptides described herein can be further combined with antiproliferative agents (such as paclitaxel, actinomycin D, rapamycin, tacrolimus, everolimus, dexamethasone and rapamycin analogues).

In some aspects, the anti-microbial agents used in combination with the anti-microbial peptides described herein can be further combined with local anaesthetics (such as benzocaine, bupivacaine, amethocaine, lignocaine, lidocaine, cocaine, cinchocaine, dibucaine, mepivacaine, prilocaine, etidocaine, veratridine (specific c-fiber blocker) and procaine).

In some aspects, the anti-microbial agents used in combination with the anti-microbial peptides described herein can be further combined with antifungals (such as amorolfine, isoconazole, clotrimazole, econazole, miconazole, nystatin, terbinafine, bifonazole, amphotericin, griseo fluvin, ketoconazole, fluconazole and flucytosine, salicylic acid, fezatione, ticlatone, tolnaftate, triacetin, zinc, pyrithione and sodium pyrithione).

In some aspects, the anti-microbial agents used in combination with the anti-microbial peptides described herein can be further combined with agents/chemicals that block microbial attachment to target cells and/or inhibits entry of infectious pathogens (e.g., sulphated and sulfonated polymers such as PC-515 (carrageenan), Pro-2000, and Dextrin 2 Sulphate); agents which change the condition of the tissue to make it hostile to the pathogen (such as substances which alter mucosal pH (e.g., Buffer Gel and Acidform).

In some aspects, the anti-microbial agents used in combination with the anti-microbial peptides described herein can be further combined with antiretroviral agents (e.g., PMPA gel) that prevent retroviruses from replicating in the cells.

In some aspects, the anti-microbial agents used in combination with the anti-microbial peptides described herein can be further combined with agents that treat or prevent an allergic or immune response and/or cellular proliferation (such as various cytokine inhibitors such as humanized anti-cytokine antibodies, anti-cytokine receptor antibodies, recombinant antagonists, or soluble receptors; various leukotriene modifiers such as zafirlukast, montelukast and zileuton; immunoglobulin E (IgE) inhibitors such as Omalizumab (an anti-IgE monoclonal antibody) and secretory leukocyte protease inhibitor) and SYK Kinase inhibitors).

In some aspects, the anti-microbial agents used in combination with the anti-microbial peptides described herein can be further combined with antibodies and antibody fragments (such as, but are not limited to, therapeutic antibodies include trastuzumab, alemtuzumab, gemtuzumab, rituximab, ibritumomab, tositumomab, edrecolomab, cetuximab, bevacizumab, Ranibizumab, satumomab, pertuzumab, and daclizumab).

In some aspects, the anti-microbial agents used in combination with the anti-microbial peptides described herein can be further combined with steroids (such as glucocorticoids, estrogens and androgens. By way of example, steroids can include dexamethasone, dexamethasone acetate, dexamethasone sodium phosphate, cortisone, cortisone acetate, hydrocortisone, hydrocortisone acetate, hydrocortisone cypionate, hydrocortisone sodium phosphate, hydrocortisone sodium succinate, prednisone, prednisolone, prednisolone acetate, prednisolone sodium phosphate, prednisolone tebutate, prednisolone pivalate, triamcinolone, triamcinolone acetonide, triamcinolone hexacetonide, triamcinolone diacetate, methylprednisolone, methylprednisolone acetate, methylprednisolone sodium succinate, flunisolide, beclomethasone dipropionate, betamethasone sodium phosphate, betamethasone, vetamethasone disodium phosphate, vetamethasone sodium phosphate, betamethasone acetate, betamethasone disodium phosphate, chloroprednisone acetate, corticosterone, desoxycorticosterone, desoxycorticosterone acetate, desoxycorticosterone pivalate, desoximethasone, estradiol, fluorocortisone, fluorocortisone acetate, dichlorisone acetate, fluorohydrocortisone, fluorometholone, fluprednisolone, paramethasone, paramethasone acetate, androsterone, fluoxymesterone, aldosterone, methandrostenolone, methylandrostenediol, methyl testosterone, norethandrolone, testosterone, testosterone enanthate, testosterone propionate, equilenin, equilin, estradiol benzoate, estradiol dipropionate, estriol, estrone, estrone benzoate, acetoxypregnenolone, anagestone acetate, chlormadinone acetate, fluorogestone acetate, hydroxymethylprogesterone, hydroxymethylprogesterone acetate, hydroxyprogesterone, hydroxyprogesterone acetate, hydroxyprogesterone caproate, melengestrol acetate, norethisterone, pregnenolone, progesterone, ethynyl estradiol, mestranol, dimethisterone, ethisterone, ethynodiol diacetate, norethindrone, norethindrone acetate, norethisterone, fluocinolone acetonide, flurandrenolone, hydrocortisone sodium succinate, methylprednisolone sodium succinate, prednisolone phosphate sodium, triamcinolone acetonide, hydroxydione sodium, spironolactone, oxandrolone, oxymetholone, prometholone, testosterone cypionate, testosterone phenylacetate, estradiol cypionate, and norethynodrel, analogs thereof, or combinations thereof).

Additives in Animal Foodstuff

In some aspects described herein, the antimicrobial peptides may be used as animal feed stock additives. In this way, animal feeds will contain one or more of an anti-microbial peptide in an amount effective to increase weight gain and/or feed conversion while also preventing infection by a pathogenic organism. The anti-microbial peptides described herein are not structurally similar to clinically used antibiotics for the treatment of human infection and do not lead to increased antibiotic resistence, thus, representing a new a needed method for controlling microbial growth in animals, while reducing the development of multi-resistant antibiotic bacterial strains from antibiotic use in animals. Hancock, The Lancet Infectious Diseases 1(3): 156-164 (2001).

The animal feeds are generally formulated to provide nutrients in accordance with industry standards. The feeds may be formulated from a variety of different feed ingredients, which are chosen according to market price and availability. Accordingly, some components of the feed may change over time. For discussions on animal feed formulations and NRC guidelines, see Church, Livestock Feeds and Feeding, O&B Books, Inc., Corvallis Oreg. (1984) and Feeds and Nutrition Digest, Ensminger, Oldfield and Heineman eds., Ensminger Publishing Corporation, Clovis, Calif. (1990), each of which is incorporated herein by reference.

Animal feeds are traditionally balanced based upon protein and energy requirements, and then adjusted if needed to meet the other requirements, which will vary for the different stages of growth and maintenance of the animal. Growing young animals will require higher protein feeds, while finishing animals close to market will require higher energy, high carbohydrate, feeds. For example, typical hog prestarter, starter and grower-finisher feeds will generally contain about 20-24% protein, 18-20% protein, and 13-17% protein respectively. In some feeding situations, care must be taken to provide the appropriate amino acids as well as overall protein content. For example, hogs fed large amounts of corn must have adequate lysine made available in the feed. In most animal diets, energy requirements are met by starches in cereal grains. Energy requirements may also be met by addition of fat to the feed. Animal feeds containing the anti-microbial peptides as described herein may also be formulated for any animal including dogs, cats, poultry, fish, and cattle, hogs, horses, goats, sheep, among others.

Other ingredients may be added to the animal feed in addition to the anti-microbial peptides described herein, as needed to promote the health and growth of the animal. The ingredients include, without limitation, sugars, complex carbohydrates, amino acids (e.g., arginine, histidine, isoleucine, leucine, lysine, methionine, phenylalanine, threonine, tryptophan, valine, tyrosine, alanine, aspartic acid, sodium glutamate, glycine, proline, serine, and cysteine, among others), vitamins (e.g., thiamine, riboflavin, pyridoxine, niacin, niacinamide, inositol, choline chloride, calcium pantothenate, biotin, folic acid, ascorbic acid, and vitamins A, B, K, D, E, among others), minerals, protein (e.g., meat meal, fish meal, liquid or powdered egg, fish solubles, whey protein concentrate), oils (e.g., soybean oil), cornstarch, calcium, inorganic phosphate, copper sulfate, and sodium chloride. Any medicament ingredients known in the art may also be added to the animal feed, including, without limitation, antibiotics and hormones. For vitamin, mineral and antibiotic supplementation of animal feeds see Church, Livestock Feeds and Feeding, O&B Books, Inc., Corvallis Oreg. (1984).

Any animal feed blend known in the art can be used in accordance with the present invention, including, without limitation, forages, such as orchard grass, timothy, tall fescue, ryegrass, alfalfa, sainfoin, clovers, and vetches, grain feeds, such as corn, wheat, barley sorghum, triticale, rye, canola, and soya beans, crop residues, cereal grains, legume by-products, and other agricultural by-products. In situations where the resulting feed is to be processed or preserved, the feed may be treated with oxidatively transformed carotenoid or a component thereof before processing or preservation. Desirably, the animal feed of the invention includes rapeseed meal, cottonseed meal, soybean meal, or cornmeal.

Processing may include drying, ensiling, chopping, pelleting, cubing, baling, rolling, tempering, grinding, cracking, popping, extruding, micronizing, roasting, flaking, cooking, and/or exploding. For example, pelleted feed is created by first mixing feed components and then compacting and extruding the feed components through a die with heat and pressure. Animal feeds of the invention can be pelleted as described in, for example, MacBain, Pelleting Animal Feed, American Feed Manufacturers Association, Arlington, Va. (1974) incorporated herein by reference for its teachings thereof.

In some aspects, the one or more antimicrobial peptides supplemented in feed stock decreases acetate and methane production, increases propionate, enhances nitrogen efficiency, improves the digestion of dry matter in ruminants, and improves feeding efficiency. In some aspects, the anti-microbial peptides increase weight gain by its anti-cachexia effects described herein, and increases in feed conversions. In some aspects, weight gain in animals provided with feedstock supplemented with the one or more antimicrobial peptides is increased from about 2% to about 50%, including all integers within the specified range. In some aspects, food consumption by animals provided with feedstock supplemented with the one or more antimicrobial peptides is decreased from about 2% to about 25%, including all integers within the specified range. In some aspects, growth rate of animals provided with feedstock supplemented with the one or more antimicrobial peptides is increased from about 2% to about 25%, including all integers within the specified range.

In some aspects, one or more of the antimicrobial peptides described herein are supplemented with an antibiotic in a feed stock as described herein. In some aspects, one or more of the antimicrobial peptides described herein are supplemented with an ionophore or non-ionophore antibiotic, a phosphoglycolipid antibiotic, or other naturally occuring anti-microbial peptide, or a combination thereof in an animal feed stock. Exemplary non-limiting compounds safe for use in animal feed stocks include bambermycins, lasalocid sodium, monensin sodium, salinomycin, virginiamycin, and zinc bacitracin. In some aspects, the antimicrobial peptides described herein are supplemented in combination with about 6 ppm to about 100 ppm of another antibiotic or antimicrobial.

In some aspects, the use of the anti-microbial peptides described herein synergizes with an antibiotic. In this aspect, there is a reduction in the total amount of antibiotic and anti-microbial peptide required in the feed stock, thereby reducing feedstock cost.

In some aspects, the selection of one or more antimicrobial peptides modifies the growth rate of gram-negative or gram-positive bacteria selectively. The animal gut is made-up of a complex mixture of bacteria and protozoa. Gram negative bacteria are generally considered beneficial since they contribute to the break-down of cellulose into compounds beneficial for animal growth and energy. Gram positive bacteria and protozoa are generally not beneficial since their digestive byproducts are not beneficial to the animal. The gram positive organisms that need to be controlled include Ruminococcus albus, R. flavefaciens and Butyrivibrio fibrisolvens. Controlling these micro-organisms has the beneficial effect of decreasing fermentation thus allowing more energy nutrients to go to the animal. Controlling the bacterium Methanobacterium ruminantium reduces the conversion of H₂ to methane gas. Controlling the various species of Streptococci and Lactobacilli also reduce the undesirable use of H₂ and allows more to be used in the desirable formation of propionate. Proprionate is largely responsible for animal growth. Isotricha and Entodini are two protozoa which commonly infect the rumin that can also take away energy and nutrients from the farm animal.

In some aspects, the selection of one or more antimicrobial peptides, as described herein decreases the growth of gram-positive bacteria, while not affective the growth of gram-negative bacteria. In some aspects, the selection of one or more antimicrobial peptides, as described herein decreases the growth of gram-negative bacteria, while not affective the growth of gram-positive bacteria. In some aspects, the selection of one or more antimicrobial peptides, as described herein decreases the growth of gram-negative bacteria and gram-positive bacteria.

In some aspects, the anti-microbial peptides, as described herein are useful in foodstuffs and can be in the form of a health bar, preferably supplied in foil or other types of wrappers, as is commonly seen in most food markets, convenience stores, and health food stores. Typically, such health bars are commonly made by a machine extrusion process that extrudes the mixed ingredients into the desired size and shape bar, which is then conveyed to automatic wrapping machinery. Health bars may be baked, rather than extruded.

In some aspects, the anti-microbial peptides, as described herein are useful in other foodstuffs. Exemplary non-limiting foodstuffs may also be extruded, baked, rolled, pressed, cut or otherwise formed into bars or baked goods, such as cookies, brownies, cakes, or muffins. In the manufacturing process for bars that are extruded, ingredients such as glycerine, lecithin, vegetable and other oils (such as sunflower oil) are used in part to help bind ingredients together so as to help form a uniformly shaped bar in the extrusion machinery. Such known processes can be used to produce the health bars and baked goods of the present invention.

In some aspects, the anti-microbial peptides can be in the form of a ready-to-drink beverage, requiring no addition of water and/or mixing with water or other liquids, or a powder or a liquid concentrate that is mixed with water, fruit juice, fruit and/or other flavored drinks, and/or fruit drink concentrates to make, for example, a flavored beverage, or with milk to make a drink having a character similar to that of a milk-shake.

In some aspects, the anti-microbial peptides can be in the form of a therapeutic nutraceutical used for the treatment, reduction in symptoms of, or therapy of a subject. The nutraceutical may be in the form of a tablet or capsule described herein, a ready-to-drink beverage or other liquid, a powder or a liquid concentrate that is mixed with water.

It will be readily apparent to one of ordinary skill in the relevant arts that suitable modifications and adaptations to the compositions, methods, and applications described herein can be made without departing from the scope of any embodiments or aspects thereof. The compositions and methods provided are exemplary and are not intended to limit the scope of the claimed embodiments. All of the various embodiments, aspects, and options disclosed herein can be combined in all variations. The scope of the compositions and methods described herein include all actual or potential combinations of embodiments, aspects, options, examples, and preferences herein described. All patents and publications cited herein are entirely incorporated by reference herein for the specific teachings thereof.

EXAMPLES Example 1 Solution NMR Studies of a Representative Anti-Microbial Peptide

To understand the importance of the structure of the anti-microbial peptides described herein we performed solution NMR on a representative peptide TCAM207 Ac-Nle-c[Asp-Pro-D-NaI(2′)-Arg-Trp-Lys]-D-Val-D-Pro-NH₂ (SEQ NO: 209). While initial studies could assign spatial coordinates to the ring, interference from a-hydrogens obscured assignment of the amino acid residue's side-chains. To suppress interference, we replaced the a-hydrogens with deuterium; repeatedly dissolving the peptide in heavy water, followed by lyophilization. The result was an NMR image shown in FIG. 2 where spatial assignment of both ring and side-chains were possible. Computer analysis of the coordinates suggested that the ring is stabilized in a β2 conformation by a hydrogen bond between the adjacent Pro and NaI residues (dashed yellow line in the lower half of the ring). Thus, analysis of products from our platform technology shows the importance of both the C-terminal di-peptide sequence and the secondary structure of the lactam ring for oral activity and blood brain barrier transport.

Example 2 Cationic-Aromatic Peptide Safety in a Large Animal Model

We further conducted a preliminary study in a large animal canine model to assess cardiovascular and hematologic safety and clearance of the peptide TCAM207 (SEQ NO: 209) from plasma over a multiple day dosing. Male and female purpose bred beagles were randomized to treatment and instrumented with Holter 9 lead electrocardiograph (ECG) jackets and non-invasive oscillographic paw blood pressure monitoring (emkaPAC 4G telemetry). ECG and BP signals were sampled at 500 Hz using GLP compliant software (IOX, EMKA). ECG signals were saved continuously and blood pressure determined hourly. Blood samples were taken before and after 14 days of SC or oral drug administration for complete chemistry panel and CBC analysis. Samples were taken 1, 2, 4, 8, 12, and 24 hours after drug administration on days 1 and 5 for assay of plasma IIP to assess PK profile. After a 1-2 week washout, dogs were randomized to the other arm of the study. FIG. 3 shows the change in red blood cell (RBC) count, hemoglobin (Hg), and hematocrit (Hct) produced by 5 days of 5× therapeutic dose of TCMCB07 in normal beagles (n=4). While there were slight (statistically insignificant) decreases in all parameters, no RBC casts were noted. These small attributes decreases in the blood parameters are likely attributable to the amount of blood drawn during this PK study.

Example 2 Blood Concentration of Orally-Administered Anti-Microbial Peptide TCAM207 (SEQ NO: 209) in Canines

The concentration of anti-microbial peptide TCAM207 (SEQ NO: 209) was subsequently tested in canines (beagles) to determine stability of the peptides orally. As shown in FIG. 4, peptides were stable and remained in the plasma for up to 24 hrs.

Example 3 Selective Anti-Microbial Activity of the Anti-Microbial Peptides to Gram-Positive or Gram-Negative Bacteria

An emerging problem in the treatment of infectious diseases is biofilms (Sanchez C J, Jr., et al. Biofilm formation by clinical isolates and the implications in chronic infections. BMC infectious diseases. 2013; 13:47. PMCID: 3568419, PMID 23356488; and Dean S N, et al., Natural and synthetic cathelicidin peptides with anti-microbial and anti-biofilm activity against Staphylococcus aureus. BMC microbiology. 2011;11:114. PMCID: 3397408, PMID 21605457). Bacteria and fungi can assume a planktonic or free swimming phenotype, or they can exist as part of a colony (typically attached to a surface): a biofilm. A colony of bacteria in a biofilm are surrounded by an exopolysaccharide matrix for protection. Biofilms are found in 60-80% of chronic hospital-associated infections: A biofilm allows infections to “escape” virtually any therapeutic agent (Van Acker H, et al., Molecular mechanisms of antimicrobial tolerance and resistance in bacterial and fungal biofilms. Trends in microbiology. 2014; 22(6):326-33, PMID 24598086). There is evidence that development of antibiotic-resistant strains of bacteria enhances biofilm production (Burmolle M, et al., Enhanced biofilm formation and increased resistance to antimicrobial agents and bacterial invasion are caused by synergistic interactions in multispecies biofilms. Applied and environmental microbiology. 2006; 72(6):3916-23. PMCID: 1489630, PMID 16751497).

Because there are both antimicrobial peptides (Dathe M, et al., Biochemistry. 2004; 43(28):9140-50, PMID 15248771; and Strom M B, et al., Journal of peptide science: an official publication of the European Peptide Society. 2002; 8(8):431-7, PMID 12212806) and antibiofilm peptides (Dean S N, et al., BMC microbiology. 2011; 11:114. PMCID: 3397408, PMID 21605457; and de la Fuente-Nunez C, et al., 2014; 10(5):e1004152. PMCID: 4031209, PMID 24852171), we developed a hybrid peptide that combines the activities of both these classes of peptides: an anti-biofilm/anti-microbial peptide, AB01: Ac-FRIRVRV-c[Asp-RR-dNaI(21-FWR-Lys]-dVal-dPro-CONH₂.

Further, a set of the anti-microbial peptides described herein were tested for their anti-microbial activity on both Gram-positive and Gram-negative bacteria. All five of the tested anti-microbial peptides demonstrated substantial observable cell agglutination effects and non-membrane activity as outlined in Table 1. Unexpectedly, it was further observed that the C-terminal residues (denoted by bold font) selectively target gram-negative or gram-positive bacteria, as indicated.

TABLE 1 Optimization selective anti-microbial activity of peptide TCAM207 (SEQ NO: 209): Ac-Nle¹c[Asp²-Pro³-D-Nal(2′)⁴-Arg⁵-Trp⁶-Lys⁷]-D-Val⁸-D-Pro⁹-NH₂ Amino Acid IC₅₀, E. coli; IC50 B. subtilis Membrane Non-Membrane Addition Substitution^(#) μg/mL μg/mL Disruption? Activity? Asp²-Arg-Pro³ & D- 5.3 0.7 Yes, and Agglutination Septum inhibition, Nal(2′)⁶ (Opt 1) protein aggregation Asp²-Arg-Pro³ & D- 2.6 0.7 Yes, and Agglutination Septum inhibition, Nal(2′)⁶-Arg-Lys⁷ (Opt 2) protein aggregation Asp²-Arg-Pro³ & D-Phe⁸- 0.7 10.4 Yes, and Agglutination None observed dVal⁹ (Opt 3) Asp²⁻Arg-Pro³ & Phe⁸-Val⁹ 0.7 10.4 Yes, and Agglutination Septum inhibition, (Opt 4) protein aggregation Asp²⁻Arg-Pro³ & Val⁸-Phe⁹ 1.3 20.8 Yes, and Agglutination Altered cell (Opt 5) division, nonspecific Melittin (Control) 0.7 20.8 Yes None observed

Exemplary, non-limiting representations of hybrid peptides having anti-microbial, anti-biofilm, or anti-microbial and anti-biofilm activity from the embodiments and aspects described herein are shown in Table 1 above.

A hybrid peptide was produced that combines an AMP(anti-microbial peptide) with an anti-biofilm peptide that also has anti-microbial activity. To this construct, a newly discovered series of C-terminal di-peptides was added that direct AMP anti-microbial activity to either Gram-positive or Gram-negative organisms. This produced a peptide with a micro molar MIC (anti-microbial activity) against planktonic bacteria, and the ability to disrupt bacterial adhesion in a biofilm. Concerns regarding potential hemolytic actions of AMPs were addressed in a 28-day canine administration study, showing no effects on hematocrit, RBC count, or reticulocytosis at 3× the dose required for μM blood levels.

Table 1 shows the first series of AMPs. Core sequences were cyclized to enhance druggability and anti-microbial activity. Multiple cationic residues increased binding to anionic membrane and intracellular structures. Naphthylalanine (NaI) and proline are residues that also enhanced anti-microbial activity. The C-terminal di-peptides in these AMPs were used for their ability to enhance oral activity in peptides. It was discovered that they also directed relative anti-microbial activity towards either Gram-positive or negative organisms (Table 1 and FIG. 5). These AMPs appear to have multiple mechanisms of action (Table 1), potentially mediated by specific binding to the bacterial membrane, and their intracellular accumulation (data not shown). In essence, these AMPs are a form of combination therapy.

Table 1 depicts a series of derivatives of an orally active AMP. Anti-microbial activity is reported as the concentration needed to inhibit 50% of bacterial division (IC₅₀, a standard used in the AMP field). Opt 1 & Opt 2 have a Val-Pro C-terminal di-peptide and are relatively specific for B. subtilis, a Gram-positive organism. In contrast, Opt 3-5 have a Phe for Pro substitution in the C-terminal di-peptide, which produces relatively specificity for Gram-negative organisms (e.g. E. coli). Melittin is a cationic-hydrophobic AMP that served as anti-microbial positive control. Agglutination, an attribute assisting in the clearance of bacterial cells during infection, was assessed via microscopy, and was present with all five AMPs.

A second series of cationic-aromatic AMPs was designed, and linked (via the N-terminus) to linear anti-biofilm peptides. This created a hybrid anti-biofilm/AMP (AB01), with a Gram-positive specific C-terminal di-peptide (dVal-dPro). A model Gram positive organism that rapidly forms biofilms (M. smegmatis; Ojha, A. and G. F. Hatfull, The role of iron in Mycobacterium smegmatis biofilm formation: the exochelin siderophore is essential in limiting iron conditions for biofilm formation but not for planktonic growth. Mol Microbiol, 2007. 66(2): p. 468-83) was used to assess the inhibition of adhesion/anti-biofilm activity of AB01 & two control AMPs, using a 2 day old biofilm. AB01 was ˜100-fold more potent than Model 01; a previously described AMP (Liu, Z., et al., Length effects in antimicrobial peptides of the (RW)n series. Antimicrob Agents Chemother, 2007. 51(2): p. 597-603) (FIG. 6). AB01 uses the technology of U.S. Pat. No. 8,541,545 that results in enhanced in vivo half-life (4-6 hours), oral activity, and blood-brain-barrier transport. In addition, AB01 had an MIC (minimum inhibtory concentration) against Gram-positive bacteria of 5 μM, and 25 μM for E. coli (a Gram-negative organism). When incubated with Gram-positive bacteria, AB01 was found in the cytoplasm, because it was released by sonication, concurrent with DNA release. This is similar to the AMPs reported in Table 6.

The effect of three AMPs on M. smegmatis adhesion was measured on day 0 (data not shown) & after 2 days of biofilm growth, counting crystal violet-positive cells (FIG. 5; see O′Toole, G. A., Microtiter dish biofilm formation assay. J Vis Exp, 2011(47)). Control bacterial adhesion was designated as 100%, and the effect of an added AMP on the cell count was quantified as a percent of the control. The AMPs included Model 01, an AMP of the (RW)_(n) series, (RW)₄: [17]; AM11, a cyclized analog of the (RW)_(n) series _(c)(RW)₃; and AB01, a hybrid of a cyclized AMP and a linear anti-biofilm peptide. While 10 μM Model-01 prevented adhesion on day 0, ≧100 μM was needed to prevent adhesion in a 2 day old biofilm. In contrast, AB01 prevented adhesion at 1 μM on day 0 and at 3-5 μM in a 2 day old biofilm.

Example 4 Naturally Occuring Anti-Microbial Pharmacophores

Known naturally occuring anti-microbial pharmacophores that can be artifically modified are show in Table 2 below.

TABLE 2 Naturally Occuring Anti-microbial Pharmacophores Melanocortin His-Phe-Arg-Trp SEQ NO: 1 Lactoferrin Arg-Arg-Trp-Gln-Gln-Arg SEQ NO: 2 Polyphemusin Arg-Arg-Trp-Cys-Arg SEQ NO: 3 Tachyplesin Arg-Trp-Cys-Phe-Arg SEQ NO: 4 Protegrin Tyr-Cys-Arg-Arg-Phe SEQ NO: 5 Defensin Ala-Cys-Arg-Arg-Arg-Phe SEQ NO: 6 Other Natural Arg-Arg-Trp-Trp-Arg SEQ NO: 7

Example 5 Peptides that have Blood Brain Barrier Transport and/or Oral Activity

Known peptides having blood brain barrier transport and/or oral activity are show in Table 3 below.

TABLE 3 Peptides that have blood brain barrier transport and/or oral activity Vasopressin c[Cys-Tr-Phe-Gln-Asn-Cys]-Pro-Arg-Gly-NH₂ Neurotensin Analog N^(α)Arg^(Me)-Lys-Pro-Trp-Tle-Leu Model Cyclic Peptide c[Phe(C3)-Gly-Gly-Gly-Gly-Phe]-NH₂ MC cyclic Analog c[CO—(CH₂)₂—CO-Phe-D-Phe-Arg-Trp- N—(CH₂)₂—NH]—CH₂CO—NH₂ PG932 Ac-Nle-c[Asp-Pro-D-Nal2′-Arg-Trp]-Pro-Val- NH₂

Example 6 Anti-Biofilm Peptides

Exemplary Anti-biofilm peptide sequences that can be used for preventing or reducing the viability of a microbial biofilm are shown in Table 4 below.

TABLE 4 Anti-biofilm Peptide Sequences SEQ NO Peptide Peptide Sequence  8 1018 Val-Arg-Leu-Ile-Val-Ala-Val-Arg- Ile-Trp-Arg-Arg  9 ATRA1 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys- Lys-Leu-Lys 10 ATRA1Arg Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg- Arg-Leu-Arg 11 ABF1 Val-Arg-Leu-Ile-Val-Ala-Val-Arg 12 ABF2 Val-Arg-Ile-Trp-Arg-Arg 13 ABF3 Val-Arg-Leu-Ile-Val-Ala 14 ABF4 Lys-Lys-Phe-Lys-Lys-Phe-Phe 15 ABF4Arg Arg-Arg-Phe-Arg-Arg-Phe-Phe 16 ABF5 Phe-Phe-Lys-Lys-Leu-Lys 17 ABF5Arg Phe-Phe-Arg-Arg-Leu-Arg 18 ABF6 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys- Lys 19 ABF6Arg Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg- Arg 20 ABF7 Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys 21 ABF7ARG Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg

Example 7 Exemplary Testing of Antimicrobial Activity Through MIC Determination

Bacteria MIC can be determined by using a standard 96 well plate assay with serial dilutions of AMP peptides will be performed as previously described targeting the nosocomial pathogens Staphylococcus aureus USA100 and Klebsiella pneumoniae KPPR1. Hicks et al., Bioorganic & Medicinal Chemistry 21(1): 205-214 (2013). The MIC can be determined using standard methods, using the lowest dilution of peptide without significant growth above the original inoculum. In the case of bacteriostatic effects, the IC₅₀ (effective concentration for 50% inhibition of growth) and MIC can be determined. Direct bacteriocidal effects can further be assayed by observation of a loss in OD₅₉₅ from original inoculum readings (P<0.05, t-test).

The determination of the timing of the killing or inhibition of bacteria with AMPs, can be repeated and modified from the above assay with the following modification. Overnight cultures are resuspended in sterile PBS, and seeded into wells with peptides and PBS. In addition, BacLight Live/Dead Viability Staining dyes (Life Technologies) are used as an additional measure of bacterial viability. This kit contains Syto9, a nucleic acid dye that readily penetrates the cells and stains the DNA. Additionally, this kit contains propidium iodide (PI) that will only penetrate disrupted membranes, and will dye the nucleic acids.

Example 8 Exemplary Testing Protocols to Determine the Anti-Microbial Peptide Mode of Action

Anti-microbial peptides can have activity through membrane disruption, internally through DNA/RNA synthesis inhibition, septum inhibition, or combinations thereof. Brogden, Nature Reviews Microbiology 3(3): 238-250 (2005). To determine preliminary mode of action analysis, Staphylococcus aureus USA100 and Klebsiella pneumoniae KPPR1 bacteria will be subjected to treatment at different concentrations of anti-microbial peptides, and subjected to the following analyses.

(1) Microscopy. Bacteria can be treated with dilutions of AMPs were directly analyzed via microscopy for membrane disruption phenotypes, including cell agglutination, cell lysis, and cell elongation/septum disruption. Cells can be also monitored for septum inhibition and elongation through use of the membrane dye FM5-95 and DAPI. Additionally the cells can be imaged and stained with the Life Technologies LIVE/DEAD® BacLight™ Bacterial Viability Kit For killing kinetics of the anti-microbial peptides.

(2) Agglutination and Protein Aggregation. Using the antimicrobial 96 well assay described above, imaging of the 96 well plate and can provide a method for the determination of the MAC (minimum agglutination concentration) for the bacteria, as described. Torrent et al., PLoS Pathogens 8(11): e1003005 (2012).

(3) Penetration of the AMPs into the cell. Penetration and localization can be determined via biotinylation of the AMPs prior to treatment. Exemplary treatments of the peptides with biotin and treatment is as follows: Cell cultures of Staphylococcus/Klebsiella are subjected to biotinylated AMP for 1 hour. After the one hour, the culture is evenly split into two smaller cultures. For the first culture, the cells are washed, and analyzed via a Biotin Quantitative HABA-Avidin Premix Kit (ThermoSci) giving a quantitative analysis of the exposed biotin. For the second tube, the cells are lysed via 2% Sarkosyl and vortexed, and the assay repeated as above to determine total biotin. The ratio of #2 minus #1 is representative of the intracellular concentration of the peptide. The positive control was a known amount of biotin added to a control reaction, the negative controls were cells without AMP added.

(4) Visualization of the penetration of the AMPs. The AMPs can be fluorescein or Alexa Fluor 488 tagged at their N- or C-termini and delivered to the cells and treated with the membrane dye FM5-95. The presence of fluorescein/Alexa Fluor 488 and localization within the cells is indicative of the internalization of the peptides.

(5) RNA synthesis and Protein synthesis inhibition can be determined with exemplary bacterial lines, such as, Staphylococcus aureus, USA100 and Klebsiella pneumoniae KPPR1 strains. These strains can be created to constitutively express an unstable GFP variant under a housekeeping gene as previously described. Anderson et al., Trends in Ecology & Evolution 13(11): 444-449 (1998); Barysheva et al., Microbiology 154(4): 1015-1025 (2008). The expressing cells can be treated for 1 hour with sublethal doses of anti-microbial peptides, and the fluorescence of the cells can be compared to that of an untreated culture via fluorescence microscopy or flow cytometry to determine effects on RNA synthesis or Protein synthesis.

(6) Protein Synthesis. Inducible β-galactosidase expression constructs can be utilized for the quantitation of de novo protein synthesis in S. aureus. Rosey et al., Journal of Bacteriology 173(19): 5992-5998 (1991); Oskouian et al., Journal of Bacteriology 172(7): 3804-3812 (1990). Thus, this model can be utilized to determine protein synthesis inhibition responses to the anti-microbial peptides by detecting the amount of β-galactosidase activity compared to a normalized untreated control (normalized to live cell number).

(7) Hemolysis. Because anti-microbial peptides can act as cell membrane disrupters, a potential “toxic” effect is hemolysis (i.e., a narrow hemolytic therapeutic window). Thus, it is necessary to measure an AMP drug candidate's hemolytic therapeutic index to insure an adequate margin of safety. These assays can be performed in phosphate-buffered saline (PBS) w/wo 10% fetal bovine serum and human RBCs, as previously described for AMP development. Fernandez-Lopez et al., Nature 412(6845): 452-455 (2001). Peptide concentrations will be 1-1000 mg. Hemolysis will be assessed with a hemocytometer, using PBS and Triton X-100 as negative and positive controls for zero and 100% hemolysis. An acceptable index for an Anti-microbial peptide should be equivalent to the negative control at a concentration of 5× the proposed in vivo therapeutic dose (therapeutic index=5). In support of the potential safety of cationic-aromatic AMPs, cationic-aromatic peptides (e.g., MCs) have been used clinically, with no evidence of hemolytic activity. Safarinejad, J. Sex Med. 5(4): 887-897 (2008).

Example 9

Exemplary non-limiting representations of peptides having anti-microbial, anti-biofilm, or anti-microbial and anti-biofilm activity from the embodiments and aspects described herein are shown in Table 5 below.

TABLE 5 Exemplary Anti-microbial peptides SEQ NO: Peptide Peptide Sequence 22 TCAM020 Ac-Nle-c[Asp-Pro-Arg-Arg-Trp-Trp-Arg-Phe-Lys]-D-Val-D-Pro-NH2 23 TCAM021 Ac-Nle-c[Asp-Pro-Arg-Arg-Trp-Trp-Arg-Phe-Lys]-D-Val-D-Phe-NH2 24 TCAM022 Ac-Nle-c[Asp-Pro-Arg-Arg-Trp-Trp-Arg-Phe-Lys]-D-Pro-D-Val-NH2 25 TCAM023 Ac-Nle-c[Asp-Pro-Arg-Arg-Trp-Trp-Arg-Phe-Lys]-D-Phe-D-Val-NH2 26 TCAM024 Ac-Nle-c[Asp-Pro-Arg-Arg-Trp-Trp-Tyr-Phe-Lys]-D-Val-D-Pro-NH2 27 TCAM025 Ac-Nle-c[Asp-Pro-Arg-Arg-Trp-Trp-Tyr-Phe-Lys]-D-Val-D-Phe-NH2 28 TCAM026 Ac-Nle-c[Asp-Pro-Arg-Arg-Trp-Trp-Tyr-Phe-Lys]-D-Pro-D-Val-NH2 29 TCAM027 Ac-Nle-c[Asp-Pro-Arg-Arg-Trp-Trp-Tyr-Phe-Lys]-D-Phe-D-Val-NH2 30 TCAM028 Ac-Nle-c[Asp-Pro-Arg-Arg-Tyr-Tyr-Arg-Phe-Lys]-D-Val-D-Pro-NH2 31 TCAM029 Ac-Nle-c[Asp-Pro-Arg-Arg-Tyr-Tyr-Arg-Phe-Lys]-D-Val-D-Phe-NH2 32 TCAM030 Ac-Nle-c[Asp-Pro-Arg-Arg-Tyr-Tyr-Arg-Phe-Lys]-D-Pro-D-Val-NH2 33 TCAM031 Ac-Nle-c[Asp-Pro-Arg-Arg-Tyr-Tyr-Arg-Phe-Lys]-D-Phe-D-Val-NH2 34 TCAM032 Ac-Nle-c[Asp-Pro-Arg-Arg-Nal-Nal-Arg-Phe-Lys]-D-Val-D-Pro-NH2 35 TCAM033 Ac-Nle-c[Asp-Pro-Arg-Arg-Nal-Nal-Arg-Phe-Lys]-D-Val-D-Phe-NH2 36 TCAM034 Ac-Nle-c[Asp-Pro-Arg-Arg-Nal-Nal-Arg-Phe-Lys]-D-Pro-D-Val-NH2 37 TCAM035 Ac-Nle-c[Asp-Pro-Arg-Arg-Nal-Nal-Arg-Phe-Lys]-D-Phe-D-Val-NH2 38 TCAM036 Ac-Nle-c[Asp-Pro-Arg-Arg-Leu-Trp-Leu-Trp-Lys]-D-Val-D-Pro-NH2 39 TCAM037 Ac-Nle-c[Asp-Pro-Arg-Arg-Leu-Trp-Leu-Trp-Lys]-D-Val-D-Phe-NH2 40 TCAM038 Ac-Nle-c[Asp-Pro-Arg-Arg-Leu-Trp-Leu-Trp-Lys]-D-Pro-D-Val-NH2 41 TCAM039 Ac-Nle-c[Asp-Pro-Arg-Arg-Leu-Trp-Leu-Trp-Lys]-D-Phe-D-Val-NH2 42 TCAM040 Ac-Nle-c[Asp-Pro-Arg-Arg-Leu-Trp-Leu-Trp-Lys]-D-Val-D-Pro-NH2 43 TCAM041 Ac-Nle-c[Asp-Pro-Arg-Arg-Leu-Trp-Leu-Trp-Lys]-D-Val-D-Phe-NH2 44 TCAM042 Ac-Nle-c[Asp-Pro-Arg-Arg-Leu-Trp-Leu-Trp-Lys]-D-Pro-D-Val-NH2 45 TCAM043 Ac-Nle-c[Asp-Pro-Arg-Arg-Leu-Trp-Leu-Trp-Lys]-D-Phe-D-Val-NH2 46 TCAM044 Ac-Nle-c[Asp-Arg-Arg-Arg-Trp-Leu-Trp-Leu-Trp-Lys]-D-Val-D-Pro-NH2 47 TCAM045 Ac-Nle-c[Asp-Pro-Arg-Arg-Arg-Trp-Leu-Trp-Leu-Trp-Lys]-D-Val-D-Phe-NH2 48 TCAM046 Ac-Nle-c[Asp-Pro-Arg-Arg-Arg-Trp-Leu-Trp-Leu-Trp-Lys]-D-Pro-D-Val-NH2 49 TCAM047 Ac-Nle-c[Asp-Pro-Arg-Arg-Arg-Trp-Leu-Trp-Leu-Trp-Lys]-D-Phe-D-Val-NH2 50 TCAM048 Ac-Nle-c[Asp-Pro-Arg-Gln-Arg-Arg-Trp-Leu-Trp-Leu-Trp-Lys]-D-Val-D-Pro-NH2 51 TCAM049 Ac-Nle-c[Asp-Pro-Arg-Gln-Arg-Arg-Trp-Leu-Trp-Leu-Trp-Lys]-D-Val-D-Phe-NH2 52 TCAM050 Ac-Nle-c[Asp-Pro-Arg-Gln-Arg-Arg-Trp-Leu-Trp-Leu-Trp-Lys]-D-Pro-D-Val-NH2 53 TCAM051 Ac-Nle-c[Asp-Pro-Arg-Gln-Arg-Arg-Trp-Leu-Trp-Leu-Trp-Lys]-D-Phe-D-Val-NH2 54 TCAM052 Ac-Nle-c[Asp-Pro-Trp-Arg-Trp-Trp-Arg-Arg-Lys]-D-Val-D-Phe-NH2 55 TCAM053 Ac-Nle-c[Asp-Pro-Trp-Arg-Trp-Trp-Arg-Arg-Lys]-D-Pro-D-Val-NH2 56 TCAM054 Ac-Nle-c[Asp-Pro-Trp-Arg-Trp-Trp-Arg-Arg-Lys]-D-Phe-D-Val-NH2 57 TCAM055 Ac-Nle-c[Asp-Pro-Trp-Trp-Arg-Arg-Trp-Trp-Arg-Arg-Lys]-D-Val-D-Pro-NH2 58 TCAM056 Ac-Nle-c[Asp-Pro-Trp-Trp-Arg-Arg-Trp-Trp-Arg-Arg-Lys]-D-Val-D-Phe-NH2 59 TCAM057 Ac-Nle-c[Asp-Pro-Trp-Trp-Arg-Arg-Trp-Trp-Arg-Arg-Lys]-D-Pro-D-Val-NH2 60 TCAM058 Ac-Nle-c[Asp-Pro-Trp-Trp-Arg-Arg-Trp-Trp-Arg-Arg-Lys]-D-Phe-D-Val-NH2 61 TCAM059 Ac-Nle-c[Asp-Pro-Trp-Arg-Trp-Arg-Trp-Arg-Lys]-D-Val-D-Pro-NH2 62 TCAM060 Ac-Nle-c[Asp-Pro-Trp-Arg-Trp-Arg-Trp-Arg-Lys]-D-Val-D-Phe-NH2 63 TCAM061 Ac-Nle-c[Asp-Pro-Trp-Arg-Trp-Arg-Trp-Arg-Lys]-D-Pro-D-Val-NH2 64 TCAM062 Ac-Nle-c[Asp-Pro-Trp-Arg-Trp-Arg-Trp-Arg-Lys]-D-Phe-D-Val-NH2 65 TCAM063 Ac-Nle-c[Asp-Pro-Arg-Trp-Arg-Trp-Arg-Trp-Lys]-D-Val-D-Pro-NH2 66 TCAM064 Ac-Nle-c[Asp-Pro-Arg-Trp-Arg-Trp-Arg-Trp-Lys]-D-Val-D-Phe-NH2 67 TCAM065 Ac-Nle-c[Asp-Pro-Arg-Trp-Arg-Trp-Arg-Trp-Lys]-D-Pro-D-Val-NH2 68 TCAM066 Ac-Nle-c[Asp-Pro-Arg-Trp-Arg-Trp-Arg-Trp-Lys]-D-Phe-D-Val-NH2 69 TCAM067 Ac-Nle-c[Asp-Pro-Arg-Trp-Trp-Arg-Arg-Lys]-D-Val-D-Pro-NH2 70 TCAM068 Ac-Nle-c[Asp-Pro-Arg-Trp-Trp-Arg-Arg-Lys]-D-Val-D-Phe-NH2 71 TCAM069 Ac-Nle-c[Asp-Pro-Arg-Trp-Trp-Arg-Arg-Lys]-D-Pro-D-Val-NH2 72 TCAM070 Ac-Nle-c[Asp-Pro-Arg-Trp-Trp-Arg-Arg-Lys]-D-Phe-D-Val-NH2 73 TCAM071 Ac-Nle-c[Asp-Pro-Trp-Trp-Arg-Arg-Trp-Lys]-D-Val-D-Pro-NH2 74 TCAM072 Ac-Nle-c[Asp-Pro-Trp-Trp-Arg-Arg-Trp-Lys]-D-Val-D-Phe-NH2 75 TCAM073 Ac-Nle-c[Asp-Pro-Trp-Trp-Arg-Arg-Trp-Lys]-D-Pro-D-Val-NH2 76 TCAM074 Ac-Nle-c[Asp-Pro-Trp-Trp-Arg-Arg-Trp-Lys]-D-Phe-D-Val-NH2 77 TCAM075 Ac-Nle-c[Asp-Pro-Trp-Arg-Trp-Arg-Trp-Lys]-D-Val-D-Pro-NH2 78 TCAM076 Ac-Nle-c[Asp-Pro-Trp-Arg-Trp-Arg-Trp-Lys]-D-Val-D-Phe-NH2 79 TCAM077 Ac-Nle-c[Asp-Pro-Trp-Arg-Trp-Arg-Trp-Lys]-D-Pro-D-Val-NH2 80 TCAM078 Ac-Nle-c[Asp-Pro-Trp-Arg-Trp-Arg-Trp-Lys]-D-Phe-D-Val-NH2 81 TCAM079 Ac-Nle-c[Asp-Pro-Arg-Trp-Arg-Trp-Arg-Lys]-D-Val-D-Pro-NH2 82 TCAM080 Ac-Nle-c[Asp-Pro-Arg-Trp-Arg-Trp-Arg-Lys]-D-Val-D-Phe-NH2 83 TCAM081 Ac-Nle-c[Asp-Pro-Arg-Trp-Arg-Trp-Arg-Lys]-D-Pro-D-Val-NH2 84 TCAM082 Ac-Nle-c[Asp-Pro-Arg-Trp-Arg-Trp-Arg-Lys]-D-Phe-D-Val-NH2 85 TCAM083 Ac-Nle-c[Asp-Pro-Trp-Arg-Tyr-Arg-Trp-Lys]-D-Val-D-Pro-NH2 86 TCAM084 Ac-Nle-c[Asp-Pro-Trp-Arg-Tyr-Arg-Trp-Lys]-D-Val-D-Phe-NH2 87 TCAM085 Ac-Nle-c[Asp-Pro-Trp-Arg-Tyr-Arg-Trp-Lys]-D-Pro-D-Val-NH2 88 TCAM086 Ac-Nle-c[Asp-Pro-Trp-Arg-Tyr-Arg-Trp-Lys]-D-Phe-D-Val-NH2 89 TCAM087 Ac-Nle-c[Asp-Pro-Trp-Arg-Trp-Arg-Tyr-Lys]-D-Val-D-Pro-NH2 90 TCAM088 Ac-Nle-c[Asp-Pro-Trp-Arg-Trp-Arg-Tyr-Lys]-D-Val-D-Phe-NH2 91 TCAM089 Ac-Nle-c[Asp-Pro-Trp-Arg-Trp-Arg-Tyr-Lys]-D-Pro-D-Val-NH2 92 TCAM090 Ac-Nle-c[Asp-Pro-Trp-Arg-Trp-Arg-Tyr-Lys]-D-Phe-D-Val-NH2 93 TCAM091 Ac-Nle-c[Asp-Pro-Trp-Arg-Trp-Arg-Lys]-D-Val-D-Pro-NH2 94 TCAM092 Ac-Nle-c[Asp-Pro-Trp-Arg-Trp-Arg-Lys]-D-Val-D-Phe-NH2 95 TCAM093 Ac-Nle-c[Asp-Pro-Trp-Arg-Trp-Arg-Lys]-D-Pro-D-Val-NH2 96 TCAM094 Ac-Nle-c[Asp-Pro-Trp-Arg-Trp-Arg-Lys]-D-Phe-D-Val-NH2 97 TCAM095 Ac-Nle-c[Asp-Pro-Trp-Arg-Arg-Trp-Lys]-D-Val-D-Pro-NH2 98 TCAM096 Ac-Nle-c[Asp-Pro-Trp-Arg-Arg-Trp-Lys]-D-Val-D-Phe-NH2 99 TCAM097 Ac-Nle-c[Asp-Pro-Trp-Arg-Arg-Trp-Lys]-D-Pro-D-Val-NH2 100 TCAM098 Ac-Nle-c[Asp-Pro-Trp-Arg-Arg-Trp-Lys]-D-Phe-D-Val-NH2 101 TCAM099 Ac-Nle-c[Asp-Pro-Arg-Trp-Trp-Arg-Lys]-D-Val-D-Pro-NH2 102 TCAM100 Ac-Nle-c[Asp-Pro-Arg-Trp-Trp-Arg-Lys]-D-Val-D-Phe-NH2 103 TCAM101 Ac-Nle-c[Asp-Pro-Arg-Trp-Trp-Arg-Lys]-D-Pro-D-Val-NH2 104 TCAM102 Ac-Nle-c[Asp-Pro-Arg-Trp-Trp-Arg-Lys]-D-Phe-D-Val-NH2 105 TCAM103 Ac-Nle-c[Asp-Pro-Trp-Arg-Trp-Lys]-D-Val-D-Pro-NH2 106 TCAM104 Ac-Nle-c[Asp-Pro-Trp-Arg-Trp-Lys]-D-Val-D-Phe-NH2 107 TCAM105 Ac-Nle-c[Asp-Pro-Trp-Arg-Trp-Lys]-D-Pro-D-Val-NH2 108 TCAM106 Ac-Nle-c[Asp-Pro-Trp-Arg-Trp-Lys]-D-Phe-D-Val-NH2 109 TCAM107 Ac-Nle-c[Asp-Pro-Arg-Trp-Arg-Lys]-D-Val-D-Pro-NH2 110 TCAM108 Ac-Nle-c[Asp-Pro-Arg-Trp-Arg-Lys]-D-Val-D-Phe-NH2 111 TCAM109 Ac-Nle-c[Asp-Pro-Arg-Trp-Arg-Lys]-D-Pro-D-Val-NH2 112 TCAM110 Ac-Nle-c[Asp-Pro-Arg-Trp-Arg-Lys]-D-Phe-D-Val-NH2 113 TCAM111 Ac-Nle-c[Asp-Arg-Arg-Trp-Trp-Arg-Phe-Lys]-D-Val-D-Pro-NH2 114 TCAM112 Ac-Nle-c[Asp-Arg-Arg-Trp-Trp-Arg-Phe-Lys]-D-Val-D-Phe-NH2 115 TCAM113 Ac-Nle-c[Asp-Arg-Arg-Trp-Trp-Arg-Phe-Lys]-D-Pro-D-Val-NH2 116 TCAM114 Ac-Nle-c[Asp-Arg-Arg-Trp-Trp-Arg-Phe-Lys]-D-Phe-D-Val-NH2 117 TCAM115 Ac-Nle-c[Asp-Arg-Arg-Trp-Trp-Arg-Phe-Lys]-D-Val-D-Pro-NH2 118 TCAM116 Ac-Nle-c[Asp-Arg-Arg-Trp-Trp-Arg-Phe-Lys]-D-Val-D-Phe-NH2 119 TCAM117 Ac-Nle-c[Asp-Arg-Arg-Trp-Trp-Arg-Phe-Lys]-D-Pro-D-Val-NH2 120 TCAM118 Ac-Nle-c[Asp-Arg-Arg-Trp-Trp-Arg-Phe-Lys]-D-Phe-D-Val-NH2 121 TCAM119 Ac-Nle-c[Asp-Arg-Arg-Tyr-Tyr-Arg-Phe-Lys]-D-Val-D-Pro-NH2 122 TCAM120 Ac-Nle-c[Asp-Arg-Arg-Tyr-Tyr-Arg-Phe-Lys]-D-Val-D-Phe-NH2 123 TCAM121 Ac-Nle-c[Asp-Arg-Arg-Tyr-Tyr-Arg-Phe-Lys]-D-Pro-D-Val-NH2 124 TCAM122 Ac-Nle-c[Asp-Arg-Arg-Tyr-Tyr-Arg-Phe-Lys]-D-Phe-D-Val-NH2 125 TCAM123 Ac-Nle-c[Asp-Arg-Arg-Nal-Nal-Arg-Phe-Lys]-D-Val-D-Pro-NH2 126 TCAM124 Ac-Nle-c[Asp-Arg-Arg-Nal-Nal-Arg-Phe-Lys]-D-Val-D-Phe-NH2 127 TCAM125 Ac-Nle-c[Asp-Arg-Arg-Nal-Nal-Arg-Phe-Lys]-D-Pro-D-Val-NH2 128 TCAM126 Ac-Nle-c[Asp-Arg-Arg-Nal-Nal-Arg-Phe-Lys]-D-Phe-D-Val-NH2 129 TCAM127 Ac-Nle-c[Asp-Arg-Arg-Leu-Trp-Leu-Trp-Lys]-D-Val-D-Pro-NH2 130 TCAM128 Ac-Nle-c[Asp-Arg-Arg-Leu-Trp-Leu-Trp-Lys]-D-Val-D-Phe-NH2 131 TCAM129 Ac-Nle-c[Asp-Arg-Arg-Leu-Trp-Leu-Trp-Lys]-D-Pro-D-Val-NH2 132 TCAM130 Ac-Nle-c[Asp-Arg-Arg-Leu-Trp-Leu-Trp-Lys]-D-Phe-D-Val-NH2 133 TCAM131 Ac-Nle-c[Asp-Arg-Arg-Leu-Trp-Leu-Trp-Lys]-D-Val-D-Pro-NH2 134 TCAM132 Ac-Nle-c[Asp-Arg-Arg-Leu-Trp-Leu-Trp-Lys]-D-Val-D-Phe-NH2 135 TCAM133 Ac-Nle-c[Asp-Arg-Arg-Leu-Trp-Leu-Trp-Lys]-D-Pro-D-Val-NH2 136 TCAM134 Ac-Nle-c[Asp-Arg-Arg-Leu-Trp-Leu-Trp-Lys]-D-Phe-D-Val-NH2 137 TCAM135 Ac-Nle-c[Asp-Arg-Arg-Arg-Trp-Leu-Trp-Leu-Trp-Lys]-D-Val-D-Pro-NH2 138 TCAM136 Ac-Nle-c[Asp-Arg-Arg-Arg-Trp-Leu-Trp-Leu-Trp-Lys]-D-Val-D-Phe-NH2 139 TCAM137 Ac-Nle-c[Asp-Arg-Arg-Arg-Trp-Leu-Trp-Leu-Trp-Lys]-D-Pro-D-Val-NH2 140 TCAM138 Ac-Nle-c[Asp-Arg-Arg-Arg-Trp-Leu-Trp-Leu-Trp-Lys]-D-Phe-D-Val-NH2 141 TCAM139 Ac-Nle-c[Asp-Arg-Gln-Arg-Arg-Trp-Leu-Trp-Leu-Trp-Lys]-D-Val-D-Pro-NH2 142 TCAM140 Ac-Nle-c[Asp-Arg-Gln-Arg-Arg-Trp-Leu-Trp-Leu-Trp-Lys]-D-Val-D-Phe-NH2 143 TCAM141 Ac-Nle-c[Asp-Arg-Gln-Arg-Arg-Trp-Leu-Trp-Leu-Trp-Lys]-D-Pro-D-Val-NH2 144 TCAM142 Ac-Nle-c[Asp-Arg-Gln-Arg-Arg-Trp-Leu-Trp-Leu-Trp-Lys]-D-Phe-D-Val-NH2 145 TCAM143 Ac-Nle-c[Asp-Trp-Arg-Trp-Trp-Arg-Arg-Lys]-D-Val-D-Pro-NH2 146 TCAM144 Ac-Nle-c[Asp-Trp-Arg-Trp-Trp-Arg-Arg-Lys]-D-Val-D-Phe-NH2 147 TCAM145 Ac-Nle-c[Asp-Trp-Arg-Trp-Trp-Arg-Arg-Lys]-D-Pro-D-Val-NH2 148 TCAM146 Ac-Nle-c[Asp-Trp-Arg-Trp-Trp-Arg-Arg-Lys]-D-Phe-D-Val-NH2 149 TCAM147 Ac-Nle-c[Asp-Trp-Trp-Arg-Arg-Trp-Trp-Arg-Arg-Lys]-D-Val-D-Pro-NH2 150 TCAM148 Ac-Nle-c[Asp-Trp-Trp-Arg-Arg-Trp-Trp-Arg-Arg-Lys]-D-Val-D-Phe-NH2 151 TCAM149 Ac-Nle-c[Asp-Trp-Trp-Arg-Arg-Trp-Trp-Arg-Arg-Lys]-D-Pro-D-Val-NH2 152 TCAM150 Ac-Nle-c[Asp-Trp-Trp-Arg-Arg-Trp-Trp-Arg-Arg-Lys]-D-Phe-D-Val-NH2 153 TCAM151 Ac-Nle-c[Asp-Trp-Arg-Trp-Arg-Trp-Arg-Lys]-D-Val-D-Pro-NH2 154 TCAM152 Ac-Nle-c[Asp-Trp-Arg-Trp-Arg-Trp-Arg-Lys]-D-Val-D-Phe-NH2 155 TCAM153 Ac-Nle-c[Asp-Trp-Arg-Trp-Arg-Trp-Arg-Lys]-D-Pro-D-Val-NH2 156 TCAM154 Ac-Nle-c[Asp-Trp-Arg-Trp-Arg-Trp-Arg-Lys]-D-Phe-D-Val-NH2 157 TCAM155 Ac-Nle-c[Asp-Arg-Trp-Arg-Trp-Arg-Trp-Lys]-D-Val-D-Pro-NH2 158 TCAM156 Ac-Nle-c[Asp-Arg-Trp-Arg-Trp-Arg-Trp-Lys]-D-Val-D-Phe-NH2 159 TCAM157 Ac-Nle-c[Asp-Arg-Trp-Arg-Trp-Arg-Trp-Lys]-D-Pro-D-Val-NH2 160 TCAM158 Ac-Nle-c[Asp-Arg-Trp-Arg-Trp-Arg-Trp-Lys]-D-Phe-D-Val-NH2 161 TCAM159 Ac-Nle-c[Asp-Arg-Trp-Trp-Arg-Arg-Lys]-D-Val-D-Pro-NH2 162 TCAM160 Ac-Nle-c[Asp-Arg-Trp-Trp-Arg-Arg-Lys]-D-Val-D-Phe-NH2 163 TCAM161 Ac-Nle-c[Asp-Arg-Trp-Trp-Arg-Arg-Lys]-D-Pro-D-Val-NH2 164 TCAM162 Ac-Nle-c[Asp-Arg-Trp-Trp-Arg-Arg-Lys]-D-Phe-D-Val-NH2 165 TCAM163 Ac-Nle-c[Asp-Arg-Trp-Arg-Trp-Arg-Lys]-D-Val-D-Pro-NH2 166 TCAM164 Ac-Nle-c[Asp-Arg-Trp-Arg-Trp-Arg-Lys]-D-Val-D-Phe-NH2 167 TCAM165 Ac-Nle-c[Asp-Arg-Trp-Arg-Trp-Arg-Lys]-D-Pro-D-Val-NH2 168 TCAM166 Ac-Nle-c[Asp-Arg-Trp-Arg-Trp-Arg-Lys]-D-Phe-D-Val-NH2 169 TCAM167 Ac-Nle-c[Asp-Trp-Trp-Arg-Arg-Trp-Lys]-D-Val-D-Pro-NH2 170 TCAM168 Ac-Nle-c[Asp-Trp-Trp-Arg-Arg-Trp-Lys]-D-Val-D-Phe-NH2 171 TCAM169 Ac-Nle-c[Asp-Trp-Trp-Arg-Arg-Trp-Lys]-D-Pro-D-Val-NH2 172 TCAM170 Ac-Nle-c[Asp-Trp-Trp-Arg-Arg-Trp-Lys]-D-Phe-D-Val-NH2 173 TCAM171 Ac-Nle-c[Asp-Trp-Arg-Trp-Arg-Trp-Lys]-D-Val-D-Pro-NH2 174 TCAM172 Ac-Nle-c[Asp-Trp-Arg-Trp-Arg-Trp-Lys]-D-Val-D-Phe-NH2 175 TCAM173 Ac-Nle-c[Asp-Trp-Arg-Trp-Arg-Trp-Lys]-D-Pro-D-Val-NH2 176 TCAM174 Ac-Nle-c[Asp-Trp-Arg-Trp-Arg-Trp-Lys]-D-Phe-D-Val-NH2 177 TCAM175 Ac-Nle-c[Asp-Trp-Arg-Tyr-Arg-Trp-Lys]-D-Val-D-Pro-NH2 178 TCAM176 Ac-Nle-c[Asp-Trp-Arg-Tyr-Arg-Trp-Lys]-D-Val-D-Phe-NH2 179 TCAM177 Ac-Nle-c[Asp-Trp-Arg-Tyr-Arg-Trp-Lys]-D-Pro-D-Val-NH2 180 TCAM178 Ac-Nle-c[Asp-Trp-Arg-Tyr-Arg-Trp-Lys]-D-Phe-D-Val-NH2 181 TCAM179 Ac-Nle-c[Asp-Trp-Arg-Trp-Arg-Tyr-Lys]-D-Val-D-Pro-NH2 182 TCAM180 Ac-Nle-c[Asp-Trp-Arg-Trp-Arg-Tyr-Lys]-D-Val-D-Phe-NH2 183 TCAM181 Ac-Nle-c[Asp-Trp-Arg-Trp-Arg-Tyr-Lys]-D-Pro-D-Val-NH2 184 TCAM182 Ac-Nle-c[Asp-Trp-Arg-Trp-Arg-Tyr-Lys]-D-Phe-D-Val-NH2 185 TCAM183 Ac-Nle-c[Asp-Trp-Arg-Trp-Arg-Lys]-D-Val-D-Pro-NH2 186 TCAM184 Ac-Nle-c[Asp-Trp-Arg-Trp-Arg-Lys]-D-Val-D-Phe-NH2 187 TCAM185 Ac-Nle-c[Asp-Trp-Arg-Trp-Arg-Lys]-D-Pro-D-Val-NH2 188 TCAM186 Ac-Nle-c[Asp-Trp-Arg-Trp-Arg-Lys]-D-Phe-D-Val-NH2 189 TCAM187 Ac-Nle-c[Asp-Trp-Arg-Arg-Trp-Lys]-D-Val-D-Pro-NH2 190 TCAM188 Ac-Nle-c[Asp-Trp-Arg-Arg-Trp-Lys]-D-Val-D-Phe-NH2 191 TCAM189 Ac-Nle-c[Asp-Trp-Arg-Arg-Trp-Lys]-D-Pro-D-Val-NH2 192 TCAM190 Ac-Nle-c[Asp-Trp-Arg-Arg-Trp-Lys]-D-Phe-D-Val-NH2 193 TCAM191 Ac-Nle-c[Asp-Arg-Trp-Trp-Arg-Lys]-D-Val-D-Pro-NH2 194 TCAM192 Ac-Nle-c[Asp-Arg-Trp-Trp-Arg-Lys]-D-Val-D-Phe-NH2 195 TCAM193 Ac-Nle-c[Asp-Arg-Trp-Trp-Arg-Lys]-D-Pro-D-Val-NH2 196 TCAM194 Ac-Nle-c[Asp-Arg-Trp-Trp-Arg-Lys]-D-Phe-D-Val-NH2 197 TCAM195 Ac-Nle-c[Asp-Trp-Arg-Trp-Lys]-D-Val-D-Pro-NH2 198 TCAM196 Ac-Nle-c[Asp-Trp-Arg-Trp-Lys]-D-Val-D-Phe-NH2 199 TCAM197 Ac-Nle-c[Asp-Trp-Arg-Trp-Lys]-D-Pro-D-Val-NH2 200 TCAM198 Ac-Nle-c[Asp-Trp-Arg-Trp-Lys]-D-Phe-D-Val-NH2 201 TCAM199 Ac-Nle-c[Asp-Arg-Trp-Arg-Lys]-D-Val-D-Pro-NH2 202 TCAM200 Ac-Nle-c[Asp-Arg-Trp-Arg-Lys]-D-Val-D-Phe-NH2 203 TCAM201 Ac-Nle-c[Asp-Arg-Trp-Arg-Lys]-D-Pro-D-Val-NH2 204 TCAM202 Ac-Nle-c[Asp-Arg-Trp-Arg-Lys]-D-Phe-D-Val-NH2 205 TCAM203 Ac-Nle-c[Asp-His-D-Nal(2′)-Arg-Trp-Lys]-D-Val-D-Pro-NH2 206 TCAM204 Ac-Nle-c[Asp-His-D-Nal(2′)-Arg-Trp-Lys]-D-Pro-D-Val-NH2 207 TCAM205 Ac-Nle-c[Asp-His-D-Nal(2′)-Arg-Trp-Lys]-D-Val-D-Phe-NH2 208 TCAM206 Ac-Nle-c[Asp-His-D-Nal(2′)-Arg-Trp-Lys]-D-Phe-D-Val-NH2 209 TCAM207 Ac-Nle-c[Asp-Pro-D-Nal(2′)-Arg-Trp-Lys]-D-Val-D-Pro-NH2 210 TCAM208 Ac-Nle-c[Asp-Pro-D-Nal(2′)-Arg-Trp-Lys]-D-Pro-D-Val-NH2 211 TCAM209 Ac-Nle-c[Asp-Pro-D-Nal(2′)-Arg-Trp-Lys]-D-Val-D-Phe-NH2 212 TCAM210 Ac-Nle-c[Asp-Pro-D-Nal(2′)-Arg-Trp-Lys]-D-Phe-D-Val-NH2 213 TCAM211 Ac-Nle-c[Asp-Arg-Arg-Nal(2′)-Arg-Trp-Lys]-D-Val-D-Pro-NH2 214 TCAM212 Ac-Nle-c[Asp-Arg-Arg-Nal(2′)-Arg-Trp-Lys]-D-Pro-D-Val-NH2 215 TCAM213 Ac-Nle-c[Asp-Arg-Arg-Nal(2′)-Arg-Trp-Lys]-D-Val-D-Phe-NH2 216 TCAM214 Ac-Nle-c[Asp-Arg-Arg-Nal(2′)-Arg-Trp-Lys]-D-Phe-D-Val-NH2 217 TCAM215 Ac-Nle-c[Asp-Arg-Arg-Pro-Nal(2′)-Arg-Trp-Lys]-D-Val-D-Pro-NH2 218 TCAM216 Ac-Nle-c[Asp-Arg-Arg-Pro-D-Nal(2′)-Arg-Trp-Lys]-D-Pro-D-Val-NH2 219 TCAM217 Ac-Nle-c[Asp-Arg-Arg-Pro-D-Nal(2′)-Arg-Trp-Lys]-D-Val-D-Phe-NH2 220 TCAM218 Ac-Nle-c[Asp-Arg-Arg-Pro-Nal(2′)-Arg-Trp-Lys]-D-Phe-D-Val-NH2 221 TCAM219 Ac-Nle-c[Asp-Arg-D-Nal(2′)-Arg-Trp-Lys]-D-Val-D-Pro-NH2 222 TCAM220 Ac-Nle-c[Asp-Arg-D-Nal(2′)-Arg-Trp-Lys]-D-Pro-D-Val-NH2 223 TCAM221 Ac-Nle-c[Asp-Arg-D-Nal(2′)-Arg-Trp-Lys]-D-Val-D-Phe-NH2 224 TCAM222 Ac-Nle-c[Asp-Arg-D-Nal(2′)-Arg-Trp-Lys]-D-Phe-D-Val-NH2 225 TCAM223 Ac-Nle-c[Asp-Arg-Pro-D-Nal(2′)-Arg-Trp-Lys]-D-Val-D-Pro-NH2 226 TCAM224 Ac-Nle-c[Asp-Arg-Pro-D-Nal(2′)-Arg-Trp-Lys]-D-Pro-D-Val-NH2 227 TCAM225 Ac-Nle-c[Asp-Arg-Pro-D-Nal(2′)-Arg-Trp-Lys]-D-Val-D-Phe-NH2 228 TCAM226 Ac-Nle-c[Asp-Arg-Pro-D-Nal(2′)-Arg-Trp-Lys]-D-Phe-D-Val-NH2 229 TCAM227 Ac-Nle-Arg-Arg-c[Asp-Pro-D-Nal(2′)-Arg-Trp-Lys]-D-Val-D-Pro-NH2 230 TCAM228 Ac-Nle-Arg-Arg-c[Asp-Pro-D-Nal(2′)-Arg-Trp-Lys]-D-Pro-D-Val-NH2 231 TCAM229 Ac-Nle-Arg-Arg-c[Asp-Pro-D-Nal(2′)-Arg-Trp-Lys]-D-Val-D-Phe-NH2 232 TCAM230 Ac-Nle-Arg-Arg-c[Asp-Pro-D-Nal(2′)-Arg-Trp-Lys]-D-Phe-D-Val-NH2 233 TCAM231 Ac-Nle-Arg-Arg-c[Asp-His-D-Nal(2′)-Arg-Trp-Lys]-D-Val-D-Pro-NH2 234 TCAM232 Ac-Nle-Arg-Arg-c[Asp-His-D-Nal(2′)-Arg-Trp-Lys]-D-Pro-D-Val-NH2 235 TCAM233 Ac-Nle-Arg-Arg-c[Asp-His-D-Nal(2′)-Arg-Trp-Lys]-D-Val-D-Phe-NH2 236 TCAM234 Ac-Nle-Arg-Arg-c[Asp-His-D-Nal(2′)-Arg-Trp-Lys]-D-Phe-D-Val-NH2 237 TCAM235 Ac-Nle-c[Asp-Arg-Pro-D-Nal(2′)-Arg-Trp-Arg-Lys]-D-Val-D-Pro-NH2 238 TCAM236 Ac-Nle-c[Asp-Arg-Pro-D-Nal(2′)-Arg-Trp-Arg-Lys]-D-Pro-D-Val-NH2 239 TCAM237 Ac-Nle-c[Asp-Arg-Pro-D-Nal(2′)-Arg-Trp-Arg-Lys]-D-Val-D-Phe-NH2 240 TCAM238 Ac-Nle-c[Asp-Arg-Pro-D-Nal(2′)-Arg-Trp-Arg-Lys]-D-Phe-D-Val-NH2 241 TCAM239 Ac-Nle-c[Asp-Arg-His-D-Nal(2′)-Arg-Trp-Arg-Lys]-D-Val-D-Pro-NH2 242 TCAM240 Ac-Nle-c[Asp-Arg-His-D-Nal(2′)-Arg-Trp-Arg-Lys]-D-Pro-D-Val-NH2 243 TCAM241 Ac-Nle-c[Asp-Arg-His-D-Nal(2′)-Arg-Trp-Arg-Lys]-D-Val-D-Phe-NH2 244 TCAM242 Ac-Nle-c[Asp-Arg-His-D-Nal(2′)-Arg-Trp-Arg-Lys]-D-Phe-D-Val-NH2 245 TCAM243 Ac-Nle-c[Asp-His-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Val-D-Phe-NH2 246 TCAM244 Ac-Nle-c[Asp-His-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Phe-D-Val-NH2 247 TCAM245 Ac-Nle-c[Asp-Pro-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Val-D-Pro-NH2 248 TCAM246 Ac-Nle-c[Asp-Pro-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Pro-D-Val-NH2 249 TCAM247 Ac-Nle-c[Asp-Pro-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Val-D-Phe-NH2 250 TCAM248 Ac-Nle-c[Asp-Pro-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Phe-D-Val-NH2 251 TCAM249 Ac-Nle-c[Asp-Arg-Arg-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Val-D-Pro-NH2 252 TCAM250 Ac-Nle-c[Asp-Arg-Arg-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Pro-D-Val-NH2 253 TCAM251 Ac-Nle-c[Asp-Arg-Arg-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Val-D-Phe-NH2 254 TCAM252 Ac-Nle-c[Asp-Arg-Arg-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Phe-D-Val-NH2 255 TCAM253 Ac-Nle-c[Asp-Arg-Arg-Pro-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Val-D-Pro-NH2 256 TCAM254 Ac-Nle-c[Asp-Arg-Arg-Pro-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Pro-D-Val-NH2 257 TCAM255 Ac-Nle-c[Asp-Arg-Arg-Pro-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Val-D-Phe-NH2 258 TCAM256 Ac-Nle-c[Asp-Arg-Arg-Pro-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Phe-D-Val-NH2 259 TCAM257 Ac-Nle-c[Asp-Arg-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Val-D-Pro-NH2 260 TCAM258 Ac-Nle-c[Asp-Arg-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Pro-D-Val-NH2 261 TCAM259 Ac-Nle-c[Asp-Arg-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Val-D-Phe-NH2 262 TCAM260 Ac-Nle-c[Asp-Arg-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Phe-D-Val-NH2 263 TCAM261 Ac-Nle-c[Asp-Arg-Pro-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Val-D-Pro-NH2 264 TCAM262 Ac-Nle-c[Asp-Arg-Pro-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Pro-D-Val-NH2 265 TCAM263 Ac-Nle-c[Asp-Arg-Pro-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Val-D-Phe-NH2 266 TCAM264 Ac-Nle-c[Asp-Arg-Pro-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Phe-D-Val-NH2 267 TCAM265 Ac-Nle-c[Asp-Arg-His-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Val-D-Pro-NH2 268 TCAM266 Ac-Nle-c[Asp-Arg-His-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Pro-D-Val-NH2 269 TCAM267 Ac-Nle-c[Asp-Arg-His-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Val-D-Phe-NH2 270 TCAM268 Ac-Nle-c[Asp-Arg-His-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Phe-D-Val-NH2 271 TCAM269 Ac-Nle-c[Asp-Arg-D-D-Nal(2′)-Arg-D-Nal(2′)-Arg-Lys]-D-Val-D-Pro-NH2 272 TCAM270 Ac-Nle-c[Asp-Arg-D-Nal(2′)-Arg-D-Nal(2′)-Arg-Lys]-D-Pro-D-Val-NH2 273 TCAM271 Ac-Nle-c[Asp-Arg-D-Nal(2′)-Arg-D-Nal(2′)-Arg-Lys]-D-Val-D-Phe-NH2 274 TCAM272 Ac-Nle-c[Asp-Arg-D-Nal(2′)-Arg-D-Nal(2′)-Arg-Lys]-D-Phe-D-Val-NH2 275 TCAM273 Ac-Nle-c[Asp-Arg-Pro-D-Nal(2′)-Arg-D-Nal(2′)-Arg-Lys]-D-Val-D-Pro-NH2 276 TCAM274 Ac-Nle-c[Asp-Arg-Pro-D-Nal(2′)-Arg-D-Nal(2′)-Arg-Lys]-D-Pro-D-Val-NH2 277 TCAM275 Ac-Nle-c[Asp-Arg-Pro-D-Nal(2′)-Arg-D-Nal(2′)-Arg-Lys]-D-Val-D-Phe-NH2 278 TCAM276 Ac-Nle-c[Asp-Arg-Pro-D-Nal(2′)-Arg-D-Nal(2′)-Arg-Lys]-D-Phe-D-Val-NH2 279 TCAM277 Ac-Nle-c[Asp-Arg-His-D-Nal(2′)-Arg-D-Nal(2′)-Arg-Lys]-D-Val-D-Pro-NH2 280 TCAM278 Ac-Nle-c[Asp-Arg-His-D-Nal(2′)-Arg-D-Nal(2′)-Arg-Lys]-D-Pro-D-Val-NH2 281 TCAM279 Ac-Nle-c[Asp-Arg-His-D-Nal(2′)-Arg-D-Nal(2′)-Arg-Lys]-D-Val-D-Phe-NH2 282 TCAM280 Ac-Nle-c[Asp-Arg-His-D-Nal(2′)-Arg-D-Nal(2′)-Arg-Lys]-D-Phe-D-Val-NH2 283 TCAM281 Ac-Nle-Arg-Arg-c[Asp-Pro-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Val-D-Pro-NH2 284 TCAM282 Ac-Nle-Arg-Arg-c[Asp-Pro-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Pro-D-Val-NH2 285 TCAM283 Ac-Nle-Arg-Arg-c[Asp-Pro-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Val-D-Phe-NH2 286 TCAM284 Ac-Nle-Arg-Arg-c[Asp-Pro-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Phe-D-Val-NH2 287 TCAM285 Ac-Nle-Arg-Arg-c[Asp-His-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Val-D-Pro-NH2 288 TCAM286 Ac-Nle-Arg-Arg-c[Asp-His-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Pro-D-Val-NH2 289 TCAM287 Ac-Nle-Arg-Arg-c[Asp-His-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Val-D-Phe-NH2 290 TCAM288 Ac-Nle-Arg-Arg-c[Asp-His-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Phe-D-Val-NH2 291 TCAM289 Ac-Nle-c[Asp-Arg-Pro-D-Nal(2′)-Arg-D-Nal(2′)-Arg-Lys]-D-Val-D-Pro-NH2 292 TCAM290 Ac-Nle-c[Asp-Arg-Pro-D-Nal(2′)-Arg-D-Nal(2′)-Arg-Lys]-D-Pro-D-Val-NH2 293 TCAM291 Ac-Nle-c[Asp-Arg-Pro-D-Nal(2′)-Arg-D-Nal(2′)-Arg-Lys]-D-Val-D-Phe-NH2 294 TCAM292 Ac-Nle-c[Asp-Arg-Pro-D-Nal(2′)-Arg-D-Nal(2′)-Arg-Lys]-D-Phe-D-Val-NH2 295 TCAM293 Ac-Nle-c[Asp-Arg-His-D-Nal(2′)-Arg-D-Nal(2′)-Arg-Lys]-D-Val-D-Pro-NH2 296 TCAM294 Ac-Nle-c[Asp-Arg-His-D-Nal(2′)-Arg-D-Nal(2′)-Arg-Lys]-D-Pro-D-Val-NH2 297 TCAM295 Ac-Nle-c[Asp-Arg-His-D-Nal(2′)-Arg-D-Nal(2′)-Arg-Lys]-D-Val-D-Phe-NH2 298 TCAM296 Ac-Nle-c[Asp-Arg-His-D-Nal(2′)-Arg-D-Nal(2′)-Arg-Lys]-D-Phe-D-Val-NH2 299 TCAM296 Ac-Nle-c[Asp-His-D-Nal(2′)-Arg-Trp-Lys]-Arg-Arg-D-Val-D-Pro-NH2 300 TCAM297 Ac-Nle-c[Asp-His-D-Nal(2′)-Arg-Trp-Lys]-Arg-Arg-D-Pro-D-Val-NH2 301 TCAM298 Ac-Nle-c[Asp-His-D-Nal(2′)-Arg-Trp-Lys]-Arg-Arg-D-Val-D-Phe-NH2 302 TCAM299 Ac-Nle-c[Asp-His-D-Nal(2′)-Arg-Trp-Lys]-Arg-Arg-D-Phe-D-Val-NH2 303 TCAM300 Ac-Nle-c[Asp-Pro-D-Nal(2′)-Arg-Trp-Lys]-Arg-Arg-D-Val-D-Pro-NH2 304 TCAM301 Ac-Nle-c[Asp-Pro-D-Nal(2′)-Arg-Trp-Lys]-Arg-Arg-D-Pro-D-Val-NH2 305 TCAM302 Ac-Nle-c[Asp-Pro-D-Nal(2′)-Arg-Trp-Lys]-Arg-Arg-D-Val-D-Phe-NH2 306 TCAM303 Ac-Nle-c[Asp-Pro-D-Nal(2′)-Arg-Trp-Lys]-Arg-Arg-D-Phe-D-Val-NH2 Anti-biofilm peptide 1018 linked to anti-microbial peptides 307 TCAM304 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Pro-Arg-Arg-Trp-Trp-Arg-Phe- Lys]-D-Val-D-Pro-NH2 308 TCAM305 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Pro-Arg-Arg-Trp-Trp-Arg-Phe- Lys]-D-Val-D-Phe-NH2 309 TCAM306 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Pro-Arg-Arg-Trp-Trp-Arg-Phe- Lys]-D-Pro-D-Val-NH2 310 TCAM307 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Pro-Arg-Arg-Trp-Trp-Arg-Phe- Lys]-D-Phe-D-Val-NH2 311 TCAM308 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Pro-Arg-Arg-Trp-Trp-Tyr-Phe- Lys]-D-Val-D-Pro-NH2 312 TCAM309 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Pro-Arg-Arg-Trp-Trp-Tyr-Phe- Lys]-D-Val-D-Phe-NH2 313 TCAM310 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Pro-Arg-Arg-Trp-Trp-Tyr-Phe- Lys]-D-Pro-D-Val-NH2 314 TCAM311 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Pro-Arg-Arg-Trp-Trp-Tyr-Phe- Lys]-D-Phe-D-Val-NH2 315 TCAM312 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Pro-Arg-Arg-Tyr-Tyr-Arg-Phe- Lys]-D-Val-D-Pro-NH2 316 TCAM313 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Pro-Arg-Arg-Tyr-Tyr-Arg-Phe- Lys]-D-Val-D-Phe-NH2 317 TCAM314 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Pro-Arg-Arg-Tyr-Tyr-Arg-Phe- Lys]-D-Pro-D-Val-NH2 318 TCAM315 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Pro-Arg-Arg-Tyr-Tyr-Arg-Phe- Lys]-D-Phe-D-Val-NH2 319 TCAM316 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Pro-Arg-Arg-Nal-Nal-Arg-Phe- Lys]-D-Val-D-Pro-NH2 320 TCAM317 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Pro-Arg-Arg-Nal-Nal-Arg-Phe- Lys]-D-Val-D-Phe-NH2 321 TCAM318 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Pro-Arg-Arg-Nal-Nal-Arg-Phe- Lys]-D-Pro-D-Val-NH2 322 TCAM319 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Pro-Arg-Arg-Nal-Nal-Arg-Phe- Lys]-D-Phe-D-Val-NH2 323 TCAM320 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Pro-Arg-Arg-Leu-Trp-Leu-Trp- Lys]-D-Val-D-Pro-NH2 324 TCAM321 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Pro-Arg-Arg-Leu-Trp-Leu-Trp- Lys]-D-Val-D-Phe-NH2 325 TCAM322 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Pro-Arg-Arg-Leu-Trp-Leu-Trp- Lys]-D-Pro-D-Val-NH2 326 TCAM323 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Pro-Arg-Arg-Leu-Trp-Leu-Trp- Lys]-D-Phe-D-Val-NH2 327 TCAM324 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Pro-Arg-Arg-Leu-Trp-Leu-Trp- Lys]-D-Val-D-Pro-NH2 328 TCAM325 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Pro-Arg-Arg-Leu-Trp-Leu-Trp- Lys]-D-Val-D-Phe-NH2 329 TCAM326 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Pro-Arg-Arg-Leu-Trp-Leu-Trp- Lys]-D-Pro-D-Val-NH2 330 TCAM327 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Pro-Arg-Arg-Leu-Trp-Leu-Trp- Lys]-D-Phe-D-Val-NH2 331 TCAM328 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Arg-Arg-Arg-Trp-Leu-Trp-Leu- Trp-Lys]-D-Val-D-Pro-NH2 332 TCAM329 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Pro-Arg-Arg-Arg-Trp-Leu-Trp- Leu-Trp-Lys]-D-Val-D-Phe-NH2 333 TCAM330 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Pro-Arg-Arg-Arg-Trp-Leu-Trp- Leu-Trp-Lys]-D-Pro-D-Val-NH2 334 TCAM331 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Pro-Arg-Arg-Arg-Trp-Leu-Trp- Leu-Trp-Lys]-D-Phe-D-Val-NH2 335 TCAM332 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Pro-Arg-Gln-Arg-Arg-Trp-Leu- Trp-Leu-Trp-Lys]-D-Val-D-Pro-NH2 336 TCAM333 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Pro-Arg-Gln-Arg-Arg-Trp-Leu- Trp-Leu-Trp-Lys]-D-Val-D-Phe-NH2 337 TCAM334 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Pro-Arg-Gln-Arg-Arg-Trp-Leu- Trp-Leu-Trp-Lys]-D-Pro-D-Val-NH2 338 TCAM335 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Pro-Arg-Gln-Arg-Arg-Trp-Leu- Trp-Leu-Trp-Lys]-D-Phe-D-Val-NH2 339 TCAM336 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Pro-Trp-Arg-Trp-Trp-Arg-Arg- Lys]-D-Val-D-Phe-NH2 340 TCAM337 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Pro-Trp-Arg-Trp-Trp-Arg-Arg- Lys]-D-Pro-D-Val-NH2 341 TCAM338 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Pro-Trp-Arg-Trp-Trp-Arg-Arg- Lys]-D-Phe-D-Val-NH2 342 TCAM339 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Pro-Trp-Trp-Arg-Arg-Trp-Trp- Arg-Arg-Lys]-D-Val-D-Pro-NH2 343 TCAM340 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Pro-Trp-Trp-Arg-Arg-Trp-Trp- Arg-Arg-Lys]-D-Val-D-Phe-NH2 344 TCAM341 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Pro-Trp-Trp-Arg-Arg-Trp-Trp- Arg-Arg-Lys]-D-Pro-D-Val-NH2 345 TCAM342 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Pro-Trp-Trp-Arg-Arg-Trp-Trp- Arg-Arg-Lys]-D-Phe-D-Val-NH2 346 TCAM343 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Pro-Trp-Arg-Trp-Arg-Trp-Arg- Lys]-D-Val-D-Pro-NH2 347 TCAM344 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Pro-Trp-Arg-Trp-Arg-Trp-Arg- Lys]-D-Val-D-Phe-NH2 348 TCAM345 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Pro-Trp-Arg-Trp-Arg-Trp-Arg- Lys]-D-Pro-D-Val-NH2 349 TCAM346 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Pro-Trp-Arg-Trp-Arg-Trp-Arg- Lys]-D-Phe-D-Val-NH2 350 TCAM347 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Pro-Arg-Trp-Arg-Trp-Arg-Trp- Lys]-D-Val-D-Pro-NH2 351 TCAM348 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Pro-Arg-Trp-Arg-Trp-Arg-Trp- Lys]-D-Val-D-Phe-NH2 352 TCAM349 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Pro-Arg-Trp-Arg-Trp-Arg-Trp- Lys]-D-Pro-D-Val-NH2 353 TCAM350 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Pro-Arg-Trp-Arg-Trp-Arg-Trp- Lys]-D-Phe-D-Val-NH2 354 TCAM351 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Pro-Arg-Trp-Trp-Arg-Arg-Lys]- D-Val-D-Pro-NH2 355 TCAM352 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Pro-Arg-Trp-Trp-Arg-Arg-Lys]- D-Val-D-Phe-NH2 356 TCAM353 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Pro-Arg-Trp-Trp-Arg-Arg-Lys]- D-Pro-D-Val-NH2 357 TCAM354 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Pro-Arg-Trp-Trp-Arg-Arg-Lys]- D-Phe-D-Val-NH2 358 TCAM355 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Pro-Trp-Trp-Arg-Arg-Trp-Lys]- D-Val-D-Pro-NH2 359 TCAM356 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Pro-Trp-Trp-Arg-Arg-Trp-Lys]- D-Val-D-Phe-NH2 360 TCAM357 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Pro-Trp-Trp-Arg-Arg-Trp-Lys]- D-Pro-D-Val-NH2 361 TCAM358 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Pro-Trp-Trp-Arg-Arg-Trp-Lys]- D-Phe-D-Val-NH2 362 TCAM359 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Pro-Trp-Arg-Trp-Arg-Trp-Lys]- D-Val-D-Pro-NH2 363 TCAM360 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Pro-Trp-Arg-Trp-Arg-Trp-Lys]- D-Val-D-Phe-NH2 364 TCAM361 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Pro-Trp-Arg-Trp-Arg-Trp-Lys]- D-Pro-D-Val-NH2 365 TCAM362 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Pro-Trp-Arg-Trp-Arg-Trp-Lys]- D-Phe-D-Val-NH2 366 TCAM363 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Pro-Arg-Trp-Arg-Trp-Arg-Lys]- D-Val-D-Pro-NH2 367 TCAM364 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Pro-Arg-Trp-Arg-Trp-Arg-Lys]- D-Val-D-Phe-NH2 368 TCAM365 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Pro-Arg-Trp-Arg-Trp-Arg-Lys]- D-Pro-D-Val-NH2 369 TCAM366 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Pro-Arg-Trp-Arg-Trp-Arg-Lys]- D-Phe-D-Val-NH2 370 TCAM367 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Pro-Trp-Arg-Tyr-Arg-Trp-Lys]- D-Val-D-Pro-NH2 371 TCAM368 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Pro-Trp-Arg-Tyr-Arg-Trp-Lys]- D-Val-D-Phe-NH2 372 TCAM369 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Pro-Trp-Arg-Tyr-Arg-Trp-Lys]- D-Pro-D-Val-NH2 373 TCAM370 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Pro-Trp-Arg-Tyr-Arg-Trp-Lys]- D-Phe-D-Val-NH2 374 TCAM371 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Pro-Trp-Arg-Trp-Arg-Tyr-Lys]- D-Val-D-Pro-NH2 375 TCAM372 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Pro-Trp-Arg-Trp-Arg-Tyr-Lys]- D-Val-D-Phe-NH2 376 TCAM373 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Pro-Trp-Arg-Trp-Arg-Tyr-Lys]- D-Pro-D-Val-NH2 377 TCAM374 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Pro-Trp-Arg-Trp-Arg-Tyr-Lys]- D-Phe-D-Val-NH2 378 TCAM375 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Pro-Trp-Arg-Trp-Arg-Lys]-D- Val-D-Pro-NH2 379 TCAM376 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Pro-Trp-Arg-Trp-Arg-Lys]-D- Val-D-Phe-NH2 380 TCAM377 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Pro-Trp-Arg-Trp-Arg-Lys]-D- Pro-D-Val-NH2 381 TCAM378 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Pro-Trp-Arg-Trp-Arg-Lys]-D- Phe-D-Val-NH2 382 TCAM379 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Pro-Trp-Arg-Arg-Trp-Lys]-D- Val-D-Pro-NH2 383 TCAM380 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Pro-Trp-Arg-Arg-Trp-Lys]-D- Val-D-Phe-NH2 384 TCAM381 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Pro-Trp-Arg-Arg-Trp-Lys]-D- Pro-D-Val-NH2 385 TCAM382 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Pro-Trp-Arg-Arg-Trp-Lys]-D- Phe-D-Val-NH2 386 TCAM383 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Pro-Arg-Trp-Trp-Arg-Lys]-D- Val-D-Pro-NH2 387 TCAM384 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Pro-Arg-Trp-Trp-Arg-Lys]-D- Val-D-Phe-NH2 388 TCAM385 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Pro-Arg-Trp-Trp-Arg-Lys]-D- Pro-D-Val-NH2 389 TCAM386 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Pro-Arg-Trp-Trp-Arg-Lys]-D- Phe-D-Val-NH2 390 TCAM387 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Pro-Trp-Arg-Trp-Lys]-D-Val-D- Pro-NH2 391 TCAM388 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Pro-Trp-Arg-Trp-Lys]-D-Val-D- Phe-NH2 392 TCAM389 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Pro-Trp-Arg-Trp-Lys]-D-Pro-D- Val-NH2 393 TCAM390 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Pro-Trp-Arg-Trp-Lys]-D-Phe- D-Val-NH2 394 TCAM391 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Pro-Arg-Trp-Arg-Lys]-D-Val-D- Pro-NH2 395 TCAM392 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Pro-Arg-Trp-Arg-Lys]-D-Val-D- Phe-NH2 396 TCAM393 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Pro-Arg-Trp-Arg-Lys]-D-Pro-D- Val-NH2 397 TCAM394 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Pro-Arg-Trp-Arg-Lys]-D-Phe- D-Val-NH2 398 TCAM395 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Arg-Arg-Trp-Trp-Arg-Phe- Lys]-D-Val-D-Pro-NH2 399 TCAM396 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Arg-Arg-Trp-Trp-Arg-Phe- Lys]-D-Val-D-Phe-NH2 400 TCAM397 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Arg-Arg-Trp-Trp-Arg-Phe- Lys]-D-Pro-D-Val-NH2 401 TCAM398 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Arg-Arg-Trp-Trp-Arg-Phe- Lys]-D-Phe-D-Val-NH2 402 TCAM399 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Arg-Arg-Trp-Trp-Arg-Phe- Lys]-D-Val-D-Pro-NH2 403 TCAM400 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Arg-Arg-Trp-Trp-Arg-Phe- Lys]-D-Val-D-Phe-NH2 404 TCAM401 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Arg-Arg-Trp-Trp-Arg-Phe- Lys]-D-Pro-D-Val-NH2 405 TCAM402 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Arg-Arg-Trp-Trp-Arg-Phe- Lys]-D-Phe-D-Val-NH2 406 TCAM403 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Arg-Arg-Tyr-Tyr-Arg-Phe-Lys]- D-Val-D-Pro-NH2 407 TCAM404 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Arg-Arg-Tyr-Tyr-Arg-Phe-Lys]- D-Val-D-Phe-NH2 408 TCAM405 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Arg-Arg-Tyr-Tyr-Arg-Phe-Lys]- D-Pro-D-Val-NH2 409 TCAM406 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Arg-Arg-Tyr-Tyr-Arg-Phe-Lys]- D-Phe-D-Val-NH2 410 TCAM407 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Arg-Arg-Nal-Nal-Arg-Phe- Lys]-D-Val-D-Pro-NH2 411 TCAM408 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Arg-Arg-Nal-Nal-Arg-Phe- Lys]-D-Val-D-Phe-NH2 412 TCAM409 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Arg-Arg-Nal-Nal-Arg-Phe- Lys]-D-Pro-D-Val-NH2 413 TCAM410 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Arg-Arg-Nal-Nal-Arg-Phe- Lys]-D-Phe-D-Val-NH2 414 TCAM411 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Arg-Arg-Leu-Trp-Leu-Trp- Lys]-D-Val-D-Pro-NH2 415 TCAM412 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Arg-Arg-Leu-Trp-Leu-Trp- Lys]-D-Val-D-Phe-NH2 416 TCAM413 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Arg-Arg-Leu-Trp-Leu-Trp- Lys]-D-Pro-D-Val-NH2 417 TCAM414 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Arg-Arg-Leu-Trp-Leu-Trp- Lys]-D-Phe-D-Val-NH2 418 TCAM415 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Arg-Arg-Leu-Trp-Leu-Trp- Lys]-D-Val-D-Pro-NH2 419 TCAM416 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Arg-Arg-Leu-Trp-Leu-Trp- Lys]-D-Val-D-Phe-NH2 420 TCAM417 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Arg-Arg-Leu-Trp-Leu-Trp- Lys]-D-Pro-D-Val-NH2 421 TCAM418 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Arg-Arg-Leu-Trp-Leu-Trp- Lys]-D-Phe-D-Val-NH2 422 TCAM419 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Arg-Arg-Arg-Trp-Leu-Trp-Leu- Trp-Lys]-D-Val-D-Pro-NH2 423 TCAM420 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Arg-Arg-Arg-Trp-Leu-Trp-Leu- Trp-Lys]-D-Val-D-Phe-NH2 424 TCAM421 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Arg-Arg-Arg-Trp-Leu-Trp-Leu- Trp-Lys]-D-Pro-D-Val-NH2 425 TCAM422 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Arg-Arg-Arg-Trp-Leu-Trp-Leu- Trp-Lys]-D-Phe-D-Val-NH2 426 TCAM423 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Arg-Gln-Arg-Arg-Trp-Leu-Trp- Leu-Trp-Lys]-D-Val-D-Pro-NH2 427 TCAM424 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Arg-Gln-Arg-Arg-Trp-Leu-Trp- Leu-Trp-Lys]-D-Val-D-Phe-NH2 428 TCAM425 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Arg-Gln-Arg-Arg-Trp-Leu-Trp- Leu-Trp-Lys]-D-Pro-D-Val-NH2 429 TCAM426 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Arg-Gln-Arg-Arg-Trp-Leu-Trp- Leu-Trp-Lys]-D-Phe-D-Val-NH2 430 TCAM427 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Trp-Arg-Trp-Trp-Arg-Arg-Lys]- D-Val-D-Pro-NH2 431 TCAM428 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Trp-Arg-Trp-Trp-Arg-Arg-Lys]- D-Val-D-Phe-NH2 432 TCAM429 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Trp-Arg-Trp-Trp-Arg-Arg-Lys]- D-Pro-D-Val-NH2 433 TCAM430 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Trp-Arg-Trp-Trp-Arg-Arg-Lys]- D-Phe-D-Val-NH2 434 TCAM431 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Trp-Trp-Arg-Arg-Trp-Trp-Arg- Arg-Lys]-D-Val-D-Pro-NH2 435 TCAM432 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Trp-Trp-Arg-Arg-Trp-Trp-Arg- Arg-Lys]-D-Val-D-Phe-NH2 436 TCAM433 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Trp-Trp-Arg-Arg-Trp-Trp-Arg- Arg-Lys]-D-Pro-D-Val-NH2 437 TCAM434 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Trp-Trp-Arg-Arg-Trp-Trp-Arg- Arg-Lys]-D-Phe-D-Val-NH2 438 TCAM435 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Trp-Arg-Trp-Arg-Trp-Arg-Lys]- D-Val-D-Pro-NH2 439 TCAM436 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Trp-Arg-Trp-Arg-Trp-Arg-Lys]- D-Val-D-Phe-NH2 440 TCAM437 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Trp-Arg-Trp-Arg-Trp-Arg-Lys]- D-Pro-D-Val-NH2 441 TCAM438 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Trp-Arg-Trp-Arg-Trp-Arg-Lys]- D-Phe-D-Val-NH2 442 TCAM439 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Arg-Trp-Arg-Trp-Arg-Trp-Lys]- D-Val-D-Pro-NH2 443 TCAM440 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Arg-Trp-Arg-Trp-Arg-Trp-Lys]- D-Val-D-Phe-NH2 444 TCAM441 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Arg-Trp-Arg-Trp-Arg-Trp-Lys]- D-Pro-D-Val-NH2 445 TCAM442 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Arg-Trp-Arg-Trp-Arg-Trp-Lys]- D-Phe-D-Val-NH2 446 TCAM443 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Arg-Trp-Trp-Arg-Arg-Lys]-D- Val-D-Pro-NH2 447 TCAM444 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Arg-Trp-Trp-Arg-Arg-Lys]-D- Val-D-Phe-NH2 448 TCAM445 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Arg-Trp-Trp-Arg-Arg-Lys]-D- Pro-D-Val-NH2 449 TCAM446 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Arg-Trp-Trp-Arg-Arg-Lys]-D- Phe-D-Val-NH2 450 TCAM447 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Arg-Trp-Arg-Trp-Arg-Lys]-D- Val-D-Pro-NH2 451 TCAM448 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Arg-Trp-Arg-Trp-Arg-Lys]-D- Val-D-Phe-NH2 452 TCAM449 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Arg-Trp-Arg-Trp-Arg-Lys]-D- Pro-D-Val-NH2 453 TCAM450 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Arg-Trp-Arg-Trp-Arg-Lys]-D- Phe-D-Val-NH2 454 TCAM451 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Trp-Trp-Arg-Arg-Trp-Lys]-D- Val-D-Pro-NH2 455 TCAM452 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Trp-Trp-Arg-Arg-Trp-Lys]-D- Val-D-Phe-NH2 456 TCAM453 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Trp-Trp-Arg-Arg-Trp-Lys]-D- Pro-D-Val-NH2 457 TCAM454 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Trp-Trp-Arg-Arg-Trp-Lys]-D- Phe-D-Val-NH2 458 TCAM455 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Trp-Arg-Trp-Arg-Trp-Lys]-D- Val-D-Pro-NH2 459 TCAM456 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Trp-Arg-Trp-Arg-Trp-Lys]-D- Val-D-Phe-NH2 460 TCAM457 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Trp-Arg-Trp-Arg-Trp-Lys]-D- Pro-D-Val-NH2 461 TCAM458 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Trp-Arg-Trp-Arg-Trp-Lys]-D- Phe-D-Val-NH2 462 TCAM459 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Trp-Arg-Tyr-Arg-Trp-Lys]-D- Val-D-Pro-NH2 463 TCAM460 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Trp-Arg-Tyr-Arg-Trp-Lys]-D- Val-D-Phe-NH2 464 TCAM461 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Trp-Arg-Tyr-Arg-Trp-Lys]-D- Pro-D-Val-NH2 465 TCAM462 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Trp-Arg-Tyr-Arg-Trp-Lys]-D- Phe-D-Val-NH2 466 TCAM463 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Trp-Arg-Trp-Arg-Tyr-Lys]-D- Val-D-Pro-NH2 467 TCAM464 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Trp-Arg-Trp-Arg-Tyr-Lys]-D- Val-D-Phe-NH2 468 TCAM465 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Trp-Arg-Trp-Arg-Tyr-Lys]-D- Pro-D-Val-NH2 469 TCAM466 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Trp-Arg-Trp-Arg-Tyr-Lys]-D- Phe-D-Val-NH2 470 TCAM467 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Trp-Arg-Trp-Arg-Lys]-D-Val-D- Pro-NH2 471 TCAM468 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Trp-Arg-Trp-Arg-Lys]-D-Val-D- Phe-NH2 472 TCAM469 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Trp-Arg-Trp-Arg-Lys]-D-Pro-D- Val-NH2 473 TCAM470 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Trp-Arg-Trp-Arg-Lys]-D-Phe- D-Val-NH2 474 TCAM471 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Trp-Arg-Arg-Trp-Lys]-D-Val-D- Pro-NH2 475 TCAM472 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Trp-Arg-Arg-Trp-Lys]-D-Val-D- Phe-NH2 476 TCAM473 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Trp-Arg-Arg-Trp-Lys]-D-Pro-D- Val-NH2 477 TCAM474 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Trp-Arg-Arg-Trp-Lys]-D-Phe- D-Val-NH2 478 TCAM475 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Arg-Trp-Trp-Arg-Lys]-D-Val-D- Pro-NH2 479 TCAM476 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Arg-Trp-Trp-Arg-Lys]-D-Val-D- Phe-NH2 480 TCAM477 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Arg-Trp-Trp-Arg-Lys]-D-Pro-D- Val-NH2 481 TCAM478 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Arg-Trp-Trp-Arg-Lys]-D-Phe- D-Val-NH2 482 TCAM479 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Trp-Arg-Trp-Lys]-D-Val-D-Pro- NH2 483 TCAM480 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Trp-Arg-Trp-Lys]-D-Val-D-Phe- NH2 484 TCAM481 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Trp-Arg-Trp-Lys]-D-Pro-D-Val- NH2 485 TCAM482 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Trp-Arg-Trp-Lys]-D-Phe-D-Val- NH2 486 TCAM483 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Arg-Trp-Arg-Lys]-D-Val-D-Pro- NH2 487 TCAM484 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Arg-Trp-Arg-Lys]-D-Val-D-Phe- NH2 488 TCAM485 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Arg-Trp-Arg-Lys]-D-Pro-D-Val- NH2 489 TCAM486 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Arg-Trp-Arg-Lys]-D-Phe-D-Val- NH2 490 TCAM487 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-Ile-Trp-Arg-Arg-c[Asp-His-D-Nal(2′)-Arg-Trp-Lys]-D- Val-D-Pro-NH2 491 TCAM488 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-Ile-Trp-Arg-Arg-c[Asp-His-D-Nal(2′)-Arg-Trp-Lys]-D- Pro-D-Val-NH2 492 TCAM489 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-Ile-Trp-Arg-Arg-c[Asp-His-D-Nal(2′)-Arg-Trp-Lys]-D- Val-D-Phe-NH2 493 TCAM490 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-Ile-Trp-Arg-Arg-c[Asp-His-D-Nal(2′)-Arg-Trp-Lys]-D- Phe-D-Val-NH2 494 TCAM491 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Pro-D-Nal(2′)-Arg-Trp-Lys]-D- Val-D-Pro-NH2 495 TCAM492 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Pro-D-Nal(2′)-Arg-Trp-Lys]-D- Pro-D-Val-NH2 496 TCAM493 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Pro-D-Nal(2′)-Arg-Trp-Lys]-D- Val-D-Phe-NH2 497 TCAM494 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Pro-D-Nal(2′)-Arg-Trp-Lys]-D- Phe-D-Val-NH2 498 TCAM495 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Arg-Arg-Nal(2′)-Arg-Trp-Lys]- D-Val-D-Pro-NH2 499 TCAM496 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Arg-Arg-Nal(2′)-Arg-Trp-Lys]- D-Pro-D-Val-NH2 500 TCAM497 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Arg-Arg-Nal(2′)-Arg-Trp-Lys]- D-Val-D-Phe-NH2 501 TCAM498 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Arg-Arg-Nal(2′)-Arg-Trp-Lys]- D-Phe-D-Val-NH2 502 TCAM499 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Arg-Arg-Pro-Nal(2′)-Arg-Trp- Lys]-D-Val-D-Pro-NH2 503 TCAM500 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Arg-Arg-Pro-D-Nal(2′)-Arg- Trp-Lys]-D-Pro-D-Val-NH2 504 TCAM501 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Arg-Arg-Pro-D-Nal(2′)-Arg- Trp-Lys]-D-Val-D-Phe-NH2 505 TCAM502 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Arg-Arg-Pro-Nal(2′)-Arg-Trp- Lys]-D-Phe-D-Val-NH2 506 TCAM503 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Arg-D-Nal(2′)-Arg-Trp-Lys]-D- Val-D-Pro-NH2 507 TCAM504 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Arg-D-Nal(2′)-Arg-Trp-Lys]-D- Pro-D-Val-NH2 508 TCAM505 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Arg-D-Nal(2′)-Arg-Trp-Lys]-D- Val-D-Phe-NH2 509 TCAM506 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Arg-D-Nal(2′)-Arg-Trp-Lys]-D- Phe-D-Val-NH2 510 TCAM507 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Arg-Pro-D-Nal(2′)-Arg-Trp- Lys]-D-Val-D-Pro-NH2 511 TCAM508 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Arg-Pro-D-Nal(2′)-Arg-Trp- Lys]-D-Pro-D-Val-NH2 512 TCAM509 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Arg-Pro-D-Nal(2′)-Arg-Trp- Lys]-D-Val-D-Phe-NH2 513 TCAM510 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Arg-Pro-D-Nal(2′)-Arg-Trp- Lys]-D-Phe-D-Val-NH2 514 TCAM511 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-Ile-Trp-Arg-Arg-Arg-Arg-c[Asp-Pro-D-Nal(2′)-Arg- Trp-Lys]-D-Val-D-Pro-NH2 515 TCAM512 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-Ile-Trp-Arg-Arg-Arg-Arg-c[Asp-Pro-D-Nal(2′)-Arg- Trp-Lys]-D-Pro-D-Val-NH2 516 TCAM513 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-Ile-Trp-Arg-Arg-Arg-Arg-c[Asp-Pro-D-Nal(2′)-Arg- Trp-Lys]-D-Val-D-Phe-NH2 517 TCAM514 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-Ile-Trp-Arg-Arg-Arg-Arg-c[Asp-Pro-D-Nal(2′)-Arg- Trp-Lys]-D-Phe-D-Val-NH2 518 TCAM515 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-Ile-Trp-Arg-Arg-Arg-Arg-c[Asp-His-D-Nal(2′)-Arg- Trp-Lys]-D-Val-D-Pro-NH2 519 TCAM516 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-Ile-Trp-Arg-Arg-Arg-Arg-c[Asp-His-D-Nal(2′)-Arg- Trp-Lys]-D-Pro-D-Val-NH2 520 TCAM517 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-Ile-Trp-Arg-Arg-Arg-Arg-c[Asp-His-D-Nal(2′)-Arg- Trp-Lys]-D-Val-D-Phe-NH2 521 TCAM518 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-Ile-Trp-Arg-Arg-Arg-Arg-c[Asp-His-D-Nal(2′)-Arg- Trp-Lys]-D-Phe-D-Val-NH2 522 TCAM519 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Arg-Pro-D-Nal(2′)-Arg-Trp- Arg-Lys]-D-Val-D-Pro-NH2 523 TCAM520 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Arg-Pro-D-Nal(2′)-Arg-Trp- Arg-Lys]-D-Pro-D-Val-NH2 524 TCAM521 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Arg-Pro-D-Nal(2′)-Arg-Trp- Arg-Lys]-D-Val-D-Phe-NH2 525 TCAM522 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Arg-Pro-D-Nal(2′)-Arg-Trp- Arg-Lys]-D-Phe-D-Val-NH2 526 TCAM523 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Arg-His-D-Nal(2′)-Arg-Trp- Arg-Lys]-D-Val-D-Pro-NH2 527 TCAM524 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Arg-His-D-Nal(2′)-Arg-Trp- Arg-Lys]-D-Pro-D-Val-NH2 528 TCAM525 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Arg-His-D-Nal(2′)-Arg-Trp- Arg-Lys]-D-Val-D-Phe-NH2 529 TCAM526 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Arg-His-D-Nal(2′)-Arg-Trp- Arg-Lys]-D-Phe-D-Val-NH2 530 TCAM527 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-Ile-Trp-Arg-Arg-c[Asp-His-D-Nal(2′)-Arg-D-Nal(2′)- Lys]-D-Val-D-Phe-NH2 531 TCAM528 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-Ile-Trp-Arg-Arg-c[Asp-His-D-Nal(2′)-Arg-D-Nal(2′)- Lys]-D-Phe-D-Val-NH2 532 TCAM529 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Pro-D-Nal(2′)-Arg-D-Nal(2′)- Lys]-D-Val-D-Pro-NH2 533 TCAM530 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Pro-D-Nal(2′)-Arg-D-Nal(2′)- Lys]-D-Pro-D-Val-NH2 534 TCAM531 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Pro-D-Nal(2′)-Arg-D-Nal(2′)- Lys]-D-Val-D-Phe-NH2 535 TCAM532 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Pro-D-Nal(2′)-Arg-D-Nal(2′)- Lys]-D-Phe-D-Val-NH2 536 TCAM533 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Arg-Arg-D-Nal(2′)-Arg-D- Nal(2')-Lys]-D-Val-D-Pro-NH2 537 TCAM534 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Arg-Arg-D-Nal(2′)-Arg-D- Nal(2')-Lys]-D-Pro-D-Val-NH2 538 TCAM535 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Arg-Arg-D-Nal(2′)-Arg-D- Nal(2')-Lys]-D-Val-D-Phe-NH2 539 TCAM536 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Arg-Arg-D-Nal(2′)-Arg-D- Nal(2')-Lys]-D-Phe-D-Val-NH2 540 TCAM537 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Arg-Arg-Pro-D-Nal(2′)-Arg-D- Nal(2')-Lys]-D-Val-D-Pro-NH2 541 TCAM538 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Arg-Arg-Pro-D-Nal(2′)-Arg-D- Nal(2')-Lys]-D-Pro-D-Val-NH2 542 TCAM539 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Arg-Arg-Pro-D-Nal(2′)-Arg-D- Nal(2')-Lys]-D-Val-D-Phe-NH2 543 TCAM540 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Arg-Arg-Pro-D-Nal(2′)-Arg-D- Nal(2')-Lys]-D-Phe-D-Val-NH2 544 TCAM541 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Arg-D-Nal(2′)-Arg-D-Nal(2′)- Lys]-D-Val-D-Pro-NH2 545 TCAM542 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Arg-D-Nal(2′)-Arg-D-Nal(2′)- Lys]-D-Pro-D-Val-NH2 546 TCAM543 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Arg-Nal(2′)-Arg-D-Nal(2′)- Lys]-D-Val-D-Phe-NH2 547 TCAM544 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Arg-D-Nal(2′)-Arg-D-Nal(2′)- Lys]-D-Phe-D-Val-NH2 548 TCAM545 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Arg-Pro-D-Nal(2′)-Arg-D- Nal(2')-Lys]-D-Val-D-Pro-NH2 549 TCAM546 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Arg-Pro-D-Nal(2′)-Arg-D- Nal(2')-Lys]-D-Pro-D-Val-NH2 550 TCAM547 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Arg-Pro-D-Nal(2′)-Arg-D- Nal(2')-Lys]-D-Val-D-Phe-NH2 551 TCAM548 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Arg-Pro-D-Nal(2′)-Arg-D- Nal(2')-Lys]-D-Phe-D-Val-NH2 552 TCAM549 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Arg-His-D-Nal(2′)-Arg-D- Nal(2')-Lys]-D-Val-D-Pro-NH2 553 TCAM550 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Arg-His-D-Nal(2′)-Arg-D- Nal(2')-Lys]-D-Pro-D-Val-NH2 554 TCAM551 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Arg-His-Nal(2′)-Arg-D-Nal(2′)- Lys]-D-Val-D-Phe-NH2 555 TCAM552 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Arg-His-Nal(2′)-Arg-D-Nal(2′)- Lys]-D-Phe-D-Val-NH2 556 TCAM553 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Arg-D-D-Nal(2′)-Arg-D-Nal(2′)- Arg-Lys]-D-Val-D-Pro-NH2 557 TCAM554 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Arg-D-Nal(2′)-Arg-D-Nal(2′)- Arg-Lys]-D-Pro-D-Val-NH2 558 TCAM555 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Arg-D-Nal(2′)-Arg-D-Nal(2′)- Arg-Lys]-D-Val-D-Phe-NH2 559 TCAM556 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Arg-D-Nal(2′)-Arg-D-Nal(2′)- Arg-Lys]-D-Phe-D-Val-NH2 560 TCAM557 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Arg-Pro-D-Nal(2′)-Arg-D- Nal(2')-Arg-Lys]-D-Val-D-Pro-NH2 561 TCAM558 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Arg-Pro-D-Nal(2′)-Arg-D- Nal(2')-Arg-Lys]-D-Pro-D-Val-NH2 562 TCAM559 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Arg-Pro-D-Nal(2′)-Arg-D- Nal(2')-Arg-Lys]-D-Val-D-Phe-NH2 563 TCAM560 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Arg-Pro-D-Nal(2′)-Arg-D- Nal(2')-Arg-Lys]-D-Phe-D-Val-NH2 564 TCAM561 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Arg-His-D-Nal(2′)-Arg-D- Nal(2')-Arg-Lys]-D-Val-D-Pro-NH2 565 TCAM562 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Arg-His-D-Nal(2′)-Arg-D- Nal(2')-Arg-Lys]-D-Pro-D-Val-NH2 566 TCAM563 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Arg-His-D-Nal(2′)-Arg-D- Nal(2')-Arg-Lys]-D-Val-D-Phe-NH2 567 TCAM564 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Arg-His-D-Nal(2′)-Arg-D- Nal(2')-Arg-Lys]-D-Phe-D-Val-NH2 568 TCAM565 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-Ile-Trp-Arg-Arg-Arg-Arg-c[Asp-Pro-D-Nal(2′)-Arg-D- Nal(2')-Lys]-D-Val-D-Pro-NH2 569 TCAM566 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-Ile-Trp-Arg-Arg-Arg-Arg-c[Asp-Pro-D-Nal(2′)-Arg-D- Nal(2')-Lys]-D-Pro-D-Val-NH2 570 TCAM567 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-Ile-Trp-Arg-Arg-Arg-Arg-c[Asp-Pro-D-Nal(2′)-Arg-D- Nal(2')-Lys]-D-Val-D-Phe-NH2 571 TCAM568 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-Ile-Trp-Arg-Arg-Arg-Arg-c[Asp-Pro-D-Nal(2′)-Arg-D- Nal(2')-Lys]-D-Phe-D-Val-NH2 572 TCAM569 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-Ile-Trp-Arg-Arg-Arg-Arg-c[Asp-His-D-Nal(2′)-Arg-D- Nal(2')-Lys]-D-Val-D-Pro-NH2 573 TCAM570 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-Ile-Trp-Arg-Arg-Arg-Arg-c[Asp-His-D-Nal(2′)-Arg-D- Nal(2')-Lys]-D-Pro-D-Val-NH2 574 TCAM571 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-Ile-Trp-Arg-Arg-Arg-Arg-c[Asp-His-D-Nal(2′)-Arg-D- Nal(2')-Lys]-D-Val-D-Phe-NH2 575 TCAM572 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-Ile-Trp-Arg-Arg-Arg-Arg-c[Asp-His-D-Nal(2′)-Arg-D- Nal(2')-Lys]-D-Phe-D-Val-NH2 576 TCAM573 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Arg-Pro-D-Nal(2′)-Arg-D- Nal(2')-Arg-Lys]-D-Val-D-Pro-NH2 577 TCAM574 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Arg-Pro-D-Nal(2′)-Arg-D- Nal(2')-Arg-Lys]-D-Pro-D-Val-NH2 578 TCAM575 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Arg-Pro-D-Nal(2′)-Arg-D- Nal(2')-Arg-Lys]-D-Val-D-Phe-NH2 579 TCAM576 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Arg-Pro-D-Nal(2′)-Arg-D- Nal(2')-Arg-Lys]-D-Phe-D-Val-NH2 580 TCAM577 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Arg-His-D-Nal(2′)-Arg-D- Nal(2')-Arg-Lys]-D-Val-D-Pro-NH2 581 TCAM578 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Arg-His-D-Nal(2′)-Arg-D- Nal(2')-Arg-Lys]-D-Pro-D-Val-NH2 582 TCAM579 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Arg-His-D-Nal(2′)-Arg-D- Nal(2')-Arg-Lys]-D-Val-D-Phe-NH2 583 TCAM580 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Arg-His-D-Nal(2′)-Arg-D- Nal(2')-Arg-Lys]-D-Phe-D-Val-NH2 584 TCAM581 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-Ile-Trp-Arg-Arg-c[Asp-His-D-Nal(2′)-Arg-Trp-Lys]- Arg-Arg-D-Val-D-Pro-NH2 585 TCAM582 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-Ile-Trp-Arg-Arg-c[Asp-His-D-Nal(2′)-Arg-Trp-Lys]- Arg-Arg-D-Pro-D-Val-NH2 586 TCAM583 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-Ile-Trp-Arg-Arg-c[Asp-His-D-Nal(2′)-Arg-Trp-Lys]- Arg-Arg-D-Val-D-Phe-NH2 587 TCAM584 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-Ile-Trp-Arg-Arg-c[Asp-His-D-Nal(2′)-Arg-Trp-Lys]- Arg-Arg-D-Phe-D-Val-NH2 588 TCAM585 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Pro-D-Nal(2′)-Arg-Trp-Lys]- Arg-Arg-D-Val-D-Pro-NH2 589 TCAM586 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Pro-D-Nal(2′)-Arg-Trp-Lys]- Arg-Arg-D-Pro-D-Val-NH2 590 TCAM587 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Pro-D-Nal(2′)-Arg-Trp-Lys]- Arg-Arg-D-Val-D-Phe-NH2 591 TCAM588 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Pro-D-Nal(2′)-Arg-Trp-Lys]- Arg-Arg-D-Phe-D-Val-NH2 Anti-biofilm peptide ATRA1 linked to anti-microbial peptides 592 TCAM589 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Pro-Arg-Arg-Trp-Trp-Arg-Phe- Lys]-D-Val-D-Pro-NH2 593 TCAM590 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Pro-Arg-Arg-Trp-Trp-Arg-Phe- Lys]-D-Val-D-Phe-NH2 594 TCAM591 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Pro-Arg-Arg-Trp-Trp-Arg-Phe- Lys]-D-Pro-D-Val-NH2 595 TCAM592 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Pro-Arg-Arg-Trp-Trp-Arg-Phe- Lys]-D-Phe-D-Val-NH2 596 TCAM593 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Pro-Arg-Arg-Trp-Trp-Tyr-Phe- Lys]-D-Val-D-Pro-NH2 597 TCAM594 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Pro-Arg-Arg-Trp-Trp-Tyr-Phe- Lys]-D-Val-D-Phe-NH2 598 TCAM595 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Pro-Arg-Arg-Trp-Trp-Tyr-Phe- Lys]-D-Pro-D-Val-NH2 599 TCAM596 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Pro-Arg-Arg-Trp-Trp-Tyr-Phe- Lys]-D-Phe-D-Val-NH2 600 TCAM597 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Pro-Arg-Arg-Tyr-Tyr-Arg-Phe- Lys]-D-Val-D-Pro-NH2 601 TCAM598 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Pro-Arg-Arg-Tyr-Tyr-Arg-Phe- Lys]-D-Val-D-Phe-NH2 602 TCAM599 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Pro-Arg-Arg-Tyr-Tyr-Arg-Phe- Lys]-D-Pro-D-Val-NH2 603 TCAM600 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Pro-Arg-Arg-Tyr-Tyr-Arg-Phe- Lys]-D-Phe-D-Val-NH2 604 TCAM601 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Pro-Arg-Arg-Nal-Nal-Arg-Phe- Lys]-D-Val-D-Pro-NH2 605 TCAM602 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Pro-Arg-Arg-Nal-Nal-Arg-Phe- Lys]-D-Val-D-Phe-NH2 606 TCAM603 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Pro-Arg-Arg-Nal-Nal-Arg-Phe- Lys]-D-Pro-D-Val-NH2 607 TCAM604 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Pro-Arg-Arg-Nal-Nal-Arg-Phe- Lys]-D-Phe-D-Val-NH2 608 TCAM605 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Pro-Arg-Arg-Leu-Trp-Leu-Trp- Lys]-D-Val-D-Pro-NH2 609 TCAM606 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Pro-Arg-Arg-Leu-Trp-Leu-Trp- Lys]-D-Val-D-Phe-NH2 610 TCAM607 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Pro-Arg-Arg-Leu-Trp-Leu-Trp- Lys]-D-Pro-D-Val-NH2 611 TCAM608 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Pro-Arg-Arg-Leu-Trp-Leu-Trp- Lys]-D-Phe-D-Val-NH2 612 TCAM609 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Pro-Arg-Arg-Leu-Trp-Leu-Trp- Lys]-D-Val-D-Pro-NH2 613 TCAM610 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Pro-Arg-Arg-Leu-Trp-Leu-Trp- Lys]-D-Val-D-Phe-NH2 614 TCAM611 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Pro-Arg-Arg-Leu-Trp-Leu-Trp- Lys]-D-Pro-D-Val-NH2 615 TCAM612 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Pro-Arg-Arg-Leu-Trp-Leu-Trp- Lys]-D-Phe-D-Val-NH2 616 TCAM613 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Arg-Arg-Arg-Trp-Leu-Trp-Leu- Trp-Lys]-D-Val-D-Pro-NH2 617 TCAM614 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Pro-Arg-Arg-Arg-Trp-Leu-Trp- Leu-Trp-Lys]-D-Val-D-Phe-NH2 618 TCAM615 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Pro-Arg-Arg-Arg-Trp-Leu-Trp- Leu-Trp-Lys]-D-Pro-D-Val-NH2 619 TCAM616 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Pro-Arg-Arg-Arg-Trp-Leu-Trp- Leu-Trp-Lys]-D-Phe-D-Val-NH2 620 TCAM617 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Pro-Arg-Gln-Arg-Arg-Trp-Leu- Trp-Leu-Trp-Lys]-D-Val-D-Pro-NH2 621 TCAM618 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Pro-Arg-Gln-Arg-Arg-Trp-Leu- Trp-Leu-Trp-Lys]-D-Val-D-Phe-NH2 622 TCAM619 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Pro-Arg-Gln-Arg-Arg-Trp-Leu- Trp-Leu-Trp-Lys]-D-Pro-D-Val-NH2 623 TCAM620 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Pro-Arg-Gln-Arg-Arg-Trp-Leu- Trp-Leu-Trp-Lys]-D-Phe-D-Val-NH2 624 TCAM621 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Pro-Trp-Arg-Trp-Trp-Arg-Arg- Lys]-D-Val-D-Phe-NH2 625 TCAM622 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Pro-Trp-Arg-Trp-Trp-Arg-Arg- Lys]-D-Pro-D-Val-NH2 626 TCAM623 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Pro-Trp-Arg-Trp-Trp-Arg-Arg- Lys]-D-Phe-D-Val-NH2 627 TCAM624 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Pro-Trp-Trp-Arg-Arg-Trp-Trp- Arg-Arg-Lys]-D-Val-D-Pro-NH2 628 TCAM625 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Pro-Trp-Trp-Arg-Arg-Trp-Trp- Arg-Arg-Lys]-D-Val-D-Phe-NH2 629 TCAM626 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Pro-Trp-Trp-Arg-Arg-Trp-Trp- Arg-Arg-Lys]-D-Pro-D-Val-NH2 630 TCAM627 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Pro-Trp-Trp-Arg-Arg-Trp-Trp- Arg-Arg-Lys]-D-Phe-D-Val-NH2 631 TCAM628 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Pro-Trp-Arg-Trp-Arg-Trp-Arg- Lys]-D-Val-D-Pro-NH2 632 TCAM629 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Pro-Trp-Arg-Trp-Arg-Trp-Arg- Lys]-D-Val-D-Phe-NH2 633 TCAM630 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Pro-Trp-Arg-Trp-Arg-Trp-Arg- Lys]-D-Pro-D-Val-NH2 634 TCAM631 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Pro-Trp-Arg-Trp-Arg-Trp-Arg- Lys]-D-Phe-D-Val-NH2 635 TCAM632 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Pro-Arg-Trp-Arg-Trp-Arg-Trp- Lys]-D-Val-D-Pro-NH2 636 TCAM633 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Pro-Arg-Trp-Arg-Trp-Arg-Trp- Lys]-D-Val-D-Phe-NH2 637 TCAM634 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Pro-Arg-Trp-Arg-Trp-Arg-Trp- Lys]-D-Pro-D-Val-NH2 638 TCAM635 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Pro-Arg-Trp-Arg-Trp-Arg-Trp- Lys]-D-Phe-D-Val-NH2 639 TCAM636 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Pro-Arg-Trp-Trp-Arg-Arg-Lys]-D- Val-D-Pro-NH2 640 TCAM637 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Pro-Arg-Trp-Trp-Arg-Arg-Lys]-D- Val-D-Phe-NH2 641 TCAM638 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Pro-Arg-Trp-Trp-Arg-Arg-Lys]-D- Pro-D-Val-NH2 642 TCAM639 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Pro-Arg-Trp-Trp-Arg-Arg-Lys]-D- Phe-D-Val-NH2 643 TCAM640 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Pro-Trp-Trp-Arg-Arg-Trp-Lys]-D- Val-D-Pro-NH2 644 TCAM641 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Pro-Trp-Trp-Arg-Arg-Trp-Lys]-D- Val-D-Phe-NH2 645 TCAM642 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Pro-Trp-Trp-Arg-Arg-Trp-Lys]-D- Pro-D-Val-NH2 646 TCAM643 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Pro-Trp-Trp-Arg-Arg-Trp-Lys]-D- Phe-D-Val-NH2 647 TCAM644 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Pro-Trp-Arg-Trp-Arg-Trp-Lys]-D- Val-D-Pro-NH2 648 TCAM645 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Pro-Trp-Arg-Trp-Arg-Trp-Lys]-D- Val-D-Phe-NH2 649 TCAM646 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Pro-Trp-Arg-Trp-Arg-Trp-Lys]-D- Pro-D-Val-NH2 650 TCAM647 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Pro-Trp-Arg-Trp-Arg-Trp-Lys]-D- Phe-D-Val-NH2 651 TCAM648 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Pro-Arg-Trp-Arg-Trp-Arg-Lys]-D- Val-D-Pro-NH2 652 TCAM649 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Pro-Arg-Trp-Arg-Trp-Arg-Lys]-D- Val-D-Phe-NH2 653 TCAM650 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Pro-Arg-Trp-Arg-Trp-Arg-Lys]-D- Pro-D-Val-NH2 654 TCAM651 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Pro-Arg-Trp-Arg-Trp-Arg-Lys]-D- Phe-D-Val-NH2 655 TCAM652 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Pro-Trp-Arg-Tyr-Arg-Trp-Lys]-D- Val-D-Pro-NH2 656 TCAM653 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Pro-Trp-Arg-Tyr-Arg-Trp-Lys]-D- Val-D-Phe-NH2 657 TCAM654 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Pro-Trp-Arg-Tyr-Arg-Trp-Lys]-D- Pro-D-Val-NH2 658 TCAM655 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Pro-Trp-Arg-Tyr-Arg-Trp-Lys]-D- Phe-D-Val-NH2 659 TCAM656 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Pro-Trp-Arg-Trp-Arg-Tyr-Lys]-D- Val-D-Pro-NH2 660 TCAM657 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Pro-Trp-Arg-Trp-Arg-Tyr-Lys]-D- Val-D-Phe-NH2 661 TCAM658 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Pro-Trp-Arg-Trp-Arg-Tyr-Lys]-D- Pro-D-Val-NH2 662 TCAM659 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Pro-Trp-Arg-Trp-Arg-Tyr-Lys]-D- Phe-D-Val-NH2 663 TCAM660 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Pro-Trp-Arg-Trp-Arg-Lys]-D-Val- D-Pro-NH2 664 TCAM661 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Pro-Trp-Arg-Trp-Arg-Lys]-D-Val- D-Phe-NH2 665 TCAM662 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Pro-Trp-Arg-Trp-Arg-Lys]-D-Pro- D-Val-NH2 666 TCAM663 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Pro-Trp-Arg-Trp-Arg-Lys]-D- Phe-D-Val-NH2 667 TCAM664 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Pro-Trp-Arg-Arg-Trp-Lys]-D-Val- D-Pro-NH2 668 TCAM665 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Pro-Trp-Arg-Arg-Trp-Lys]-D-Val- D-Phe-NH2 669 TCAM666 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Pro-Trp-Arg-Arg-Trp-Lys]-D-Pro- D-Val-NH2 670 TCAM667 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Pro-Trp-Arg-Arg-Trp-Lys]-D- Phe-D-Val-NH2 671 TCAM668 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Pro-Arg-Trp-Trp-Arg-Lys]-D-Val- D-Pro-NH2 672 TCAM669 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Pro-Arg-Trp-Trp-Arg-Lys]-D-Val- D-Phe-NH2 673 TCAM670 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Pro-Arg-Trp-Trp-Arg-Lys]-D-Pro- D-Val-NH2 674 TCAM671 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Pro-Arg-Trp-Trp-Arg-Lys]-D- Phe-D-Val-NH2 675 TCAM672 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Pro-Trp-Arg-Trp-Lys]-D-Val-D- Pro-NH2 676 TCAM673 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Pro-Trp-Arg-Trp-Lys]-D-Val-D- Phe-NH2 677 TCAM674 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Pro-Trp-Arg-Trp-Lys]-D-Pro-D- Val-NH2 678 TCAM675 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Pro-Trp-Arg-Trp-Lys]-D-Phe-D- Val-NH2 679 TCAM676 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Pro-Arg-Trp-Arg-Lys]-D-Val-D- Pro-NH2 680 TCAM677 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Pro-Arg-Trp-Arg-Lys]-D-Val-D- Phe-NH2 681 TCAM678 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Pro-Arg-Trp-Arg-Lys]-D-Pro-D- Val-NH2 682 TCAM679 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Pro-Arg-Trp-Arg-Lys]-D-Phe-D- Val-NH2 683 TCAM680 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Arg-Arg-Trp-Trp-Arg-Phe-Lys]- D-Val-D-Pro-NH2 684 TCAM681 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Arg-Arg-Trp-Trp-Arg-Phe-Lys]- D-Val-D-Phe-NH2 685 TCAM682 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Arg-Arg-Trp-Trp-Arg-Phe-Lys]- D-Pro-D-Val-NH2 686 TCAM683 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Arg-Arg-Trp-Trp-Arg-Phe-Lys]- D-Phe-D-Val-NH2 687 TCAM684 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Arg-Arg-Trp-Trp-Arg-Phe-Lys]- D-Val-D-Pro-NH2 688 TCAM685 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Arg-Arg-Trp-Trp-Arg-Phe-Lys]- D-Val-D-Phe-NH2 689 TCAM686 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Arg-Arg-Trp-Trp-Arg-Phe-Lys]- D-Pro-D-Val-NH2 690 TCAM687 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Arg-Arg-Trp-Trp-Arg-Phe-Lys]- D-Phe-D-Val-NH2 691 TCAM688 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Arg-Arg-Tyr-Tyr-Arg-Phe-Lys]-D- Val-D-Pro-NH2 692 TCAM689 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Arg-Arg-Tyr-Tyr-Arg-Phe-Lys]-D- Val-D-Phe-NH2 693 TCAM690 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Arg-Arg-Tyr-Tyr-Arg-Phe-Lys]-D- Pro-D-Val-NH2 694 TCAM691 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Arg-Arg-Tyr-Tyr-Arg-Phe-Lys]-D- Phe-D-Val-NH2 695 TCAM692 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Arg-Arg-Nal-Nal-Arg-Phe-Lys]- D-Val-D-Pro-NH2 696 TCAM693 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Arg-Arg-Nal-Nal-Arg-Phe-Lys]- D-Val-D-Phe-NH2 697 TCAM694 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Arg-Arg-Nal-Nal-Arg-Phe-Lys]- D-Pro-D-Val-NH2 698 TCAM695 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Arg-Arg-Nal-Nal-Arg-Phe-Lys]- D-Phe-D-Val-NH2 699 TCAM696 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Arg-Arg-Leu-Trp-Leu-Trp-Lys]- D-Val-D-Pro-NH2 700 TCAM697 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Arg-Arg-Leu-Trp-Leu-Trp-Lys]- D-Val-D-Phe-NH2 701 TCAM698 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Arg-Arg-Leu-Trp-Leu-Trp-Lys]- D-Pro-D-Val-NH2 702 TCAM699 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Arg-Arg-Leu-Trp-Leu-Trp-Lys]- D-Phe-D-Val-NH2 703 TCAM700 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Arg-Arg-Leu-Trp-Leu-Trp-Lys]- D-Val-D-Pro-NH2 704 TCAM701 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Arg-Arg-Leu-Trp-Leu-Trp-Lys]- D-Val-D-Phe-NH2 705 TCAM702 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Arg-Arg-Leu-Trp-Leu-Trp-Lys]- D-Pro-D-Val-NH2 706 TCAM703 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Arg-Arg-Leu-Trp-Leu-Trp-Lys]- D-Phe-D-Val-NH2 707 TCAM704 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Arg-Arg-Arg-Trp-Leu-Trp-Leu- Trp-Lys]-D-Val-D-Pro-NH2 708 TCAM705 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Arg-Arg-Arg-Trp-Leu-Trp-Leu- Trp-Lys]-D-Val-D-Phe-NH2 709 TCAM706 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Arg-Arg-Arg-Trp-Leu-Trp-Leu- Trp-Lys]-D-Pro-D-Val-NH2 710 TCAM707 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Arg-Arg-Arg-Trp-Leu-Trp-Leu- Trp-Lys]-D-Phe-D-Val-NH2 711 TCAM708 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Arg-Gln-Arg-Arg-Trp-Leu-Trp- Leu-Trp-Lys]-D-Val-D-Pro-NH2 712 TCAM709 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Arg-Gln-Arg-Arg-Trp-Leu-Trp- Leu-Trp-Lys]-D-Val-D-Phe-NH2 713 TCAM710 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Arg-Gln-Arg-Arg-Trp-Leu-Trp- Leu-Trp-Lys]-D-Pro-D-Val-NH2 714 TCAM711 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Arg-Gln-Arg-Arg-Trp-Leu-Trp- Leu-Trp-Lys]-D-Phe-D-Val-NH2 715 TCAM712 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Trp-Arg-Trp-Trp-Arg-Arg-Lys]-D- Val-D-Pro-NH2 716 TCAM713 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Trp-Arg-Trp-Trp-Arg-Arg-Lys]-D- Val-D-Phe-NH2 717 TCAM714 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Trp-Arg-Trp-Trp-Arg-Arg-Lys]-D- Pro-D-Val-NH2 718 TCAM715 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Trp-Arg-Trp-Trp-Arg-Arg-Lys]-D- Phe-D-Val-NH2 719 TCAM716 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Trp-Trp-Arg-Arg-Trp-Trp-Arg- Arg-Lys]-D-Val-D-Pro-NH2 720 TCAM717 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Trp-Trp-Arg-Arg-Trp-Trp-Arg- Arg-Lys]-D-Val-D-Phe-NH2 721 TCAM718 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Trp-Trp-Arg-Arg-Trp-Trp-Arg- Arg-Lys]-D-Pro-D-Val-NH2 722 TCAM719 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Trp-Trp-Arg-Arg-Trp-Trp-Arg- Arg-Lys]-D-Phe-D-Val-NH2 723 TCAM720 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Trp-Arg-Trp-Arg-Trp-Arg-Lys]-D- Val-D-Pro-NH2 724 TCAM721 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Trp-Arg-Trp-Arg-Trp-Arg-Lys]-D- Val-D-Phe-NH2 725 TCAM722 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Trp-Arg-Trp-Arg-Trp-Arg-Lys]-D- Pro-D-Val-NH2 726 TCAM723 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Trp-Arg-Trp-Arg-Trp-Arg-Lys]-D- Phe-D-Val-NH2 727 TCAM724 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Arg-Trp-Arg-Trp-Arg-Trp-Lys]-D- Val-D-Pro-NH2 728 TCAM725 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Arg-Trp-Arg-Trp-Arg-Trp-Lys]-D- Val-D-Phe-NH2 729 TCAM726 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Arg-Trp-Arg-Trp-Arg-Trp-Lys]-D- Pro-D-Val-NH2 730 TCAM727 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Arg-Trp-Arg-Trp-Arg-Trp-Lys]-D- Phe-D-Val-NH2 731 TCAM728 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Arg-Trp-Trp-Arg-Arg-Lys]-D-Val- D-Pro-NH2 732 TCAM729 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Arg-Trp-Trp-Arg-Arg-Lys]-D-Val- D-Phe-NH2 733 TCAM730 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Arg-Trp-Trp-Arg-Arg-Lys]-D-Pro- D-Val-NH2 734 TCAM731 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Arg-Trp-Trp-Arg-Arg-Lys]-D- Phe-D-Val-NH2 735 TCAM732 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Arg-Trp-Arg-Trp-Arg-Lys]-D-Val- D-Pro-NH2 736 TCAM733 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Arg-Trp-Arg-Trp-Arg-Lys]-D-Val- D-Phe-NH2 737 TCAM734 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Arg-Trp-Arg-Trp-Arg-Lys]-D-Pro- D-Val-NH2 738 TCAM735 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Arg-Trp-Arg-Trp-Arg-Lys]-D- Phe-D-Val-NH2 739 TCAM736 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Trp-Trp-Arg-Arg-Trp-Lys]-D-Val- D-Pro-NH2 740 TCAM737 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Trp-Trp-Arg-Arg-Trp-Lys]-D-Val- D-Phe-NH2 741 TCAM738 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Trp-Trp-Arg-Arg-Trp-Lys]-D-Pro- D-Val-NH2 742 TCAM739 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Trp-Trp-Arg-Arg-Trp-Lys]-D- Phe-D-Val-NH2 743 TCAM740 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Trp-Arg-Trp-Arg-Trp-Lys]-D-Val- D-Pro-NH2 744 TCAM741 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Trp-Arg-Trp-Arg-Trp-Lys]-D-Val- D-Phe-NH2 745 TCAM742 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Trp-Arg-Trp-Arg-Trp-Lys]-D-Pro- D-Val-NH2 746 TCAM743 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Trp-Arg-Trp-Arg-Trp-Lys]-D- Phe-D-Val-NH2 747 TCAM744 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Trp-Arg-Tyr-Arg-Trp-Lys]-D-Val- D-Pro-NH2 748 TCAM745 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Trp-Arg-Tyr-Arg-Trp-Lys]-D-Val- D-Phe-NH2 749 TCAM746 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Trp-Arg-Tyr-Arg-Trp-Lys]-D-Pro- D-Val-NH2 750 TCAM747 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Trp-Arg-Tyr-Arg-Trp-Lys]-D-Phe- D-Val-NH2 751 TCAM748 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Trp-Arg-Trp-Arg-Tyr-Lys]-D-Val- D-Pro-NH2 752 TCAM749 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Trp-Arg-Trp-Arg-Tyr-Lys]-D-Val- D-Phe-NH2 753 TCAM750 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Trp-Arg-Trp-Arg-Tyr-Lys]-D-Pro- D-Val-NH2 754 TCAM751 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Trp-Arg-Trp-Arg-Tyr-Lys]-D-Phe- D-Val-NH2 755 TCAM752 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Trp-Arg-Trp-Arg-Lys]-D-Val-D- Pro-NH2 756 TCAM753 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Trp-Arg-Trp-Arg-Lys]-D-Val-D- Phe-NH2 757 TCAM754 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Trp-Arg-Trp-Arg-Lys]-D-Pro-D- Val-NH2 758 TCAM755 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Trp-Arg-Trp-Arg-Lys]-D-Phe-D- Val-NH2 759 TCAM756 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Trp-Arg-Arg-Trp-Lys]-D-Val-D- Pro-NH2 760 TCAM757 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Trp-Arg-Arg-Trp-Lys]-D-Val-D- Phe-NH2 761 TCAM758 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Trp-Arg-Arg-Trp-Lys]-D-Pro-D- Val-NH2 762 TCAM759 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Trp-Arg-Arg-Trp-Lys]-D-Phe-D- Val-NH2 763 TCAM760 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Arg-Trp-Trp-Arg-Lys]-D-Val-D- Pro-NH2 764 TCAM761 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Arg-Trp-Trp-Arg-Lys]-D-Val-D- Phe-NH2 765 TCAM762 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Arg-Trp-Trp-Arg-Lys]-D-Pro-D- Val-NH2 766 TCAM763 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Arg-Trp-Trp-Arg-Lys]-D-Phe-D- Val-NH2 767 TCAM764 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Trp-Arg-Trp-Lys]-D-Val-D-Pro- NH2 768 TCAM765 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Trp-Arg-Trp-Lys]-D-Val-D-Phe- NH2 769 TCAM766 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Trp-Arg-Trp-Lys]-D-Pro-D-Val- NH2 770 TCAM767 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Trp-Arg-Trp-Lys]-D-Phe-D-Val- NH2 771 TCAM768 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Arg-Trp-Arg-Lys]-D-Val-D-Pro- NH2 772 TCAM769 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Arg-Trp-Arg-Lys]-D-Val-D-Phe- NH2 773 TCAM770 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Arg-Trp-Arg-Lys]-D-Pro-D-Val- NH2 774 TCAM771 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Arg-Trp-Arg-Lys]-D-Phe-D-Val- NH2 775 TCAM772 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-His-D-Nal(2′)-Arg-Trp-Lys]-D- Val-D-Pro-NH2 776 TCAM773 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-His-D-Nal(2′)-Arg-Trp-Lys]-D- Pro-D-Val-NH2 777 TCAM774 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-His-D-Nal(2′)-Arg-Trp-Lys]-D- Val-D-Phe-NH2 778 TCAM775 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-His-D-Nal(2′)-Arg-Trp-Lys]-D- Phe-D-Val-NH2 779 TCAM776 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Pro-D-Nal(2′)-Arg-Trp-Lys]-D- Val-D-Pro-NH2 780 TCAM777 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Pro-D-Nal(2′)-Arg-Trp-Lys]-D- Pro-D-Val-NH2 781 TCAM778 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Pro-D-Nal(2′)-Arg-Trp-Lys]-D- Val-D-Phe-NH2 782 TCAM779 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Pro-D-Nal(2′)-Arg-Trp-Lys]-D- Phe-D-Val-NH2 783 TCAM780 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Arg-Arg-Nal(2′)-Arg-Trp-Lys]-D- Val-D-Pro-NH2 784 TCAM781 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Arg-Arg-Nal(2′)-Arg-Trp-Lys]-D- Pro-D-Val-NH2 785 TCAM782 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Arg-Arg-Nal(2′)-Arg-Trp-Lys]-D- Val-D-Phe-NH2 786 TCAM783 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Arg-Arg-Nal(2′)-Arg-Trp-Lys]-D- Phe-D-Val-NH2 787 TCAM784 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Arg-Arg-Pro-Nal(2′)-Arg-Trp- Lys]-D-Val-D-Pro-NH2 788 TCAM785 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Arg-Arg-Pro-D-Nal(2′)-Arg-Trp- Lys]-D-Pro-D-Val-NH2 789 TCAM786 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Arg-Arg-Pro-D-Nal(2′)-Arg-Trp- Lys]-D-Val-D-Phe-NH2 790 TCAM787 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Arg-Arg-Pro-Nal(2′)-Arg-Trp- Lys]-D-Phe-D-Val-NH2 791 TCAM788 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Arg-D-Nal(2′)-Arg-Trp-Lys]-D- Val-D-Pro-NH2 792 TCAM789 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Arg-D-Nal(2′)-Arg-Trp-Lys]-D- Pro-D-Val-NH2 793 TCAM790 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Arg-D-Nal(2′)-Arg-Trp-Lys]-D- Val-D-Phe-NH2 794 TCAM791 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Arg-D-Nal(2′)-Arg-Trp-Lys]-D- Phe-D-Val-NH2 795 TCAM792 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Arg-Pro-D-Nal(2′)-Arg-Trp-Lys]- D-Val-D-Pro-NH2 796 TCAM793 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Arg-Pro-D-Nal(2′)-Arg-Trp-Lys]- D-Pro-D-Val-NH2 797 TCAM794 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Arg-Pro-D-Nal(2′)-Arg-Trp-Lys]- D-Val-D-Phe-NH2 798 TCAM795 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Arg-Pro-D-Nal(2′)-Arg-Trp-Lys]- D-Phe-D-Val-NH2 799 TCAM796 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-Arg-Arg-c[Asp-Pro-D-Nal(2′)-Arg-Trp- Lys]-D-Val-D-Pro-NH2 800 TCAM797 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-Arg-Arg-c[Asp-Pro-D-Nal(2′)-Arg-Trp- Lys]-D-Pro-D-Val-NH2 801 TCAM798 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-Arg-Arg-c[Asp-Pro-D-Nal(2′)-Arg-Trp- Lys]-D-Val-D-Phe-NH2 802 TCAM799 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-Arg-Arg-c[Asp-Pro-D-Nal(2′)-Arg-Trp- Lys]-D-Phe-D-Val-NH2 803 TCAM800 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-Arg-Arg-c[Asp-His-D-Nal(2′)-Arg-Trp- Lys]-D-Val-D-Pro-NH2 804 TCAM801 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-Arg-Arg-c[Asp-His-D-Nal(2′)-Arg-Trp- Lys]-D-Pro-D-Val-NH2 805 TCAM802 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-Arg-Arg-c[Asp-His-D-Nal(2′)-Arg-Trp- Lys]-D-Val-D-Phe-NH2 806 TCAM803 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-Arg-Arg-c[Asp-His-D-Nal(2′)-Arg-Trp- Lys]-D-Phe-D-Val-NH2 807 TCAM804 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Arg-Pro-D-Nal(2′)-Arg-Trp-Arg- Lys]-D-Val-D-Pro-NH2 808 TCAM805 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Arg-Pro-D-Nal(2′)-Arg-Trp-Arg- Lys]-D-Pro-D-Val-NH2 809 TCAM806 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Arg-Pro-D-Nal(2′)-Arg-Trp-Arg- Lys]-D-Val-D-Phe-NH2 810 TCAM807 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Arg-Pro-D-Nal(2′)-Arg-Trp-Arg- Lys]-D-Phe-D-Val-NH2 811 TCAM808 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Arg-His-D-Nal(2′)-Arg-Trp-Arg- Lys]-D-Val-D-Pro-NH2 812 TCAM809 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Arg-His-D-Nal(2′)-Arg-Trp-Arg- Lys]-D-Pro-D-Val-NH2 813 TCAM810 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Arg-His-D-Nal(2′)-Arg-Trp-Arg- Lys]-D-Val-D-Phe-NH2 814 TCAM811 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Arg-His-D-Nal(2′)-Arg-Trp-Arg- Lys]-D-Phe-D-Val-NH2 815 TCAM812 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-His-D-Nal(2′)-Arg-D-Nal(2′)-Lys]- D-Val-D-Phe-NH2 816 TCAM813 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-His-D-Nal(2′)-Arg-D-Nal(2′)-Lys]- D-Phe-D-Val-NH2 817 TCAM814 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Pro-D-Nal(2′)-Arg-D-Nal(2′)-Lys]- D-Val-D-Pro-NH2 818 TCAM815 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Pro-D-Nal(2′)-Arg-D-Nal(2′)-Lys]- D-Pro-D-Val-NH2 819 TCAM816 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Pro-D-Nal(2′)-Arg-D-Nal(2′)-Lys]- D-Val-D-Phe-NH2 820 TCAM817 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Pro-D-Nal(2′)-Arg-D-Nal(2′)-Lys]- D-Phe-D-Val-NH2 821 TCAM818 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Arg-Arg-D-Nal(2′)-Arg-D-Nal(2′)- Lys]-D-Val-D-Pro-NH2 822 TCAM819 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Arg-Arg-D-Nal(2′)-Arg-D-Nal(2′)- Lys]-D-Pro-D-Val-NH2 823 TCAM820 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Arg-Arg-D-Nal(2′)-Arg-D-Nal(2′)- Lys]-D-Val-D-Phe-NH2 824 TCAM821 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Arg-Arg-D-Nal(2′)-Arg-D-Nal(2′)- Lys]-D-Phe-D-Val-NH2 825 TCAM822 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Arg-Arg-Pro-D-Nal(2′)-Arg-D- Nal(2')-Lys]-D-Val-D-Pro-NH2 826 TCAM823 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Arg-Arg-Pro-D-Nal(2′)-Arg-D- Nal(2')-Lys]-D-Pro-D-Val-NH2 827 TCAM824 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Arg-Arg-Pro-D-Nal(2′)-Arg-D- Nal(2')-Lys]-D-Val-D-Phe-NH2 828 TCAM825 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Arg-Arg-Pro-D-Nal(2′)-Arg-D- Nal(2')-Lys]-D-Phe-D-Val-NH2 829 TCAM826 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Arg-D-Nal(2′)-Arg-D-Nal(2′)-Lys]- D-Val-D-Pro-NH2 830 TCAM827 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Arg-D-Nal(2′)-Arg-D-Nal(2′)-Lys]- D-Pro-D-Val-NH2 831 TCAM828 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Arg-Nal(2′)-Arg-D-Nal(2′)-Lys]-D- Val-D-Phe-NH2 832 TCAM829 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Arg-D-Nal(2′)-Arg-D-Nal(2′)-Lys]- D-Phe-D-Val-NH2 833 TCAM830 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Arg-Pro-D-Nal(2′)-Arg-D-Nal(2′)- Lys]-D-Val-D-Pro-NH2 834 TCAM831 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Arg-Pro-D-Nal(2′)-Arg-D-Nal(2′)- Lys]-D-Pro-D-Val-NH2 835 TCAM832 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Arg-Pro-D-Nal(2′)-Arg-D-Nal(2′)- Lys]-D-Val-D-Phe-NH2 836 TCAM833 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Arg-Pro-D-Nal(2′)-Arg-D-Nal(2′)- Lys]-D-Phe-D-Val-NH2 837 TCAM834 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Arg-His-D-Nal(2′)-Arg-D-Nal(2′)- Lys]-D-Val-D-Pro-NH2 838 TCAM835 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Arg-His-D-Nal(2′)-Arg-D-Nal(2′)- Lys]-D-Pro-D-Val-NH2 839 TCAM836 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Arg-His-Nal(2′)-Arg-D-Nal(2′)- Lys]-D-Val-D-Phe-NH2 840 TCAM837 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Arg-His-Nal(2′)-Arg-D-Nal(2′)- Lys]-D-Phe-D-Val-NH2 841 TCAM838 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Arg-D-D-Nal(2′)-Arg-D-Nal(2′)- Arg-Lys]-D-Val-D-Pro-NH2 842 TCAM839 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Arg-D-Nal(2′)-Arg-D-Nal(2′)-Arg- Lys]-D-Pro-D-Val-NH2 843 TCAM840 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Arg-D-Nal(2′)-Arg-D-Nal(2′)-Arg- Lys]-D-Val-D-Phe-NH2 844 TCAM841 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Arg-D-Nal(2′)-Arg-D-Nal(2′)-Arg- Lys]-D-Phe-D-Val-NH2 845 TCAM842 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Arg-Pro-D-Nal(2′)-Arg-D-Nal(2′)- Arg-Lys]-D-Val-D-Pro-NH2 846 TCAM843 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Arg-Pro-D-Nal(2′)-Arg-D-Nal(2′)- Arg-Lys]-D-Pro-D-Val-NH2 847 TCAM844 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Arg-Pro-D-Nal(2′)-Arg-D-Nal(2′)- Arg-Lys]-D-Val-D-Phe-NH2 848 TCAM845 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Arg-Pro-D-Nal(2′)-Arg-D-Nal(2′)- Arg-Lys]-D-Phe-D-Val-NH2 849 TCAM846 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Arg-His-D-Nal(2′)-Arg-D-Nal(2′)- Arg-Lys]-D-Val-D-Pro-NH2 850 TCAM847 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Arg-His-D-Nal(2′)-Arg-D-Nal(2′)- Arg-Lys]-D-Pro-D-Val-NH2 851 TCAM848 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Arg-His-D-Nal(2′)-Arg-D-Nal(2′)- Arg-Lys]-D-Val-D-Phe-NH2 852 TCAM849 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Arg-His-D-Nal(2′)-Arg-D-Nal(2′)- Arg-Lys]-D-Phe-D-Val-NH2 853 TCAM850 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-Arg-Arg-c[Asp-Pro-D-Nal(2′)-Arg-D- Nal(2')-Lys]-D-Val-D-Pro-NH2 854 TCAM851 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-Arg-Arg-c[Asp-Pro-D-Nal(2′)-Arg-D- Nal(2')-Lys]-D-Pro-D-Val-NH2 855 TCAM852 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-Arg-Arg-c[Asp-Pro-D-Nal(2′)-Arg-D- Nal(2')-Lys]-D-Val-D-Phe-NH2 856 TCAM853 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-Arg-Arg-c[Asp-Pro-D-Nal(2′)-Arg-D- Nal(2')-Lys]-D-Phe-D-Val-NH2 857 TCAM854 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-Arg-Arg-c[Asp-His-D-Nal(2′)-Arg-D- Nal(2')-Lys]-D-Val-D-Pro-NH2 858 TCAM855 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-Arg-Arg-c[Asp-His-D-Nal(2′)-Arg-D- Nal(2')-Lys]-D-Pro-D-Val-NH2 859 TCAM856 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-Arg-Arg-c[Asp-His-D-Nal(2′)-Arg-D- Nal(2')-Lys]-D-Val-D-Phe-NH2 860 TCAM857 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-Arg-Arg-c[Asp-His-D-Nal(2′)-Arg-D- Nal(2')-Lys]-D-Phe-D-Val-NH2 861 TCAM858 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Arg-Pro-D-Nal(2′)-Arg-D-Nal(2′)- Arg-Lys]-D-Val-D-Pro-NH2 862 TCAM859 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Arg-Pro-D-Nal(2′)-Arg-D-Nal(2′)- Arg-Lys]-D-Pro-D-Val-NH2 863 TCAM860 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Arg-Pro-D-Nal(2′)-Arg-D-Nal(2′)- Arg-Lys]-D-Val-D-Phe-NH2 864 TCAM861 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Arg-Pro-D-Nal(2′)-Arg-D-Nal(2′)- Arg-Lys]-D-Phe-D-Val-NH2 865 TCAM862 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Arg-His-D-Nal(2′)-Arg-D-Nal(2′)- Arg-Lys]-D-Val-D-Pro-NH2 866 TCAM863 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Arg-His-D-Nal(2′)-Arg-D-Nal(2′)- Arg-Lys]-D-Pro-D-Val-NH2 867 TCAM864 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Arg-His-D-Nal(2′)-Arg-D-Nal(2′)- Arg-Lys]-D-Val-D-Phe-NH2 868 TCAM865 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Arg-His-D-Nal(2′)-Arg-D-Nal(2′)- Arg-Lys]-D-Phe-D-Val-NH2 869 TCAM866 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-His-D-Nal(2′)-Arg-Trp-Lys]-Arg- Arg-D-Val-D-Pro-NH2 870 TCAM867 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-His-D-Nal(2′)-Arg-Trp-Lys]-Arg- Arg-D-Pro-D-Val-NH2 871 TCAM868 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-His-D-Nal(2′)-Arg-Trp-Lys]-Arg- Arg-D-Val-D-Phe-NH2 872 TCAM869 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-His-D-Nal(2′)-Arg-Trp-Lys]-Arg- Arg-D-Phe-D-Val-NH2 873 TCAM870 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Pro-D-Nal(2′)-Arg-Trp-Lys]-Arg- Arg-D-Val-D-Pro-NH2 874 TCAM871 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Pro-D-Nal(2′)-Arg-Trp-Lys]-Arg- Arg-D-Pro-D-Val-NH2 875 TCAM872 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Pro-D-Nal(2′)-Arg-Trp-Lys+-Arg- Arg-D-Val-D-Phe-NH2 876 TCAM873 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Pro-D-Nal(2′)-Arg-Trp-Lys]-Arg- Arg-D-Phe-D-Val-NH2 Anti-biofilm peptide ATRA1ARG linked to anti-microbial peptides 877 TCAM874 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Pro-Arg-Arg-Trp-Trp-Arg- Phe-Lys]-D-Val-D-Pro-NH2 878 TCAM875 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Pro-Arg-Arg-Trp-Trp-Arg- Phe-Lys]-D-Val-D-Phe-NH2 879 TCAM876 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Pro-Arg-Arg-Trp-Trp-Arg- Phe-Lys]-D-Pro-D-Val-NH2 880 TCAM877 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Pro-Arg-Arg-Trp-Trp-Arg- Phe-Lys]-D-Phe-D-Val-NH2 881 TCAM878 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Pro-Arg-Arg-Trp-Trp-Tyr-Phe- Lys]-D-Val-D-Pro-NH2 882 TCAM879 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Pro-Arg-Arg-Trp-Trp-Tyr-Phe- Lys]-D-Val-D-Phe-NH2 883 TCAM880 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Pro-Arg-Arg-Trp-Trp-Tyr-Phe- Lys]-D-Pro-D-Val-NH2 884 TCAM881 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Pro-Arg-Arg-Trp-Trp-Tyr-Phe- Lys]-D-Phe-D-Val-NH2 885 TCAM882 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Pro-Arg-Arg-Tyr-Tyr-Arg-Phe- Lys]-D-Val-D-Pro-NH2 886 TCAM883 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Pro-Arg-Arg-Tyr-Tyr-Arg-Phe- Lys]-D-Val-D-Phe-NH2 887 TCAM884 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Pro-Arg-Arg-Tyr-Tyr-Arg-Phe- Lys]-D-Pro-D-Val-NH2 888 TCAM885 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Pro-Arg-Arg-Tyr-Tyr-Arg-Phe- Lys]-D-Phe-D-Val-NH2 889 TCAM886 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Pro-Arg-Arg-Nal-Nal-Arg- Phe-Lys]-D-Val-D-Pro-NH2 890 TCAM887 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Pro-Arg-Arg-Nal-Nal-Arg- Phe-Lys]-D-Val-D-Phe-NH2 891 TCAM888 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Pro-Arg-Arg-Nal-Nal-Arg- Phe-Lys]-D-Pro-D-Val-NH2 892 TCAM889 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Pro-Arg-Arg-Nal-Nal-Arg- Phe-Lys]-D-Phe-D-Val-NH2 893 TCAM890 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Pro-Arg-Arg-Leu-Trp-Leu-Trp- Lys]-D-Val-D-Pro-NH2 894 TCAM891 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Pro-Arg-Arg-Leu-Trp-Leu-Trp- Lys]-D-Val-D-Phe-NH2 895 TCAM892 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Pro-Arg-Arg-Leu-Trp-Leu-Trp- Lys]-D-Pro-D-Val-NH2 896 TCAM893 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Pro-Arg-Arg-Leu-Trp-Leu-Trp- Lys]-D-Phe-D-Val-NH2 897 TCAM894 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Pro-Arg-Arg-Leu-Trp-Leu-Trp- Lys]-D-Val-D-Pro-NH2 898 TCAM895 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Pro-Arg-Arg-Leu-Trp-Leu-Trp- Lys]-D-Val-D-Phe-NH2 899 TCAM896 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Pro-Arg-Arg-Leu-Trp-Leu-Trp- Lys+-D-Pro-D-Val-NH2 900 TCAM897 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Pro-Arg-Arg-Leu-Trp-Leu-Trp- Lys]-D-Phe-D-Val-NH2 901 TCAM898 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-Arg-Arg-Trp-Leu-Trp-Leu- Trp-Lys]-D-Val-D-Pro-NH2 902 TCAM899 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Pro-Arg-Arg-Arg-Trp-Leu-Trp- Leu-Trp-Lys]-D-Val-D-Phe-NH2 903 TCAM900 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Pro-Arg-Arg-Arg-Trp-Leu-Trp- Leu-Trp-Lys]-D-Pro-D-Val-NH2 904 TCAM901 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Pro-Arg-Arg-Arg-Trp-Leu-Trp- Leu-Trp-Lys]-D-Phe-D-Val-NH2 905 TCAM902 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Pro-Arg-Gln-Arg-Arg-Trp-Leu- Trp-Leu-Trp-Lys]-D-Val-D-Pro-NH2 906 TCAM903 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Pro-Arg-Gln-Arg-Arg-Trp-Leu- Trp-Leu-Trp-Lys]-D-Val-D-Phe-NH2 907 TCAM904 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Pro-Arg-Gln-Arg-Arg-Trp-Leu- Trp-Leu-Trp-Lys]-D-Pro-D-Val-NH2 908 TCAM905 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Pro-Arg-Gln-Arg-Arg-Trp-Leu- Trp-Leu-Trp-Lys]-D-Phe-D-Val-NH2 909 TCAM906 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Pro-Trp-Arg-Trp-Trp-Arg-Arg- Lys]-D-Val-D-Phe-NH2 910 TCAM907 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Pro-Trp-Arg-Trp-Trp-Arg-Arg- Lys]-D-Pro-D-Val-NH2 911 TCAM908 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Pro-Trp-Arg-Trp-Trp-Arg-Arg- Lys]-D-Phe-D-Val-NH2 912 TCAM909 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Pro-Trp-Trp-Arg-Arg-Trp-Trp- Arg-Arg-Lys]-D-Val-D-Pro-NH2 913 TCAM910 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Pro-Trp-Trp-Arg-Arg-Trp-Trp- Arg-Arg-Lys]-D-Val-D-Phe-NH2 914 TCAM911 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Pro-Trp-Trp-Arg-Arg-Trp-Trp- Arg-Arg-Lys]-D-Pro-D-Val-NH2 915 TCAM912 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Pro-Trp-Trp-Arg-Arg-Trp-Trp- Arg-Arg-Lys]-D-Phe-D-Val-NH2 916 TCAM913 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Pro-Trp-Arg-Trp-Arg-Trp-Arg- Lys]-D-Val-D-Pro-NH2 917 TCAM914 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Pro-Trp-Arg-Trp-Arg-Trp-Arg- Lys]-D-Val-D-Phe-NH2 918 TCAM915 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Pro-Trp-Arg-Trp-Arg-Trp-Arg- Lys]-D-Pro-D-Val-NH2 919 TCAM916 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Pro-Trp-Arg-Trp-Arg-Trp-Arg- Lys]-D-Phe-D-Val-NH2 920 TCAM917 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Pro-Arg-Trp-Arg-Trp-Arg-Trp- Lys]-D-Val-D-Pro-NH2 921 TCAM918 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Pro-Arg-Trp-Arg-Trp-Arg-Trp- Lys]-D-Val-D-Phe-NH2 922 TCAM919 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Pro-Arg-Trp-Arg-Trp-Arg-Trp- Lys]-D-Pro-D-Val-NH2 923 TCAM920 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Pro-Arg-Trp-Arg-Trp-Arg-Trp- Lys]-D-Phe-D-Val-NH2 924 TCAM921 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Pro-Arg-Trp-Trp-Arg-Arg- Lys]-D-Val-D-Pro-NH2 925 TCAM922 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Pro-Arg-Trp-Trp-Arg-Arg- Lys]-D-Val-D-Phe-NH2 926 TCAM923 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Pro-Arg-Trp-Trp-Arg-Arg- Lys]-D-Pro-D-Val-NH2 927 TCAM924 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Pro-Arg-Trp-Trp-Arg-Arg- Lys]-D-Phe-D-Val-NH2 928 TCAM925 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Pro-Trp-Trp-Arg-Arg-Trp- Lys]-D-Val-D-Pro-NH2 929 TCAM926 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Pro-Trp-Trp-Arg-Arg-Trp- Lys]-D-Val-D-Phe-NH2 930 TCAM927 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Pro-Trp-Trp-Arg-Arg-Trp- Lys]-D-Pro-D-Val-NH2 931 TCAM928 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Pro-Trp-Trp-Arg-Arg-Trp- Lys]-D-Phe-D-Val-NH2 932 TCAM929 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Pro-Trp-Arg-Trp-Arg-Trp- Lys]-D-Val-D-Pro-NH2 933 TCAM930 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Pro-Trp-Arg-Trp-Arg-Trp- Lys]-D-Val-D-Phe-NH2 934 TCAM931 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Pro-Trp-Arg-Trp-Arg-Trp- Lys]-D-Pro-D-Val-NH2 935 TCAM932 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Pro-Trp-Arg-Trp-Arg-Trp- Lys]-D-Phe-D-Val-NH2 936 TCAM933 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Pro-Arg-Trp-Arg-Trp-Arg- Lys]-D-Val-D-Pro-NH2 937 TCAM934 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Pro-Arg-Trp-Arg-Trp-Arg- Lys]-D-Val-D-Phe-NH2 938 TCAM935 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Pro-Arg-Trp-Arg-Trp-Arg- Lys]-D-Pro-D-Val-NH2 939 TCAM936 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Pro-Arg-Trp-Arg-Trp-Arg- Lys]-D-Phe-D-Val-NH2 940 TCAM937 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Pro-Trp-Arg-Tyr-Arg-Trp-Lys]- D-Val-D-Pro-NH2 941 TCAM938 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Pro-Trp-Arg-Tyr-Arg-Trp-Lys]- D-Val-D-Phe-NH2 942 TCAM939 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Pro-Trp-Arg-Tyr-Arg-Trp-Lys]- D-Pro-D-Val-NH2 943 TCAM940 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Pro-Trp-Arg-Tyr-Arg-Trp-Lys]- D-Phe-D-Val-NH2 944 TCAM941 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Pro-Trp-Arg-Trp-Arg-Tyr-Lys]- D-Val-D-Pro-NH2 945 TCAM942 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Pro-Trp-Arg-Trp-Arg-Tyr-Lys]- D-Val-D-Phe-NH2 946 TCAM943 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Pro-Trp-Arg-Trp-Arg-Tyr-Lys]- D-Pro-D-Val-NH2 947 TCAM944 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Pro-Trp-Arg-Trp-Arg-Tyr-Lys]- D-Phe-D-Val-NH2 948 TCAM945 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Pro-Trp-Arg-Trp-Arg-Lys]-D- Val-D-Pro-NH2 949 TCAM946 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Pro-Trp-Arg-Trp-Arg-Lys]-D- Val-D-Phe-NH2 950 TCAM947 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Pro-Trp-Arg-Trp-Arg-Lys]-D- Pro-D-Val-NH2 951 TCAM948 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Pro-Trp-Arg-Trp-Arg-Lys]-D- Phe-D-Val-NH2 952 TCAM949 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Pro-Trp-Arg-Arg-Trp-Lys]-D- Val-D-Pro-NH2 953 TCAM950 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Pro-Trp-Arg-Arg-Trp-Lys]-D- Val-D-Phe-NH2 954 TCAM951 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Pro-Trp-Arg-Arg-Trp-Lys]-D- Pro-D-Val-NH2 955 TCAM952 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Pro-Trp-Arg-Arg-Trp-Lys]-D- Phe-D-Val-NH2 956 TCAM953 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Pro-Arg-Trp-Trp-Arg-Lys]-D- Val-D-Pro-NH2 957 TCAM954 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Pro-Arg-Trp-Trp-Arg-Lys]-D- Val-D-Phe-NH2 958 TCAM955 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Pro-Arg-Trp-Trp-Arg-Lys]-D- Pro-D-Val-NH2 959 TCAM956 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Pro-Arg-Trp-Trp-Arg-Lys]-D- Phe-D-Val-NH2 960 TCAM957 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Pro-Trp-Arg-Trp-Lys]-D-Val-D- Pro-NH2 961 TCAM958 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Pro-Trp-Arg-Trp-Lys]-D-Val-D- Phe-NH2 962 TCAM959 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Pro-Trp-Arg-Trp-Lys]-D-Pro-D- Val-NH2 963 TCAM960 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Pro-Trp-Arg-Trp-Lys]-D-Phe- D-Val-NH2 964 TCAM961 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Pro-Arg-Trp-Arg-Lys]-D-Val-D- Pro-NH2 965 TCAM962 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Pro-Arg-Trp-Arg-Lys]-D-Val-D- Phe-NH2 966 TCAM963 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Pro-Arg-Trp-Arg-Lys]-D-Pro- D-Val-NH2 967 TCAM964 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Pro-Arg-Trp-Arg-Lys]-D-Phe- D-Val-NH2 968 TCAM965 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-Arg-Trp-Trp-Arg-Phe- Lys]-D-Val-D-Pro-NH2 969 TCAM966 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-Arg-Trp-Trp-Arg-Phe- Lys]-D-Val-D-Phe-NH2 970 TCAM967 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-Arg-Trp-Trp-Arg-Phe- Lys]-D-Pro-D-Val-NH2 971 TCAM968 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-Arg-Trp-Trp-Arg-Phe- Lys]-D-Phe-D-Val-NH2 972 TCAM969 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-Arg-Trp-Trp-Arg-Phe- Lys]-D-Val-D-Pro-NH2 973 TCAM970 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-Arg-Trp-Trp-Arg-Phe- Lys]-D-Val-D-Phe-NH2 974 TCAM971 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-Arg-Trp-Trp-Arg-Phe- Lys]-D-Pro-D-Val-NH2 975 TCAM972 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-Arg-Trp-Trp-Arg-Phe- Lys]-D-Phe-D-Val-NH2 976 TCAM973 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-Arg-Tyr-Tyr-Arg-Phe- Lys]-D-Val-D-Pro-NH2 977 TCAM974 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-Arg-Tyr-Tyr-Arg-Phe- Lys]-D-Val-D-Phe-NH2 978 TCAM975 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-Arg-Tyr-Tyr-Arg-Phe- Lys]-D-Pro-D-Val-NH2 979 TCAM976 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-Arg-Tyr-Tyr-Arg-Phe- Lys]-D-Phe-D-Val-NH2 980 TCAM977 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-Arg-Nal-Nal-Arg-Phe- Lys]-D-Val-D-Pro-NH2 981 TCAM978 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-Arg-Nal-Nal-Arg-Phe- Lys]-D-Val-D-Phe-NH2 982 TCAM979 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-Arg-Nal-Nal-Arg-Phe- Lys]-D-Pro-D-Val-NH2 983 TCAM980 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-Arg-Nal-Nal-Arg-Phe- Lys]-D-Phe-D-Val-NH2 984 TCAM981 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-Arg-Leu-Trp-Leu-Trp- Lys]-D-Val-D-Pro-NH2 985 TCAM982 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-Arg-Leu-Trp-Leu-Trp- Lys]-D-Val-D-Phe-NH2 986 TCAM983 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-Arg-Leu-Trp-Leu-Trp- Lys]-D-Pro-D-Val-NH2 987 TCAM984 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-Arg-Leu-Trp-Leu-Trp- Lys]-D-Phe-D-Val-NH2 988 TCAM985 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-Arg-Leu-Trp-Leu-Trp- Lys]-D-Val-D-Pro-NH2 989 TCAM986 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-Arg-Leu-Trp-Leu-Trp- Lys]-D-Val-D-Phe-NH2 990 TCAM987 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-Arg-Leu-Trp-Leu-Trp- Lys]-D-Pro-D-Val-NH2 991 TCAM988 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-Arg-Leu-Trp-Leu-Trp- Lys]-D-Phe-D-Val-NH2 992 TCAM989 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-Arg-Arg-Trp-Leu-Trp-Leu- Trp-Lys]-D-Val-D-Pro-NH2 993 TCAM990 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-Arg-Arg-Trp-Leu-Trp-Leu- Trp-Lys]-D-Val-D-Phe-NH2 994 TCAM991 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-Arg-Arg-Trp-Leu-Trp-Leu- Trp-Lys]-D-Pro-D-Val-NH2 995 TCAM992 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-Arg-Arg-Trp-Leu-Trp-Leu- Trp-Lys]-D-Phe-D-Val-NH2 996 TCAM993 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-Gln-Arg-Arg-Trp-Leu-Trp- Leu-Trp-Lys]-D-Val-D-Pro-NH2 997 TCAM994 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-Gln-Arg-Arg-Trp-Leu-Trp- Leu-Trp-Lys]-D-Val-D-Phe-NH2 998 TCAM995 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-Gln-Arg-Arg-Trp-Leu-Trp- Leu-Trp-Lys]-D-Pro-D-Val-NH2 999 TCAM996 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-Gln-Arg-Arg-Trp-Leu-Trp- Leu-Trp-Lys]-D-Phe-D-Val-NH2 1000 TCAM997 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Trp-Arg-Trp-Trp-Arg-Arg- Lys]-D-Val-D-Pro-NH2 1001 TCAM998 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Trp-Arg-Trp-Trp-Arg-Arg- Lys]-D-Val-D-Phe-NH2 1002 TCAM999 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Trp-Arg-Trp-Trp-Arg-Arg- Lys]-D-Pro-D-Val-NH2 1003 TCAM1000 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Trp-Arg-Trp-Trp-Arg-Arg- Lys]-D-Phe-D-Val-NH2 1004 TCAM1001 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Trp-Trp-Arg-Arg-Trp-Trp-Arg- Arg-Lys]-D-Val-D-Pro-NH2 1005 TCAM1002 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Trp-Trp-Arg-Arg-Trp-Trp-Arg- Arg-Lys]-D-Val-D-Phe-NH2 1006 TCAM1003 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Trp-Trp-Arg-Arg-Trp-Trp-Arg- Arg-Lys]-D-Pro-D-Val-NH2 1007 TCAM1004 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Trp-Trp-Arg-Arg-Trp-Trp-Arg- Arg-Lys]-D-Phe-D-Val-NH2 1008 TCAM1005 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Trp-Arg-Trp-Arg-Trp-Arg- Lys]-D-Val-D-Pro-NH2 1009 TCAM1006 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Trp-Arg-Trp-Arg-Trp-Arg- Lys]-D-Val-D-Phe-NH2 1010 TCAM1007 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Trp-Arg-Trp-Arg-Trp-Arg- Lys]-D-Pro-D-Val-NH2 1011 TCAM1008 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Trp-Arg-Trp-Arg-Trp-Arg- Lys]-D-Phe-D-Val-NH2 1012 TCAM1009 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-Trp-Arg-Trp-Arg-Trp- Lys]-D-Val-D-Pro-NH2 1013 TCAM1010 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-Trp-Arg-Trp-Arg-Trp- Lys]-D-Val-D-Phe-NH2 1014 TCAM1011 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-Trp-Arg-Trp-Arg-Trp- Lys]-D-Pro-D-Val-NH2 1015 TCAM1012 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-Trp-Arg-Trp-Arg-Trp- Lys]-D-Phe-D-Val-NH2 1016 TCAM1013 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-Trp-Trp-Arg-Arg-Lys]-D- Val-D-Pro-NH2 1017 TCAM1014 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-Trp-Trp-Arg-Arg-Lys]-D- Val-D-Phe-NH2 1018 TCAM1015 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-Trp-Trp-Arg-Arg-Lys]-D- Pro-D-Val-NH2 1019 TCAM1016 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-Trp-Trp-Arg-Arg-Lys]-D- Phe-D-Val-NH2 1020 TCAM1017 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-Trp-Arg-Trp-Arg-Lys]-D- Val-D-Pro-NH2 1021 TCAM1018 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-Trp-Arg-Trp-Arg-Lys]-D- Val-D-Phe-NH2 1022 TCAM1019 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-Trp-Arg-Trp-Arg-Lys]-D- Pro-D-Val-NH2 1023 TCAM1020 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-Trp-Arg-Trp-Arg-Lys]-D- Phe-D-Val-NH2 1024 TCAM1021 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Trp-Trp-Arg-Arg-Trp-Lys]-D- Val-D-Pro-NH2 1025 TCAM1022 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Trp-Trp-Arg-Arg-Trp-Lys]-D- Val-D-Phe-NH2 1026 TCAM1023 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Trp-Trp-Arg-Arg-Trp-Lys]-D- Pro-D-Val-NH2 1027 TCAM1024 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Trp-Trp-Arg-Arg-Trp-Lys]-D- Phe-D-Val-NH2 1028 TCAM1025 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Trp-Arg-Trp-Arg-Trp-Lys]-D- Val-D-Pro-NH2 1029 TCAM1026 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Trp-Arg-Trp-Arg-Trp-Lys]-D- Val-D-Phe-NH2 1030 TCAM1027 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Trp-Arg-Trp-Arg-Trp-Lys]-D- Pro-D-Val-NH2 1031 TCAM1028 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Trp-Arg-Trp-Arg-Trp-Lys]-D- Phe-D-Val-NH2 1032 TCAM1029 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Trp-Arg-Tyr-Arg-Trp-Lys]-D- Val-D-Pro-NH2 1033 TCAM1030 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Trp-Arg-Tyr-Arg-Trp-Lys]-D- Val-D-Phe-NH2 1034 TCAM1031 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Trp-Arg-Tyr-Arg-Trp-Lys]-D- Pro-D-Val-NH2 1035 TCAM1032 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Trp-Arg-Tyr-Arg-Trp-Lys]-D- Phe-D-Val-NH2 1036 TCAM1033 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Trp-Arg-Trp-Arg-Tyr-Lys]-D- Val-D-Pro-NH2 1037 TCAM1034 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Trp-Arg-Trp-Arg-Tyr-Lys]-D- Val-D-Phe-NH2 1038 TCAM1035 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Trp-Arg-Trp-Arg-Tyr-Lys]-D- Pro-D-Val-NH2 1039 TCAM1036 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Trp-Arg-Trp-Arg-Tyr-Lys]-D- Phe-D-Val-NH2 1040 TCAM1037 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Trp-Arg-Trp-Arg-Lys]-D-Val-D- Pro-NH2 1041 TCAM1038 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Trp-Arg-Trp-Arg-Lys]-D-Val-D- Phe-NH2 1042 TCAM1039 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Trp-Arg-Trp-Arg-Lys]-D-Pro-D- Val-NH2 1043 TCAM1040 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Trp-Arg-Trp-Arg-Lys]-D-Phe- D-Val-NH2 1044 TCAM1041 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Trp-Arg-Arg-Trp-Lys]-D-Val-D- Pro-NH2 1045 TCAM1042 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Trp-Arg-Arg-Trp-Lys]-D-Val-D- Phe-NH2 1046 TCAM1043 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Trp-Arg-Arg-Trp-Lys]-D-Pro-D- Val-NH2 1047 TCAM1044 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Trp-Arg-Arg-Trp-Lys]-D-Phe- D-Val-NH2 1048 TCAM1045 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-Trp-Trp-Arg-Lys]-D-Val-D- Pro-NH2 1049 TCAM1046 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-Trp-Trp-Arg-Lys]-D-Val-D- Phe-NH2 1050 TCAM1047 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-Trp-Trp-Arg-Lys]-D-Pro-D- Val-NH2 1051 TCAM1048 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-Trp-Trp-Arg-Lys]-D-Phe- D-Val-NH2 1052 TCAM1049 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Trp-Arg-Trp-Lys]-D-Val-D-Pro- NH2 1053 TCAM1050 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Trp-Arg-Trp-Lys]-D-Val-D-Phe- NH2 1054 TCAM1051 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Trp-Arg-Trp-Lys]-D-Pro-D-Val- NH2 1055 TCAM1052 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Trp-Arg-Trp-Lys]-D-Phe-D-Val- NH2 1056 TCAM1053 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-Trp-Arg-Lys]-D-Val-D-Pro- NH2 1057 TCAM1054 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-Trp-Arg-Lys]-D-Val-D- Phe-NH2 1058 TCAM1055 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-Trp-Arg-Lys]-D-Pro-D-Val- NH2 1059 TCAM1056 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-Trp-Arg-Lys]-D-Phe-D- Val-NH2 1060 TCAM1057 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-His-D-Nal(2′)-Arg-Trp-Lys]-D- Val-D-Pro-NH2 1061 TCAM1058 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-His-D-Nal(2′)-Arg-Trp-Lys]-D- Pro-D-Val-NH2 1062 TCAM1059 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-His-D-Nal(2′)-Arg-Trp-Lys]-D- Val-D-Phe-NH2 1063 TCAM1060 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-His-D-Nal(2′)-Arg-Trp-Lys]-D- Phe-D-Val-NH2 1064 TCAM1061 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Pro-D-Nal(2′)-Arg-Trp-Lys]-D- Val-D-Pro-NH2 1065 TCAM1062 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Pro-D-Nal(2′)-Arg-Trp-Lys]-D- Pro-D-Val-NH2 1066 TCAM1063 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Pro-D-Nal(2′)-Arg-Trp-Lys]-D- Val-D-Phe-NH2 1067 TCAM1064 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Pro-D-Nal(2′)-Arg-Trp-Lys]-D- Phe-D-Val-NH2 1068 TCAM1065 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-Arg-Nal(2′)-Arg-Trp-Lys]- D-Val-D-Pro-NH2 1069 TCAM1066 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-Arg-Nal(2′)-Arg-Trp-Lys]- D-Pro-D-Val-NH2 1070 TCAM1067 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-Arg-Nal(2′)-Arg-Trp-Lys]- D-Val-D-Phe-NH2 1071 TCAM1068 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-Arg-Nal(2′)-Arg-Trp-Lys]- D-Phe-D-Val-NH2 1072 TCAM1069 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-Arg-Pro-Nal(2′)-Arg-Trp- Lys]-D-Val-D-Pro-NH2 1073 TCAM1070 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-Arg-Pro-D-Nal(2′)-Arg- Trp-Lys]-D-Pro-D-Val-NH2 1074 TCAM1071 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-Arg-Pro-D-Nal(2′)-Arg- Trp-Lys]-D-Val-D-Phe-NH2 1075 TCAM1072 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-Arg-Pro-Nal(2′)-Arg-Trp- Lys]-D-Phe-D-Val-NH2 1076 TCAM1073 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-D-Nal(2′)-Arg-Trp-Lys]-D- Val-D-Pro-NH2 1077 TCAM1074 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-D-Nal(2′)-Arg-Trp-Lys]-D- Pro-D-Val-NH2 1078 TCAM1075 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-D-Nal(2′)-Arg-Trp-Lys]-D- Val-D-Phe-NH2 1079 TCAM1076 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-D-Nal(2′)-Arg-Trp-Lys]-D- Phe-D-Val-NH2 1080 TCAM1077 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-Pro-D-Nal(2′)-Arg-Trp- Lys]-D-Val-D-Pro-NH2 1081 TCAM1078 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-Pro-D-Nal(2′)-Arg-Trp- Lys]-D-Pro-D-Val-NH2 1082 TCAM1079 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-Pro-D-Nal(2′)-Arg-Trp- Lys]-D-Val-D-Phe-NH2 1083 TCAM1080 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-Pro-D-Nal(2′)-Arg-Trp- Lys]-D-Phe-D-Val-NH2 1084 TCAM1081 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-Arg-Arg-c[Asp-Pro-D-Nal(2′)-Arg- Trp-Lys]-D-Val-D-Pro-NH2 1085 TCAM1082 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-Arg-Arg-c[Asp-Pro-D-Nal(2′)-Arg- Trp-Lys]-D-Pro-D-Val-NH2 1086 TCAM1083 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-Arg-Arg-c[Asp-Pro-D-Nal(2′)-Arg- Trp-Lys]-D-Val-D-Phe-NH2 1087 TCAM1084 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-Arg-Arg-c[Asp-Pro-D-Nal(2′)-Arg- Trp-Lys]-D-Phe-D-Val-NH2 1088 TCAM1085 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-Arg-Arg-c[Asp-His-D-Nal(2′)-Arg- Trp-Lys]-D-Val-D-Pro-NH2 1089 TCAM1086 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-Arg-Arg-c[Asp-His-D-Nal(2′)-Arg- Trp-Lys]-D-Pro-D-Val-NH2 1090 TCAM1087 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-Arg-Arg-c[Asp-His-D-Nal(2′)-Arg- Trp-Lys]-D-Val-D-Phe-NH2 1091 TCAM1088 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-Arg-Arg-c[Asp-His-D-Nal(2′)-Arg- Trp-Lys]-D-Phe-D-Val-NH2 1092 TCAM1089 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-Pro-D-Nal(2′)-Arg-Trp- Arg-Lys]-D-Val-D-Pro-NH2 1093 TCAM1090 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-Pro-D-Nal(2′)-Arg-Trp- Arg-Lys]-D-Pro-D-Val-NH2 1094 TCAM1091 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-Pro-D-Nal(2′)-Arg-Trp- Arg-Lys]-D-Val-D-Phe-NH2 1095 TCAM1092 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-Pro-D-Nal(2′)-Arg-Trp- Arg-Lys]-D-Phe-D-Val-NH2 1096 TCAM1093 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-His-D-Nal(2′)-Arg-Trp- Arg-Lys]-D-Val-D-Pro-NH2 1097 TCAM1094 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-His-D-Nal(2′)-Arg-Trp- Arg-Lys]-D-Pro-D-Val-NH2 1098 TCAM1095 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-His-D-Nal(2′)-Arg-Trp- Arg-Lys]-D-Val-D-Phe-NH2 1099 TCAM1096 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-His-D-Nal(2′)-Arg-Trp- Arg-Lys]-D-Phe-D-Val-NH2 1100 TCAM1097 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-His-D-Nal(2′)-Arg-D-Nal(2′)- Lys]-D-Val-D-Phe-NH2 1101 TCAM1098 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-His-D-Nal(2′)-Arg-D-Nal(2′)- Lys]-D-Phe-D-Val-NH2 1102 TCAM1099 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Pro-D-Nal(2′)-Arg-D-Nal(2′)- Lys]-D-Val-D-Pro-NH2 1103 TCAM1100 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Pro-D-Nal(2′)-Arg-D-Nal(2′)- Lys]-D-Pro-D-Val-NH2 1104 TCAM1101 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Pro-D-Nal(2′)-Arg-D-Nal(2′)- Lys]-D-Val-D-Phe-NH2 1105 TCAM1102 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Pro-D-Nal(2′)-Arg-D-Nal(2′)- Lys]-D-Phe-D-Val-NH2 1106 TCAM1103 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-Arg-D-Nal(2′)-Arg-D- Nal(2')-Lys]-D-Val-D-Pro-NH2 1107 TCAM1104 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-Arg-D-Nal(2′)-Arg-D- Nal(2′)-Lys]-D-Pro-D-Val-NH2 1108 TCAM1105 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-Arg-D-Nal(2′)-Arg-D- Nal(2')-Lys]-D-Val-D-Phe-NH2 1109 TCAM1106 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-Arg-D-Nal(2′)-Arg-D- Nal(2')-Lys]-D-Phe-D-Val-NH2 1110 TCAM1107 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-Arg-Pro-D-Nal(2′)-Arg-D- Nal(2')-Lys]-D-Val-D-Pro-NH2 1111 TCAM1108 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-Arg-Pro-D-Nal(2′)-Arg-D- Nal(2')-Lys]-D-Pro-D-Val-NH2 1112 TCAM1109 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-Arg-Pro-D-Nal(2′)-Arg-D- Nal(2')-Lys]-D-Val-D-Phe-NH2 1113 TCAM1110 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-Arg-Pro-D-Nal(2′)-Arg-D- Nal(2')-Lys]-D-Phe-D-Val-NH2 1114 TCAM1111 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-D-Nal(2′)-Arg-D-Nal(2′)- Lys]-D-Val-D-Pro-NH2 1115 TCAM1112 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-D-Nal(2′)-Arg-D-Nal(2′)- Lys]-D-Pro-D-Val-NH2 1116 TCAM1113 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-Nal(2′)-Arg-D-Nal(2′)- Lys]-D-Val-D-Phe-NH2 1117 TCAM1114 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-D-Nal(2′)-Arg-D-Nal(2′)- Lys]-D-Phe-D-Val-NH2 1118 TCAM1115 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-Pro-D-Nal(2′)-Arg-D- Nal(2')-Lys]-D-Val-D-Pro-NH2 1119 TCAM1116 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-Pro-D-Nal(2′)-Arg-D- Nal(2')-Lys]-D-Pro-D-Val-NH2 1120 TCAM1117 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-Pro-D-Nal(2′)-Arg-D- Nal(2')-Lys]-D-Val-D-Phe-NH2 1121 TCAM1118 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-Pro-D-Nal(2′)-Arg-D- Nal(2')-Lys]-D-Phe-D-Val-NH2 1122 TCAM1119 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-His-D-Nal(2′)-Arg-D- Nal(2')-Lys]-D-Val-D-Pro-NH2 1123 TCAM1120 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-His-D-Nal(2′)-Arg-D- Nal(2')-Lys]-D-Pro-D-Val-NH2 1124 TCAM1121 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-His-Nal(2′)-Arg-D-Nal(2′)- Lys]-D-Val-D-Phe-NH2 1125 TCAM1122 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-His-Nal(2′)-Arg-D-Nal(2′)- Lys]-D-Phe-D-Val-NH2 1126 TCAM1123 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-D-D-Nal(2′)-Arg-D-Nal(2′)- Arg-Lys]-D-Val-D-Pro-NH2 1127 TCAM1124 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-D-Nal(2′)-Arg-D-Nal(2′)- Arg-Lys]-D-Pro-D-Val-NH2 1128 TCAM1125 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-D-Nal(2′)-Arg-D-Nal(2′)- Arg-Lys]-D-Val-D-Phe-NH2 1129 TCAM1126 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-D-Nal(2′)-Arg-D-Nal(2′)- Arg-Lys]-D-Phe-D-Val-NH2 1130 TCAM1127 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-Pro-D-Nal(2′)-Arg-D- Nal(2')-Arg-Lys]-D-Val-D-Pro-NH2 1131 TCAM1128 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-Pro-D-Nal(2′)-Arg-D- Nal(2')-Arg-Lys]-D-Pro-D-Val-NH2 1132 TCAM1129 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-Pro-D-Nal(2′)-Arg-D- Nal(2')-Arg-Lys]-D-Val-D-Phe-NH2 1133 TCAM1130 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-Pro-D-Nal(2′)-Arg-D- Nal(2')-Arg-Lys]-D-Phe-D-Val-NH2 1134 TCAM1131 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-His-D-Nal(2′)-Arg-D- Nal(2')-Arg-Lys]-D-Val-D-Pro-NH2 1135 TCAM1132 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-His-D-Nal(2′)-Arg-D- Nal(2')-Arg-Lys]-D-Pro-D-Val-NH2 1136 TCAM1133 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-His-D-Nal(2′)-Arg-D- Nal(2')-Arg-Lys]-D-Val-D-Phe-NH2 1137 TCAM1134 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-His-D-Nal(2′)-Arg-D- Nal(2')-Arg-Lys]-D-Phe-D-Val-NH2 1138 TCAM1135 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-Arg-Arg-c[Asp-Pro-D-Nal(2′)-Arg-D- Nal(2')-Lys]-D-Val-D-Pro-NH2 1139 TCAM1136 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-Arg-Arg-c[Asp-Pro-D-Nal(2′)-Arg-D- Nal(2')-Lys]-D-Pro-D-Val-NH2 1140 TCAM1137 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-Arg-Arg-c[Asp-Pro-D-Nal(2′)-Arg-D- Nal(2')-Lys]-D-Val-D-Phe-NH2 1141 TCAM1138 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-Arg-Arg-c[Asp-Pro-D-Nal(2′)-Arg-D- Nal(2')-Lys]-D-Phe-D-Val-NH2 1142 TCAM1139 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-Arg-Arg-c[Asp-His-D-Nal(2′)-Arg-D- Nal(2')-Lys]-D-Val-D-Pro-NH2 1143 TCAM1140 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-Arg-Arg-c[Asp-His-D-Nal(2′)-Arg-D- Nal(2')-Lys]-D-Pro-D-Val-NH2 1144 TCAM1141 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-Arg-Arg-c[Asp-His-D-Nal(2′)-Arg-D- Nal(2')-Lys]-D-Val-D-Phe-NH2 1145 TCAM1142 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-Arg-Arg-c[Asp-His-D-Nal(2′)-Arg-D- Nal(2')-Lys]-D-Phe-D-Val-NH2 1146 TCAM1143 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-Pro-D-Nal(2′)-Arg-D- Nal(2')-Arg-Lys]-D-Val-D-Pro-NH2 1147 TCAM1144 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-Pro-D-Nal(2′)-Arg-D- Nal(2')-Arg-Lys]-D-Pro-D-Val-NH2 1148 TCAM1145 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-Pro-D-Nal(2′)-Arg-D- Nal(2')-Arg-Lys]-D-Val-D-Phe-NH2 1149 TCAM1146 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-Pro-D-Nal(2′)-Arg-D- Nal(2')-Arg-Lys]-D-Phe-D-Val-NH2 1150 TCAM1147 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-His-D-Nal(2′)-Arg-D- Nal(2')-Arg-Lys]-D-Val-D-Pro-NH2 1151 TCAM1148 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-His-D-Nal(2′)-Arg-D- Nal(2')-Arg-Lys]-D-Pro-D-Val-NH2 1152 TCAM1149 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-His-D-Nal(2′)-Arg-D- Nal(2')-Arg-Lys]-D-Val-D-Phe-NH2 1153 TCAM1150 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-His-D-Nal(2′)-Arg-D- Nal(2')-Arg-Lys]-D-Phe-D-Val-NH2 1154 TCAM1151 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-His-D-Nal(2′)-Arg-Trp-Lys]- Arg-Arg-D-Val-D-Pro-NH2 1155 TCAM1152 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-His-D-Nal(2′)-Arg-Trp-Lys]- Arg-Arg-D-Pro-D-Val-NH2 1156 TCAM1153 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-His-D-Nal(2′)-Arg-Trp-Lys]- Arg-Arg-D-Val-D-Phe-NH2 1157 TCAM1154 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-His-D-Nal(2′)-Arg-Trp-Lys]- Arg-Arg-D-Phe-D-Val-NH2 1158 TCAM1155 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Pro-D-Nal(2′)-Arg-Trp-Lys]- Arg-Arg-D-Val-D-Pro-NH2 1159 TCAM1156 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Pro-D-Nal(2′)-Arg-Trp-Lys]- Arg-Arg-D-Pro-D-Val-NH2 1160 TCAM1157 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Pro-D-Nal(2′)-Arg-Trp-Lys]- Arg-Arg-D-Val-D-Phe-NH2 1161 TCAM1158 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Pro-D-Nal(2′)-Arg-Trp-Lys]- Arg-Arg-D-Phe-D-Val-NH2 Anti-biofilm peptide ABF1 linked to anti-microbial peptides 1162 TCAM1159 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-c[Asp-Pro-Arg-Arg-Trp-Trp-Arg-Phe-Lys]-D-Val-D- Pro-NH2 1163 TCAM1160 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-c[Asp-Pro-Arg-Arg-Trp-Trp-Arg-Phe-Lys]-D-Val-D- Phe-NH2 1164 TCAM1161 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-c[Asp-Pro-Arg-Arg-Trp-Trp-Arg-Phe-Lys]-D-Pro-D- Val-NH2 1165 TCAM1162 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-c[Asp-Pro-Arg-Arg-Trp-Trp-Arg-Phe-Lys]-D-Phe-D- Val-NH2 1166 TCAM1163 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-c[Asp-Pro-Arg-Arg-Trp-Trp-Tyr-Phe-Lys]-D-Val-D- Pro-NH2 1167 TCAM1164 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-c[Asp-Pro-Arg-Arg-Trp-Trp-Tyr-Phe-Lys]-D-Val-D- Phe-NH2 1168 TCAM1165 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-c[Asp-Pro-Arg-Arg-Trp-Trp-Tyr-Phe-Lys]-D-Pro-D- Val-NH2 1169 TCAM1166 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-c[Asp-Pro-Arg-Arg-Trp-Trp-Tyr-Phe-Lys]-D-Phe-D- Val-NH2 1170 TCAM1167 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-c[Asp-Pro-Arg-Arg-Tyr-Tyr-Arg-Phe-Lys]-D-Val-D- Pro-NH2 1171 TCAM1168 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-c[Asp-Pro-Arg-Arg-Tyr-Tyr-Arg-Phe-Lys]-D-Val-D- Phe-NH2 1172 TCAM1169 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-c[Asp-Pro-Arg-Arg-Tyr-Tyr-Arg-Phe-Lys]-D-Pro-D- Val-NH2 1173 TCAM1170 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-c[Asp-Pro-Arg-Arg-Tyr-Tyr-Arg-Phe-Lys]-D-Phe-D- Val-NH2 1174 TCAM1171 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-c[Asp-Pro-Arg-Arg-Nal-Nal-Arg-Phe-Lys]-D-Val-D- Pro-NH2 1175 TCAM1172 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-c[Asp-Pro-Arg-Arg-Nal-Nal-Arg-Phe-Lys]-D-Val-D- Phe-NH2 1176 TCAM1173 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-c[Asp-Pro-Arg-Arg-Nal-Nal-Arg-Phe-Lys]-D-Pro-D- Val-NH2 1177 TCAM1174 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-c[Asp-Pro-Arg-Arg-Nal-Nal-Arg-Phe-Lys]-D-Phe-D- Val-NH2 1178 TCAM1175 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-c[Asp-Pro-Arg-Arg-Leu-Trp-Leu-Trp-Lys]-D-Val-D- Pro-NH2 1179 TCAM1176 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-c[Asp-Pro-Arg-Arg-Leu-Trp-Leu-Trp-Lys]-D-Val-D- Phe-NH2 1180 TCAM1177 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-c[Asp-Pro-Arg-Arg-Leu-Trp-Leu-Trp-Lys]-D-Pro-D- Val-NH2 1181 TCAM1178 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-c[Asp-Pro-Arg-Arg-Leu-Trp-Leu-Trp-Lys]-D-Phe-D- Val-NH2 1182 TCAM1179 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-c[Asp-Pro-Arg-Arg-Leu-Trp-Leu-Trp-Lys]-D-Val-D- Pro-NH2 1183 TCAM1180 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-c[Asp-Pro-Arg-Arg-Leu-Trp-Leu-Trp-Lys]-D-Val-D- Phe-NH2 1184 TCAM1181 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-c[Asp-Pro-Arg-Arg-Leu-Trp-Leu-Trp-Lys]-D-Pro-D- Val-NH2 1185 TCAM1182 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-c[Asp-Pro-Arg-Arg-Leu-Trp-Leu-Trp-Lys]-D-Phe-D- Val-NH2 1186 TCAM1183 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-c[Asp-Arg-Arg-Arg-Trp-Leu-Trp-Leu-Trp-Lys]-D-Val- D-Pro-NH2 1187 TCAM1184 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-c[Asp-Pro-Arg-Arg-Arg-Trp-Leu-Trp-Leu-Trp-Lys]-D- Val-D-Phe-NH2 1188 TCAM1185 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-c[Asp-Pro-Arg-Arg-Arg-Trp-Leu-Trp-Leu-Trp-Lys]-D- Pro-D-Val-NH2 1189 TCAM1186 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-c[Asp-Pro-Arg-Arg-Arg-Trp-Leu-Trp-Leu-Trp-Lys]-D- Phe-D-Val-NH2 1190 TCAM1187 Val-Arg-Leu-lle-Val-Ala-Val-Arg-c[Asp-Pro-Arg-Gln-Arg-Arg-Trp-Leu-Trp-Leu-Trp- Lys]-D-Val-D-Pro-NH2 1191 TCAM1188 Val-Arg-Leu-lle-Val-Ala-Val-Arg-c[Asp-Pro-Arg-Gln-Arg-Arg-Trp-Leu-Trp-Leu-Trp- Lys]-D-Val-D-Phe-NH2 1192 TCAM1189 Val-Arg-Leu-lle-Val-Ala-Val-Arg-c[Asp-Pro-Arg-Gln-Arg-Arg-Trp-Leu-Trp-Leu-Trp- Lys]-D-Pro-D-Val-NH2 1193 TCAM1190 Val-Arg-Leu-lle-Val-Ala-Val-Arg-c[Asp-Pro-Arg-Gln-Arg-Arg-Trp-Leu-Trp-Leu-Trp- Lys]-D-Phe-D-Val-NH2 1194 TCAM1191 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-c[Asp-Pro-Trp-Arg-Trp-Trp-Arg-Arg-Lys]-D-Val-D- Phe-NH2 1195 TCAM1192 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-c[Asp-Pro-Trp-Arg-Trp-Trp-Arg-Arg-Lys]-D-Pro-D- Val-NH2 1196 TCAM1193 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-c[Asp-Pro-Trp-Arg-Trp-Trp-Arg-Arg-Lys]-D-Phe-D- Val-NH2 1197 TCAM1194 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-c[Asp-Pro-Trp-Trp-Arg-Arg-Trp-Trp-Arg-Arg-Lys]-D- Val-D-Pro-NH2 1198 TCAM1195 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-c[Asp-Pro-Trp-Trp-Arg-Arg-Trp-Trp-Arg-Arg-Lys]-D- Val-D-Phe-NH2 1199 TCAM1196 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-c[Asp-Pro-Trp-Trp-Arg-Arg-Trp-Trp-Arg-Arg-Lys]-D- Pro-D-Val-NH2 1200 TCAM1197 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-c[Asp-Pro-Trp-Trp-Arg-Arg-Trp-Trp-Arg-Arg-Lys]-D- Phe-D-Val-NH2 1201 TCAM1198 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-c[Asp-Pro-Trp-Arg-Trp-Arg-Trp-Arg-Lys]-D-Val-D- Pro-NH2 1202 TCAM1199 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-c[Asp-Pro-Trp-Arg-Trp-Arg-Trp-Arg-Lys]-D-Val-D- Phe-NH2 1203 TCAM1200 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-c[Asp-Pro-Trp-Arg-Trp-Arg-Trp-Arg-Lys]-D-Pro-D- Val-NH2 1204 TCAM1201 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-c[Asp-Pro-Trp-Arg-Trp-Arg-Trp-Arg-Lys]-D-Phe-D- Val-NH2 1205 TCAM1202 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-c[Asp-Pro-Arg-Trp-Arg-Trp-Arg-Trp-Lys]-D-Val-D- Pro-NH2 1206 TCAM1203 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-c[Asp-Pro-Arg-Trp-Arg-Trp-Arg-Trp-Lys]-D-Val-D- Phe-NH2 1207 TCAM1204 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-c[Asp-Pro-Arg-Trp-Arg-Trp-Arg-Trp-Lys]-D-Pro-D- Val-NH2 1208 TCAM1205 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-c[Asp-Pro-Arg-Trp-Arg-Trp-Arg-Trp-Lys]-D-Phe-D- Val-NH2 1209 TCAM1206 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-c[Asp-Pro-Arg-Trp-Trp-Arg-Arg-Lys]-D-Val-D-Pro- NH2 1210 TCAM1207 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-c[Asp-Pro-Arg-Trp-Trp-Arg-Arg-Lys]-D-Val-D-Phe- NH2 1211 TCAM1208 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-c[Asp-Pro-Arg-Trp-Trp-Arg-Arg-Lys]-D-Pro-D-Val- NH2 1212 TCAM1209 Val-Arg-Leu-lle-Val-Ala-Val-Arg-c[Asp-Pro-Arg-Trp-Trp-Arg-Arg-Lys]-D-Phe-D-Val- NH2 1213 TCAM1210 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-c[Asp-Pro-Trp-Trp-Arg-Arg-Trp-Lys]-D-Val-D-Pro- NH2 1214 TCAM1211 Val-Arg-Leu-lle-Val-Ala-Val-Arg-c[Asp-Pro-Trp-Trp-Arg-Arg-Trp-Lys]-D-Val-D-Phe- NH2 1215 TCAM1212 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-c[Asp-Pro-Trp-Trp-Arg-Arg-Trp-Lys]-D-Pro-D-Val- NH2 1216 TCAM1213 Val-Arg-Leu-lle-Val-Ala-Val-Arg-c[Asp-Pro-Trp-Trp-Arg-Arg-Trp-Lys]-D-Phe-D-Val- NH2 1217 TCAM1214 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-c[Asp-Pro-Trp-Arg-Trp-Arg-Trp-Lys]-D-Val-D-Pro- NH2 1218 TCAM1215 Val-Arg-Leu-lle-Val-Ala-Val-Arg-c[Asp-Pro-Trp-Arg-Trp-Arg-Trp-Lys]-D-Val-D-Phe- NH2 1219 TCAM1216 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-c[Asp-Pro-Trp-Arg-Trp-Arg-Trp-Lys]-D-Pro-D-Val- NH2 1220 TCAM1217 Val-Arg-Leu-lle-Val-Ala-Val-Arg-c[Asp-Pro-Trp-Arg-Trp-Arg-Trp-Lys]-D-Phe-D-Val- NH2 1221 TCAM1218 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-c[Asp-Pro-Arg-Trp-Arg-Trp-Arg-Lys]-D-Val-D-Pro- NH2 1222 TCAM1219 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-c[Asp-Pro-Arg-Trp-Arg-Trp-Arg-Lys]-D-Val-D-Phe- NH2 1223 TCAM1220 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-c[Asp-Pro-Arg-Trp-Arg-Trp-Arg-Lys]-D-Pro-D-Val- NH2 1224 TCAM1221 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-c[Asp-Pro-Arg-Trp-Arg-Trp-Arg-Lys]-D-Phe-D-Val- NH2 1225 TCAM1222 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-c[Asp-Pro-Trp-Arg-Tyr-Arg-Trp-Lys]-D-Val-D-Pro- NH2 1226 TCAM1223 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-c[Asp-Pro-Trp-Arg-Tyr-Arg-Trp-Lys]-D-Val-D-Phe- NH2 1227 TCAM1224 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-c[Asp-Pro-Trp-Arg-Tyr-Arg-Trp-Lys]-D-Pro-D-Val- NH2 1228 TCAM1225 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-c[Asp-Pro-Trp-Arg-Tyr-Arg-Trp-Lys]-D-Phe-D-Val- NH2 1229 TCAM1226 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-c[Asp-Pro-Trp-Arg-Trp-Arg-Tyr-Lys]-D-Val-D-Pro- NH2 1230 TCAM1227 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-c[Asp-Pro-Trp-Arg-Trp-Arg-Tyr-Lys]-D-Val-D-Phe- NH2 1231 TCAM1228 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-c[Asp-Pro-Trp-Arg-Trp-Arg-Tyr-Lys]-D-Pro-D-Val- NH2 1232 TCAM1229 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-c[Asp-Pro-Trp-Arg-Trp-Arg-Tyr-Lys]-D-Phe-D-Val- NH2 1233 TCAM1230 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-c[Asp-Pro-Trp-Arg-Trp-Arg-Lys]-D-Val-D-Pro-NH2 1234 TCAM1231 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-c[Asp-Pro-Trp-Arg-Trp-Arg-Lys]-D-Val-D-Phe-NH2 1235 TCAM1232 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-c[Asp-Pro-Trp-Arg-Trp-Arg-Lys]-D-Pro-D-Val-NH2 1236 TCAM1233 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-c[Asp-Pro-Trp-Arg-Trp-Arg-Lys]-D-Phe-D-Val-NH2 1237 TCAM1234 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-c[Asp-Pro-Trp-Arg-Arg-Trp-Lys]-D-Val-D-Pro-NH2 1238 TCAM1235 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-c[Asp-Pro-Trp-Arg-Arg-Trp-Lys]-D-Val-D-Phe-NH2 1239 TCAM1236 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-c[Asp-Pro-Trp-Arg-Arg-Trp-Lys]-D-Pro-D-Val-NH2 1240 TCAM1237 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-c[Asp-Pro-Trp-Arg-Arg-Trp-Lys]-D-Phe-D-Val-NH2 1241 TCAM1238 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-c[Asp-Pro-Arg-Trp-Trp-Arg-Lys]-D-Val-D-Pro-NH2 1242 TCAM1239 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-c[Asp-Pro-Arg-Trp-Trp-Arg-Lys]-D-Val-D-Phe-NH2 1243 TCAM1240 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-c[Asp-Pro-Arg-Trp-Trp-Arg-Lys]-D-Pro-D-Val-NH2 1244 TCAM1241 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-c[Asp-Pro-Arg-Trp-Trp-Arg-Lys]-D-Phe-D-Val-NH2 1245 TCAM1242 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-c[Asp-Pro-Trp-Arg-Trp-Lys]-D-Val-D-Pro-NH2 1246 TCAM1243 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-c[Asp-Pro-Trp-Arg-Trp-Lys]-D-Val-D-Phe-NH2 1247 TCAM1244 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-c[Asp-Pro-Trp-Arg-Trp-Lys]-D-Pro-D-Val-NH2 1248 TCAM1245 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-c[Asp-Pro-Trp-Arg-Trp-Lys]-D-Phe-D-Val-NH2 1249 TCAM1246 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-c[Asp-Pro-Arg-Trp-Arg-Lys]-D-Val-D-Pro-NH2 1250 TCAM1247 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-c[Asp-Pro-Arg-Trp-Arg-Lys]-D-Val-D-Phe-NH2 1251 TCAM1248 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-c[Asp-Pro-Arg-Trp-Arg-Lys]-D-Pro-D-Val-NH2 1252 TCAM1249 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-c[Asp-Pro-Arg-Trp-Arg-Lys]-D-Phe-D-Val-NH2 1253 TCAM1250 -Val-Arg-Leu-Ile-Val-Ala-Val-Arg-c[Asp-Arg-Arg-Trp-Trp-Arg-Phe-Lys]-D-Val-D-Pro- NH2 1254 TCAM1251 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-c[Asp-Arg-Arg-Trp-Trp-Arg-Phe-Lys]-D-Val-D-Phe- NH2 1255 TCAM1252 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-c[Asp-Arg-Arg-Trp-Trp-Arg-Phe-Lys]-D-Pro-D-Val- NH2 1256 TCAM1253 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-c[Asp-Arg-Arg-Trp-Trp-Arg-Phe-Lys]-D-Phe-D-Val- NH2 1257 TCAM1254 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-c[Asp-Arg-Arg-Trp-Trp-Arg-Phe-Lys]-D-Val-D-Pro- NH2 1258 TCAM1255 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-c[Asp-Arg-Arg-Trp-Trp-Arg-Phe-Lys]-D-Val-D-Phe- NH2 1259 TCAM1256 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-c[Asp-Arg-Arg-Trp-Trp-Arg-Phe-Lys]-D-Pro-D-Val- NH2 1260 TCAM1257 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-c[Asp-Arg-Arg-Trp-Trp-Arg-Phe-Lys]-D-Phe-D-Val- NH2 1261 TCAM1258 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-c[Asp-Arg-Arg-Tyr-Tyr-Arg-Phe-Lys]-D-Val-D-Pro- NH2 1262 TCAM1259 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-c[Asp-Arg-Arg-Tyr-Tyr-Arg-Phe-Lys]-D-Val-D-Phe- NH2 1263 TCAM1260 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-c[Asp-Arg-Arg-Tyr-Tyr-Arg-Phe-Lys]-D-Pro-D-Val- NH2 1264 TCAM1261 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-c[Asp-Arg-Arg-Tyr-Tyr-Arg-Phe-Lys]-D-Phe-D-Val- NH2 1265 TCAM1262 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-c[Asp-Arg-Arg-Nal-Nal-Arg-Phe-Lys]-D-Val-D-Pro- NH2 1266 TCAM1263 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-c[Asp-Arg-Arg-Nal-Nal-Arg-Phe-Lys]-D-Val-D-Phe- NH2 1267 TCAM1264 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-c[Asp-Arg-Arg-Nal-Nal-Arg-Phe-Lys]-D-Pro-D-Val- NH2 1268 TCAM1265 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-c[Asp-Arg-Arg-Nal-Nal-Arg-Phe-Lys]-D-Phe-D-Val- NH2 1269 TCAM1266 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-c[Asp-Arg-Arg-Leu-Trp-Leu-Trp-Lys]-D-Val-D-Pro- NH2 1270 TCAM1267 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-c[Asp-Arg-Arg-Leu-Trp-Leu-Trp-Lys]-D-Val-D-Phe- NH2 1271 TCAM1268 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-c[Asp-Arg-Arg-Leu-Trp-Leu-Trp-Lys]-D-Pro-D-Val- NH2 1272 TCAM1269 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-c[Asp-Arg-Arg-Leu-Trp-Leu-Trp-Lys]-D-Phe-D-Val- NH2 1273 TCAM1270 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-c[Asp-Arg-Arg-Leu-Trp-Leu-Trp-Lys]-D-Val-D-Pro- NH2 1274 TCAM1271 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-c[Asp-Arg-Arg-Leu-Trp-Leu-Trp-Lys]-D-Val-D-Phe- NH2 1275 TCAM1272 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-c[Asp-Arg-Arg-Leu-Trp-Leu-Trp-Lys]-D-Pro-D-Val- NH2 1276 TCAM1273 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-c[Asp-Arg-Arg-Leu-Trp-Leu-Trp-Lys]-D-Phe-D-Val- NH2 1277 TCAM1274 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-c[Asp-Arg-Arg-Arg-Trp-Leu-Trp-Leu-Trp-Lys]-D-Val- D-Pro-NH2 1278 TCAM1275 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-c[Asp-Arg-Arg-Arg-Trp-Leu-Trp-Leu-Trp-Lys]-D-Val- D-Phe-NH2 1279 TCAM1276 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-c[Asp-Arg-Arg-Arg-Trp-Leu-Trp-Leu-Trp-Lys]-D-Pro- D-Val-NH2 1280 TCAM1277 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-c[Asp-Arg-Arg-Arg-Trp-Leu-Trp-Leu-Trp-Lys]-D-Phe- D-Val-NH2 1281 TCAM1278 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-c[Asp-Arg-Gln-Arg-Arg-Trp-Leu-Trp-Leu-Trp-Lys]-D- Val-D-Pro-NH2 1282 TCAM1279 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-c[Asp-Arg-Gln-Arg-Arg-Trp-Leu-Trp-Leu-Trp-Lys]-D- Val-D-Phe-NH2 1283 TCAM1280 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-c[Asp-Arg-Gln-Arg-Arg-Trp-Leu-Trp-Leu-Trp-Lys]-D- Pro-D-Val-NH2 1284 TCAM1281 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-c[Asp-Arg-Gln-Arg-Arg-Trp-Leu-Trp-Leu-Trp-Lys]-D- Phe-D-Val-NH2 1285 TCAM1282 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-c[Asp-Trp-Arg-Trp-Trp-Arg-Arg-Lys]-D-Val-D-Pro- NH2 1286 TCAM1283 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-c[Asp-Trp-Arg-Trp-Trp-Arg-Arg-Lys]-D-Val-D-Phe- NH2 1287 TCAM1284 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-c[Asp-Trp-Arg-Trp-Trp-Arg-Arg-Lys]-D-Pro-D-Val- NH2 1288 TCAM1285 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-c[Asp-Trp-Arg-Trp-Trp-Arg-Arg-Lys]-D-Phe-D-Val- NH2 1289 TCAM1286 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-c[Asp-Trp-Trp-Arg-Arg-Trp-Trp-Arg-Arg-Lys]-D-Val- D-Pro-NH2 1290 TCAM1287 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-c[Asp-Trp-Trp-Arg-Arg-Trp-Trp-Arg-Arg-Lys]-D-Val- D-Phe-NH2 1291 TCAM1288 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-c[Asp-Trp-Trp-Arg-Arg-Trp-Trp-Arg-Arg-Lys]-D-Pro- D-Val-NH2 1292 TCAM1289 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-c[Asp-Trp-Trp-Arg-Arg-Trp-Trp-Arg-Arg-Lys]-D-Phe- D-Val-NH2 1293 TCAM1290 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-c[Asp-Trp-Arg-Trp-Arg-Trp-Arg-Lys]-D-Val-D-Pro- NH2 1294 TCAM1291 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-c[Asp-Trp-Arg-Trp-Arg-Trp-Arg-Lys]-D-Val-D-Phe- NH2 1295 TCAM1292 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-c[Asp-Trp-Arg-Trp-Arg-Trp-Arg-Lys]-D-Pro-D-Val- NH2 1296 TCAM1293 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-c[Asp-Trp-Arg-Trp-Arg-Trp-Arg-Lys]-D-Phe-D-Val- NH2 1297 TCAM1294 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-c[Asp-Arg-Trp-Arg-Trp-Arg-Trp-Lys]-D-Val-D-Pro- NH2 1298 TCAM1295 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-c[Asp-Arg-Trp-Arg-Trp-Arg-Trp-Lys]-D-Val-D-Phe- NH2 1299 TCAM1296 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-c[Asp-Arg-Trp-Arg-Trp-Arg-Trp-Lys]-D-Pro-D-Val- NH2 1300 TCAM1297 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-c[Asp-Arg-Trp-Arg-Trp-Arg-Trp-Lys]-D-Phe-D-Val- NH2 1301 TCAM1298 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-c[Asp-Arg-Trp-Trp-Arg-Arg-Lys]-D-Val-D-Pro-NH2 1302 TCAM1299 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-c[Asp-Arg-Trp-Trp-Arg-Arg-Lys]-D-Val-D-Phe-NH2 1303 TCAM1300 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-c[Asp-Arg-Trp-Trp-Arg-Arg-Lys]-D-Pro-D-Val-NH2 1304 TCAM1301 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-c[Asp-Arg-Trp-Trp-Arg-Arg-Lys]-D-Phe-D-Val-NH2 1305 TCAM1302 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-c[Asp-Arg-Trp-Arg-Trp-Arg-Lys]-D-Val-D-Pro-NH2 1306 TCAM1303 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-c[Asp-Arg-Trp-Arg-Trp-Arg-Lys]-D-Val-D-Phe-NH2 1307 TCAM1304 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-c[Asp-Arg-Trp-Arg-Trp-Arg-Lys]-D-Pro-D-Val-NH2 1308 TCAM1305 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-c[Asp-Arg-Trp-Arg-Trp-Arg-Lys]-D-Phe-D-Val-NH2 1309 TCAM1306 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-c[Asp-Trp-Trp-Arg-Arg-Trp-Lys]-D-Val-D-Pro-NH2 1310 TCAM1307 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-c[Asp-Trp-Trp-Arg-Arg-Trp-Lys]-D-Val-D-Phe-NH2 1311 TCAM1308 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-c[Asp-Trp-Trp-Arg-Arg-Trp-Lys]-D-Pro-D-Val-NH2 1312 TCAM1309 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-c[Asp-Trp-Trp-Arg-Arg-Trp-Lys]-D-Phe-D-Val-NH2 1313 TCAM1310 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-c[Asp-Trp-Arg-Trp-Arg-Trp-Lys]-D-Val-D-Pro-NH2 1314 TCAM1311 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-c[Asp-Trp-Arg-Trp-Arg-Trp-Lys]-D-Val-D-Phe-NH2 1315 TCAM1312 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-c[Asp-Trp-Arg-Trp-Arg-Trp-Lys]-D-Pro-D-Val-NH2 1316 TCAM1313 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-c[Asp-Trp-Arg-Trp-Arg-Trp-Lys]-D-Phe-D-Val-NH2 1317 TCAM1314 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-c[Asp-Trp-Arg-Tyr-Arg-Trp-Lys]-D-Val-D-Pro-NH2 1318 TCAM1315 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-c[Asp-Trp-Arg-Tyr-Arg-Trp-Lys]-D-Val-D-Phe-NH2 1319 TCAM1316 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-c[Asp-Trp-Arg-Tyr-Arg-Trp-Lys]-D-Pro-D-Val-NH2 1320 TCAM1317 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-c[Asp-Trp-Arg-Tyr-Arg-Trp-Lys]-D-Phe-D-Val-NH2 1321 TCAM1318 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-c[Asp-Trp-Arg-Trp-Arg-Tyr-Lys]-D-Val-D-Pro-NH2 1322 TCAM1319 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-c[Asp-Trp-Arg-Trp-Arg-Tyr-Lys]-D-Val-D-Phe-NH2 1323 TCAM1320 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-c[Asp-Trp-Arg-Trp-Arg-Tyr-Lys]-D-Pro-D-Val-NH2 1324 TCAM1321 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-c[Asp-Trp-Arg-Trp-Arg-Tyr-Lys]-D-Phe-D-Val-NH2 1325 TCAM1322 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-c[Asp-Trp-Arg-Trp-Arg-Lys]-D-Val-D-Pro-NH2 1326 TCAM1323 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-c[Asp-Trp-Arg-Trp-Arg-Lys]-D-Val-D-Phe-NH2 1327 TCAM1324 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-c[Asp-Trp-Arg-Trp-Arg-Lys]-D-Pro-D-Val-NH2 1328 TCAM1325 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-c[Asp-Trp-Arg-Trp-Arg-Lys]-D-Phe-D-Val-NH2 1329 TCAM1326 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-c[Asp-Trp-Arg-Arg-Trp-Lys]-D-Val-D-Pro-NH2 1330 TCAM1327 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-c[Asp-Trp-Arg-Arg-Trp-Lys]-D-Val-D-Phe-NH2 1331 TCAM1328 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-c[Asp-Trp-Arg-Arg-Trp-Lys]-D-Pro-D-Val-NH2 1332 TCAM1329 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-c[Asp-Trp-Arg-Arg-Trp-Lys]-D-Phe-D-Val-NH2 1333 TCAM1330 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-c[Asp-Arg-Trp-Trp-Arg-Lys]-D-Val-D-Pro-NH2 1334 TCAM1331 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-c[Asp-Arg-Trp-Trp-Arg-Lys]-D-Val-D-Phe-NH2 1335 TCAM1332 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-c[Asp-Arg-Trp-Trp-Arg-Lys]-D-Pro-D-Val-NH2 1336 TCAM1333 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-c[Asp-Arg-Trp-Trp-Arg-Lys]-D-Phe-D-Val-NH2 1337 TCAM1334 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-c[Asp-Trp-Arg-Trp-Lys]-D-Val-D-Pro-NH2 1338 TCAM1335 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-c[Asp-Trp-Arg-Trp-Lys]-D-Val-D-Phe-NH2 1339 TCAM1336 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-c[Asp-Trp-Arg-Trp-Lys]-D-Pro-D-Val-NH2 1340 TCAM1337 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-c[Asp-Trp-Arg-Trp-Lys]-D-Phe-D-Val-NH2 1341 TCAM1338 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-c[Asp-Arg-Trp-Arg-Lys]-D-Val-D-Pro-NH2 1342 TCAM1339 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-c[Asp-Arg-Trp-Arg-Lys]-D-Val-D-Phe-NH2 1343 TCAM1340 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-c[Asp-Arg-Trp-Arg-Lys]-D-Pro-D-Val-NH2 1344 TCAM1341 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-c[Asp-Arg-Trp-Arg-Lys]-D-Phe-D-Val-NH2 1345 TCAM1342 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-c[Asp-His-D-Nal(2′)-Arg-Trp-Lys]-D-Val-D-Pro-NH2 1346 TCAM1343 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-c[Asp-His-D-Nal(2′)-Arg-Trp-Lys]-D-Pro-D-Val-NH2 1347 TCAM1344 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-c[Asp-His-D-Nal(2′)-Arg-Trp-Lys]-D-Val-D-Phe-NH2 1348 TCAM1345 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-c[Asp-His-D-Nal(2′)-Arg-Trp-Lys]-D-Phe-D-Val-NH2 1349 TCAM1346 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-c[Asp-Pro-D-Nal(2′)-Arg-Trp-Lys]-D-Val-D-Pro-NH2 1350 TCAM1347 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-c[Asp-Pro-D-Nal(2′)-Arg-Trp-Lys]-D-Pro-D-Val-NH2 1351 TCAM1348 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-c[Asp-Pro-D-Nal(2′)-Arg-Trp-Lys]-D-Val-D-Phe-NH2 1352 TCAM1349 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-c[Asp-Pro-D-Nal(2′)-Arg-Trp-Lys]-D-Phe-D-Val-NH2 1353 TCAM1350 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-c[Asp-Arg-Arg-Nal(2')-Arg-Trp-Lys]-D-Val-D-Pro-NH2 1354 TCAM1351 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-c[Asp-Arg-Arg-Nal(2')-Arg-Trp-Lys]-D-Pro-D-Val-NH2 1355 TCAM1352 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-c[Asp-Arg-Arg-Nal(2′)-Arg-Trp-Lys]-D-Val-D-Phe- NH2 1356 TCAM1353 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-c[Asp-Arg-Arg-Nal(2′)-Arg-Trp-Lys]-D-Phe-D-Val- NH2 1357 TCAM1354 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-c[Asp-Arg-Arg-Pro-Nal(2′)-Arg-Trp-Lys]-D-Val-D-Pro- NH2 1358 TCAM1355 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-c[Asp-Arg-Arg-Pro-D-Nal(2′)-Arg-Trp-Lys]-D-Pro-D- Val-NH2 1359 TCAM1356 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-c[Asp-Arg-Arg-Pro-D-Nal(2′)-Arg-Trp-Lys]-D-Val-D- Phe-NH2 1360 TCAM1357 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-c[Asp-Arg-Arg-Pro-Nal(2′)-Arg-Trp-Lys]-D-Phe-D-Val- NH2 1361 TCAM1358 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-c[Asp-Arg-D-Nal(2′)-Arg-Trp-Lys]-D-Val-D-Pro-NH2 1362 TCAM1359 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-c[Asp-Arg-D-Nal(2′)-Arg-Trp-Lys]-D-Pro-D-Val-NH2 1363 TCAM1360 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-c[Asp-Arg-D-Nal(2′)-Arg-Trp-Lys]-D-Val-D-Phe-NH2 1364 TCAM1361 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-c[Asp-Arg-D-Nal(2′)-Arg-Trp-Lys]-D-Phe-D-Val-NH2 1365 TCAM1362 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-c[Asp-Arg-Pro-D-Nal(2′)-Arg-Trp-Lys]-D-Val-D-Pro- NH2 1366 TCAM1363 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-c[Asp-Arg-Pro-D-Nal(2′)-Arg-Trp-Lys]-D-Pro-D-Val- NH2 1367 TCAM1364 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-c[Asp-Arg-Pro-D-Nal(2′)-Arg-Trp-Lys]-D-Val-D-Phe- NH2 1368 TCAM1365 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-c[Asp-Arg-Pro-D-Nal(2′)-Arg-Trp-Lys]-D-Phe-D-Val- NH2 1369 TCAM1366 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-Arg-Arg-c[Asp-Pro-D-Nal(2′)-Arg-Trp-Lys]-D-Val-D- Pro-NH2 1370 TCAM1367 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-Arg-Arg-c[Asp-Pro-D-Nal(2′)-Arg-Trp-Lys]-D-Pro-D- Val-NH2 1371 TCAM1368 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-Arg-Arg-c[Asp-Pro-D-Nal(2′)-Arg-Trp-Lys]-D-Val-D- Phe-NH2 1372 TCAM1369 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-Arg-Arg-c[Asp-Pro-D-Nal(2′)-Arg-Trp-Lys]-D-Phe-D- Val-NH2 1373 TCAM1370 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-Arg-Arg-c[Asp-His-D-Nal(2′)-Arg-Trp-Lys]-D-Val-D- Pro-NH2 1374 TCAM1371 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-Arg-Arg-c[Asp-His-D-Nal(2′)-Arg-Trp-Lys]-D-Pro-D- Val-NH2 1375 TCAM1372 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-Arg-Arg-c[Asp-His-D-Nal(2′)-Arg-Trp-Lys]-D-Val-D- Phe-NH2 1376 TCAM1373 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-Arg-Arg-c[Asp-His-D-Nal(2′)-Arg-Trp-Lys]-D-Phe-D- Val-NH2 1377 TCAM1374 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-c[Asp-Arg-Pro-D-Nal(2′)-Arg-Trp-Arg-Lys]-D-Val-D- Pro-NH2 1378 TCAM1375 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-c[Asp-Arg-Pro-D-Nal(2′)-Arg-Trp-Arg-Lys]-D-Pro-D- Val-NH2 1379 TCAM1376 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-c[Asp-Arg-Pro-D-Nal(2′)-Arg-Trp-Arg-Lys]-D-Val-D- Phe-NH2 1380 TCAM1377 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-c[Asp-Arg-Pro-D-Nal(2′)-Arg-Trp-Arg-Lys]-D-Phe-D- Val-NH2 1381 TCAM1378 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-c[Asp-Arg-His-D-Nal(2′)-Arg-Trp-Arg-Lys]-D-Val-D- Pro-NH2 1382 TCAM1379 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-c[Asp-Arg-His-D-Nal(2′)-Arg-Trp-Arg-Lys]-D-Pro-D- Val-NH2 1383 TCAM1380 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-c[Asp-Arg-His-D-Nal(2′)-Arg-Trp-Arg-Lys]-D-Val-D- Phe-NH2 1384 TCAM1381 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-c[Asp-Arg-His-D-Nal(2′)-Arg-Trp-Arg-Lys]-D-Phe-D- Val-NH2 1385 TCAM1382 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-c[Asp-His-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Val-D-Phe- NH2 1386 TCAM1383 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-c[Asp-His-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Phe-D-Val- NH2 1387 TCAM1384 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-c[Asp-Pro-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Val-D-Pro- NH2 1388 TCAM1385 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-c[Asp-Pro-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Pro-D-Val- NH2 1389 TCAM1386 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-c[Asp-Pro-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Val-D-Phe- NH2 1390 TCAM1387 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-c[Asp-Pro-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Phe-D-Val- NH2 1391 TCAM1388 Val-Arg-Leu-lle-Val-Ala-Val-Arg-c[Asp-Arg-Arg-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Val-D- Pro-NH2 1392 TCAM1389 Val-Arg-Leu-lle-Val-Ala-Val-Arg-c[Asp-Arg-Arg-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Pro-D- Val-NH2 1393 TCAM1390 Val-Arg-Leu-lle-Val-Ala-Val-Arg-c[Asp-Arg-Arg-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Val-D- Phe-NH2 1394 TCAM1391 Val-Arg-Leu-lle-Val-Ala-Val-Arg-c[Asp-Arg-Arg-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Phe-D- Val-NH2 1395 TCAM1392 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-c[Asp-Arg-Arg-Pro-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D- Val-D-Pro-NH2 1396 TCAM1393 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-c[Asp-Arg-Arg-Pro-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D- Pro-D-Val-NH2 1397 TCAM1394 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-c[Asp-Arg-Arg-Pro-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D- Val-D-Phe-NH2 1398 TCAM1395 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-c[Asp-Arg-Arg-Pro-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D- Phe-D-Val-NH2 1399 TCAM1396 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-c[Asp-Arg-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Val-D-Pro- NH2 1400 TCAM1397 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-c[Asp-Arg-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Pro-D-Val- NH2 1401 TCAM1398 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-c[Asp-Arg-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Val-D-Phe- NH2 1402 TCAM1399 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-c[Asp-Arg-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Phe-D-Val- NH2 1403 TCAM1400 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-c[Asp-Arg-Pro-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Val-D- Pro-NH2 1404 TCAM1401 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-c[Asp-Arg-Pro-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Pro-D- Val-NH2 1405 TCAM1402 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-c[Asp-Arg-Pro-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Val-D- Phe-NH2 1406 TCAM1403 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-c[Asp-Arg-Pro-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Phe-D- Val-NH2 1407 TCAM1404 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-c[Asp-Arg-His-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Val-D- Pro-NH2 1408 TCAM1405 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-c[Asp-Arg-His-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Pro-D- Val-NH2 1409 TCAM1406 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-c[Asp-Arg-His-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Val-D- Phe-NH2 1410 TCAM1407 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-c[Asp-Arg-His-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Phe-D- Val-NH2 1411 TCAM1408 Val-Arg-Leu-lle-Val-Ala-Val-Arg-c[Asp-Arg-D-D-Nal(2′)-Arg-D-Nal(2′)-Arg-Lys]-D-Val- D-Pro-NH2 1412 TCAM1409 Val-Arg-Leu-lle-Val-Ala-Val-Arg-c[Asp-Arg-D-Nal(2′)-Arg-D-Nal(2′)-Arg-Lys]-D-Pro-D- Val-NH2 1413 TCAM1410 Val-Arg-Leu-lle-Val-Ala-Val-Arg-c[Asp-Arg-D-Nal(2′)-Arg-D-Nal(2′)-Arg-Lys]-D-Val-D- Phe-NH2 1414 TCAM1411 Val-Arg-Leu-lle-Val-Ala-Val-Arg-c[Asp-Arg-D-Nal(2′)-Arg-D-Nal(2′)-Arg-Lys]-D-Phe-D- Val-NH2 1415 TCAM1412 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-c[Asp-Arg-Pro-D-Nal(2′)-Arg-D-Nal(2′)-Arg-Lys]-D- Val-D-Pro-NH2 1416 TCAM1413 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-c[Asp-Arg-Pro-D-Nal(2′)-Arg-D-Nal(2′)-Arg-Lys]-D- Pro-D-Val-NH2 1417 TCAM1414 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-c[Asp-Arg-Pro-D-Nal(2′)-Arg-D-Nal(2′)-Arg-Lys]-D- Val-D-Phe-NH2 1418 TCAM1415 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-c[Asp-Arg-Pro-D-Nal(2′)-Arg-D-Nal(2′)-Arg-Lys]-D- Phe-D-Val-NH2 1419 TCAM1416 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-c[Asp-Arg-His-D-Nal(2′)-Arg-D-Nal(2′)-Arg-Lys]-D- Val-D-Pro-NH2 1420 TCAM1417 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-c[Asp-Arg-His-D-Nal(2′)-Arg-D-Nal(2′)-Arg-Lys]-D- Pro-D-Val-NH2 1421 TCAM1418 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-c[Asp-Arg-His-D-Nal(2′)-Arg-D-Nal(2′)-Arg-Lys]-D- Val-D-Phe-NH2 1422 TCAM1419 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-c[Asp-Arg-His-D-Nal(2′)-Arg-D-Nal(2′)-Arg-Lys]-D- Phe-D-Val-NH2 1423 TCAM1420 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-Arg-Arg-c[Asp-Pro-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D- Val-D-Pro-NH2 1424 TCAM1421 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-Arg-Arg-c[Asp-Pro-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D- Pro-D-Val-NH2 1425 TCAM1422 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-Arg-Arg-c[Asp-Pro-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D- Val-D-Phe-NH2 1426 TCAM1423 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-Arg-Arg-c[Asp-Pro-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D- Phe-D-Val-NH2 1427 TCAM1424 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-Arg-Arg-c[Asp-His-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D- Val-D-Pro-NH2 1428 TCAM1425 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-Arg-Arg-c[Asp-His-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D- Pro-D-Val-NH2 1429 TCAM1426 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-Arg-Arg-c[Asp-His-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D- Val-D-Phe-NH2 1430 TCAM1427 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-Arg-Arg-c[Asp-His-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D- Phe-D-Val-NH2 1431 TCAM1428 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-c[Asp-Arg-Pro-D-Nal(2′)-Arg-D-Nal(2′)-Arg-Lys]-D- Val-D-Pro-NH2 1432 TCAM1429 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-c[Asp-Arg-Pro-D-Nal(2′)-Arg-D-Nal(2′)-Arg-Lys]-D- Pro-D-Val-NH2 1433 TCAM1430 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-c[Asp-Arg-Pro-D-Nal(2′)-Arg-D-Nal(2′)-Arg-Lys]-D- Val-D-Phe-NH2 1434 TCAM1431 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-c[Asp-Arg-Pro-D-Nal(2′)-Arg-D-Nal(2′)-Arg-Lys]-D- Phe-D-Val-NH2 1435 TCAM1432 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-c[Asp-Arg-His-D-Nal(2′)-Arg-D-Nal(2′)-Arg-Lys]-D- Val-D-Pro-NH2 1436 TCAM1433 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-c[Asp-Arg-His-D-Nal(2′)-Arg-D-Nal(2′)-Arg-Lys]-D- Pro-D-Val-NH2 1437 TCAM1434 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-c[Asp-Arg-His-D-Nal(2′)-Arg-D-Nal(2′)-Arg-Lys]-D- Val-D-Phe-NH2 1438 TCAM1435 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-c[Asp-Arg-His-D-Nal(2′)-Arg-D-Nal(2′)-Arg-Lys]-D- Phe-D-Val-NH2 1439 TCAM1436 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-c[Asp-His-D-Nal(2′)-Arg-Trp-Lys]-Arg-Arg-D-Val-D- Pro-NH2 1440 TCAM1437 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-c[Asp-His-D-Nal(2′)-Arg-Trp-Lys]-Arg-Arg-D-Pro-D- Val-NH2 1441 TCAM1438 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-c[Asp-His-D-Nal(2′)-Arg-Trp-Lys]-Arg-Arg-D-Val-D- Phe-NH2 1442 TCAM1439 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-c[Asp-His-D-Nal(2′)-Arg-Trp-Lys]-Arg-Arg-D-Phe-D- Val-NH2 1443 TCAM1440 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-c[Asp-Pro-D-Nal(2′)-Arg-Trp-Lys]-Arg-Arg-D-Val-D- Pro-NH2 1444 TCAM1441 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-c[Asp-Pro-D-Nal(2′)-Arg-Trp-Lys]-Arg-Arg-D-Pro-D- Val-NH2 1445 TCAM1442 Val-Arg-Leu-Ile-Val-Ala-Val-Arg-c[Asp-Pro-D-Nal(2′)-Arg-Trp-Lys]-Arg-Arg-D-Val-D- Phe-NH2 1446 TCAM1443 Val-Arg-Leu-lle-Val-Ala-Val-Arg-c[Asp-Pro-D-Nal(2′)-Arg-Trp-Lys]-Arg-Arg-D-Phe-D- Val-NH2 Anti-biofilm peptide ABF2 linked to anti-microbial peptides 1447 TCAM1444 Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Pro-Arg-Arg-Trp-Trp-Arg-Phe-Lys]-D-Val-D-Pro-NH2 1448 TCAM1445 Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Pro-Arg-Arg-Trp-Trp-Arg-Phe-Lys]-D-Val-D-Phe-NH2 1449 TCAM1446 Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Pro-Arg-Arg-Trp-Trp-Arg-Phe-Lys]-D-Pro-D-Val-NH2 1450 TCAM1447 Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Pro-Arg-Arg-Trp-Trp-Arg-Phe-Lys]-D-Phe-D-Val-NH2 1451 TCAM1448 Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Pro-Arg-Arg-Trp-Trp-Tyr-Phe-Lys]-D-Val-D-Pro-NH2 1452 TCAM1449 Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Pro-Arg-Arg-Trp-Trp-Tyr-Phe-Lys]-D-Val-D-Phe-NH2 1453 TCAM1450 Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Pro-Arg-Arg-Trp-Trp-Tyr-Phe-Lys]-D-Pro-D-Val-NH2 1454 TCAM1451 Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Pro-Arg-Arg-Trp-Trp-Tyr-Phe-Lys]-D-Phe-D-Val-NH2 1455 TCAM1452 Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Pro-Arg-Arg-Tyr-Tyr-Arg-Phe-Lys]-D-Val-D-Pro-NH2 1456 TCAM1453 Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Pro-Arg-Arg-Tyr-Tyr-Arg-Phe-Lys]-D-Val-D-Phe-NH2 1457 TCAM1454 Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Pro-Arg-Arg-Tyr-Tyr-Arg-Phe-Lys]-D-Pro-D-Val-NH2 1458 TCAM1455 Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Pro-Arg-Arg-Tyr-Tyr-Arg-Phe-Lys]-D-Phe-D-Val-NH2 1459 TCAM1456 Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Pro-Arg-Arg-Nal-Nal-Arg-Phe-Lys]-D-Val-D-Pro-NH2 1460 TCAM1457 Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Pro-Arg-Arg-Nal-Nal-Arg-Phe-Lys]-D-Val-D-Phe-NH2 1461 TCAM1458 Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Pro-Arg-Arg-Nal-Nal-Arg-Phe-Lys]-D-Pro-D-Val-NH2 1462 TCAM1459 Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Pro-Arg-Arg-Nal-Nal-Arg-Phe-Lys]-D-Phe-D-Val-NH2 1463 TCAM1460 Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Pro-Arg-Arg-Leu-Trp-Leu-Trp-Lys]-D-Val-D-Pro-NH2 1464 TCAM1461 Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Pro-Arg-Arg-Leu-Trp-Leu-Trp-Lys]-D-Val-D-Phe-NH2 1465 TCAM1462 Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Pro-Arg-Arg-Leu-Trp-Leu-Trp-Lys]-D-Pro-D-Val-NH2 1466 TCAM1463 Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Pro-Arg-Arg-Leu-Trp-Leu-Trp-Lys]-D-Phe-D-Val-NH2 1467 TCAM1464 Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Pro-Arg-Arg-Leu-Trp-Leu-Trp-Lys]-D-Val-D-Pro-NH2 1468 TCAM1465 Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Pro-Arg-Arg-Leu-Trp-Leu-Trp-Lys]-D-Val-D-Phe-NH2 1469 TCAM1466 Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Pro-Arg-Arg-Leu-Trp-Leu-Trp-Lys]-D-Pro-D-Val-NH2 1470 TCAM1467 Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Pro-Arg-Arg-Leu-Trp-Leu-Trp-Lys]-D-Phe-D-Val-NH2 1471 TCAM1468 Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Arg-Arg-Arg-Trp-Leu-Trp-Leu-Trp-Lys]-D-Val-D-Pro- NH2 1472 TCAM1469 Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Pro-Arg-Arg-Arg-Trp-Leu-Trp-Leu-Trp-Lys]-D-Val-D- Phe-NH2 1473 TCAM1470 Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Pro-Arg-Arg-Arg-Trp-Leu-Trp-Leu-Trp-Lys]-D-Pro-D- Val-NH2 1474 TCAM1471 Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Pro-Arg-Arg-Arg-Trp-Leu-Trp-Leu-Trp-Lys]-D-Phe-D- Val-NH2 1475 TCAM1472 Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Pro-Arg-Gln-Arg-Arg-Trp-Leu-Trp-Leu-Trp-Lys]-D-Val- D-Pro-NH2 1476 TCAM1473 Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Pro-Arg-Gln-Arg-Arg-Trp-Leu-Trp-Leu-Trp-Lys]-D-Val- D-Phe-NH2 1477 TCAM1474 Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Pro-Arg-Gln-Arg-Arg-Trp-Leu-Trp-Leu-Trp-Lys]-D-Pro- D-Val-NH2 1478 TCAM1475 Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Pro-Arg-Gln-Arg-Arg-Trp-Leu-Trp-Leu-Trp-Lys]-D- Phe-D-Val-NH2 1479 TCAM1476 Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Pro-Trp-Arg-Trp-Trp-Arg-Arg-Lys]-D-Val-D-Phe-NH2 1480 TCAM1477 Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Pro-Trp-Arg-Trp-Trp-Arg-Arg-Lys]-D-Pro-D-Val-NH2 1481 TCAM1478 Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Pro-Trp-Arg-Trp-Trp-Arg-Arg-Lys]-D-Phe-D-Val-NH2 1482 TCAM1479 Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Pro-Trp-Trp-Arg-Arg-Trp-Trp-Arg-Arg-Lys]-D-Val-D- Pro-NH2 1483 TCAM1480 Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Pro-Trp-Trp-Arg-Arg-Trp-Trp-Arg-Arg-Lys]-D-Val-D- Phe-NH2 1484 TCAM1481 Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Pro-Trp-Trp-Arg-Arg-Trp-Trp-Arg-Arg-Lys]-D-Pro-D- Val-NH2 1485 TCAM1482 Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Pro-Trp-Trp-Arg-Arg-Trp-Trp-Arg-Arg-Lys]-D-Phe-D- Val-NH2 1486 TCAM1483 Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Pro-Trp-Arg-Trp-Arg-Trp-Arg-Lys]-D-Val-D-Pro-NH2 1487 TCAM1484 Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Pro-Trp-Arg-Trp-Arg-Trp-Arg-Lys]-D-Val-D-Phe-NH2 1488 TCAM1485 Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Pro-Trp-Arg-Trp-Arg-Trp-Arg-Lys]-D-Pro-D-Val-NH2 1489 TCAM1486 Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Pro-Trp-Arg-Trp-Arg-Trp-Arg-Lys]-D-Phe-D-Val-NH2 1490 TCAM1487 Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Pro-Arg-Trp-Arg-Trp-Arg-Trp-Lys]-D-Val-D-Pro-NH2 1491 TCAM1488 Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Pro-Arg-Trp-Arg-Trp-Arg-Trp-Lys]-D-Val-D-Phe-NH2 1492 TCAM1489 Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Pro-Arg-Trp-Arg-Trp-Arg-Trp-Lys]-D-Pro-D-Val-NH2 1493 TCAM1490 Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Pro-Arg-Trp-Arg-Trp-Arg-Trp-Lys]-D-Phe-D-Val-NH2 1494 TCAM1491 Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Pro-Arg-Trp-Trp-Arg-Arg-Lys]-D-Val-D-Pro-NH2 1495 TCAM1492 Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Pro-Arg-Trp-Trp-Arg-Arg-Lys]-D-Val-D-Phe-NH2 1496 TCAM1493 Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Pro-Arg-Trp-Trp-Arg-Arg-Lys]-D-Pro-D-Val-NH2 1497 TCAM1494 Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Pro-Arg-Trp-Trp-Arg-Arg-Lys]-D-Phe-D-Val-NH2 1498 TCAM1495 Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Pro-Trp-Trp-Arg-Arg-Trp-Lys]-D-Val-D-Pro-NH2 1499 TCAM1496 Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Pro-Trp-Trp-Arg-Arg-Trp-Lys]-D-Val-D-Phe-NH2 1500 TCAM1497 Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Pro-Trp-Trp-Arg-Arg-Trp-Lys]-D-Pro-D-Val-NH2 1501 TCAM1498 Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Pro-Trp-Trp-Arg-Arg-Trp-Lys]-D-Phe-D-Val-NH2 1502 TCAM1499 Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Pro-Trp-Arg-Trp-Arg-Trp-Lys]-D-Val-D-Pro-NH2 1503 TCAM1500 Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Pro-Trp-Arg-Trp-Arg-Trp-Lys]-D-Val-D-Phe-NH2 1504 TCAM1501 Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Pro-Trp-Arg-Trp-Arg-Trp-Lys]-D-Pro-D-Val-NH2 1505 TCAM1502 Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Pro-Trp-Arg-Trp-Arg-Trp-Lys]-D-Phe-D-Val-NH2 1506 TCAM1503 Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Pro-Arg-Trp-Arg-Trp-Arg-Lys]-D-Val-D-Pro-NH2 1507 TCAM1504 Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Pro-Arg-Trp-Arg-Trp-Arg-Lys]-D-Val-D-Phe-NH2 1508 TCAM1505 Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Pro-Arg-Trp-Arg-Trp-Arg-Lys]-D-Pro-D-Val-NH2 1509 TCAM1506 Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Pro-Arg-Trp-Arg-Trp-Arg-Lys]-D-Phe-D-Val-NH2 1510 TCAM1507 Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Pro-Trp-Arg-Tyr-Arg-Trp-Lys]-D-Val-D-Pro-NH2 1511 TCAM1508 Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Pro-Trp-Arg-Tyr-Arg-Trp-Lys]-D-Val-D-Phe-NH2 1512 TCAM1509 Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Pro-Trp-Arg-Tyr-Arg-Trp-Lys]-D-Pro-D-Val-NH2 1513 TCAM1510 Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Pro-Trp-Arg-Tyr-Arg-Trp-Lys]-D-Phe-D-Val-NH2 1514 TCAM1511 Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Pro-Trp-Arg-Trp-Arg-Tyr-Lys]-D-Val-D-Pro-NH2 1515 TCAM1512 Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Pro-Trp-Arg-Trp-Arg-Tyr-Lys]-D-Val-D-Phe-NH2 1516 TCAM1513 Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Pro-Trp-Arg-Trp-Arg-Tyr-Lys]-D-Pro-D-Val-NH2 1517 TCAM1514 Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Pro-Trp-Arg-Trp-Arg-Tyr-Lys]-D-Phe-D-Val-NH2 1518 TCAM1515 Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Pro-Trp-Arg-Trp-Arg-Lys]-D-Val-D-Pro-NH2 1519 TCAM1516 Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Pro-Trp-Arg-Trp-Arg-Lys]-D-Val-D-Phe-NH2 1520 TCAM1517 Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Pro-Trp-Arg-Trp-Arg-Lys]-D-Pro-D-Val-NH2 1521 TCAM1518 Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Pro-Trp-Arg-Trp-Arg-Lys]-D-Phe-D-Val-NH2 1522 TCAM1519 Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Pro-Trp-Arg-Arg-Trp-Lys]-D-Val-D-Pro-NH2 1523 TCAM1520 Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Pro-Trp-Arg-Arg-Trp-Lys]-D-Val-D-Phe-NH2 1524 TCAM1521 Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Pro-Trp-Arg-Arg-Trp-Lys]-D-Pro-D-Val-NH2 1525 TCAM1522 Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Pro-Trp-Arg-Arg-Trp-Lys]-D-Phe-D-Val-NH2 1526 TCAM1523 Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Pro-Arg-Trp-Trp-Arg-Lys]-D-Val-D-Pro-NH2 1527 TCAM1524 Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Pro-Arg-Trp-Trp-Arg-Lys]-D-Val-D-Phe-NH2 1528 TCAM1525 Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Pro-Arg-Trp-Trp-Arg-Lys]-D-Pro-D-Val-NH2 1529 TCAM1526 Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Pro-Arg-Trp-Trp-Arg-Lys]-D-Phe-D-Val-NH2 1530 TCAM1527 Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Pro-Trp-Arg-Trp-Lys]-D-Val-D-Pro-NH2 1531 TCAM1528 Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Pro-Trp-Arg-Trp-Lys]-D-Val-D-Phe-NH2 1532 TCAM1529 Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Pro-Trp-Arg-Trp-Lys]-D-Pro-D-Val-NH2 1533 TCAM1530 Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Pro-Trp-Arg-Trp-Lys]-D-Phe-D-Val-NH2 1534 TCAM1531 Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Pro-Arg-Trp-Arg-Lys]-D-Val-D-Pro-NH2 1535 TCAM1532 Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Pro-Arg-Trp-Arg-Lys]-D-Val-D-Phe-NH2 1536 TCAM1533 Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Pro-Arg-Trp-Arg-Lys]-D-Pro-D-Val-NH2 1537 TCAM1534 Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Pro-Arg-Trp-Arg-Lys]-D-Phe-D-Val-NH2 1538 TCAM1535 Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Arg-Arg-Trp-Trp-Arg-Phe-Lys]-D-Val-D-Pro-NH2 1539 TCAM1536 Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Arg-Arg-Trp-Trp-Arg-Phe-Lys]-D-Val-D-Phe-NH2 1540 TCAM1537 Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Arg-Arg-Trp-Trp-Arg-Phe-Lys]-D-Pro-D-Val-NH2 1541 TCAM1538 Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Arg-Arg-Trp-Trp-Arg-Phe-Lys]-D-Phe-D-Val-NH2 1542 TCAM1539 Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Arg-Arg-Trp-Trp-Arg-Phe-Lys]-D-Val-D-Pro-NH2 1543 TCAM1540 Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Arg-Arg-Trp-Trp-Arg-Phe-Lys]-D-Val-D-Phe-NH2 1544 TCAM1541 Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Arg-Arg-Trp-Trp-Arg-Phe-Lys]-D-Pro-D-Val-NH2 1545 TCAM1542 Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Arg-Arg-Trp-Trp-Arg-Phe-Lys]-D-Phe-D-Val-NH2 1546 TCAM1543 Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Arg-Arg-Tyr-Tyr-Arg-Phe-Lys]-D-Val-D-Pro-NH2 1547 TCAM1544 Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Arg-Arg-Tyr-Tyr-Arg-Phe-Lys]-D-Val-D-Phe-NH2 1548 TCAM1545 Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Arg-Arg-Tyr-Tyr-Arg-Phe-Lys]-D-Pro-D-Val-NH2 1549 TCAM1546 Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Arg-Arg-Tyr-Tyr-Arg-Phe-Lys]-D-Phe-D-Val-NH2 1550 TCAM1547 Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Arg-Arg-Nal-Nal-Arg-Phe-Lys]-D-Val-D-Pro-NH2 1551 TCAM1548 Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Arg-Arg-Nal-Nal-Arg-Phe-Lys]-D-Val-D-Phe-NH2 1552 TCAM1549 Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Arg-Arg-Nal-Nal-Arg-Phe-Lys]-D-Pro-D-Val-NH2 1553 TCAM1550 Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Arg-Arg-Nal-Nal-Arg-Phe-Lys]-D-Phe-D-Val-NH2 1554 TCAM1551 Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Arg-Arg-Leu-Trp-Leu-Trp-Lys]-D-Val-D-Pro-NH2 1555 TCAM1552 Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Arg-Arg-Leu-Trp-Leu-Trp-Lys]-D-Val-D-Phe-NH2 1556 TCAM1553 Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Arg-Arg-Leu-Trp-Leu-Trp-Lys]-D-Pro-D-Val-NH2 1557 TCAM1554 Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Arg-Arg-Leu-Trp-Leu-Trp-Lys]-D-Phe-D-Val-NH2 1558 TCAM1555 Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Arg-Arg-Leu-Trp-Leu-Trp-Lys]-D-Val-D-Pro-NH2 1559 TCAM1556 Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Arg-Arg-Leu-Trp-Leu-Trp-Lys]-D-Val-D-Phe-NH2 1560 TCAM1557 Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Arg-Arg-Leu-Trp-Leu-Trp-Lys]-D-Pro-D-Val-NH2 1561 TCAM1558 Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Arg-Arg-Leu-Trp-Leu-Trp-Lys]-D-Phe-D-Val-NH2 1562 TCAM1559 Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Arg-Arg-Arg-Trp-Leu-Trp-Leu-Trp-Lys]-D-Val-D-Pro- NH2 1563 TCAM1560 Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Arg-Arg-Arg-Trp-Leu-Trp-Leu-Trp-Lys]-D-Val-D-Phe- NH2 1564 TCAM1561 Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Arg-Arg-Arg-Trp-Leu-Trp-Leu-Trp-Lys]-D-Pro-D-Val- NH2 1565 TCAM1562 Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Arg-Arg-Arg-Trp-Leu-Trp-Leu-Trp-Lys]-D-Phe-D-Val- NH2 1566 TCAM1563 Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Arg-Gln-Arg-Arg-Trp-Leu-Trp-Leu-Trp-Lys]-D-Val-D- Pro-NH2 1567 TCAM1564 Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Arg-Gln-Arg-Arg-Trp-Leu-Trp-Leu-Trp-Lys]-D-Val-D- Phe-NH2 1568 TCAM1565 Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Arg-Gln-Arg-Arg-Trp-Leu-Trp-Leu-Trp-Lys]-D-Pro-D- Val-NH2 1569 TCAM1566 Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Arg-Gln-Arg-Arg-Trp-Leu-Trp-Leu-Trp-Lys]-D-Phe-D- Val-NH2 1570 TCAM1567 Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Trp-Arg-Trp-Trp-Arg-Arg-Lys]-D-Val-D-Pro-NH2 1571 TCAM1568 Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Trp-Arg-Trp-Trp-Arg-Arg-Lys]-D-Val-D-Phe-NH2 1572 TCAM1569 Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Trp-Arg-Trp-Trp-Arg-Arg-Lys]-D-Pro-D-Val-NH2 1573 TCAM1570 Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Trp-Arg-Trp-Trp-Arg-Arg-Lys]-D-Phe-D-Val-NH2 1574 TCAM1571 Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Trp-Trp-Arg-Arg-Trp-Trp-Arg-Arg-Lys]-D-Val-D-Pro- NH2 1575 TCAM1572 Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Trp-Trp-Arg-Arg-Trp-Trp-Arg-Arg-Lys]-D-Val-D-Phe- NH2 1576 TCAM1573 Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Trp-Trp-Arg-Arg-Trp-Trp-Arg-Arg-Lys]-D-Pro-D-Val- NH2 1577 TCAM1574 Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Trp-Trp-Arg-Arg-Trp-Trp-Arg-Arg-Lys]-D-Phe-D-Val- NH2 1578 TCAM1575 Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Trp-Arg-Trp-Arg-Trp-Arg-Lys]-D-Val-D-Pro-NH2 1579 TCAM1576 Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Trp-Arg-Trp-Arg-Trp-Arg-Lys]-D-Val-D-Phe-NH2 1580 TCAM1577 Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Trp-Arg-Trp-Arg-Trp-Arg-Lys]-D-Pro-D-Val-NH2 1581 TCAM1578 Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Trp-Arg-Trp-Arg-Trp-Arg-Lys]-D-Phe-D-Val-NH2 1582 TCAM1579 Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Arg-Trp-Arg-Trp-Arg-Trp-Lys]-D-Val-D-Pro-NH2 1583 TCAM1580 Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Arg-Trp-Arg-Trp-Arg-Trp-Lys]-D-Val-D-Phe-NH2 1584 TCAM1581 Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Arg-Trp-Arg-Trp-Arg-Trp-Lys]-D-Pro-D-Val-NH2 1585 TCAM1582 Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Arg-Trp-Arg-Trp-Arg-Trp-Lys]-D-Phe-D-Val-NH2 1586 TCAM1583 Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Arg-Trp-Trp-Arg-Arg-Lys]-D-Val-D-Pro-NH2 1587 TCAM1584 Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Arg-Trp-Trp-Arg-Arg-Lys]-D-Val-D-Phe-NH2 1588 TCAM1585 Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Arg-Trp-Trp-Arg-Arg-Lys]-D-Pro-D-Val-NH2 1589 TCAM1586 Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Arg-Trp-Trp-Arg-Arg-Lys]-D-Phe-D-Val-NH2 1590 TCAM1587 Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Arg-Trp-Arg-Trp-Arg-Lys]-D-Val-D-Pro-NH2 1591 TCAM1588 Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Arg-Trp-Arg-Trp-Arg-Lys]-D-Val-D-Phe-NH2 1592 TCAM1589 Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Arg-Trp-Arg-Trp-Arg-Lys]-D-Pro-D-Val-NH2 1593 TCAM1590 Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Arg-Trp-Arg-Trp-Arg-Lys]-D-Phe-D-Val-NH2 1594 TCAM1591 Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Trp-Trp-Arg-Arg-Trp-Lys]-D-Val-D-Pro-NH2 1595 TCAM1592 Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Trp-Trp-Arg-Arg-Trp-Lys]-D-Val-D-Phe-NH2 1596 TCAM1593 Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Trp-Trp-Arg-Arg-Trp-Lys]-D-Pro-D-Val-NH2 1597 TCAM1594 Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Trp-Trp-Arg-Arg-Trp-Lys]-D-Phe-D-Val-NH2 1598 TCAM1595 Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Trp-Arg-Trp-Arg-Trp-Lys]-D-Val-D-Pro-NH2 1599 TCAM1596 Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Trp-Arg-Trp-Arg-Trp-Lys]-D-Val-D-Phe-NH2 1600 TCAM1597 Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Trp-Arg-Trp-Arg-Trp-Lys]-D-Pro-D-Val-NH2 1601 TCAM1598 Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Trp-Arg-Trp-Arg-Trp-Lys]-D-Phe-D-Val-NH2 1602 TCAM1599 Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Trp-Arg-Tyr-Arg-Trp-Lys]-D-Val-D-Pro-NH2 1603 TCAM1600 Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Trp-Arg-Tyr-Arg-Trp-Lys]-D-Val-D-Phe-NH2 1604 TCAM1601 Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Trp-Arg-Tyr-Arg-Trp-Lys]-D-Pro-D-Val-NH2 1605 TCAM1602 Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Trp-Arg-Tyr-Arg-Trp-Lys]-D-Phe-D-Val-NH2 1606 TCAM1603 Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Trp-Arg-Trp-Arg-Tyr-Lys]-D-Val-D-Pro-NH2 1607 TCAM1604 Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Trp-Arg-Trp-Arg-Tyr-Lys]-D-Val-D-Phe-NH2 1608 TCAM1605 Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Trp-Arg-Trp-Arg-Tyr-Lys]-D-Pro-D-Val-NH2 1609 TCAM1606 Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Trp-Arg-Trp-Arg-Tyr-Lys]-D-Phe-D-Val-NH2 1610 TCAM1607 Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Trp-Arg-Trp-Arg-Lys]-D-Val-D-Pro-NH2 1611 TCAM1608 Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Trp-Arg-Trp-Arg-Lys]-D-Val-D-Phe-NH2 1612 TCAM1609 Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Trp-Arg-Trp-Arg-Lys]-D-Pro-D-Val-NH2 1613 TCAM1610 Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Trp-Arg-Trp-Arg-Lys]-D-Phe-D-Val-NH2 1614 TCAM1611 Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Trp-Arg-Arg-Trp-Lys]-D-Val-D-Pro-NH2 1615 TCAM1612 Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Trp-Arg-Arg-Trp-Lys]-D-Val-D-Phe-NH2 1616 TCAM1613 Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Trp-Arg-Arg-Trp-Lys]-D-Pro-D-Val-NH2 1617 TCAM1614 Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Trp-Arg-Arg-Trp-Lys]-D-Phe-D-Val-NH2 1618 TCAM1615 Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Arg-Trp-Trp-Arg-Lys]-D-Val-D-Pro-NH2 1619 TCAM1616 Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Arg-Trp-Trp-Arg-Lys]-D-Val-D-Phe-NH2 1620 TCAM1617 Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Arg-Trp-Trp-Arg-Lys]-D-Pro-D-Val-NH2 1621 TCAM1618 Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Arg-Trp-Trp-Arg-Lys]-D-Phe-D-Val-NH2 1622 TCAM1619 Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Trp-Arg-Trp-Lys]-D-Val-D-Pro-NH2 1623 TCAM1620 Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Trp-Arg-Trp-Lys]-D-Val-D-Phe-NH2 1624 TCAM1621 Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Trp-Arg-Trp-Lys]-D-Pro-D-Val-NH2 1625 TCAM1622 Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Trp-Arg-Trp-Lys]-D-Phe-D-Val-NH2 1626 TCAM1623 Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Arg-Trp-Arg-Lys]-D-Val-D-Pro-NH2 1627 TCAM1624 Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Arg-Trp-Arg-Lys]-D-Val-D-Phe-NH2 1628 TCAM1625 Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Arg-Trp-Arg-Lys]-D-Pro-D-Val-NH2 1629 TCAM1626 Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Arg-Trp-Arg-Lys]-D-Phe-D-Val-NH2 1630 TCAM1627 Val-Arg-Ile-Trp-Arg-Arg-c[Asp-His-D-Nal(2′)-Arg-Trp-Lys]-D-Val-D-Pro-NH2 1631 TCAM1628 Val-Arg-Ile-Trp-Arg-Arg-c[Asp-His-D-Nal(2′)-Arg-Trp-Lys]-D-Pro-D-Val-NH2 1632 TCAM1629 Val-Arg-Ile-Trp-Arg-Arg-c[Asp-His-D-Nal(2′)-Arg-Trp-Lys]-D-Val-D-Phe-NH2 1633 TCAM1630 Val-Arg-Ile-Trp-Arg-Arg-c[Asp-His-D-Nal(2′)-Arg-Trp-Lys]-D-Phe-D-Val-NH2 1634 TCAM1631 Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Pro-D-Nal(2′)-Arg-Trp-Lys]-D-Val-D-Pro-NH2 1635 TCAM1632 Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Pro-D-Nal(2′)-Arg-Trp-Lys]-D-Pro-D-Val-NH2 1636 TCAM1633 Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Pro-D-Nal(2′)-Arg-Trp-Lys]-D-Val-D-Phe-NH2 1637 TCAM1634 Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Pro-D-Nal(2′)-Arg-Trp-Lys]-D-Phe-D-Val-NH2 1638 TCAM1635 Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Arg-Arg-Nal(2′)-Arg-Trp-Lys]-D-Val-D-Pro-NH2 1639 TCAM1636 Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Arg-Arg-Nal(2′)-Arg-Trp-Lys]-D-Pro-D-Val-NH2 1640 TCAM1637 Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Arg-Arg-Nal(2′)-Arg-Trp-Lys]-D-Val-D-Phe-NH2 1641 TCAM1638 Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Arg-Arg-Nal(2′)-Arg-Trp-Lys]-D-Phe-D-Val-NH2 1642 TCAM1639 Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Arg-Arg-Pro-Nal(2′)-Arg-Trp-Lys]-D-Val-D-Pro-NH2 1643 TCAM1640 Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Arg-Arg-Pro-D-Nal(2′)-Arg-Trp-Lys]-D-Pro-D-Val-NH2 1644 TCAM1641 Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Arg-Arg-Pro-D-Nal(2′)-Arg-Trp-Lys]-D-Val-D-Phe-NH2 1645 TCAM1642 Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Arg-Arg-Pro-Nal(2′)-Arg-Trp-Lys]-D-Phe-D-Val-NH2 1646 TCAM1643 Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Arg-D-Nal(2′)-Arg-Trp-Lys]-D-Val-D-Pro-NH2 1647 TCAM1644 Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Arg-D-Nal(2′)-Arg-Trp-Lys]-D-Pro-D-Val-NH2 1648 TCAM1645 Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Arg-D-Nal(2′)-Arg-Trp-Lys]-D-Val-D-Phe-NH2 1649 TCAM1646 Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Arg-D-Nal(2′)-Arg-Trp-Lys]-D-Phe-D-Val-NH2 1650 TCAM1647 Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Arg-Pro-D-Nal(2′)-Arg-Trp-Lys]-D-Val-D-Pro-NH2 1651 TCAM1648 Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Arg-Pro-D-Nal(2′)-Arg-Trp-Lys]-D-Pro-D-Val-NH2 1652 TCAM1649 Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Arg-Pro-D-Nal(2′)-Arg-Trp-Lys]-D-Val-D-Phe-NH2 1653 TCAM1650 Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Arg-Pro-D-Nal(2′)-Arg-Trp-Lys]-D-Phe-D-Val-NH2 1654 TCAM1651 Val-Arg-Ile-Trp-Arg-Arg-Arg-Arg-c[Asp-Pro-D-Nal(2′)-Arg-Trp-Lys]-D-Val-D-Pro-NH2 1655 TCAM1652 Val-Arg-Ile-Trp-Arg-Arg-Arg-Arg-c[Asp-Pro-D-Nal(2′)-Arg-Trp-Lys]-D-Pro-D-Val-NH2 1656 TCAM1653 Val-Arg-Ile-Trp-Arg-Arg-Arg-Arg-c[Asp-Pro-D-Nal(2′)-Arg-Trp-Lys]-D-Val-D-Phe-NH2 1657 TCAM1654 Val-Arg-Ile-Trp-Arg-Arg-Arg-Arg-c[Asp-Pro-D-Nal(2′)-Arg-Trp-Lys]-D-Phe-D-Val-NH2 1658 TCAM1655 Val-Arg-Ile-Trp-Arg-Arg-Arg-Arg-c[Asp-His-D-Nal(2′)-Arg-Trp-Lys]-D-Val-D-Pro-NH2 1659 TCAM1656 Val-Arg-Ile-Trp-Arg-Arg-Arg-Arg-c[Asp-His-D-Nal(2′)-Arg-Trp-Lys]-D-Pro-D-Val-NH2 1660 TCAM1657 Val-Arg-Ile-Trp-Arg-Arg-Arg-Arg-c[Asp-His-D-Nal(2′)-Arg-Trp-Lys]-D-Val-D-Phe-NH2 1661 TCAM1658 Val-Arg-Ile-Trp-Arg-Arg-Arg-Arg-c[Asp-His-D-Nal(2′)-Arg-Trp-Lys]-D-Phe-D-Val-NH2 1662 TCAM1659 Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Arg-Pro-D-Nal(2′)-Arg-Trp-Arg-Lys]-D-Val-D-Pro-NH2 1663 TCAM1660 Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Arg-Pro-D-Nal(2′)-Arg-Trp-Arg-Lys]-D-Pro-D-Val-NH2 1664 TCAM1661 Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Arg-Pro-D-Nal(2′)-Arg-Trp-Arg-Lys]-D-Val-D-Phe-NH2 1665 TCAM1662 Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Arg-Pro-D-Nal(2′)-Arg-Trp-Arg-Lys]-D-Phe-D-Val-NH2 1666 TCAM1663 Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Arg-His-D-Nal(2′)-Arg-Trp-Arg-Lys]-D-Val-D-Pro-NH2 1667 TCAM1664 Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Arg-His-D-Nal(2′)-Arg-Trp-Arg-Lys]-D-Pro-D-Val-NH2 1668 TCAM1665 Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Arg-His-D-Nal(2′)-Arg-Trp-Arg-Lys]-D-Val-D-Phe-NH2 1669 TCAM1666 Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Arg-His-D-Nal(2′)-Arg-Trp-Arg-Lys]-D-Phe-D-Val-NH2 1670 TCAM1667 Val-Arg-Ile-Trp-Arg-Arg-c[Asp-His-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Val-D-Phe-NH2 1671 TCAM1668 Val-Arg-Ile-Trp-Arg-Arg-c[Asp-His-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Phe-D-Val-NH2 1672 TCAM1669 Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Pro-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Val-D-Pro-NH2 1673 TCAM1670 Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Pro-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Pro-D-Val-NH2 1674 TCAM1671 Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Pro-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Val-D-Phe-NH2 1675 TCAM1672 Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Pro-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Phe-D-Val-NH2 1676 TCAM1673 Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Arg-Arg-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Val-D-Pro-NH2 1677 TCAM1674 Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Arg-Arg-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Pro-D-Val-NH2 1678 TCAM1675 Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Arg-Arg-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Val-D-Phe-NH2 1679 TCAM1676 Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Arg-Arg-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Phe-D-Val-NH2 1680 TCAM1677 Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Arg-Arg-Pro-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Val-D-Pro- NH2 1681 TCAM1678 Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Arg-Arg-Pro-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Pro-D-Val- NH2 1682 TCAM1679 Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Arg-Arg-Pro-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Val-D-Phe- NH2 1683 TCAM1680 Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Arg-Arg-Pro-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Phe-D-Val- NH2 1684 TCAM1681 Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Arg-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Val-D-Pro-NH2 1685 TCAM1682 Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Arg-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Pro-D-Val-NH2 1686 TCAM1683 Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Arg-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Val-D-Phe-NH2 1687 TCAM1684 Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Arg-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Phe-D-Val-NH2 1688 TCAM1685 Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Arg-Pro-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Val-D-Pro-NH2 1689 TCAM1686 Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Arg-Pro-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Pro-D-Val-NH2 1690 TCAM1687 Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Arg-Pro-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Val-D-Phe-NH2 1691 TCAM1688 Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Arg-Pro-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Phe-D-Val-NH2 1692 TCAM1689 Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Arg-His-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Val-D-Pro-NH2 1693 TCAM1690 Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Arg-His-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Pro-D-Val-NH2 1694 TCAM1691 Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Arg-His-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Val-D-Phe-NH2 1695 TCAM1692 Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Arg-His-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Phe-D-Val-NH2 1696 TCAM1693 Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Arg-D-D-Nal(2′)-Arg-D-Nal(2′)-Arg-Lys]-D-Val-D-Pro- NH2 1697 TCAM1694 Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Arg-D-Nal(2′)-Arg-D-Nal(2′)-Arg-Lys]-D-Pro-D-Val-NH2 1698 TCAM1695 Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Arg-D-Nal(2′)-Arg-D-Nal(2′)-Arg-Lys]-D-Val-D-Phe-NH2 1699 TCAM1696 Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Arg-D-Nal(2′)-Arg-D-Nal(2′)-Arg-Lys]-D-Phe-D-Val-NH2 1700 TCAM1697 Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Arg-Pro-D-Nal(2′)-Arg-D-Nal(2′)-Arg-Lys]-D-Val-D-Pro- NH2 1701 TCAM1698 Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Arg-Pro-D-Nal(2′)-Arg-D-Nal(2′)-Arg-Lys]-D-Pro-D-Val- NH2 1702 TCAM1699 Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Arg-Pro-D-Nal(2′)-Arg-D-Nal(2′)-Arg-Lys]-D-Val-D-Phe- NH2 1703 TCAM1700 Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Arg-Pro-D-Nal(2′)-Arg-D-Nal(2′)-Arg-Lys]-D-Phe-D-Val- NH2 1704 TCAM1701 Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Arg-His-D-Nal(2′)-Arg-D-Nal(2′)-Arg-Lys]-D-Val-D-Pro- NH2 1705 TCAM1702 Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Arg-His-D-Nal(2′)-Arg-D-Nal(2′)-Arg-Lys]-D-Pro-D-Val- NH2 1706 TCAM1703 Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Arg-His-D-Nal(2′)-Arg-D-Nal(2′)-Arg-Lys]-D-Val-D-Phe- NH2 1707 TCAM1704 Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Arg-His-D-Nal(2′)-Arg-D-Nal(2′)-Arg-Lys]-D-Phe-D-Val- NH2 1708 TCAM1705 Val-Arg-Ile-Trp-Arg-Arg-Arg-Arg-c[Asp-Pro-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Val-D-Pro- NH2 1709 TCAM1706 Val-Arg-Ile-Trp-Arg-Arg-Arg-Arg-c[Asp-Pro-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Pro-D-Val- NH2 1710 TCAM1707 Val-Arg-Ile-Trp-Arg-Arg-Arg-Arg-c[Asp-Pro-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Val-D-Phe- NH2 1711 TCAM1708 Val-Arg-Ile-Trp-Arg-Arg-Arg-Arg-c[Asp-Pro-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Phe-D-Val- NH2 1712 TCAM1709 Val-Arg-Ile-Trp-Arg-Arg-Arg-Arg-c[Asp-His-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Val-D-Pro- NH2 1713 TCAM1710 Val-Arg-Ile-Trp-Arg-Arg-Arg-Arg-c[Asp-His-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Pro-D-Val- NH2 1714 TCAM1711 Val-Arg-Ile-Trp-Arg-Arg-Arg-Arg-c[Asp-His-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Val-D-Phe- NH2 1715 TCAM1712 Val-Arg-Ile-Trp-Arg-Arg-Arg-Arg-c[Asp-His-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Phe-D-Val- NH2 1716 TCAM1713 Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Arg-Pro-D-Nal(2′)-Arg-D-Nal(2′)-Arg-Lys]-D-Val-D-Pro- NH2 1717 TCAM1714 Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Arg-Pro-D-Nal(2′)-Arg-D-Nal(2′)-Arg-Lys]-D-Pro-D-Val- NH2 1718 TCAM1715 Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Arg-Pro-D-Nal(2′)-Arg-D-Nal(2′)-Arg-Lys]-D-Val-D-Phe- NH2 1719 TCAM1716 Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Arg-Pro-D-Nal(2′)-Arg-D-Nal(2′)-Arg-Lys]-D-Phe-D-Val- NH2 1720 TCAM1717 Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Arg-His-D-Nal(2′)-Arg-D-Nal(2′)-Arg-Lys]-D-Val-D-Pro- NH2 1721 TCAM1718 Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Arg-His-D-Nal(2′)-Arg-D-Nal(2′)-Arg-Lys]-D-Pro-D-Val- NH2 1722 TCAM1719 Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Arg-His-D-Nal(2′)-Arg-D-Nal(2′)-Arg-Lys]-D-Val-D-Phe- NH2 1723 TCAM1720 Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Arg-His-D-Nal(2′)-Arg-D-Nal(2′)-Arg-Lys]-D-Phe-D-Val- NH2 1724 TCAM1721 Val-Arg-Ile-Trp-Arg-Arg-c[Asp-His-D-Nal(2′)-Arg-Trp-Lys]-Arg-Arg-D-Val-D-Pro-NH2 1725 TCAM1722 Val-Arg-Ile-Trp-Arg-Arg-c[Asp-His-D-Nal(2′)-Arg-Trp-Lys]-Arg-Arg-D-Pro-D-Val-NH2 1726 TCAM1723 Val-Arg-Ile-Trp-Arg-Arg-c[Asp-His-D-Nal(2′)-Arg-Trp-Lys]-Arg-Arg-D-Val-D-Phe-NH2 1727 TCAM1724 Val-Arg-Ile-Trp-Arg-Arg-c[Asp-His-D-Nal(2′)-Arg-Trp-Lys]-Arg-Arg-D-Phe-D-Val-NH2 1728 TCAM1725 Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Pro-D-Nal(2′)-Arg-Trp-Lys]-Arg-Arg-D-Val-D-Pro-NH2 1729 TCAM1726 Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Pro-D-Nal(2′)-Arg-Trp-Lys]-Arg-Arg-D-Pro-D-Val-NH2 1730 TCAM1727 Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Pro-D-Nal(2′)-Arg-Trp-Lys]-Arg-Arg-D-Val-D-Phe-NH2 1731 TCAM1728 Val-Arg-Ile-Trp-Arg-Arg-c[Asp-Pro-D-Nal(2′)-Arg-Trp-Lys]-Arg-Arg-D-Phe-D-Val-NH2 Anti-biofilm peptide ABF3 linked to anti-microbial peptides 1732 TCAM1729 Val-Arg-Leu-Ile-Val-Ala-c[Asp-Pro-Arg-Arg-Trp-Trp-Arg-Phe-Lys]-D-Val-D-Pro-NH2 1733 TCAM1730 Val-Arg-Leu-Ile-Val-Ala-c[Asp-Pro-Arg-Arg-Trp-Trp-Arg-Phe-Lys]-D-Val-D-Phe-NH2 1734 TCAM1731 Val-Arg-Leu-Ile-Val-Ala-c[Asp-Pro-Arg-Arg-Trp-Trp-Arg-Phe-Lys]-D-Pro-D-Val-NH2 1735 TCAM1732 Val-Arg-Leu-Ile-Val-Ala-c[Asp-Pro-Arg-Arg-Trp-Trp-Arg-Phe-Lys]-D-Phe-D-Val-NH2 1736 TCAM1733 Val-Arg-Leu-Ile-Val-Ala-c[Asp-Pro-Arg-Arg-Trp-Trp-Tyr-Phe-Lys]-D-Val-D-Pro-NH2 1737 TCAM1734 Val-Arg-Leu-Ile-Val-Ala-c[Asp-Pro-Arg-Arg-Trp-Trp-Tyr-Phe-Lys]-D-Val-D-Phe-NH2 1738 TCAM1735 Val-Arg-Leu-Ile-Val-Ala-c[Asp-Pro-Arg-Arg-Trp-Trp-Tyr-Phe-Lys]-D-Pro-D-Val-NH2 1739 TCAM1736 Val-Arg-Leu-Ile-Val-Ala-c[Asp-Pro-Arg-Arg-Trp-Trp-Tyr-Phe-Lys]-D-Phe-D-Val-NH2 1740 TCAM1737 Val-Arg-Leu-Ile-Val-Ala-c[Asp-Pro-Arg-Arg-Tyr-Tyr-Arg-Phe-Lys]-D-Val-D-Pro-NH2 1741 TCAM1738 Val-Arg-Leu-Ile-Val-Ala-c[Asp-Pro-Arg-Arg-Tyr-Tyr-Arg-Phe-Lys]-D-Val-D-Phe-NH2 1742 TCAM1739 Val-Arg-Leu-Ile-Val-Ala-c[Asp-Pro-Arg-Arg-Tyr-Tyr-Arg-Phe-Lys]-D-Pro-D-Val-NH2 1743 TCAM1740 Val-Arg-Leu-Ile-Val-Ala-c[Asp-Pro-Arg-Arg-Tyr-Tyr-Arg-Phe-Lys]-D-Phe-D-Val-NH2 1744 TCAM1741 Val-Arg-Leu-Ile-Val-Ala-c[Asp-Pro-Arg-Arg-Nal-Nal-Arg-Phe-Lys]-D-Val-D-Pro-NH2 1745 TCAM1742 Val-Arg-Leu-Ile-Val-Ala-c[Asp-Pro-Arg-Arg-Nal-Nal-Arg-Phe-Lys]-D-Val-D-Phe-NH2 1746 TCAM1743 Val-Arg-Leu-Ile-Val-Ala-c[Asp-Pro-Arg-Arg-Nal-Nal-Arg-Phe-Lys]-D-Pro-D-Val-NH2 1747 TCAM1744 Val-Arg-Leu-Ile-Val-Ala-c[Asp-Pro-Arg-Arg-Nal-Nal-Arg-Phe-Lys]-D-Phe-D-Val-NH2 1748 TCAM1745 Val-Arg-Leu-Ile-Val-Ala-c[Asp-Pro-Arg-Arg-Leu-Trp-Leu-Trp-Lys]-D-Val-D-Pro-NH2 1749 TCAM1746 Val-Arg-Leu-Ile-Val-Ala-c[Asp-Pro-Arg-Arg-Leu-Trp-Leu-Trp-Lys]-D-Val-D-Phe-NH2 1750 TCAM1747 Val-Arg-Leu-Ile-Val-Ala-c[Asp-Pro-Arg-Arg-Leu-Trp-Leu-Trp-Lys]-D-Pro-D-Val-NH2 1751 TCAM1748 Val-Arg-Leu-Ile-Val-Ala-c[Asp-Pro-Arg-Arg-Leu-Trp-Leu-Trp-Lys]-D-Phe-D-Val-NH2 1752 TCAM1749 Val-Arg-Leu-Ile-Val-Ala-c[Asp-Pro-Arg-Arg-Leu-Trp-Leu-Trp-Lys]-D-Val-D-Pro-NH2 1753 TCAM1750 Val-Arg-Leu-Ile-Val-Ala-c[Asp-Pro-Arg-Arg-Leu-Trp-Leu-Trp-Lys]-D-Val-D-Phe-NH2 1754 TCAM1751 Val-Arg-Leu-Ile-Val-Ala-c[Asp-Pro-Arg-Arg-Leu-Trp-Leu-Trp-Lys]-D-Pro-D-Val-NH2 1755 TCAM1752 Val-Arg-Leu-Ile-Val-Ala-c[Asp-Pro-Arg-Arg-Leu-Trp-Leu-Trp-Lys]-D-Phe-D-Val-NH2 1756 TCAM1753 Val-Arg-Leu-Ile-Val-Ala-c[Asp-Arg-Arg-Arg-Trp-Leu-Trp-Leu-Trp-Lys]-D-Val-D-Pro- NH2 1757 TCAM1754 Val-Arg-Leu-Ile-Val-Ala-c[Asp-Pro-Arg-Arg-Arg-Trp-Leu-Trp-Leu-Trp-Lys]-D-Val-D- Phe-NH2 1758 TCAM1755 Val-Arg-Leu-Ile-Val-Ala-c[Asp-Pro-Arg-Arg-Arg-Trp-Leu-Trp-Leu-Trp-Lys]-D-Pro-D- Val-NH2 1759 TCAM1756 Val-Arg-Leu-Ile-Val-Ala-c[Asp-Pro-Arg-Arg-Arg-Trp-Leu-Trp-Leu-Trp-Lys]-D-Phe-D- Val-NH2 1760 TCAM1757 Val-Arg-Leu-Ile-Val-Ala-c[Asp-Pro-Arg-Gln-Arg-Arg-Trp-Leu-Trp-Leu-Trp-Lys]-D-Val- D-Pro-NH2 1761 TCAM1758 Val-Arg-Leu-Ile-Val-Ala-c[Asp-Pro-Arg-Gln-Arg-Arg-Trp-Leu-Trp-Leu-Trp-Lys]-D-Val- D-Phe-NH2 1762 TCAM1759 Val-Arg-Leu-Ile-Val-Ala-c[Asp-Pro-Arg-Gln-Arg-Arg-Trp-Leu-Trp-Leu-Trp-Lys]-D-Pro- D-Val-NH2 1763 TCAM1760 Val-Arg-Leu-Ile-Val-Ala-c[Asp-Pro-Arg-Gln-Arg-Arg-Trp-Leu-Trp-Leu-Trp-Lys]-D-Phe- D-Val-NH2 1764 TCAM1761 Val-Arg-Leu-Ile-Val-Ala-c[Asp-Pro-Trp-Arg-Trp-Trp-Arg-Arg-Lys]-D-Val-D-Phe-NH2 1765 TCAM1762 Val-Arg-Leu-Ile-Val-Ala-c[Asp-Pro-Trp-Arg-Trp-Trp-Arg-Arg-Lys]-D-Pro-D-Val-NH2 1766 TCAM1763 Val-Arg-Leu-Ile-Val-Ala-c[Asp-Pro-Trp-Arg-Trp-Trp-Arg-Arg-Lys]-D-Phe-D-Val-NH2 1767 TCAM1764 Val-Arg-Leu-Ile-Val-Ala-c[Asp-Pro-Trp-Trp-Arg-Arg-Trp-Trp-Arg-Arg-Lys]-D-Val-D- Pro-NH2 1768 TCAM1765 Val-Arg-Leu-Ile-Val-Ala-c[Asp-Pro-Trp-Trp-Arg-Arg-Trp-Trp-Arg-Arg-Lys]-D-Val-D- Phe-NH2 1769 TCAM1766 Val-Arg-Leu-Ile-Val-Ala-c[Asp-Pro-Trp-Trp-Arg-Arg-Trp-Trp-Arg-Arg-Lys]-D-Pro-D- Val-NH2 1770 TCAM1767 Val-Arg-Leu-lle-Val-Ala-c[Asp-Pro-Trp-Trp-Arg-Arg-Trp-Trp-Arg-Arg-Lys]-D-Phe-D- Val-NH2 1771 TCAM1768 Val-Arg-Leu-Ile-Val-Ala-c[Asp-Pro-Trp-Arg-Trp-Arg-Trp-Arg-Lys]-D-Val-D-Pro-NH2 1772 TCAM1769 Val-Arg-Leu-Ile-Val-Ala-c[Asp-Pro-Trp-Arg-Trp-Arg-Trp-Arg-Lys]-D-Val-D-Phe-NH2 1773 TCAM1770 Val-Arg-Leu-Ile-Val-Ala-c[Asp-Pro-Trp-Arg-Trp-Arg-Trp-Arg-Lys]-D-Pro-D-Val-NH2 1774 TCAM1771 Val-Arg-Leu-Ile-Val-Ala-c[Asp-Pro-Trp-Arg-Trp-Arg-Trp-Arg-Lys]-D-Phe-D-Val-NH2 1775 TCAM1772 Val-Arg-Leu-Ile-Val-Ala-c[Asp-Pro-Arg-Trp-Arg-Trp-Arg-Trp-Lys]-D-Val-D-Pro-NH2 1776 TCAM1773 Val-Arg-Leu-Ile-Val-Ala-c[Asp-Pro-Arg-Trp-Arg-Trp-Arg-Trp-Lys]-D-Val-D-Phe-NH2 1777 TCAM1774 Val-Arg-Leu-Ile-Val-Ala-c[Asp-Pro-Arg-Trp-Arg-Trp-Arg-Trp-Lys]-D-Pro-D-Val-NH2 1778 TCAM1775 Val-Arg-Leu-Ile-Val-Ala-c[Asp-Pro-Arg-Trp-Arg-Trp-Arg-Trp-Lys]-D-Phe-D-Val-NH2 1779 TCAM1776 Val-Arg-Leu-Ile-Val-Ala-c[Asp-Pro-Arg-Trp-Trp-Arg-Arg-Lys]-D-Val-D-Pro-NH2 1780 TCAM1777 Val-Arg-Leu-Ile-Val-Ala-c[Asp-Pro-Arg-Trp-Trp-Arg-Arg-Lys]-D-Val-D-Phe-NH2 1781 TCAM1778 Val-Arg-Leu-Ile-Val-Ala-c[Asp-Pro-Arg-Trp-Trp-Arg-Arg-Lys]-D-Pro-D-Val-NH2 1782 TCAM1779 Val-Arg-Leu-Ile-Val-Ala-c[Asp-Pro-Arg-Trp-Trp-Arg-Arg-Lys]-D-Phe-D-Val-NH2 1783 TCAM1780 Val-Arg-Leu-Ile-Val-Ala-c[Asp-Pro-Trp-Trp-Arg-Arg-Trp-Lys]-D-Val-D-Pro-NH2 1784 TCAM1781 Val-Arg-Leu-Ile-Val-Ala-c[Asp-Pro-Trp-Trp-Arg-Arg-Trp-Lys]-D-Val-D-Phe-NH2 1785 TCAM1782 Val-Arg-Leu-Ile-Val-Ala-c[Asp-Pro-Trp-Trp-Arg-Arg-Trp-Lys]-D-Pro-D-Val-NH2 1786 TCAM1783 Val-Arg-Leu-Ile-Val-Ala-c[Asp-Pro-Trp-Trp-Arg-Arg-Trp-Lys]-D-Phe-D-Val-NH2 1787 TCAM1784 Val-Arg-Leu-Ile-Val-Ala-c[Asp-Pro-Trp-Arg-Trp-Arg-Trp-Lys]-D-Val-D-Pro-NH2 1788 TCAM1785 Val-Arg-Leu-Ile-Val-Ala-c[Asp-Pro-Trp-Arg-Trp-Arg-Trp-Lys]-D-Val-D-Phe-NH2 1789 TCAM1786 Val-Arg-Leu-Ile-Val-Ala-c[Asp-Pro-Trp-Arg-Trp-Arg-Trp-Lys]-D-Pro-D-Val-NH2 1790 TCAM1787 Val-Arg-Leu-Ile-Val-Ala-c[Asp-Pro-Trp-Arg-Trp-Arg-Trp-Lys]-D-Phe-D-Val-NH2 1791 TCAM1788 Val-Arg-Leu-Ile-Val-Ala-c[Asp-Pro-Arg-Trp-Arg-Trp-Arg-Lys]-D-Val-D-Pro-NH2 1792 TCAM1789 Val-Arg-Leu-Ile-Val-Ala-c[Asp-Pro-Arg-Trp-Arg-Trp-Arg-Lys]-D-Val-D-Phe-NH2 1793 TCAM1790 Val-Arg-Leu-Ile-Val-Ala-c[Asp-Pro-Arg-Trp-Arg-Trp-Arg-Lys]-D-Pro-D-Val-NH2 1794 TCAM1791 Val-Arg-Leu-Ile-Val-Ala-c[Asp-Pro-Arg-Trp-Arg-Trp-Arg-Lys]-D-Phe-D-Val-NH2 1795 TCAM1792 Val-Arg-Leu-Ile-Val-Ala-c[Asp-Pro-Trp-Arg-Tyr-Arg-Trp-Lys]-D-Val-D-Pro-NH2 1796 TCAM1793 Val-Arg-Leu-Ile-Val-Ala-c[Asp-Pro-Trp-Arg-Tyr-Arg-Trp-Lys]-D-Val-D-Phe-NH2 1797 TCAM1794 Val-Arg-Leu-Ile-Val-Ala-c[Asp-Pro-Trp-Arg-Tyr-Arg-Trp-Lys]-D-Pro-D-Val-NH2 1798 TCAM1795 Val-Arg-Leu-Ile-Val-Ala-c[Asp-Pro-Trp-Arg-Tyr-Arg-Trp-Lys]-D-Phe-D-Val-NH2 1799 TCAM1796 Val-Arg-Leu-Ile-Val-Ala-c[Asp-Pro-Trp-Arg-Trp-Arg-Tyr-Lys]-D-Val-D-Pro-NH2 1800 TCAM1797 Val-Arg-Leu-Ile-Val-Ala-c[Asp-Pro-Trp-Arg-Trp-Arg-Tyr-Lys]-D-Val-D-Phe-NH2 1801 TCAM1798 Val-Arg-Leu-Ile-Val-Ala-c[Asp-Pro-Trp-Arg-Trp-Arg-Tyr-Lys]-D-Pro-D-Val-NH2 1802 TCAM1799 Val-Arg-Leu-Ile-Val-Ala-c[Asp-Pro-Trp-Arg-Trp-Arg-Tyr-Lys]-D-Phe-D-Val-NH2 1803 TCAM1800 Val-Arg-Leu-Ile-Val-Ala-c[Asp-Pro-Trp-Arg-Trp-Arg-Lys]-D-Val-D-Pro-NH2 1804 TCAM1801 Val-Arg-Leu-Ile-Val-Ala-c[Asp-Pro-Trp-Arg-Trp-Arg-Lys]-D-Val-D-Phe-NH2 1805 TCAM1802 Val-Arg-Leu-Ile-Val-Ala-c[Asp-Pro-Trp-Arg-Trp-Arg-Lys]-D-Pro-D-Val-NH2 1806 TCAM1803 Val-Arg-Leu-Ile-Val-Ala-c[Asp-Pro-Trp-Arg-Trp-Arg-Lys]-D-Phe-D-Val-NH2 1807 TCAM1804 Val-Arg-Leu-Ile-Val-Ala-c[Asp-Pro-Trp-Arg-Arg-Trp-Lys]-D-Val-D-Pro-NH2 1808 TCAM1805 Val-Arg-Leu-Ile-Val-Ala-c[Asp-Pro-Trp-Arg-Arg-Trp-Lys]-D-Val-D-Phe-NH2 1809 TCAM1806 Val-Arg-Leu-Ile-Val-Ala-c[Asp-Pro-Trp-Arg-Arg-Trp-Lys]-D-Pro-D-Val-NH2 1810 TCAM1807 Val-Arg-Leu-Ile-Val-Ala-c[Asp-Pro-Trp-Arg-Arg-Trp-Lys]-D-Phe-D-Val-NH2 1811 TCAM1808 Val-Arg-Leu-Ile-Val-Ala-c[Asp-Pro-Arg-Trp-Trp-Arg-Lys]-D-Val-D-Pro-NH2 1812 TCAM1809 Val-Arg-Leu-Ile-Val-Ala-c[Asp-Pro-Arg-Trp-Trp-Arg-Lys]-D-Val-D-Phe-NH2 1813 TCAM1810 Val-Arg-Leu-Ile-Val-Ala-c[Asp-Pro-Arg-Trp-Trp-Arg-Lys]-D-Pro-D-Val-NH2 1814 TCAM1811 Val-Arg-Leu-Ile-Val-Ala-c[Asp-Pro-Arg-Trp-Trp-Arg-Lys]-D-Phe-D-Val-NH2 1815 TCAM1812 Val-Arg-Leu-Ile-Val-Ala-c[Asp-Pro-Trp-Arg-Trp-Lys]-D-Val-D-Pro-NH2 1816 TCAM1813 Val-Arg-Leu-Ile-Val-Ala-c[Asp-Pro-Trp-Arg-Trp-Lys]-D-Val-D-Phe-NH2 1817 TCAM1814 Val-Arg-Leu-Ile-Val-Ala-c[Asp-Pro-Trp-Arg-Trp-Lys]-D-Pro-D-Val-NH2 1818 TCAM1815 Val-Arg-Leu-Ile-Val-Ala-c[Asp-Pro-Trp-Arg-Trp-Lys]-D-Phe-D-Val-NH2 1819 TCAM1816 Val-Arg-Leu-Ile-Val-Ala-c[Asp-Pro-Arg-Trp-Arg-Lys]-D-Val-D-Pro-NH2 1820 TCAM1817 Val-Arg-Leu-Ile-Val-Ala-c[Asp-Pro-Arg-Trp-Arg-Lys]-D-Val-D-Phe-NH2 1821 TCAM1818 Val-Arg-Leu-Ile-Val-Ala-c[Asp-Pro-Arg-Trp-Arg-Lys]-D-Pro-D-Val-NH2 1822 TCAM1819 Val-Arg-Leu-Ile-Val-Ala-c[Asp-Pro-Arg-Trp-Arg-Lys]-D-Phe-D-Val-NH2 1823 TCAM1820 -Val-Arg-Leu-Ile-Val-Ala-c[Asp-Arg-Arg-Trp-Trp-Arg-Phe-Lys]-D-Val-D-Pro-NH2 1824 TCAM1821 Val-Arg-Leu-Ile-Val-Ala-c[Asp-Arg-Arg-Trp-Trp-Arg-Phe-Lys]-D-Val-D-Phe-NH2 1825 TCAM1822 Val-Arg-Leu-Ile-Val-Ala-c[Asp-Arg-Arg-Trp-Trp-Arg-Phe-Lys]-D-Pro-D-Val-NH2 1826 TCAM1823 Val-Arg-Leu-Ile-Val-Ala-c[Asp-Arg-Arg-Trp-Trp-Arg-Phe-Lys]-D-Phe-D-Val-NH2 1827 TCAM1824 Val-Arg-Leu-Ile-Val-Ala-c[Asp-Arg-Arg-Trp-Trp-Arg-Phe-Lys]-D-Val-D-Pro-NH2 1828 TCAM1825 Val-Arg-Leu-Ile-Val-Ala-c[Asp-Arg-Arg-Trp-Trp-Arg-Phe-Lys]-D-Val-D-Phe-NH2 1829 TCAM1826 Val-Arg-Leu-Ile-Val-Ala-c[Asp-Arg-Arg-Trp-Trp-Arg-Phe-Lys]-D-Pro-D-Val-NH2 1830 TCAM1827 Val-Arg-Leu-Ile-Val-Ala-c[Asp-Arg-Arg-Trp-Trp-Arg-Phe-Lys]-D-Phe-D-Val-NH2 1831 TCAM1828 Val-Arg-Leu-Ile-Val-Ala-c[Asp-Arg-Arg-Tyr-Tyr-Arg-Phe-Lys]-D-Val-D-Pro-NH2 1832 TCAM1829 Val-Arg-Leu-Ile-Val-Ala-c[Asp-Arg-Arg-Tyr-Tyr-Arg-Phe-Lys]-D-Val-D-Phe-NH2 1833 TCAM1830 Val-Arg-Leu-Ile-Val-Ala-c[Asp-Arg-Arg-Tyr-Tyr-Arg-Phe-Lys]-D-Pro-D-Val-NH2 1834 TCAM1831 Val-Arg-Leu-Ile-Val-Ala-c[Asp-Arg-Arg-Tyr-Tyr-Arg-Phe-Lys]-D-Phe-D-Val-NH2 1835 TCAM1832 Val-Arg-Leu-Ile-Val-Ala-c[Asp-Arg-Arg-Nal-Nal-Arg-Phe-Lys]-D-Val-D-Pro-NH2 1836 TCAM1833 Val-Arg-Leu-Ile-Val-Ala-c[Asp-Arg-Arg-Nal-Nal-Arg-Phe-Lys]-D-Val-D-Phe-NH2 1837 TCAM1834 Val-Arg-Leu-Ile-Val-Ala-c[Asp-Arg-Arg-Nal-Nal-Arg-Phe-Lys]-D-Pro-D-Val-NH2 1838 TCAM1835 Val-Arg-Leu-Ile-Val-Ala-c[Asp-Arg-Arg-Nal-Nal-Arg-Phe-Lys]-D-Phe-D-Val-NH2 1839 TCAM1836 Val-Arg-Leu-Ile-Val-Ala-c[Asp-Arg-Arg-Leu-Trp-Leu-Trp-Lys]-D-Val-D-Pro-NH2 1840 TCAM1837 Val-Arg-Leu-Ile-Val-Ala-c[Asp-Arg-Arg-Leu-Trp-Leu-Trp-Lys]-D-Val-D-Phe-NH2 1841 TCAM1838 Val-Arg-Leu-Ile-Val-Ala-c[Asp-Arg-Arg-Leu-Trp-Leu-Trp-Lys]-D-Pro-D-Val-NH2 1842 TCAM1839 Val-Arg-Leu-Ile-Val-Ala-c[Asp-Arg-Arg-Leu-Trp-Leu-Trp-Lys]-D-Phe-D-Val-NH2 1843 TCAM1840 Val-Arg-Leu-Ile-Val-Ala-c[Asp-Arg-Arg-Leu-Trp-Leu-Trp-Lys]-D-Val-D-Pro-NH2 1844 TCAM1841 Val-Arg-Leu-Ile-Val-Ala-c[Asp-Arg-Arg-Leu-Trp-Leu-Trp-Lys]-D-Val-D-Phe-NH2 1845 TCAM1842 Val-Arg-Leu-Ile-Val-Ala-c[Asp-Arg-Arg-Leu-Trp-Leu-Trp-Lys]-D-Pro-D-Val-NH2 1846 TCAM1843 Val-Arg-Leu-Ile-Val-Ala-c[Asp-Arg-Arg-Leu-Trp-Leu-Trp-Lys]-D-Phe-D-Val-NH2 1847 TCAM1844 Val-Arg-Leu-Ile-Val-Ala-c[Asp-Arg-Arg-Arg-Trp-Leu-Trp-Leu-Trp-Lys]-D-Val-D-Pro- NH2 1848 TCAM1845 Val-Arg-Leu-Ile-Val-Ala-c[Asp-Arg-Arg-Arg-Trp-Leu-Trp-Leu-Trp-Lys]-D-Val-D-Phe- NH2 1849 TCAM1846 Val-Arg-Leu-Ile-Val-Ala-c[Asp-Arg-Arg-Arg-Trp-Leu-Trp-Leu-Trp-Lys]-D-Pro-D-Val- NH2 1850 TCAM1847 Val-Arg-Leu-Ile-Val-Ala-c[Asp-Arg-Arg-Arg-Trp-Leu-Trp-Leu-Trp-Lys]-D-Phe-D-Val- NH2 1851 TCAM1848 Val-Arg-Leu-Ile-Val-Ala-c[Asp-Arg-Gln-Arg-Arg-Trp-Leu-Trp-Leu-Trp-Lys]-D-Val-D- Pro-NH2 1852 TCAM1849 Val-Arg-Leu-Ile-Val-Ala-c[Asp-Arg-Gln-Arg-Arg-Trp-Leu-Trp-Leu-Trp-Lys]-D-Val-D- Phe-NH2 1853 TCAM1850 Val-Arg-Leu-Ile-Val-Ala-c[Asp-Arg-Gln-Arg-Arg-Trp-Leu-Trp-Leu-Trp-Lys]-D-Pro-D- Val-NH2 1854 TCAM1851 Val-Arg-Leu-Ile-Val-Ala-c[Asp-Arg-Gln-Arg-Arg-Trp-Leu-Trp-Leu-Trp-Lys]-D-Phe-D- Val-NH2 1855 TCAM1852 Val-Arg-Leu-Ile-Val-Ala-c[Asp-Trp-Arg-Trp-Trp-Arg-Arg-Lys]-D-Val-D-Pro-NH2 1856 TCAM1853 Val-Arg-Leu-Ile-Val-Ala-c[Asp-Trp-Arg-Trp-Trp-Arg-Arg-Lys]-D-Val-D-Phe-NH2 1857 TCAM1854 Val-Arg-Leu-Ile-Val-Ala-c[Asp-Trp-Arg-Trp-Trp-Arg-Arg-Lys]-D-Pro-D-Val-NH2 1858 TCAM1855 Val-Arg-Leu-Ile-Val-Ala-c[Asp-Trp-Arg-Trp-Trp-Arg-Arg-Lys]-D-Phe-D-Val-NH2 1859 TCAM1856 Val-Arg-Leu-Ile-Val-Ala-c[Asp-Trp-Trp-Arg-Arg-Trp-Trp-Arg-Arg-Lys]-D-Val-D-Pro- NH2 1860 TCAM1857 Val-Arg-Leu-Ile-Val-Ala-c[Asp-Trp-Trp-Arg-Arg-Trp-Trp-Arg-Arg-Lys]-D-Val-D-Phe- NH2 1861 TCAM1858 Val-Arg-Leu-Ile-Val-Ala-c[Asp-Trp-Trp-Arg-Arg-Trp-Trp-Arg-Arg-Lys]-D-Pro-D-Val- NH2 1862 TCAM1859 Val-Arg-Leu-Ile-Val-Ala-c[Asp-Trp-Trp-Arg-Arg-Trp-Trp-Arg-Arg-Lys]-D-Phe-D-Val- NH2 1863 TCAM1860 Val-Arg-Leu-Ile-Val-Ala-c[Asp-Trp-Arg-Trp-Arg-Trp-Arg-Lys]-D-Val-D-Pro-NH2 1864 TCAM1861 Val-Arg-Leu-Ile-Val-Ala-c[Asp-Trp-Arg-Trp-Arg-Trp-Arg-Lys]-D-Val-D-Phe-NH2 1865 TCAM1862 Val-Arg-Leu-Ile-Val-Ala-c[Asp-Trp-Arg-Trp-Arg-Trp-Arg-Lys]-D-Pro-D-Val-NH2 1866 TCAM1863 Val-Arg-Leu-Ile-Val-Ala-c[Asp-Trp-Arg-Trp-Arg-Trp-Arg-Lys]-D-Phe-D-Val-NH2 1867 TCAM1864 Val-Arg-Leu-Ile-Val-Ala-c[Asp-Arg-Trp-Arg-Trp-Arg-Trp-Lys]-D-Val-D-Pro-NH2 1868 TCAM1865 Val-Arg-Leu-Ile-Val-Ala-c[Asp-Arg-Trp-Arg-Trp-Arg-Trp-Lys]-D-Val-D-Phe-NH2 1869 TCAM1866 Val-Arg-Leu-Ile-Val-Ala-c[Asp-Arg-Trp-Arg-Trp-Arg-Trp-Lys]-D-Pro-D-Val-NH2 1870 TCAM1867 Val-Arg-Leu-Ile-Val-Ala-c[Asp-Arg-Trp-Arg-Trp-Arg-Trp-Lys]-D-Phe-D-Val-NH2 1871 TCAM1868 Val-Arg-Leu-Ile-Val-Ala-c[Asp-Arg-Trp-Trp-Arg-Arg-Lys]-D-Val-D-Pro-NH2 1872 TCAM1869 Val-Arg-Leu-Ile-Val-Ala-c[Asp-Arg-Trp-Trp-Arg-Arg-Lys]-D-Val-D-Phe-NH2 1873 TCAM1870 Val-Arg-Leu-Ile-Val-Ala-c[Asp-Arg-Trp-Trp-Arg-Arg-Lys]-D-Pro-D-Val-NH2 1874 TCAM1871 Val-Arg-Leu-Ile-Val-Ala-c[Asp-Arg-Trp-Trp-Arg-Arg-Lys]-D-Phe-D-Val-NH2 1875 TCAM1872 Val-Arg-Leu-Ile-Val-Ala-c[Asp-Arg-Trp-Arg-Trp-Arg-Lys]-D-Val-D-Pro-NH2 1876 TCAM1873 Val-Arg-Leu-Ile-Val-Ala-c[Asp-Arg-Trp-Arg-Trp-Arg-Lys]-D-Val-D-Phe-NH2 1877 TCAM1874 Val-Arg-Leu-Ile-Val-Ala-c[Asp-Arg-Trp-Arg-Trp-Arg-Lys]-D-Pro-D-Val-NH2 1878 TCAM1875 Val-Arg-Leu-Ile-Val-Ala-c[Asp-Arg-Trp-Arg-Trp-Arg-Lys]-D-Phe-D-Val-NH2 1879 TCAM1876 Val-Arg-Leu-Ile-Val-Ala-c[Asp-Trp-Trp-Arg-Arg-Trp-Lys]-D-Val-D-Pro-NH2 1880 TCAM1877 Val-Arg-Leu-Ile-Val-Ala-c[Asp-Trp-Trp-Arg-Arg-Trp-Lys]-D-Val-D-Phe-NH2 1881 TCAM1878 Val-Arg-Leu-Ile-Val-Ala-c[Asp-Trp-Trp-Arg-Arg-Trp-Lys]-D-Pro-D-Val-NH2 1882 TCAM1879 Val-Arg-Leu-Ile-Val-Ala-c[Asp-Trp-Trp-Arg-Arg-Trp-Lys]-D-Phe-D-Val-NH2 1883 TCAM1880 Val-Arg-Leu-Ile-Val-Ala-c[Asp-Trp-Arg-Trp-Arg-Trp-Lys]-D-Val-D-Pro-NH2 1884 TCAM1881 Val-Arg-Leu-Ile-Val-Ala-c[Asp-Trp-Arg-Trp-Arg-Trp-Lys]-D-Val-D-Phe-NH2 1885 TCAM1882 Val-Arg-Leu-Ile-Val-Ala-c[Asp-Trp-Arg-Trp-Arg-Trp-Lys]-D-Pro-D-Val-NH2 1886 TCAM1883 Val-Arg-Leu-Ile-Val-Ala-c[Asp-Trp-Arg-Trp-Arg-Trp-Lys]-D-Phe-D-Val-NH2 1887 TCAM1884 Val-Arg-Leu-Ile-Val-Ala-c[Asp-Trp-Arg-Tyr-Arg-Trp-Lys]-D-Val-D-Pro-NH2 1888 TCAM1885 Val-Arg-Leu-Ile-Val-Ala-c[Asp-Trp-Arg-Tyr-Arg-Trp-Lys]-D-Val-D-Phe-NH2 1889 TCAM1886 Val-Arg-Leu-Ile-Val-Ala-c[Asp-Trp-Arg-Tyr-Arg-Trp-Lys]-D-Pro-D-Val-NH2 1890 TCAM1887 Val-Arg-Leu-Ile-Val-Ala-c[Asp-Trp-Arg-Tyr-Arg-Trp-Lys]-D-Phe-D-Val-NH2 1891 TCAM1888 Val-Arg-Leu-Ile-Val-Ala-c[Asp-Trp-Arg-Trp-Arg-Tyr-Lys]-D-Val-D-Pro-NH2 1892 TCAM1889 Val-Arg-Leu-Ile-Val-Ala-c[Asp-Trp-Arg-Trp-Arg-Tyr-Lys]-D-Val-D-Phe-NH2 1893 TCAM1890 Val-Arg-Leu-Ile-Val-Ala-c[Asp-Trp-Arg-Trp-Arg-Tyr-Lys]-D-Pro-D-Val-NH2 1894 TCAM1891 Val-Arg-Leu-Ile-Val-Ala-c[Asp-Trp-Arg-Trp-Arg-Tyr-Lys]-D-Phe-D-Val-NH2 1895 TCAM1892 Val-Arg-Leu-Ile-Val-Ala-c[Asp-Trp-Arg-Trp-Arg-Lys]-D-Val-D-Pro-NH2 1896 TCAM1893 Val-Arg-Leu-Ile-Val-Ala-c[Asp-Trp-Arg-Trp-Arg-Lys]-D-Val-D-Phe-NH2 1897 TCAM1894 Val-Arg-Leu-Ile-Val-Ala-c[Asp-Trp-Arg-Trp-Arg-Lys]-D-Pro-D-Val-NH2 1898 TCAM1895 Val-Arg-Leu-Ile-Val-Ala-c[Asp-Trp-Arg-Trp-Arg-Lys]-D-Phe-D-Val-NH2 1899 TCAM1896 Val-Arg-Leu-Ile-Val-Ala-c[Asp-Trp-Arg-Arg-Trp-Lys]-D-Val-D-Pro-NH2 1900 TCAM1897 Val-Arg-Leu-Ile-Val-Ala-c[Asp-Trp-Arg-Arg-Trp-Lys]-D-Val-D-Phe-NH2 1901 TCAM1898 Val-Arg-Leu-Ile-Val-Ala-c[Asp-Trp-Arg-Arg-Trp-Lys]-D-Pro-D-Val-NH2 1902 TCAM1899 Val-Arg-Leu-Ile-Val-Ala-c[Asp-Trp-Arg-Arg-Trp-Lys]-D-Phe-D-Val-NH2 1903 TCAM1900 Val-Arg-Leu-Ile-Val-Ala-c[Asp-Arg-Trp-Trp-Arg-Lys]-D-Val-D-Pro-NH2 1904 TCAM1901 Val-Arg-Leu-Ile-Val-Ala-c[Asp-Arg-Trp-Trp-Arg-Lys]-D-Val-D-Phe-NH2 1905 TCAM1902 Val-Arg-Leu-Ile-Val-Ala-c[Asp-Arg-Trp-Trp-Arg-Lys]-D-Pro-D-Val-NH2 1906 TCAM1903 Val-Arg-Leu-Ile-Val-Ala-c[Asp-Arg-Trp-Trp-Arg-Lys]-D-Phe-D-Val-NH2 1907 TCAM1904 Val-Arg-Leu-Ile-Val-Ala-c[Asp-Trp-Arg-Trp-Lys]-D-Val-D-Pro-NH2 1908 TCAM1905 Val-Arg-Leu-Ile-Val-Ala-c[Asp-Trp-Arg-Trp-Lys]-D-Val-D-Phe-NH2 1909 TCAM1906 Val-Arg-Leu-Ile-Val-Ala-c[Asp-Trp-Arg-Trp-Lys]-D-Pro-D-Val-NH2 1910 TCAM1907 Val-Arg-Leu-Ile-Val-Ala-c[Asp-Trp-Arg-Trp-Lys]-D-Phe-D-Val-NH2 1911 TCAM1908 Val-Arg-Leu-Ile-Val-Ala-c[Asp-Arg-Trp-Arg-Lys]-D-Val-D-Pro-NH2 1912 TCAM1909 Val-Arg-Leu-Ile-Val-Ala-c[Asp-Arg-Trp-Arg-Lys]-D-Val-D-Phe-NH2 1913 TCAM1910 Val-Arg-Leu-Ile-Val-Ala-c[Asp-Arg-Trp-Arg-Lys]-D-Pro-D-Val-NH2 1914 TCAM1911 Val-Arg-Leu-Ile-Val-Ala-c[Asp-Arg-Trp-Arg-Lys]-D-Phe-D-Val-NH2 1915 TCAM1912 Val-Arg-Leu-Ile-Val-Ala-c[Asp-His-D-Nal(2′)-Arg-Trp-Lys]-D-Val-D-Pro-NH2 1916 TCAM1913 Val-Arg-Leu-Ile-Val-Ala-c[Asp-His-D-Nal(2′)-Arg-Trp-Lys]-D-Pro-D-Val-NH2 1917 TCAM1914 Val-Arg-Leu-Ile-Val-Ala-c[Asp-His-D-Nal(2′)-Arg-Trp-Lys]-D-Val-D-Phe-NH2 1918 TCAM1915 Val-Arg-Leu-Ile-Val-Ala-c[Asp-His-D-Nal(2′)-Arg-Trp-Lys]-D-Phe-D-Val-NH2 1919 TCAM1916 Val-Arg-Leu-Ile-Val-Ala-c[Asp-Pro-D-Nal(2′)-Arg-Trp-Lys]-D-Val-D-Pro-NH2 1920 TCAM1917 Val-Arg-Leu-Ile-Val-Ala-c[Asp-Pro-D-Nal(2′)-Arg-Trp-Lys]-D-Pro-D-Val-NH2 1921 TCAM1918 Val-Arg-Leu-Ile-Val-Ala-c[Asp-Pro-D-Nal(2′)-Arg-Trp-Lys]-D-Val-D-Phe-NH2 1922 TCAM1919 Val-Arg-Leu-Ile-Val-Ala-c[Asp-Pro-D-Nal(2′)-Arg-Trp-Lys]-D-Phe-D-Val-NH2 1923 TCAM1920 Val-Arg-Leu-Ile-Val-Ala-c[Asp-Arg-Arg-Nal(2′)-Arg-Trp-Lys]-D-Val-D-Pro-NH2 1924 TCAM1921 Val-Arg-Leu-Ile-Val-Ala-c[Asp-Arg-Arg-Nal(2′)-Arg-Trp-Lys]-D-Pro-D-Val-NH2 1925 TCAM1922 Val-Arg-Leu-Ile-Val-Ala-c[Asp-Arg-Arg-Nal(2′)-Arg-Trp-Lys]-D-Val-D-Phe-NH2 1926 TCAM1923 Val-Arg-Leu-Ile-Val-Ala-c[Asp-Arg-Arg-Nal(2′)-Arg-Trp-Lys]-D-Phe-D-Val-NH2 1927 TCAM1924 Val-Arg-Leu-Ile-Val-Ala-c[Asp-Arg-Arg-Pro-Nal(2′)-Arg-Trp-Lys]-D-Val-D-Pro-NH2 1928 TCAM1925 Val-Arg-Leu-Ile-Val-Ala-c[Asp-Arg-Arg-Pro-D-Nal(2′)-Arg-Trp-Lys]-D-Pro-D-Val-NH2 1929 TCAM1926 Val-Arg-Leu-Ile-Val-Ala-c[Asp-Arg-Arg-Pro-D-Nal(2′)-Arg-Trp-Lys]-D-Val-D-Phe-NH2 1930 TCAM1927 Val-Arg-Leu-Ile-Val-Ala-c[Asp-Arg-Arg-Pro-Nal(2′)-Arg-Trp-Lys]-D-Phe-D-Val-NH2 1931 TCAM1928 Val-Arg-Leu-Ile-Val-Ala-c[Asp-Arg-D-Nal(2′)-Arg-Trp-Lys]-D-Val-D-Pro-NH2 1932 TCAM1929 Val-Arg-Leu-Ile-Val-Ala-c[Asp-Arg-D-Nal(2′)-Arg-Trp-Lys]-D-Pro-D-Val-NH2 1933 TCAM1930 Val-Arg-Leu-Ile-Val-Ala-c[Asp-Arg-D-Nal(2′)-Arg-Trp-Lys]-D-Val-D-Phe-NH2 1934 TCAM1931 Val-Arg-Leu-Ile-Val-Ala-c[Asp-Arg-D-Nal(2′)-Arg-Trp-Lys]-D-Phe-D-Val-NH2 1935 TCAM1932 Val-Arg-Leu-Ile-Val-Ala-c[Asp-Arg-Pro-D-Nal(2′)-Arg-Trp-Lys]-D-Val-D-Pro-NH2 1936 TCAM1933 Val-Arg-Leu-Ile-Val-Ala-c[Asp-Arg-Pro-D-Nal(2′)-Arg-Trp-Lys]-D-Pro-D-Val-NH2 1937 TCAM1934 Val-Arg-Leu-Ile-Val-Ala-c[Asp-Arg-Pro-D-Nal(2′)-Arg-Trp-Lys]-D-Val-D-Phe-NH2 1938 TCAM1935 Val-Arg-Leu-Ile-Val-Ala-c[Asp-Arg-Pro-D-Nal(2′)-Arg-Trp-Lys]-D-Phe-D-Val-NH2 1939 TCAM1936 Val-Arg-Leu-Ile-Val-Ala-Arg-Arg-c[Asp-Pro-D-Nal(2′)-Arg-Trp-Lys]-D-Val-D-Pro-NH2 1940 TCAM1937 Val-Arg-Leu-Ile-Val-Ala-Arg-Arg-c[Asp-Pro-D-Nal(2′)-Arg-Trp-Lys]-D-Pro-D-Val-NH2 1941 TCAM1938 Val-Arg-Leu-Ile-Val-Ala-Arg-Arg-c[Asp-Pro-D-Nal(2′)-Arg-Trp-Lys]-D-Val-D-Phe-NH2 1942 TCAM1939 Val-Arg-Leu-Ile-Val-Ala-Arg-Arg-c[Asp-Pro-D-Nal(2′)-Arg-Trp-Lys]-D-Phe-D-Val-NH2 1943 TCAM1940 Val-Arg-Leu-Ile-Val-Ala-Arg-Arg-c[Asp-His-D-Nal(2′)-Arg-Trp-Lys]-D-Val-D-Pro-NH2 1944 TCAM1941 Val-Arg-Leu-Ile-Val-Ala-Arg-Arg-c[Asp-His-D-Nal(2′)-Arg-Trp-Lys]-D-Pro-D-Val-NH2 1945 TCAM1942 Val-Arg-Leu-Ile-Val-Ala-Arg-Arg-c[Asp-His-D-Nal(2′)-Arg-Trp-Lys]-D-Val-D-Phe-NH2 1946 TCAM1943 Val-Arg-Leu-Ile-Val-Ala-Arg-Arg-c[Asp-His-D-Nal(2′)-Arg-Trp-Lys]-D-Phe-D-Val-NH2 1947 TCAM1944 Val-Arg-Leu-Ile-Val-Ala-c[Asp-Arg-Pro-D-Nal(2′)-Arg-Trp-Arg-Lys]-D-Val-D-Pro-NH2 1948 TCAM1945 Val-Arg-Leu-Ile-Val-Ala-c[Asp-Arg-Pro-D-Nal(2′)-Arg-Trp-Arg-Lys]-D-Pro-D-Val-NH2 1949 TCAM1946 Val-Arg-Leu-Ile-Val-Ala-c[Asp-Arg-Pro-D-Nal(2′)-Arg-Trp-Arg-Lys]-D-Val-D-Phe-NH2 1950 TCAM1947 Val-Arg-Leu-Ile-Val-Ala-c[Asp-Arg-Pro-D-Nal(2′)-Arg-Trp-Arg-Lys]-D-Phe-D-Val-NH2 1951 TCAM1948 Val-Arg-Leu-Ile-Val-Ala-c[Asp-Arg-His-D-Nal(2′)-Arg-Trp-Arg-Lys]-D-Val-D-Pro-NH2 1952 TCAM1949 Val-Arg-Leu-Ile-Val-Ala-c[Asp-Arg-His-D-Nal(2′)-Arg-Trp-Arg-Lys]-D-Pro-D-Val-NH2 1953 TCAM1950 Val-Arg-Leu-Ile-Val-Ala-c[Asp-Arg-His-D-Nal(2′)-Arg-Trp-Arg-Lys]-D-Val-D-Phe-NH2 1954 TCAM1951 Val-Arg-Leu-Ile-Val-Ala-c[Asp-Arg-His-D-Nal(2′)-Arg-Trp-Arg-Lys]-D-Phe-D-Val-NH2 1955 TCAM1952 Val-Arg-Leu-Ile-Val-Ala-c[Asp-His-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Val-D-Phe-NH2 1956 TCAM1953 Val-Arg-Leu-Ile-Val-Ala-c[Asp-His-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Phe-D-Val-NH2 1957 TCAM1954 Val-Arg-Leu-Ile-Val-Ala-c[Asp-Pro-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Val-D-Pro-NH2 1958 TCAM1955 Val-Arg-Leu-Ile-Val-Ala-c[Asp-Pro-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Pro-D-Val-NH2 1959 TCAM1956 Val-Arg-Leu-Ile-Val-Ala-c[Asp-Pro-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Val-D-Phe-NH2 1960 TCAM1957 Val-Arg-Leu-Ile-Val-Ala-c[Asp-Pro-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Phe-D-Val-NH2 1961 TCAM1958 Val-Arg-Leu-Ile-Val-Ala-c[Asp-Arg-Arg-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Val-D-Pro-NH2 1962 TCAM1959 Val-Arg-Leu-Ile-Val-Ala-c[Asp-Arg-Arg-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Pro-D-Val-NH2 1963 TCAM1960 Val-Arg-Leu-Ile-Val-Ala-c[Asp-Arg-Arg-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Val-D-Phe-NH2 1964 TCAM1961 Val-Arg-Leu-Ile-Val-Ala-c[Asp-Arg-Arg-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Phe-D-Val-NH2 1965 TCAM1962 Val-Arg-Leu-Ile-Val-Ala-c[Asp-Arg-Arg-Pro-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Val-D-Pro- NH2 1966 TCAM1963 Val-Arg-Leu-Ile-Val-Ala-c[Asp-Arg-Arg-Pro-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Pro-D-Val- NH2 1967 TCAM1964 Val-Arg-Leu-Ile-Val-Ala-c[Asp-Arg-Arg-Pro-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Val-D-Phe- NH2 1968 TCAM1965 Val-Arg-Leu-Ile-Val-Ala-c[Asp-Arg-Arg-Pro-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Phe-D-Val- NH2 1969 TCAM1966 Val-Arg-Leu-Ile-Val-Ala-c[Asp-Arg-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Val-D-Pro-NH2 1970 TCAM1967 Val-Arg-Leu-Ile-Val-Ala-c[Asp-Arg-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Pro-D-Val-NH2 1971 TCAM1968 Val-Arg-Leu-Ile-Val-Ala-c[Asp-Arg-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Val-D-Phe-NH2 1972 TCAM1969 Val-Arg-Leu-Ile-Val-Ala-c[Asp-Arg-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Phe-D-Val-NH2 1973 TCAM1970 Val-Arg-Leu-Ile-Val-Ala-c[Asp-Arg-Pro-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Val-D-Pro-NH2 1974 TCAM1971 Val-Arg-Leu-Ile-Val-Ala-c[Asp-Arg-Pro-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Pro-D-Val-NH2 1975 TCAM1972 Val-Arg-Leu-Ile-Val-Ala-c[Asp-Arg-Pro-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Val-D-Phe-NH2 1976 TCAM1973 Val-Arg-Leu-Ile-Val-Ala-c[Asp-Arg-Pro-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Phe-D-Val-NH2 1977 TCAM1974 Val-Arg-Leu-Ile-Val-Ala-c[Asp-Arg-His-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Val-D-Pro-NH2 1978 TCAM1975 Val-Arg-Leu-Ile-Val-Ala-c[Asp-Arg-His-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Pro-D-Val-NH2 1979 TCAM1976 Val-Arg-Leu-Ile-Val-Ala-c[Asp-Arg-His-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Val-D-Phe-NH2 1980 TCAM1977 Val-Arg-Leu-Ile-Val-Ala-c[Asp-Arg-His-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Phe-D-Val-NH2 1981 TCAM1978 Val-Arg-Leu-Ile-Val-Ala-c[Asp-Arg-D-D-Nal(2′)-Arg-D-Nal(2′)-Arg-Lys]-D-Val-D-Pro- NH2 1982 TCAM1979 Val-Arg-Leu-Ile-Val-Ala-c[Asp-Arg-D-Nal(2′)-Arg-D-Nal(2′)-Arg-Lys]-D-Pro-D-Val-NH2 1983 TCAM1980 Val-Arg-Leu-Ile-Val-Ala-c[Asp-Arg-D-Nal(2′)-Arg-D-Nal(2′)-Arg-Lys]-D-Val-D-Phe-NH2 1984 TCAM1981 Val-Arg-Leu-Ile-Val-Ala-c[Asp-Arg-D-Nal(2′)-Arg-D-Nal(2′)-Arg-Lys]-D-Phe-D-Val-NH2 1985 TCAM1982 Val-Arg-Leu-Ile-Val-Ala-c[Asp-Arg-Pro-D-Nal(2′)-Arg-D-Nal(2′)-Arg-Lys]-D-Val-D-Pro- NH2 1986 TCAM1983 Val-Arg-Leu-Ile-Val-Ala-c[Asp-Arg-Pro-D-Nal(2′)-Arg-D-Nal(2′)-Arg-Lys]-D-Pro-D-Val- NH2 1987 TCAM1984 Val-Arg-Leu-Ile-Val-Ala-c[Asp-Arg-Pro-D-Nal(2′)-Arg-D-Nal(2′)-Arg-Lys]-D-Val-D-Phe- NH2 1988 TCAM1985 Val-Arg-Leu-Ile-Val-Ala-c[Asp-Arg-Pro-D-Nal(2′)-Arg-D-Nal(2′)-Arg-Lys]-D-Phe-D-Val- NH2 1989 TCAM1986 Val-Arg-Leu-Ile-Val-Ala-c[Asp-Arg-His-D-Nal(2′)-Arg-D-Nal(2′)-Arg-Lys]-D-Val-D-Pro- NH2 1990 TCAM1987 Val-Arg-Leu-Ile-Val-Ala-c[Asp-Arg-His-D-Nal(2′)-Arg-D-Nal(2′)-Arg-Lys]-D-Pro-D-Val- NH2 1991 TCAM1988 Val-Arg-Leu-Ile-Val-Ala-c[Asp-Arg-His-D-Nal(2′)-Arg-D-Nal(2′)-Arg-Lys]-D-Val-D-Phe- NH2 1992 TCAM1989 Val-Arg-Leu-Ile-Val-Ala-c[Asp-Arg-His-D-Nal(2′)-Arg-D-Nal(2′)-Arg-Lys]-D-Phe-D-Val- NH2 1993 TCAM1990 Val-Arg-Leu-Ile-Val-Ala-Arg-Arg-c[Asp-Pro-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Val-D-Pro- NH2 1994 TCAM1991 Val-Arg-Leu-Ile-Val-Ala-Arg-Arg-c[Asp-Pro-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Pro-D-Val- NH2 1995 TCAM1992 Val-Arg-Leu-Ile-Val-Ala-Arg-Arg-c[Asp-Pro-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Val-D-Phe- NH2 1996 TCAM1993 Val-Arg-Leu-Ile-Val-Ala-Arg-Arg-c[Asp-Pro-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Phe-D-Val- NH2 1997 TCAM1994 Val-Arg-Leu-Ile-Val-Ala-Arg-Arg-c[Asp-His-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Val-D-Pro- NH2 1998 TCAM1995 Val-Arg-Leu-Ile-Val-Ala-Arg-Arg-c[Asp-His-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Pro-D-Val- NH2 1999 TCAM1996 Val-Arg-Leu-Ile-Val-Ala-Arg-Arg-c[Asp-His-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Val-D-Phe- NH2 2000 TCAM1997 Val-Arg-Leu-Ile-Val-Ala-Arg-Arg-c[Asp-His-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Phe-D-Val- NH2 2001 TCAM1998 Val-Arg-Leu-Ile-Val-Ala-c[Asp-Arg-Pro-D-Nal(2′)-Arg-D-Nal(2′)-Arg-Lys]-D-Val-D-Pro- NH2 2002 TCAM1999 Val-Arg-Leu-Ile-Val-Ala-c[Asp-Arg-Pro-D-Nal(2′)-Arg-D-Nal(2′)-Arg-Lys]-D-Pro-D-Val- NH2 2003 TCAM2000 Val-Arg-Leu-Ile-Val-Ala-c[Asp-Arg-Pro-D-Nal(2′)-Arg-D-Nal(2′)-Arg-Lys]-D-Val-D-Phe- NH2 2004 TCAM2001 Val-Arg-Leu-Ile-Val-Ala-c[Asp-Arg-Pro-D-Nal(2′)-Arg-D-Nal(2′)-Arg-Lys]-D-Phe-D-Val- NH2 2005 TCAM2002 Val-Arg-Leu-Ile-Val-Ala-c[Asp-Arg-His-D-Nal(2′)-Arg-D-Nal(2′)-Arg-Lys]-D-Val-D-Pro- NH2 2006 TCAM2003 Val-Arg-Leu-Ile-Val-Ala-c[Asp-Arg-His-D-Nal(2′)-Arg-D-Nal(2′)-Arg-Lys]-D-Pro-D-Val- NH2 2007 TCAM2004 Val-Arg-Leu-Ile-Val-Ala-c[Asp-Arg-His-D-Nal(2′)-Arg-D-Nal(2′)-Arg-Lys]-D-Val-D-Phe- NH2 2008 TCAM2005 Val-Arg-Leu-Ile-Val-Ala-c[Asp-Arg-His-D-Nal(2′)-Arg-D-Nal(2′)-Arg-Lys]-D-Phe-D-Val- NH2 2009 TCAM2006 Val-Arg-Leu-Ile-Val-Ala-c[Asp-His-D-Nal(2′)-Arg-Trp-Lys]-Arg-Arg-D-Val-D-Pro-NH2 2010 TCAM2007 Val-Arg-Leu-Ile-Val-Ala-c[Asp-His-D-Nal(2′)-Arg-Trp-Lys]-Arg-Arg-D-Pro-D-Val-NH2 2011 TCAM2008 Val-Arg-Leu-Ile-Val-Ala-c[Asp-His-D-Nal(2′)-Arg-Trp-Lys]-Arg-Arg-D-Val-D-Phe-NH2 2012 TCAM2009 Val-Arg-Leu-Ile-Val-Ala-c[Asp-His-D-Nal(2′)-Arg-Trp-Lys]-Arg-Arg-D-Phe-D-Val-NH2 2013 TCAM2010 Val-Arg-Leu-Ile-Val-Ala-c[Asp-Pro-D-Nal(2′)-Arg-Trp-Lys]-Arg-Arg-D-Val-D-Pro-NH2 2014 TCAM2011 Val-Arg-Leu-Ile-Val-Ala-c[Asp-Pro-D-Nal(2′)-Arg-Trp-Lys]-Arg-Arg-D-Pro-D-Val-NH2 2015 TCAM2012 Val-Arg-Leu-Ile-Val-Ala-c[Asp-Pro-D-Nal(2′)-Arg-Trp-Lys]-Arg-Arg-D-Val-D-Phe-NH2 2016 TCAM2013 Val-Arg-Leu-Ile-Val-Ala-c[Asp-Pro-D-Nal(2′)-Arg-Trp-Lys]-Arg-Arg-D-Phe-D-Val-NH2 Anti-biofilm pptide ABF4 linked to anti-microbial peptides 2017 TCAM2014 Lys-Lys-Phe-Lys-Lys-Phe-Phe-c[Asp-Pro-Arg-Arg-Trp-Trp-Arg-Phe-Lys]-D-Val-D-Pro- NH2 2018 TCAM2015 Lys-Lys-Phe-Lys-Lys-Phe-Phe-c[Asp-Pro-Arg-Arg-Trp-Trp-Arg-Phe-Lys]-D-Val-D-Phe- NH2 2019 TCAM2016 Lys-Lys-Phe-Lys-Lys-Phe-Phe-c[Asp-Pro-Arg-Arg-Trp-Trp-Arg-Phe-Lys]-D-Pro-D-Val- NH2 2020 TCAM2017 Lys-Lys-Phe-Lys-Lys-Phe-Phe-c[Asp-Pro-Arg-Arg-Trp-Trp-Arg-Phe-Lys]-D-Phe-D-Val- NH2 2021 TCAM2018 Lys-Lys-Phe-Lys-Lys-Phe-Phe-c[Asp-Pro-Arg-Arg-Trp-Trp-Tyr-Phe-Lys]-D-Val-D-Pro- NH2 2022 TCAM2019 Lys-Lys-Phe-Lys-Lys-Phe-Phe-c[Asp-Pro-Arg-Arg-Trp-Trp-Tyr-Phe-Lys]-D-Val-D-Phe- NH2 2023 TCAM2020 Lys-Lys-Phe-Lys-Lys-Phe-Phe-c[Asp-Pro-Arg-Arg-Trp-Trp-Tyr-Phe-Lys]-D-Pro-D-Val- NH2 2024 TCAM2021 Lys-Lys-Phe-Lys-Lys-Phe-Phe-c[Asp-Pro-Arg-Arg-Trp-Trp-Tyr-Phe-Lys]-D-Phe-D-Val- NH2 2025 TCAM2022 Lys-Lys-Phe-Lys-Lys-Phe-Phe-c[Asp-Pro-Arg-Arg-Tyr-Tyr-Arg-Phe-Lys]-D-Val-D-Pro- NH2 2026 TCAM2023 Lys-Lys-Phe-Lys-Lys-Phe-Phe-c[Asp-Pro-Arg-Arg-Tyr-Tyr-Arg-Phe-Lys]-D-Val-D-Phe- NH2 2027 TCAM2024 Lys-Lys-Phe-Lys-Lys-Phe-Phe-c[Asp-Pro-Arg-Arg-Tyr-Tyr-Arg-Phe-Lys]-D-Pro-D-Val- NH2 2028 TCAM2025 Lys-Lys-Phe-Lys-Lys-Phe-Phe-c[Asp-Pro-Arg-Arg-Tyr-Tyr-Arg-Phe-Lys]-D-Phe-D-Val- NH2 2029 TCAM2026 Lys-Lys-Phe-Lys-Lys-Phe-Phe-c[Asp-Pro-Arg-Arg-Nal-Nal-Arg-Phe-Lys]-D-Val-D-Pro- NH2 2030 TCAM2027 Lys-Lys-Phe-Lys-Lys-Phe-Phe-c[Asp-Pro-Arg-Arg-Nal-Nal-Arg-Phe-Lys]-D-Val-D-Phe- NH2 2031 TCAM2028 Lys-Lys-Phe-Lys-Lys-Phe-Phe-c[Asp-Pro-Arg-Arg-Nal-Nal-Arg-Phe-Lys]-D-Pro-D-Val- NH2 2032 TCAM2029 Lys-Lys-Phe-Lys-Lys-Phe-Phe-c[Asp-Pro-Arg-Arg-Nal-Nal-Arg-Phe-Lys]-D-Phe-D-Val- NH2 2033 TCAM2030 Lys-Lys-Phe-Lys-Lys-Phe-Phe-c[Asp-Pro-Arg-Arg-Leu-Trp-Leu-Trp-Lys]-D-Val-D-Pro- NH2 2034 TCAM2031 Lys-Lys-Phe-Lys-Lys-Phe-Phe-c[Asp-Pro-Arg-Arg-Leu-Trp-Leu-Trp-Lys]-D-Val-D-Phe- NH2 2035 TCAM2032 Lys-Lys-Phe-Lys-Lys-Phe-Phe-c[Asp-Pro-Arg-Arg-Leu-Trp-Leu-Trp-Lys]-D-Pro-D-Val- NH2 2036 TCAM2033 Lys-Lys-Phe-Lys-Lys-Phe-Phe-c[Asp-Pro-Arg-Arg-Leu-Trp-Leu-Trp-Lys]-D-Phe-D-Val- NH2 2037 TCAM2034 Lys-Lys-Phe-Lys-Lys-Phe-Phe-c[Asp-Pro-Arg-Arg-Leu-Trp-Leu-Trp-Lys]-D-Val-D-Pro- NH2 2038 TCAM2035 Lys-Lys-Phe-Lys-Lys-Phe-Phe-c[Asp-Pro-Arg-Arg-Leu-Trp-Leu-Trp-Lys]-D-Val-D-Phe- NH2 2039 TCAM2036 Lys-Lys-Phe-Lys-Lys-Phe-Phe-c[Asp-Pro-Arg-Arg-Leu-Trp-Leu-Trp-Lys]-D-Pro-D-Val- NH2 2040 TCAM2037 Lys-Lys-Phe-Lys-Lys-Phe-Phe-c[Asp-Pro-Arg-Arg-Leu-Trp-Leu-Trp-Lys]-D-Phe-D-Val- NH2 2041 TCAM2038 Lys-Lys-Phe-Lys-Lys-Phe-Phe-c[Asp-Arg-Arg-Arg-Trp-Leu-Trp-Leu-Trp-Lys]-D-Val-D- Pro-NH2 2042 TCAM2039 Lys-Lys-Phe-Lys-Lys-Phe-Phe-c[Asp-Pro-Arg-Arg-Arg-Trp-Leu-Trp-Leu-Trp-Lys]-D- Val-D-Phe-NH2 2043 TCAM2040 Lys-Lys-Phe-Lys-Lys-Phe-Phe-c[Asp-Pro-Arg-Arg-Arg-Trp-Leu-Trp-Leu-Trp-Lys]-D- Pro-D-Val-NH2 2044 TCAM2041 Lys-Lys-Phe-Lys-Lys-Phe-Phe-c[Asp-Pro-Arg-Arg-Arg-Trp-Leu-Trp-Leu-Trp-Lys]-D- Phe-D-Val-NH2 2045 TCAM2042 Lys-Lys-Phe-Lys-Lys-Phe-Phe-c[Asp-Pro-Arg-Gln-Arg-Arg-Trp-Leu-Trp-Leu-Trp-Lys]- D-Val-D-Pro-NH2 2046 TCAM2043 Lys-Lys-Phe-Lys-Lys-Phe-Phe-c[Asp-Pro-Arg-Gln-Arg-Arg-Trp-Leu-Trp-Leu-Trp-Lys]- D-Val-D-Phe-NH2 2047 TCAM2044 Lys-Lys-Phe-Lys-Lys-Phe-Phe-c[Asp-Pro-Arg-Gln-Arg-Arg-Trp-Leu-Trp-Leu-Trp-Lys]- D-Pro-D-Val-NH2 2048 TCAM2045 Lys-Lys-Phe-Lys-Lys-Phe-Phe-c[Asp-Pro-Arg-Gln-Arg-Arg-Trp-Leu-Trp-Leu-Trp-Lys]- D-Phe-D-Val-NH2 2049 TCAM2046 Lys-Lys-Phe-Lys-Lys-Phe-Phe-c[Asp-Pro-Trp-Arg-Trp-Trp-Arg-Arg-Lys]-D-Val-D-Phe- NH2 2050 TCAM2047 Lys-Lys-Phe-Lys-Lys-Phe-Phe-c[Asp-Pro-Trp-Arg-Trp-Trp-Arg-Arg-Lys]-D-Pro-D-Val- NH2 2051 TCAM2048 Lys-Lys-Phe-Lys-Lys-Phe-Phe-c[Asp-Pro-Trp-Arg-Trp-Trp-Arg-Arg-Lys]-D-Phe-D-Val- NH2 2052 TCAM2049 Lys-Lys-Phe-Lys-Lys-Phe-Phe-c[Asp-Pro-Trp-Trp-Arg-Arg-Trp-Trp-Arg-Arg-Lys]-D- Val-D-Pro-NH2 2053 TCAM2050 Lys-Lys-Phe-Lys-Lys-Phe-Phe-c[Asp-Pro-Trp-Trp-Arg-Arg-Trp-Trp-Arg-Arg-Lys]-D- Val-D-Phe-NH2 2054 TCAM2051 Lys-Lys-Phe-Lys-Lys-Phe-Phe-c[Asp-Pro-Trp-Trp-Arg-Arg-Trp-Trp-Arg-Arg-Lys]-D- Pro-D-Val-NH2 2055 TCAM2052 Lys-Lys-Phe-Lys-Lys-Phe-Phe-c[Asp-Pro-Trp-Trp-Arg-Arg-Trp-Trp-Arg-Arg-Lys]-D- Phe-D-Val-NH2 2056 TCAM2053 Lys-Lys-Phe-Lys-Lys-Phe-Phe-c[Asp-Pro-Trp-Arg-Trp-Arg-Trp-Arg-Lys]-D-Val-D-Pro- NH2 2057 TCAM2054 Lys-Lys-Phe-Lys-Lys-Phe-Phe-c[Asp-Pro-Trp-Arg-Trp-Arg-Trp-Arg-Lys]-D-Val-D-Phe- NH2 2058 TCAM2055 Lys-Lys-Phe-Lys-Lys-Phe-Phe-c[Asp-Pro-Trp-Arg-Trp-Arg-Trp-Arg-Lys]-D-Pro-D-Val- NH2 2059 TCAM2056 Lys-Lys-Phe-Lys-Lys-Phe-Phe-c[Asp-Pro-Trp-Arg-Trp-Arg-Trp-Arg-Lys]-D-Phe-D-Val- NH2 2060 TCAM2057 Lys-Lys-Phe-Lys-Lys-Phe-Phe-c[Asp-Pro-Arg-Trp-Arg-Trp-Arg-Trp-Lys]-D-Val-D-Pro- NH2 2061 TCAM2058 Lys-Lys-Phe-Lys-Lys-Phe-Phe-c[Asp-Pro-Arg-Trp-Arg-Trp-Arg-Trp-Lys]-D-Val-D-Phe- NH2 2062 TCAM2059 Lys-Lys-Phe-Lys-Lys-Phe-Phe-c[Asp-Pro-Arg-Trp-Arg-Trp-Arg-Trp-Lys]-D-Pro-D-Val- NH2 2063 TCAM2060 Lys-Lys-Phe-Lys-Lys-Phe-Phe-c[Asp-Pro-Arg-Trp-Arg-Trp-Arg-Trp-Lys]-D-Phe-D-Val- NH2 2064 TCAM2061 Lys-Lys-Phe-Lys-Lys-Phe-Phe-c[Asp-Pro-Arg-Trp-Trp-Arg-Arg-Lys]-D-Val-D-Pro-NH2 2065 TCAM2062 Lys-Lys-Phe-Lys-Lys-Phe-Phe-c[Asp-Pro-Arg-Trp-Trp-Arg-Arg-Lys]-D-Val-D-Phe-NH2 2066 TCAM2063 Lys-Lys-Phe-Lys-Lys-Phe-Phe-c[Asp-Pro-Arg-Trp-Trp-Arg-Arg-Lys]-D-Pro-D-Val-NH2 2067 TCAM2064 Lys-Lys-Phe-Lys-Lys-Phe-Phe-c[Asp-Pro-Arg-Trp-Trp-Arg-Arg-Lys]-D-Phe-D-Val-NH2 2068 TCAM2065 Lys-Lys-Phe-Lys-Lys-Phe-Phe-c[Asp-Pro-Trp-Trp-Arg-Arg-Trp-Lys]-D-Val-D-Pro-NH2 2069 TCAM2066 Lys-Lys-Phe-Lys-Lys-Phe-Phe-c[Asp-Pro-Trp-Trp-Arg-Arg-Trp-Lys]-D-Val-D-Phe-NH2 2070 TCAM2067 Lys-Lys-Phe-Lys-Lys-Phe-Phe-c[Asp-Pro-Trp-Trp-Arg-Arg-Trp-Lys]-D-Pro-D-Val-NH2 2071 TCAM2068 Lys-Lys-Phe-Lys-Lys-Phe-Phe-c[Asp-Pro-Trp-Trp-Arg-Arg-Trp-Lys]-D-Phe-D-Val-NH2 2072 TCAM2069 Lys-Lys-Phe-Lys-Lys-Phe-Phe-c[Asp-Pro-Trp-Arg-Trp-Arg-Trp-Lys]-D-Val-D-Pro-NH2 2073 TCAM2070 Lys-Lys-Phe-Lys-Lys-Phe-Phe-c[Asp-Pro-Trp-Arg-Trp-Arg-Trp-Lys]-D-Val-D-Phe-NH2 2074 TCAM2071 Lys-Lys-Phe-Lys-Lys-Phe-Phe-c[Asp-Pro-Trp-Arg-Trp-Arg-Trp-Lys]-D-Pro-D-Val-NH2 2075 TCAM2072 Lys-Lys-Phe-Lys-Lys-Phe-Phe-c[Asp-Pro-Trp-Arg-Trp-Arg-Trp-Lys]-D-Phe-D-Val-NH2 2076 TCAM2073 Lys-Lys-Phe-Lys-Lys-Phe-Phe-c[Asp-Pro-Arg-Trp-Arg-Trp-Arg-Lys]-D-Val-D-Pro-NH2 2077 TCAM2074 Lys-Lys-Phe-Lys-Lys-Phe-Phe-c[Asp-Pro-Arg-Trp-Arg-Trp-Arg-Lys]-D-Val-D-Phe-NH2 2078 TCAM2075 Lys-Lys-Phe-Lys-Lys-Phe-Phe-c[Asp-Pro-Arg-Trp-Arg-Trp-Arg-Lys]-D-Pro-D-Val-NH2 2079 TCAM2076 Lys-Lys-Phe-Lys-Lys-Phe-Phe-c[Asp-Pro-Arg-Trp-Arg-Trp-Arg-Lys]-D-Phe-D-Val-NH2 2080 TCAM2077 Lys-Lys-Phe-Lys-Lys-Phe-Phe-c[Asp-Pro-Trp-Arg-Tyr-Arg-Trp-Lys]-D-Val-D-Pro-NH2 2081 TCAM2078 Lys-Lys-Phe-Lys-Lys-Phe-Phe-c[Asp-Pro-Trp-Arg-Tyr-Arg-Trp-Lys]-D-Val-D-Phe-NH2 2082 TCAM2079 Lys-Lys-Phe-Lys-Lys-Phe-Phe-c[Asp-Pro-Trp-Arg-Tyr-Arg-Trp-Lys]-D-Pro-D-Val-NH2 2083 TCAM2080 Lys-Lys-Phe-Lys-Lys-Phe-Phe-c[Asp-Pro-Trp-Arg-Tyr-Arg-Trp-Lys]-D-Phe-D-Val-NH2 2084 TCAM2081 Lys-Lys-Phe-Lys-Lys-Phe-Phe-c[Asp-Pro-Trp-Arg-Trp-Arg-Tyr-Lys]-D-Val-D-Pro-NH2 2085 TCAM2082 Lys-Lys-Phe-Lys-Lys-Phe-Phe-c[Asp-Pro-Trp-Arg-Trp-Arg-Tyr-Lys]-D-Val-D-Phe-NH2 2086 TCAM2083 Lys-Lys-Phe-Lys-Lys-Phe-Phe-c[Asp-Pro-Trp-Arg-Trp-Arg-Tyr-Lys]-D-Pro-D-Val-NH2 2087 TCAM2084 Lys-Lys-Phe-Lys-Lys-Phe-Phe-c[Asp-Pro-Trp-Arg-Trp-Arg-Tyr-Lys]-D-Phe-D-Val-NH2 2088 TCAM2085 Lys-Lys-Phe-Lys-Lys-Phe-Phe-c[Asp-Pro-Trp-Arg-Trp-Arg-Lys]-D-Val-D-Pro-NH2 2089 TCAM2086 Lys-Lys-Phe-Lys-Lys-Phe-Phe-c[Asp-Pro-Trp-Arg-Trp-Arg-Lys]-D-Val-D-Phe-NH2 2090 TCAM2087 Lys-Lys-Phe-Lys-Lys-Phe-Phe-c[Asp-Pro-Trp-Arg-Trp-Arg-Lys]-D-Pro-D-Val-NH2 2091 TCAM2088 Lys-Lys-Phe-Lys-Lys-Phe-Phe-c[Asp-Pro-Trp-Arg-Trp-Arg-Lys]-D-Phe-D-Val-NH2 2092 TCAM2089 Lys-Lys-Phe-Lys-Lys-Phe-Phe-c[Asp-Pro-Trp-Arg-Arg-Trp-Lys]-D-Val-D-Pro-NH2 2093 TCAM2090 Lys-Lys-Phe-Lys-Lys-Phe-Phe-c[Asp-Pro-Trp-Arg-Arg-Trp-Lys]-D-Val-D-Phe-NH2 2094 TCAM2091 Lys-Lys-Phe-Lys-Lys-Phe-Phe-c[Asp-Pro-Trp-Arg-Arg-Trp-Lys]-D-Pro-D-Val-NH2 2095 TCAM2092 Lys-Lys-Phe-Lys-Lys-Phe-Phe-c[Asp-Pro-Trp-Arg-Arg-Trp-Lys]-D-Phe-D-Val-NH2 2096 TCAM2093 Lys-Lys-Phe-Lys-Lys-Phe-Phe-c[Asp-Pro-Arg-Trp-Trp-Arg-Lys]-D-Val-D-Pro-NH2 2097 TCAM2094 Lys-Lys-Phe-Lys-Lys-Phe-Phe-c[Asp-Pro-Arg-Trp-Trp-Arg-Lys]-D-Val-D-Phe-NH2 2098 TCAM2095 Lys-Lys-Phe-Lys-Lys-Phe-Phe-c[Asp-Pro-Arg-Trp-Trp-Arg-Lys]-D-Pro-D-Val-NH2 2099 TCAM2096 Lys-Lys-Phe-Lys-Lys-Phe-Phe-c[Asp-Pro-Arg-Trp-Trp-Arg-Lys]-D-Phe-D-Val-NH2 2100 TCAM2097 Lys-Lys-Phe-Lys-Lys-Phe-Phe-c[Asp-Pro-Trp-Arg-Trp-Lys]-D-Val-D-Pro-NH2 2101 TCAM2098 Lys-Lys-Phe-Lys-Lys-Phe-Phe-c[Asp-Pro-Trp-Arg-Trp-Lys]-D-Val-D-Phe-NH2 2102 TCAM2099 Lys-Lys-Phe-Lys-Lys-Phe-Phe-c[Asp-Pro-Trp-Arg-Trp-Lys]-D-Pro-D-Val-NH2 2103 TCAM2100 Lys-Lys-Phe-Lys-Lys-Phe-Phe-c[Asp-Pro-Trp-Arg-Trp-Lys]-D-Phe-D-Val-NH2 2104 TCAM2101 Lys-Lys-Phe-Lys-Lys-Phe-Phe-c[Asp-Pro-Arg-Trp-Arg-Lys]-D-Val-D-Pro-NH2 2105 TCAM2102 Lys-Lys-Phe-Lys-Lys-Phe-Phe-c[Asp-Pro-Arg-Trp-Arg-Lys]-D-Val-D-Phe-NH2 2106 TCAM2103 Lys-Lys-Phe-Lys-Lys-Phe-Phe-c[Asp-Pro-Arg-Trp-Arg-Lys]-D-Pro-D-Val-NH2 2107 TCAM2104 Lys-Lys-Phe-Lys-Lys-Phe-Phe-c[Asp-Pro-Arg-Trp-Arg-Lys]-D-Phe-D-Val-NH2 2108 TCAM2105 -Lys-Lys-Phe-Lys-Lys-Phe-Phe-c[Asp-Arg-Arg-Trp-Trp-Arg-Phe-Lys]-D-Val-D-Pro-NH2 2109 TCAM2106 Lys-Lys-Phe-Lys-Lys-Phe-Phe-c[Asp-Arg-Arg-Trp-Trp-Arg-Phe-Lys]-D-Val-D-Phe-NH2 2110 TCAM2107 Lys-Lys-Phe-Lys-Lys-Phe-Phe-c[Asp-Arg-Arg-Trp-Trp-Arg-Phe-Lys]-D-Pro-D-Val-NH2 2111 TCAM2108 Lys-Lys-Phe-Lys-Lys-Phe-Phe-c[Asp-Arg-Arg-Trp-Trp-Arg-Phe-Lys]-D-Phe-D-Val-NH2 2112 TCAM2109 Lys-Lys-Phe-Lys-Lys-Phe-Phe-c[Asp-Arg-Arg-Trp-Trp-Arg-Phe-Lys]-D-Val-D-Pro-NH2 2113 TCAM2110 Lys-Lys-Phe-Lys-Lys-Phe-Phe-c[Asp-Arg-Arg-Trp-Trp-Arg-Phe-Lys]-D-Val-D-Phe-NH2 2114 TCAM2111 Lys-Lys-Phe-Lys-Lys-Phe-Phe-c[Asp-Arg-Arg-Trp-Trp-Arg-Phe-Lys]-D-Pro-D-Val-NH2 2115 TCAM2112 Lys-Lys-Phe-Lys-Lys-Phe-Phe-c[Asp-Arg-Arg-Trp-Trp-Arg-Phe-Lys]-D-Phe-D-Val-NH2 2116 TCAM2113 Lys-Lys-Phe-Lys-Lys-Phe-Phe-c[Asp-Arg-Arg-Tyr-Tyr-Arg-Phe-Lys]-D-Val-D-Pro-NH2 2117 TCAM2114 Lys-Lys-Phe-Lys-Lys-Phe-Phe-c[Asp-Arg-Arg-Tyr-Tyr-Arg-Phe-Lys]-D-Val-D-Phe-NH2 2118 TCAM2115 Lys-Lys-Phe-Lys-Lys-Phe-Phe-c[Asp-Arg-Arg-Tyr-Tyr-Arg-Phe-Lys]-D-Pro-D-Val-NH2 2119 TCAM2116 Lys-Lys-Phe-Lys-Lys-Phe-Phe-c[Asp-Arg-Arg-Tyr-Tyr-Arg-Phe-Lys]-D-Phe-D-Val-NH2 2120 TCAM2117 Lys-Lys-Phe-Lys-Lys-Phe-Phe-c[Asp-Arg-Arg-Nal-Nal-Arg-Phe-Lys]-D-Val-D-Pro-NH2 2121 TCAM2118 Lys-Lys-Phe-Lys-Lys-Phe-Phe-c[Asp-Arg-Arg-Nal-Nal-Arg-Phe-Lys]-D-Val-D-Phe-NH2 2122 TCAM2119 Lys-Lys-Phe-Lys-Lys-Phe-Phe-c[Asp-Arg-Arg-Nal-Nal-Arg-Phe-Lys]-D-Pro-D-Val-NH2 2123 TCAM2120 Lys-Lys-Phe-Lys-Lys-Phe-Phe-c[Asp-Arg-Arg-Nal-Nal-Arg-Phe-Lys]-D-Phe-D-Val-NH2 2124 TCAM2121 Lys-Lys-Phe-Lys-Lys-Phe-Phe-c[Asp-Arg-Arg-Leu-Trp-Leu-Trp-Lys]-D-Val-D-Pro-NH2 2125 TCAM2122 Lys-Lys-Phe-Lys-Lys-Phe-Phe-c[Asp-Arg-Arg-Leu-Trp-Leu-Trp-Lys]-D-Val-D-Phe-NH2 2126 TCAM2123 Lys-Lys-Phe-Lys-Lys-Phe-Phe-c[Asp-Arg-Arg-Leu-Trp-Leu-Trp-Lys]-D-Pro-D-Val-NH2 2127 TCAM2124 Lys-Lys-Phe-Lys-Lys-Phe-Phe-c[Asp-Arg-Arg-Leu-Trp-Leu-Trp-Lys]-D-Phe-D-Val-NH2 2128 TCAM2125 Lys-Lys-Phe-Lys-Lys-Phe-Phe-c[Asp-Arg-Arg-Leu-Trp-Leu-Trp-Lys]-D-Val-D-Pro-NH2 2129 TCAM2126 Lys-Lys-Phe-Lys-Lys-Phe-Phe-c[Asp-Arg-Arg-Leu-Trp-Leu-Trp-Lys]-D-Val-D-Phe-NH2 2130 TCAM2127 Lys-Lys-Phe-Lys-Lys-Phe-Phe-c[Asp-Arg-Arg-Leu-Trp-Leu-Trp-Lys]-D-Pro-D-Val-NH2 2131 TCAM2128 Lys-Lys-Phe-Lys-Lys-Phe-Phe-c[Asp-Arg-Arg-Leu-Trp-Leu-Trp-Lys]-D-Phe-D-Val-NH2 2132 TCAM2129 Lys-Lys-Phe-Lys-Lys-Phe-Phe-c[Asp-Arg-Arg-Arg-Trp-Leu-Trp-Leu-Trp-Lys]-D-Val-D- Pro-NH2 2133 TCAM2130 Lys-Lys-Phe-Lys-Lys-Phe-Phe-c[Asp-Arg-Arg-Arg-Trp-Leu-Trp-Leu-Trp-Lys]-D-Val-D- Phe-NH2 2134 TCAM2131 Lys-Lys-Phe-Lys-Lys-Phe-Phe-c[Asp-Arg-Arg-Arg-Trp-Leu-Trp-Leu-Trp-Lys]-D-Pro-D- Val-NH2 2135 TCAM2132 Lys-Lys-Phe-Lys-Lys-Phe-Phe-c[Asp-Arg-Arg-Arg-Trp-Leu-Trp-Leu-Trp-Lys]-D-Phe-D- Val-NH2 2136 TCAM2133 Lys-Lys-Phe-Lys-Lys-Phe-Phe-c[Asp-Arg-Gln-Arg-Arg-Trp-Leu-Trp-Leu-Trp-Lys]-D- Val-D-Pro-NH2 2137 TCAM2134 Lys-Lys-Phe-Lys-Lys-Phe-Phe-c[Asp-Arg-Gln-Arg-Arg-Trp-Leu-Trp-Leu-Trp-Lys]-D- Val-D-Phe-NH2 2138 TCAM2135 Lys-Lys-Phe-Lys-Lys-Phe-Phe-c[Asp-Arg-Gln-Arg-Arg-Trp-Leu-Trp-Leu-Trp-Lys]-D- Pro-D-Val-NH2 2139 TCAM2136 Lys-Lys-Phe-Lys-Lys-Phe-Phe-c[Asp-Arg-Gln-Arg-Arg-Trp-Leu-Trp-Leu-Trp-Lys]-D- Phe-D-Val-NH2 2140 TCAM2137 Lys-Lys-Phe-Lys-Lys-Phe-Phe-c[Asp-Trp-Arg-Trp-Trp-Arg-Arg-Lys]-D-Val-D-Pro-NH2 2141 TCAM2138 Lys-Lys-Phe-Lys-Lys-Phe-Phe-c[Asp-Trp-Arg-Trp-Trp-Arg-Arg-Lys]-D-Val-D-Phe-NH2 2142 TCAM2139 Lys-Lys-Phe-Lys-Lys-Phe-Phe-c[Asp-Trp-Arg-Trp-Trp-Arg-Arg-Lys]-D-Pro-D-Val-NH2 2143 TCAM2140 Lys-Lys-Phe-Lys-Lys-Phe-Phe-c[Asp-Trp-Arg-Trp-Trp-Arg-Arg-Lys]-D-Phe-D-Val-NH2 2144 TCAM2141 Lys-Lys-Phe-Lys-Lys-Phe-Phe-c[Asp-Trp-Trp-Arg-Arg-Trp-Trp-Arg-Arg-Lys]-D-Val-D- Pro-NH2 2145 TCAM2142 Lys-Lys-Phe-Lys-Lys-Phe-Phe-c[Asp-Trp-Trp-Arg-Arg-Trp-Trp-Arg-Arg-Lys]-D-Val-D- Phe-NH2 2146 TCAM2143 Lys-Lys-Phe-Lys-Lys-Phe-Phe-c[Asp-Trp-Trp-Arg-Arg-Trp-Trp-Arg-Arg-Lys]-D-Pro-D- Val-NH2 2147 TCAM2144 Lys-Lys-Phe-Lys-Lys-Phe-Phe-c[Asp-Trp-Trp-Arg-Arg-Trp-Trp-Arg-Arg-Lys]-D-Phe-D- Val-NH2 2148 TCAM2145 Lys-Lys-Phe-Lys-Lys-Phe-Phe-c[Asp-Trp-Arg-Trp-Arg-Trp-Arg-Lys]-D-Val-D-Pro-NH2 2149 TCAM2146 Lys-Lys-Phe-Lys-Lys-Phe-Phe-c[Asp-Trp-Arg-Trp-Arg-Trp-Arg-Lys]-D-Val-D-Phe-NH2 2150 TCAM2147 Lys-Lys-Phe-Lys-Lys-Phe-Phe-c[Asp-Trp-Arg-Trp-Arg-Trp-Arg-Lys]-D-Pro-D-Val-NH2 2151 TCAM2148 Lys-Lys-Phe-Lys-Lys-Phe-Phe-c[Asp-Trp-Arg-Trp-Arg-Trp-Arg-Lys]-D-Phe-D-Val-NH2 2152 TCAM2149 Lys-Lys-Phe-Lys-Lys-Phe-Phe-c[Asp-Arg-Trp-Arg-Trp-Arg-Trp-Lys]-D-Val-D-Pro-NH2 2153 TCAM2150 Lys-Lys-Phe-Lys-Lys-Phe-Phe-c[Asp-Arg-Trp-Arg-Trp-Arg-Trp-Lys]-D-Val-D-Phe-NH2 2154 TCAM2151 Lys-Lys-Phe-Lys-Lys-Phe-Phe-c[Asp-Arg-Trp-Arg-Trp-Arg-Trp-Lys]-D-Pro-D-Val-NH2 2155 TCAM2152 Lys-Lys-Phe-Lys-Lys-Phe-Phe-c[Asp-Arg-Trp-Arg-Trp-Arg-Trp-Lys]-D-Phe-D-Val-NH2 2156 TCAM2153 Lys-Lys-Phe-Lys-Lys-Phe-Phe-c[Asp-Arg-Trp-Trp-Arg-Arg-Lys]-D-Val-D-Pro-NH2 2157 TCAM2154 Lys-Lys-Phe-Lys-Lys-Phe-Phe-c[Asp-Arg-Trp-Trp-Arg-Arg-Lys]-D-Val-D-Phe-NH2 2158 TCAM2155 Lys-Lys-Phe-Lys-Lys-Phe-Phe-c[Asp-Arg-Trp-Trp-Arg-Arg-Lys]-D-Pro-D-Val-NH2 2159 TCAM2156 Lys-Lys-Phe-Lys-Lys-Phe-Phe-c[Asp-Arg-Trp-Trp-Arg-Arg-Lys]-D-Phe-D-Val-NH2 2160 TCAM2157 Lys-Lys-Phe-Lys-Lys-Phe-Phe-c[Asp-Arg-Trp-Arg-Trp-Arg-Lys]-D-Val-D-Pro-NH2 2161 TCAM2158 Lys-Lys-Phe-Lys-Lys-Phe-Phe-c[Asp-Arg-Trp-Arg-Trp-Arg-Lys]-D-Val-D-Phe-NH2 2162 TCAM2159 Lys-Lys-Phe-Lys-Lys-Phe-Phe-c[Asp-Arg-Trp-Arg-Trp-Arg-Lys]-D-Pro-D-Val-NH2 2163 TCAM2160 Lys-Lys-Phe-Lys-Lys-Phe-Phe-c[Asp-Arg-Trp-Arg-Trp-Arg-Lys]-D-Phe-D-Val-NH2 2164 TCAM2161 Lys-Lys-Phe-Lys-Lys-Phe-Phe-c[Asp-Trp-Trp-Arg-Arg-Trp-Lys]-D-Val-D-Pro-NH2 2165 TCAM2162 Lys-Lys-Phe-Lys-Lys-Phe-Phe-c[Asp-Trp-Trp-Arg-Arg-Trp-Lys]-D-Val-D-Phe-NH2 2166 TCAM2163 Lys-Lys-Phe-Lys-Lys-Phe-Phe-c[Asp-Trp-Trp-Arg-Arg-Trp-Lys]-D-Pro-D-Val-NH2 2167 TCAM2164 Lys-Lys-Phe-Lys-Lys-Phe-Phe-c[Asp-Trp-Trp-Arg-Arg-Trp-Lys]-D-Phe-D-Val-NH2 2168 TCAM2165 Lys-Lys-Phe-Lys-Lys-Phe-Phe-c[Asp-Trp-Arg-Trp-Arg-Trp-Lys]-D-Val-D-Pro-NH2 2169 TCAM2166 Lys-Lys-Phe-Lys-Lys-Phe-Phe-c[Asp-Trp-Arg-Trp-Arg-Trp-Lys]-D-Val-D-Phe-NH2 2170 TCAM2167 Lys-Lys-Phe-Lys-Lys-Phe-Phe-c[Asp-Trp-Arg-Trp-Arg-Trp-Lys]-D-Pro-D-Val-NH2 2171 TCAM2168 Lys-Lys-Phe-Lys-Lys-Phe-Phe-c[Asp-Trp-Arg-Trp-Arg-Trp-Lys]-D-Phe-D-Val-NH2 2172 TCAM2169 Lys-Lys-Phe-Lys-Lys-Phe-Phe-c[Asp-Trp-Arg-Tyr-Arg-Trp-Lys]-D-Val-D-Pro-NH2 2173 TCAM2170 Lys-Lys-Phe-Lys-Lys-Phe-Phe-c[Asp-Trp-Arg-Tyr-Arg-Trp-Lys]-D-Val-D-Phe-NH2 2174 TCAM2171 Lys-Lys-Phe-Lys-Lys-Phe-Phe-c[Asp-Trp-Arg-Tyr-Arg-Trp-Lys]-D-Pro-D-Val-NH2 2175 TCAM2172 Lys-Lys-Phe-Lys-Lys-Phe-Phe-c[Asp-Trp-Arg-Tyr-Arg-Trp-Lys]-D-Phe-D-Val-NH2 2176 TCAM2173 Lys-Lys-Phe-Lys-Lys-Phe-Phe-c[Asp-Trp-Arg-Trp-Arg-Tyr-Lys]-D-Val-D-Pro-NH2 2177 TCAM2174 Lys-Lys-Phe-Lys-Lys-Phe-Phe-c[Asp-Trp-Arg-Trp-Arg-Tyr-Lys]-D-Val-D-Phe-NH2 2178 TCAM2175 Lys-Lys-Phe-Lys-Lys-Phe-Phe-c[Asp-Trp-Arg-Trp-Arg-Tyr-Lys]-D-Pro-D-Val-NH2 2179 TCAM2176 Lys-Lys-Phe-Lys-Lys-Phe-Phe-c[Asp-Trp-Arg-Trp-Arg-Tyr-Lys]-D-Phe-D-Val-NH2 2180 TCAM2177 Lys-Lys-Phe-Lys-Lys-Phe-Phe-c[Asp-Trp-Arg-Trp-Arg-Lys]-D-Val-D-Pro-NH2 2181 TCAM2178 Lys-Lys-Phe-Lys-Lys-Phe-Phe-c[Asp-Trp-Arg-Trp-Arg-Lys]-D-Val-D-Phe-NH2 2182 TCAM2179 Lys-Lys-Phe-Lys-Lys-Phe-Phe-c[Asp-Trp-Arg-Trp-Arg-Lys]-D-Pro-D-Val-NH2 2183 TCAM2180 Lys-Lys-Phe-Lys-Lys-Phe-Phe-c[Asp-Trp-Arg-Trp-Arg-Lys]-D-Phe-D-Val-NH2 2184 TCAM2181 Lys-Lys-Phe-Lys-Lys-Phe-Phe-c[Asp-Trp-Arg-Arg-Trp-Lys]-D-Val-D-Pro-NH2 2185 TCAM2182 Lys-Lys-Phe-Lys-Lys-Phe-Phe-c[Asp-Trp-Arg-Arg-Trp-Lys]-D-Val-D-Phe-NH2 2186 TCAM2183 Lys-Lys-Phe-Lys-Lys-Phe-Phe-c[Asp-Trp-Arg-Arg-Trp-Lys]-D-Pro-D-Val-NH2 2187 TCAM2184 Lys-Lys-Phe-Lys-Lys-Phe-Phe-c[Asp-Trp-Arg-Arg-Trp-Lys]-D-Phe-D-Val-NH2 2188 TCAM2185 Lys-Lys-Phe-Lys-Lys-Phe-Phe-c[Asp-Arg-Trp-Trp-Arg-Lys]-D-Val-D-Pro-NH2 2189 TCAM2186 Lys-Lys-Phe-Lys-Lys-Phe-Phe-c[Asp-Arg-Trp-Trp-Arg-Lys]-D-Val-D-Phe-NH2 2190 TCAM2187 Lys-Lys-Phe-Lys-Lys-Phe-Phe-c[Asp-Arg-Trp-Trp-Arg-Lys]-D-Pro-D-Val-NH2 2191 TCAM2188 Lys-Lys-Phe-Lys-Lys-Phe-Phe-c[Asp-Arg-Trp-Trp-Arg-Lys]-D-Phe-D-Val-NH2 2192 TCAM2189 Lys-Lys-Phe-Lys-Lys-Phe-Phe-c[Asp-Trp-Arg-Trp-Lys]-D-Val-D-Pro-NH2 2193 TCAM2190 Lys-Lys-Phe-Lys-Lys-Phe-Phe-c[Asp-Trp-Arg-Trp-Lys]-D-Val-D-Phe-NH2 2194 TCAM2191 Lys-Lys-Phe-Lys-Lys-Phe-Phe-c[Asp-Trp-Arg-Trp-Lys]-D-Pro-D-Val-NH2 2195 TCAM2192 Lys-Lys-Phe-Lys-Lys-Phe-Phe-c[Asp-Trp-Arg-Trp-Lys]-D-Phe-D-Val-NH2 2196 TCAM2193 Lys-Lys-Phe-Lys-Lys-Phe-Phe-c[Asp-Arg-Trp-Arg-Lys]-D-Val-D-Pro-NH2 2197 TCAM2194 Lys-Lys-Phe-Lys-Lys-Phe-Phe-c[Asp-Arg-Trp-Arg-Lys]-D-Val-D-Phe-NH2 2198 TCAM2195 Lys-Lys-Phe-Lys-Lys-Phe-Phe-c[Asp-Arg-Trp-Arg-Lys]-D-Pro-D-Val-NH2 2199 TCAM2196 Lys-Lys-Phe-Lys-Lys-Phe-Phe-c[Asp-Arg-Trp-Arg-Lys]-D-Phe-D-Val-NH2 2200 TCAM2197 Lys-Lys-Phe-Lys-Lys-Phe-Phe-c[Asp-His-D-Nal(2′)-Arg-Trp-Lys]-D-Val-D-Pro-NH2 2201 TCAM2198 Lys-Lys-Phe-Lys-Lys-Phe-Phe-c[Asp-His-D-Nal(2′)-Arg-Trp-Lys]-D-Pro-D-Val-NH2 2202 TCAM2199 Lys-Lys-Phe-Lys-Lys-Phe-Phe-c[Asp-His-D-Nal(2′)-Arg-Trp-Lys]-D-Val-D-Phe-NH2 2203 TCAM2200 Lys-Lys-Phe-Lys-Lys-Phe-Phe-c[Asp-His-D-Nal(2′)-Arg-Trp-Lys]-D-Phe-D-Val-NH2 2204 TCAM2201 Lys-Lys-Phe-Lys-Lys-Phe-Phe-c[Asp-Pro-D-Nal(2′)-Arg-Trp-Lys]-D-Val-D-Pro-NH2 2205 TCAM2202 Lys-Lys-Phe-Lys-Lys-Phe-Phe-c[Asp-Pro-D-Nal(2′)-Arg-Trp-Lys]-D-Pro-D-Val-NH2 2206 TCAM2203 Lys-Lys-Phe-Lys-Lys-Phe-Phe-c[Asp-Pro-D-Nal(2′)-Arg-Trp-Lys]-D-Val-D-Phe-NH2 2207 TCAM2204 Lys-Lys-Phe-Lys-Lys-Phe-Phe-c[Asp-Pro-D-Nal(2′)-Arg-Trp-Lys]-D-Phe-D-Val-NH2 2208 TCAM2205 Lys-Lys-Phe-Lys-Lys-Phe-Phe-c[Asp-Arg-Arg-Nal(2′)-Arg-Trp-Lys]-D-Val-D-Pro-NH2 2209 TCAM2206 Lys-Lys-Phe-Lys-Lys-Phe-Phe-c[Asp-Arg-Arg-Nal(2′)-Arg-Trp-Lys]-D-Pro-D-Val-NH2 2210 TCAM2207 Lys-Lys-Phe-Lys-Lys-Phe-Phe-c[Asp-Arg-Arg-Nal(2′)-Arg-Trp-Lys]-D-Val-D-Phe-NH2 2211 TCAM2208 Lys-Lys-Phe-Lys-Lys-Phe-Phe-c[Asp-Arg-Arg-Nal(2′)-Arg-Trp-Lys]-D-Phe-D-Val-NH2 2212 TCAM2209 Lys-Lys-Phe-Lys-Lys-Phe-Phe-c[Asp-Arg-Arg-Pro-Nal(2′)-Arg-Trp-Lys]-D-Val-D-Pro- NH2 2213 TCAM2210 Lys-Lys-Phe-Lys-Lys-Phe-Phe-c[Asp-Arg-Arg-Pro-D-Nal(2′)-Arg-Trp-Lys]-D-Pro-D-Val- NH2 2214 TCAM2211 Lys-Lys-Phe-Lys-Lys-Phe-Phe-c[Asp-Arg-Arg-Pro-D-Nal(2′)-Arg-Trp-Lys]-D-Val-D-Phe- NH2 2215 TCAM2212 Lys-Lys-Phe-Lys-Lys-Phe-Phe-c[Asp-Arg-Arg-Pro-Nal(2′)-Arg-Trp-Lys]-D-Phe-D-Val- NH2 2216 TCAM2213 Lys-Lys-Phe-Lys-Lys-Phe-Phe-c[Asp-Arg-D-Nal(2′)-Arg-Trp-Lys]-D-Val-D-Pro-NH2 2217 TCAM2214 Lys-Lys-Phe-Lys-Lys-Phe-Phe-c[Asp-Arg-D-Nal(2′)-Arg-Trp-Lys]-D-Pro-D-Val-NH2 2218 TCAM2215 Lys-Lys-Phe-Lys-Lys-Phe-Phe-c[Asp-Arg-D-Nal(2′)-Arg-Trp-Lys]-D-Val-D-Phe-NH2 2219 TCAM2216 Lys-Lys-Phe-Lys-Lys-Phe-Phe-c[Asp-Arg-D-Nal(2′)-Arg-Trp-Lys]-D-Phe-D-Val-NH2 2220 TCAM2217 Lys-Lys-Phe-Lys-Lys-Phe-Phe-c[Asp-Arg-Pro-D-Nal(2′)-Arg-Trp-Lys]-D-Val-D-Pro-NH2 2221 TCAM2218 Lys-Lys-Phe-Lys-Lys-Phe-Phe-c[Asp-Arg-Pro-D-Nal(2′)-Arg-Trp-Lys]-D-Pro-D-Val-NH2 2222 TCAM2219 Lys-Lys-Phe-Lys-Lys-Phe-Phe-c[Asp-Arg-Pro-D-Nal(2′)-Arg-Trp-Lys]-D-Val-D-Phe-NH2 2223 TCAM2220 Lys-Lys-Phe-Lys-Lys-Phe-Phe-c[Asp-Arg-Pro-D-Nal(2′)-Arg-Trp-Lys]-D-Phe-D-Val-NH2 2224 TCAM2221 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Arg-Arg-c[Asp-Pro-D-Nal(2′)-Arg-Trp-Lys]-D-Val-D-Pro- NH2 2225 TCAM2222 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Arg-Arg-c[Asp-Pro-D-Nal(2′)-Arg-Trp-Lys]-D-Pro-D-Val- NH2 2226 TCAM2223 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Arg-Arg-c[Asp-Pro-D-Nal(2′)-Arg-Trp-Lys]-D-Val-D-Phe- NH2 2227 TCAM2224 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Arg-Arg-c[Asp-Pro-D-Nal(2′)-Arg-Trp-Lys]-D-Phe-D-Val- NH2 2228 TCAM2225 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Arg-Arg-c[Asp-His-D-Nal(2′)-Arg-Trp-Lys]-D-Val-D-Pro- NH2 2229 TCAM2226 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Arg-Arg-c[Asp-His-D-Nal(2′)-Arg-Trp-Lys]-D-Pro-D-Val- NH2 2230 TCAM2227 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Arg-Arg-c[Asp-His-D-Nal(2′)-Arg-Trp-Lys]-D-Val-D-Phe- NH2 2231 TCAM2228 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Arg-Arg-c[Asp-His-D-Nal(2′)-Arg-Trp-Lys]-D-Phe-D-Val- NH2 2232 TCAM2229 Lys-Lys-Phe-Lys-Lys-Phe-Phe-c[Asp-Arg-Pro-D-Nal(2′)-Arg-Trp-Arg-Lys]-D-Val-D-Pro- NH2 2233 TCAM2230 Lys-Lys-Phe-Lys-Lys-Phe-Phe-c[Asp-Arg-Pro-D-Nal(2′)-Arg-Trp-Arg-Lys]-D-Pro-D-Val- NH2 2234 TCAM2231 Lys-Lys-Phe-Lys-Lys-Phe-Phe-c[Asp-Arg-Pro-D-Nal(2′)-Arg-Trp-Arg-Lys]-D-Val-D-Phe- NH2 2235 TCAM2232 Lys-Lys-Phe-Lys-Lys-Phe-Phe-c[Asp-Arg-Pro-D-Nal(2′)-Arg-Trp-Arg-Lys]-D-Phe-D-Val- NH2 2236 TCAM2233 Lys-Lys-Phe-Lys-Lys-Phe-Phe-c[Asp-Arg-His-D-Nal(2′)-Arg-Trp-Arg-Lys]-D-Val-D-Pro- NH2 2237 TCAM2234 Lys-Lys-Phe-Lys-Lys-Phe-Phe-c[Asp-Arg-His-D-Nal(2′)-Arg-Trp-Arg-Lys]-D-Pro-D-Val- NH2 2238 TCAM2235 Lys-Lys-Phe-Lys-Lys-Phe-Phe-c[Asp-Arg-His-D-Nal(2′)-Arg-Trp-Arg-Lys]-D-Val-D-Phe- NH2 2239 TCAM2236 Lys-Lys-Phe-Lys-Lys-Phe-Phe-c[Asp-Arg-His-D-Nal(2′)-Arg-Trp-Arg-Lys]-D-Phe-D-Val- NH2 2240 TCAM2237 Lys-Lys-Phe-Lys-Lys-Phe-Phe-c[Asp-His-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Val-D-Phe- NH2 2241 TCAM2238 Lys-Lys-Phe-Lys-Lys-Phe-Phe-c[Asp-His-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Phe-D-Val- NH2 2242 TCAM2239 Lys-Lys-Phe-Lys-Lys-Phe-Phe-c[Asp-Pro-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Val-D-Pro- NH2 2243 TCAM2240 Lys-Lys-Phe-Lys-Lys-Phe-Phe-c[Asp-Pro-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Pro-D-Val- NH2 2244 TCAM2241 Lys-Lys-Phe-Lys-Lys-Phe-Phe-c[Asp-Pro-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Val-D-Phe- NH2 2245 TCAM2242 Lys-Lys-Phe-Lys-Lys-Phe-Phe-c[Asp-Pro-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Phe-D-Val- NH2 2246 TCAM2243 Lys-Lys-Phe-Lys-Lys-Phe-Phe-c[Asp-Arg-Arg-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Val-D- Pro-NH2 2247 TCAM2244 Lys-Lys-Phe-Lys-Lys-Phe-Phe-c[Asp-Arg-Arg-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Pro-D- Val-NH2 2248 TCAM2245 Lys-Lys-Phe-Lys-Lys-Phe-Phe-c[Asp-Arg-Arg-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Val-D- Phe-NH2 2249 TCAM2246 Lys-Lys-Phe-Lys-Lys-Phe-Phe-c[Asp-Arg-Arg-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Phe-D- Val-NH2 2250 TCAM2247 Lys-Lys-Phe-Lys-Lys-Phe-Phe-c[Asp-Arg-Arg-Pro-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Val- D-Pro-NH2 2251 TCAM2248 Lys-Lys-Phe-Lys-Lys-Phe-Phe-c[Asp-Arg-Arg-Pro-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Pro- D-Val-NH2 2252 TCAM2249 Lys-Lys-Phe-Lys-Lys-Phe-Phe-c[Asp-Arg-Arg-Pro-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Val- D-Phe-NH2 2253 TCAM2250 Lys-Lys-Phe-Lys-Lys-Phe-Phe-c[Asp-Arg-Arg-Pro-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Phe- D-Val-NH2 2254 TCAM2251 Lys-Lys-Phe-Lys-Lys-Phe-Phe-c[Asp-Arg-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Val-D-Pro- NH2 2255 TCAM2252 Lys-Lys-Phe-Lys-Lys-Phe-Phe-c[Asp-Arg-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Pro-D-Val- NH2 2256 TCAM2253 Lys-Lys-Phe-Lys-Lys-Phe-Phe-c[Asp-Arg-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Val-D-Phe-NH2 2257 TCAM2254 Lys-Lys-Phe-Lys-Lys-Phe-Phe-c[Asp-Arg-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Phe-D-Val- NH2 2258 TCAM2255 Lys-Lys-Phe-Lys-Lys-Phe-Phe-c[Asp-Arg-Pro-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Val-D- Pro-NH2 2259 TCAM2256 Lys-Lys-Phe-Lys-Lys-Phe-Phe-c[Asp-Arg-Pro-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Pro-D- Val-NH2 2260 TCAM2257 Lys-Lys-Phe-Lys-Lys-Phe-Phe-c[Asp-Arg-Pro-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Val-D- Phe-NH2 2261 TCAM2258 Lys-Lys-Phe-Lys-Lys-Phe-Phe-c[Asp-Arg-Pro-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Phe-D- Val-NH2 2262 TCAM2259 Lys-Lys-Phe-Lys-Lys-Phe-Phe-c[Asp-Arg-His-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Val-D-Pro- NH2 2263 TCAM2260 Lys-Lys-Phe-Lys-Lys-Phe-Phe-c[Asp-Arg-His-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Pro-D-Val- NH2 2264 TCAM2261 Lys-Lys-Phe-Lys-Lys-Phe-Phe-c[Asp-Arg-His-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Val-D-Phe- NH2 2265 TCAM2262 Lys-Lys-Phe-Lys-Lys-Phe-Phe-c[Asp-Arg-His-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Phe-D-Val- NH2 2266 TCAM2263 Lys-Lys-Phe-Lys-Lys-Phe-Phe-c[Asp-Arg-D-D-Nal(2′)-Arg-D-Nal(2′)-Arg-Lys]-D-Val-D- Pro-NH2 2267 TCAM2264 Lys-Lys-Phe-Lys-Lys-Phe-Phe-c[Asp-Arg-D-Nal(2′)-Arg-D-Nal(2′)-Arg-Lys]-D-Pro-D- Val-NH2 2268 TCAM2265 Lys-Lys-Phe-Lys-Lys-Phe-Phe-c[Asp-Arg-D-Nal(2′)-Arg-D-Nal(2′)-Arg-Lys]-D-Val-D- Phe-NH2 2269 TCAM2266 Lys-Lys-Phe-Lys-Lys-Phe-Phe-c[Asp-Arg-D-Nal(2′)-Arg-D-Nal(2′)-Arg-Lys]-D-Phe-D- Val-NH2 2270 TCAM2267 Lys-Lys-Phe-Lys-Lys-Phe-Phe-c[Asp-Arg-Pro-D-Nal(2′)-Arg-D-Nal(2′)-Arg-Lys]-D-Val- D-Pro-NH2 2271 TCAM2268 Lys-Lys-Phe-Lys-Lys-Phe-Phe-c[Asp-Arg-Pro-D-Nal(2′)-Arg-D-Nal(2′)-Arg-Lys]-D-Pro- D-Val-NH2 2272 TCAM2269 Lys-Lys-Phe-Lys-Lys-Phe-Phe-c[Asp-Arg-Pro-D-Nal(2′)-Arg-D-Nal(2′)-Arg-Lys]-D-Val- D-Phe-NH2 2273 TCAM2270 Lys-Lys-Phe-Lys-Lys-Phe-Phe-c[Asp-Arg-Pro-D-Nal(2′)-Arg-D-Nal(2′)-Arg-Lys]-D-Phe- D-Val-NH2 2274 TCAM2271 Lys-Lys-Phe-Lys-Lys-Phe-Phe-c[Asp-Arg-His-D-Nal(2′)-Arg-D-Nal(2′)-Arg-Lys]-D-Val-D- Pro-NH2 2275 TCAM2272 Lys-Lys-Phe-Lys-Lys-Phe-Phe-c[Asp-Arg-His-D-Nal(2′)-Arg-D-Nal(2′)-Arg-Lys]-D-Pro- D-Val-NH2 2276 TCAM2273 Lys-Lys-Phe-Lys-Lys-Phe-Phe-c[Asp-Arg-His-D-Nal(2′)-Arg-D-Nal(2′)-Arg-Lys]-D-Val-D- Phe-NH2 2277 TCAM2274 Lys-Lys-Phe-Lys-Lys-Phe-Phe-c[Asp-Arg-His-D-Nal(2′)-Arg-D-Nal(2′)-Arg-Lys]-D-Phe- D-Val-NH2 2278 TCAM2275 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Arg-Arg-c[Asp-Pro-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Val- D-Pro-NH2 2279 TCAM2276 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Arg-Arg-c[Asp-Pro-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Pro- D-Val-NH2 2280 TCAM2277 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Arg-Arg-c[Asp-Pro-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Val- D-Phe-NH2 2281 TCAM2278 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Arg-Arg-c[Asp-Pro-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Phe- D-Val-NH2 2282 TCAM2279 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Arg-Arg-c[Asp-His-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Val-D- Pro-NH2 2283 TCAM2280 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Arg-Arg-c[Asp-His-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Pro- D-Val-NH2 2284 TCAM2281 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Arg-Arg-c[Asp-His-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Val-D- Phe-NH2 2285 TCAM2282 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Arg-Arg-c[Asp-His-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Phe- D-Val-NH2 2286 TCAM2283 Lys-Lys-Phe-Lys-Lys-Phe-Phe-c[Asp-Arg-Pro-D-Nal(2′)-Arg-D-Nal(2′)-Arg-Lys]-D-Val- D-Pro-NH2 2287 TCAM2284 Lys-Lys-Phe-Lys-Lys-Phe-Phe-c[Asp-Arg-Pro-D-Nal(2′)-Arg-D-Nal(2′)-Arg-Lys]-D-Pro- D-Val-NH2 2288 TCAM2285 Lys-Lys-Phe-Lys-Lys-Phe-Phe-c[Asp-Arg-Pro-D-Nal(2′)-Arg-D-Nal(2′)-Arg-Lys]-D-Val- D-Phe-NH2 2289 TCAM2286 Lys-Lys-Phe-Lys-Lys-Phe-Phe-c[Asp-Arg-Pro-D-Nal(2′)-Arg-D-Nal(2′)-Arg-Lys]-D-Phe- D-Val-NH2 2290 TCAM2287 Lys-Lys-Phe-Lys-Lys-Phe-Phe-c[Asp-Arg-His-D-Nal(2′)-Arg-D-Nal(2′)-Arg-Lys]-D-Val-D- Pro-NH2 2291 TCAM2288 Lys-Lys-Phe-Lys-Lys-Phe-Phe-c[Asp-Arg-His-D-Nal(2′)-Arg-D-Nal(2′)-Arg-Lys]-D-Pro- D-Val-NH2 2292 TCAM2289 Lys-Lys-Phe-Lys-Lys-Phe-Phe-c[Asp-Arg-His-D-Nal(2′)-Arg-D-Nal(2′)-Arg-Lys]-D-Val-D- Phe-NH2 2293 TCAM2290 Lys-Lys-Phe-Lys-Lys-Phe-Phe-c[Asp-Arg-His-D-Nal(2′)-Arg-D-Nal(2′)-Arg-Lys]-D-Phe- D-Val-NH2 2294 TCAM2291 Lys-Lys-Phe-Lys-Lys-Phe-Phe-c[Asp-His-D-Nal(2′)-Arg-Trp-Lys]-Arg-Arg-D-Val-D-Pro- NH2 2295 TCAM2292 Lys-Lys-Phe-Lys-Lys-Phe-Phe-c[Asp-His-D-Nal(2′)-Arg-Trp-Lys]-Arg-Arg-D-Pro-D-Val- NH2 2296 TCAM2293 Lys-Lys-Phe-Lys-Lys-Phe-Phe-c[Asp-His-D-Nal(2′)-Arg-Trp-Lys]-Arg-Arg-D-Val-D-Phe- NH2 2297 TCAM2294 Lys-Lys-Phe-Lys-Lys-Phe-Phe-c[Asp-His-D-Nal(2′)-Arg-Trp-Lys]-Arg-Arg-D-Phe-D-Val- NH2 2298 TCAM2295 Lys-Lys-Phe-Lys-Lys-Phe-Phe-c[Asp-Pro-D-Nal(2′)-Arg-Trp-Lys]-Arg-Arg-D-Val-D-Pro- NH2 2299 TCAM2296 Lys-Lys-Phe-Lys-Lys-Phe-Phe-c[Asp-Pro-D-Nal(2′)-Arg-Trp-Lys]-Arg-Arg-D-Pro-D-Val- NH2 2300 TCAM2297 Lys-Lys-Phe-Lys-Lys-Phe-Phe-c[Asp-Pro-D-Nal(2′)-Arg-Trp-Lys]-Arg-Arg-D-Val-D-Phe- NH2 2301 TCAM2298 Lys-Lys-Phe-Lys-Lys-Phe-Phe-c[Asp-Pro-D-Nal(2′)-Arg-Trp-Lys]-Arg-Arg-D-Phe-D-Val- NH2 Anti-biofilm peptide ABF4ARG linked to anti-microbial peptides 2302 TCAM2299 Arg-Arg-Phe-Arg-Arg-Phe-Phe-c[Asp-Pro-Arg-Arg-Trp-Trp-Arg-Phe-Lys]-D-Val-D-Pro- NH2 2303 TCAM2300 Arg-Arg-Phe-Arg-Arg-Phe-Phe-c[Asp-Pro-Arg-Arg-Trp-Trp-Arg-Phe-Lys]-D-Val-D- Phe-NH2 2304 TCAM2301 Arg-Arg-Phe-Arg-Arg-Phe-Phe-c[Asp-Pro-Arg-Arg-Trp-Trp-Arg-Phe-Lys]-D-Pro-D-Val- NH2 2305 TCAM2302 Arg-Arg-Phe-Arg-Arg-Phe-Phe-c[Asp-Pro-Arg-Arg-Trp-Trp-Arg-Phe-Lys]-D-Phe-D- Val-NH2 2306 TCAM2303 Arg-Arg-Phe-Arg-Arg-Phe-Phe-c[Asp-Pro-Arg-Arg-Trp-Trp-Tyr-Phe-Lys]-D-Val-D-Pro- NH2 2307 TCAM2304 Arg-Arg-Phe-Arg-Arg-Phe-Phe-c[Asp-Pro-Arg-Arg-Trp-Trp-Tyr-Phe-Lys]-D-Val-D-Phe- NH2 2308 TCAM2305 Arg-Arg-Phe-Arg-Arg-Phe-Phe-c[Asp-Pro-Arg-Arg-Trp-Trp-Tyr-Phe-Lys]-D-Pro-D-Val- NH2 2309 TCAM2306 Arg-Arg-Phe-Arg-Arg-Phe-Phe-c[Asp-Pro-Arg-Arg-Trp-Trp-Tyr-Phe-Lys]-D-Phe-D-Val- NH2 2310 TCAM2307 Arg-Arg-Phe-Arg-Arg-Phe-Phe-c[Asp-Pro-Arg-Arg-Tyr-Tyr-Arg-Phe-Lys]-D-Val-D-Pro- NH2 2311 TCAM2308 Arg-Arg-Phe-Arg-Arg-Phe-Phe-c[Asp-Pro-Arg-Arg-Tyr-Tyr-Arg-Phe-Lys]-D-Val-D-Phe- NH2 2312 TCAM2309 Arg-Arg-Phe-Arg-Arg-Phe-Phe-c[Asp-Pro-Arg-Arg-Tyr-Tyr-Arg-Phe-Lys]-D-Pro-D-Val- NH2 2313 TCAM2310 Arg-Arg-Phe-Arg-Arg-Phe-Phe-c[Asp-Pro-Arg-Arg-Tyr-Tyr-Arg-Phe-Lys]-D-Phe-D-Val- NH2 2314 TCAM2311 Arg-Arg-Phe-Arg-Arg-Phe-Phe-c[Asp-Pro-Arg-Arg-Nal-Nal-Arg-Phe-Lys]-D-Val-D-Pro- NH2 2315 TCAM2312 Arg-Arg-Phe-Arg-Arg-Phe-Phe-c[Asp-Pro-Arg-Arg-Nal-Nal-Arg-Phe-Lys]-D-Val-D- Phe-NH2 2316 TCAM2313 Arg-Arg-Phe-Arg-Arg-Phe-Phe-c[Asp-Pro-Arg-Arg-Nal-Nal-Arg-Phe-Lys]-D-Pro-D-Val- NH2 2317 TCAM2314 Arg-Arg-Phe-Arg-Arg-Phe-Phe-c[Asp-Pro-Arg-Arg-Nal-Nal-Arg-Phe-Lys]-D-Phe-D- Val-NH2 2318 TCAM2315 Arg-Arg-Phe-Arg-Arg-Phe-Phe-c[Asp-Pro-Arg-Arg-Leu-Trp-Leu-Trp-Lys]-D-Val-D-Pro- NH2 2319 TCAM2316 Arg-Arg-Phe-Arg-Arg-Phe-Phe-c[Asp-Pro-Arg-Arg-Leu-Trp-Leu-Trp-Lys]-D-Val-D- Phe-NH2 2320 TCAM2317 Arg-Arg-Phe-Arg-Arg-Phe-Phe-c[Asp-Pro-Arg-Arg-Leu-Trp-Leu-Trp-Lys]-D-Pro-D-Val- NH2 2321 TCAM2318 Arg-Arg-Phe-Arg-Arg-Phe-Phe-c[Asp-Pro-Arg-Arg-Leu-Trp-Leu-Trp-Lys]-D-Phe-D- Val-NH2 2322 TCAM2319 Arg-Arg-Phe-Arg-Arg-Phe-Phe-c[Asp-Pro-Arg-Arg-Leu-Trp-Leu-Trp-Lys]-D-Val-D-Pro- NH2 2323 TCAM2320 Arg-Arg-Phe-Arg-Arg-Phe-Phe-c[Asp-Pro-Arg-Arg-Leu-Trp-Leu-Trp-Lys]-D-Val-D- Phe-NH2 2324 TCAM2321 Arg-Arg-Phe-Arg-Arg-Phe-Phe-c[Asp-Pro-Arg-Arg-Leu-Trp-Leu-Trp-Lys]-D-Pro-D-Val- NH2 2325 TCAM2322 Arg-Arg-Phe-Arg-Arg-Phe-Phe-c[Asp-Pro-Arg-Arg-Leu-Trp-Leu-Trp-Lys]-D-Phe-D- Val-NH2 2326 TCAM2323 Arg-Arg-Phe-Arg-Arg-Phe-Phe-c[Asp-Arg-Arg-Arg-Trp-Leu-Trp-Leu-Trp-Lys]-D-Val-D- Pro-NH2 2327 TCAM2324 Arg-Arg-Phe-Arg-Arg-Phe-Phe-c[Asp-Pro-Arg-Arg-Arg-Trp-Leu-Trp-Leu-Trp-Lys]-D- Val-D-Phe-NH2 2328 TCAM2325 Arg-Arg-Phe-Arg-Arg-Phe-Phe-c[Asp-Pro-Arg-Arg-Arg-Trp-Leu-Trp-Leu-Trp-Lys]-D- Pro-D-Val-NH2 2329 TCAM2326 Arg-Arg-Phe-Arg-Arg-Phe-Phe-c[Asp-Pro-Arg-Arg-Arg-Trp-Leu-Trp-Leu-Trp-Lys]-D- Phe-D-Val-NH2 2330 TCAM2327 Arg-Arg-Phe-Arg-Arg-Phe-Phe-c[Asp-Pro-Arg-Gln-Arg-Arg-Trp-Leu-Trp-Leu-Trp- Lys]-D-Val-D-Pro-NH2 2331 TCAM2328 Arg-Arg-Phe-Arg-Arg-Phe-Phe-c[Asp-Pro-Arg-Gln-Arg-Arg-Trp-Leu-Trp-Leu-Trp- Lys]-D-Val-D-Phe-NH2 2332 TCAM2329 Arg-Arg-Phe-Arg-Arg-Phe-Phe-c[Asp-Pro-Arg-Gln-Arg-Arg-Trp-Leu-Trp-Leu-Trp- Lys]-D-Pro-D-Val-NH2 2333 TCAM2330 Arg-Arg-Phe-Arg-Arg-Phe-Phe-c[Asp-Pro-Arg-Gln-Arg-Arg-Trp-Leu-Trp-Leu-Trp- Lys]-D-Phe-D-Val-NH2 2334 TCAM2331 Arg-Arg-Phe-Arg-Arg-Phe-Phe-c[Asp-Pro-Trp-Arg-Trp-Trp-Arg-Arg-Lys]-D-Val-D-Phe- NH2 2335 TCAM2332 Arg-Arg-Phe-Arg-Arg-Phe-Phe-c[Asp-Pro-Trp-Arg-Trp-Trp-Arg-Arg-Lys]-D-Pro-D-Val- NH2 2336 TCAM2333 Arg-Arg-Phe-Arg-Arg-Phe-Phe-c[Asp-Pro-Trp-Arg-Trp-Trp-Arg-Arg-Lys]-D-Phe-D-Val- NH2 2337 TCAM2334 Arg-Arg-Phe-Arg-Arg-Phe-Phe-c[Asp-Pro-Trp-Trp-Arg-Arg-Trp-Trp-Arg-Arg-Lys]-D- Val-D-Pro-NH2 2338 TCAM2335 Arg-Arg-Phe-Arg-Arg-Phe-Phe-c[Asp-Pro-Trp-Trp-Arg-Arg-Trp-Trp-Arg-Arg-Lys]-D- Val-D-Phe-NH2 2339 TCAM2336 Arg-Arg-Phe-Arg-Arg-Phe-Phe-c[Asp-Pro-Trp-Trp-Arg-Arg-Trp-Trp-Arg-Arg-Lys]-D- Pro-D-Val-NH2 2340 TCAM2337 Arg-Arg-Phe-Arg-Arg-Phe-Phe-c[Asp-Pro-Trp-Trp-Arg-Arg-Trp-Trp-Arg-Arg-Lys]-D- Phe-D-Val-NH2 2341 TCAM2338 Arg-Arg-Phe-Arg-Arg-Phe-Phe-c[Asp-Pro-Trp-Arg-Trp-Arg-Trp-Arg-Lys]-D-Val-D-Pro- NH2 2342 TCAM2339 Arg-Arg-Phe-Arg-Arg-Phe-Phe-c[Asp-Pro-Trp-Arg-Trp-Arg-Trp-Arg-Lys]-D-Val-D-Phe- NH2 2343 TCAM2340 Arg-Arg-Phe-Arg-Arg-Phe-Phe-c[Asp-Pro-Trp-Arg-Trp-Arg-Trp-Arg-Lys]-D-Pro-D-Val- NH2 2344 TCAM2341 Arg-Arg-Phe-Arg-Arg-Phe-Phe-c[Asp-Pro-Trp-Arg-Trp-Arg-Trp-Arg-Lys]-D-Phe-D-Val- NH2 2345 TCAM2342 Arg-Arg-Phe-Arg-Arg-Phe-Phe-c[Asp-Pro-Arg-Trp-Arg-Trp-Arg-Trp-Lys]-D-Val-D-Pro- NH2 2346 TCAM2343 Arg-Arg-Phe-Arg-Arg-Phe-Phe-c[Asp-Pro-Arg-Trp-Arg-Trp-Arg-Trp-Lys]-D-Val-D-Phe- NH2 2347 TCAM2344 Arg-Arg-Phe-Arg-Arg-Phe-Phe-c[Asp-Pro-Arg-Trp-Arg-Trp-Arg-Trp-Lys]-D-Pro-D-Val- NH2 2348 TCAM2345 Arg-Arg-Phe-Arg-Arg-Phe-Phe-c[Asp-Pro-Arg-Trp-Arg-Trp-Arg-Trp-Lys]-D-Phe-D-Val- NH2 2349 TCAM2346 Arg-Arg-Phe-Arg-Arg-Phe-Phe-c[Asp-Pro-Arg-Trp-Trp-Arg-Arg-Lys]-D-Val-D-Pro-NH2 2350 TCAM2347 Arg-Arg-Phe-Arg-Arg-Phe-Phe-c[Asp-Pro-Arg-Trp-Trp-Arg-Arg-Lys]-D-Val-D-Phe- NH2 2351 TCAM2348 Arg-Arg-Phe-Arg-Arg-Phe-Phe-c[Asp-Pro-Arg-Trp-Trp-Arg-Arg-Lys]-D-Pro-D-Val-NH2 2352 TCAM2349 Arg-Arg-Phe-Arg-Arg-Phe-Phe-c[Asp-Pro-Arg-Trp-Trp-Arg-Arg-Lys]-D-Phe-D-Val- NH2 2353 TCAM2350 Arg-Arg-Phe-Arg-Arg-Phe-Phe-c[Asp-Pro-Trp-Trp-Arg-Arg-Trp-Lys]-D-Val-D-Pro-NH2 2354 TCAM2351 Arg-Arg-Phe-Arg-Arg-Phe-Phe-c[Asp-Pro-Trp-Trp-Arg-Arg-Trp-Lys]-D-Val-D-Phe-NH2 2355 TCAM2352 Arg-Arg-Phe-Arg-Arg-Phe-Phe-c[Asp-Pro-Trp-Trp-Arg-Arg-Trp-Lys]-D-Pro-D-Val-NH2 2356 TCAM2353 Arg-Arg-Phe-Arg-Arg-Phe-Phe-c[Asp-Pro-Trp-Trp-Arg-Arg-Trp-Lys]-D-Phe-D-Val-NH2 2357 TCAM2354 Arg-Arg-Phe-Arg-Arg-Phe-Phe-c[Asp-Pro-Trp-Arg-Trp-Arg-Trp-Lys]-D-Val-D-Pro-NH2 2358 TCAM2355 Arg-Arg-Phe-Arg-Arg-Phe-Phe-c[Asp-Pro-Trp-Arg-Trp-Arg-Trp-Lys]-D-Val-D-Phe-NH2 2359 TCAM2356 Arg-Arg-Phe-Arg-Arg-Phe-Phe-c[Asp-Pro-Trp-Arg-Trp-Arg-Trp-Lys]-D-Pro-D-Val-NH2 2360 TCAM2357 Arg-Arg-Phe-Arg-Arg-Phe-Phe-c[Asp-Pro-Trp-Arg-Trp-Arg-Trp-Lys]-D-Phe-D-Val-NH2 2361 TCAM2358 Arg-Arg-Phe-Arg-Arg-Phe-Phe-c[Asp-Pro-Arg-Trp-Arg-Trp-Arg-Lys]-D-Val-D-Pro-NH2 2362 TCAM2359 Arg-Arg-Phe-Arg-Arg-Phe-Phe-c[Asp-Pro-Arg-Trp-Arg-Trp-Arg-Lys]-D-Val-D-Phe- NH2 2363 TCAM2360 Arg-Arg-Phe-Arg-Arg-Phe-Phe-c[Asp-Pro-Arg-Trp-Arg-Trp-Arg-Lys]-D-Pro-D-Val-NH2 2364 TCAM2361 Arg-Arg-Phe-Arg-Arg-Phe-Phe-c[Asp-Pro-Arg-Trp-Arg-Trp-Arg-Lys]-D-Phe-D-Val- NH2 2365 TCAM2362 Arg-Arg-Phe-Arg-Arg-Phe-Phe-c[Asp-Pro-Trp-Arg-Tyr-Arg-Trp-Lys]-D-Val-D-Pro-NH2 2366 TCAM2363 Arg-Arg-Phe-Arg-Arg-Phe-Phe-c[Asp-Pro-Trp-Arg-Tyr-Arg-Trp-Lys]-D-Val-D-Phe-NH2 2367 TCAM2364 Arg-Arg-Phe-Arg-Arg-Phe-Phe-c[Asp-Pro-Trp-Arg-Tyr-Arg-Trp-Lys]-D-Pro-D-Val-NH2 2368 TCAM2365 Arg-Arg-Phe-Arg-Arg-Phe-Phe-c[Asp-Pro-Trp-Arg-Tyr-Arg-Trp-Lys]-D-Phe-D-Val-NH2 2369 TCAM2366 Arg-Arg-Phe-Arg-Arg-Phe-Phe-c[Asp-Pro-Trp-Arg-Trp-Arg-Tyr-Lys]-D-Val-D-Pro-NH2 2370 TCAM2367 Arg-Arg-Phe-Arg-Arg-Phe-Phe-c[Asp-Pro-Trp-Arg-Trp-Arg-Tyr-Lys]-D-Val-D-Phe-NH2 2371 TCAM2368 Arg-Arg-Phe-Arg-Arg-Phe-Phe-c[Asp-Pro-Trp-Arg-Trp-Arg-Tyr-Lys]-D-Pro-D-Val-NH2 2372 TCAM2369 Arg-Arg-Phe-Arg-Arg-Phe-Phe-c[Asp-Pro-Trp-Arg-Trp-Arg-Tyr-Lys]-D-Phe-D-Val-NH2 2373 TCAM2370 Arg-Arg-Phe-Arg-Arg-Phe-Phe-c[Asp-Pro-Trp-Arg-Trp-Arg-Lys]-D-Val-D-Pro-NH2 2374 TCAM2371 Arg-Arg-Phe-Arg-Arg-Phe-Phe-c[Asp-Pro-Trp-Arg-Trp-Arg-Lys]-D-Val-D-Phe-NH2 2375 TCAM2372 Arg-Arg-Phe-Arg-Arg-Phe-Phe-c[Asp-Pro-Trp-Arg-Trp-Arg-Lys]-D-Pro-D-Val-NH2 2376 TCAM2373 Arg-Arg-Phe-Arg-Arg-Phe-Phe-c[Asp-Pro-Trp-Arg-Trp-Arg-Lys]-D-Phe-D-Val-NH2 2377 TCAM2374 Arg-Arg-Phe-Arg-Arg-Phe-Phe-c[Asp-Pro-Trp-Arg-Arg-Trp-Lys]-D-Val-D-Pro-NH2 2378 TCAM2375 Arg-Arg-Phe-Arg-Arg-Phe-Phe-c[Asp-Pro-Trp-Arg-Arg-Trp-Lys]-D-Val-D-Phe-NH2 2379 TCAM2376 Arg-Arg-Phe-Arg-Arg-Phe-Phe-c[Asp-Pro-Trp-Arg-Arg-Trp-Lys]-D-Pro-D-Val-NH2 2380 TCAM2377 Arg-Arg-Phe-Arg-Arg-Phe-Phe-c[Asp-Pro-Trp-Arg-Arg-Trp-Lys]-D-Phe-D-Val-NH2 2381 TCAM2378 Arg-Arg-Phe-Arg-Arg-Phe-Phe-c[Asp-Pro-Arg-Trp-Trp-Arg-Lys]-D-Val-D-Pro-NH2 2382 TCAM2379 Arg-Arg-Phe-Arg-Arg-Phe-Phe-c[Asp-Pro-Arg-Trp-Trp-Arg-Lys]-D-Val-D-Phe-NH2 2383 TCAM2380 Arg-Arg-Phe-Arg-Arg-Phe-Phe-c[Asp-Pro-Arg-Trp-Trp-Arg-Lys]-D-Pro-D-Val-NH2 2384 TCAM2381 Arg-Arg-Phe-Arg-Arg-Phe-Phe-c[Asp-Pro-Arg-Trp-Trp-Arg-Lys]-D-Phe-D-Val-NH2 2385 TCAM2382 Arg-Arg-Phe-Arg-Arg-Phe-Phe-c[Asp-Pro-Trp-Arg-Trp-Lys]-D-Val-D-Pro-NH2 2386 TCAM2383 Arg-Arg-Phe-Arg-Arg-Phe-Phe-c[Asp-Pro-Trp-Arg-Trp-Lys]-D-Val-D-Phe-NH2 2387 TCAM2384 Arg-Arg-Phe-Arg-Arg-Phe-Phe-c[Asp-Pro-Trp-Arg-Trp-Lys]-D-Pro-D-Val-NH2 2388 TCAM2385 Arg-Arg-Phe-Arg-Arg-Phe-Phe-c[Asp-Pro-Trp-Arg-Trp-Lys]-D-Phe-D-Val-NH2 2389 TCAM2386 Arg-Arg-Phe-Arg-Arg-Phe-Phe-c[Asp-Pro-Arg-Trp-Arg-Lys]-D-Val-D-Pro-NH2 2390 TCAM2387 Arg-Arg-Phe-Arg-Arg-Phe-Phe-c[Asp-Pro-Arg-Trp-Arg-Lys]-D-Val-D-Phe-NH2 2391 TCAM2388 Arg-Arg-Phe-Arg-Arg-Phe-Phe-c[Asp-Pro-Arg-Trp-Arg-Lys]-D-Pro-D-Val-NH2 2392 TCAM2389 Arg-Arg-Phe-Arg-Arg-Phe-Phe-c[Asp-Pro-Arg-Trp-Arg-Lys]-D-Phe-D-Val-NH2 2393 TCAM2390 -Arg-Arg-Phe-Arg-Arg-Phe-Phe-c[Asp-Arg-Arg-Trp-Trp-Arg-Phe-Lys]-D-Val-D-Pro- NH2 2394 TCAM2391 Arg-Arg-Phe-Arg-Arg-Phe-Phe-c[Asp-Arg-Arg-Trp-Trp-Arg-Phe-Lys]-D-Val-D-Phe- NH2 2395 TCAM2392 Arg-Arg-Phe-Arg-Arg-Phe-Phe-c[Asp-Arg-Arg-Trp-Trp-Arg-Phe-Lys]-D-Pro-D-Val- NH2 2396 TCAM2393 Arg-Arg-Phe-Arg-Arg-Phe-Phe-c[Asp-Arg-Arg-Trp-Trp-Arg-Phe-Lys]-D-Phe-D-Val- NH2 2397 TCAM2394 Arg-Arg-Phe-Arg-Arg-Phe-Phe-c[Asp-Arg-Arg-Trp-Trp-Arg-Phe-Lys]-D-Val-D-Pro- NH2 2398 TCAM2395 Arg-Arg-Phe-Arg-Arg-Phe-Phe-c[Asp-Arg-Arg-Trp-Trp-Arg-Phe-Lys]-D-Val-D-Phe- NH2 2399 TCAM2396 Arg-Arg-Phe-Arg-Arg-Phe-Phe-c[Asp-Arg-Arg-Trp-Trp-Arg-Phe-Lys]-D-Pro-D-Val- NH2 2400 TCAM2397 Arg-Arg-Phe-Arg-Arg-Phe-Phe-c[Asp-Arg-Arg-Trp-Trp-Arg-Phe-Lys]-D-Phe-D-Val- NH2 2401 TCAM2398 Arg-Arg-Phe-Arg-Arg-Phe-Phe-c[Asp-Arg-Arg-Tyr-Tyr-Arg-Phe-Lys]-D-Val-D-Pro-NH2 2402 TCAM2399 Arg-Arg-Phe-Arg-Arg-Phe-Phe-c[Asp-Arg-Arg-Tyr-Tyr-Arg-Phe-Lys]-D-Val-D-Phe- NH2 2403 TCAM2400 Arg-Arg-Phe-Arg-Arg-Phe-Phe-c[Asp-Arg-Arg-Tyr-Tyr-Arg-Phe-Lys]-D-Pro-D-Val-NH2 2404 TCAM2401 Arg-Arg-Phe-Arg-Arg-Phe-Phe-c[Asp-Arg-Arg-Tyr-Tyr-Arg-Phe-Lys]-D-Phe-D-Val- NH2 2405 TCAM2402 Arg-Arg-Phe-Arg-Arg-Phe-Phe-c[Asp-Arg-Arg-Nal-Nal-Arg-Phe-Lys]-D-Val-D-Pro- NH2 2406 TCAM2403 Arg-Arg-Phe-Arg-Arg-Phe-Phe-c[Asp-Arg-Arg-Nal-Nal-Arg-Phe-Lys]-D-Val-D-Phe- NH2 2407 TCAM2404 Arg-Arg-Phe-Arg-Arg-Phe-Phe-c[Asp-Arg-Arg-Nal-Nal-Arg-Phe-Lys]-D-Pro-D-Val- NH2 2408 TCAM2405 Arg-Arg-Phe-Arg-Arg-Phe-Phe-c[Asp-Arg-Arg-Nal-Nal-Arg-Phe-Lys]-D-Phe-D-Val- NH2 2409 TCAM2406 Arg-Arg-Phe-Arg-Arg-Phe-Phe-c[Asp-Arg-Arg-Leu-Trp-Leu-Trp-Lys]-D-Val-D-Pro-NH2 2410 TCAM2407 Arg-Arg-Phe-Arg-Arg-Phe-Phe-c[Asp-Arg-Arg-Leu-Trp-Leu-Trp-Lys]-D-Val-D-Phe- NH2 2411 TCAM2408 Arg-Arg-Phe-Arg-Arg-Phe-Phe-c[Asp-Arg-Arg-Leu-Trp-Leu-Trp-Lys]-D-Pro-D-Val-NH2 2412 TCAM2409 Arg-Arg-Phe-Arg-Arg-Phe-Phe-c[Asp-Arg-Arg-Leu-Trp-Leu-Trp-Lys]-D-Phe-D-Val- NH2 2413 TCAM2410 Arg-Arg-Phe-Arg-Arg-Phe-Phe-c[Asp-Arg-Arg-Leu-Trp-Leu-Trp-Lys]-D-Val-D-Pro-NH2 2414 TCAM2411 Arg-Arg-Phe-Arg-Arg-Phe-Phe-c[Asp-Arg-Arg-Leu-Trp-Leu-Trp-Lys]-D-Val-D-Phe- NH2 2415 TCAM2412 Arg-Arg-Phe-Arg-Arg-Phe-Phe-c[Asp-Arg-Arg-Leu-Trp-Leu-Trp-Lys]-D-Pro-D-Val-NH2 2416 TCAM2413 Arg-Arg-Phe-Arg-Arg-Phe-Phe-c[Asp-Arg-Arg-Leu-Trp-Leu-Trp-Lys]-D-Phe-D-Val- NH2 2417 TCAM2414 Arg-Arg-Phe-Arg-Arg-Phe-Phe-c[Asp-Arg-Arg-Arg-Trp-Leu-Trp-Leu-Trp-Lys]-D-Val-D- Pro-NH2 2418 TCAM2415 Arg-Arg-Phe-Arg-Arg-Phe-Phe-c[Asp-Arg-Arg-Arg-Trp-Leu-Trp-Leu-Trp-Lys]-D-Val-D- Phe-NH2 2419 TCAM2416 Arg-Arg-Phe-Arg-Arg-Phe-Phe-c[Asp-Arg-Arg-Arg-Trp-Leu-Trp-Leu-Trp-Lys]-D-Pro-D- Val-NH2 2420 TCAM2417 Arg-Arg-Phe-Arg-Arg-Phe-Phe-c[Asp-Arg-Arg-Arg-Trp-Leu-Trp-Leu-Trp-Lys]-D-Phe- D-Val-NH2 2421 TCAM2418 Arg-Arg-Phe-Arg-Arg-Phe-Phe-c[Asp-Arg-Gln-Arg-Arg-Trp-Leu-Trp-Leu-Trp-Lys]-D- Val-D-Pro-NH2 2422 TCAM2419 Arg-Arg-Phe-Arg-Arg-Phe-Phe-c[Asp-Arg-Gln-Arg-Arg-Trp-Leu-Trp-Leu-Trp-Lys]-D- Val-D-Phe-NH2 2423 TCAM2420 Arg-Arg-Phe-Arg-Arg-Phe-Phe-c[Asp-Arg-Gln-Arg-Arg-Trp-Leu-Trp-Leu-Trp-Lys]-D- Pro-D-Val-NH2 2424 TCAM2421 Arg-Arg-Phe-Arg-Arg-Phe-Phe-c[Asp-Arg-Gln-Arg-Arg-Trp-Leu-Trp-Leu-Trp-Lys]-D- Phe-D-Val-NH2 2425 TCAM2422 Arg-Arg-Phe-Arg-Arg-Phe-Phe-c[Asp-Trp-Arg-Trp-Trp-Arg-Arg-Lys]-D-Val-D-Pro-NH2 2426 TCAM2423 Arg-Arg-Phe-Arg-Arg-Phe-Phe-c[Asp-Trp-Arg-Trp-Trp-Arg-Arg-Lys]-D-Val-D-Phe-NH2 2427 TCAM2424 Arg-Arg-Phe-Arg-Arg-Phe-Phe-c[Asp-Trp-Arg-Trp-Trp-Arg-Arg-Lys]-D-Pro-D-Val-NH2 2428 TCAM2425 Arg-Arg-Phe-Arg-Arg-Phe-Phe-c[Asp-Trp-Arg-Trp-Trp-Arg-Arg-Lys]-D-Phe-D-Val-NH2 2429 TCAM2426 Arg-Arg-Phe-Arg-Arg-Phe-Phe-c[Asp-Trp-Trp-Arg-Arg-Trp-Trp-Arg-Arg-Lys]-D-Val-D- Pro-NH2 2430 TCAM2427 Arg-Arg-Phe-Arg-Arg-Phe-Phe-c[Asp-Trp-Trp-Arg-Arg-Trp-Trp-Arg-Arg-Lys]-D-Val-D- Phe-NH2 2431 TCAM2428 Arg-Arg-Phe-Arg-Arg-Phe-Phe-c[Asp-Trp-Trp-Arg-Arg-Trp-Trp-Arg-Arg-Lys]-D-Pro-D- Val-NH2 2432 TCAM2429 Arg-Arg-Phe-Arg-Arg-Phe-Phe-c]Asp-Trp-Trp-Arg-Arg-Trp-Trp-Arg-Arg-Lys]-D-Phe-D- Val-NH2 2433 TCAM2430 Arg-Arg-Phe-Arg-Arg-Phe-Phe-c[Asp-Trp-Arg-Trp-Arg-Trp-Arg-Lys]-D-Val-D-Pro-NH2 2434 TCAM2431 Arg-Arg-Phe-Arg-Arg-Phe-Phe-c[Asp-Trp-Arg-Trp-Arg-Trp-Arg-Lys]-D-Val-D-Phe-NH2 2435 TCAM2432 Arg-Arg-Phe-Arg-Arg-Phe-Phe-c[Asp-Trp-Arg-Trp-Arg-Trp-Arg-Lys]-D-Pro-D-Val-NH2 2436 TCAM2433 Arg-Arg-Phe-Arg-Arg-Phe-Phe-c[Asp-Trp-Arg-Trp-Arg-Trp-Arg-Lys]-D-Phe-D-Val-NH2 2437 TCAM2434 Arg-Arg-Phe-Arg-Arg-Phe-Phe-c[Asp-Arg-Trp-Arg-Trp-Arg-Trp-Lys]-D-Val-D-Pro-NH2 2438 TCAM2435 Arg-Arg-Phe-Arg-Arg-Phe-Phe-c[Asp-Arg-Trp-Arg-Trp-Arg-Trp-Lys]-D-Val-D-Phe-NH2 2439 TCAM2436 Arg-Arg-Phe-Arg-Arg-Phe-Phe-c[Asp-Arg-Trp-Arg-Trp-Arg-Trp-Lys]-D-Pro-D-Val-NH2 2440 TCAM2437 Arg-Arg-Phe-Arg-Arg-Phe-Phe-c[Asp-Arg-Trp-Arg-Trp-Arg-Trp-Lys]-D-Phe-D-Val-NH2 2441 TCAM2438 Arg-Arg-Phe-Arg-Arg-Phe-Phe-c[Asp-Arg-Trp-Trp-Arg-Arg-Lys]-D-Val-D-Pro-NH2 2442 TCAM2439 Arg-Arg-Phe-Arg-Arg-Phe-Phe-c[Asp-Arg-Trp-Trp-Arg-Arg-Lys]-D-Val-D-Phe-NH2 2443 TCAM2440 Arg-Arg-Phe-Arg-Arg-Phe-Phe-c[Asp-Arg-Trp-Trp-Arg-Arg-Lys]-D-Pro-D-Val-NH2 2444 TCAM2441 Arg-Arg-Phe-Arg-Arg-Phe-Phe-c[Asp-Arg-Trp-Trp-Arg-Arg-Lys]-D-Phe-D-Val-NH2 2445 TCAM2442 Arg-Arg-Phe-Arg-Arg-Phe-Phe-c[Asp-Arg-Trp-Arg-Trp-Arg-Lys]-D-Val-D-Pro-NH2 2446 TCAM2443 Arg-Arg-Phe-Arg-Arg-Phe-Phe-c[Asp-Arg-Trp-Arg-Trp-Arg-Lys]-D-Val-D-Phe-NH2 2447 TCAM2444 Arg-Arg-Phe-Arg-Arg-Phe-Phe-c[Asp-Arg-Trp-Arg-Trp-Arg-Lys]-D-Pro-D-Val-NH2 2448 TCAM2445 Arg-Arg-Phe-Arg-Arg-Phe-Phe-c[Asp-Arg-Trp-Arg-Trp-Arg-Lys]-D-Phe-D-Val-NH2 2449 TCAM2446 Arg-Arg-Phe-Arg-Arg-Phe-Phe-c[Asp-Trp-Trp-Arg-Arg-Trp-Lys]-D-Val-D-Pro-NH2 2450 TCAM2447 Arg-Arg-Phe-Arg-Arg-Phe-Phe-c[Asp-Trp-Trp-Arg-Arg-Trp-Lys]-D-Val-D-Phe-NH2 2451 TCAM2448 Arg-Arg-Phe-Arg-Arg-Phe-Phe-c[Asp-Trp-Trp-Arg-Arg-Trp-Lys]-D-Pro-D-Val-NH2 2452 TCAM2449 Arg-Arg-Phe-Arg-Arg-Phe-Phe-c[Asp-Trp-Trp-Arg-Arg-Trp-Lys]-D-Phe-D-Val-NH2 2453 TCAM2450 Arg-Arg-Phe-Arg-Arg-Phe-Phe-c[Asp-Trp-Arg-Trp-Arg-Trp-Lys]-D-Val-D-Pro-NH2 2454 TCAM2451 Arg-Arg-Phe-Arg-Arg-Phe-Phe-c[Asp-Trp-Arg-Trp-Arg-Trp-Lys]-D-Val-D-Phe-NH2 2455 TCAM2452 Arg-Arg-Phe-Arg-Arg-Phe-Phe-c[Asp-Trp-Arg-Trp-Arg-Trp-Lys]-D-Pro-D-Val-NH2 2456 TCAM2453 Arg-Arg-Phe-Arg-Arg-Phe-Phe-c[Asp-Trp-Arg-Trp-Arg-Trp-Lys]-D-Phe-D-Val-NH2 2457 TCAM2454 Arg-Arg-Phe-Arg-Arg-Phe-Phe-c[Asp-Trp-Arg-Tyr-Arg-Trp-Lys]-D-Val-D-Pro-NH2 2458 TCAM2455 Arg-Arg-Phe-Arg-Arg-Phe-Phe-c[Asp-Trp-Arg-Tyr-Arg-Trp-Lys]-D-Val-D-Phe-NH2 2459 TCAM2456 Arg-Arg-Phe-Arg-Arg-Phe-Phe-c[Asp-Trp-Arg-Tyr-Arg-Trp-Lys]-D-Pro-D-Val-NH2 2460 TCAM2457 Arg-Arg-Phe-Arg-Arg-Phe-Phe-c[Asp-Trp-Arg-Tyr-Arg-Trp-Lys]-D-Phe-D-Val-NH2 2461 TCAM2458 Arg-Arg-Phe-Arg-Arg-Phe-Phe-c[Asp-Trp-Arg-Trp-Arg-Tyr-Lys]-D-Val-D-Pro-NH2 2462 TCAM2459 Arg-Arg-Phe-Arg-Arg-Phe-Phe-c[Asp-Trp-Arg-Trp-Arg-Tyr-Lys]-D-Val-D-Phe-NH2 2463 TCAM2460 Arg-Arg-Phe-Arg-Arg-Phe-Phe-c[Asp-Trp-Arg-Trp-Arg-Tyr-Lys]-D-Pro-D-Val-NH2 2464 TCAM2461 Arg-Arg-Phe-Arg-Arg-Phe-Phe-c[Asp-Trp-Arg-Trp-Arg-Tyr-Lys]-D-Phe-D-Val-NH2 2465 TCAM2462 Arg-Arg-Phe-Arg-Arg-Phe-Phe-c[Asp-Trp-Arg-Trp-Arg-Lys]-D-Val-D-Pro-NH2 2466 TCAM2463 Arg-Arg-Phe-Arg-Arg-Phe-Phe-c[Asp-Trp-Arg-Trp-Arg-Lys]-D-Val-D-Phe-NH2 2467 TCAM2464 Arg-Arg-Phe-Arg-Arg-Phe-Phe-c[Asp-Trp-Arg-Trp-Arg-Lys]-D-Pro-D-Val-NH2 2468 TCAM2465 Arg-Arg-Phe-Arg-Arg-Phe-Phe-c[Asp-Trp-Arg-Trp-Arg-Lys]-D-Phe-D-Val-NH2 2469 TCAM2466 Arg-Arg-Phe-Arg-Arg-Phe-Phe-c[Asp-Trp-Arg-Arg-Trp-Lys]-D-Val-D-Pro-NH2 2470 TCAM2467 Arg-Arg-Phe-Arg-Arg-Phe-Phe-c[Asp-Trp-Arg-Arg-Trp-Lys]-D-Val-D-Phe-NH2 2471 TCAM2468 Arg-Arg-Phe-Arg-Arg-Phe-Phe-c[Asp-Trp-Arg-Arg-Trp-Lys]-D-Pro-D-Val-NH2 2472 TCAM2469 Arg-Arg-Phe-Arg-Arg-Phe-Phe-c[Asp-Trp-Arg-Arg-Trp-Lys]-D-Phe-D-Val-NH2 2473 TCAM2470 Arg-Arg-Phe-Arg-Arg-Phe-Phe-c[Asp-Arg-Trp-Trp-Arg-Lys]-D-Val-D-Pro-NH2 2474 TCAM2471 Arg-Arg-Phe-Arg-Arg-Phe-Phe-c[Asp-Arg-Trp-Trp-Arg-Lys]-D-Val-D-Phe-NH2 2475 TCAM2472 Arg-Arg-Phe-Arg-Arg-Phe-Phe-c[Asp-Arg-Trp-Trp-Arg-Lys]-D-Pro-D-Val-NH2 2476 TCAM2473 Arg-Arg-Phe-Arg-Arg-Phe-Phe-c[Asp-Arg-Trp-Trp-Arg-Lys]-D-Phe-D-Val-NH2 2477 TCAM2474 Arg-Arg-Phe-Arg-Arg-Phe-Phe-c[Asp-Trp-Arg-Trp-Lys]-D-Val-D-Pro-NH2 2478 TCAM2475 Arg-Arg-Phe-Arg-Arg-Phe-Phe-c[Asp-Trp-Arg-Trp-Lys]-D-Val-D-Phe-NH2 2479 TCAM2476 Arg-Arg-Phe-Arg-Arg-Phe-Phe-c[Asp-Trp-Arg-Trp-Lys]-D-Pro-D-Val-NH2 2480 TCAM2477 Arg-Arg-Phe-Arg-Arg-Phe-Phe-c[Asp-Trp-Arg-Trp-Lys]-D-Phe-D-Val-NH2 2481 TCAM2478 Arg-Arg-Phe-Arg-Arg-Phe-Phe-c[Asp-Arg-Trp-Arg-Lys]-D-Val-D-Pro-NH2 2482 TCAM2479 Arg-Arg-Phe-Arg-Arg-Phe-Phe-c[Asp-Arg-Trp-Arg-Lys]-D-Val-D-Phe-NH2 2483 TCAM2480 Arg-Arg-Phe-Arg-Arg-Phe-Phe-c[Asp-Arg-Trp-Arg-Lys]-D-Pro-D-Val-NH2 2484 TCAM2481 Arg-Arg-Phe-Arg-Arg-Phe-Phe-c[Asp-Arg-Trp-Arg-Lys]-D-Phe-D-Val-NH2 2485 TCAM2482 Arg-Arg-Phe-Arg-Arg-Phe-Phe-c[Asp-His-D-Nal(2′)-Arg-Trp-Lys]-D-Val-D-Pro-NH2 2486 TCAM2483 Arg-Arg-Phe-Arg-Arg-Phe-Phe-c[Asp-His-D-Nal(2′)-Arg-Trp-Lys]-D-Pro-D-Val-NH2 2487 TCAM2484 Arg-Arg-Phe-Arg-Arg-Phe-Phe-c[Asp-His-D-Nal(2′)-Arg-Trp-Lys]-D-Val-D-Phe-NH2 2488 TCAM2485 Arg-Arg-Phe-Arg-Arg-Phe-Phe-c[Asp-His-D-Nal(2′)-Arg-Trp-Lys]-D-Phe-D-Val-NH2 2489 TCAM2486 Arg-Arg-Phe-Arg-Arg-Phe-Phe-c[Asp-Pro-D-Nal(2′)-Arg-Trp-Lys]-D-Val-D-Pro-NH2 2490 TCAM2487 Arg-Arg-Phe-Arg-Arg-Phe-Phe-c[Asp-Pro-D-Nal(2′)-Arg-Trp-Lys]-D-Pro-D-Val-NH2 2491 TCAM2488 Arg-Arg-Phe-Arg-Arg-Phe-Phe-c[Asp-Pro-D-Nal(2′)-Arg-Trp-Lys]-D-Val-D-Phe-NH2 2492 TCAM2489 Arg-Arg-Phe-Arg-Arg-Phe-Phe-c[Asp-Pro-D-Nal(2′)-Arg-Trp-Lys]-D-Phe-D-Val-NH2 2493 TCAM2490 Arg-Arg-Phe-Arg-Arg-Phe-Phe-c[Asp-Arg-Arg-Nal(2′)-Arg-Trp-Lys]-D-Val-D-Pro-NH2 2494 TCAM2491 Arg-Arg-Phe-Arg-Arg-Phe-Phe-c[Asp-Arg-Arg-Nal(2′)-Arg-Trp-Lys]-D-Pro-D-Val-NH2 2495 TCAM2492 Arg-Arg-Phe-Arg-Arg-Phe-Phe-c[Asp-Arg-Arg-Nal(2′)-Arg-Trp-Lys]-D-Val-D-Phe-NH2 2496 TCAM2493 Arg-Arg-Phe-Arg-Arg-Phe-Phe-c[Asp-Arg-Arg-Nal(2′)-Arg-Trp-Lys]-D-Phe-D-Val-NH2 2497 TCAM2494 Arg-Arg-Phe-Arg-Arg-Phe-Phe-c[Asp-Arg-Arg-Pro-Nal(2′)-Arg-Trp-Lys]-D-Val-D-Pro- NH2 2498 TCAM2495 Arg-Arg-Phe-Arg-Arg-Phe-Phe-c[Asp-Arg-Arg-Pro-D-Nal(2′)-Arg-Trp-Lys]-D-Pro-D- Val-NH2 2499 TCAM2496 Arg-Arg-Phe-Arg-Arg-Phe-Phe-c[Asp-Arg-Arg-Pro-D-Nal(2′)-Arg-Trp-Lys]-D-Val-D- Phe-NH2 2500 TCAM2497 Arg-Arg-Phe-Arg-Arg-Phe-Phe-c[Asp-Arg-Arg-Pro-Nal(2′)-Arg-Trp-Lys]-D-Phe-D-Val- NH2 2501 TCAM2498 Arg-Arg-Phe-Arg-Arg-Phe-Phe-c[Asp-Arg-D-Nal(2′)-Arg-Trp-Lys]-D-Val-D-Pro-NH2 2502 TCAM2499 Arg-Arg-Phe-Arg-Arg-Phe-Phe-c[Asp-Arg-D-Nal(2′)-Arg-Trp-Lys]-D-Pro-D-Val-NH2 2503 TCAM2500 Arg-Arg-Phe-Arg-Arg-Phe-Phe-c[Asp-Arg-D-Nal(2′)-Arg-Trp-Lys]-D-Val-D-Phe-NH2 2504 TCAM2501 Arg-Arg-Phe-Arg-Arg-Phe-Phe-c[Asp-Arg-D-Nal(2′)-Arg-Trp-Lys]-D-Phe-D-Val-NH2 2505 TCAM2502 Arg-Arg-Phe-Arg-Arg-Phe-Phe-c[Asp-Arg-Pro-D-Nal(2′)-Arg-Trp-Lys]-D-Val-D-Pro- NH2 2506 TCAM2503 Arg-Arg-Phe-Arg-Arg-Phe-Phe-c[Asp-Arg-Pro-D-Nal(2′)-Arg-Trp-Lys]-D-Pro-D-Val- NH2 2507 TCAM2504 Arg-Arg-Phe-Arg-Arg-Phe-Phe-c[Asp-Arg-Pro-D-Nal(2′)-Arg-Trp-Lys]-D-Val-D-Phe- NH2 2508 TCAM2505 Arg-Arg-Phe-Arg-Arg-Phe-Phe-c[Asp-Arg-Pro-D-Nal(2′)-Arg-Trp-Lys]-D-Phe-D-Val- NH2 2509 TCAM2506 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-c[Asp-Pro-D-Nal(2′)-Arg-Trp-Lys]-D-Val-D- Pro-NH2 2510 TCAM2507 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-c[Asp-Pro-D-Nal(2′)-Arg-Trp-Lys]-D-Pro-D- Val-NH2 2511 TCAM2508 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-c[Asp-Pro-D-Nal(2′)-Arg-Trp-Lys]-D-Val-D- Phe-NH2 2512 TCAM2509 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-c[Asp-Pro-D-Nal(2′)-Arg-Trp-Lys]-D-Phe-D- Val-NH2 2513 TCAM2510 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-c[Asp-His-D-Nal(2′)-Arg-Trp-Lys]-D-Val-D- Pro-NH2 2514 TCAM2511 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-c[Asp-His-D-Nal(2′)-Arg-Trp-Lys]-D-Pro-D- Val-NH2 2515 TCAM2512 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-c[Asp-His-D-Nal(2′)-Arg-Trp-Lys]-D-Val-D- Phe-NH2 2516 TCAM2513 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-c[Asp-His-D-Nal(2′)-Arg-Trp-Lys]-D-Phe-D- Val-NH2 2517 TCAM2514 Arg-Arg-Phe-Arg-Arg-Phe-Phe-c[Asp-Arg-Pro-D-Nal(2′)-Arg-Trp-Arg-Lys]-D-Val-D- Pro-NH2 2518 TCAM2515 Arg-Arg-Phe-Arg-Arg-Phe-Phe-c[Asp-Arg-Pro-D-Nal(2′)-Arg-Trp-Arg-Lys]-D-Pro-D- Val-NH2 2519 TCAM2516 Arg-Arg-Phe-Arg-Arg-Phe-Phe-c[Asp-Arg-Pro-D-Nal(2′)-Arg-Trp-Arg-Lys]-D-Val-D- Phe-NH2 2520 TCAM2517 Arg-Arg-Phe-Arg-Arg-Phe-Phe-c[Asp-Arg-Pro-D-Nal(2′)-Arg-Trp-Arg-Lys]-D-Phe-D- Val-NH2 2521 TCAM2518 Arg-Arg-Phe-Arg-Arg-Phe-Phe-c[Asp-Arg-His-D-Nal(2′)-Arg-Trp-Arg-Lys]-D-Val-D- Pro-NH2 2522 TCAM2519 Arg-Arg-Phe-Arg-Arg-Phe-Phe-c[Asp-Arg-His-D-Nal(2′)-Arg-Trp-Arg-Lys]-D-Pro-D- Val-NH2 2523 TCAM2520 Arg-Arg-Phe-Arg-Arg-Phe-Phe-c[Asp-Arg-His-D-Nal(2′)-Arg-Trp-Arg-Lys]-D-Val-D- Phe-NH2 2524 TCAM2521 Arg-Arg-Phe-Arg-Arg-Phe-Phe-c[Asp-Arg-His-D-Nal(2′)-Arg-Trp-Arg-Lys]-D-Phe-D- Val-NH2 2525 TCAM2522 Arg-Arg-Phe-Arg-Arg-Phe-Phe-c[Asp-His-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Val-D-Phe- NH2 2526 TCAM2523 Arg-Arg-Phe-Arg-Arg-Phe-Phe-c[Asp-His-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Phe-D-Val- NH2 2527 TCAM2524 Arg-Arg-Phe-Arg-Arg-Phe-Phe-c[Asp-Pro-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Val-D-Pro- NH2 2528 TCAM2525 Arg-Arg-Phe-Arg-Arg-Phe-Phe-c[Asp-Pro-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Pro-D-Val- NH2 2529 TCAM2526 Arg-Arg-Phe-Arg-Arg-Phe-Phe-c[Asp-Pro-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Val-D-Phe- NH2 2530 TCAM2527 Arg-Arg-Phe-Arg-Arg-Phe-Phe-c[Asp-Pro-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Phe-D-Val- NH2 2531 TCAM2528 Arg-Arg-Phe-Arg-Arg-Phe-Phe-c[Asp-Arg-Arg-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Val-D- Pro-NH2 2532 TCAM2529 Arg-Arg-Phe-Arg-Arg-Phe-Phe-c[Asp-Arg-Arg-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Pro-D- Val-NH2 2533 TCAM2530 Arg-Arg-Phe-Arg-Arg-Phe-Phe-c[Asp-Arg-Arg-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Val-D- Phe-NH2 2534 TCAM2531 Arg-Arg-Phe-Arg-Arg-Phe-Phe-c[Asp-Arg-Arg-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Phe-D- Val-NH2 2535 TCAM2532 Arg-Arg-Phe-Arg-Arg-Phe-Phe-c[Asp-Arg-Arg-Pro-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Val- D-Pro-NH2 2536 TCAM2533 Arg-Arg-Phe-Arg-Arg-Phe-Phe-c[Asp-Arg-Arg-Pro-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Pro- D-Val-NH2 2537 TCAM2534 Arg-Arg-Phe-Arg-Arg-Phe-Phe-c[Asp-Arg-Arg-Pro-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Val- D-Phe-NH2 2538 TCAM2535 Arg-Arg-Phe-Arg-Arg-Phe-Phe-c[Asp-Arg-Arg-Pro-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D- Phe-D-Val-NH2 2539 TCAM2536 Arg-Arg-Phe-Arg-Arg-Phe-Phe-c[Asp-Arg-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Val-D-Pro- NH2 2540 TCAM2537 Arg-Arg-Phe-Arg-Arg-Phe-Phe-c[Asp-Arg-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Pro-D-Val- NH2 2541 TCAM2538 Arg-Arg-Phe-Arg-Arg-Phe-Phe-c[Asp-Arg-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Val-D-Phe- NH2 2542 TCAM2539 Arg-Arg-Phe-Arg-Arg-Phe-Phe-c[Asp-Arg-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Phe-D-Val- NH2 2543 TCAM2540 Arg-Arg-Phe-Arg-Arg-Phe-Phe-c[Asp-Arg-Pro-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Val-D- Pro-NH2 2544 TCAM2541 Arg-Arg-Phe-Arg-Arg-Phe-Phe-c[Asp-Arg-Pro-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Pro-D- Val-NH2 2545 TCAM2542 Arg-Arg-Phe-Arg-Arg-Phe-Phe-c[Asp-Arg-Pro-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Val-D- Phe-NH2 2546 TCAM2543 Arg-Arg-Phe-Arg-Arg-Phe-Phe-c[Asp-Arg-Pro-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Phe-D- Val-NH2 2547 TCAM2544 Arg-Arg-Phe-Arg-Arg-Phe-Phe-c[Asp-Arg-His-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Val-D- Pro-NH2 2548 TCAM2545 Arg-Arg-Phe-Arg-Arg-Phe-Phe-c[Asp-Arg-His-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Pro-D- Val-NH2 2549 TCAM2546 Arg-Arg-Phe-Arg-Arg-Phe-Phe-c[Asp-Arg-His-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Val-D-Phe- NH2 2550 TCAM2547 Arg-Arg-Phe-Arg-Arg-Phe-Phe-c[Asp-Arg-His-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Phe-D-Val- NH2 2551 TCAM2548 Arg-Arg-Phe-Arg-Arg-Phe-Phe-c[Asp-Arg-D-D-Nal(2′)-Arg-D-Nal(2′)-Arg-Lys]-D-Val-D- Pro-NH2 2552 TCAM2549 Arg-Arg-Phe-Arg-Arg-Phe-Phe-c[Asp-Arg-D-Nal(2′)-Arg-D-Nal(2′)-Arg-Lys]-D-Pro-D- Val-NH2 2553 TCAM2550 Arg-Arg-Phe-Arg-Arg-Phe-Phe-c[Asp-Arg-D-Nal(2′)-Arg-D-Nal(2′)-Arg-Lys]-D-Val-D- Phe-NH2 2554 TCAM2551 Arg-Arg-Phe-Arg-Arg-Phe-Phe-c[Asp-Arg-D-Nal(2′)-Arg-D-Nal(2′)-Arg-Lys]-D-Phe-D- Val-NH2 2555 TCAM2552 Arg-Arg-Phe-Arg-Arg-Phe-Phe-c[Asp-Arg-Pro-D-Nal(2′)-Arg-D-Nal(2′)-Arg-Lys]-D-Val- D-Pro-NH2 2556 TCAM2553 Arg-Arg-Phe-Arg-Arg-Phe-Phe-c[Asp-Arg-Pro-D-Nal(2′)-Arg-D-Nal(2′)-Arg-Lys]-D-Pro- D-Val-NH2 2557 TCAM2554 Arg-Arg-Phe-Arg-Arg-Phe-Phe-c[Asp-Arg-Pro-D-Nal(2′)-Arg-D-Nal(2′)-Arg-Lys]-D-Val- D-Phe-NH2 2558 TCAM2555 Arg-Arg-Phe-Arg-Arg-Phe-Phe-c[Asp-Arg-Pro-D-Nal(2′)-Arg-D-Nal(2′)-Arg-Lys]-D- Phe-D-Val-NH2 2559 TCAM2556 Arg-Arg-Phe-Arg-Arg-Phe-Phe-c[Asp-Arg-His-D-Nal(2′)-Arg-D-Nal(2′)-Arg-Lys]-D-Val- D-Pro-NH2 2560 TCAM2557 Arg-Arg-Phe-Arg-Arg-Phe-Phe-c[Asp-Arg-His-D-Nal(2′)-Arg-D-Nal(2′)-Arg-Lys]-D-Pro- D-Val-NH2 2561 TCAM2558 Arg-Arg-Phe-Arg-Arg-Phe-Phe-c[Asp-Arg-His-D-Nal(2′)-Arg-D-Nal(2′)-Arg-Lys]-D-Val- D-Phe-NH2 2562 TCAM2559 Arg-Arg-Phe-Arg-Arg-Phe-Phe-c[Asp-Arg-His-D-Nal(2′)-Arg-D-Nal(2′)-Arg-Lys]-D-Phe- D-Val-NH2 2563 TCAM2560 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-c[Asp-Pro-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Val- D-Pro-NH2 2564 TCAM2561 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-c[Asp-Pro-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Pro- D-Val-NH2 2565 TCAM2562 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-c[Asp-Pro-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Val- D-Phe-NH2 2566 TCAM2563 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-c[Asp-Pro-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D- Phe-D-Val-NH2 2567 TCAM2564 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-c[Asp-His-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Val- D-Pro-NH2 2568 TCAM2565 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-c[Asp-His-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Pro- D-Val-NH2 2569 TCAM2566 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-c[Asp-His-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Val- D-Phe-NH2 2570 TCAM2567 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-c[Asp-His-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Phe- D-Val-NH2 2571 TCAM2568 Arg-Arg-Phe-Arg-Arg-Phe-Phe-c[Asp-Arg-Pro-D-Nal(2′)-Arg-D-Nal(2′)-Arg-Lys]-D-Val- D-Pro-NH2 2572 TCAM2569 Arg-Arg-Phe-Arg-Arg-Phe-Phe-c[Asp-Arg-Pro-D-Nal(2′)-Arg-D-Nal(2′)-Arg-Lys]-D-Pro- D-Val-NH2 2573 TCAM2570 Arg-Arg-Phe-Arg-Arg-Phe-Phe-c[Asp-Arg-Pro-D-Nal(2′)-Arg-D-Nal(2′)-Arg-Lys]-D-Val- D-Phe-NH2 2574 TCAM2571 Arg-Arg-Phe-Arg-Arg-Phe-Phe-c[Asp-Arg-Pro-D-Nal(2′)-Arg-D-Nal(2′)-Arg-Lys]-D- Phe-D-Val-NH2 2575 TCAM2572 Arg-Arg-Phe-Arg-Arg-Phe-Phe-c[Asp-Arg-His-D-Nal(2′)-Arg-D-Nal(2′)-Arg-Lys]-D-Val- D-Pro-NH2 2576 TCAM2573 Arg-Arg-Phe-Arg-Arg-Phe-Phe-c[Asp-Arg-His-D-Nal(2′)-Arg-D-Nal(2′)-Arg-Lys]-D-Pro- D-Val-NH2 2577 TCAM2574 Arg-Arg-Phe-Arg-Arg-Phe-Phe-c[Asp-Arg-His-D-Nal(2′)-Arg-D-Nal(2′)-Arg-Lys]-D-Val- D-Phe-NH2 2578 TCAM2575 Arg-Arg-Phe-Arg-Arg-Phe-Phe-c[Asp-Arg-His-D-Nal(2′)-Arg-D-Nal(2′)-Arg-Lys]-D-Phe- D-Val-NH2 2579 TCAM2576 Arg-Arg-Phe-Arg-Arg-Phe-Phe-c[Asp-His-D-Nal(2′)-Arg-Trp-Lys]-Arg-Arg-D-Val-D- Pro-NH2 2580 TCAM2577 Arg-Arg-Phe-Arg-Arg-Phe-Phe-c[Asp-His-D-Nal(2′)-Arg-Trp-Lys]-Arg-Arg-D-Pro-D- Val-NH2 2581 TCAM2578 Arg-Arg-Phe-Arg-Arg-Phe-Phe-c[Asp-His-D-Nal(2′)-Arg-Trp-Lys]-Arg-Arg-D-Val-D- Phe-NH2 2582 TCAM2579 Arg-Arg-Phe-Arg-Arg-Phe-Phe-c[Asp-His-D-Nal(2′)-Arg-Trp-Lys]-Arg-Arg-D-Phe-D- Val-NH2 2583 TCAM2580 Arg-Arg-Phe-Arg-Arg-Phe-Phe-c[Asp-Pro-D-Nal(2′)-Arg-Trp-Lys]-Arg-Arg-D-Val-D- Pro-NH2 2584 TCAM2581 Arg-Arg-Phe-Arg-Arg-Phe-Phe-c[Asp-Pro-D-Nal(2′)-Arg-Trp-Lys]-Arg-Arg-D-Pro-D- Val-NH2 2585 TCAM2582 Arg-Arg-Phe-Arg-Arg-Phe-Phe-c[Asp-Pro-D-Nal(2′)-Arg-Trp-Lys]-Arg-Arg-D-Val-D- Phe-NH2 2586 TCAM2583 Arg-Arg-Phe-Arg-Arg-Phe-Phe-c[Asp-Pro-D-Nal(2′)-Arg-Trp-Lys]-Arg-Arg-D-Phe-D- Val-NH2 Anti-biofilm peptide of ABF5 linked to anti-microbial peptides 2587 TCAM2584 Phe-Phe-Arg-Arg-Leu-Lys-c[Asp-Pro-Arg-Arg-Trp-Trp-Arg-Phe-Lys]-D-Val-D-Pro-NH2 2588 TCAM2585 Phe-Phe-Arg-Arg-Leu-Lys-c[Asp-Pro-Arg-Arg-Trp-Trp-Arg-Phe-Lys]-D-Val-D-Phe-NH2 2589 TCAM2586 Phe-Phe-Arg-Arg-Leu-Lys-c[Asp-Pro-Arg-Arg-Trp-Trp-Arg-Phe-Lys]-D-Pro-D-Val-NH2 2590 TCAM2587 Phe-Phe-Arg-Arg-Leu-Lys-c[Asp-Pro-Arg-Arg-Trp-Trp-Arg-Phe-Lys]-D-Phe-D-Val-NH2 2591 TCAM2588 Phe-Phe-Arg-Arg-Leu-Lys-c[Asp-Pro-Arg-Arg-Trp-Trp-Tyr-Phe-Lys]-D-Val-D-Pro-NH2 2592 TCAM2589 Phe-Phe-Arg-Arg-Leu-Lys-c[Asp-Pro-Arg-Arg-Trp-Trp-Tyr-Phe-Lys]-D-Val-D-Phe-NH2 2593 TCAM2590 Phe-Phe-Arg-Arg-Leu-Lys-c[Asp-Pro-Arg-Arg-Trp-Trp-Tyr-Phe-Lys]-D-Pro-D-Val-NH2 2594 TCAM2591 Phe-Phe-Arg-Arg-Leu-Lys-c[Asp-Pro-Arg-Arg-Trp-Trp-Tyr-Phe-Lys]-D-Phe-D-Val-NH2 2595 TCAM2592 Phe-Phe-Arg-Arg-Leu-Lys-c[Asp-Pro-Arg-Arg-Tyr-Tyr-Arg-Phe-Lys]-D-Val-D-Pro-NH2 2596 TCAM2593 Phe-Phe-Arg-Arg-Leu-Lys-c[Asp-Pro-Arg-Arg-Tyr-Tyr-Arg-Phe-Lys]-D-Val-D-Phe-NH2 2597 TCAM2594 Phe-Phe-Arg-Arg-Leu-Lys-c[Asp-Pro-Arg-Arg-Tyr-Tyr-Arg-Phe-Lys]-D-Pro-D-Val-NH2 2598 TCAM2595 Phe-Phe-Arg-Arg-Leu-Lys-c[Asp-Pro-Arg-Arg-Tyr-Tyr-Arg-Phe-Lys]-D-Phe-D-Val-NH2 2599 TCAM2596 Phe-Phe-Arg-Arg-Leu-Lys-c[Asp-Pro-Arg-Arg-Nal-Nal-Arg-Phe-Lys]-D-Val-D-Pro-NH2 2600 TCAM2597 Phe-Phe-Arg-Arg-Leu-Lys-c[Asp-Pro-Arg-Arg-Nal-Nal-Arg-Phe-Lys]-D-Val-D-Phe-NH2 2601 TCAM2598 Phe-Phe-Arg-Arg-Leu-Lys-c[Asp-Pro-Arg-Arg-Nal-Nal-Arg-Phe-Lys]-D-Pro-D-Val-NH2 2602 TCAM2599 Phe-Phe-Arg-Arg-Leu-Lys-c[Asp-Pro-Arg-Arg-Nal-Nal-Arg-Phe-Lys]-D-Phe-D-Val-NH2 2603 TCAM2600 Phe-Phe-Arg-Arg-Leu-Lys-c[Asp-Pro-Arg-Arg-Leu-Trp-Leu-Trp-Lys]-D-Val-D-Pro-NH2 2604 TCAM2601 Phe-Phe-Arg-Arg-Leu-Lys-c[Asp-Pro-Arg-Arg-Leu-Trp-Leu-Trp-Lys]-D-Val-D-Phe-NH2 2605 TCAM2602 Phe-Phe-Arg-Arg-Leu-Lys-c[Asp-Pro-Arg-Arg-Leu-Trp-Leu-Trp-Lys]-D-Pro-D-Val-NH2 2606 TCAM2603 Phe-Phe-Arg-Arg-Leu-Lys-c[Asp-Pro-Arg-Arg-Leu-Trp-Leu-Trp-Lys]-D-Phe-D-Val-NH2 2607 TCAM2604 Phe-Phe-Arg-Arg-Leu-Lys-c[Asp-Pro-Arg-Arg-Leu-Trp-Leu-Trp-Lys]-D-Val-D-Pro-NH2 2608 TCAM2605 Phe-Phe-Arg-Arg-Leu-Lys-c[Asp-Pro-Arg-Arg-Leu-Trp-Leu-Trp-Lys]-D-Val-D-Phe-NH2 2609 TCAM2606 Phe-Phe-Arg-Arg-Leu-Lys-c[Asp-Pro-Arg-Arg-Leu-Trp-Leu-Trp-Lys]-D-Pro-D-Val-NH2 2610 TCAM2607 Phe-Phe-Arg-Arg-Leu-Lys-c[Asp-Pro-Arg-Arg-Leu-Trp-Leu-Trp-Lys]-D-Phe-D-Val-NH2 2611 TCAM2608 Phe-Phe-Arg-Arg-Leu-Lys-c[Asp-Arg-Arg-Arg-Trp-Leu-Trp-Leu-Trp-Lys]-D-Val-D-Pro- NH2 2612 TCAM2609 Phe-Phe-Arg-Arg-Leu-Lys-c[Asp-Pro-Arg-Arg-Arg-Trp-Leu-Trp-Leu-Trp-Lys]-D-Val-D- Phe-NH2 2613 TCAM2610 Phe-Phe-Arg-Arg-Leu-Lys-c[Asp-Pro-Arg-Arg-Arg-Trp-Leu-Trp-Leu-Trp-Lys]-D-Pro-D- Val-NH2 2614 TCAM2611 Phe-Phe-Arg-Arg-Leu-Lys-c[Asp-Pro-Arg-Arg-Arg-Trp-Leu-Trp-Leu-Trp-Lys]-D-Phe-D- Val-NH2 2615 TCAM2612 Phe-Phe-Arg-Arg-Leu-Lys-c[Asp-Pro-Arg-Gln-Arg-Arg-Trp-Leu-Trp-Leu-Trp-Lys]-D- Val-D-Pro-NH2 2616 TCAM2613 Phe-Phe-Arg-Arg-Leu-Lys-c[Asp-Pro-Arg-Gln-Arg-Arg-Trp-Leu-Trp-Leu-Trp-Lys]-D- Val-D-Phe-NH2 2617 TCAM2614 Phe-Phe-Arg-Arg-Leu-Lys-c[Asp-Pro-Arg-Gln-Arg-Arg-Trp-Leu-Trp-Leu-Trp-Lys]-D- Pro-D-Val-NH2 2618 TCAM2615 Phe-Phe-Arg-Arg-Leu-Lys-c[Asp-Pro-Arg-Gln-Arg-Arg-Trp-Leu-Trp-Leu-Trp-Lys]-D- Phe-D-Val-NH2 2619 TCAM2616 Phe-Phe-Arg-Arg-Leu-Lys-c[Asp-Pro-Trp-Arg-Trp-Trp-Arg-Arg-Lys]-D-Val-D-Phe-NH2 2620 TCAM2617 Phe-Phe-Arg-Arg-Leu-Lys-c[Asp-Pro-Trp-Arg-Trp-Trp-Arg-Arg-Lys]-D-Pro-D-Val-NH2 2621 TCAM2618 Phe-Phe-Arg-Arg-Leu-Lys-c[Asp-Pro-Trp-Arg-Trp-Trp-Arg-Arg-Lys]-D-Phe-D-Val-NH2 2622 TCAM2619 Phe-Phe-Arg-Arg-Leu-Lys-c[Asp-Pro-Trp-Trp-Arg-Arg-Trp-Trp-Arg-Arg-Lys]-D-Val-D- Pro-NH2 2623 TCAM2620 Phe-Phe-Arg-Arg-Leu-Lys-c[Asp-Pro-Trp-Trp-Arg-Arg-Trp-Trp-Arg-Arg-Lys]-D-Val-D- Phe-NH2 2624 TCAM2621 Phe-Phe-Arg-Arg-Leu-Lys-c[Asp-Pro-Trp-Trp-Arg-Arg-Trp-Trp-Arg-Arg-Lys]-D-Pro-D- Val-NH2 2625 TCAM2622 Phe-Phe-Arg-Arg-Leu-Lys-c[Asp-Pro-Trp-Trp-Arg-Arg-Trp-Trp-Arg-Arg-Lys]-D-Phe-D- Val-NH2 2626 TCAM2623 Phe-Phe-Arg-Arg-Leu-Lys-c[Asp-Pro-Trp-Arg-Trp-Arg-Trp-Arg-Lys]-D-Val-D-Pro-NH2 2627 TCAM2624 Phe-Phe-Arg-Arg-Leu-Lys-c[Asp-Pro-Trp-Arg-Trp-Arg-Trp-Arg-Lys]-D-Val-D-Phe-NH2 2628 TCAM2625 Phe-Phe-Arg-Arg-Leu-Lys-c[Asp-Pro-Trp-Arg-Trp-Arg-Trp-Arg-Lys]-D-Pro-D-Val-NH2 2629 TCAM2626 Phe-Phe-Arg-Arg-Leu-Lys-c[Asp-Pro-Trp-Arg-Trp-Arg-Trp-Arg-Lys]-D-Phe-D-Val-NH2 2630 TCAM2627 Phe-Phe-Arg-Arg-Leu-Lys-c[Asp-Pro-Arg-Trp-Arg-Trp-Arg-Trp-Lys]-D-Val-D-Pro-NH2 2631 TCAM2628 Phe-Phe-Arg-Arg-Leu-Lys-c[Asp-Pro-Arg-Trp-Arg-Trp-Arg-Trp-Lys]-D-Val-D-Phe-NH2 2632 TCAM2629 Phe-Phe-Arg-Arg-Leu-Lys-c[Asp-Pro-Arg-Trp-Arg-Trp-Arg-Trp-Lys]-D-Pro-D-Val-NH2 2633 TCAM2630 Phe-Phe-Arg-Arg-Leu-Lys-c[Asp-Pro-Arg-Trp-Arg-Trp-Arg-Trp-Lys]-D-Phe-D-Val-NH2 2634 TCAM2631 Phe-Phe-Arg-Arg-Leu-Lys-c[Asp-Pro-Arg-Trp-Trp-Arg-Arg-Lys]-D-Val-D-Pro-NH2 2635 TCAM2632 Phe-Phe-Arg-Arg-Leu-Lys-c[Asp-Pro-Arg-Trp-Trp-Arg-Arg-Lys]-D-Val-D-Phe-NH2 2636 TCAM2633 Phe-Phe-Arg-Arg-Leu-Lys-c[Asp-Pro-Arg-Trp-Trp-Arg-Arg-Lys]-D-Pro-D-Val-NH2 2637 TCAM2634 Phe-Phe-Arg-Arg-Leu-Lys-c[Asp-Pro-Arg-Trp-Trp-Arg-Arg-Lys]-D-Phe-D-Val-NH2 2638 TCAM2635 Phe-Phe-Arg-Arg-Leu-Lys-c[Asp-Pro-Trp-Trp-Arg-Arg-Trp-Lys]-D-Val-D-Pro-NH2 2639 TCAM2636 Phe-Phe-Arg-Arg-Leu-Lys-c[Asp-Pro-Trp-Trp-Arg-Arg-Trp-Lys]-D-Val-D-Phe-NH2 2640 TCAM2637 Phe-Phe-Arg-Arg-Leu-Lys-c[Asp-Pro-Trp-Trp-Arg-Arg-Trp-Lys]-D-Pro-D-Val-NH2 2641 TCAM2638 Phe-Phe-Arg-Arg-Leu-Lys-c[Asp-Pro-Trp-Trp-Arg-Arg-Trp-Lys]-D-Phe-D-Val-NH2 2642 TCAM2639 Phe-Phe-Arg-Arg-Leu-Lys-c[Asp-Pro-Trp-Arg-Trp-Arg-Trp-Lys]-D-Val-D-Pro-NH2 2643 TCAM2640 Phe-Phe-Arg-Arg-Leu-Lys-c[Asp-Pro-Trp-Arg-Trp-Arg-Trp-Lys]-D-Val-D-Phe-NH2 2644 TCAM2641 Phe-Phe-Arg-Arg-Leu-Lys-c[Asp-Pro-Trp-Arg-Trp-Arg-Trp-Lys]-D-Pro-D-Val-NH2 2645 TCAM2642 Phe-Phe-Arg-Arg-Leu-Lys-c[Asp-Pro-Trp-Arg-Trp-Arg-Trp-Lys]-D-Phe-D-Val-NH2 2646 TCAM2643 Phe-Phe-Arg-Arg-Leu-Lys-c[Asp-Pro-Arg-Trp-Arg-Trp-Arg-Lys]-D-Val-D-Pro-NH2 2647 TCAM2644 Phe-Phe-Arg-Arg-Leu-Lys-c[Asp-Pro-Arg-Trp-Arg-Trp-Arg-Lys]-D-Val-D-Phe-NH2 2648 TCAM2645 Phe-Phe-Arg-Arg-Leu-Lys-c[Asp-Pro-Arg-Trp-Arg-Trp-Arg-Lys]-D-Pro-D-Val-NH2 2649 TCAM2646 Phe-Phe-Arg-Arg-Leu-Lys-c[Asp-Pro-Arg-Trp-Arg-Trp-Arg-Lys]-D-Phe-D-Val-NH2 2650 TCAM2647 Phe-Phe-Arg-Arg-Leu-Lys-c[Asp-Pro-Trp-Arg-Tyr-Arg-Trp-Lys]-D-Val-D-Pro-NH2 2651 TCAM2648 Phe-Phe-Arg-Arg-Leu-Lys-c[Asp-Pro-Trp-Arg-Tyr-Arg-Trp-Lys]-D-Val-D-Phe-NH2 2652 TCAM2649 Phe-Phe-Arg-Arg-Leu-Lys-c[Asp-Pro-Trp-Arg-Tyr-Arg-Trp-Lys]-D-Pro-D-Val-NH2 2653 TCAM2650 Phe-Phe-Arg-Arg-Leu-Lys-c[Asp-Pro-Trp-Arg-Tyr-Arg-Trp-Lys]-D-Phe-D-Val-NH2 2654 TCAM2651 Phe-Phe-Arg-Arg-Leu-Lys-c[Asp-Pro-Trp-Arg-Trp-Arg-Tyr-Lys]-D-Val-D-Pro-NH2 2655 TCAM2652 Phe-Phe-Arg-Arg-Leu-Lys-c[Asp-Pro-Trp-Arg-Trp-Arg-Tyr-Lys]-D-Val-D-Phe-NH2 2656 TCAM2653 Phe-Phe-Arg-Arg-Leu-Lys-c[Asp-Pro-Trp-Arg-Trp-Arg-Tyr-Lys]-D-Pro-D-Val-NH2 2657 TCAM2654 Phe-Phe-Arg-Arg-Leu-Lys-c[Asp-Pro-Trp-Arg-Trp-Arg-Tyr-Lys]-D-Phe-D-Val-NH2 2658 TCAM2655 Phe-Phe-Arg-Arg-Leu-Lys-c[Asp-Pro-Trp-Arg-Trp-Arg-Lys]-D-Val-D-Pro-NH2 2659 TCAM2656 Phe-Phe-Arg-Arg-Leu-Lys-c[Asp-Pro-Trp-Arg-Trp-Arg-Lys]-D-Val-D-Phe-NH2 2660 TCAM2657 Phe-Phe-Arg-Arg-Leu-Lys-c[Asp-Pro-Trp-Arg-Trp-Arg-Lys]-D-Pro-D-Val-NH2 2661 TCAM2658 Phe-Phe-Arg-Arg-Leu-Lys-c[Asp-Pro-Trp-Arg-Trp-Arg-Lys]-D-Phe-D-Val-NH2 2662 TCAM2659 Phe-Phe-Arg-Arg-Leu-Lys-c[Asp-Pro-Trp-Arg-Arg-Trp-Lys]-D-Val-D-Pro-NH2 2663 TCAM2660 Phe-Phe-Arg-Arg-Leu-Lys-c[Asp-Pro-Trp-Arg-Arg-Trp-Lys]-D-Val-D-Phe-NH2 2664 TCAM2661 Phe-Phe-Arg-Arg-Leu-Lys-c[Asp-Pro-Trp-Arg-Arg-Trp-Lys]-D-Pro-D-Val-NH2 2665 TCAM2662 Phe-Phe-Arg-Arg-Leu-Lys-c[Asp-Pro-Trp-Arg-Arg-Trp-Lys]-D-Phe-D-Val-NH2 2666 TCAM2663 Phe-Phe-Arg-Arg-Leu-Lys-c[Asp-Pro-Arg-Trp-Trp-Arg-Lys]-D-Val-D-Pro-NH2 2667 TCAM2664 Phe-Phe-Arg-Arg-Leu-Lys-c[Asp-Pro-Arg-Trp-Trp-Arg-Lys]-D-Val-D-Phe-NH2 2668 TCAM2665 Phe-Phe-Arg-Arg-Leu-Lys-c[Asp-Pro-Arg-Trp-Trp-Arg-Lys]-D-Pro-D-Val-NH2 2669 TCAM2666 Phe-Phe-Arg-Arg-Leu-Lys-c[Asp-Pro-Arg-Trp-Trp-Arg-Lys]-D-Phe-D-Val-NH2 2670 TCAM2667 Phe-Phe-Arg-Arg-Leu-Lys-c[Asp-Pro-Trp-Arg-Trp-Lys]-D-Val-D-Pro-NH2 2671 TCAM2668 Phe-Phe-Arg-Arg-Leu-Lys-c[Asp-Pro-Trp-Arg-Trp-Lys]-D-Val-D-Phe-NH2 2672 TCAM2669 Phe-Phe-Arg-Arg-Leu-Lys-c[Asp-Pro-Trp-Arg-Trp-Lys]-D-Pro-D-Val-NH2 2673 TCAM2670 Phe-Phe-Arg-Arg-Leu-Lys-c[Asp-Pro-Trp-Arg-Trp-Lys]-D-Phe-D-Val-NH2 2674 TCAM2671 Phe-Phe-Arg-Arg-Leu-Lys-c[Asp-Pro-Arg-Trp-Arg-Lys]-D-Val-D-Pro-NH2 2675 TCAM2672 Phe-Phe-Arg-Arg-Leu-Lys-c[Asp-Pro-Arg-Trp-Arg-Lys]-D-Val-D-Phe-NH2 2676 TCAM2673 Phe-Phe-Arg-Arg-Leu-Lys-c[Asp-Pro-Arg-Trp-Arg-Lys]-D-Pro-D-Val-NH2 2677 TCAM2674 Phe-Phe-Arg-Arg-Leu-Lys-c[Asp-Pro-Arg-Trp-Arg-Lys]-D-Phe-D-Val-NH2 2678 TCAM2675 Phe-Phe-Arg-Arg-Leu-Lys-c[Asp-Arg-Arg-Trp-Trp-Arg-Phe-Lys]-D-Val-D-Pro-NH2 2679 TCAM2676 Phe-Phe-Arg-Arg-Leu-Lys-c[Asp-Arg-Arg-Trp-Trp-Arg-Phe-Lys]-D-Val-D-Phe-NH2 2680 TCAM2677 Phe-Phe-Arg-Arg-Leu-Lys-c[Asp-Arg-Arg-Trp-Trp-Arg-Phe-Lys]-D-Pro-D-Val-NH2 2681 TCAM2678 Phe-Phe-Arg-Arg-Leu-Lys-c[Asp-Arg-Arg-Trp-Trp-Arg-Phe-Lys]-D-Phe-D-Val-NH2 2682 TCAM2679 Phe-Phe-Arg-Arg-Leu-Lys-c[Asp-Arg-Arg-Trp-Trp-Arg-Phe-Lys]-D-Val-D-Pro-NH2 2683 TCAM2680 Phe-Phe-Arg-Arg-Leu-Lys-c[Asp-Arg-Arg-Trp-Trp-Arg-Phe-Lys]-D-Val-D-Phe-NH2 2684 TCAM2681 Phe-Phe-Arg-Arg-Leu-Lys-c[Asp-Arg-Arg-Trp-Trp-Arg-Phe-Lys]-D-Pro-D-Val-NH2 2685 TCAM2682 Phe-Phe-Arg-Arg-Leu-Lys-c[Asp-Arg-Arg-Trp-Trp-Arg-Phe-Lys]-D-Phe-D-Val-NH2 2686 TCAM2683 Phe-Phe-Arg-Arg-Leu-Lys-c[Asp-Arg-Arg-Tyr-Tyr-Arg-Phe-Lys]-D-Val-D-Pro-NH2 2687 TCAM2684 Phe-Phe-Arg-Arg-Leu-Lys-c[Asp-Arg-Arg-Tyr-Tyr-Arg-Phe-Lys]-D-Val-D-Phe-NH2 2688 TCAM2685 Phe-Phe-Arg-Arg-Leu-Lys-c[Asp-Arg-Arg-Tyr-Tyr-Arg-Phe-Lys]-D-Pro-D-Val-NH2 2689 TCAM2686 Phe-Phe-Arg-Arg-Leu-Lys-c[Asp-Arg-Arg-Tyr-Tyr-Arg-Phe-Lys]-D-Phe-D-Val-NH2 2690 TCAM2687 Phe-Phe-Arg-Arg-Leu-Lys-c[Asp-Arg-Arg-Nal-Nal-Arg-Phe-Lys]-D-Val-D-Pro-NH2 2691 TCAM2688 Phe-Phe-Arg-Arg-Leu-Lys-c[Asp-Arg-Arg-Nal-Nal-Arg-Phe-Lys]-D-Val-D-Phe-NH2 2692 TCAM2689 Phe-Phe-Arg-Arg-Leu-Lys-c[Asp-Arg-Arg-Nal-Nal-Arg-Phe-Lys]-D-Pro-D-Val-NH2 2693 TCAM2690 Phe-Phe-Arg-Arg-Leu-Lys-c[Asp-Arg-Arg-Nal-Nal-Arg-Phe-Lys]-D-Phe-D-Val-NH2 2694 TCAM2691 Phe-Phe-Arg-Arg-Leu-Lys-c[Asp-Arg-Arg-Leu-Trp-Leu-Trp-Lys]-D-Val-D-Pro-NH2 2695 TCAM2692 Phe-Phe-Arg-Arg-Leu-Lys-c[Asp-Arg-Arg-Leu-Trp-Leu-Trp-Lys]-D-Val-D-Phe-NH2 2696 TCAM2693 Phe-Phe-Arg-Arg-Leu-Lys-c[Asp-Arg-Arg-Leu-Trp-Leu-Trp-Lys]-D-Pro-D-Val-NH2 2697 TCAM2694 Phe-Phe-Arg-Arg-Leu-Lys-c[Asp-Arg-Arg-Leu-Trp-Leu-Trp-Lys]-D-Phe-D-Val-NH2 2698 TCAM2695 Phe-Phe-Arg-Arg-Leu-Lys-c[Asp-Arg-Arg-Leu-Trp-Leu-Trp-Lys]-D-Val-D-Pro-NH2 2699 TCAM2696 Phe-Phe-Arg-Arg-Leu-Lys-c[Asp-Arg-Arg-Leu-Trp-Leu-Trp-Lys]-D-Val-D-Phe-NH2 2700 TCAM2697 Phe-Phe-Arg-Arg-Leu-Lys-c[Asp-Arg-Arg-Leu-Trp-Leu-Trp-Lys]-D-Pro-D-Val-NH2 2701 TCAM2698 Phe-Phe-Arg-Arg-Leu-Lys-c[Asp-Arg-Arg-Leu-Trp-Leu-Trp-Lys]-D-Phe-D-Val-NH2 2702 TCAM2699 Phe-Phe-Arg-Arg-Leu-Lys-c[Asp-Arg-Arg-Arg-Trp-Leu-Trp-Leu-Trp-Lys]-D-Val-D-Pro- NH2 2703 TCAM2700 Phe-Phe-Arg-Arg-Leu-Lys-c[Asp-Arg-Arg-Arg-Trp-Leu-Trp-Leu-Trp-Lys]-D-Val-D-Phe- NH2 2704 TCAM2701 Phe-Phe-Arg-Arg-Leu-Lys-c[Asp-Arg-Arg-Arg-Trp-Leu-Trp-Leu-Trp-Lys]-D-Pro-D-Val- NH2 2705 TCAM2702 Phe-Phe-Arg-Arg-Leu-Lys-c[Asp-Arg-Arg-Arg-Trp-Leu-Trp-Leu-Trp-Lys]-D-Phe-D-Val- NH2 2706 TCAM2703 Phe-Phe-Arg-Arg-Leu-Lys-c[Asp-Arg-Gln-Arg-Arg-Trp-Leu-Trp-Leu-Trp-Lys]-D-Val-D- Pro-NH2 2707 TCAM2704 Phe-Phe-Arg-Arg-Leu-Lys-c[Asp-Arg-Gln-Arg-Arg-Trp-Leu-Trp-Leu-Trp-Lys]-D-Val-D- Phe-NH2 2708 TCAM2705 Phe-Phe-Arg-Arg-Leu-Lys-c[Asp-Arg-Gln-Arg-Arg-Trp-Leu-Trp-Leu-Trp-Lys]-D-Pro-D- Val-NH2 2709 TCAM2706 Phe-Phe-Arg-Arg-Leu-Lys-c[Asp-Arg-Gln-Arg-Arg-Trp-Leu-Trp-Leu-Trp-Lys]-D-Phe-D- Val-NH2 2710 TCAM2707 Phe-Phe-Arg-Arg-Leu-Lys-c[Asp-Trp-Arg-Trp-Trp-Arg-Arg-Lys]-D-Val-D-Pro-NH2 2711 TCAM2708 Phe-Phe-Arg-Arg-Leu-Lys-c[Asp-Trp-Arg-Trp-Trp-Arg-Arg-Lys]-D-Val-D-Phe-NH2 2712 TCAM2709 Phe-Phe-Arg-Arg-Leu-Lys-c[Asp-Trp-Arg-Trp-Trp-Arg-Arg-Lys]-D-Pro-D-Val-NH2 2713 TCAM2710 Phe-Phe-Arg-Arg-Leu-Lys-c[Asp-Trp-Arg-Trp-Trp-Arg-Arg-Lys]-D-Phe-D-Val-NH2 2714 TCAM2711 Phe-Phe-Arg-Arg-Leu-Lys-c[Asp-Trp-Trp-Arg-Arg-Trp-Trp-Arg-Arg-Lys]-D-Val-D-Pro- NH2 2715 TCAM2712 Phe-Phe-Arg-Arg-Leu-Lys-c[Asp-Trp-Trp-Arg-Arg-Trp-Trp-Arg-Arg-Lys]-D-Val-D-Phe- NH2 2716 TCAM2713 Phe-Phe-Arg-Arg-Leu-Lys-c[Asp-Trp-Trp-Arg-Arg-Trp-Trp-Arg-Arg-Lys]-D-Pro-D-Val- NH2 2717 TCAM2714 Phe-Phe-Arg-Arg-Leu-Lys-c[Asp-Trp-Trp-Arg-Arg-Trp-Trp-Arg-Arg-Lys]-D-Phe-D-Val- NH2 2718 TCAM2715 Phe-Phe-Arg-Arg-Leu-Lys-c[Asp-Trp-Arg-Trp-Arg-Trp-Arg-Lys]-D-Val-D-Pro-NH2 2719 TCAM2716 Phe-Phe-Arg-Arg-Leu-Lys-c[Asp-Trp-Arg-Trp-Arg-Trp-Arg-Lys]-D-Val-D-Phe-NH2 2720 TCAM2717 Phe-Phe-Arg-Arg-Leu-Lys-c[Asp-Trp-Arg-Trp-Arg-Trp-Arg-Lys]-D-Pro-D-Val-NH2 2721 TCAM2718 Phe-Phe-Arg-Arg-Leu-Lys-c[Asp-Trp-Arg-Trp-Arg-Trp-Arg-Lys]-D-Phe-D-Val-NH2 2722 TCAM2719 Phe-Phe-Arg-Arg-Leu-Lys-c[Asp-Arg-Trp-Arg-Trp-Arg-Trp-Lys]-D-Val-D-Pro-NH2 2723 TCAM2720 Phe-Phe-Arg-Arg-Leu-Lys-c[Asp-Arg-Trp-Arg-Trp-Arg-Trp-Lys]-D-Val-D-Phe-NH2 2724 TCAM2721 Phe-Phe-Arg-Arg-Leu-Lys-c[Asp-Arg-Trp-Arg-Trp-Arg-Trp-Lys]-D-Pro-D-Val-NH2 2725 TCAM2722 Phe-Phe-Arg-Arg-Leu-Lys-c[Asp-Arg-Trp-Arg-Trp-Arg-Trp-Lys]-D-Phe-D-Val-NH2 2726 TCAM2723 Phe-Phe-Arg-Arg-Leu-Lys-c[Asp-Arg-Trp-Trp-Arg-Arg-Lys]-D-Val-D-Pro-NH2 2727 TCAM2724 Phe-Phe-Arg-Arg-Leu-Lys-c[Asp-Arg-Trp-Trp-Arg-Arg-Lys]-D-Val-D-Phe-NH2 2728 TCAM2725 Phe-Phe-Arg-Arg-Leu-Lys-c[Asp-Arg-Trp-Trp-Arg-Arg-Lys]-D-Pro-D-Val-NH2 2729 TCAM2726 Phe-Phe-Arg-Arg-Leu-Lys-c[Asp-Arg-Trp-Trp-Arg-Arg-Lys]-D-Phe-D-Val-NH2 2730 TCAM2727 Phe-Phe-Arg-Arg-Leu-Lys-c[Asp-Arg-Trp-Arg-Trp-Arg-Lys]-D-Val-D-Pro-NH2 2731 TCAM2728 Phe-Phe-Arg-Arg-Leu-Lys-c[Asp-Arg-Trp-Arg-Trp-Arg-Lys]-D-Val-D-Phe-NH2 2732 TCAM2729 Phe-Phe-Arg-Arg-Leu-Lys-c[Asp-Arg-Trp-Arg-Trp-Arg-Lys]-D-Pro-D-Val-NH2 2733 TCAM2730 Phe-Phe-Arg-Arg-Leu-Lys-c[Asp-Arg-Trp-Arg-Trp-Arg-Lys]-D-Phe-D-Val-NH2 2734 TCAM2731 Phe-Phe-Arg-Arg-Leu-Lys-c[Asp-Trp-Trp-Arg-Arg-Trp-Lys]-D-Val-D-Pro-NH2 2735 TCAM2732 Phe-Phe-Arg-Arg-Leu-Lys-c[Asp-Trp-Trp-Arg-Arg-Trp-Lys]-D-Val-D-Phe-NH2 2736 TCAM2733 Phe-Phe-Arg-Arg-Leu-Lys-c[Asp-Trp-Trp-Arg-Arg-Trp-Lys]-D-Pro-D-Val-NH2 2737 TCAM2734 Phe-Phe-Arg-Arg-Leu-Lys-c[Asp-Trp-Trp-Arg-Arg-Trp-Lys]-D-Phe-D-Val-NH2 2738 TCAM2735 Phe-Phe-Arg-Arg-Leu-Lys-c[Asp-Trp-Arg-Trp-Arg-Trp-Lys]-D-Val-D-Pro-NH2 2739 TCAM2736 Phe-Phe-Arg-Arg-Leu-Lys-c[Asp-Trp-Arg-Trp-Arg-Trp-Lys]-D-Val-D-Phe-NH2 2740 TCAM2737 Phe-Phe-Arg-Arg-Leu-Lys-c[Asp-Trp-Arg-Trp-Arg-Trp-Lys]-D-Pro-D-Val-NH2 2741 TCAM2738 Phe-Phe-Arg-Arg-Leu-Lys-c[Asp-Trp-Arg-Trp-Arg-Trp-Lys]-D-Phe-D-Val-NH2 2742 TCAM2739 Phe-Phe-Arg-Arg-Leu-Lys-c[Asp-Trp-Arg-Tyr-Arg-Trp-Lys]-D-Val-D-Pro-NH2 2743 TCAM2740 Phe-Phe-Arg-Arg-Leu-Lys-c[Asp-Trp-Arg-Tyr-Arg-Trp-Lys]-D-Val-D-Phe-NH2 2744 TCAM2741 Phe-Phe-Arg-Arg-Leu-Lys-c[Asp-Trp-Arg-Tyr-Arg-Trp-Lys]-D-Pro-D-Val-NH2 2745 TCAM2742 Phe-Phe-Arg-Arg-Leu-Lys-c[Asp-Trp-Arg-Tyr-Arg-Trp-Lys]-D-Phe-D-Val-NH2 2746 TCAM2743 Phe-Phe-Arg-Arg-Leu-Lys-c[Asp-Trp-Arg-Trp-Arg-Tyr-Lys]-D-Val-D-Pro-NH2 2747 TCAM2744 Phe-Phe-Arg-Arg-Leu-Lys-c[Asp-Trp-Arg-Trp-Arg-Tyr-Lys]-D-Val-D-Phe-NH2 2748 TCAM2745 Phe-Phe-Arg-Arg-Leu-Lys-c[Asp-Trp-Arg-Trp-Arg-Tyr-Lys]-D-Pro-D-Val-NH2 2749 TCAM2746 Phe-Phe-Arg-Arg-Leu-Lys-c[Asp-Trp-Arg-Trp-Arg-Tyr-Lys]-D-Phe-D-Val-NH2 2750 TCAM2747 Phe-Phe-Arg-Arg-Leu-Lys-c[Asp-Trp-Arg-Trp-Arg-Lys]-D-Val-D-Pro-NH2 2751 TCAM2748 Phe-Phe-Arg-Arg-Leu-Lys-c[Asp-Trp-Arg-Trp-Arg-Lys]-D-Val-D-Phe-NH2 2752 TCAM2749 Phe-Phe-Arg-Arg-Leu-Lys-c[Asp-Trp-Arg-Trp-Arg-Lys]-D-Pro-D-Val-NH2 2753 TCAM2750 Phe-Phe-Arg-Arg-Leu-Lys-c[Asp-Trp-Arg-Trp-Arg-Lys]-D-Phe-D-Val-NH2 2754 TCAM2751 Phe-Phe-Arg-Arg-Leu-Lys-c[Asp-Trp-Arg-Arg-Trp-Lys]-D-Val-D-Pro-NH2 2755 TCAM2752 Phe-Phe-Arg-Arg-Leu-Lys-c[Asp-Trp-Arg-Arg-Trp-Lys]-D-Val-D-Phe-NH2 2756 TCAM2753 Phe-Phe-Arg-Arg-Leu-Lys-c[Asp-Trp-Arg-Arg-Trp-Lys]-D-Pro-D-Val-NH2 2757 TCAM2754 Phe-Phe-Arg-Arg-Leu-Lys-c[Asp-Trp-Arg-Arg-Trp-Lys]-D-Phe-D-Val-NH2 2758 TCAM2755 Phe-Phe-Arg-Arg-Leu-Lys-c[Asp-Arg-Trp-Trp-Arg-Lys]-D-Val-D-Pro-NH2 2759 TCAM2756 Phe-Phe-Arg-Arg-Leu-Lys-c[Asp-Arg-Trp-Trp-Arg-Lys]-D-Val-D-Phe-NH2 2760 TCAM2757 Phe-Phe-Arg-Arg-Leu-Lys-c[Asp-Arg-Trp-Trp-Arg-Lys]-D-Pro-D-Val-NH2 2761 TCAM2758 Phe-Phe-Arg-Arg-Leu-Lys-c[Asp-Arg-Trp-Trp-Arg-Lys]-D-Phe-D-Val-NH2 2762 TCAM2759 Phe-Phe-Arg-Arg-Leu-Lys-c[Asp-Trp-Arg-Trp-Lys]-D-Val-D-Pro-NH2 2763 TCAM2760 Phe-Phe-Arg-Arg-Leu-Lys-c[Asp-Trp-Arg-Trp-Lys]-D-Val-D-Phe-NH2 2764 TCAM2761 Phe-Phe-Arg-Arg-Leu-Lys-c[Asp-Trp-Arg-Trp-Lys]-D-Pro-D-Val-NH2 2765 TCAM2762 Phe-Phe-Arg-Arg-Leu-Lys-c[Asp-Trp-Arg-Trp-Lys]-D-Phe-D-Val-NH2 2766 TCAM2763 Phe-Phe-Arg-Arg-Leu-Lys-c[Asp-Arg-Trp-Arg-Lys]-D-Val-D-Pro-NH2 2767 TCAM2764 Phe-Phe-Arg-Arg-Leu-Lys-c[Asp-Arg-Trp-Arg-Lys]-D-Val-D-Phe-NH2 2768 TCAM2765 Phe-Phe-Arg-Arg-Leu-Lys-c[Asp-Arg-Trp-Arg-Lys]-D-Pro-D-Val-NH2 2769 TCAM2766 Phe-Phe-Arg-Arg-Leu-Lys-c[Asp-Arg-Trp-Arg-Lys]-D-Phe-D-Val-NH2 2770 TCAM2767 Phe-Phe-Arg-Arg-Leu-Lys-c[Asp-His-D-Nal(2′)-Arg-Trp-Lys]-D-Val-D-Pro-NH2 2771 TCAM2768 Phe-Phe-Arg-Arg-Leu-Lys-c[Asp-His-D-Nal(2′)-Arg-Trp-Lys]-D-Pro-D-Val-NH2 2772 TCAM2769 Phe-Phe-Arg-Arg-Leu-Lys-c[Asp-His-D-Nal(2′)-Arg-Trp-Lys]-D-Val-D-Phe-NH2 2773 TCAM2770 Phe-Phe-Arg-Arg-Leu-Lys-c[Asp-His-D-Nal(2′)-Arg-Trp-Lys]-D-Phe-D-Val-NH2 2774 TCAM2771 Phe-Phe-Arg-Arg-Leu-Lys-c[Asp-Pro-D-Nal(2′)-Arg-Trp-Lys]-D-Val-D-Pro-NH2 2775 TCAM2772 Phe-Phe-Arg-Arg-Leu-Lys-c[Asp-Pro-D-Nal(2′)-Arg-Trp-Lys]-D-Pro-D-Val-NH2 2776 TCAM2773 Phe-Phe-Arg-Arg-Leu-Lys-c[Asp-Pro-D-Nal(2′)-Arg-Trp-Lys]-D-Val-D-Phe-NH2 2777 TCAM2774 Phe-Phe-Arg-Arg-Leu-Lys-c[Asp-Pro-D-Nal(2′)-Arg-Trp-Lys]-D-Phe-D-Val-NH2 2778 TCAM2775 Phe-Phe-Arg-Arg-Leu-Lys-c[Asp-Arg-Arg-Nal(2′)-Arg-Trp-Lys]-D-Val-D-Pro-NH2 2779 TCAM2776 Phe-Phe-Arg-Arg-Leu-Lys-c[Asp-Arg-Arg-Nal(2′)-Arg-Trp-Lys]-D-Pro-D-Val-NH2 2780 TCAM2777 Phe-Phe-Arg-Arg-Leu-Lys-c[Asp-Arg-Arg-Nal(2′)-Arg-Trp-Lys]-D-Val-D-Phe-NH2 2781 TCAM2778 Phe-Phe-Arg-Arg-Leu-Lys-c[Asp-Arg-Arg-Nal(2′)-Arg-Trp-Lys]-D-Phe-D-Val-NH2 2782 TCAM2779 Phe-Phe-Arg-Arg-Leu-Lys-c[Asp-Arg-Arg-Pro-Nal(2′)-Arg-Trp-Lys]-D-Val-D-Pro-NH2 2783 TCAM2780 Phe-Phe-Arg-Arg-Leu-Lys-c[Asp-Arg-Arg-Pro-D-Nal(2′)-Arg-Trp-Lys]-D-Pro-D-Val- NH2 2784 TCAM2781 Phe-Phe-Arg-Arg-Leu-Lys-c[Asp-Arg-Arg-Pro-D-Nal(2′)-Arg-Trp-Lys]-D-Val-D-Phe- NH2 2785 TCAM2782 Phe-Phe-Arg-Arg-Leu-Lys-c[Asp-Arg-Arg-Pro-Nal(2′)-Arg-Trp-Lys]-D-Phe-D-Val-NH2 2786 TCAM2783 Phe-Phe-Arg-Arg-Leu-Lys-c[Asp-Arg-D-Nal(2′)-Arg-Trp-Lys]-D-Val-D-Pro-NH2 2787 TCAM2784 Phe-Phe-Arg-Arg-Leu-Lys-c[Asp-Arg-D-Nal(2′)-Arg-Trp-Lys]-D-Pro-D-Val-NH2 2788 TCAM2785 Phe-Phe-Arg-Arg-Leu-Lys-c[Asp-Arg-D-Nal(2′)-Arg-Trp-Lys]-D-Val-D-Phe-NH2 2789 TCAM2786 Phe-Phe-Arg-Arg-Leu-Lys-c[Asp-Arg-D-Nal(2′)-Arg-Trp-Lys]-D-Phe-D-Val-NH2 2790 TCAM2787 Phe-Phe-Arg-Arg-Leu-Lys-c[Asp-Arg-Pro-D-Nal(2′)-Arg-Trp-Lys]-D-Val-D-Pro-NH2 2791 TCAM2788 Phe-Phe-Arg-Arg-Leu-Lys-c[Asp-Arg-Pro-D-Nal(2′)-Arg-Trp-Lys]-D-Pro-D-Val-NH2 2792 TCAM2789 Phe-Phe-Arg-Arg-Leu-Lys-c[Asp-Arg-Pro-D-Nal(2′)-Arg-Trp-Lys]-D-Val-D-Phe-NH2 2793 TCAM2790 Phe-Phe-Arg-Arg-Leu-Lys-c[Asp-Arg-Pro-D-Nal(2′)-Arg-Trp-Lys]-D-Phe-D-Val-NH2 2794 TCAM2791 Phe-Phe-Arg-Arg-Leu-Lys-Arg-Arg-c[Asp-Pro-D-Nal(2′)-Arg-Trp-Lys]-D-Val-D-Pro- NH2 2795 TCAM2792 Phe-Phe-Arg-Arg-Leu-Lys-Arg-Arg-c[Asp-Pro-D-Nal(2′)-Arg-Trp-Lys]-D-Pro-D-Val- NH2 2796 TCAM2793 Phe-Phe-Arg-Arg-Leu-Lys-Arg-Arg-c[Asp-Pro-D-Nal(2′)-Arg-Trp-Lys]-D-Val-D-Phe- NH2 2797 TCAM2794 Phe-Phe-Arg-Arg-Leu-Lys-Arg-Arg-c[Asp-Pro-D-Nal(2′)-Arg-Trp-Lys]-D-Phe-D-Val- NH2 2798 TCAM2795 Phe-Phe-Arg-Arg-Leu-Lys-Arg-Arg-c[Asp-His-D-Nal(2′)-Arg-Trp-Lys]-D-Val-D-Pro-NH2 2799 TCAM2796 Phe-Phe-Arg-Arg-Leu-Lys-Arg-Arg-c[Asp-His-D-Nal(2′)-Arg-Trp-Lys]-D-Pro-D-Val-NH2 2800 TCAM2797 Phe-Phe-Arg-Arg-Leu-Lys-Arg-Arg-c[Asp-His-D-Nal(2′)-Arg-Trp-Lys]-D-Val-D-Phe- NH2 2801 TCAM2798 Phe-Phe-Arg-Arg-Leu-Lys-Arg-Arg-c[Asp-His-D-Nal(2′)-Arg-Trp-Lys]-D-Phe-D-Val- NH2 2802 TCAM2799 Phe-Phe-Arg-Arg-Leu-Lys-c[Asp-Arg-Pro-D-Nal(2′)-Arg-Trp-Arg-Lys]-D-Val-D-Pro- NH2 2803 TCAM2800 Phe-Phe-Arg-Arg-Leu-Lys-c[Asp-Arg-Pro-D-Nal(2′)-Arg-Trp-Arg-Lys]-D-Pro-D-Val- NH2 2804 TCAM2801 Phe-Phe-Arg-Arg-Leu-Lys-c[Asp-Arg-Pro-D-Nal(2′)-Arg-Trp-Arg-Lys]-D-Val-D-Phe- NH2 2805 TCAM2802 Phe-Phe-Arg-Arg-Leu-Lys-c[Asp-Arg-Pro-D-Nal(2′)-Arg-Trp-Arg-Lys]-D-Phe-D-Val- NH2 2806 TCAM2803 Phe-Phe-Arg-Arg-Leu-Lys-c[Asp-Arg-His-D-Nal(2′)-Arg-Trp-Arg-Lys]-D-Val-D-Pro-NH2 2807 TCAM2804 Phe-Phe-Arg-Arg-Leu-Lys-c[Asp-Arg-His-D-Nal(2′)-Arg-Trp-Arg-Lys]-D-Pro-D-Val-NH2 2808 TCAM2805 Phe-Phe-Arg-Arg-Leu-Lys-c[Asp-Arg-His-D-Nal(2′)-Arg-Trp-Arg-Lys]-D-Val-D-Phe- NH2 2809 TCAM2806 Phe-Phe-Arg-Arg-Leu-Lys-c[Asp-Arg-His-D-Nal(2′)-Arg-Trp-Arg-Lys]-D-Phe-D-Val- NH2 2810 TCAM2807 Phe-Phe-Arg-Arg-Leu-Lys-c[Asp-His-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Val-D-Phe-NH2 2811 TCAM2808 Phe-Phe-Arg-Arg-Leu-Lys-c[Asp-His-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Phe-D-Val-NH2 2812 TCAM2809 Phe-Phe-Arg-Arg-Leu-Lys-c[Asp-Pro-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Val-D-Pro-NH2 2813 TCAM2810 Phe-Phe-Arg-Arg-Leu-Lys-c[Asp-Pro-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Pro-D-Val-NH2 2814 TCAM2811 Phe-Phe-Arg-Arg-Leu-Lys-c[Asp-Pro-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Val-D-Phe-NH2 2815 TCAM2812 Phe-Phe-Arg-Arg-Leu-Lys-c[Asp-Pro-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Phe-D-Val-NH2 2816 TCAM2813 Phe-Phe-Arg-Arg-Leu-Lys-c[Asp-Arg-Arg-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Val-D-Pro- NH2 2817 TCAM2814 Phe-Phe-Arg-Arg-Leu-Lys-c[Asp-Arg-Arg-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Pro-D-Val- NH2 2818 TCAM2815 Phe-Phe-Arg-Arg-Leu-Lys-c[Asp-Arg-Arg-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Val-D-Phe- NH2 2819 TCAM2816 Phe-Phe-Arg-Arg-Leu-Lys-c[Asp-Arg-Arg-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Phe-D-Val- NH2 2820 TCAM2817 Phe-Phe-Arg-Arg-Leu-Lys-c[Asp-Arg-Arg-Pro-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Val-D- Pro-NH2 2821 TCAM2818 Phe-Phe-Arg-Arg-Leu-Lys-c[Asp-Arg-Arg-Pro-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Pro-D- Val-NH2 2822 TCAM2819 Phe-Phe-Arg-Arg-Leu-Lys-c[Asp-Arg-Arg-Pro-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Val-D- Phe-NH2 2823 TCAM2820 Phe-Phe-Arg-Arg-Leu-Lys-c[Asp-Arg-Arg-Pro-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Phe-D- Val-NH2 2824 TCAM2821 Phe-Phe-Arg-Arg-Leu-Lys-c[Asp-Arg-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Val-D-Pro-NH2 2825 TCAM2822 Phe-Phe-Arg-Arg-Leu-Lys-c[Asp-Arg-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Pro-D-Val-NH2 2826 TCAM2823 Phe-Phe-Arg-Arg-Leu-Lys-c[Asp-Arg-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Val-D-Phe-NH2 2827 TCAM2824 Phe-Phe-Arg-Arg-Leu-Lys-c[Asp-Arg-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Phe-D-Val-NH2 2828 TCAM2825 Phe-Phe-Arg-Arg-Leu-Lys-c[Asp-Arg-Pro-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Val-D-Pro- NH2 2829 TCAM2826 Phe-Phe-Arg-Arg-Leu-Lys-c[Asp-Arg-Pro-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Pro-D-Val- NH2 2830 TCAM2827 Phe-Phe-Arg-Arg-Leu-Lys-c[Asp-Arg-Pro-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Val-D-Phe- NH2 2831 TCAM2828 Phe-Phe-Arg-Arg-Leu-Lys-c[Asp-Arg-Pro-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Phe-D-Val- NH2 2832 TCAM2829 Phe-Phe-Arg-Arg-Leu-Lys-c[Asp-Arg-His-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Val-D-Pro- NH2 2833 TCAM2830 Phe-Phe-Arg-Arg-Leu-Lys-c[Asp-Arg-His-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Pro-D-Val- NH2 2834 TCAM2831 Phe-Phe-Arg-Arg-Leu-Lys-c[Asp-Arg-His-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Val-D-Phe-NH2 2835 TCAM2832 Phe-Phe-Arg-Arg-Leu-Lys-c[Asp-Arg-His-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Phe-D-Val-NH2 2836 TCAM2833 Phe-Phe-Arg-Arg-Leu-Lys-c[Asp-Arg-D-D-Nal(2′)-Arg-D-Nal(2′)-Arg-Lys]-D-Val-D-Pro- NH2 2837 TCAM2834 Phe-Phe-Arg-Arg-Leu-Lys-c[Asp-Arg-D-Nal(2′)-Arg-D-Nal(2′)-Arg-Lys]-D-Pro-D-Val- NH2 2838 TCAM2835 Phe-Phe-Arg-Arg-Leu-Lys-c[Asp-Arg-D-Nal(2′)-Arg-D-Nal(2′)-Arg-Lys]-D-Val-D-Phe- NH2 2839 TCAM2836 Phe-Phe-Arg-Arg-Leu-Lys-c[Asp-Arg-D-Nal(2′)-Arg-D-Nal(2′)-Arg-Lys]-D-Phe-D-Val- NH2 2840 TCAM2837 Phe-Phe-Arg-Arg-Leu-Lys-c[Asp-Arg-Pro-D-Nal(2′)-Arg-D-Nal(2′)-Arg-Lys]-D-Val-D- Pro-NH2 2841 TCAM2838 Phe-Phe-Arg-Arg-Leu-Lys-c[Asp-Arg-Pro-D-Nal(2′)-Arg-D-Nal(2′)-Arg-Lys]-D-Pro-D- Val-NH2 2842 TCAM2839 Phe-Phe-Arg-Arg-Leu-Lys-c[Asp-Arg-Pro-D-Nal(2′)-Arg-D-Nal(2′)-Arg-Lys]-D-Val-D- Phe-NH2 2843 TCAM2840 Phe-Phe-Arg-Arg-Leu-Lys-c[Asp-Arg-Pro-D-Nal(2′)-Arg-D-Nal(2′)-Arg-Lys]-D-Phe-D- Val-NH2 2844 TCAM2841 Phe-Phe-Arg-Arg-Leu-Lys-c[Asp-Arg-His-D-Nal(2′)-Arg-D-Nal(2′)-Arg-Lys]-D-Val-D- Pro-NH2 2845 TCAM2842 Phe-Phe-Arg-Arg-Leu-Lys-c[Asp-Arg-His-D-Nal(2′)-Arg-D-Nal(2′)-Arg-Lys]-D-Pro-D- Val-NH2 2846 TCAM2843 Phe-Phe-Arg-Arg-Leu-Lys-c[Asp-Arg-His-D-Nal(2′)-Arg-D-Nal(2′)-Arg-Lys]-D-Val-D- Phe-NH2 2847 TCAM2844 Phe-Phe-Arg-Arg-Leu-Lys-c[Asp-Arg-His-D-Nal(2′)-Arg-D-Nal(2′)-Arg-Lys]-D-Phe-D- Val-NH2 2848 TCAM2845 Phe-Phe-Arg-Arg-Leu-Lys-Arg-Arg-c[Asp-Pro-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Val-D- Pro-NH2 2849 TCAM2846 Phe-Phe-Arg-Arg-Leu-Lys-Arg-Arg-c[Asp-Pro-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Pro-D- Val-NH2 2850 TCAM2847 Phe-Phe-Arg-Arg-Leu-Lys-Arg-Arg-c[Asp-Pro-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Val-D- Phe-NH2 2851 TCAM2848 Phe-Phe-Arg-Arg-Leu-Lys-Arg-Arg-c[Asp-Pro-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Phe-D- Val-NH2 2852 TCAM2849 Phe-Phe-Arg-Arg-Leu-Lys-Arg-Arg-c[Asp-His-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Val-D- Pro-NH2 2853 TCAM2850 Phe-Phe-Arg-Arg-Leu-Lys-Arg-Arg-c[Asp-His-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Pro-D- Val-NH2 2854 TCAM2851 Phe-Phe-Arg-Arg-Leu-Lys-Arg-Arg-c[Asp-His-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Val-D- Phe-NH2 2855 TCAM2852 Phe-Phe-Arg-Arg-Leu-Lys-Arg-Arg-c[Asp-His-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Phe-D- Val-NH2 2856 TCAM2853 Phe-Phe-Arg-Arg-Leu-Lys-c[Asp-Arg-Pro-D-Nal(2′)-Arg-D-Nal(2′)-Arg-Lys]-D-Val-D- Pro-NH2 2857 TCAM2854 Phe-Phe-Arg-Arg-Leu-Lys-c[Asp-Arg-Pro-D-Nal(2′)-Arg-D-Nal(2′)-Arg-Lys]-D-Pro-D- Val-NH2 2858 TCAM2855 Phe-Phe-Arg-Arg-Leu-Lys-c[Asp-Arg-Pro-D-Nal(2′)-Arg-D-Nal(2′)-Arg-Lys]-D-Val-D- Phe-NH2 2859 TCAM2856 Phe-Phe-Arg-Arg-Leu-Lys-c[Asp-Arg-Pro-D-Nal(2′)-Arg-D-Nal(2′)-Arg-Lys]-D-Phe-D- Val-NH2 2860 TCAM2857 Phe-Phe-Arg-Arg-Leu-Lys-c[Asp-Arg-His-D-Nal(2′)-Arg-D-Nal(2′)-Arg-Lys]-D-Val-D- Pro-NH2 2861 TCAM2858 Phe-Phe-Arg-Arg-Leu-Lys-c[Asp-Arg-His-D-Nal(2′)-Arg-D-Nal(2′)-Arg-Lys]-D-Pro-D- Val-NH2 2862 TCAM2859 Phe-Phe-Arg-Arg-Leu-Lys-c[Asp-Arg-His-D-Nal(2′)-Arg-D-Nal(2′)-Arg-Lys]-D-Val-D- Phe-NH2 2863 TCAM2860 Phe-Phe-Arg-Arg-Leu-Lys-c[Asp-Arg-His-D-Nal(2′)-Arg-D-Nal(2′)-Arg-Lys]-D-Phe-D- Val-NH2 2864 TCAM2861 Phe-Phe-Arg-Arg-Leu-Lys-c[Asp-His-D-Nal(2′)-Arg-Trp-Lys]-Arg-Arg-D-Val-D-Pro-NH2 2865 TCAM2862 Phe-Phe-Arg-Arg-Leu-Lys-c[Asp-His-D-Nal(2′)-Arg-Trp-Lys]-Arg-Arg-D-Pro-D-Val-NH2 2866 TCAM2863 Phe-Phe-Arg-Arg-Leu-Lys-c[Asp-His-D-Nal(2′)-Arg-Trp-Lys]-Arg-Arg-D-Val-D-Phe- NH2 2867 TCAM2864 Phe-Phe-Arg-Arg-Leu-Lys-c[Asp-His-D-Nal(2′)-Arg-Trp-Lys]-Arg-Arg-D-Phe-D-Val- NH2 2868 TCAM2865 Phe-Phe-Arg-Arg-Leu-Lys-c[Asp-Pro-D-Nal(2′)-Arg-Trp-Lys]-Arg-Arg-D-Val-D-Pro- NH2 2869 TCAM2866 Phe-Phe-Arg-Arg-Leu-Lys-c[Asp-Pro-D-Nal(2′)-Arg-Trp-Lys]-Arg-Arg-D-Pro-D-Val- NH2 2870 TCAM2867 Phe-Phe-Arg-Arg-Leu-Lys-c[Asp-Pro-D-Nal(2′)-Arg-Trp-Lys]-Arg-Arg-D-Val-D-Phe- NH2 2871 TCAM2868 Phe-Phe-Arg-Arg-Leu-Lys-c[Asp-Pro-D-Nal(2′)-Arg-Trp-Lys]-Arg-Arg-D-Phe-D-Val- NH2 Anti-biofilm peptide ABF5ARG linked to anti-microbial peptides 2872 TCAM2869 Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Pro-Arg-Arg-Trp-Trp-Arg-Phe-Lys]-D-Val-D-Pro-NH2 2873 TCAM2870 Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Pro-Arg-Arg-Trp-Trp-Arg-Phe-Lys]-D-Val-D-Phe- NH2 2874 TCAM2871 Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Pro-Arg-Arg-Trp-Trp-Arg-Phe-Lys]-D-Pro-D-Val-NH2 2875 TCAM2872 Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Pro-Arg-Arg-Trp-Trp-Arg-Phe-Lys]-D-Phe-D-Val- NH2 2876 TCAM2873 Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Pro-Arg-Arg-Trp-Trp-Tyr-Phe-Lys]-D-Val-D-Pro-NH2 2877 TCAM2874 Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Pro-Arg-Arg-Trp-Trp-Tyr-Phe-Lys]-D-Val-D-Phe-NH2 2878 TCAM2875 Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Pro-Arg-Arg-Trp-Trp-Tyr-Phe-Lys]-D-Pro-D-Val-NH2 2879 TCAM2876 Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Pro-Arg-Arg-Trp-Trp-Tyr-Phe-Lys]-D-Phe-D-Val-NH2 2880 TCAM2877 Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Pro-Arg-Arg-Tyr-Tyr-Arg-Phe-Lys]-D-Val-D-Pro-NH2 2881 TCAM2878 Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Pro-Arg-Arg-Tyr-Tyr-Arg-Phe-Lys]-D-Val-D-Phe-NH2 2882 TCAM2879 Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Pro-Arg-Arg-Tyr-Tyr-Arg-Phe-Lys]-D-Pro-D-Val-NH2 2883 TCAM2880 Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Pro-Arg-Arg-Tyr-Tyr-Arg-Phe-Lys]-D-Phe-D-Val-NH2 2884 TCAM2881 Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Pro-Arg-Arg-Nal-Nal-Arg-Phe-Lys]-D-Val-D-Pro-NH2 2885 TCAM2882 Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Pro-Arg-Arg-Nal-Nal-Arg-Phe-Lys]-D-Val-D-Phe- NH2 2886 TCAM2883 Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Pro-Arg-Arg-Nal-Nal-Arg-Phe-Lys]-D-Pro-D-Val-NH2 2887 TCAM2884 Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Pro-Arg-Arg-Nal-Nal-Arg-Phe-Lys]-D-Phe-D-Val- NH2 2888 TCAM2885 Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Pro-Arg-Arg-Leu-Trp-Leu-Trp-Lys]-D-Val-D-Pro-NH2 2889 TCAM2886 Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Pro-Arg-Arg-Leu-Trp-Leu-Trp-Lys]-D-Val-D-Phe- NH2 2890 TCAM2887 Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Pro-Arg-Arg-Leu-Trp-Leu-Trp-Lys]-D-Pro-D-Val-NH2 2891 TCAM2888 Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Pro-Arg-Arg-Leu-Trp-Leu-Trp-Lys]-D-Phe-D-Val- NH2 2892 TCAM2889 Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Pro-Arg-Arg-Leu-Trp-Leu-Trp-Lys]-D-Val-D-Pro-NH2 2893 TCAM2890 Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Pro-Arg-Arg-Leu-Trp-Leu-Trp-Lys]-D-Val-D-Phe- NH2 2894 TCAM2891 Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Pro-Arg-Arg-Leu-Trp-Leu-Trp-Lys]-D-Pro-D-Val-NH2 2895 TCAM2892 Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Pro-Arg-Arg-Leu-Trp-Leu-Trp-Lys]-D-Phe-D-Val- NH2 2896 TCAM2893 Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-Arg-Arg-Trp-Leu-Trp-Leu-Trp-Lys]-D-Val-D-Pro- NH2 2897 TCAM2894 Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Pro-Arg-Arg-Arg-Trp-Leu-Trp-Leu-Trp-Lys]-D-Val-D- Phe-NH2 2898 TCAM2895 Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Pro-Arg-Arg-Arg-Trp-Leu-Trp-Leu-Trp-Lys]-D-Pro-D- Val-NH2 2899 TCAM2896 Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Pro-Arg-Arg-Arg-Trp-Leu-Trp-Leu-Trp-Lys]-D-Phe- D-Val-NH2 2900 TCAM2897 Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Pro-Arg-Gln-Arg-Arg-Trp-Leu-Trp-Leu-Trp-Lys]-D- Val-D-Pro-NH2 2901 TCAM2898 Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Pro-Arg-Gln-Arg-Arg-Trp-Leu-Trp-Leu-Trp-Lys]-D- Val-D-Phe-NH2 2902 TCAM2899 Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Pro-Arg-Gln-Arg-Arg-Trp-Leu-Trp-Leu-Trp-Lys]-D- Pro-D-Val-NH2 2903 TCAM2900 Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Pro-Arg-Gln-Arg-Arg-Trp-Leu-Trp-Leu-Trp-Lys]-D- Phe-D-Val-NH2 2904 TCAM2901 Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Pro-Trp-Arg-Trp-Trp-Arg-Arg-Lys]-D-Val-D-Phe-NH2 2905 TCAM2902 Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Pro-Trp-Arg-Trp-Trp-Arg-Arg-Lys]-D-Pro-D-Val-NH2 2906 TCAM2903 Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Pro-Trp-Arg-Trp-Trp-Arg-Arg-Lys]-D-Phe-D-Val-NH2 2907 TCAM2904 Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Pro-Trp-Trp-Arg-Arg-Trp-Trp-Arg-Arg-Lys]-D-Val-D- Pro-NH2 2908 TCAM2905 Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Pro-Trp-Trp-Arg-Arg-Trp-Trp-Arg-Arg-Lys]-D-Val-D- Phe-NH2 2909 TCAM2906 Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Pro-Trp-Trp-Arg-Arg-Trp-Trp-Arg-Arg-Lys]-D-Pro-D- Val-NH2 2910 TCAM2907 Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Pro-Trp-Trp-Arg-Arg-Trp-Trp-Arg-Arg-Lys]-D-Phe-D- Val-NH2 2911 TCAM2908 Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Pro-Trp-Arg-Trp-Arg-Trp-Arg-Lys]-D-Val-D-Pro-NH2 2912 TCAM2909 Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Pro-Trp-Arg-Trp-Arg-Trp-Arg-Lys]-D-Val-D-Phe-NH2 2913 TCAM2910 Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Pro-Trp-Arg-Trp-Arg-Trp-Arg-Lys]-D-Pro-D-Val-NH2 2914 TCAM2911 Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Pro-Trp-Arg-Trp-Arg-Trp-Arg-Lys]-D-Phe-D-Val-NH2 2915 TCAM2912 Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Pro-Arg-Trp-Arg-Trp-Arg-Trp-Lys]-D-Val-D-Pro-NH2 2916 TCAM2913 Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Pro-Arg-Trp-Arg-Trp-Arg-Trp-Lys]-D-Val-D-Phe-NH2 2917 TCAM2914 Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Pro-Arg-Trp-Arg-Trp-Arg-Trp-Lys]-D-Pro-D-Val-NH2 2918 TCAM2915 Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Pro-Arg-Trp-Arg-Trp-Arg-Trp-Lys]-D-Phe-D-Val-NH2 2919 TCAM2916 Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Pro-Arg-Trp-Trp-Arg-Arg-Lys]-D-Val-D-Pro-NH2 2920 TCAM2917 Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Pro-Arg-Trp-Trp-Arg-Arg-Lys]-D-Val-D-Phe-NH2 2921 TCAM2918 Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Pro-Arg-Trp-Trp-Arg-Arg-Lys]-D-Pro-D-Val-NH2 2922 TCAM2919 Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Pro-Arg-Trp-Trp-Arg-Arg-Lys]-D-Phe-D-Val-NH2 2923 TCAM2920 Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Pro-Trp-Trp-Arg-Arg-Trp-Lys]-D-Val-D-Pro-NH2 2924 TCAM2921 Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Pro-Trp-Trp-Arg-Arg-Trp-Lys]-D-Val-D-Phe-NH2 2925 TCAM2922 Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Pro-Trp-Trp-Arg-Arg-Trp-Lys]-D-Pro-D-Val-NH2 2926 TCAM2923 Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Pro-Trp-Trp-Arg-Arg-Trp-Lys]-D-Phe-D-Val-NH2 2927 TCAM2924 Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Pro-Trp-Arg-Trp-Arg-Trp-Lys]-D-Val-D-Pro-NH2 2928 TCAM2925 Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Pro-Trp-Arg-Trp-Arg-Trp-Lys]-D-Val-D-Phe-NH2 2929 TCAM2926 Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Pro-Trp-Arg-Trp-Arg-Trp-Lys]-D-Pro-D-Val-NH2 2930 TCAM2927 Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Pro-Trp-Arg-Trp-Arg-Trp-Lys]-D-Phe-D-Val-NH2 2931 TCAM2928 Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Pro-Arg-Trp-Arg-Trp-Arg-Lys]-D-Val-D-Pro-NH2 2932 TCAM2929 Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Pro-Arg-Trp-Arg-Trp-Arg-Lys]-D-Val-D-Phe-NH2 2933 TCAM2930 Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Pro-Arg-Trp-Arg-Trp-Arg-Lys]-D-Pro-D-Val-NH2 2934 TCAM2931 Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Pro-Arg-Trp-Arg-Trp-Arg-Lys]-D-Phe-D-Val-NH2 2935 TCAM2932 Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Pro-Trp-Arg-Tyr-Arg-Trp-Lys]-D-Val-D-Pro-NH2 2936 TCAM2933 Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Pro-Trp-Arg-Tyr-Arg-Trp-Lys]-D-Val-D-Phe-NH2 2937 TCAM2934 Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Pro-Trp-Arg-Tyr-Arg-Trp-Lys]-D-Pro-D-Val-NH2 2938 TCAM2935 Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Pro-Trp-Arg-Tyr-Arg-Trp-Lys]-D-Phe-D-Val-NH2 2939 TCAM2936 Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Pro-Trp-Arg-Trp-Arg-Tyr-Lys]-D-Val-D-Pro-NH2 2940 TCAM2937 Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Pro-Trp-Arg-Trp-Arg-Tyr-Lys]-D-Val-D-Phe-NH2 2941 TCAM2938 Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Pro-Trp-Arg-Trp-Arg-Tyr-Lys]-D-Pro-D-Val-NH2 2942 TCAM2939 Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Pro-Trp-Arg-Trp-Arg-Tyr-Lys]-D-Phe-D-Val-NH2 2943 TCAM2940 Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Pro-Trp-Arg-Trp-Arg-Lys]-D-Val-D-Pro-NH2 2944 TCAM2941 Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Pro-Trp-Arg-Trp-Arg-Lys]-D-Val-D-Phe-NH2 2945 TCAM2942 Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Pro-Trp-Arg-Trp-Arg-Lys]-D-Pro-D-Val-NH2 2946 TCAM2943 Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Pro-Trp-Arg-Trp-Arg-Lys]-D-Phe-D-Val-NH2 2947 TCAM2944 Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Pro-Trp-Arg-Arg-Trp-Lys]-D-Val-D-Pro-NH2 2948 TCAM2945 Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Pro-Trp-Arg-Arg-Trp-Lys]-D-Val-D-Phe-NH2 2949 TCAM2946 Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Pro-Trp-Arg-Arg-Trp-Lys]-D-Pro-D-Val-NH2 2950 TCAM2947 Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Pro-Trp-Arg-Arg-Trp-Lys]-D-Phe-D-Val-NH2 2951 TCAM2948 Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Pro-Arg-Trp-Trp-Arg-Lys]-D-Val-D-Pro-NH2 2952 TCAM2949 Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Pro-Arg-Trp-Trp-Arg-Lys]-D-Val-D-Phe-NH2 2953 TCAM2950 Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Pro-Arg-Trp-Trp-Arg-Lys]-D-Pro-D-Val-NH2 2954 TCAM2951 Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Pro-Arg-Trp-Trp-Arg-Lys]-D-Phe-D-Val-NH2 2955 TCAM2952 Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Pro-Trp-Arg-Trp-Lys]-D-Val-D-Pro-NH2 2956 TCAM2953 Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Pro-Trp-Arg-Trp-Lys]-D-Val-D-Phe-NH2 2957 TCAM2954 Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Pro-Trp-Arg-Trp-Lys]-D-Pro-D-Val-NH2 2958 TCAM2955 Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Pro-Trp-Arg-Trp-Lys]-D-Phe-D-Val-NH2 2959 TCAM2956 Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Pro-Arg-Trp-Arg-Lys]-D-Val-D-Pro-NH2 2960 TCAM2957 Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Pro-Arg-Trp-Arg-Lys]-D-Val-D-Phe-NH2 2961 TCAM2958 Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Pro-Arg-Trp-Arg-Lys]-D-Pro-D-Val-NH2 2962 TCAM2959 Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Pro-Arg-Trp-Arg-Lys]-D-Phe-D-Val-NH2 2963 TCAM2960 Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-Arg-Trp-Trp-Arg-Phe-Lys]-D-Val-D-Pro-NH2 2964 TCAM2961 Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-Arg-Trp-Trp-Arg-Phe-Lys]-D-Val-D-Phe-NH2 2965 TCAM2962 Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-Arg-Trp-Trp-Arg-Phe-Lys]-D-Pro-D-Val-NH2 2966 TCAM2963 Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-Arg-Trp-Trp-Arg-Phe-Lys]-D-Phe-D-Val-NH2 2967 TCAM2964 Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-Arg-Trp-Trp-Arg-Phe-Lys]-D-Val-D-Pro-NH2 2968 TCAM2965 Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-Arg-Trp-Trp-Arg-Phe-Lys]-D-Val-D-Phe-NH2 2969 TCAM2966 Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-Arg-Trp-Trp-Arg-Phe-Lys]-D-Pro-D-Val-NH2 2970 TCAM2967 Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-Arg-Trp-Trp-Arg-Phe-Lys]-D-Phe-D-Val-NH2 2971 TCAM2968 Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-Arg-Tyr-Tyr-Arg-Phe-Lys]-D-Val-D-Pro-NH2 2972 TCAM2969 Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-Arg-Tyr-Tyr-Arg-Phe-Lys]-D-Val-D-Phe-NH2 2973 TCAM2970 Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-Arg-Tyr-Tyr-Arg-Phe-Lys]-D-Pro-D-Val-NH2 2974 TCAM2971 Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-Arg-Tyr-Tyr-Arg-Phe-Lys]-D-Phe-D-Val-NH2 2975 TCAM2972 Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-Arg-Nal-Nal-Arg-Phe-Lys]-D-Val-D-Pro-NH2 2976 TCAM2973 Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-Arg-Nal-Nal-Arg-Phe-Lys]-D-Val-D-Phe-NH2 2977 TCAM2974 Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-Arg-Nal-Nal-Arg-Phe-Lys]-D-Pro-D-Val-NH2 2978 TCAM2975 Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-Arg-Nal-Nal-Arg-Phe-Lys]-D-Phe-D-Val-NH2 2979 TCAM2976 Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-Arg-Leu-Trp-Leu-Trp-Lys]-D-Val-D-Pro-NH2 2980 TCAM2977 Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-Arg-Leu-Trp-Leu-Trp-Lys]-D-Val-D-Phe-NH2 2981 TCAM2978 Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-Arg-Leu-Trp-Leu-Trp-Lys]-D-Pro-D-Val-NH2 2982 TCAM2979 Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-Arg-Leu-Trp-Leu-Trp-Lys]-D-Phe-D-Val-NH2 2983 TCAM2980 Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-Arg-Leu-Trp-Leu-Trp-Lys]-D-Val-D-Pro-NH2 2984 TCAM2981 Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-Arg-Leu-Trp-Leu-Trp-Lys]-D-Val-D-Phe-NH2 2985 TCAM2982 Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-Arg-Leu-Trp-Leu-Trp-Lys]-D-Pro-D-Val-NH2 2986 TCAM2983 Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-Arg-Leu-Trp-Leu-Trp-Lys]-D-Phe-D-Val-NH2 2987 TCAM2984 Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-Arg-Arg-Trp-Leu-Trp-Leu-Trp-Lys]-D-Val-D-Pro- NH2 2988 TCAM2985 Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-Arg-Arg-Trp-Leu-Trp-Leu-Trp-Lys]-D-Val-D-Phe- NH2 2989 TCAM2986 Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-Arg-Arg-Trp-Leu-Trp-Leu-Trp-Lys]-D-Pro-D-Val- NH2 2990 TCAM2987 Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-Arg-Arg-Trp-Leu-Trp-Leu-Trp-Lys]-D-Phe-D-Val- NH2 2991 TCAM2988 Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-Gln-Arg-Arg-Trp-Leu-Trp-Leu-Trp-Lys]-D-Val-D- Pro-NH2 2992 TCAM2989 Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-Gln-Arg-Arg-Trp-Leu-Trp-Leu-Trp-Lys]-D-Val-D- Phe-NH2 2993 TCAM2990 Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-Gln-Arg-Arg-Trp-Leu-Trp-Leu-Trp-Lys]-D-Pro-D- Val-NH2 2994 TCAM2991 Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-Gln-Arg-Arg-Trp-Leu-Trp-Leu-Trp-Lys]-D-Phe- D-Val-NH2 2995 TCAM2992 Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Trp-Arg-Trp-Trp-Arg-Arg-Lys]-D-Val-D-Pro-NH2 2996 TCAM2993 Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Trp-Arg-Trp-Trp-Arg-Arg-Lys]-D-Val-D-Phe-NH2 2997 TCAM2994 Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Trp-Arg-Trp-Trp-Arg-Arg-Lys]-D-Pro-D-Val-NH2 2998 TCAM2995 Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Trp-Arg-Trp-Trp-Arg-Arg-Lys]-D-Phe-D-Val-NH2 2999 TCAM2996 Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Trp-Trp-Arg-Arg-Trp-Trp-Arg-Arg-Lys]-D-Val-D-Pro- NH2 3000 TCAM2997 Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Trp-Trp-Arg-Arg-Trp-Trp-Arg-Arg-Lys]-D-Val-D-Phe- NH2 3001 TCAM2998 Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Trp-Trp-Arg-Arg-Trp-Trp-Arg-Arg-Lys]-D-Pro-D-Val- NH2 3002 TCAM2999 Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Trp-Trp-Arg-Arg-Trp-Trp-Arg-Arg-Lys]-D-Phe-D-Val- NH2 3003 TCAM3000 Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Trp-Arg-Trp-Arg-Trp-Arg-Lys]-D-Val-D-Pro-NH2 3004 TCAM3001 Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Trp-Arg-Trp-Arg-Trp-Arg-Lys]-D-Val-D-Phe-NH2 3005 TCAM3002 Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Trp-Arg-Trp-Arg-Trp-Arg-Lys]-D-Pro-D-Val-NH2 3006 TCAM3003 Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Trp-Arg-Trp-Arg-Trp-Arg-Lys]-D-Phe-D-Val-NH2 3007 TCAM3004 Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-Trp-Arg-Trp-Arg-Trp-Lys]-D-Val-D-Pro-NH2 3008 TCAM3005 Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-Trp-Arg-Trp-Arg-Trp-Lys]-D-Val-D-Phe-NH2 3009 TCAM3006 Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-Trp-Arg-Trp-Arg-Trp-Lys]-D-Pro-D-Val-NH2 3010 TCAM3007 Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-Trp-Arg-Trp-Arg-Trp-Lys]-D-Phe-D-Val-NH2 3011 TCAM3008 Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-Trp-Trp-Arg-Arg-Lys]-D-Val-D-Pro-NH2 3012 TCAM3009 Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-Trp-Trp-Arg-Arg-Lys]-D-Val-D-Phe-NH2 3013 TCAM3010 Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-Trp-Trp-Arg-Arg-Lys]-D-Pro-D-Val-NH2 3014 TCAM3011 Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-Trp-Trp-Arg-Arg-Lys]-D-Phe-D-Val-NH2 3015 TCAM3012 Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-Trp-Arg-Trp-Arg-Lys]-D-Val-D-Pro-NH2 3016 TCAM3013 Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-Trp-Arg-Trp-Arg-Lys]-D-Val-D-Phe-NH2 3017 TCAM3014 Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-Trp-Arg-Trp-Arg-Lys]-D-Pro-D-Val-NH2 3018 TCAM3015 Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-Trp-Arg-Trp-Arg-Lys]-D-Phe-D-Val-NH2 3019 TCAM3016 Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Trp-Trp-Arg-Arg-Trp-Lys]-D-Val-D-Pro-NH2 3020 TCAM3017 Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Trp-Trp-Arg-Arg-Trp-Lys]-D-Val-D-Phe-NH2 3021 TCAM3018 Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Trp-Trp-Arg-Arg-Trp-Lys]-D-Pro-D-Val-NH2 3022 TCAM3019 Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Trp-Trp-Arg-Arg-Trp-Lys]-D-Phe-D-Val-NH2 3023 TCAM3020 Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Trp-Arg-Trp-Arg-Trp-Lys]-D-Val-D-Pro-NH2 3024 TCAM3021 Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Trp-Arg-Trp-Arg-Trp-Lys]-D-Val-D-Phe-NH2 3025 TCAM3022 Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Trp-Arg-Trp-Arg-Trp-Lys]-D-Pro-D-Val-NH2 3026 TCAM3023 Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Trp-Arg-Trp-Arg-Trp-Lys]-D-Phe-D-Val-NH2 3027 TCAM3024 Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Trp-Arg-Tyr-Arg-Trp-Lys]-D-Val-D-Pro-NH2 3028 TCAM3025 Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Trp-Arg-Tyr-Arg-Trp-Lys]-D-Val-D-Phe-NH2 3029 TCAM3026 Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Trp-Arg-Tyr-Arg-Trp-Lys]-D-Pro-D-Val-NH2 3030 TCAM3027 Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Trp-Arg-Tyr-Arg-Trp-Lys]-D-Phe-D-Val-NH2 3031 TCAM3028 Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Trp-Arg-Trp-Arg-Tyr-Lys]-D-Val-D-Pro-NH2 3032 TCAM3029 Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Trp-Arg-Trp-Arg-Tyr-Lys]-D-Val-D-Phe-NH2 3033 TCAM3030 Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Trp-Arg-Trp-Arg-Tyr-Lys]-D-Pro-D-Val-NH2 3034 TCAM3031 Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Trp-Arg-Trp-Arg-Tyr-Lys]-D-Phe-D-Val-NH2 3035 TCAM3032 Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Trp-Arg-Trp-Arg-Lys]-D-Val-D-Pro-NH2 3036 TCAM3033 Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Trp-Arg-Trp-Arg-Lys]-D-Val-D-Phe-NH2 3037 TCAM3034 Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Trp-Arg-Trp-Arg-Lys]-D-Pro-D-Val-NH2 3038 TCAM3035 Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Trp-Arg-Trp-Arg-Lys]-D-Phe-D-Val-NH2 3039 TCAM3036 Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Trp-Arg-Arg-Trp-Lys]-D-Val-D-Pro-NH2 3040 TCAM3037 Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Trp-Arg-Arg-Trp-Lys]-D-Val-D-Phe-NH2 3041 TCAM3038 Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Trp-Arg-Arg-Trp-Lys]-D-Pro-D-Val-NH2 3042 TCAM3039 Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Trp-Arg-Arg-Trp-Lys]-D-Phe-D-Val-NH2 3043 TCAM3040 Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-Trp-Trp-Arg-Lys]-D-Val-D-Pro-NH2 3044 TCAM3041 Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-Trp-Trp-Arg-Lys]-D-Val-D-Phe-NH2 3045 TCAM3042 Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-Trp-Trp-Arg-Lys]-D-Pro-D-Val-NH2 3046 TCAM3043 Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-Trp-Trp-Arg-Lys]-D-Phe-D-Val-NH2 3047 TCAM3044 Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Trp-Arg-Trp-Lys]-D-Val-D-Pro-NH2 3048 TCAM3045 Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Trp-Arg-Trp-Lys]-D-Val-D-Phe-NH2 3049 TCAM3046 Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Trp-Arg-Trp-Lys]-D-Pro-D-Val-NH2 3050 TCAM3047 Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Trp-Arg-Trp-Lys]-D-Phe-D-Val-NH2 3051 TCAM3048 Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-Trp-Arg-Lys]-D-Val-D-Pro-NH2 3052 TCAM3049 Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-Trp-Arg-Lys]-D-Val-D-Phe-NH2 3053 TCAM3050 Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-Trp-Arg-Lys]-D-Pro-D-Val-NH2 3054 TCAM3051 Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-Trp-Arg-Lys]-D-Phe-D-Val-NH2 3055 TCAM3052 Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-His-D-Nal(2′)-Arg-Trp-Lys]-D-Val-D-Pro-NH2 3056 TCAM3053 Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-His-D-Nal(2′)-Arg-Trp-Lys]-D-Pro-D-Val-NH2 3057 TCAM3054 Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-His-D-Nal(2′)-Arg-Trp-Lys]-D-Val-D-Phe-NH2 3058 TCAM3055 Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-His-D-Nal(2′)-Arg-Trp-Lys]-D-Phe-D-Val-NH2 3059 TCAM3056 Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Pro-D-Nal(2′)-Arg-Trp-Lys]-D-Val-D-Pro-NH2 3060 TCAM3057 Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Pro-D-Nal(2′)-Arg-Trp-Lys]-D-Pro-D-Val-NH2 3061 TCAM3058 Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Pro-D-Nal(2′)-Arg-Trp-Lys]-D-Val-D-Phe-NH2 3062 TCAM3059 Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Pro-D-Nal(2′)-Arg-Trp-Lys]-D-Phe-D-Val-NH2 3063 TCAM3060 Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-Arg-Nal(2′)-Arg-Trp-Lys]-D-Val-D-Pro-NH2 3064 TCAM3061 Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-Arg-Nal(2′)-Arg-Trp-Lys]-D-Pro-D-Val-NH2 3065 TCAM3062 Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-Arg-Nal(2′)-Arg-Trp-Lys]-D-Val-D-Phe-NH2 3066 TCAM3063 Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-Arg-Nal(2′)-Arg-Trp-Lys]-D-Phe-D-Val-NH2 3067 TCAM3064 Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-Arg-Pro-Nal(2′)-Arg-Trp-Lys]-D-Val-D-Pro-NH2 3068 TCAM3065 Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-Arg-Pro-D-Nal(2′)-Arg-Trp-Lys]-D-Pro-D-Val- NH2 3069 TCAM3066 Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-Arg-Pro-D-Nal(2′)-Arg-Trp-Lys]-D-Val-D-Phe- NH2 3070 TCAM3067 Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-Arg-Pro-Nal(2′)-Arg-Trp-Lys]-D-Phe-D-Val-NH2 3071 TCAM3068 Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-D-Nal(2′)-Arg-Trp-Lys]-D-Val-D-Pro-NH2 3072 TCAM3069 Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-D-Nal(2′)-Arg-Trp-Lys]-D-Pro-D-Val-NH2 3073 TCAM3070 Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-D-Nal(2′)-Arg-Trp-Lys]-D-Val-D-Phe-NH2 3074 TCAM3071 Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-D-Nal(2′)-Arg-Trp-Lys]-D-Phe-D-Val-NH2 3075 TCAM3072 Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-Pro-D-Nal(2′)-Arg-Trp-Lys]-D-Val-D-Pro-NH2 3076 TCAM3073 Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-Pro-D-Nal(2′)-Arg-Trp-Lys]-D-Pro-D-Val-NH2 3077 TCAM3074 Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-Pro-D-Nal(2′)-Arg-Trp-Lys]-D-Val-D-Phe-NH2 3078 TCAM3075 Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-Pro-D-Nal(2′)-Arg-Trp-Lys]-D-Phe-D-Val-NH2 3079 TCAM3076 Phe-Phe-Arg-Arg-Leu-Arg-Arg-Arg-c[Asp-Pro-D-Nal(2′)-Arg-Trp-Lys]-D-Val-D-Pro- NH2 3080 TCAM3077 Phe-Phe-Arg-Arg-Leu-Arg-Arg-Arg-c[Asp-Pro-D-Nal(2′)-Arg-Trp-Lys]-D-Pro-D-Val- NH2 3081 TCAM3078 Phe-Phe-Arg-Arg-Leu-Arg-Arg-Arg-c[Asp-Pro-D-Nal(2′)-Arg-Trp-Lys]-D-Val-D-Phe- NH2 3082 TCAM3079 Phe-Phe-Arg-Arg-Leu-Arg-Arg-Arg-c[Asp-Pro-D-Nal(2′)-Arg-Trp-Lys]-D-Phe-D-Val- NH2 3083 TCAM3080 Phe-Phe-Arg-Arg-Leu-Arg-Arg-Arg-c[Asp-His-D-Nal(2′)-Arg-Trp-Lys]-D-Val-D-Pro- NH2 3084 TCAM3081 Phe-Phe-Arg-Arg-Leu-Arg-Arg-Arg-c[Asp-His-D-Nal(2′)-Arg-Trp-Lys]-D-Pro-D-Val- NH2 3085 TCAM3082 Phe-Phe-Arg-Arg-Leu-Arg-Arg-Arg-c[Asp-His-D-Nal(2′)-Arg-Trp-Lys]-D-Val-D-Phe- NH2 3086 TCAM3083 Phe-Phe-Arg-Arg-Leu-Arg-Arg-Arg-c[Asp-His-D-Nal(2′)-Arg-Trp-Lys]-D-Phe-D-Val- NH2 3087 TCAM3084 Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-Pro-D-Nal(2′)-Arg-Trp-Arg-Lys]-D-Val-D-Pro- NH2 3088 TCAM3085 Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-Pro-D-Nal(2′)-Arg-Trp-Arg-Lys]-D-Pro-D-Val- NH2 3089 TCAM3086 Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-Pro-D-Nal(2′)-Arg-Trp-Arg-Lys]-D-Val-D-Phe- NH2 3090 TCAM3087 Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-Pro-D-Nal(2′)-Arg-Trp-Arg-Lys]-D-Phe-D-Val- NH2 3091 TCAM3088 Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-His-D-Nal(2′)-Arg-Trp-Arg-Lys]-D-Val-D-Pro- NH2 3092 TCAM3089 Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-His-D-Nal(2′)-Arg-Trp-Arg-Lys]-D-Pro-D-Val- NH2 3093 TCAM3090 Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-His-D-Nal(2′)-Arg-Trp-Arg-Lys]-D-Val-D-Phe- NH2 3094 TCAM3091 Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-His-D-Nal(2′)-Arg-Trp-Arg-Lys]-D-Phe-D-Val- NH2 3095 TCAM3092 Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-His-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Val-D-Phe-NH2 3096 TCAM3093 Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-His-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Phe-D-Val-NH2 3097 TCAM3094 Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Pro-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Val-D-Pro-NH2 3098 TCAM3095 Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Pro-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Pro-D-Val-NH2 3099 TCAM3096 Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Pro-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Val-D-Phe-NH2 3100 TCAM3097 Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Pro-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Phe-D-Val-NH2 3101 TCAM3098 Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-Arg-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Val-D-Pro- NH2 3102 TCAM3099 Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-Arg-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Pro-D-Val- NH2 3103 TCAM3100 Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-Arg-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Val-D-Phe- NH2 3104 TCAM3101 Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-Arg-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Phe-D-Val- NH2 3105 TCAM3102 Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-Arg-Pro-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Val-D- Pro-NH2 3106 TCAM3103 Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-Arg-Pro-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Pro-D- Val-NH2 3107 TCAM3104 Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-Arg-Pro-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Val-D- Phe-NH2 3108 TCAM3105 Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-Arg-Pro-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Phe-D- Val-NH2 3109 TCAM3106 Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Val-D-Pro-NH2 3110 TCAM3107 Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Pro-D-Val-NH2 3111 TCAM3108 Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Val-D-Phe-NH2 3112 TCAM3109 Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Phe-D-Val-NH2 3113 TCAM3110 Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-Pro-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Val-D-Pro- NH2 3114 TCAM3111 Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-Pro-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Pro-D-Val- NH2 3115 TCAM3112 Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-Pro-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Val-D-Phe- NH2 3116 TCAM3113 Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-Pro-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Phe-D-Val- NH2 3117 TCAM3114 Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-His-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Val-D-Pro- NH2 3118 TCAM3115 Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-His-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Pro-D-Val- NH2 3119 TCAM3116 Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-His-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Val-D-Phe-NH2 3120 TCAM3117 Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-His-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Phe-D-Val-NH2 3121 TCAM3118 Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-D-D-Nal(2′)-Arg-D-Nal(2′)-Arg-Lys]-D-Val-D-Pro- NH2 3122 TCAM3119 Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-D-Nal(2′)-Arg-D-Nal(2′)-Arg-Lys]-D-Pro-D-Val- NH2 3123 TCAM3120 Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-D-Nal(2′)-Arg-D-Nal(2′)-Arg-Lys]-D-Val-D-Phe- NH2 3124 TCAM3121 Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-D-Nal(2′)-Arg-D-Nal(2′)-Arg-Lys]-D-Phe-D-Val- NH2 3125 TCAM3122 Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-Pro-D-Nal(2′)-Arg-D-Nal(2′)-Arg-Lys]-D-Val-D- Pro-NH2 3126 TCAM3123 Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-Pro-D-Nal(2′)-Arg-D-Nal(2′)-Arg-Lys]-D-Pro-D- Val-NH2 3127 TCAM3124 Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-Pro-D-Nal(2′)-Arg-D-Nal(2′)-Arg-Lys]-D-Val-D- Phe-NH2 3128 TCAM3125 Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-Pro-D-Nal(2′)-Arg-D-Nal(2′)-Arg-Lys]-D-Phe-D- Val-NH2 3129 TCAM3126 Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-His-D-Nal(2′)-Arg-D-Nal(2′)-Arg-Lys]-D-Val-D- Pro-NH2 3130 TCAM3127 Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-His-D-Nal(2′)-Arg-D-Nal(2′)-Arg-Lys]-D-Pro-D- Val-NH2 3131 TCAM3128 Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-His-D-Nal(2′)-Arg-D-Nal(2′)-Arg-Lys]-D-Val-D- Phe-NH2 3132 TCAM3129 Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-His-D-Nal(2′)-Arg-D-Nal(2′)-Arg-Lys]-D-Phe-D- Val-NH2 3133 TCAM3130 Phe-Phe-Arg-Arg-Leu-Arg-Arg-Arg-c[Asp-Pro-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Val-D- Pro-NH2 3134 TCAM3131 Phe-Phe-Arg-Arg-Leu-Arg-Arg-Arg-c[Asp-Pro-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Pro-D- Val-NH2 3135 TCAM3132 Phe-Phe-Arg-Arg-Leu-Arg-Arg-Arg-c[Asp-Pro-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Val-D- Phe-NH2 3136 TCAM3133 Phe-Phe-Arg-Arg-Leu-Arg-Arg-Arg-c[Asp-Pro-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Phe-D- Val-NH2 3137 TCAM3134 Phe-Phe-Arg-Arg-Leu-Arg-Arg-Arg-c[Asp-His-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Val-D- Pro-NH2 3138 TCAM3135 Phe-Phe-Arg-Arg-Leu-Arg-Arg-Arg-c[Asp-His-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Pro-D- Val-NH2 3139 TCAM3136 Phe-Phe-Arg-Arg-Leu-Arg-Arg-Arg-c[Asp-His-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Val-D- Phe-NH2 3140 TCAM3137 Phe-Phe-Arg-Arg-Leu-Arg-Arg-Arg-c[Asp-His-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Phe-D- Val-NH2 3141 TCAM3138 Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-Pro-D-Nal(2′)-Arg-D-Nal(2′)-Arg-Lys]-D-Val-D- Pro-NH2 3142 TCAM3139 Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-Pro-D-Nal(2′)-Arg-D-Nal(2′)-Arg-Lys]-D-Pro-D- Val-NH2 3143 TCAM3140 Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-Pro-D-Nal(2′)-Arg-D-Nal(2′)-Arg-Lys]-D-Val-D- Phe-NH2 3144 TCAM3141 Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-Pro-D-Nal(2′)-Arg-D-Nal(2′)-Arg-Lys]-D-Phe-D- Val-NH2 3145 TCAM3142 Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-His-D-Nal(2′)-Arg-D-Nal(2′)-Arg-Lys]-D-Val-D- Pro-NH2 3146 TCAM3143 Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-His-D-Nal(2′)-Arg-D-Nal(2′)-Arg-Lys]-D-Pro-D- Val-NH2 3147 TCAM3144 Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-His-D-Nal(2′)-Arg-D-Nal(2′)-Arg-Lys]-D-Val-D- Phe-NH2 3148 TCAM3145 Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-His-D-Nal(2′)-Arg-D-Nal(2′)-Arg-Lys]-D-Phe-D- Val-NH2 3149 TCAM3146 Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-His-D-Nal(2′)-Arg-Trp-Lys]-Arg-Arg-D-Val-D-Pro- NH2 3150 TCAM3147 Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-His-D-Nal(2′)-Arg-Trp-Lys]-Arg-Arg-D-Pro-D-Val- NH2 3151 TCAM3148 Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-His-D-Nal(2′)-Arg-Trp-Lys]-Arg-Arg-D-Val-D-Phe- NH2 3152 TCAM3149 Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-His-D-Nal(2′)-Arg-Trp-Lys]-Arg-Arg-D-Phe-D-Val- NH2 3153 TCAM3150 Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Pro-D-Nal(2′)-Arg-Trp-Lys]-Arg-Arg-D-Val-D-Pro- NH2 3154 TCAM3151 Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Pro-D-Nal(2′)-Arg-Trp-Lys]-Arg-Arg-D-Pro-D-Val- NH2 3155 TCAM3152 Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Pro-D-Nal(2′)-Arg-Trp-Lys]-Arg-Arg-D-Val-D-Phe- NH2 3156 TCAM3153 Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Pro-D-Nal(2′)-Arg-Trp-Lys]-Arg-Arg-D-Phe-D-Val- NH2 Anti-biofilm peptide ABF6 linked to anti-microbial peptides 3157 TCAM3154 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-c[Asp-Pro-Arg-Arg-Trp-Trp-Arg-Phe-Lys]-D- Val-D-Pro-NH2 3158 TCAM3155 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-c[Asp-Pro-Arg-Arg-Trp-Trp-Arg-Phe-Lys]-D- Val-D-Phe-NH2 3159 TCAM3156 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-c[Asp-Pro-Arg-Arg-Trp-Trp-Arg-Phe-Lys]-D- Pro-D-Val-NH2 3160 TCAM3157 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-c[Asp-Pro-Arg-Arg-Trp-Trp-Arg-Phe-Lys]-D- Phe-D-Val-NH2 3161 TCAM3158 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-c[Asp-Pro-Arg-Arg-Trp-Trp-Tyr-Phe-Lys]-D-Val- D-Pro-NH2 3162 TCAM3159 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-c[Asp-Pro-Arg-Arg-Trp-Trp-Tyr-Phe-Lys]-D-Val- D-Phe-NH2 3163 TCAM3160 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-c[Asp-Pro-Arg-Arg-Trp-Trp-Tyr-Phe-Lys]-D- Pro-D-Val-NH2 3164 TCAM3161 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-c[Asp-Pro-Arg-Arg-Trp-Trp-Tyr-Phe-Lys]-D- Phe-D-Val-NH2 3165 TCAM3162 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-c[Asp-Pro-Arg-Arg-Tyr-Tyr-Arg-Phe-Lys]-D-Val- D-Pro-NH2 3166 TCAM3163 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-c[Asp-Pro-Arg-Arg-Tyr-Tyr-Arg-Phe-Lys]-D-Val- D-Phe-NH2 3167 TCAM3164 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-c[Asp-Pro-Arg-Arg-Tyr-Tyr-Arg-Phe-Lys]-D- Pro-D-Val-NH2 3168 TCAM3165 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-c[Asp-Pro-Arg-Arg-Tyr-Tyr-Arg-Phe-Lys]-D- Phe-D-Val-NH2 3169 TCAM3166 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-c[Asp-Pro-Arg-Arg-Nal-Nal-Arg-Phe-Lys]-D- Val-D-Pro-NH2 3170 TCAM3167 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-c[Asp-Pro-Arg-Arg-Nal-Nal-Arg-Phe-Lys]-D- Val-D-Phe-NH2 3171 TCAM3168 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-c[Asp-Pro-Arg-Arg-Nal-Nal-Arg-Phe-Lys]-D- Pro-D-Val-NH2 3172 TCAM3169 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-c[Asp-Pro-Arg-Arg-Nal-Nal-Arg-Phe-Lys]-D- Phe-D-Val-NH2 3173 TCAM3170 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-c[Asp-Pro-Arg-Arg-Leu-Trp-Leu-Trp-Lys]-D-Val- D-Pro-NH2 3174 TCAM3171 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-c[Asp-Pro-Arg-Arg-Leu-Trp-Leu-Trp-Lys]-D-Val- D-Phe-NH2 3175 TCAM3172 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-c[Asp-Pro-Arg-Arg-Leu-Trp-Leu-Trp-Lys]-D- Pro-D-Val-NH2 3176 TCAM3173 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-c[Asp-Pro-Arg-Arg-Leu-Trp-Leu-Trp-Lys]-D- Phe-D-Val-NH2 3177 TCAM3174 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-c[Asp-Pro-Arg-Arg-Leu-Trp-Leu-Trp-Lys]-D-Val- D-Pro-NH2 3178 TCAM3175 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-c[Asp-Pro-Arg-Arg-Leu-Trp-Leu-Trp-Lys]-D-Val- D-Phe-NH2 3179 TCAM3176 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-c[Asp-Pro-Arg-Arg-Leu-Trp-Leu-Trp-Lys]-D- Pro-D-Val-NH2 3180 TCAM3177 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-c[Asp-Pro-Arg-Arg-Leu-Trp-Leu-Trp-Lys]-D- Phe-D-Val-NH2 3181 TCAM3178 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-c[Asp-Arg-Arg-Arg-Trp-Leu-Trp-Leu-Trp-Lys]- D-Val-D-Pro-NH2 3182 TCAM3179 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-c[Asp-Pro-Arg-Arg-Arg-Trp-Leu-Trp-Leu-Trp- Lys]-D-Val-D-Phe-NH2 3183 TCAM3180 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-c[Asp-Pro-Arg-Arg-Arg-Trp-Leu-Trp-Leu-Trp- Lys]-D-Pro-D-Val-NH2 3184 TCAM3181 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-c[Asp-Pro-Arg-Arg-Arg-Trp-Leu-Trp-Leu-Trp- Lys]-D-Phe-D-Val-NH2 3185 TCAM3182 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-c[Asp-Pro-Arg-Gln-Arg-Arg-Trp-Leu-Trp-Leu- Trp-Lys]-D-Val-D-Pro-NH2 3186 TCAM3183 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-c[Asp-Pro-Arg-Gln-Arg-Arg-Trp-Leu-Trp-Leu- Trp-Lys]-D-Val-D-Phe-NH2 3187 TCAM3184 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-c[Asp-Pro-Arg-Gln-Arg-Arg-Trp-Leu-Trp-Leu- Trp-Lys]-D-Pro-D-Val-NH2 3188 TCAM3185 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-c[Asp-Pro-Arg-Gln-Arg-Arg-Trp-Leu-Trp-Leu- Trp-Lys]-D-Phe-D-Val-NH2 3189 TCAM3186 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-c[Asp-Pro-Trp-Arg-Trp-Trp-Arg-Arg-Lys]-D-Val- D-Phe-NH2 3190 TCAM3187 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-c[Asp-Pro-Trp-Arg-Trp-Trp-Arg-Arg-Lys]-D-Pro- D-Val-NH2 3191 TCAM3188 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-c[Asp-Pro-Trp-Arg-Trp-Trp-Arg-Arg-Lys]-D- Phe-D-Val-NH2 3192 TCAM3189 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-c[Asp-Pro-Trp-Trp-Arg-Arg-Trp-Trp-Arg-Arg- Lys]-D-Val-D-Pro-NH2 3193 TCAM3190 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-c[Asp-Pro-Trp-Trp-Arg-Arg-Trp-Trp-Arg-Arg- Lys]-D-Val-D-Phe-NH2 3194 TCAM3191 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-c[Asp-Pro-Trp-Trp-Arg-Arg-Trp-Trp-Arg-Arg- Lys]-D-Pro-D-Val-NH2 3195 TCAM3192 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-c[Asp-Pro-Trp-Trp-Arg-Arg-Trp-Trp-Arg-Arg- Lys]-D-Phe-D-Val-NH2 3196 TCAM3193 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-c[Asp-Pro-Trp-Arg-Trp-Arg-Trp-Arg-Lys]-D-Val- D-Pro-NH2 3197 TCAM3194 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-c[Asp-Pro-Trp-Arg-Trp-Arg-Trp-Arg-Lys]-D-Val- D-Phe-NH2 3198 TCAM3195 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-c[Asp-Pro-Trp-Arg-Trp-Arg-Trp-Arg-Lys]-D-Pro- D-Val-NH2 3199 TCAM3196 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-c[Asp-Pro-Trp-Arg-Trp-Arg-Trp-Arg-Lys]-D- Phe-D-Val-NH2 3200 TCAM3197 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-c[Asp-Pro-Arg-Trp-Arg-Trp-Arg-Trp-Lys]-D-Val- D-Pro-NH2 3201 TCAM3198 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-c[Asp-Pro-Arg-Trp-Arg-Trp-Arg-Trp-Lys]-D-Val- D-Phe-NH2 3202 TCAM3199 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-c[Asp-Pro-Arg-Trp-Arg-Trp-Arg-Trp-Lys]-D-Pro- D-Val-NH2 3203 TCAM3200 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-c[Asp-Pro-Arg-Trp-Arg-Trp-Arg-Trp-Lys]-D- Phe-D-Val-NH2 3204 TCAM3201 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-c[Asp-Pro-Arg-Trp-Trp-Arg-Arg-Lys]-D-Val-D- Pro-NH2 3205 TCAM3202 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-c[Asp-Pro-Arg-Trp-Trp-Arg-Arg-Lys]-D-Val-D- Phe-NH2 3206 TCAM3203 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-c[Asp-Pro-Arg-Trp-Trp-Arg-Arg-Lys]-D-Pro-D- Val-NH2 3207 TCAM3204 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-c[Asp-Pro-Arg-Trp-Trp-Arg-Arg-Lys]-D-Phe-D- Val-NH2 3208 TCAM3205 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-c[Asp-Pro-Trp-Trp-Arg-Arg-Trp-Lys]-D-Val-D- Pro-NH2 3209 TCAM3206 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-c[Asp-Pro-Trp-Trp-Arg-Arg-Trp-Lys]-D-Val-D- Phe-NH2 3210 TCAM3207 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-c[Asp-Pro-Trp-Trp-Arg-Arg-Trp-Lys]-D-Pro-D- Val-NH2 3211 TCAM3208 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-c[Asp-Pro-Trp-Trp-Arg-Arg-Trp-Lys]-D-Phe-D- Val-NH2 3212 TCAM3209 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-c[Asp-Pro-Trp-Arg-Trp-Arg-Trp-Lys]-D-Val-D- Pro-NH2 3213 TCAM3210 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-c[Asp-Pro-Trp-Arg-Trp-Arg-Trp-Lys]-D-Val-D- Phe-NH2 3214 TCAM3211 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-c[Asp-Pro-Trp-Arg-Trp-Arg-Trp-Lys]-D-Pro-D- Val-NH2 3215 TCAM3212 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-c[Asp-Pro-Trp-Arg-Trp-Arg-Trp-Lys]-D-Phe-D- Val-NH2 3216 TCAM3213 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-c[Asp-Pro-Arg-Trp-Arg-Trp-Arg-Lys]-D-Val-D- Pro-NH2 3217 TCAM3214 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-c[Asp-Pro-Arg-Trp-Arg-Trp-Arg-Lys]-D-Val-D- Phe-NH2 3218 TCAM3215 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-c[Asp-Pro-Arg-Trp-Arg-Trp-Arg-Lys]-D-Pro-D- Val-NH2 3219 TCAM3216 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-c[Asp-Pro-Arg-Trp-Arg-Trp-Arg-Lys]-D-Phe-D- Val-NH2 3220 TCAM3217 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-c[Asp-Pro-Trp-Arg-Tyr-Arg-Trp-Lys]-D-Val-D- Pro-NH2 3221 TCAM3218 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-c[Asp-Pro-Trp-Arg-Tyr-Arg-Trp-Lys]-D-Val-D- Phe-NH2 3222 TCAM3219 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-c[Asp-Pro-Trp-Arg-Tyr-Arg-Trp-Lys]-D-Pro-D- Val-NH2 3223 TCAM3220 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-c[Asp-Pro-Trp-Arg-Tyr-Arg-Trp-Lys]-D-Phe-D- Val-NH2 3224 TCAM3221 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-c[Asp-Pro-Trp-Arg-Trp-Arg-Tyr-Lys]-D-Val-D- Pro-NH2 3225 TCAM3222 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-c[Asp-Pro-Trp-Arg-Trp-Arg-Tyr-Lys]-D-Val-D- Phe-NH2 3226 TCAM3223 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-c[Asp-Pro-Trp-Arg-Trp-Arg-Tyr-Lys]-D-Pro-D- Val-NH2 3227 TCAM3224 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-c[Asp-Pro-Trp-Arg-Trp-Arg-Tyr-Lys]-D-Phe-D- Val-NH2 3228 TCAM3225 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-c[Asp-Pro-Trp-Arg-Trp-Arg-Lys]-D-Val-D-Pro- NH2 3229 TCAM3226 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-c[Asp-Pro-Trp-Arg-Trp-Arg-Lys]-D-Val-D-Phe- NH2 3230 TCAM3227 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-c[Asp-Pro-Trp-Arg-Trp-Arg-Lys]-D-Pro-D-Val- NH2 3231 TCAM3228 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-c[Asp-Pro-Trp-Arg-Trp-Arg-Lys]-D-Phe-D-Val- NH2 3232 TCAM3229 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-c[Asp-Pro-Trp-Arg-Arg-Trp-Lys]-D-Val-D-Pro- NH2 3233 TCAM3230 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-c[Asp-Pro-Trp-Arg-Arg-Trp-Lys]-D-Val-D-Phe- NH2 3234 TCAM3231 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-c[Asp-Pro-Trp-Arg-Arg-Trp-Lys]-D-Pro-D-Val- NH2 3235 TCAM3232 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-c[Asp-Pro-Trp-Arg-Arg-Trp-Lys]-D-Phe-D-Val- NH2 3236 TCAM3233 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-c[Asp-Pro-Arg-Trp-Trp-Arg-Lys]-D-Val-D-Pro- NH2 3237 TCAM3234 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-c[Asp-Pro-Arg-Trp-Trp-Arg-Lys]-D-Val-D-Phe- NH2 3238 TCAM3235 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-c[Asp-Pro-Arg-Trp-Trp-Arg-Lys]-D-Pro-D-Val- NH2 3239 TCAM3236 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-c[Asp-Pro-Arg-Trp-Trp-Arg-Lys]-D-Phe-D-Val- NH2 3240 TCAM3237 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-c[Asp-Pro-Trp-Arg-Trp-Lys]-D-Val-D-Pro-NH2 3241 TCAM3238 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-c[Asp-Pro-Trp-Arg-Trp-Lys]-D-Val-D-Phe-NH2 3242 TCAM3239 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-c[Asp-Pro-Trp-Arg-Trp-Lys]-D-Pro-D-Val-NH2 3243 TCAM3240 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-c[Asp-Pro-Trp-Arg-Trp-Lys]-D-Phe-D-Val-NH2 3244 TCAM3241 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-c[Asp-Pro-Arg-Trp-Arg-Lys]-D-Val-D-Pro-NH2 3245 TCAM3242 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-c[Asp-Pro-Arg-Trp-Arg-Lys]-D-Val-D-Phe-NH2 3246 TCAM3243 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-c[Asp-Pro-Arg-Trp-Arg-Lys]-D-Pro-D-Val-NH2 3247 TCAM3244 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-c[Asp-Pro-Arg-Trp-Arg-Lys]-D-Phe-D-Val-NH2 3248 TCAM3245 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-c[Asp-Arg-Arg-Trp-Trp-Arg-Phe-Lys]-D-Val-D- Pro-NH2 3249 TCAM3246 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-c[Asp-Arg-Arg-Trp-Trp-Arg-Phe-Lys]-D-Val-D- Phe-NH2 3250 TCAM3247 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-c[Asp-Arg-Arg-Trp-Trp-Arg-Phe-Lys]-D-Pro-D- Val-NH2 3251 TCAM3248 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-c[Asp-Arg-Arg-Trp-Trp-Arg-Phe-Lys]-D-Phe-D- Val-NH2 3252 TCAM3249 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-c[Asp-Arg-Arg-Trp-Trp-Arg-Phe-Lys]-D-Val-D- Pro-NH2 3253 TCAM3250 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-c[Asp-Arg-Arg-Trp-Trp-Arg-Phe-Lys]-D-Val-D- Phe-NH2 3254 TCAM3251 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-c[Asp-Arg-Arg-Trp-Trp-Arg-Phe-Lys]-D-Pro-D- Val-NH2 3255 TCAM3252 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-c[Asp-Arg-Arg-Trp-Trp-Arg-Phe-Lys]-D-Phe-D- Val-NH2 3256 TCAM3253 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-c[Asp-Arg-Arg-Tyr-Tyr-Arg-Phe-Lys]-D-Val-D- Pro-NH2 3257 TCAM3254 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-c[Asp-Arg-Arg-Tyr-Tyr-Arg-Phe-Lys]-D-Val-D- Phe-NH2 3258 TCAM3255 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-c[Asp-Arg-Arg-Tyr-Tyr-Arg-Phe-Lys]-D-Pro-D- Val-NH2 3259 TCAM3256 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-c[Asp-Arg-Arg-Tyr-Tyr-Arg-Phe-Lys]-D-Phe-D- Val-NH2 3260 TCAM3257 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-c[Asp-Arg-Arg-Nal-Nal-Arg-Phe-Lys]-D-Val-D- Pro-NH2 3261 TCAM3258 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-c[Asp-Arg-Arg-Nal-Nal-Arg-Phe-Lys]-D-Val-D- Phe-NH2 3262 TCAM3259 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-c[Asp-Arg-Arg-Nal-Nal-Arg-Phe-Lys]-D-Pro-D- Val-NH2 3263 TCAM3260 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-c[Asp-Arg-Arg-Nal-Nal-Arg-Phe-Lys]-D-Phe-D- Val-NH2 3264 TCAM3261 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-c[Asp-Arg-Arg-Leu-Trp-Leu-Trp-Lys]-D-Val-D- Pro-NH2 3265 TCAM3262 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-c[Asp-Arg-Arg-Leu-Trp-Leu-Trp-Lys]-D-Val-D- Phe-NH2 3266 TCAM3263 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-c[Asp-Arg-Arg-Leu-Trp-Leu-Trp-Lys]-D-Pro-D- Val-NH2 3267 TCAM3264 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-c[Asp-Arg-Arg-Leu-Trp-Leu-Trp-Lys]-D-Phe-D- Val-NH2 3268 TCAM3265 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-c[Asp-Arg-Arg-Leu-Trp-Leu-Trp-Lys]-D-Val-D- Pro-NH2 3269 TCAM3266 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-c[Asp-Arg-Arg-Leu-Trp-Leu-Trp-Lys]-D-Val-D- Phe-NH2 3270 TCAM3267 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-c[Asp-Arg-Arg-Leu-Trp-Leu-Trp-Lys]-D-Pro-D- Val-NH2 3271 TCAM3268 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-c[Asp-Arg-Arg-Leu-Trp-Leu-Trp-Lys]-D-Phe-D- Val-NH2 3272 TCAM3269 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-c[Asp-Arg-Arg-Arg-Trp-Leu-Trp-Leu-Trp-Lys]- D-Val-D-Pro-NH2 3273 TCAM3270 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-c[Asp-Arg-Arg-Arg-Trp-Leu-Trp-Leu-Trp-Lys]- D-Val-D-Phe-NH2 3274 TCAM3271 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-c[Asp-Arg-Arg-Arg-Trp-Leu-Trp-Leu-Trp-Lys]- D-Pro-D-Val-NH2 3275 TCAM3272 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-c[Asp-Arg-Arg-Arg-Trp-Leu-Trp-Leu-Trp-Lys]- D-Phe-D-Val-NH2 3276 TCAM3273 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-c[Asp-Arg-Gln-Arg-Arg-Trp-Leu-Trp-Leu-Trp- Lys]-D-Val-D-Pro-NH2 3277 TCAM3274 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-c[Asp-Arg-Gln-Arg-Arg-Trp-Leu-Trp-Leu-Trp- Lys]-D-Val-D-Phe-NH2 3278 TCAM3275 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-c[Asp-Arg-Gln-Arg-Arg-Trp-Leu-Trp-Leu-Trp- Lys]-D-Pro-D-Val-NH2 3279 TCAM3276 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-c[Asp-Arg-Gln-Arg-Arg-Trp-Leu-Trp-Leu-Trp- Lys]-D-Phe-D-Val-NH2 3280 TCAM3277 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-c[Asp-Trp-Arg-Trp-Trp-Arg-Arg-Lys]-D-Val-D- Pro-NH2 3281 TCAM3278 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-c[Asp-Trp-Arg-Trp-Trp-Arg-Arg-Lys]-D-Val-D- Phe-NH2 3282 TCAM3279 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-c[Asp-Trp-Arg-Trp-Trp-Arg-Arg-Lys]-D-Pro-D- Val-NH2 3283 TCAM3280 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-c[Asp-Trp-Arg-Trp-Trp-Arg-Arg-Lys]-D-Phe-D- Val-NH2 3284 TCAM3281 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-c[Asp-Trp-Trp-Arg-Arg-Trp-Trp-Arg-Arg-Lys]-D- Val-D-Pro-NH2 3285 TCAM3282 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-c[Asp-Trp-Trp-Arg-Arg-Trp-Trp-Arg-Arg-Lys]-D- Val-D-Phe-NH2 3286 TCAM3283 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-c[Asp-Trp-Trp-Arg-Arg-Trp-Trp-Arg-Arg-Lys]-D- Pro-D-Val-NH2 3287 TCAM3284 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-c[Asp-Trp-Trp-Arg-Arg-Trp-Trp-Arg-Arg-Lys]-D- Phe-D-Val-NH2 3288 TCAM3285 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-c[Asp-Trp-Arg-Trp-Arg-Trp-Arg-Lys]-D-Val-D- Pro-NH2 3289 TCAM3286 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-c[Asp-Trp-Arg-Trp-Arg-Trp-Arg-Lys]-D-Val-D- Phe-NH2 3290 TCAM3287 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-c[Asp-Trp-Arg-Trp-Arg-Trp-Arg-Lys]-D-Pro-D- Val-NH2 3291 TCAM3288 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-c[Asp-Trp-Arg-Trp-Arg-Trp-Arg-Lys]-D-Phe-D- Val-NH2 3292 TCAM3289 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-c[Asp-Arg-Trp-Arg-Trp-Arg-Trp-Lys]-D-Val-D- Pro-NH2 3293 TCAM3290 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-c[Asp-Arg-Trp-Arg-Trp-Arg-Trp-Lys]-D-Val-D- Phe-NH2 3294 TCAM3291 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-c[Asp-Arg-Trp-Arg-Trp-Arg-Trp-Lys]-D-Pro-D- Val-NH2 3295 TCAM3292 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-c[Asp-Arg-Trp-Arg-Trp-Arg-Trp-Lys]-D-Phe-D- Val-NH2 3296 TCAM3293 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-c[Asp-Arg-Trp-Trp-Arg-Arg-Lys]-D-Val-D-Pro- NH2 3297 TCAM3294 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-c[Asp-Arg-Trp-Trp-Arg-Arg-Lys]-D-Val-D-Phe- NH2 3298 TCAM3295 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-c[Asp-Arg-Trp-Trp-Arg-Arg-Lys]-D-Pro-D-Val- NH2 3299 TCAM3296 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-c[Asp-Arg-Trp-Trp-Arg-Arg-Lys]-D-Phe-D-Val- NH2 3300 TCAM3297 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-c[Asp-Arg-Trp-Arg-Trp-Arg-Lys]-D-Val-D-Pro- NH2 3301 TCAM3298 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-c[Asp-Arg-Trp-Arg-Trp-Arg-Lys]-D-Val-D-Phe- NH2 3302 TCAM3299 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-c[Asp-Arg-Trp-Arg-Trp-Arg-Lys]-D-Pro-D-Val- NH2 3303 TCAM3300 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-c[Asp-Arg-Trp-Arg-Trp-Arg-Lys]-D-Phe-D-Val- NH2 3304 TCAM3301 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-c[Asp-Trp-Trp-Arg-Arg-Trp-Lys]-D-Val-D-Pro- NH2 3305 TCAM3302 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-c[Asp-Trp-Trp-Arg-Arg-Trp-Lys]-D-Val-D-Phe- NH2 3306 TCAM3303 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-c[Asp-Trp-Trp-Arg-Arg-Trp-Lys]-D-Pro-D-Val- NH2 3307 TCAM3304 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-c[Asp-Trp-Trp-Arg-Arg-Trp-Lys]-D-Phe-D-Val- NH2 3308 TCAM3305 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-c[Asp-Trp-Arg-Trp-Arg-Trp-Lys]-D-Val-D-Pro- NH2 3309 TCAM3306 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-c[Asp-Trp-Arg-Trp-Arg-Trp-Lys]-D-Val-D-Phe- NH2 3310 TCAM3307 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-c[Asp-Trp-Arg-Trp-Arg-Trp-Lys]-D-Pro-D-Val- NH2 3311 TCAM3308 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-c[Asp-Trp-Arg-Trp-Arg-Trp-Lys]-D-Phe-D-Val- NH2 3312 TCAM3309 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-c[Asp-Trp-Arg-Tyr-Arg-Trp-Lys]-D-Val-D-Pro- NH2 3313 TCAM3310 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-c[Asp-Trp-Arg-Tyr-Arg-Trp-Lys]-D-Val-D-Phe- NH2 3314 TCAM3311 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-c[Asp-Trp-Arg-Tyr-Arg-Trp-Lys]-D-Pro-D-Val- NH2 3315 TCAM3312 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-c[Asp-Trp-Arg-Tyr-Arg-Trp-Lys]-D-Phe-D-Val- NH2 3316 TCAM3313 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-c[Asp-Trp-Arg-Trp-Arg-Tyr-Lys]-D-Val-D-Pro- NH2 3317 TCAM3314 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-c[Asp-Trp-Arg-Trp-Arg-Tyr-Lys]-D-Val-D-Phe- NH2 3318 TCAM3315 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-c[Asp-Trp-Arg-Trp-Arg-Tyr-Lys]-D-Pro-D-Val- NH2 3319 TCAM3316 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-c[Asp-Trp-Arg-Trp-Arg-Tyr-Lys]-D-Phe-D-Val- NH2 3320 TCAM3317 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-c[Asp-Trp-Arg-Trp-Arg-Lys]-D-Val-D-Pro-NH2 3321 TCAM3318 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-c[Asp-Trp-Arg-Trp-Arg-Lys]-D-Val-D-Phe-NH2 3322 TCAM3319 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-c[Asp-Trp-Arg-Trp-Arg-Lys]-D-Pro-D-Val-NH2 3323 TCAM3320 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-c[Asp-Trp-Arg-Trp-Arg-Lys]-D-Phe-D-Val-NH2 3324 TCAM3321 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-c[Asp-Trp-Arg-Arg-Trp-Lys]-D-Val-D-Pro-NH2 3325 TCAM3322 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-c[Asp-Trp-Arg-Arg-Trp-Lys]-D-Val-D-Phe-NH2 3326 TCAM3323 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-c[Asp-Trp-Arg-Arg-Trp-Lys]-D-Pro-D-Val-NH2 3327 TCAM3324 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-c[Asp-Trp-Arg-Arg-Trp-Lys]-D-Phe-D-Val-NH2 3328 TCAM3325 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-c[Asp-Arg-Trp-Trp-Arg-Lys]-D-Val-D-Pro-NH2 3329 TCAM3326 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-c[Asp-Arg-Trp-Trp-Arg-Lys]-D-Val-D-Phe-NH2 3330 TCAM3327 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-c[Asp-Arg-Trp-Trp-Arg-Lys]-D-Pro-D-Val-NH2 3331 TCAM3328 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-c[Asp-Arg-Trp-Trp-Arg-Lys]-D-Phe-D-Val-NH2 3332 TCAM3329 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-c[Asp-Trp-Arg-Trp-Lys]-D-Val-D-Pro-NH2 3333 TCAM3330 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-c[Asp-Trp-Arg-Trp-Lys]-D-Val-D-Phe-NH2 3334 TCAM3331 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-c[Asp-Trp-Arg-Trp-Lys]-D-Pro-D-Val-NH2 3335 TCAM3332 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-c[Asp-Trp-Arg-Trp-Lys]-D-Phe-D-Val-NH2 3336 TCAM3333 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-c[Asp-Arg-Trp-Arg-Lys]-D-Val-D-Pro-NH2 3337 TCAM3334 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-c[Asp-Arg-Trp-Arg-Lys]-D-Val-D-Phe-NH2 3338 TCAM3335 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-c[Asp-Arg-Trp-Arg-Lys]-D-Pro-D-Val-NH2 3339 TCAM3336 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-c[Asp-Arg-Trp-Arg-Lys]-D-Phe-D-Val-NH2 3340 TCAM3337 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-c[Asp-His-D-Nal(2′)-Arg-Trp-Lys]-D-Val-D-Pro- NH2 3341 TCAM3338 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-c[Asp-His-D-Nal(2′)-Arg-Trp-Lys]-D-Pro-D-Val- NH2 3342 TCAM3339 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-c[Asp-His-D-Nal(2′)-Arg-Trp-Lys]-D-Val-D-Phe- NH2 3343 TCAM3340 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-c[Asp-His-D-Nal(2′)-Arg-Trp-Lys]-D-Phe-D-Val- NH2 3344 TCAM3341 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-c[Asp-Pro-D-Nal(2′)-Arg-Trp-Lys]-D-Val-D-Pro- NH2 3345 TCAM3342 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-c[Asp-Pro-D-Nal(2′)-Arg-Trp-Lys]-D-Pro-D-Val- NH2 3346 TCAM3343 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-c[Asp-Pro-D-Nal(2′)-Arg-Trp-Lys]-D-Val-D-Phe- NH2 3347 TCAM3344 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-c[Asp-Pro-D-Nal(2′)-Arg-Trp-Lys]-D-Phe-D-Val- NH2 3348 TCAM3345 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-c[Asp-Arg-Arg-Nal(2′)-Arg-Trp-Lys]-D-Val-D- Pro-NH2 3349 TCAM3346 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-c[Asp-Arg-Arg-Nal(2′)-Arg-Trp-Lys]-D-Pro-D- Val-NH2 3350 TCAM3347 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-c[Asp-Arg-Arg-Nal(2′)-Arg-Trp-Lys]-D-Val-D- Phe-NH2 3351 TCAM3348 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-c[Asp-Arg-Arg-Nal(2′)-Arg-Trp-Lys]-D-Phe-D- Val-NH2 3352 TCAM3349 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-c[Asp-Arg-Arg-Pro-Nal(2′)-Arg-Trp-Lys]-D-Val- D-Pro-NH2 3353 TCAM3350 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-c[Asp-Arg-Arg-Pro-D-Nal(2′)-Arg-Trp-Lys]-D- Pro-D-Val-NH2 3354 TCAM3351 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-c[Asp-Arg-Arg-Pro-D-Nal(2′)-Arg-Trp-Lys]-D- Val-D-Phe-NH2 3355 TCAM3352 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-c[Asp-Arg-Arg-Pro-Nal(2′)-Arg-Trp-Lys]-D-Phe- D-Val-NH2 3356 TCAM3353 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-c[Asp-Arg-D-Nal(2′)-Arg-Trp-Lys]-D-Val-D-Pro- NH2 3357 TCAM3354 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-c[Asp-Arg-D-Nal(2′)-Arg-Trp-Lys]-D-Pro-D-Val- NH2 3358 TCAM3355 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-c[Asp-Arg-D-Nal(2′)-Arg-Trp-Lys]-D-Val-D-Phe- NH2 3359 TCAM3356 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-c[Asp-Arg-D-Nal(2′)-Arg-Trp-Lys]-D-Phe-D-Val- NH2 3360 TCAM3357 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-c[Asp-Arg-Pro-D-Nal(2′)-Arg-Trp-Lys]-D-Val-D- Pro-NH2 3361 TCAM3358 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-c[Asp-Arg-Pro-D-Nal(2′)-Arg-Trp-Lys]-D-Pro-D- Val-NH2 3362 TCAM3359 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-c[Asp-Arg-Pro-D-Nal(2′)-Arg-Trp-Lys]-D-Val-D- Phe-NH2 3363 TCAM3360 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-c[Asp-Arg-Pro-D-Nal(2′)-Arg-Trp-Lys]-D-Phe-D- Val-NH2 3364 TCAM3361 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-Arg-Arg-c[Asp-Pro-D-Nal(2′)-Arg-Trp-Lys]-D- Val-D-Pro-NH2 3365 TCAM3362 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-Arg-Arg-c[Asp-Pro-D-Nal(2′)-Arg-Trp-Lys]-D- Pro-D-Val-NH2 3366 TCAM3363 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-Arg-Arg-c[Asp-Pro-D-Nal(2′)-Arg-Trp-Lys]-D- Val-D-Phe-NH2 3367 TCAM3364 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-Arg-Arg-c[Asp-Pro-D-Nal(2′)-Arg-Trp-Lys]-D- Phe-D-Val-NH2 3368 TCAM3365 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-Arg-Arg-c[Asp-His-D-Nal(2′)-Arg-Trp-Lys]-D- Val-D-Pro-NH2 3369 TCAM3366 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-Arg-Arg-c[Asp-His-D-Nal(2′)-Arg-Trp-Lys]-D- Pro-D-Val-NH2 3370 TCAM3367 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-Arg-Arg-c[Asp-His-D-Nal(2′)-Arg-Trp-Lys]-D- Val-D-Phe-NH2 3371 TCAM3368 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-Arg-Arg-c[Asp-His-D-Nal(2′)-Arg-Trp-Lys]-D- Phe-D-Val-NH2 3372 TCAM3369 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-c[Asp-Arg-Pro-D-Nal(2′)-Arg-Trp-Arg-Lys]-D- Val-D-Pro-NH2 3373 TCAM3370 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-c[Asp-Arg-Pro-D-Nal(2′)-Arg-Trp-Arg-Lys]-D- Pro-D-Val-NH2 3374 TCAM3371 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-c[Asp-Arg-Pro-D-Nal(2′)-Arg-Trp-Arg-Lys]-D- Val-D-Phe-NH2 3375 TCAM3372 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-c[Asp-Arg-Pro-D-Nal(2′)-Arg-Trp-Arg-Lys]-D- Phe-D-Val-NH2 3376 TCAM3373 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-c[Asp-Arg-His-D-Nal(2′)-Arg-Trp-Arg-Lys]-D- Val-D-Pro-NH2 3377 TCAM3374 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-c[Asp-Arg-His-D-Nal(2′)-Arg-Trp-Arg-Lys]-D- Pro-D-Val-NH2 3378 TCAM3375 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-c[Asp-Arg-His-D-Nal(2′)-Arg-Trp-Arg-Lys]-D- Val-D-Phe-NH2 3379 TCAM3376 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-c[Asp-Arg-His-D-Nal(2′)-Arg-Trp-Arg-Lys]-D- Phe-D-Val-NH2 3380 TCAM3377 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-c[Asp-His-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Val-D- Phe-NH2 3381 TCAM3378 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-c[Asp-His-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Phe-D- Val-NH2 3382 TCAM3379 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-c[Asp-Pro-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Val-D- Pro-NH2 3383 TCAM3380 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-c[Asp-Pro-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Pro-D- Val-NH2 3384 TCAM3381 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-c[Asp-Pro-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Val-D- Phe-NH2 3385 TCAM3382 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-c[Asp-Pro-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Phe- D-Val-NH2 3386 TCAM3383 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-c[Asp-Arg-Arg-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D- Val-D-Pro-NH2 3387 TCAM3384 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-c[Asp-Arg-Arg-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D- Pro-D-Val-NH2 3388 TCAM3385 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-c[Asp-Arg-Arg-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D- Val-D-Phe-NH2 3389 TCAM3386 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-c[Asp-Arg-Arg-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D- Phe-D-Val-NH2 3390 TCAM3387 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-c[Asp-Arg-Arg-Pro-D-Nal(2′)-Arg-D-Nal(2′)- Lys]-D-Val-D-Pro-NH2 3391 TCAM3388 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-c[Asp-Arg-Arg-Pro-D-Nal(2′)-Arg-D-Nal(2′)- Lys]-D-Pro-D-Val-NH2 3392 TCAM3389 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-c[Asp-Arg-Arg-Pro-D-Nal(2′)-Arg-D-Nal(2′)- Lys]-D-Val-D-Phe-NH2 3393 TCAM3390 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-c[Asp-Arg-Arg-Pro-D-Nal(2′)-Arg-D-Nal(2′)- Lys]-D-Phe-D-Val-NH2 3394 TCAM3391 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-c[Asp-Arg-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Val-D- Pro-NH2 3395 TCAM3392 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-c[Asp-Arg-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Pro-D- Val-NH2 3396 TCAM3393 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-c[Asp-Arg-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Val-D- Phe-NH2 3397 TCAM3394 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-c[Asp-Arg-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Phe- D-Val-NH2 3398 TCAM3395 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-c[Asp-Arg-Pro-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D- Val-D-Pro-NH2 3399 TCAM3396 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-c[Asp-Arg-Pro-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D- Pro-D-Val-NH2 3400 TCAM3397 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-c[Asp-Arg-Pro-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D- Val-D-Phe-NH2 3401 TCAM3398 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-c[Asp-Arg-Pro-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D- Phe-D-Val-NH2 3402 TCAM3399 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-c[Asp-Arg-His-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D- Val-D-Pro-NH2 3403 TCAM3400 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-c[Asp-Arg-His-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D- Pro-D-Val-NH2 3404 TCAM3401 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-c[Asp-Arg-His-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Val- D-Phe-NH2 3405 TCAM3402 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-c[Asp-Arg-His-Nal(2′)-Arg-D-Nal(2′)-Lys]-D- Phe-D-Val-NH2 3406 TCAM3403 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-c[Asp-Arg-D-D-Nal(2′)-Arg-D-Nal(2′)-Arg-Lys]-D- Val-D-Pro-NH2 3407 TCAM3404 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-c[Asp-Arg-D-Nal(2′)-Arg-D-Nal(2′)-Arg-Lys]-D- Pro-D-Val-NH2 3408 TCAM3405 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-c[Asp-Arg-D-Nal(2′)-Arg-D-Nal(2′)-Arg-Lys]-D- Val-D-Phe-NH2 3409 TCAM3406 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-c[Asp-Arg-D-Nal(2′)-Arg-D-Nal(2′)-Arg-Lys]-D- Phe-D-Val-NH2 3410 TCAM3407 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-c[Asp-Arg-Pro-D-Nal(2′)-Arg-D-Nal(2′)-Arg- Lys]-D-Val-D-Pro-NH2 3411 TCAM3408 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-c[Asp-Arg-Pro-D-Nal(2′)-Arg-D-Nal(2′)-Arg- Lys]-D-Pro-D-Val-NH2 3412 TCAM3409 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-c[Asp-Arg-Pro-D-Nal(2′)-Arg-D-Nal(2′)-Arg- Lys]-D-Val-D-Phe-NH2 3413 TCAM3410 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-c[Asp-Arg-Pro-D-Nal(2′)-Arg-D-Nal(2′)-Arg- Lys]-D-Phe-D-Val-NH2 3414 TCAM3411 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-c[Asp-Arg-His-D-Nal(2′)-Arg-D-Nal(2′)-Arg-Lys]- D-Val-D-Pro-NH2 3415 TCAM3412 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-c[Asp-Arg-His-D-Nal(2′)-Arg-D-Nal(2′)-Arg-Lys]- D-Pro-D-Val-NH2 3416 TCAM3413 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-c[Asp-Arg-His-D-Nal(2′)-Arg-D-Nal(2′)-Arg-Lys]- D-Val-D-Phe-NH2 3417 TCAM3414 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-c[Asp-Arg-His-D-Nal(2′)-Arg-D-Nal(2′)-Arg-Lys]- D-Phe-D-Val-NH2 3418 TCAM3415 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-Arg-Arg-c[Asp-Pro-D-Nal(2′)-Arg-D-Nal(2′)- Lys]-D-Val-D-Pro-NH2 3419 TCAM3416 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-Arg-Arg-c[Asp-Pro-D-Nal(2′)-Arg-D-Nal(2′)- Lys]-D-Pro-D-Val-NH2 3420 TCAM3417 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-Arg-Arg-c[Asp-Pro-D-Nal(2′)-Arg-D-Nal(2′)- Lys]-D-Val-D-Phe-NH2 3421 TCAM3418 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-Arg-Arg-c[Asp-Pro-D-Nal(2′)-Arg-D-Nal(2′)- Lys]-D-Phe-D-Val-NH2 3422 TCAM3419 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-Arg-Arg-c[Asp-His-D-Nal(2′)-Arg-D-Nal(2′)-Lys]- D-Val-D-Pro-NH2 3423 TCAM3420 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-Arg-Arg-c[Asp-His-D-Nal(2′)-Arg-D-Nal(2′)-Lys]- D-Pro-D-Val-NH2 3424 TCAM3421 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-Arg-Arg-c[Asp-His-D-Nal(2′)-Arg-D-Nal(2′)-Lys]- D-Val-D-Phe-NH2 3425 TCAM3422 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-Arg-Arg-c[Asp-His-D-Nal(2′)-Arg-D-Nal(2′)-Lys]- D-Phe-D-Val-NH2 3426 TCAM3423 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-c[Asp-Arg-Pro-D-Nal(2′)-Arg-D-Nal(2′)-Arg- Lys]-D-Val-D-Pro-NH2 3427 TCAM3424 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-c[Asp-Arg-Pro-D-Nal(2′)-Arg-D-Nal(2′)-Arg- Lys]-D-Pro-D-Val-NH2 3428 TCAM3425 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-c[Asp-Arg-Pro-D-Nal(2′)-Arg-D-Nal(2′)-Arg- Lys]-D-Val-D-Phe-NH2 3429 TCAM3426 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-c[Asp-Arg-Pro-D-Nal(2′)-Arg-D-Nal(2′)-Arg- Lys]-D-Phe-D-Val-NH2 3430 TCAM3427 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-c[Asp-Arg-His-D-Nal(2′)-Arg-D-Nal(2′)-Arg-Lys]- D-Val-D-Pro-NH2 3431 TCAM3428 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-c[Asp-Arg-His-D-Nal(2′)-Arg-D-Nal(2′)-Arg-Lys]- D-Pro-D-Val-NH2 3432 TCAM3429 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-c[Asp-Arg-His-D-Nal(2′)-Arg-D-Nal(2′)-Arg-Lys]- D-Val-D-Phe-NH2 3433 TCAM3430 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-c[Asp-Arg-His-D-Nal(2′)-Arg-D-Nal(2′)-Arg-Lys]- D-Phe-D-Val-NH2 3434 TCAM3431 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-c[Asp-His-D-Nal(2′)-Arg-Trp-Lys]-Arg-Arg-D- Val-D-Pro-NH2 3435 TCAM3432 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-c[Asp-His-D-Nal(2′)-Arg-Trp-Lys]-Arg-Arg-D- Pro-D-Val-NH2 3436 TCAM3433 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-c[Asp-His-D-Nal(2′)-Arg-Trp-Lys]-Arg-Arg-D- Val-D-Phe-NH2 3437 TCAM3434 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-c[Asp-His-D-Nal(2′)-Arg-Trp-Lys]-Arg-Arg-D- Phe-D-Val-NH2 3438 TCAM3435 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-c[Asp-Pro-D-Nal(2′)-Arg-Trp-Lys]-Arg-Arg-D- Val-D-Pro-NH2 3439 TCAM3436 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-c[Asp-Pro-D-Nal(2′)-Arg-Trp-Lys]-Arg-Arg-D- Pro-D-Val-NH2 3440 TCAM3437 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-c[Asp-Pro-D-Nal(2′)-Arg-Trp-Lys]-Arg-Arg-D- Val-D-Phe-NH2 3441 TCAM3438 Lys-Lys-Phe-Lys-Lys-Phe-Phe-Lys-Lys-c[Asp-Pro-D-Nal(2′)-Arg-Trp-Lys]-Arg-Arg-D- Phe-D-Val-NH2 Anti-biofilm peptide ABF6ARG linked to anti-microbial peptides 3442 TCAM3439 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-c[Asp-Pro-Arg-Arg-Trp-Trp-Arg-Phe-Lys]-D- Val-D-Pro-NH2 3443 TCAM3440 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-c[Asp-Pro-Arg-Arg-Trp-Trp-Arg-Phe-Lys]-D- Val-D-Phe-NH2 3444 TCAM3441 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-c[Asp-Pro-Arg-Arg-Trp-Trp-Arg-Phe-Lys]-D- Pro-D-Val-NH2 3445 TCAM3442 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-c[Asp-Pro-Arg-Arg-Trp-Trp-Arg-Phe-Lys]-D- Phe-D-Val-NH2 3446 TCAM3443 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-c[Asp-Pro-Arg-Arg-Trp-Trp-Tyr-Phe-Lys]-D- Val-D-Pro-NH2 3447 TCAM3444 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-c[Asp-Pro-Arg-Arg-Trp-Trp-Tyr-Phe-Lys]-D- Val-D-Phe-NH2 3448 TCAM3445 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-c[Asp-Pro-Arg-Arg-Trp-Trp-Tyr-Phe-Lys]-D- Pro-D-Val-NH2 3449 TCAM3446 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-c[Asp-Pro-Arg-Arg-Trp-Trp-Tyr-Phe-Lys]-D- Phe-D-Val-NH2 3450 TCAM3447 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-c[Asp-Pro-Arg-Arg-Tyr-Tyr-Arg-Phe-Lys]-D- Val-D-Pro-NH2 3451 TCAM3448 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-c[Asp-Pro-Arg-Arg-Tyr-Tyr-Arg-Phe-Lys]-D- Val-D-Phe-NH2 3452 TCAM3449 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-c[Asp-Pro-Arg-Arg-Tyr-Tyr-Arg-Phe-Lys]-D- Pro-D-Val-NH2 3453 TCAM3450 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-c[Asp-Pro-Arg-Arg-Tyr-Tyr-Arg-Phe-Lys]-D- Phe-D-Val-NH2 3454 TCAM3451 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-c[Asp-Pro-Arg-Arg-Nal-Nal-Arg-Phe-Lys]-D- Val-D-Pro-NH2 3455 TCAM3452 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-c[Asp-Pro-Arg-Arg-Nal-Nal-Arg-Phe-Lys]-D- Val-D-Phe-NH2 3456 TCAM3453 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-c[Asp-Pro-Arg-Arg-Nal-Nal-Arg-Phe-Lys]-D- Pro-D-Val-NH2 3457 TCAM3454 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-c[Asp-Pro-Arg-Arg-Nal-Nal-Arg-Phe-Lys]-D- Phe-D-Val-NH2 3458 TCAM3455 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-c[Asp-Pro-Arg-Arg-Leu-Trp-Leu-Trp-Lys]-D- Val-D-Pro-NH2 3459 TCAM3456 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-c[Asp-Pro-Arg-Arg-Leu-Trp-Leu-Trp-Lys]-D- Val-D-Phe-NH2 3460 TCAM3457 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-c[Asp-Pro-Arg-Arg-Leu-Trp-Leu-Trp-Lys]-D- Pro-D-Val-NH2 3461 TCAM3458 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-c[Asp-Pro-Arg-Arg-Leu-Trp-Leu-Trp-Lys]-D- Phe-D-Val-NH2 3462 TCAM3459 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-c[Asp-Pro-Arg-Arg-Leu-Trp-Leu-Trp-Lys]-D- Val-D-Pro-NH2 3463 TCAM3460 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-c[Asp-Pro-Arg-Arg-Leu-Trp-Leu-Trp-Lys]-D- Val-D-Phe-NH2 3464 TCAM3461 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-c[Asp-Pro-Arg-Arg-Leu-Trp-Leu-Trp-Lys]-D- Pro-D-Val-NH2 3465 TCAM3462 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-c[Asp-Pro-Arg-Arg-Leu-Trp-Leu-Trp-Lys]-D- Phe-D-Val-NH2 3466 TCAM3463 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-c[Asp-Arg-Arg-Arg-Trp-Leu-Trp-Leu-Trp- Lys]-D-Val-D-Pro-NH2 3467 TCAM3464 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-c[Asp-Pro-Arg-Arg-Arg-Trp-Leu-Trp-Leu-Trp- Lys]-D-Val-D-Phe-NH2 3468 TCAM3465 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-c[Asp-Pro-Arg-Arg-Arg-Trp-Leu-Trp-Leu-Trp- Lys]-D-Pro-D-Val-NH2 3469 TCAM3466 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-c[Asp-Pro-Arg-Arg-Arg-Trp-Leu-Trp-Leu-Trp- Lys]-D-Phe-D-Val-NH2 3470 TCAM3467 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-c[Asp-Pro-Arg-Gln-Arg-Arg-Trp-Leu-Trp-Leu- Trp-Lys]-D-Val-D-Pro-NH2 3471 TCAM3468 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-c[Asp-Pro-Arg-Gln-Arg-Arg-Trp-Leu-Trp-Leu- Trp-Lys]-D-Val-D-Phe-NH2 3472 TCAM3469 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-c[Asp-Pro-Arg-Gln-Arg-Arg-Trp-Leu-Trp-Leu- Trp-Lys]-D-Pro-D-Val-NH2 3473 TCAM3470 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-c[Asp-Pro-Arg-Gln-Arg-Arg-Trp-Leu-Trp-Leu- Trp-Lys]-D-Phe-D-Val-NH2 3474 TCAM3471 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-c[Asp-Pro-Trp-Arg-Trp-Trp-Arg-Arg-Lys]-D- Val-D-Phe-NH2 3475 TCAM3472 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-c[Asp-Pro-Trp-Arg-Trp-Trp-Arg-Arg-Lys]-D- Pro-D-Val-NH2 3476 TCAM3473 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-c[Asp-Pro-Trp-Arg-Trp-Trp-Arg-Arg-Lys]-D- Phe-D-Val-NH2 3477 TCAM3474 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-c[Asp-Pro-Trp-Trp-Arg-Arg-Trp-Trp-Arg-Arg- Lys]-D-Val-D-Pro-NH2 3478 TCAM3475 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-c[Asp-Pro-Trp-Trp-Arg-Arg-Trp-Trp-Arg-Arg- Lys]-D-Val-D-Phe-NH2 3479 TCAM3476 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-c[Asp-Pro-Trp-Trp-Arg-Arg-Trp-Trp-Arg-Arg- Lys]-D-Pro-D-Val-NH2 3480 TCAM3477 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-c[Asp-Pro-Trp-Trp-Arg-Arg-Trp-Trp-Arg-Arg- Lys]-D-Phe-D-Val-NH2 3481 TCAM3478 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-c[Asp-Pro-Trp-Arg-Trp-Arg-Trp-Arg-Lys]-D- Val-D-Pro-NH2 3482 TCAM3479 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-c[Asp-Pro-Trp-Arg-Trp-Arg-Trp-Arg-Lys]-D- Val-D-Phe-NH2 3483 TCAM3480 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-c[Asp-Pro-Trp-Arg-Trp-Arg-Trp-Arg-Lys]-D- Pro-D-Val-NH2 3484 TCAM3481 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-c[Asp-Pro-Trp-Arg-Trp-Arg-Trp-Arg-Lys]-D- Phe-D-Val-NH2 3485 TCAM3482 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-c[Asp-Pro-Arg-Trp-Arg-Trp-Arg-Trp-Lys]-D- Val-D-Pro-NH2 3486 TCAM3483 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-c[Asp-Pro-Arg-Trp-Arg-Trp-Arg-Trp-Lys]-D- Val-D-Phe-NH2 3487 TCAM3484 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-c[Asp-Pro-Arg-Trp-Arg-Trp-Arg-Trp-Lys]-D- Pro-D-Val-NH2 3488 TCAM3485 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-c[Asp-Pro-Arg-Trp-Arg-Trp-Arg-Trp-Lys]-D- Phe-D-Val-NH2 3489 TCAM3486 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-c[Asp-Pro-Arg-Trp-Trp-Arg-Arg-Lys]-D-Val-D- Pro-NH2 3490 TCAM3487 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-c[Asp-Pro-Arg-Trp-Trp-Arg-Arg-Lys]-D-Val-D- Phe-NH2 3491 TCAM3488 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-c[Asp-Pro-Arg-Trp-Trp-Arg-Arg-Lys]-D-Pro-D- Val-NH2 3492 TCAM3489 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-c[Asp-Pro-Arg-Trp-Trp-Arg-Arg-Lys]-D-Phe- D-Val-NH2 3493 TCAM3490 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-c[Asp-Pro-Trp-Trp-Arg-Arg-Trp-Lys]-D-Val-D- Pro-NH2 3494 TCAM3491 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-c[Asp-Pro-Trp-Trp-Arg-Arg-Trp-Lys]-D-Val-D- Phe-NH2 3495 TCAM3492 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-c[Asp-Pro-Trp-Trp-Arg-Arg-Trp-Lys]-D-Pro-D- Val-NH2 3496 TCAM3493 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-c[Asp-Pro-Trp-Trp-Arg-Arg-Trp-Lys]-D-Phe- D-Val-NH2 3497 TCAM3494 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-c[Asp-Pro-Trp-Arg-Trp-Arg-Trp-Lys]-D-Val-D- Pro-NH2 3498 TCAM3495 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-c[Asp-Pro-Trp-Arg-Trp-Arg-Trp-Lys]-D-Val-D- Phe-NH2 3499 TCAM3496 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-c[Asp-Pro-Trp-Arg-Trp-Arg-Trp-Lys]-D-Pro-D- Val-NH2 3500 TCAM3497 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-c[Asp-Pro-Trp-Arg-Trp-Arg-Trp-Lys]-D-Phe- D-Val-NH2 3501 TCAM3498 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-c[Asp-Pro-Arg-Trp-Arg-Trp-Arg-Lys]-D-Val-D- Pro-NH2 3502 TCAM3499 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-c[Asp-Pro-Arg-Trp-Arg-Trp-Arg-Lys]-D-Val-D- Phe-NH2 3503 TCAM3500 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-c[Asp-Pro-Arg-Trp-Arg-Trp-Arg-Lys]-D-Pro-D- Val-NH2 3504 TCAM3501 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-c[Asp-Pro-Arg-Trp-Arg-Trp-Arg-Lys]-D-Phe- D-Val-NH2 3505 TCAM3502 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-c[Asp-Pro-Trp-Arg-Tyr-Arg-Trp-Lys]-D-Val-D- Pro-NH2 3506 TCAM3503 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-c[Asp-Pro-Trp-Arg-Tyr-Arg-Trp-Lys]-D-Val-D- Phe-NH2 3507 TCAM3504 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-c[Asp-Pro-Trp-Arg-Tyr-Arg-Trp-Lys]-D-Pro-D- Val-NH2 3508 TCAM3505 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-c[Asp-Pro-Trp-Arg-Tyr-Arg-Trp-Lys]-D-Phe-D- Val-NH2 3509 TCAM3506 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-c[Asp-Pro-Trp-Arg-Trp-Arg-Tyr-Lys]-D-Val-D- Pro-NH2 3510 TCAM3507 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-c[Asp-Pro-Trp-Arg-Trp-Arg-Tyr-Lys]-D-Val-D- Phe-NH2 3511 TCAM3508 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-c[Asp-Pro-Trp-Arg-Trp-Arg-Tyr-Lys]-D-Pro-D- Val-NH2 3512 TCAM3509 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-c[Asp-Pro-Trp-Arg-Trp-Arg-Tyr-Lys]-D-Phe-D- Val-NH2 3513 TCAM3510 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-c[Asp-Pro-Trp-Arg-Trp-Arg-Lys]-D-Val-D-Pro- NH2 3514 TCAM3511 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-c[Asp-Pro-Trp-Arg-Trp-Arg-Lys]-D-Val-D-Phe- NH2 3515 TCAM3512 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-c[Asp-Pro-Trp-Arg-Trp-Arg-Lys]-D-Pro-D-Val- NH2 3516 TCAM3513 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-c[Asp-Pro-Trp-Arg-Trp-Arg-Lys]-D-Phe-D-Val- NH2 3517 TCAM3514 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-c[Asp-Pro-Trp-Arg-Arg-Trp-Lys]-D-Val-D-Pro- NH2 3518 TCAM3515 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-c[Asp-Pro-Trp-Arg-Arg-Trp-Lys]-D-Val-D-Phe- NH2 3519 TCAM3516 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-c[Asp-Pro-Trp-Arg-Arg-Trp-Lys]-D-Pro-D-Val- NH2 3520 TCAM3517 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-c[Asp-Pro-Trp-Arg-Arg-Trp-Lys]-D-Phe-D-Val- NH2 3521 TCAM3518 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-c[Asp-Pro-Arg-Trp-Trp-Arg-Lys]-D-Val-D-Pro- NH2 3522 TCAM3519 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-c[Asp-Pro-Arg-Trp-Trp-Arg-Lys]-D-Val-D-Phe- NH2 3523 TCAM3520 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-c[Asp-Pro-Arg-Trp-Trp-Arg-Lys]-D-Pro-D-Val- NH2 3524 TCAM3521 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-c[Asp-Pro-Arg-Trp-Trp-Arg-Lys]-D-Phe-D-Val- NH2 3525 TCAM3522 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-c[Asp-Pro-Trp-Arg-Trp-Lys]-D-Val-D-Pro-NH2 3526 TCAM3523 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-c[Asp-Pro-Trp-Arg-Trp-Lys]-D-Val-D-Phe- NH2 3527 TCAM3524 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-c[Asp-Pro-Trp-Arg-Trp-Lys]-D-Pro-D-Val-NH2 3528 TCAM3525 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-c[Asp-Pro-Trp-Arg-Trp-Lys]-D-Phe-D-Val- NH2 3529 TCAM3526 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-c[Asp-Pro-Arg-Trp-Arg-Lys]-D-Val-D-Pro-NH2 3530 TCAM3527 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-c[Asp-Pro-Arg-Trp-Arg-Lys]-D-Val-D-Phe- NH2 3531 TCAM3528 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-c[Asp-Pro-Arg-Trp-Arg-Lys]-D-Pro-D-Val-NH2 3532 TCAM3529 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-c[Asp-Pro-Arg-Trp-Arg-Lys]-D-Phe-D-Val- NH2 3533 TCAM3530 -Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-c[Asp-Arg-Arg-Trp-Trp-Arg-Phe-Lys]-D-Val- D-Pro-NH2 3534 TCAM3531 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-c[Asp-Arg-Arg-Trp-Trp-Arg-Phe-Lys]-D-Val-D- Phe-NH2 3535 TCAM3532 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-c[Asp-Arg-Arg-Trp-Trp-Arg-Phe-Lys]-D-Pro- D-Val-NH2 3536 TCAM3533 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-c[Asp-Arg-Arg-Trp-Trp-Arg-Phe-Lys]-D-Phe- D-Val-NH2 3537 TCAM3534 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-c[Asp-Arg-Arg-Trp-Trp-Arg-Phe-Lys]-D-Val-D- Pro-NH2 3538 TCAM3535 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-c[Asp-Arg-Arg-Trp-Trp-Arg-Phe-Lys]-D-Val-D- Phe-NH2 3539 TCAM3536 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-c[Asp-Arg-Arg-Trp-Trp-Arg-Phe-Lys]-D-Pro- D-Val-NH2 3540 TCAM3537 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-c[Asp-Arg-Arg-Trp-Trp-Arg-Phe-Lys]-D-Phe- D-Val-NH2 3541 TCAM3538 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-c[Asp-Arg-Arg-Tyr-Tyr-Arg-Phe-Lys]-D-Val-D- Pro-NH2 3542 TCAM3539 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-c[Asp-Arg-Arg-Tyr-Tyr-Arg-Phe-Lys]-D-Val-D- Phe-NH2 3543 TCAM3540 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-c[Asp-Arg-Arg-Tyr-Tyr-Arg-Phe-Lys]-D-Pro-D- Val-NH2 3544 TCAM3541 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-c[Asp-Arg-Arg-Tyr-Tyr-Arg-Phe-Lys]-D-Phe- D-Val-NH2 3545 TCAM3542 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-c[Asp-Arg-Arg-Nal-Nal-Arg-Phe-Lys]-D-Val-D- Pro-NH2 3546 TCAM3543 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-c[Asp-Arg-Arg-Nal-Nal-Arg-Phe-Lys]-D-Val-D- Phe-NH2 3547 TCAM3544 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-c[Asp-Arg-Arg-Nal-Nal-Arg-Phe-Lys]-D-Pro- D-Val-NH2 3548 TCAM3545 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-c[Asp-Arg-Arg-Nal-Nal-Arg-Phe-Lys]-D-Phe- D-Val-NH2 3549 TCAM3546 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-c[Asp-Arg-Arg-Leu-Trp-Leu-Trp-Lys]-D-Val-D- Pro-NH2 3550 TCAM3547 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-c[Asp-Arg-Arg-Leu-Trp-Leu-Trp-Lys]-D-Val-D- Phe-NH2 3551 TCAM3548 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-c[Asp-Arg-Arg-Leu-Trp-Leu-Trp-Lys]-D-Pro- D-Val-NH2 3552 TCAM3549 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-c[Asp-Arg-Arg-Leu-Trp-Leu-Trp-Lys]-D-Phe- D-Val-NH2 3553 TCAM3550 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-c[Asp-Arg-Arg-Leu-Trp-Leu-Trp-Lys]-D-Val-D- Pro-NH2 3554 TCAM3551 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-c[Asp-Arg-Arg-Leu-Trp-Leu-Trp-Lys]-D-Val-D- Phe-NH2 3555 TCAM3552 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-c[Asp-Arg-Arg-Leu-Trp-Leu-Trp-Lys]-D-Pro- D-Val-NH2 3556 TCAM3553 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-c[Asp-Arg-Arg-Leu-Trp-Leu-Trp-Lys]-D-Phe- D-Val-NH2 3557 TCAM3554 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-c[Asp-Arg-Arg-Arg-Trp-Leu-Trp-Leu-Trp- Lys]-D-Val-D-Pro-NH2 3558 TCAM3555 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-c[Asp-Arg-Arg-Arg-Trp-Leu-Trp-Leu-Trp- Lys]-D-Val-D-Phe-NH2 3559 TCAM3556 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-c[Asp-Arg-Arg-Arg-Trp-Leu-Trp-Leu-Trp- Lys]-D-Pro-D-Val-NH2 3560 TCAM3557 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-c[Asp-Arg-Arg-Arg-Trp-Leu-Trp-Leu-Trp- Lys]-D-Phe-D-Val-NH2 3561 TCAM3558 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-c[Asp-Arg-Gln-Arg-Arg-Trp-Leu-Trp-Leu-Trp- Lys]-D-Val-D-Pro-NH2 3562 TCAM3559 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-c[Asp-Arg-Gln-Arg-Arg-Trp-Leu-Trp-Leu-Trp- Lys]-D-Val-D-Phe-NH2 3563 TCAM3560 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-c[Asp-Arg-Gln-Arg-Arg-Trp-Leu-Trp-Leu-Trp- Lys]-D-Pro-D-Val-NH2 3564 TCAM3561 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-c[Asp-Arg-Gln-Arg-Arg-Trp-Leu-Trp-Leu-Trp- Lys]-D-Phe-D-Val-NH2 3565 TCAM3562 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-c[Asp-Trp-Arg-Trp-Trp-Arg-Arg-Lys]-D-Val-D- Pro-NH2 3566 TCAM3563 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-c[Asp-Trp-Arg-Trp-Trp-Arg-Arg-Lys]-D-Val-D- Phe-NH2 3567 TCAM3564 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-c[Asp-Trp-Arg-Trp-Trp-Arg-Arg-Lys]-D-Pro-D- Val-NH2 3568 TCAM3565 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-c[Asp-Trp-Arg-Trp-Trp-Arg-Arg-Lys]-D-Phe- D-Val-NH2 3569 TCAM3566 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-c[Asp-Trp-Trp-Arg-Arg-Trp-Trp-Arg-Arg-Lys]- D-Val-D-Pro-NH2 3570 TCAM3567 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-c[Asp-Trp-Trp-Arg-Arg-Trp-Trp-Arg-Arg-Lys]- D-Val-D-Phe-NH2 3571 TCAM3568 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-c[Asp-Trp-Trp-Arg-Arg-Trp-Trp-Arg-Arg-Lys]- D-Pro-D-Val-NH2 3572 TCAM3569 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-c[Asp-Trp-Trp-Arg-Arg-Trp-Trp-Arg-Arg-Lys]- D-Phe-D-Val-NH2 3573 TCAM3570 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-c[Asp-Trp-Arg-Trp-Arg-Trp-Arg-Lys]-D-Val-D- Pro-NH2 3574 TCAM3571 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-c[Asp-Trp-Arg-Trp-Arg-Trp-Arg-Lys]-D-Val-D- Phe-NH2 3575 TCAM3572 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-c[Asp-Trp-Arg-Trp-Arg-Trp-Arg-Lys]-D-Pro-D- Val-NH2 3576 TCAM3573 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-c[Asp-Trp-Arg-Trp-Arg-Trp-Arg-Lys]-D-Phe- D-Val-NH2 3577 TCAM3574 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-c[Asp-Arg-Trp-Arg-Trp-Arg-Trp-Lys]-D-Val-D- Pro-NH2 3578 TCAM3575 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-c[Asp-Arg-Trp-Arg-Trp-Arg-Trp-Lys]-D-Val-D- Phe-NH2 3579 TCAM3576 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-c[Asp-Arg-Trp-Arg-Trp-Arg-Trp-Lys]-D-Pro-D- Val-NH2 3580 TCAM3577 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-c[Asp-Arg-Trp-Arg-Trp-Arg-Trp-Lys]-D-Phe- D-Val-NH2 3581 TCAM3578 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-c[Asp-Arg-Trp-Trp-Arg-Arg-Lys]-D-Val-D-Pro- NH2 3582 TCAM3579 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-c[Asp-Arg-Trp-Trp-Arg-Arg-Lys]-D-Val-D-Phe- NH2 3583 TCAM3580 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-c[Asp-Arg-Trp-Trp-Arg-Arg-Lys]-D-Pro-D-Val- NH2 3584 TCAM3581 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-c[Asp-Arg-Trp-Trp-Arg-Arg-Lys]-D-Phe-D-Val- NH2 3585 TCAM3582 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-c[Asp-Arg-Trp-Arg-Trp-Arg-Lys]-D-Val-D-Pro- NH2 3586 TCAM3583 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-c[Asp-Arg-Trp-Arg-Trp-Arg-Lys]-D-Val-D-Phe- NH2 3587 TCAM3584 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-c[Asp-Arg-Trp-Arg-Trp-Arg-Lys]-D-Pro-D-Val- NH2 3588 TCAM3585 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-c[Asp-Arg-Trp-Arg-Trp-Arg-Lys]-D-Phe-D-Val- NH2 3589 TCAM3586 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-c[Asp-Trp-Trp-Arg-Arg-Trp-Lys]-D-Val-D-Pro- NH2 3590 TCAM3587 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-c[Asp-Trp-Trp-Arg-Arg-Trp-Lys]-D-Val-D-Phe- NH2 3591 TCAM3588 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-c[Asp-Trp-Trp-Arg-Arg-Trp-Lys]-D-Pro-D-Val- NH2 3592 TCAM3589 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-c[Asp-Trp-Trp-Arg-Arg-Trp-Lys]-D-Phe-D-Val- NH2 3593 TCAM3590 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-c[Asp-Trp-Arg-Trp-Arg-Trp-Lys]-D-Val-D-Pro- NH2 3594 TCAM3591 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-c[Asp-Trp-Arg-Trp-Arg-Trp-Lys]-D-Val-D-Phe- NH2 3595 TCAM3592 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-c[Asp-Trp-Arg-Trp-Arg-Trp-Lys]-D-Pro-D-Val- NH2 3596 TCAM3593 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-c[Asp-Trp-Arg-Trp-Arg-Trp-Lys]-D-Phe-D-Val- NH2 3597 TCAM3594 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-c[Asp-Trp-Arg-Tyr-Arg-Trp-Lys]-D-Val-D-Pro- NH2 3598 TCAM3595 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-c[Asp-Trp-Arg-Tyr-Arg-Trp-Lys]-D-Val-D-Phe- NH2 3599 TCAM3596 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-c[Asp-Trp-Arg-Tyr-Arg-Trp-Lys]-D-Pro-D-Val- NH2 3600 TCAM3597 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-c[Asp-Trp-Arg-Tyr-Arg-Trp-Lys]-D-Phe-D-Val- NH2 3601 TCAM3598 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-c[Asp-Trp-Arg-Trp-Arg-Tyr-Lys]-D-Val-D-Pro- NH2 3602 TCAM3599 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-c[Asp-Trp-Arg-Trp-Arg-Tyr-Lys]-D-Val-D-Phe- NH2 3603 TCAM3600 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-c[Asp-Trp-Arg-Trp-Arg-Tyr-Lys]-D-Pro-D-Val- NH2 3604 TCAM3601 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-c[Asp-Trp-Arg-Trp-Arg-Tyr-Lys]-D-Phe-D-Val- NH2 3605 TCAM3602 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-c[Asp-Trp-Arg-Trp-Arg-Lys]-D-Val-D-Pro-NH2 3606 TCAM3603 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-c[Asp-Trp-Arg-Trp-Arg-Lys]-D-Val-D-Phe- NH2 3607 TCAM3604 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-c[Asp-Trp-Arg-Trp-Arg-Lys]-D-Pro-D-Val-NH2 3608 TCAM3605 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-c[Asp-Trp-Arg-Trp-Arg-Lys]-D-Phe-D-Val- NH2 3609 TCAM3606 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-c[Asp-Trp-Arg-Arg-Trp-Lys]-D-Val-D-Pro-NH2 3610 TCAM3607 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-c[Asp-Trp-Arg-Arg-Trp-Lys]-D-Val-D-Phe- NH2 3611 TCAM3608 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-c[Asp-Trp-Arg-Arg-Trp-Lys]-D-Pro-D-Val-NH2 3612 TCAM3609 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-c[Asp-Trp-Arg-Arg-Trp-Lys]-D-Phe-D-Val- NH2 3613 TCAM3610 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-c[Asp-Arg-Trp-Trp-Arg-Lys]-D-Val-D-Pro-NH2 3614 TCAM3611 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-c[Asp-Arg-Trp-Trp-Arg-Lys]-D-Val-D-Phe- NH2 3615 TCAM3612 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-c[Asp-Arg-Trp-Trp-Arg-Lys]-D-Pro-D-Val-NH2 3616 TCAM3613 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-c[Asp-Arg-Trp-Trp-Arg-Lys]-D-Phe-D-Val- NH2 3617 TCAM3614 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-c[Asp-Trp-Arg-Trp-Lys]-D-Val-D-Pro-NH2 3618 TCAM3615 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-c[Asp-Trp-Arg-Trp-Lys]-D-Val-D-Phe-NH2 3619 TCAM3616 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-c[Asp-Trp-Arg-Trp-Lys]-D-Pro-D-Val-NH2 3620 TCAM3617 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-c[Asp-Trp-Arg-Trp-Lys]-D-Phe-D-Val-NH2 3621 TCAM3618 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-c[Asp-Arg-Trp-Arg-Lys]-D-Val-D-Pro-NH2 3622 TCAM3619 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-c[Asp-Arg-Trp-Arg-Lys]-D-Val-D-Phe-NH2 3623 TCAM3620 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-c[Asp-Arg-Trp-Arg-Lys]-D-Pro-D-Val-NH2 3624 TCAM3621 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-c[Asp-Arg-Trp-Arg-Lys]-D-Phe-D-Val-NH2 3625 TCAM3622 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-c[Asp-His-D-Nal(2′)-Arg-Trp-Lys]-D-Val-D- Pro-NH2 3626 TCAM3623 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-c[Asp-His-D-Nal(2′)-Arg-Trp-Lys]-D-Pro-D- Val-NH2 3627 TCAM3624 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-c[Asp-His-D-Nal(2′)-Arg-Trp-Lys]-D-Val-D- Phe-NH2 3628 TCAM3625 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-c[Asp-His-D-Nal(2′)-Arg-Trp-Lys]-D-Phe-D- Val-NH2 3629 TCAM3626 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-c[Asp-Pro-D-Nal(2′)-Arg-Trp-Lys]-D-Val-D- Pro-NH2 3630 TCAM3627 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-c[Asp-Pro-D-Nal(2′)-Arg-Trp-Lys]-D-Pro-D- Val-NH2 3631 TCAM3628 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-c[Asp-Pro-D-Nal(2′)-Arg-Trp-Lys]-D-Val-D- Phe-NH2 3632 TCAM3629 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-c[Asp-Pro-D-Nal(2′)-Arg-Trp-Lys]-D-Phe-D- Val-NH2 3633 TCAM3630 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-c[Asp-Arg-Arg-Nal(2′)-Arg-Trp-Lys]-D-Val-D- Pro-NH2 3634 TCAM3631 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-c[Asp-Arg-Arg-Nal(2′)-Arg-Trp-Lys]-D-Pro-D- Val-NH2 3635 TCAM3632 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-c[Asp-Arg-Arg-Nal(2′)-Arg-Trp-Lys]-D-Val-D- Phe-NH2 3636 TCAM3633 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-c[Asp-Arg-Arg-Nal(2′)-Arg-Trp-Lys]-D-Phe-D- Val-NH2 3637 TCAM3634 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-c[Asp-Arg-Arg-Pro-Nal(2′)-Arg-Trp-Lys]-D- Val-D-Pro-NH2 3638 TCAM3635 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-c[Asp-Arg-Arg-Pro-D-Nal(2′)-Arg-Trp-Lys]-D- Pro-D-Val-NH2 3639 TCAM3636 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-c[Asp-Arg-Arg-Pro-D-Nal(2′)-Arg-Trp-Lys]-D- Val-D-Phe-NH2 3640 TCAM3637 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-c[Asp-Arg-Arg-Pro-Nal(2′)-Arg-Trp-Lys]-D- Phe-D-Val-NH2 3641 TCAM3638 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-c[Asp-Arg-D-Nal(2′)-Arg-Trp-Lys]-D-Val-D- Pro-NH2 3642 TCAM3639 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-c[Asp-Arg-D-Nal(2′)-Arg-Trp-Lys]-D-Pro-D- Val-NH2 3643 TCAM3640 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-c[Asp-Arg-D-Nal(2′)-Arg-Trp-Lys]-D-Val-D- Phe-NH2 3644 TCAM3641 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-c[Asp-Arg-D-Nal(2′)-Arg-Trp-Lys]-D-Phe-D- Val-NH2 3645 TCAM3642 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-c[Asp-Arg-Pro-D-Nal(2′)-Arg-Trp-Lys]-D-Val- D-Pro-NH2 3646 TCAM3643 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-c[Asp-Arg-Pro-D-Nal(2′)-Arg-Trp-Lys]-D-Pro- D-Val-NH2 3647 TCAM3644 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-c[Asp-Arg-Pro-D-Nal(2′)-Arg-Trp-Lys]-D-Val- D-Phe-NH2 3648 TCAM3645 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-c[Asp-Arg-Pro-D-Nal(2′)-Arg-Trp-Lys]-D-Phe- D-Val-NH2 3649 TCAM3646 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-Arg-Arg-c[Asp-Pro-D-Nal(2′)-Arg-Trp-Lys]-D- Val-D-Pro-NH2 3650 TCAM3647 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-Arg-Arg-c[Asp-Pro-D-Nal(2′)-Arg-Trp-Lys]-D- Pro-D-Val-NH2 3651 TCAM3648 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-Arg-Arg-c[Asp-Pro-D-Nal(2′)-Arg-Trp-Lys]-D- Val-D-Phe-NH2 3652 TCAM3649 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-Arg-Arg-c[Asp-Pro-D-Nal(2′)-Arg-Trp-Lys]-D- Phe-D-Val-NH2 3653 TCAM3650 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-Arg-Arg-c[Asp-His-D-Nal(2′)-Arg-Trp-Lys]-D- Val-D-Pro-NH2 3654 TCAM3651 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-Arg-Arg-c[Asp-His-D-Nal(2′)-Arg-Trp-Lys]-D- Pro-D-Val-NH2 3655 TCAM3652 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-Arg-Arg-c[Asp-His-D-Nal(2′)-Arg-Trp-Lys]-D- Val-D-Phe-NH2 3656 TCAM3653 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-Arg-Arg-c[Asp-His-D-Nal(2′)-Arg-Trp-Lys]-D- Phe-D-Val-NH2 3657 TCAM3654 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-c[Asp-Arg-Pro-D-Nal(2′)-Arg-Trp-Arg-Lys]-D- Val-D-Pro-NH2 3658 TCAM3655 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-c[Asp-Arg-Pro-D-Nal(2′)-Arg-Trp-Arg-Lys]-D- Pro-D-Val-NH2 3659 TCAM3656 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-c[Asp-Arg-Pro-D-Nal(2′)-Arg-Trp-Arg-Lys]-D- Val-D-Phe-NH2 3660 TCAM3657 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-c[Asp-Arg-Pro-D-Nal(2′)-Arg-Trp-Arg-Lys]-D- Phe-D-Val-NH2 3661 TCAM3658 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-c[Asp-Arg-His-D-Nal(2′)-Arg-Trp-Arg-Lys]-D- Val-D-Pro-NH2 3662 TCAM3659 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-c[Asp-Arg-His-D-Nal(2′)-Arg-Trp-Arg-Lys]-D- Pro-D-Val-NH2 3663 TCAM3660 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-c[Asp-Arg-His-D-Nal(2′)-Arg-Trp-Arg-Lys]-D- Val-D-Phe-NH2 3664 TCAM3661 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-c[Asp-Arg-His-D-Nal(2′)-Arg-Trp-Arg-Lys]-D- Phe-D-Val-NH2 3665 TCAM3662 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-c[Asp-His-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Val- D-Phe-NH2 3666 TCAM3663 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-c[Asp-His-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Phe- D-Val-NH2 3667 TCAM3664 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-c[Asp-Pro-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Val- D-Pro-NH2 3668 TCAM3665 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-c[Asp-Pro-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Pro- D-Val-NH2 3669 TCAM3666 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-c[Asp-Pro-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Val- D-Phe-NH2 3670 TCAM3667 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-c[Asp-Pro-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D- Phe-D-Val-NH2 3671 TCAM3668 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-c[Asp-Arg-Arg-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D- Val-D-Pro-NH2 3672 TCAM3669 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-c[Asp-Arg-Arg-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D- Pro-D-Val-NH2 3673 TCAM3670 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-c[Asp-Arg-Arg-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D- Val-D-Phe-NH2 3674 TCAM3671 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-c[Asp-Arg-Arg-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D- Phe-D-Val-NH2 3675 TCAM3672 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-c[Asp-Arg-Arg-Pro-D-Nal(2′)-Arg-D-Nal(2′)- Lys]-D-Val-D-Pro-NH2 3676 TCAM3673 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-c[Asp-Arg-Arg-Pro-D-Nal(2′)-Arg-D-Nal(2′)- Lys]-D-Pro-D-Val-NH2 3677 TCAM3674 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-c[Asp-Arg-Arg-Pro-D-Nal(2′)-Arg-D-Nal(2′)- Lys]-D-Val-D-Phe-NH2 3678 TCAM3675 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-c[Asp-Arg-Arg-Pro-D-Nal(2′)-Arg-D-Nal(2′)- Lys]-D-Phe-D-Val-NH2 3679 TCAM3676 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-c[Asp-Arg-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Val- D-Pro-NH2 3680 TCAM3677 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-c[Asp-Arg-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Pro- D-Val-NH2 3681 TCAM3678 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-c[Asp-Arg-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Val-D- Phe-NH2 3682 TCAM3679 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-c[Asp-Arg-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D- Phe-D-Val-NH2 3683 TCAM3680 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-c[Asp-Arg-Pro-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D- Val-D-Pro-NH2 3684 TCAM3681 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-c[Asp-Arg-Pro-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D- Pro-D-Val-NH2 3685 TCAM3682 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-c[Asp-Arg-Pro-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D- Val-D-Phe-NH2 3686 TCAM3683 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-c[Asp-Arg-Pro-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D- Phe-D-Val-NH2 3687 TCAM3684 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-c[Asp-Arg-His-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D- Val-D-Pro-NH2 3688 TCAM3685 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-c[Asp-Arg-His-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D- Pro-D-Val-NH2 3689 TCAM3686 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-c[Asp-Arg-His-Nal(2′)-Arg-D-Nal(2′)-Lys]-D- Val-D-Phe-NH2 3690 TCAM3687 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-c[Asp-Arg-His-Nal(2′)-Arg-D-Nal(2′)-Lys]-D- Phe-D-Val-NH2 3691 TCAM3688 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-c[Asp-Arg-D-D-Nal(2′)-Arg-D-Nal(2′)-Arg-Lys]- D-Val-D-Pro-NH2 3692 TCAM3689 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-c[Asp-Arg-D-Nal(2′)-Arg-D-Nal(2′)-Arg-Lys]-D- Pro-D-Val-NH2 3693 TCAM3690 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-c[Asp-Arg-D-Nal(2′)-Arg-D-Nal(2′)-Arg-Lys]-D- Val-D-Phe-NH2 3694 TCAM3691 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-c[Asp-Arg-D-Nal(2′)-Arg-D-Nal(2′)-Arg-Lys]-D- Phe-D-Val-NH2 3695 TCAM3692 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-c[Asp-Arg-Pro-D-Nal(2′)-Arg-D-Nal(2′)-Arg- Lys]-D-Val-D-Pro-NH2 3696 TCAM3693 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-c[Asp-Arg-Pro-D-Nal(2′)-Arg-D-Nal(2′)-Arg- Lys]-D-Pro-D-Val-NH2 3697 TCAM3694 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-c[Asp-Arg-Pro-D-Nal(2′)-Arg-D-Nal(2′)-Arg- Lys]-D-Val-D-Phe-NH2 3698 TCAM3695 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-c[Asp-Arg-Pro-D-Nal(2′)-Arg-D-Nal(2′)-Arg- Lys]-D-Phe-D-Val-NH2 3699 TCAM3696 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-c[Asp-Arg-His-D-Nal(2′)-Arg-D-Nal(2′)-Arg- Lys]-D-Val-D-Pro-NH2 3700 TCAM3697 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-c[Asp-Arg-His-D-Nal(2′)-Arg-D-Nal(2′)-Arg- Lys]-D-Pro-D-Val-NH2 3701 TCAM3698 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-c[Asp-Arg-His-D-Nal(2′)-Arg-D-Nal(2′)-Arg- Lys]-D-Val-D-Phe-NH2 3702 TCAM3699 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-c[Asp-Arg-His-D-Nal(2′)-Arg-D-Nal(2′)-Arg- Lys]-D-Phe-D-Val-NH2 3703 TCAM3700 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-Arg-Arg-c[Asp-Pro-D-Nal(2′)-Arg-D-Nal(2′)- Lys]-D-Val-D-Pro-NH2 3704 TCAM3701 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-Arg-Arg-c[Asp-Pro-D-Nal(2′)-Arg-D-Nal(2′)- Lys]-D-Pro-D-Val-NH2 3705 TCAM3702 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-Arg-Arg-c[Asp-Pro-D-Nal(2′)-Arg-D-Nal(2′)- Lys]-D-Val-D-Phe-NH2 3706 TCAM3703 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-Arg-Arg-c[Asp-Pro-D-Nal(2′)-Arg-D-Nal(2′)- Lys]-D-Phe-D-Val-NH2 3707 TCAM3704 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-Arg-Arg-c[Asp-His-D-Nal(2′)-Arg-D-Nal(2′)- Lys]-D-Val-D-Pro-NH2 3708 TCAM3705 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-Arg-Arg-c[Asp-His-D-Nal(2′)-Arg-D-Nal(2′)- Lys]-D-Pro-D-Val-NH2 3709 TCAM3706 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-Arg-Arg-c[Asp-His-D-Nal(2′)-Arg-D-Nal(2′)- Lys]-D-Val-D-Phe-NH2 3710 TCAM3707 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-Arg-Arg-c[Asp-His-D-Nal(2′)-Arg-D-Nal(2′)- Lys]-D-Phe-D-Val-NH2 3711 TCAM3708 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-c[Asp-Arg-Pro-D-Nal(2′)-Arg-D-Nal(2′)-Arg- Lys]-D-Val-D-Pro-NH2 3712 TCAM3709 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-c[Asp-Arg-Pro-D-Nal(2′)-Arg-D-Nal(2′)-Arg- Lys]-D-Pro-D-Val-NH2 3713 TCAM3710 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-c[Asp-Arg-Pro-D-Nal(2′)-Arg-D-Nal(2′)-Arg- Lys]-D-Val-D-Phe-NH2 3714 TCAM3711 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-c[Asp-Arg-Pro-D-Nal(2′)-Arg-D-Nal(2′)-Arg- Lys]-D-Phe-D-Val-NH2 3715 TCAM3712 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-c[Asp-Arg-His-D-Nal(2′)-Arg-D-Nal(2′)-Arg- Lys]-D-Val-D-Pro-NH2 3716 TCAM3713 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-c[Asp-Arg-His-D-Nal(2′)-Arg-D-Nal(2′)-Arg- Lys]-D-Pro-D-Val-NH2 3717 TCAM3714 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-c[Asp-Arg-His-D-Nal(2′)-Arg-D-Nal(2′)-Arg- Lys]-D-Val-D-Phe-NH2 3718 TCAM3715 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-c[Asp-Arg-His-D-Nal(2′)-Arg-D-Nal(2′)-Arg- Lys]-D-Phe-D-Val-NH2 3719 TCAM3716 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-c[Asp-His-D-Nal(2′)-Arg-Trp-Lys]-Arg-Arg-D- Val-D-Pro-NH2 3720 TCAM3717 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-c[Asp-His-D-Nal(2′)-Arg-Trp-Lys]-Arg-Arg-D- Pro-D-Val-NH2 3721 TCAM3718 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-c[Asp-His-D-Nal(2′)-Arg-Trp-Lys]-Arg-Arg-D- Val-D-Phe-NH2 3722 TCAM3719 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-c[Asp-His-D-Nal(2′)-Arg-Trp-Lys]-Arg-Arg-D- Phe-D-Val-NH2 3723 TCAM3720 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-c[Asp-Pro-D-Nal(2′)-Arg-Trp-Lys]-Arg-Arg-D- Val-D-Pro-NH2 3724 TCAM3721 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-c[Asp-Pro-D-Nal(2′)-Arg-Trp-Lys]-Arg-Arg-D- Pro-D-Val-NH2 3725 TCAM3722 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-c[Asp-Pro-D-Nal(2′)-Arg-Trp-Lys]-Arg-Arg-D- Val-D-Phe-NH2 3726 TCAM3723 Arg-Arg-Phe-Arg-Arg-Phe-Phe-Arg-Arg-c[Asp-Pro-D-Nal(2′)-Arg-Trp-Lys]-Arg-Arg-D- Phe-D-Val-NH2 Anti-biofilm peptide ABF7 linked to anti-microbial peptides 3727 TCAM3724 Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Pro-Arg-Arg-Trp-Trp-Arg-Phe-Lys]-D-Val-D- Pro-NH2 3728 TCAM3725 Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Pro-Arg-Arg-Trp-Trp-Arg-Phe-Lys]-D-Val-D- Phe-NH2 3729 TCAM3726 Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Pro-Arg-Arg-Trp-Trp-Arg-Phe-Lys]-D-Pro-D- Val-NH2 3730 TCAM3727 Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Pro-Arg-Arg-Trp-Trp-Arg-Phe-Lys]-D-Phe-D- Val-NH2 3731 TCAM3728 Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Pro-Arg-Arg-Trp-Trp-Tyr-Phe-Lys]-D-Val-D- Pro-NH2 3732 TCAM3729 Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Pro-Arg-Arg-Trp-Trp-Tyr-Phe-Lys]-D-Val-D- Phe-NH2 3733 TCAM3730 Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Pro-Arg-Arg-Trp-Trp-Tyr-Phe-Lys]-D-Pro-D- Val-NH2 3734 TCAM3731 Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Pro-Arg-Arg-Trp-Trp-Tyr-Phe-Lys]-D-Phe-D- Val-NH2 3735 TCAM3732 Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Pro-Arg-Arg-Tyr-Tyr-Arg-Phe-Lys]-D-Val-D- Pro-NH2 3736 TCAM3733 Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Pro-Arg-Arg-Tyr-Tyr-Arg-Phe-Lys]-D-Val-D- Phe-NH2 3737 TCAM3734 Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Pro-Arg-Arg-Tyr-Tyr-Arg-Phe-Lys]-D-Pro-D- Val-NH2 3738 TCAM3735 Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Pro-Arg-Arg-Tyr-Tyr-Arg-Phe-Lys]-D-Phe-D- Val-NH2 3739 TCAM3736 Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Pro-Arg-Arg-Nal-Nal-Arg-Phe-Lys]-D-Val-D- Pro-NH2 3740 TCAM3737 Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Pro-Arg-Arg-Nal-Nal-Arg-Phe-Lys]-D-Val-D- Phe-NH2 3741 TCAM3738 Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Pro-Arg-Arg-Nal-Nal-Arg-Phe-Lys]-D-Pro-D- Val-NH2 3742 TCAM3739 Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Pro-Arg-Arg-Nal-Nal-Arg-Phe-Lys]-D-Phe-D- Val-NH2 3743 TCAM3740 Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Pro-Arg-Arg-Leu-Trp-Leu-Trp-Lys]-D-Val-D- Pro-NH2 3744 TCAM3741 Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Pro-Arg-Arg-Leu-Trp-Leu-Trp-Lys]-D-Val-D- Phe-NH2 3745 TCAM3742 Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Pro-Arg-Arg-Leu-Trp-Leu-Trp-Lys]-D-Pro-D- Val-NH2 3746 TCAM3743 Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Pro-Arg-Arg-Leu-Trp-Leu-Trp-Lys]-D-Phe-D- Val-NH2 3747 TCAM3744 Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Pro-Arg-Arg-Leu-Trp-Leu-Trp-Lys]-D-Val-D- Pro-NH2 3748 TCAM3745 Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Pro-Arg-Arg-Leu-Trp-Leu-Trp-Lys]-D-Val-D- Phe-NH2 3749 TCAM3746 Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Pro-Arg-Arg-Leu-Trp-Leu-Trp-Lys]-D-Pro-D- Val-NH2 3750 TCAM3747 Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Pro-Arg-Arg-Leu-Trp-Leu-Trp-Lys]-D-Phe-D- Val-NH2 3751 TCAM3748 Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Arg-Arg-Arg-Trp-Leu-Trp-Leu-Trp-Lys]-D-Val- D-Pro-NH2 3752 TCAM3749 Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Pro-Arg-Arg-Arg-Trp-Leu-Trp-Leu-Trp-Lys]- D-Val-D-Phe-NH2 3753 TCAM3750 Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Pro-Arg-Arg-Arg-Trp-Leu-Trp-Leu-Trp-Lys]- D-Pro-D-Val-NH2 3754 TCAM3751 Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Pro-Arg-Arg-Arg-Trp-Leu-Trp-Leu-Trp-Lys]- D-Phe-D-Val-NH2 3755 TCAM3752 Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Pro-Arg-Gln-Arg-Arg-Trp-Leu-Trp-Leu-Trp- Lys]-D-Val-D-Pro-NH2 3756 TCAM3753 Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Pro-Arg-Gln-Arg-Arg-Trp-Leu-Trp-Leu-Trp- Lys]-D-Val-D-Phe-NH2 3757 TCAM3754 Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Pro-Arg-Gln-Arg-Arg-Trp-Leu-Trp-Leu-Trp- Lys]-D-Pro-D-Val-NH2 3758 TCAM3755 Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Pro-Arg-Gln-Arg-Arg-Trp-Leu-Trp-Leu-Trp- Lys]-D-Phe-D-Val-NH2 3759 TCAM3756 Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Pro-Trp-Arg-Trp-Trp-Arg-Arg-Lys]-D-Val-D- Phe-NH2 3760 TCAM3757 Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Pro-Trp-Arg-Trp-Trp-Arg-Arg-Lys]-D-Pro-D- Val-NH2 3761 TCAM3758 Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Pro-Trp-Arg-Trp-Trp-Arg-Arg-Lys]-D-Phe-D- Val-NH2 3762 TCAM3759 Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Pro-Trp-Trp-Arg-Arg-Trp-Trp-Arg-Arg-Lys]-D- Val-D-Pro-NH2 3763 TCAM3760 Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Pro-Trp-Trp-Arg-Arg-Trp-Trp-Arg-Arg-Lys]-D- Val-D-Phe-NH2 3764 TCAM3761 Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Pro-Trp-Trp-Arg-Arg-Trp-Trp-Arg-Arg-Lys]-D- Pro-D-Val-NH2 3765 TCAM3762 Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Pro-Trp-Trp-Arg-Arg-Trp-Trp-Arg-Arg-Lys]-D- Phe-D-Val-NH2 3766 TCAM3763 Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Pro-Trp-Arg-Trp-Arg-Trp-Arg-Lys]-D-Val-D- Pro-NH2 3767 TCAM3764 Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Pro-Trp-Arg-Trp-Arg-Trp-Arg-Lys]-D-Val-D- Phe-NH2 3768 TCAM3765 Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Pro-Trp-Arg-Trp-Arg-Trp-Arg-Lys]-D-Pro-D- Val-NH2 3769 TCAM3766 Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Pro-Trp-Arg-Trp-Arg-Trp-Arg-Lys]-D-Phe-D- Val-NH2 3770 TCAM3767 Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Pro-Arg-Trp-Arg-Trp-Arg-Trp-Lys]-D-Val-D- Pro-NH2 3771 TCAM3768 Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Pro-Arg-Trp-Arg-Trp-Arg-Trp-Lys]-D-Val-D- Phe-NH2 3772 TCAM3769 Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Pro-Arg-Trp-Arg-Trp-Arg-Trp-Lys]-D-Pro-D- Val-NH2 3773 TCAM3770 Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Pro-Arg-Trp-Arg-Trp-Arg-Trp-Lys]-D-Phe-D- Val-NH2 3774 TCAM3771 Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Pro-Arg-Trp-Trp-Arg-Arg-Lys]-D-Val-D-Pro- NH2 3775 TCAM3772 Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Pro-Arg-Trp-Trp-Arg-Arg-Lys]-D-Val-D-Phe- NH2 3776 TCAM3773 Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Pro-Arg-Trp-Trp-Arg-Arg-Lys]-D-Pro-D-Val- NH2 3777 TCAM3774 Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Pro-Arg-Trp-Trp-Arg-Arg-Lys]-D-Phe-D-Val- NH2 3778 TCAM3775 Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Pro-Trp-Trp-Arg-Arg-Trp-Lys]-D-Val-D-Pro- NH2 3779 TCAM3776 Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Pro-Trp-Trp-Arg-Arg-Trp-Lys]-D-Val-D-Phe- NH2 3780 TCAM3777 Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Pro-Trp-Trp-Arg-Arg-Trp-Lys]-D-Pro-D-Val- NH2 3781 TCAM3778 Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Pro-Trp-Trp-Arg-Arg-Trp-Lys]-D-Phe-D-Val- NH2 3782 TCAM3779 Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Pro-Trp-Arg-Trp-Arg-Trp-Lys]-D-Val-D-Pro- NH2 3783 TCAM3780 Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Pro-Trp-Arg-Trp-Arg-Trp-Lys]-D-Val-D-Phe- NH2 3784 TCAM3781 Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Pro-Trp-Arg-Trp-Arg-Trp-Lys]-D-Pro-D-Val- NH2 3785 TCAM3782 Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Pro-Trp-Arg-Trp-Arg-Trp-Lys]-D-Phe-D-Val- NH2 3786 TCAM3783 Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Pro-Arg-Trp-Arg-Trp-Arg-Lys]-D-Val-D-Pro- NH2 3787 TCAM3784 Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Pro-Arg-Trp-Arg-Trp-Arg-Lys]-D-Val-D-Phe- NH2 3788 TCAM3785 Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Pro-Arg-Trp-Arg-Trp-Arg-Lys]-D-Pro-D-Val- NH2 3789 TCAM3786 Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Pro-Arg-Trp-Arg-Trp-Arg-Lys]-D-Phe-D-Val- NH2 3790 TCAM3787 Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Pro-Trp-Arg-Tyr-Arg-Trp-Lys]-D-Val-D-Pro- NH2 3791 TCAM3788 Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Pro-Trp-Arg-Tyr-Arg-Trp-Lys]-D-Val-D-Phe- NH2 3792 TCAM3789 Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Pro-Trp-Arg-Tyr-Arg-Trp-Lys]-D-Pro-D-Val- NH2 3793 TCAM3790 Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Pro-Trp-Arg-Tyr-Arg-Trp-Lys]-D-Phe-D-Val- NH2 3794 TCAM3791 Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Pro-Trp-Arg-Trp-Arg-Tyr-Lys]-D-Val-D-Pro- NH2 3795 TCAM3792 Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Pro-Trp-Arg-Trp-Arg-Tyr-Lys]-D-Val-D-Phe- NH2 3796 TCAM3793 Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Pro-Trp-Arg-Trp-Arg-Tyr-Lys]-D-Pro-D-Val- NH2 3797 TCAM3794 Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Pro-Trp-Arg-Trp-Arg-Tyr-Lys]-D-Phe-D-Val- NH2 3798 TCAM3795 Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Pro-Trp-Arg-Trp-Arg-Lys]-D-Val-D-Pro-NH2 3799 TCAM3796 Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Pro-Trp-Arg-Trp-Arg-Lys]-D-Val-D-Phe-NH2 3800 TCAM3797 Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Pro-Trp-Arg-Trp-Arg-Lys]-D-Pro-D-Val-NH2 3801 TCAM3798 Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Pro-Trp-Arg-Trp-Arg-Lys]-D-Phe-D-Val-NH2 3802 TCAM3799 Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Pro-Trp-Arg-Arg-Trp-Lys]-D-Val-D-Pro-NH2 3803 TCAM3800 Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Pro-Trp-Arg-Arg-Trp-Lys]-D-Val-D-Phe-NH2 3804 TCAM3801 Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Pro-Trp-Arg-Arg-Trp-Lys]-D-Pro-D-Val-NH2 3805 TCAM3802 Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Pro-Trp-Arg-Arg-Trp-Lys]-D-Phe-D-Val-NH2 3806 TCAM3803 Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Pro-Arg-Trp-Trp-Arg-Lys]-D-Val-D-Pro-NH2 3807 TCAM3804 Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Pro-Arg-Trp-Trp-Arg-Lys]-D-Val-D-Phe-NH2 3808 TCAM3805 Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Pro-Arg-Trp-Trp-Arg-Lys]-D-Pro-D-Val-NH2 3809 TCAM3806 Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Pro-Arg-Trp-Trp-Arg-Lys]-D-Phe-D-Val-NH2 3810 TCAM3807 Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Pro-Trp-Arg-Trp-Lys]-D-Val-D-Pro-NH2 3811 TCAM3808 Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Pro-Trp-Arg-Trp-Lys]-D-Val-D-Phe-NH2 3812 TCAM3809 Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Pro-Trp-Arg-Trp-Lys]-D-Pro-D-Val-NH2 3813 TCAM3810 Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Pro-Trp-Arg-Trp-Lys]-D-Phe-D-Val-NH2 3814 TCAM3811 Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Pro-Arg-Trp-Arg-Lys]-D-Val-D-Pro-NH2 3815 TCAM3812 Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Pro-Arg-Trp-Arg-Lys]-D-Val-D-Phe-NH2 3816 TCAM3813 Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Pro-Arg-Trp-Arg-Lys]-D-Pro-D-Val-NH2 3817 TCAM3814 Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Pro-Arg-Trp-Arg-Lys]-D-Phe-D-Val-NH2 3818 TCAM3815 -Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Arg-Arg-Trp-Trp-Arg-Phe-Lys]-D-Val-D-Pro- NH2 3819 TCAM3816 Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Arg-Arg-Trp-Trp-Arg-Phe-Lys]-D-Val-D-Phe- NH2 3820 TCAM3817 Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Arg-Arg-Trp-Trp-Arg-Phe-Lys]-D-Pro-D-Val- NH2 3821 TCAM3818 Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Arg-Arg-Trp-Trp-Arg-Phe-Lys]-D-Phe-D-Val- NH2 3822 TCAM3819 Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Arg-Arg-Trp-Trp-Arg-Phe-Lys]-D-Val-D-Pro- NH2 3823 TCAM3820 Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Arg-Arg-Trp-Trp-Arg-Phe-Lys]-D-Val-D-Phe- NH2 3824 TCAM3821 Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Arg-Arg-Trp-Trp-Arg-Phe-Lys]-D-Pro-D-Val- NH2 3825 TCAM3822 Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Arg-Arg-Trp-Trp-Arg-Phe-Lys]-D-Phe-D-Val- NH2 3826 TCAM3823 Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Arg-Arg-Tyr-Tyr-Arg-Phe-Lys]-D-Val-D-Pro- NH2 3827 TCAM3824 Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Arg-Arg-Tyr-Tyr-Arg-Phe-Lys]-D-Val-D-Phe- NH2 3828 TCAM3825 Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Arg-Arg-Tyr-Tyr-Arg-Phe-Lys]-D-Pro-D-Val- NH2 3829 TCAM3826 Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Arg-Arg-Tyr-Tyr-Arg-Phe-Lys]-D-Phe-D-Val- NH2 3830 TCAM3827 Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Arg-Arg-Nal-Nal-Arg-Phe-Lys]-D-Val-D-Pro- NH2 3831 TCAM3828 Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Arg-Arg-Nal-Nal-Arg-Phe-Lys]-D-Val-D-Phe- NH2 3832 TCAM3829 Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Arg-Arg-Nal-Nal-Arg-Phe-Lys]-D-Pro-D-Val- NH2 3833 TCAM3830 Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Arg-Arg-Nal-Nal-Arg-Phe-Lys]-D-Phe-D-Val- NH2 3834 TCAM3831 Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Arg-Arg-Leu-Trp-Leu-Trp-Lys]-D-Val-D-Pro- NH2 3835 TCAM3832 Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Arg-Arg-Leu-Trp-Leu-Trp-Lys]-D-Val-D-Phe- NH2 3836 TCAM3833 Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Arg-Arg-Leu-Trp-Leu-Trp-Lys]-D-Pro-D-Val- NH2 3837 TCAM3834 Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Arg-Arg-Leu-Trp-Leu-Trp-Lys]-D-Phe-D-Val- NH2 3838 TCAM3835 Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Arg-Arg-Leu-Trp-Leu-Trp-Lys]-D-Val-D-Pro- NH2 3839 TCAM3836 Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Arg-Arg-Leu-Trp-Leu-Trp-Lys]-D-Val-D-Phe- NH2 3840 TCAM3837 Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Arg-Arg-Leu-Trp-Leu-Trp-Lys]-D-Pro-D-Val- NH2 3841 TCAM3838 Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Arg-Arg-Leu-Trp-Leu-Trp-Lys]-D-Phe-D-Val- NH2 3842 TCAM3839 Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Arg-Arg-Arg-Trp-Leu-Trp-Leu-Trp-Lys]-D-Val- D-Pro-NH2 3843 TCAM3840 Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Arg-Arg-Arg-Trp-Leu-Trp-Leu-Trp-Lys]-D-Val- D-Phe-NH2 3844 TCAM3841 Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Arg-Arg-Arg-Trp-Leu-Trp-Leu-Trp-Lys]-D- Pro-D-Val-NH2 3845 TCAM3842 Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Arg-Arg-Arg-Trp-Leu-Trp-Leu-Trp-Lys]-D- Phe-D-Val-NH2 3846 TCAM3843 Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Arg-Gln-Arg-Arg-Trp-Leu-Trp-Leu-Trp-Lys]- D-Val-D-Pro-NH2 3847 TCAM3844 Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Arg-Gln-Arg-Arg-Trp-Leu-Trp-Leu-Trp-Lys]- D-Val-D-Phe-NH2 3848 TCAM3845 Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Arg-Gln-Arg-Arg-Trp-Leu-Trp-Leu-Trp-Lys]- D-Pro-D-Val-NH2 3849 TCAM3846 Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Arg-Gln-Arg-Arg-Trp-Leu-Trp-Leu-Trp-Lys]- D-Phe-D-Val-NH2 3850 TCAM3847 Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Trp-Arg-Trp-Trp-Arg-Arg-Lys]-D-Val-D-Pro- NH2 3851 TCAM3848 Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Trp-Arg-Trp-Trp-Arg-Arg-Lys]-D-Val-D-Phe- NH2 3852 TCAM3849 Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Trp-Arg-Trp-Trp-Arg-Arg-Lys]-D-Pro-D-Val- NH2 3853 TCAM3850 Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Trp-Arg-Trp-Trp-Arg-Arg-Lys]-D-Phe-D-Val- NH2 3854 TCAM3851 Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Trp-Trp-Arg-Arg-Trp-Trp-Arg-Arg-Lys]-D-Val- D-Pro-NH2 3855 TCAM3852 Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Trp-Trp-Arg-Arg-Trp-Trp-Arg-Arg-Lys]-D-Val- D-Phe-NH2 3856 TCAM3853 Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Trp-Trp-Arg-Arg-Trp-Trp-Arg-Arg-Lys]-D-Pro- D-Val-NH2 3857 TCAM3854 Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Trp-Trp-Arg-Arg-Trp-Trp-Arg-Arg-Lys]-D- Phe-D-Val-NH2 3858 TCAM3855 Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Trp-Arg-Trp-Arg-Trp-Arg-Lys]-D-Val-D-Pro- NH2 3859 TCAM3856 Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Trp-Arg-Trp-Arg-Trp-Arg-Lys]-D-Val-D-Phe- NH2 3860 TCAM3857 Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Trp-Arg-Trp-Arg-Trp-Arg-Lys]-D-Pro-D-Val- NH2 3861 TCAM3858 Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Trp-Arg-Trp-Arg-Trp-Arg-Lys]-D-Phe-D-Val- NH2 3862 TCAM3859 Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Arg-Trp-Arg-Trp-Arg-Trp-Lys]-D-Val-D-Pro- NH2 3863 TCAM3860 Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Arg-Trp-Arg-Trp-Arg-Trp-Lys]-D-Val-D-Phe- NH2 3864 TCAM3861 Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Arg-Trp-Arg-Trp-Arg-Trp-Lys]-D-Pro-D-Val- NH2 3865 TCAM3862 Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Arg-Trp-Arg-Trp-Arg-Trp-Lys]-D-Phe-D-Val- NH2 3866 TCAM3863 Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Arg-Trp-Trp-Arg-Arg-Lys]-D-Val-D-Pro-NH2 3867 TCAM3864 Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Arg-Trp-Trp-Arg-Arg-Lys]-D-Val-D-Phe-NH2 3868 TCAM3865 Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Arg-Trp-Trp-Arg-Arg-Lys]-D-Pro-D-Val-NH2 3869 TCAM3866 Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Arg-Trp-Trp-Arg-Arg-Lys]-D-Phe-D-Val-NH2 3870 TCAM3867 Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Arg-Trp-Arg-Trp-Arg-Lys]-D-Val-D-Pro-NH2 3871 TCAM3868 Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Arg-Trp-Arg-Trp-Arg-Lys]-D-Val-D-Phe-NH2 3872 TCAM3869 Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Arg-Trp-Arg-Trp-Arg-Lys]-D-Pro-D-Val-NH2 3873 TCAM3870 Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Arg-Trp-Arg-Trp-Arg-Lys]-D-Phe-D-Val-NH2 3874 TCAM3871 Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Trp-Trp-Arg-Arg-Trp-Lys]-D-Val-D-Pro-NH2 3875 TCAM3872 Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Trp-Trp-Arg-Arg-Trp-Lys]-D-Val-D-Phe-NH2 3876 TCAM3873 Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Trp-Trp-Arg-Arg-Trp-Lys]-D-Pro-D-Val-NH2 3877 TCAM3874 Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Trp-Trp-Arg-Arg-Trp-Lys]-D-Phe-D-Val-NH2 3878 TCAM3875 Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Trp-Arg-Trp-Arg-Trp-Lys]-D-Val-D-Pro-NH2 3879 TCAM3876 Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Trp-Arg-Trp-Arg-Trp-Lys]-D-Val-D-Phe-NH2 3880 TCAM3877 Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Trp-Arg-Trp-Arg-Trp-Lys]-D-Pro-D-Val-NH2 3881 TCAM3878 Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Trp-Arg-Trp-Arg-Trp-Lys]-D-Phe-D-Val-NH2 3882 TCAM3879 Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Trp-Arg-Tyr-Arg-Trp-Lys]-D-Val-D-Pro-NH2 3883 TCAM3880 Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Trp-Arg-Tyr-Arg-Trp-Lys]-D-Val-D-Phe-NH2 3884 TCAM3881 Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Trp-Arg-Tyr-Arg-Trp-Lys]-D-Pro-D-Val-NH2 3885 TCAM3882 Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Trp-Arg-Tyr-Arg-Trp-Lys]-D-Phe-D-Val-NH2 3886 TCAM3883 Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Trp-Arg-Trp-Arg-Tyr-Lys]-D-Val-D-Pro-NH2 3887 TCAM3884 Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Trp-Arg-Trp-Arg-Tyr-Lys]-D-Val-D-Phe-NH2 3888 TCAM3885 Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Trp-Arg-Trp-Arg-Tyr-Lys]-D-Pro-D-Val-NH2 3889 TCAM3886 Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Trp-Arg-Trp-Arg-Tyr-Lys]-D-Phe-D-Val-NH2 3890 TCAM3887 Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Trp-Arg-Trp-Arg-Lys]-D-Val-D-Pro-NH2 3891 TCAM3888 Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Trp-Arg-Trp-Arg-Lys]-D-Val-D-Phe-NH2 3892 TCAM3889 Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Trp-Arg-Trp-Arg-Lys]-D-Pro-D-Val-NH2 3893 TCAM3890 Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Trp-Arg-Trp-Arg-Lys]-D-Phe-D-Val-NH2 3894 TCAM3891 Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Trp-Arg-Arg-Trp-Lys]-D-Val-D-Pro-NH2 3895 TCAM3892 Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Trp-Arg-Arg-Trp-Lys]-D-Val-D-Phe-NH2 3896 TCAM3893 Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Trp-Arg-Arg-Trp-Lys]-D-Pro-D-Val-NH2 3897 TCAM3894 Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Trp-Arg-Arg-Trp-Lys]-D-Phe-D-Val-NH2 3898 TCAM3895 Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Arg-Trp-Trp-Arg-Lys]-D-Val-D-Pro-NH2 3899 TCAM3896 Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Arg-Trp-Trp-Arg-Lys]-D-Val-D-Phe-NH2 3900 TCAM3897 Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Arg-Trp-Trp-Arg-Lys]-D-Pro-D-Val-NH2 3901 TCAM3898 Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Arg-Trp-Trp-Arg-Lys]-D-Phe-D-Val-NH2 3902 TCAM3899 Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Trp-Arg-Trp-Lys]-D-Val-D-Pro-NH2 3903 TCAM3900 Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Trp-Arg-Trp-Lys]-D-Val-D-Phe-NH2 3904 TCAM3901 Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Trp-Arg-Trp-Lys]-D-Pro-D-Val-NH2 3905 TCAM3902 Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Trp-Arg-Trp-Lys]-D-Phe-D-Val-NH2 3906 TCAM3903 Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Arg-Trp-Arg-Lys]-D-Val-D-Pro-NH2 3907 TCAM3904 Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Arg-Trp-Arg-Lys]-D-Val-D-Phe-NH2 3908 TCAM3905 Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Arg-Trp-Arg-Lys]-D-Pro-D-Val-NH2 3909 TCAM3906 Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Arg-Trp-Arg-Lys]-D-Phe-D-Val-NH2 3910 TCAM3907 Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-His-D-Nal(2′)-Arg-Trp-Lys]-D-Val-D-Pro-NH2 3911 TCAM3908 Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-His-D-Nal(2′)-Arg-Trp-Lys]-D-Pro-D-Val-NH2 3912 TCAM3909 Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-His-D-Nal(2′)-Arg-Trp-Lys]-D-Val-D-Phe-NH2 3913 TCAM3910 Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-His-D-Nal(2′)-Arg-Trp-Lys]-D-Phe-D-Val-NH2 3914 TCAM3911 Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Pro-D-Nal(2′)-Arg-Trp-Lys]-D-Val-D-Pro-NH2 3915 TCAM3912 Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Pro-D-Nal(2′)-Arg-Trp-Lys]-D-Pro-D-Val-NH2 3916 TCAM3913 Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Pro-D-Nal(2′)-Arg-Trp-Lys]-D-Val-D-Phe-NH2 3917 TCAM3914 Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Pro-D-Nal(2′)-Arg-Trp-Lys]-D-Phe-D-Val-NH2 3918 TCAM3915 Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Arg-Arg-Nal(2′)-Arg-Trp-Lys]-D-Val-D-Pro- NH2 3919 TCAM3916 Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Arg-Arg-Nal(2′)-Arg-Trp-Lys]-D-Pro-D-Val- NH2 3920 TCAM3917 Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Arg-Arg-Nal(2′)-Arg-Trp-Lys]-D-Val-D-Phe- NH2 3921 TCAM3918 Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Arg-Arg-Nal(2′)-Arg-Trp-Lys]-D-Phe-D-Val- NH2 3922 TCAM3919 Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Arg-Arg-Pro-Nal(2′)-Arg-Trp-Lys]-D-Val-D- Pro-NH2 3923 TCAM3920 Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Arg-Arg-Pro-D-Nal(2′)-Arg-Trp-Lys]-D-Pro-D- Val-NH2 3924 TCAM3921 Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Arg-Arg-Pro-D-Nal(2′)-Arg-Trp-Lys]-D-Val-D- Phe-NH2 3925 TCAM3922 Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Arg-Arg-Pro-Nal(2′)-Arg-Trp-Lys]-D-Phe-D- Val-NH2 3926 TCAM3923 Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Arg-D-Nal(2′)-Arg-Trp-Lys]-D-Val-D-Pro-NH2 3927 TCAM3924 Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Arg-D-Nal(2′)-Arg-Trp-Lys]-D-Pro-D-Val-NH2 3928 TCAM3925 Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Arg-D-Nal(2′)-Arg-Trp-Lys]-D-Val-D-Phe-NH2 3929 TCAM3926 Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Arg-D-Nal(2′)-Arg-Trp-Lys]-D-Phe-D-Val-NH2 3930 TCAM3927 Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Arg-Pro-D-Nal(2′)-Arg-Trp-Lys]-D-Val-D-Pro- NH2 3931 TCAM3928 Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Arg-Pro-D-Nal(2′)-Arg-Trp-Lys]-D-Pro-D-Val- NH2 3932 TCAM3929 Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Arg-Pro-D-Nal(2′)-Arg-Trp-Lys]-D-Val-D-Phe- NH2 3933 TCAM3930 Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Arg-Pro-D-Nal(2′)-Arg-Trp-Lys]-D-Phe-D-Val- NH2 3934 TCAM3931 Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-Arg-Arg-c[Asp-Pro-D-Nal(2′)-Arg-Trp-Lys]-D-Val-D- Pro-NH2 3935 TCAM3932 Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-Arg-Arg-c[Asp-Pro-D-Nal(2′)-Arg-Trp-Lys]-D-Pro-D- Val-NH2 3936 TCAM3933 Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-Arg-Arg-c[Asp-Pro-D-Nal(2′)-Arg-Trp-Lys]-D-Val-D- Phe-NH2 3937 TCAM3934 Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-Arg-Arg-c[Asp-Pro-D-Nal(2′)-Arg-Trp-Lys]-D-Phe-D- Val-NH2 3938 TCAM3935 Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-Arg-Arg-c[Asp-His-D-Nal(2′)-Arg-Trp-Lys]-D-Val-D- Pro-NH2 3939 TCAM3936 Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-Arg-Arg-c[Asp-His-D-Nal(2′)-Arg-Trp-Lys]-D-Pro-D- Val-NH2 3940 TCAM3937 Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-Arg-Arg-c[Asp-His-D-Nal(2′)-Arg-Trp-Lys]-D-Val-D- Phe-NH2 3941 TCAM3938 Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-Arg-Arg-c[Asp-His-D-Nal(2′)-Arg-Trp-Lys]-D-Phe-D- Val-NH2 3942 TCAM3939 Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Arg-Pro-D-Nal(2′)-Arg-Trp-Arg-Lys]-D-Val-D- Pro-NH2 3943 TCAM3940 Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Arg-Pro-D-Nal(2′)-Arg-Trp-Arg-Lys]-D-Pro-D- Val-NH2 3944 TCAM3941 Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Arg-Pro-D-Nal(2′)-Arg-Trp-Arg-Lys]-D-Val-D- Phe-NH2 3945 TCAM3942 Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Arg-Pro-D-Nal(2′)-Arg-Trp-Arg-Lys]-D-Phe-D- Val-NH2 3946 TCAM3943 Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Arg-His-D-Nal(2′)-Arg-Trp-Arg-Lys]-D-Val-D- Pro-NH2 3947 TCAM3944 Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Arg-His-D-Nal(2′)-Arg-Trp-Arg-Lys]-D-Pro-D- Val-NH2 3948 TCAM3945 Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Arg-His-D-Nal(2′)-Arg-Trp-Arg-Lys]-D-Val-D- Phe-NH2 3949 TCAM3946 Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Arg-His-D-Nal(2′)-Arg-Trp-Arg-Lys]-D-Phe-D- Val-NH2 3950 TCAM3947 Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-His-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Val-D-Phe- NH2 3951 TCAM3948 Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-His-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Phe-D-Val- NH2 3952 TCAM3949 Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Pro-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Val-D-Pro- NH2 3953 TCAM3950 Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Pro-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Pro-D-Val- NH2 3954 TCAM3951 Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Pro-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Val-D- Phe-NH2 3955 TCAM3952 Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Pro-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Phe-D- Val-NH2 3956 TCAM3953 Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Arg-Arg-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Val-D- Pro-NH2 3957 TCAM3954 Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Arg-Arg-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Pro- D-Val-NH2 3958 TCAM3955 Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Arg-Arg-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Val-D- Phe-NH2 3959 TCAM3956 Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Arg-Arg-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Phe- D-Val-NH2 3960 TCAM3957 Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Arg-Arg-Pro-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D- Val-D-Pro-NH2 3961 TCAM3958 Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Arg-Arg-Pro-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D- Pro-D-Val-NH2 3962 TCAM3959 Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Arg-Arg-Pro-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D- Val-D-Phe-NH2 3963 TCAM3960 Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Arg-Arg-Pro-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D- Phe-D-Val-NH2 3964 TCAM3961 Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Arg-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Val-D-Pro- NH2 3965 TCAM3962 Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Arg-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Pro-D-Val- NH2 3966 TCAM3963 Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Arg-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Val-D-Phe- NH2 3967 TCAM3964 Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Arg-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Phe-D- Val-NH2 3968 TCAM3965 Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Arg-Pro-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Val-D- Pro-NH2 3969 TCAM3966 Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Arg-Pro-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Pro- D-Val-NH2 3970 TCAM3967 Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Arg-Pro-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Val-D- Phe-NH2 3971 TCAM3968 Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Arg-Pro-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Phe- D-Val-NH2 3972 TCAM3969 Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Arg-His-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Val-D- Pro-NH2 3973 TCAM3970 Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Arg-His-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Pro-D- Val-NH2 3974 TCAM3971 Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Arg-His-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Val-D- Phe-NH2 3975 TCAM3972 Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Arg-His-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Phe-D- Val-NH2 3976 TCAM3973 Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Arg-D-D-Nal(2′)-Arg-D-Nal(2′)-Arg-Lys]-D-Val- D-Pro-NH2 3977 TCAM3974 Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Arg-D-Nal(2′)-Arg-D-Nal(2′)-Arg-Lys]-D-Pro- D-Val-NH2 3978 TCAM3975 Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Arg-D-Nal(2′)-Arg-D-Nal(2′)-Arg-Lys]-D-Val-D- Phe-NH2 3979 TCAM3976 Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Arg-D-Nal(2′)-Arg-D-Nal(2′)-Arg-Lys]-D-Phe- D-Val-NH2 3980 TCAM3977 Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Arg-Pro-D-Nal(2′)-Arg-D-Nal(2′)-Arg-Lys]-D- Val-D-Pro-NH2 3981 TCAM3978 Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Arg-Pro-D-Nal(2′)-Arg-D-Nal(2′)-Arg-Lys]-D- Pro-D-Val-NH2 3982 TCAM3979 Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Arg-Pro-D-Nal(2′)-Arg-D-Nal(2′)-Arg-Lys]-D- Val-D-Phe-NH2 3983 TCAM3980 Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Arg-Pro-D-Nal(2′)-Arg-D-Nal(2′)-Arg-Lys]-D- Phe-D-Val-NH2 3984 TCAM3981 Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Arg-His-D-Nal(2′)-Arg-D-Nal(2′)-Arg-Lys]-D- Val-D-Pro-NH2 3985 TCAM3982 Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Arg-His-D-Nal(2′)-Arg-D-Nal(2′)-Arg-Lys]-D- Pro-D-Val-NH2 3986 TCAM3983 Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Arg-His-D-Nal(2′)-Arg-D-Nal(2′)-Arg-Lys]-D- Val-D-Phe-NH2 3987 TCAM3984 Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Arg-His-D-Nal(2′)-Arg-D-Nal(2′)-Arg-Lys]-D- Phe-D-Val-NH2 3988 TCAM3985 Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-Arg-Arg-c[Asp-Pro-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D- Val-D-Pro-NH2 3989 TCAM3986 Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-Arg-Arg-c[Asp-Pro-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D- Pro-D-Val-NH2 3990 TCAM3987 Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-Arg-Arg-c[Asp-Pro-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D- Val-D-Phe-NH2 3991 TCAM3988 Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-Arg-Arg-c[Asp-Pro-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D- Phe-D-Val-NH2 3992 TCAM3989 Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-Arg-Arg-c[Asp-His-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D- Val-D-Pro-NH2 3993 TCAM3990 Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-Arg-Arg-c[Asp-His-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D- Pro-D-Val-NH2 3994 TCAM3991 Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-Arg-Arg-c[Asp-His-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D- Val-D-Phe-NH2 3995 TCAM3992 Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-Arg-Arg-c[Asp-His-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D- Phe-D-Val-NH2 3996 TCAM3993 Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Arg-Pro-D-Nal(2′)-Arg-D-Nal(2′)-Arg-Lys]-D- Val-D-Pro-NH2 3997 TCAM3994 Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Arg-Pro-D-Nal(2′)-Arg-D-Nal(2′)-Arg-Lys]-D- Pro-D-Val-NH2 3998 TCAM3995 Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Arg-Pro-D-Nal(2′)-Arg-D-Nal(2′)-Arg-Lys]-D- Val-D-Phe-NH2 3999 TCAM3996 Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Arg-Pro-D-Nal(2′)-Arg-D-Nal(2′)-Arg-Lys]-D- Phe-D-Val-NH2 4000 TCAM3997 Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Arg-His-D-Nal(2′)-Arg-D-Nal(2′)-Arg-Lys]-D- Val-D-Pro-NH2 4001 TCAM3998 Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Arg-His-D-Nal(2′)-Arg-D-Nal(2′)-Arg-Lys]-D- Pro-D-Val-NH2 4002 TCAM3999 Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Arg-His-D-Nal(2′)-Arg-D-Nal(2′)-Arg-Lys]-D- Val-D-Phe-NH2 4003 TCAM4000 Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Arg-His-D-Nal(2′)-Arg-D-Nal(2′)-Arg-Lys]-D- Phe-D-Val-NH2 4004 TCAM4001 Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-His-D-Nal(2′)-Arg-Trp-Lys]-Arg-Arg-D-Val-D- Pro-NH2 4005 TCAM4002 Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-His-D-Nal(2′)-Arg-Trp-Lys]-Arg-Arg-D-Pro-D- Val-NH2 4006 TCAM4003 Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-His-D-Nal(2′)-Arg-Trp-Lys]-Arg-Arg-D-Val-D- Phe-NH2 4007 TCAM4004 Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-His-D-Nal(2′)-Arg-Trp-Lys]-Arg-Arg-D-Phe-D- Val-NH2 4008 TCAM4005 Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Pro-D-Nal(2′)-Arg-Trp-Lys]-Arg-Arg-D-Val-D- Pro-NH2 4009 TCAM4006 Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Pro-D-Nal(2′)-Arg-Trp-Lys]-Arg-Arg-D-Pro-D- Val-NH2 4010 TCAM4007 Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Pro-D-Nal(2′)-Arg-Trp-Lys]-Arg-Arg-D-Val-D- Phe-NH2 4011 TCAM4008 Lys-Lys-Phe-Phe-Lys-Lys-Leu-Lys-c[Asp-Pro-D-Nal(2′)-Arg-Trp-Lys]-Arg-Arg-D-Phe-D- Val-NH2 Anti-biofilm peptide ABF7ARG linked to anti-microbial peptides 4012 TCAM4009 Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Pro-Arg-Arg-Trp-Trp-Arg-Phe-Lys]-D-Val-D- Pro-NH2 4013 TCAM4010 Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Pro-Arg-Arg-Trp-Trp-Arg-Phe-Lys]-D-Val-D- Phe-NH2 4014 TCAM4011 Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Pro-Arg-Arg-Trp-Trp-Arg-Phe-Lys]-D-Pro-D- Val-NH2 4015 TCAM4012 Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Pro-Arg-Arg-Trp-Trp-Arg-Phe-Lys]-D-Phe- D-Val-NH2 4016 TCAM4013 Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Pro-Arg-Arg-Trp-Trp-Tyr-Phe-Lys]-D-Val-D- Pro-NH2 4017 TCAM4014 Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Pro-Arg-Arg-Trp-Trp-Tyr-Phe-Lys]-D-Val-D- Phe-NH2 4018 TCAM4015 Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Pro-Arg-Arg-Trp-Trp-Tyr-Phe-Lys]-D-Pro-D- Val-NH2 4019 TCAM4016 Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Pro-Arg-Arg-Trp-Trp-Tyr-Phe-Lys]-D-Phe- D-Val-NH2 4020 TCAM4017 Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Pro-Arg-Arg-Tyr-Tyr-Arg-Phe-Lys]-D-Val-D- Pro-NH2 4021 TCAM4018 Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Pro-Arg-Arg-Tyr-Tyr-Arg-Phe-Lys]-D-Val-D- Phe-NH2 4022 TCAM4019 Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Pro-Arg-Arg-Tyr-Tyr-Arg-Phe-Lys]-D-Pro-D- Val-NH2 4023 TCAM4020 Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Pro-Arg-Arg-Tyr-Tyr-Arg-Phe-Lys]-D-Phe-D- Val-NH2 4024 TCAM4021 Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Pro-Arg-Arg-Nal-Nal-Arg-Phe-Lys]-D-Val-D- Pro-NH2 4025 TCAM4022 Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Pro-Arg-Arg-Nal-Nal-Arg-Phe-Lys]-D-Val-D- Phe-NH2 4026 TCAM4023 Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Pro-Arg-Arg-Nal-Nal-Arg-Phe-Lys]-D-Pro-D- Val-NH2 4027 TCAM4024 Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Pro-Arg-Arg-Nal-Nal-Arg-Phe-Lys]-D-Phe- D-Val-NH2 4028 TCAM4025 Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Pro-Arg-Arg-Leu-Trp-Leu-Trp-Lys]-D-Val-D- Pro-NH2 4029 TCAM4026 Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Pro-Arg-Arg-Leu-Trp-Leu-Trp-Lys]-D-Val-D- Phe-NH2 4030 TCAM4027 Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Pro-Arg-Arg-Leu-Trp-Leu-Trp-Lys]-D-Pro-D- Val-NH2 4031 TCAM4028 Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Pro-Arg-Arg-Leu-Trp-Leu-Trp-Lys]-D-Phe- D-Val-NH2 4032 TCAM4029 Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Pro-Arg-Arg-Leu-Trp-Leu-Trp-Lys]-D-Val-D- Pro-NH2 4033 TCAM4030 Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Pro-Arg-Arg-Leu-Trp-Leu-Trp-Lys]-D-Val-D- Phe-NH2 4034 TCAM4031 Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Pro-Arg-Arg-Leu-Trp-Leu-Trp-Lys]-D-Pro-D- Val-NH2 4035 TCAM4032 Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Pro-Arg-Arg-Leu-Trp-Leu-Trp-Lys]-D-Phe- D-Val-NH2 4036 TCAM4033 Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-Arg-Arg-Trp-Leu-Trp-Leu-Trp-Lys]-D- Val-D-Pro-NH2 4037 TCAM4034 Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Pro-Arg-Arg-Arg-Trp-Leu-Trp-Leu-Trp-Lys]- D-Val-D-Phe-NH2 4038 TCAM4035 Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Pro-Arg-Arg-Arg-Trp-Leu-Trp-Leu-Trp-Lys]- D-Pro-D-Val-NH2 4039 TCAM4036 Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Pro-Arg-Arg-Arg-Trp-Leu-Trp-Leu-Trp-Lys]- D-Phe-D-Val-NH2 4040 TCAM4037 Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Pro-Arg-Gln-Arg-Arg-Trp-Leu-Trp-Leu-Trp- Lys]-D-Val-D-Pro-NH2 4041 TCAM4038 Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Pro-Arg-Gln-Arg-Arg-Trp-Leu-Trp-Leu-Trp- Lys]-D-Val-D-Phe-NH2 4042 TCAM4039 Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Pro-Arg-Gln-Arg-Arg-Trp-Leu-Trp-Leu-Trp- Lys]-D-Pro-D-Val-NH2 4043 TCAM4040 Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Pro-Arg-Gln-Arg-Arg-Trp-Leu-Trp-Leu-Trp- Lys]-D-Phe-D-Val-NH2 4044 TCAM4041 Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Pro-Trp-Arg-Trp-Trp-Arg-Arg-Lys]-D-Val-D- Phe-NH2 4045 TCAM4042 Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Pro-Trp-Arg-Trp-Trp-Arg-Arg-Lys]-D-Pro-D- Val-NH2 4046 TCAM4043 Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Pro-Trp-Arg-Trp-Trp-Arg-Arg-Lys]-D-Phe-D- Val-NH2 4047 TCAM4044 Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Pro-Trp-Trp-Arg-Arg-Trp-Trp-Arg-Arg-Lys]- D-Val-D-Pro-NH2 4048 TCAM4045 Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Pro-Trp-Trp-Arg-Arg-Trp-Trp-Arg-Arg-Lys]- D-Val-D-Phe-NH2 4049 TCAM4046 Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Pro-Trp-Trp-Arg-Arg-Trp-Trp-Arg-Arg-Lys]- D-Pro-D-Val-NH2 4050 TCAM4047 Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Pro-Trp-Trp-Arg-Arg-Trp-Trp-Arg-Arg-Lys]- D-Phe-D-Val-NH2 4051 TCAM4048 Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Pro-Trp-Arg-Trp-Arg-Trp-Arg-Lys]-D-Val-D- Pro-NH2 4052 TCAM4049 Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Pro-Trp-Arg-Trp-Arg-Trp-Arg-Lys]-D-Val-D- Phe-NH2 4053 TCAM4050 Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Pro-Trp-Arg-Trp-Arg-Trp-Arg-Lys]-D-Pro-D- Val-NH2 4054 TCAM4051 Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Pro-Trp-Arg-Trp-Arg-Trp-Arg-Lys]-D-Phe-D- Val-NH2 4055 TCAM4052 Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Pro-Arg-Trp-Arg-Trp-Arg-Trp-Lys]-D-Val-D- Pro-NH2 4056 TCAM4053 Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Pro-Arg-Trp-Arg-Trp-Arg-Trp-Lys]-D-Val-D- Phe-NH2 4057 TCAM4054 Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Pro-Arg-Trp-Arg-Trp-Arg-Trp-Lys]-D-Pro-D- Val-NH2 4058 TCAM4055 Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Pro-Arg-Trp-Arg-Trp-Arg-Trp-Lys]-D-Phe-D- Val-NH2 4059 TCAM4056 Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Pro-Arg-Trp-Trp-Arg-Arg-Lys]-D-Val-D-Pro- NH2 4060 TCAM4057 Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Pro-Arg-Trp-Trp-Arg-Arg-Lys]-D-Val-D-Phe- NH2 4061 TCAM4058 Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Pro-Arg-Trp-Trp-Arg-Arg-Lys]-D-Pro-D-Val- NH2 4062 TCAM4059 Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Pro-Arg-Trp-Trp-Arg-Arg-Lys]-D-Phe-D-Val- NH2 4063 TCAM4060 Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Pro-Trp-Trp-Arg-Arg-Trp-Lys]-D-Val-D-Pro- NH2 4064 TCAM4061 Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Pro-Trp-Trp-Arg-Arg-Trp-Lys]-D-Val-D-Phe- NH2 4065 TCAM4062 Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Pro-Trp-Trp-Arg-Arg-Trp-Lys]-D-Pro-D-Val- NH2 4066 TCAM4063 Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Pro-Trp-Trp-Arg-Arg-Trp-Lys]-D-Phe-D-Val- NH2 4067 TCAM4064 Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Pro-Trp-Arg-Trp-Arg-Trp-Lys]-D-Val-D-Pro- NH2 4068 TCAM4065 Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Pro-Trp-Arg-Trp-Arg-Trp-Lys]-D-Val-D-Phe- NH2 4069 TCAM4066 Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Pro-Trp-Arg-Trp-Arg-Trp-Lys]-D-Pro-D-Val- NH2 4070 TCAM4067 Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Pro-Trp-Arg-Trp-Arg-Trp-Lys]-D-Phe-D-Val- NH2 4071 TCAM4068 Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Pro-Arg-Trp-Arg-Trp-Arg-Lys]-D-Val-D-Pro- NH2 4072 TCAM4069 Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Pro-Arg-Trp-Arg-Trp-Arg-Lys]-D-Val-D-Phe- NH2 4073 TCAM4070 Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Pro-Arg-Trp-Arg-Trp-Arg-Lys]-D-Pro-D-Val- NH2 4074 TCAM4071 Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Pro-Arg-Trp-Arg-Trp-Arg-Lys]-D-Phe-D-Val- NH2 4075 TCAM4072 Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Pro-Trp-Arg-Tyr-Arg-Trp-Lys]-D-Val-D-Pro- NH2 4076 TCAM4073 Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Pro-Trp-Arg-Tyr-Arg-Trp-Lys]-D-Val-D-Phe- NH2 4077 TCAM4074 Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Pro-Trp-Arg-Tyr-Arg-Trp-Lys]-D-Pro-D-Val- NH2 4078 TCAM4075 Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Pro-Trp-Arg-Tyr-Arg-Trp-Lys]-D-Phe-D-Val- NH2 4079 TCAM4076 Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Pro-Trp-Arg-Trp-Arg-Tyr-Lys]-D-Val-D-Pro- NH2 4080 TCAM4077 Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Pro-Trp-Arg-Trp-Arg-Tyr-Lys]-D-Val-D-Phe- NH2 4081 TCAM4078 Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Pro-Trp-Arg-Trp-Arg-Tyr-Lys]-D-Pro-D-Val- NH2 4082 TCAM4079 Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Pro-Trp-Arg-Trp-Arg-Tyr-Lys]-D-Phe-D-Val- NH2 4083 TCAM4080 Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Pro-Trp-Arg-Trp-Arg-Lys]-D-Val-D-Pro-NH2 4084 TCAM4081 Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Pro-Trp-Arg-Trp-Arg-Lys]-D-Val-D-Phe-NH2 4085 TCAM4082 Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Pro-Trp-Arg-Trp-Arg-Lys]-D-Pro-D-Val-NH2 4086 TCAM4083 Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Pro-Trp-Arg-Trp-Arg-Lys]-D-Phe-D-Val-NH2 4087 TCAM4084 Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Pro-Trp-Arg-Arg-Trp-Lys]-D-Val-D-Pro-NH2 4088 TCAM4085 Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Pro-Trp-Arg-Arg-Trp-Lys]-D-Val-D-Phe-NH2 4089 TCAM4086 Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Pro-Trp-Arg-Arg-Trp-Lys]-D-Pro-D-Val-NH2 4090 TCAM4087 Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Pro-Trp-Arg-Arg-Trp-Lys]-D-Phe-D-Val-NH2 4091 TCAM4088 Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Pro-Arg-Trp-Trp-Arg-Lys]-D-Val-D-Pro-NH2 4092 TCAM4089 Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Pro-Arg-Trp-Trp-Arg-Lys]-D-Val-D-Phe-NH2 4093 TCAM4090 Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Pro-Arg-Trp-Trp-Arg-Lys]-D-Pro-D-Val-NH2 4094 TCAM4091 Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Pro-Arg-Trp-Trp-Arg-Lys]-D-Phe-D-Val-NH2 4095 TCAM4092 Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Pro-Trp-Arg-Trp-Lys]-D-Val-D-Pro-NH2 4096 TCAM4093 Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Pro-Trp-Arg-Trp-Lys]-D-Val-D-Phe-NH2 4097 TCAM4094 Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Pro-Trp-Arg-Trp-Lys]-D-Pro-D-Val-NH2 4098 TCAM4095 Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Pro-Trp-Arg-Trp-Lys]-D-Phe-D-Val-NH2 4099 TCAM4096 Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Pro-Arg-Trp-Arg-Lys]-D-Val-D-Pro-NH2 4100 TCAM4097 Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Pro-Arg-Trp-Arg-Lys]-D-Val-D-Phe-NH2 4101 TCAM4098 Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Pro-Arg-Trp-Arg-Lys]-D-Pro-D-Val-NH2 4102 TCAM4099 Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Pro-Arg-Trp-Arg-Lys]-D-Phe-D-Val-NH2 4103 TCAM4100 -Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-Arg-Trp-Trp-Arg-Phe-Lys]-D-Val-D- Pro-NH2 4104 TCAM4101 Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-Arg-Trp-Trp-Arg-Phe-Lys]-D-Val-D-Phe- NH2 4105 TCAM4102 Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-Arg-Trp-Trp-Arg-Phe-Lys]-D-Pro-D-Val- NH2 4106 TCAM4103 Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-Arg-Trp-Trp-Arg-Phe-Lys]-D-Phe-D-Val- NH2 4107 TCAM4104 Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-Arg-Trp-Trp-Arg-Phe-Lys]-D-Val-D-Pro- NH2 4108 TCAM4105 Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-Arg-Trp-Trp-Arg-Phe-Lys]-D-Val-D-Phe- NH2 4109 TCAM4106 Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-Arg-Trp-Trp-Arg-Phe-Lys]-D-Pro-D-Val- NH2 4110 TCAM4107 Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-Arg-Trp-Trp-Arg-Phe-Lys]-D-Phe-D-Val- NH2 4111 TCAM4108 Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-Arg-Tyr-Tyr-Arg-Phe-Lys]-D-Val-D-Pro- NH2 4112 TCAM4109 Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-Arg-Tyr-Tyr-Arg-Phe-Lys]-D-Val-D-Phe- NH2 4113 TCAM4110 Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-Arg-Tyr-Tyr-Arg-Phe-Lys]-D-Pro-D-Val- NH2 4114 TCAM4111 Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-Arg-Tyr-Tyr-Arg-Phe-Lys]-D-Phe-D-Val- NH2 4115 TCAM4112 Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-Arg-Nal-Nal-Arg-Phe-Lys]-D-Val-D-Pro- NH2 4116 TCAM4113 Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-Arg-Nal-Nal-Arg-Phe-Lys]-D-Val-D-Phe- NH2 4117 TCAM4114 Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-Arg-Nal-Nal-Arg-Phe-Lys]-D-Pro-D-Val- NH2 4118 TCAM4115 Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-Arg-Nal-Nal-Arg-Phe-Lys]-D-Phe-D-Val- NH2 4119 TCAM4116 Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-Arg-Leu-Trp-Leu-Trp-Lys]-D-Val-D-Pro- NH2 4120 TCAM4117 Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-Arg-Leu-Trp-Leu-Trp-Lys]-D-Val-D-Phe- NH2 4121 TCAM4118 Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-Arg-Leu-Trp-Leu-Trp-Lys]-D-Pro-D-Val- NH2 4122 TCAM4119 Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-Arg-Leu-Trp-Leu-Trp-Lys]-D-Phe-D-Val- NH2 4123 TCAM4120 Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-Arg-Leu-Trp-Leu-Trp-Lys]-D-Val-D-Pro- NH2 4124 TCAM4121 Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-Arg-Leu-Trp-Leu-Trp-Lys]-D-Val-D-Phe- NH2 4125 TCAM4122 Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-Arg-Leu-Trp-Leu-Trp-Lys]-D-Pro-D-Val- NH2 4126 TCAM4123 Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-Arg-Leu-Trp-Leu-Trp-Lys]-D-Phe-D-Val- NH2 4127 TCAM4124 Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-Arg-Arg-Trp-Leu-Trp-Leu-Trp-Lys]-D- Val-D-Pro-NH2 4128 TCAM4125 Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-Arg-Arg-Trp-Leu-Trp-Leu-Trp-Lys]-D- Val-D-Phe-NH2 4129 TCAM4126 Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-Arg-Arg-Trp-Leu-Trp-Leu-Trp-Lys]-D- Pro-D-Val-NH2 4130 TCAM4127 Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-Arg-Arg-Trp-Leu-Trp-Leu-Trp-Lys]-D- Phe-D-Val-NH2 4131 TCAM4128 Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-Gln-Arg-Arg-Trp-Leu-Trp-Leu-Trp-Lys]- D-Val-D-Pro-NH2 4132 TCAM4129 Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-Gln-Arg-Arg-Trp-Leu-Trp-Leu-Trp-Lys]- D-Val-D-Phe-NH2 4133 TCAM4130 Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-Gln-Arg-Arg-Trp-Leu-Trp-Leu-Trp-Lys]- D-Pro-D-Val-NH2 4134 TCAM4131 Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-Gln-Arg-Arg-Trp-Leu-Trp-Leu-Trp-Lys]- D-Phe-D-Val-NH2 4135 TCAM4132 Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Trp-Arg-Trp-Trp-Arg-Arg-Lys]-D-Val-D-Pro- NH2 4136 TCAM4133 Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Trp-Arg-Trp-Trp-Arg-Arg-Lys]-D-Val-D-Phe- NH2 4137 TCAM4134 Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Trp-Arg-Trp-Trp-Arg-Arg-Lys]-D-Pro-D-Val- NH2 4138 TCAM4135 Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Trp-Arg-Trp-Trp-Arg-Arg-Lys]-D-Phe-D-Val- NH2 4139 TCAM4136 Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Trp-Trp-Arg-Arg-Trp-Trp-Arg-Arg-Lys]-D- Val-D-Pro-NH2 4140 TCAM4137 Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Trp-Trp-Arg-Arg-Trp-Trp-Arg-Arg-Lys]-D- Val-D-Phe-NH2 4141 TCAM4138 Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Trp-Trp-Arg-Arg-Trp-Trp-Arg-Arg-Lys]-D- Pro-D-Val-NH2 4142 TCAM4139 Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Trp-Trp-Arg-Arg-Trp-Trp-Arg-Arg-Lys]-D- Phe-D-Val-NH2 4143 TCAM4140 Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Trp-Arg-Trp-Arg-Trp-Arg-Lys]-D-Val-D-Pro- NH2 4144 TCAM4141 Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Trp-Arg-Trp-Arg-Trp-Arg-Lys]-D-Val-D-Phe- NH2 4145 TCAM4142 Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Trp-Arg-Trp-Arg-Trp-Arg-Lys]-D-Pro-D-Val- NH2 4146 TCAM4143 Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Trp-Arg-Trp-Arg-Trp-Arg-Lys]-D-Phe-D-Val- NH2 4147 TCAM4144 Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-Trp-Arg-Trp-Arg-Trp-Lys]-D-Val-D-Pro- NH2 4148 TCAM4145 Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-Trp-Arg-Trp-Arg-Trp-Lys]-D-Val-D-Phe- NH2 4149 TCAM4146 Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-Trp-Arg-Trp-Arg-Trp-Lys]-D-Pro-D-Val- NH2 4150 TCAM4147 Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-Trp-Arg-Trp-Arg-Trp-Lys]-D-Phe-D-Val- NH2 4151 TCAM4148 Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-Trp-Trp-Arg-Arg-Lys]-D-Val-D-Pro-NH2 4152 TCAM4149 Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-Trp-Trp-Arg-Arg-Lys]-D-Val-D-Phe-NH2 4153 TCAM4150 Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-Trp-Trp-Arg-Arg-Lys]-D-Pro-D-Val-NH2 4154 TCAM4151 Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-Trp-Trp-Arg-Arg-Lys]-D-Phe-D-Val-NH2 4155 TCAM4152 Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-Trp-Arg-Trp-Arg-Lys]-D-Val-D-Pro-NH2 4156 TCAM4153 Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-Trp-Arg-Trp-Arg-Lys]-D-Val-D-Phe-NH2 4157 TCAM4154 Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-Trp-Arg-Trp-Arg-Lys]-D-Pro-D-Val-NH2 4158 TCAM4155 Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-Trp-Arg-Trp-Arg-Lys]-D-Phe-D-Val-NH2 4159 TCAM4156 Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Trp-Trp-Arg-Arg-Trp-Lys]-D-Val-D-Pro-NH2 4160 TCAM4157 Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Trp-Trp-Arg-Arg-Trp-Lys]-D-Val-D-Phe-NH2 4161 TCAM4158 Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Trp-Trp-Arg-Arg-Trp-Lys]-D-Pro-D-Val-NH2 4162 TCAM4159 Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Trp-Trp-Arg-Arg-Trp-Lys]-D-Phe-D-Val-NH2 4163 TCAM4160 Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Trp-Arg-Trp-Arg-Trp-Lys]-D-Val-D-Pro-NH2 4164 TCAM4161 Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Trp-Arg-Trp-Arg-Trp-Lys]-D-Val-D-Phe-NH2 4165 TCAM4162 Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Trp-Arg-Trp-Arg-Trp-Lys]-D-Pro-D-Val-NH2 4166 TCAM4163 Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Trp-Arg-Trp-Arg-Trp-Lys]-D-Phe-D-Val-NH2 4167 TCAM4164 Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Trp-Arg-Tyr-Arg-Trp-Lys]-D-Val-D-Pro-NH2 4168 TCAM4165 Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Trp-Arg-Tyr-Arg-Trp-Lys]-D-Val-D-Phe-NH2 4169 TCAM4166 Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Trp-Arg-Tyr-Arg-Trp-Lys]-D-Pro-D-Val-NH2 4170 TCAM4167 Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Trp-Arg-Tyr-Arg-Trp-Lys]-D-Phe-D-Val-NH2 4171 TCAM4168 Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Trp-Arg-Trp-Arg-Tyr-Lys]-D-Val-D-Pro-NH2 4172 TCAM4169 Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Trp-Arg-Trp-Arg-Tyr-Lys]-D-Val-D-Phe-NH2 4173 TCAM4170 Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Trp-Arg-Trp-Arg-Tyr-Lys]-D-Pro-D-Val-NH2 4174 TCAM4171 Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Trp-Arg-Trp-Arg-Tyr-Lys]-D-Phe-D-Val-NH2 4175 TCAM4172 Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Trp-Arg-Trp-Arg-Lys]-D-Val-D-Pro-NH2 4176 TCAM4173 Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Trp-Arg-Trp-Arg-Lys]-D-Val-D-Phe-NH2 4177 TCAM4174 Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Trp-Arg-Trp-Arg-Lys]-D-Pro-D-Val-NH2 4178 TCAM4175 Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Trp-Arg-Trp-Arg-Lys]-D-Phe-D-Val-NH2 4179 TCAM4176 Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Trp-Arg-Arg-Trp-Lys]-D-Val-D-Pro-NH2 4180 TCAM4177 Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Trp-Arg-Arg-Trp-Lys]-D-Val-D-Phe-NH2 4181 TCAM4178 Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Trp-Arg-Arg-Trp-Lys]-D-Pro-D-Val-NH2 4182 TCAM4179 Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Trp-Arg-Arg-Trp-Lys]-D-Phe-D-Val-NH2 4183 TCAM4180 Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-Trp-Trp-Arg-Lys]-D-Val-D-Pro-NH2 4184 TCAM4181 Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-Trp-Trp-Arg-Lys]-D-Val-D-Phe-NH2 4185 TCAM4182 Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-Trp-Trp-Arg-Lys]-D-Pro-D-Val-NH2 4186 TCAM4183 Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-Trp-Trp-Arg-Lys]-D-Phe-D-Val-NH2 4187 TCAM4184 Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Trp-Arg-Trp-Lys]-D-Val-D-Pro-NH2 4188 TCAM4185 Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Trp-Arg-Trp-Lys]-D-Val-D-Phe-NH2 4189 TCAM4186 Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Trp-Arg-Trp-Lys]-D-Pro-D-Val-NH2 4190 TCAM4187 Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Trp-Arg-Trp-Lys]-D-Phe-D-Val-NH2 4191 TCAM4188 Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-Trp-Arg-Lys]-D-Val-D-Pro-NH2 4192 TCAM4189 Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-Trp-Arg-Lys]-D-Val-D-Phe-NH2 4193 TCAM4190 Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-Trp-Arg-Lys]-D-Pro-D-Val-NH2 4194 TCAM4191 Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-Trp-Arg-Lys]-D-Phe-D-Val-NH2 4195 TCAM4192 Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-His-D-Nal(2′)-Arg-Trp-Lys]-D-Val-D-Pro- NH2 4196 TCAM4193 Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-His-D-Nal(2′)-Arg-Trp-Lys]-D-Pro-D-Val- NH2 4197 TCAM4194 Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-His-D-Nal(2′)-Arg-Trp-Lys]-D-Val-D-Phe- NH2 4198 TCAM4195 Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-His-D-Nal(2′)-Arg-Trp-Lys]-D-Phe-D-Val- NH2 4199 TCAM4196 Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Pro-D-Nal(2′)-Arg-Trp-Lys]-D-Val-D-Pro- NH2 4200 TCAM4197 Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Pro-D-Nal(2′)-Arg-Trp-Lys]-D-Pro-D-Val- NH2 4201 TCAM4198 Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Pro-D-Nal(2′)-Arg-Trp-Lys]-D-Val-D-Phe- NH2 4202 TCAM4199 Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Pro-D-Nal(2′)-Arg-Trp-Lys]-D-Phe-D-Val- NH2 4203 TCAM4200 Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-Arg-Nal(2′)-Arg-Trp-Lys]-D-Val-D-Pro- NH2 4204 TCAM4201 Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-Arg-Nal(2′)-Arg-Trp-Lys]-D-Pro-D-Val- NH2 4205 TCAM4202 Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-Arg-Nal(2′)-Arg-Trp-Lys]-D-Val-D-Phe- NH2 4206 TCAM4203 Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-Arg-Nal(2′)-Arg-Trp-Lys]-D-Phe-D-Val- NH2 4207 TCAM4204 Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-Arg-Pro-Nal(2′)-Arg-Trp-Lys]-D-Val-D- Pro-NH2 4208 TCAM4205 Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-Arg-Pro-D-Nal(2′)-Arg-Trp-Lys]-D-Pro- D-Val-NH2 4209 TCAM4206 Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-Arg-Pro-D-Nal(2′)-Arg-Trp-Lys]-D-Val- D-Phe-NH2 4210 TCAM4207 Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-Arg-Pro-Nal(2′)-Arg-Trp-Lys]-D-Phe-D- Val-NH2 4211 TCAM4208 Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-D-Nal(2′)-Arg-Trp-Lys]-D-Val-D-Pro- NH2 4212 TCAM4209 Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-D-Nal(2′)-Arg-Trp-Lys]-D-Pro-D-Val- NH2 4213 TCAM4210 Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-D-Nal(2′)-Arg-Trp-Lys]-D-Val-D-Phe- NH2 4214 TCAM4211 Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-D-Nal(2′)-Arg-Trp-Lys]-D-Phe-D-Val- NH2 4215 TCAM4212 Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-Pro-D-Nal(2′)-Arg-Trp-Lys]-D-Val-D- Pro-NH2 4216 TCAM4213 Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-Pro-D-Nal(2′)-Arg-Trp-Lys]-D-Pro-D- Val-NH2 4217 TCAM4214 Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-Pro-D-Nal(2′)-Arg-Trp-Lys]-D-Val-D- Phe-NH2 4218 TCAM4215 Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-Pro-D-Nal(2′)-Arg-Trp-Lys]-D-Phe-D- Val-NH2 4219 TCAM4216 Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-Arg-Arg-c[Asp-Pro-D-Nal(2′)-Arg-Trp-Lys]-D-Val- D-Pro-NH2 4220 TCAM4217 Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-Arg-Arg-c[Asp-Pro-D-Nal(2′)-Arg-Trp-Lys]-D-Pro- D-Val-NH2 4221 TCAM4218 Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-Arg-Arg-c[Asp-Pro-D-Nal(2′)-Arg-Trp-Lys]-D-Val- D-Phe-NH2 4222 TCAM4219 Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-Arg-Arg-c[Asp-Pro-D-Nal(2′)-Arg-Trp-Lys]-D-Phe- D-Val-NH2 4223 TCAM4220 Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-Arg-Arg-c[Asp-His-D-Nal(2′)-Arg-Trp-Lys]-D-Val-D- Pro-NH2 4224 TCAM4221 Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-Arg-Arg-c[Asp-His-D-Nal(2′)-Arg-Trp-Lys]-D-Pro- D-Val-NH2 4225 TCAM4222 Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-Arg-Arg-c[Asp-His-D-Nal(2′)-Arg-Trp-Lys]-D-Val-D- Phe-NH2 4226 TCAM4223 Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-Arg-Arg-c[Asp-His-D-Nal(2′)-Arg-Trp-Lys]-D-Phe- D-Val-NH2 4227 TCAM4224 Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-Pro-D-Nal(2′)-Arg-Trp-Arg-Lys]-D-Val- D-Pro-NH2 4228 TCAM4225 Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-Pro-D-Nal(2′)-Arg-Trp-Arg-Lys]-D-Pro- D-Val-NH2 4229 TCAM4226 Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-Pro-D-Nal(2′)-Arg-Trp-Arg-Lys]-D-Val- D-Phe-NH2 4230 TCAM4227 Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-Pro-D-Nal(2′)-Arg-Trp-Arg-Lys]-D-Phe- D-Val-NH2 4231 TCAM4228 Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-His-D-Nal(2′)-Arg-Trp-Arg-Lys]-D-Val-D- Pro-NH2 4232 TCAM4229 Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-His-D-Nal(2′)-Arg-Trp-Arg-Lys]-D-Pro- D-Val-NH2 4233 TCAM4230 Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-His-D-Nal(2′)-Arg-Trp-Arg-Lys]-D-Val-D- Phe-NH2 4234 TCAM4231 Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-His-D-Nal(2′)-Arg-Trp-Arg-Lys]-D-Phe- D-Val-NH2 4235 TCAM4232 Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-His-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Val-D- Phe-NH2 4236 TCAM4233 Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-His-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Phe-D- Val-NH2 4237 TCAM4234 Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Pro-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Val-D- Pro-NH2 4238 TCAM4235 Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Pro-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Pro-D- Val-NH2 4239 TCAM4236 Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Pro-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Val-D- Phe-NH2 4240 TCAM4237 Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Pro-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Phe-D- Val-NH2 4241 TCAM4238 Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-Arg-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Val- D-Pro-NH2 4242 TCAM4239 Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-Arg-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Pro- D-Val-NH2 4243 TCAM4240 Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-Arg-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Val- D-Phe-NH2 4244 TCAM4241 Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-Arg-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D- Phe-D-Val-NH2 4245 TCAM4242 Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-Arg-Pro-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D- Val-D-Pro-NH2 4246 TCAM4243 Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-Arg-Pro-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D- Pro-D-Val-NH2 4247 TCAM4244 Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-Arg-Pro-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D- Val-D-Phe-NH2 4248 TCAM4245 Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-Arg-Pro-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D- Phe-D-Val-NH2 4249 TCAM4246 Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Val-D- Pro-NH2 4250 TCAM4247 Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Pro-D- Val-NH2 4251 TCAM4248 Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Val-D-Phe- NH2 4252 TCAM4249 Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Phe-D- Val-NH2 4253 TCAM4250 Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-Pro-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Val- D-Pro-NH2 4254 TCAM4251 Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-Pro-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Pro- D-Val-NH2 4255 TCAM4252 Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-Pro-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Val- D-Phe-NH2 4256 TCAM4253 Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-Pro-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D- Phe-D-Val-NH2 4257 TCAM4254 Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-His-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Val- D-Pro-NH2 4258 TCAM4255 Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-His-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Pro- D-Val-NH2 4259 TCAM4256 Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-His-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Val-D- Phe-NH2 4260 TCAM4257 Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-His-Nal(2′)-Arg-D-Nal(2′)-Lys]-D-Phe-D- Val-NH2 4261 TCAM4258 Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-D-D-Nal(2′)-Arg-D-Nal(2′)-Arg-Lys]-D- Val-D-Pro-NH2 4262 TCAM4259 Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-D-Nal(2′)-Arg-D-Nal(2′)-Arg-Lys]-D-Pro- D-Val-NH2 4263 TCAM4260 Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-D-Nal(2′)-Arg-D-Nal(2′)-Arg-Lys]-D-Val- D-Phe-NH2 4264 TCAM4261 Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-D-Nal(2′)-Arg-D-Nal(2′)-Arg-Lys]-D- Phe-D-Val-NH2 4265 TCAM4262 Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-Pro-D-Nal(2′)-Arg-D-Nal(2′)-Arg-Lys]-D- Val-D-Pro-NH2 4266 TCAM4263 Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-Pro-D-Nal(2′)-Arg-D-Nal(2′)-Arg-Lys]-D- Pro-D-Val-NH2 4267 TCAM4264 Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-Pro-D-Nal(2′)-Arg-D-Nal(2′)-Arg-Lys]-D- Val-D-Phe-NH2 4268 TCAM4265 Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-Pro-D-Nal(2′)-Arg-D-Nal(2′)-Arg-Lys]-D- Phe-D-Val-NH2 4269 TCAM4266 Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-His-D-Nal(2′)-Arg-D-Nal(2′)-Arg-Lys]-D- Val-D-Pro-NH2 4270 TCAM4267 Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-His-D-Nal(2′)-Arg-D-Nal(2′)-Arg-Lys]-D- Pro-D-Val-NH2 4271 TCAM4268 Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-His-D-Nal(2′)-Arg-D-Nal(2′)-Arg-Lys]-D- Val-D-Phe-NH2 4272 TCAM4269 Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-His-D-Nal(2′)-Arg-D-Nal(2′)-Arg-Lys]-D- Phe-D-Val-NH2 4273 TCAM4270 Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-Arg-Arg-c[Asp-Pro-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D- Val-D-Pro-NH2 4274 TCAM4271 Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-Arg-Arg-c[Asp-Pro-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D- Pro-D-Val-NH2 4275 TCAM4272 Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-Arg-Arg-c[Asp-Pro-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D- Val-D-Phe-NH2 4276 TCAM4273 Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-Arg-Arg-c[Asp-Pro-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D- Phe-D-Val-NH2 4277 TCAM4274 Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-Arg-Arg-c[Asp-His-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D- Val-D-Pro-NH2 4278 TCAM4275 Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-Arg-Arg-c[Asp-His-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D- Pro-D-Val-NH2 4279 TCAM4276 Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-Arg-Arg-c[Asp-His-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D- Val-D-Phe-NH2 4280 TCAM4277 Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-Arg-Arg-c[Asp-His-D-Nal(2′)-Arg-D-Nal(2′)-Lys]-D- Phe-D-Val-NH2 4281 TCAM4278 Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-Pro-D-Nal(2′)-Arg-D-Nal(2′)-Arg-Lys]-D- Val-D-Pro-NH2 4282 TCAM4279 Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-Pro-D-Nal(2′)-Arg-D-Nal(2′)-Arg-Lys]-D- Pro-D-Val-NH2 4283 TCAM4280 Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-Pro-D-Nal(2′)-Arg-D-Nal(2′)-Arg-Lys]-D- Val-D-Phe-NH2 4284 TCAM4281 Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-Pro-D-Nal(2′)-Arg-D-Nal(2′)-Arg-Lys]-D- Phe-D-Val-NH2 4285 TCAM4282 Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-His-D-Nal(2′)-Arg-D-Nal(2′)-Arg-Lys]-D- Val-D-Pro-NH2 4286 TCAM4283 Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-His-D-Nal(2′)-Arg-D-Nal(2′)-Arg-Lys]-D- Pro-D-Val-NH2 4287 TCAM4284 Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-His-D-Nal(2′)-Arg-D-Nal(2′)-Arg-Lys]-D- Val-D-Phe-NH2 4288 TCAM4285 Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Arg-His-D-Nal(2′)-Arg-D-Nal(2′)-Arg-Lys]-D- Phe-D-Val-NH2 4289 TCAM4286 Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-His-D-Nal(2′)-Arg-Trp-Lys]-Arg-Arg-D-Val-D- Pro-NH2 4290 TCAM4287 Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-His-D-Nal(2′)-Arg-Trp-Lys]-Arg-Arg-D-Pro- D-Val-NH2 4291 TCAM4288 Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-His-D-Nal(2′)-Arg-Trp-Lys]-Arg-Arg-D-Val-D- Phe-NH2 4292 TCAM4289 Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-His-D-Nal(2′)-Arg-Trp-Lys]-Arg-Arg-D-Phe- D-Val-NH2 4293 TCAM4290 Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Pro-D-Nal(2′)-Arg-Trp-Lys]-Arg-Arg-D-Val- D-Pro-NH2 4294 TCAM4291 Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Pro-D-Nal(2′)-Arg-Trp-Lys]-Arg-Arg-D-Pro- D-Val-NH2 4295 TCAM4292 Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Pro-D-Nal(2′)-Arg-Trp-Lys]-Arg-Arg-D-Val- D-Phe-NH2 4296 TCAM4293 Arg-Arg-Phe-Phe-Arg-Arg-Leu-Arg-c[Asp-Pro-D-Nal(2′)-Arg-Trp-Lys]-Arg-Arg-D-Phe- D-Val-NH2 

What is claimed is:
 1. A non-naturally occuring anti-microbial peptide comprising at least three or more amino acid or amino acid analog residues, wherein at least one of the three or more residues comprises: (a) at least one or more natural, synthetic, or chemically modified cationic amino acid residues; (b) at least one, synthetic, or chemically modified anionic amino acid residue; (c) at least one or more natural, synthetic, or chemically modified aromatic residues; or (d) a combination of natural, synthetic, or chemically modified amino acid residues thereof.
 2. The non-naturally occuring anti-microbial peptide of claim 1, wherein the length of the peptide is from about 3 residues to about 17 residues.
 3. The non-naturally occuring anti-microbial peptide of claim 2, wherein the peptide is stabilized.
 4. The non-naturally occuring anti-microbial peptide of claim 3, wherein the N-terminus of the non-naturally occuring anti-microbial peptide is stabilized.
 5. The non-naturally occuring anti-microbial peptide of claim 4, wherein the stabilization comprises the addition of between 1 and 3 natural or artificial stabilizing residues.
 6. The non-naturally occuring anti-microbial peptide of claims 4-5, wherein the N-terminal stabilizing residues comprise: D-threonine, L-threonine, D-proline, L-proline, β-homo proline, D-alanine, L-alanine, β-alanine, D-valine, L-valine, β-valine, 3-methyl-β-valine, D-leucine, L-leucine, β-leucine, D-norleucine, L-norleucine, D-isoleucine, L-isoleucine, β-isoleucine, or a piperazin-2-one ring.
 7. The non-naturally occuring anti-microbial peptide of claims 1-6, wherein the N-terminus is acylated
 8. The non-naturally occuring anti-microbial peptide of claim 3, wherein the C-terminus of the non-naturally occuring anti-microbial peptide is stabilized.
 9. The non-naturally occuring anti-microbial peptide of claim 8, wherein the stabilization comprises the addition of between 1 and 3 natural or artificial stabilizing residues.
 10. The non-naturally occuring anti-microbial peptide of claim 8-9, wherein the C-terminal stabilizing residues comprise: D-threonine, L-threonine, D-proline, L-proline, β-homo proline, D-alanine, L-alanine, D-valine, L-valine, βuvaline, 3-methyl-β-valine, D-leucine, L-leucine, β-leucine, D-norleucine, L-norleucine, D-norleucine, L-norleucine, D-isoleucine, L-isoleucine, β-isoleucine, D-phenylalanine, L-phenylalanine, or a piperazin-2-one ring.
 11. The non-naturally occuring anti-microbial peptide of claims 1-10, wherein the C-terminus is amidated.
 12. The non-naturally occuring anti-microbial peptide of claims 8-11, wherein the C-terminal stabilization also increases the specificity of the anti-microbial peptide to target gram-negative bacteria.
 13. The non-naturally occuring anti-microbial peptide of claims 8-11, wherein the C-terminal stabilization increases the specificity of the anti-microbial peptide to target gram-positive bacteria.
 14. The non-naturally occuring anti-microbial peptide of claims 8-13, wherein the C-terminal stabilizing residues comprise: D-Pro-D-Val; D-Val-D-Pro; β-Val-β-Pro; β-Pro-β-Val; 3-methyl-β-Val-β-Pro; D-Pro-D-Ala; D-Ala-D-Pro; β-Pro-β-Ala; β-Ala-β-Pro; D-Pro-D-Leu; D-Leu-D-Pro; β-Pro-β-Leu; β-Leu-β-Pro; D-Val-D-Ala; D-Ala-D-Val; β-Val-β-Ala; β-Ala-β-Val; 3-methyl-β-Val-β-Ala; D-Val-D-Leu; D-Leu-D-Val; β-Val-β-Leu; β-Leu-β-Val; 3-methyl-β-Val-β-Leu; D-Phe-D-Val; or D-Val-D-Phe.
 15. The non-naturally occuring anti-microbial peptide of claims 8-14, wherein the C-terminus is amidated.
 16. The non-naturally occuring anti-microbial peptide of any one of claims 1-15, wherein the non-naturally occuring anti-microbial peptide is cyclized.
 17. The non-naturally occuring anti-microbial peptide of claim 16, wherein the non-naturally occuring anti-microbial peptide is cyclized through a lactam linkage.
 18. The non-naturally occuring anti-microbial peptide of claim 17, wherein the non-naturally occuring anti-microbial peptide is cyclized between a positive and negative residue.
 19. The non-naturally occuring anti-microbial peptide of anyone of claims 1-19, wherein an anti-biofilm peptide is covalently linked to the anti-microbial peptide.
 20. The non-naturally occuring anti-microbial peptide of claim 19, wherein the anti-biofilm peptide is covalently linked to the N-terminus of the anti-microbial peptide.
 21. The non-naturally occuring anti-microbial peptide of claim 19, wherein the anti-biofilm peptide is covalently linked to the C-terminus of the anti-microbial peptide.
 22. The non-naturally occuring anti-microbial peptide of claim 19, wherein the anti-biofilm peptide is covalently linked to the anti-microbial peptide through at least one linker.
 23. The non-naturally occuring anti-microbial peptide of claims 19-22, wherein the anti-biofilm peptide comprises between 1 and 12 natural, synthetic, or chemically modified residues.
 24. The non-naturally occuring anti-microbial peptide of claim 23, wherein the anti-biofilm peptide comprises the sequence according to Formula IV: B¹-B²-B³-B⁴-B⁵-B⁶-B⁷-B⁸-B⁹-B¹⁰-B¹¹-B¹², wherein: each residue corresponding to positions B¹, B³, B⁴, B⁵, B⁶, B⁷, or B⁹ comprises any hydrophobic non-aromatic natural, synthetic, or chemically modified amino acid; each residue corresponding to positions B², B⁸, B¹¹, or B¹² comprises any natural, synthetic, or chemically modified positive amino acid; and each residue corresponding to position B¹⁰ comprises any natural, synthetic, or chemically modified aromatic amino acid.
 25. The non-naturally occuring anti-microbial peptide of claim 24, wherein the anti-biofilm peptide comprises the sequence B¹-B²-B³-B⁴-B⁵-B⁶-B⁷-B⁸.
 26. The non-naturally occuring anti-microbial peptide of claim 24, wherein the anti-biofilm peptide comprises the sequence B⁷-B⁸-B⁹-B¹⁰-B¹¹-B¹².
 27. The non-naturally occuring anti-microbial peptide of claim 24, wherein the anti-biofilm peptide comprises the sequence B¹-B²-B³-B⁴-B⁵-B⁶.
 28. The non-naturally occuring anti-microbial peptide of claim 24, wherein the anti-biofilm peptide comprises the sequence B¹-B²-B³-B⁴-B⁵-B⁶-B⁷.
 29. The non-naturally occuring anti-microbial peptide of claim 23, wherein the anti-biofilm peptide comprises the sequence according to Formula IV: B¹-B²-B³-B⁴-B⁵-B⁶-B⁷-B⁸-B⁹-B¹⁰-B¹¹, wherein: each residue corresponding to positions B¹, B², B⁴, B⁵, B⁸, B⁹, or B¹¹ comprises any natural, synthetic, or chemically modified positive amino acid; each residue corresponding to positions B³, B⁶, or B⁷ comprises any natural, synthetic, or chemically modified aromatic amino acid; and each residue corresponding to position B¹⁰ comprises any hydrophobic non-aromatic natural, synthetic, or chemically modified amino acid.
 30. The non-naturally occuring anti-microbial peptide of claim 29, wherein the anti-biofilm peptide comprises the sequence B¹-B²-B³-B⁴-B⁵-B⁶-B⁷.
 31. The non-naturally occuring anti-microbial peptide of claim 29, wherein the anti-biofilm peptide comprises the sequence B⁶-B⁷-B⁸-B⁹-B¹⁰-B¹¹.
 32. The non-naturally occuring anti-microbial peptide of claim 29, wherein the anti-biofilm peptide comprises the sequence B¹-B²-B³-B⁴-B⁵-B⁶-B⁷-B⁸-B⁹.
 33. The non-naturally occuring anti-microbial peptide of claim 29, wherein the anti-biofilm peptide comprises the sequence B⁴-B⁵-B⁶-B⁷-B⁸-B⁹-B¹⁰.
 34. The non-naturally occuring anti-microbial peptide of claims 19-33, wherein the anti-biofilm peptide is covalently linked to the N-terminus or C-terminus of the anti-microbial peptide.
 35. The non-naturally occuring anti-microbial peptide of claim 34, wherein the anti-microbial peptide is stabilized by the addition of between 1 and 3 natural or artificial stabilizing residues to the anti-biofilm peptide.
 36. The non-naturally occuring anti-microbial peptide of claim 35, wherein the stabilizing residues comprise: D-threonine, L-threonine, D-proline, L-proline, β-homo proline, D-alanine, L-alanine, β-alanine, D-valine, L-valine, β-valine, 3-methyl-β-valine, D-leucine, L-leucine, β-leucine, D-norleucine, L-norleucine, D-norleucine, L-norleucine, D-isoleucine, L-isoleucine, β-isoleucine, or a piperazin-2-one ring.
 37. The non-naturally occuring anti-microbial peptide of claims 19-36, wherein the anti-biofilm peptide is methylated.
 38. A non-naturally occurring anti-microbial peptide comprising the sequence according to Formula I: X¹-X²-X³-R¹-R²-[R³-R⁴-R⁵-R⁶-R⁷-R⁸-R⁹-R¹⁰-R¹¹-R¹²-R¹³-R¹⁴-R¹⁵-R¹⁶-R¹⁷]Y¹-Y²-Y³, wherein: X¹, X², and X³ represent optional N-terminal residues; R¹ to R⁷ represent residues of the anti-microbial peptide; Y¹, Y², and Y³ represent optional degradation-resistant C-terminal residues.
 39. The non-naturally occurring anti-microbial peptide of claim 38, wherein: R¹ to R¹⁷ is further represented by formula II: P ₀₋₂ −|−[N−|−(U)₀₋₁−|−(P|A)₁₋₃−|−(U)₀₋₁−|−(P|A)₀₋₃−|−(U)₀₋₁−|−(P|A)₀₋₃−|−(U)₀₋₁−|−(P|A)₀₋₃ −P], wherein: “N” is any natural, synthetic, or chemically modified negative residue; “U” is any natural, synthetic, or chemically modified polar uncharged residue or a hydrophobic non-aromatic natural, synthetic, or chemically modified residue; “P” is any natural, synthetic, or chemically modified proline residue or any natural, synthetic, or chemically modified positive residue; “A” is any natural, synthetic, or chemically modified aromatic residue.
 40. The non-naturally occuring anti-microbial peptide of claim 38-39, wherein the length of the peptide is from about 3 residues to about 17 residues.
 41. The non-naturally occuring anti-microbial peptide of claim 38-39, wherein the peptide is stabilized.
 42. The non-naturally occuring anti-microbial peptide of claim 41, wherein the N-terminus of the non-naturally occuring anti-microbial peptide is stabilized.
 43. The non-naturally occuring anti-microbial peptide of claim 42, wherein the stabilization comprises the addition of between 1 and 3 natural or artificial stabilizing residues.
 44. The non-naturally occuring anti-microbial peptide of claims 42-43, wherein the N-terminal stabilizing residues comprise: D-threonine, L-threonine, D-proline, L-proline, β-homo proline, D-alanine, L-alanine, β-alanine, D-valine, L-valine, β-valine, 3-methyl-β-valine, D-leucine, L-leucine, β-leucine, D-norleucine, L-norleucine, D-isoleucine, L-isoleucine, β-isoleucine, or a piperazin-2-one ring.
 45. The non-naturally occuring anti-microbial peptide of claims 38-44, wherein the N-terminus is acylated
 46. The non-naturally occuring anti-microbial peptide of claim 41, wherein the C-terminus of the non-naturally occuring anti-microbial peptide is stabilized.
 47. The non-naturally occuring anti-microbial peptide of claim 46, wherein the stabilization comprises the addition of between 1 and 3 natural or artificial stabilizing residues.
 48. The non-naturally occuring anti-microbial peptide of claim 46-47, wherein the C-terminal stabilizing residues comprise: D-threonine, L-threonine, D-proline, L-proline, β-homo proline, D-alanine, L-alanine, D-valine, L-valine, β-valine, 3-methyl-β-valine, D-leucine, L-leucine, β-leucine, D-norleucine, L-norleucine, D-isoleucine, L-isoleucine, β-isoleucine, D-phenylalanine, L-phenylalanine, or a piperazin-2-one ring.
 49. The non-naturally occuring anti-microbial peptide of claims 38-48, wherein the C-terminus is amidated.
 50. The non-naturally occuring anti-microbial peptide of claims 46-49, wherein the C-terminal stabilization also increases the specificity of the anti-microbial peptide to target gram-negative bacteria.
 51. The non-naturally occuring anti-microbial peptide of claims 46-49, wherein the C-terminal stabilization increases the specificity of the anti-microbial peptide to target gram-positive bacteria.
 52. The non-naturally occuring anti-microbial peptide of claims 46-51, wherein the C-terminal stabilizing residues comprise: D-Pro-D-Val; D-Val-D-Pro; β-Val-β-Pro; β-Pro-β-Val; 3-methyl-β-Val-β-Pro; D-Pro-D-Ala; D-Ala-D-Pro; βPro-β-Ala; β-Ala-β-Pro; D-Pro-D-Leu; D-Leu-D-Pro; βPro-β-Leu; βLeu-β-Pro; D-Val-D-Ala; D-Ala-D-Val; βVal-β-Ala; βAla-β-Val; 3-methyl-β-Val-β-Ala; D-Val-D-Leu; D-Leu-D-Val; β-Val-β-Leu; βLeu-β-Val; 3-methyl-β-Val-β-Leu; D-Phe-D-Val; or D-Val-D-Phe.
 53. The non-naturally occuring anti-microbial peptide of claims 50-52, wherein the C-terminus is amidated.
 54. The non-naturally occuring anti-microbial peptide of any one of claims 38-54, wherein the non-naturally occuring anti-microbial peptide is cyclized.
 55. The non-naturally occuring anti-microbial peptide of claim 54, wherein the non-naturally occuring anti-microbial peptide is cyclized through a lactam linkage.
 56. The non-naturally occuring anti-microbial peptide of claim 55, wherein the non-naturally occuring anti-microbial peptide is cyclized between a positive and negative residue.
 57. The non-naturally occuring anti-microbial peptide of anyone of claims 38-56, wherein an anti-biofilm peptide is covalently linked to the anti-microbial peptide.
 58. The non-naturally occuring anti-microbial peptide of claim 57, wherein the anti-biofilm peptide is covalently linked to the N-terminus of the anti-microbial peptide.
 59. The non-naturally occuring anti-microbial peptide of claim 57, wherein the anti-biofilm peptide is covalently linked to the C-terminus of the anti-microbial peptide.
 60. The non-naturally occuring anti-microbial peptide of claim 57, wherein the anti-biofilm peptide is covalently linked to the anti-microbial peptide through at least one linker.
 61. The non-naturally occuring anti-microbial peptide of claims 57-60, wherein the anti-biofilm peptide comprises between 1 and 12 natural, synthetic, or chemically modified residues.
 62. The non-naturally occuring anti-microbial peptide of claim 57, wherein the anti-biofilm peptide comprises the sequence according to Formula IV: B¹-B²-B³-B⁴-B⁵-B⁶-B⁷-B⁸-B⁹-B¹⁰-B¹¹-B¹², wherein: each residue corresponding to positions B¹, B³, B⁴, B⁵, B⁶, B⁷, or B⁹ comprises any hydrophobic non-aromatic natural, synthetic, or chemically modified amino acid; each residue corresponding to positions B², B⁸, B¹¹, or B¹² comprises any natural, synthetic, or chemically modified positive amino acid; and each residue corresponding to position B¹⁰ comprises any natural, synthetic, or chemically modified aromatic amino acid.
 63. The non-naturally occuring anti-microbial peptide of claim 62, wherein the anti-biofilm peptide comprises the sequence B¹-B²-B³-B⁴-B⁵-B⁶-B⁷-B⁸.
 64. The non-naturally occuring anti-microbial peptide of claim 62, wherein the anti-biofilm peptide comprises the sequence B⁷-B⁸-B⁹-B¹⁰-B¹¹-B¹².
 65. The non-naturally occuring anti-microbial peptide of claim 62, wherein the anti-biofilm peptide comprises the sequence B¹-B²-B³-B⁴-B⁵-B⁶.
 66. The non-naturally occuring anti-microbial peptide of claim 62, wherein the anti-biofilm peptide comprises the sequence B¹-B²-B³-B⁴-B⁵-B⁶-B⁷.
 67. The non-naturally occuring anti-microbial peptide of claim 57, wherein the anti-biofilm peptide comprises the sequence according to Formula IV: B¹-B²-B³-B⁴-B⁵-B⁶-B⁷-B⁸-B⁹-B¹⁰-B¹¹, wherein: each residue corresponding to positions B¹, B², B⁴, B⁵, B⁸, B⁹, or B¹¹ comprises any natural, synthetic, or chemically modified positive amino acid; each residue corresponding to positions B³, B⁶, or B² comprises any natural, synthetic, or chemically modified aromatic amino acid; and each residue corresponding to position B¹⁰ comprises any hydrophobic non-aromatic natural, synthetic, or chemically modified amino acid.
 68. The non-naturally occuring anti-microbial peptide of claim 57, wherein the anti-biofilm peptide comprises the sequence B¹-B²-B³-B⁴-B⁵-B⁶-B⁷.
 69. The non-naturally occuring anti-microbial peptide of claim 57, wherein the anti-biofilm peptide comprises the sequence B⁶-B⁷-B⁸-B⁹-B¹⁰-B¹¹.
 70. The non-naturally occuring anti-microbial peptide of claim 57, wherein the anti-biofilm peptide comprises the sequence B¹-B²-B³-B⁴-B⁵-B⁶-B⁷-B⁸-B⁹.
 71. The non-naturally occuring anti-microbial peptide of claim 57, wherein the anti-biofilm peptide comprises the sequence B⁴-B⁵-B⁶-B⁷-B⁸-B⁹-B¹⁰.
 72. The non-naturally occuring anti-microbial peptide of claims 57-71, wherein the anti-biofilm peptide is covalently linked to the N-terminus or C-terminus of the anti-microbial peptide.
 73. The non-naturally occuring anti-microbial peptide of claim 72, wherein the anti-microbial peptide is stabilized by the addition of between 1 and 3 natural or artificial stabilizing residues to the anti-biofilm peptide.
 74. The non-naturally occuring anti-microbial peptide of claim 73, wherein the stabilizing residues comprise: D-threonine, L-threonine, D-proline, L-proline, β-homo proline, D-alanine, L-alanine, β-alanine, D-valine, L-valine, β-valine, 3-methyl-β-valine, D-leucine, L-leucine, β-leucine, D-norleucine, L-norleucine, D-isoleucine, L-isoleucine, β-isoleucine, or a piperazin-2-one ring.
 75. The non-naturally occuring anti-microbial peptide of claims 57-74, wherein the anti-biofilm peptide is methylated.
 76. A non-naturally occurring anti-microbial peptide comprising the sequence according to Formula I: X¹ R¹ R² [R³ R⁴ R⁵ R⁶ R⁷ R⁸ R⁹ R¹⁰ R¹¹ R¹² R¹³ R¹⁴ R¹⁵ R¹⁶ R¹⁷]Y¹ Y², wherein: X¹ is norleucine and Y¹ Y² is D-Pro-D-Val, D-Val-D-Pro, D-Phe-D-Val or D-Val-D-Phe, wherein R¹ to R¹⁷ represent residues of the anti-microbial peptide and R¹ to R¹⁷ is further represented by formula II: P ₀₋₂ −|−[N−|−(U)₀₋₁−|−(P|A)₁₋₃−|−(U)₀₋₁−|−(P|A)₀₋₃−|−(U)₀₋₁−|−(P|A)₀₋₃−|−(U)₀₋₁−|−(P|A)₀₋₃ −P], wherein: “N” is aspartic acid; “U” glutamine or leucine; “P” is proline, histidine, lysine, or arginine; “A” is noralanine, 2′-naphthylalanine, tryptophan, tyrosine, or phenylalanine; and wherein an anti-biofilm peptide is optionally covalently attached to the N-terminus of the antimicrobial peptide of formula I and formula II.
 77. The non-naturally occuring anti-microbial peptide of claim 76, wherein the length of the peptide is from about 3 residues to about 17 residues.
 78. The non-naturally occuring anti-microbial peptide of claim 76, wherein X¹ and Y¹ Y² increase the stability of the non-naturally occuring anti-microbial peptide.
 79. The non-naturally occuring anti-microbial peptide of claims 76-78, wherein the N-terminus is acylated.
 80. The non-naturally occuring anti-microbial peptide of claims 76-79, wherein the C-terminus is amidated.
 81. The non-naturally occuring anti-microbial peptide of claim 76, wherein Y¹ Y² increases the specificity of the anti-microbial peptide to target gram-negative bacteria.
 82. The non-naturally occuring anti-microbial peptide of claim 76, wherein Y¹ Y² increases the specificity of the anti-microbial peptide to target gram-positive bacteria.
 83. The non-naturally occuring anti-microbial peptide of claims 76-82, wherein the non-naturally occuring anti-microbial peptide is cyclized through a lactam linkage between a positive and negative residue.
 84. The non-naturally occuring anti-microbial peptide of claims 76-83, wherein an anti-biofilm peptide comprising between 1 and 12 natural, synthetic, or chemically modified residues is covalently linked to the anti-microbial peptide.
 85. The non-naturally occuring anti-microbial peptide of claim 84, wherein the anti-biofilm peptide comprises the sequence according to Formula IV: B¹-B²-B³-B⁴-B⁵-B⁶-B⁷-B⁸-B⁹-B¹⁰-B¹¹-B¹², wherein: each residue corresponding to positions B¹, B³, B⁴, B⁵, B⁶, B⁷, or B⁹ is alanine, valine, or isoleucine; each residue corresponding to positions B², B⁸, B¹¹, or B¹² is arginine, histidine, or lysine; and each residue corresponding to position B¹⁰ is noralanine, 2′-naphthylalanine, tryptophan, tyrosine, or phenylalanine.
 86. The non-naturally occuring anti-microbial peptide of claim 85, wherein the anti-biofilm peptide comprises the sequence B¹-B²-B³-B⁴-B⁵-B⁶-B⁷-B⁸.
 87. The non-naturally occuring anti-microbial peptide of claim 85, wherein the anti-biofilm peptide comprises the sequence B⁷-B⁸-B⁹-B¹⁰-B¹¹-B¹².
 88. The non-naturally occuring anti-microbial peptide of claim 85, wherein the anti-biofilm peptide comprises the sequence B¹-B²-B³-B⁴-B⁵-B⁶.
 89. The non-naturally occuring anti-microbial peptide of claim 85, wherein the anti-biofilm peptide comprises the sequence B¹-B²-B³-B⁴-B⁵-B⁶-B⁷.
 90. The non-naturally occuring anti-microbial peptide of claim 84, wherein the anti-biofilm peptide comprises the sequence according to Formula IV: B¹-B²-B³-B⁴-B⁵-B⁶-B⁷-B⁸-B⁹-B¹⁰-B¹¹, wherein: each residue corresponding to positions B¹, B², B⁴, B⁵, B⁸, B⁹, or B¹¹ is arginine, histidine, or lysine; each residue corresponding to positions B³, B⁶, or B⁷ is noralanine, 2′-naphthylalanine, tryptophan, tyrosine, or phenylalanine; and each residue corresponding to position B¹⁰ is alanine, valine, or isoleucine.
 91. The non-naturally occuring anti-microbial peptide of claim 90, wherein the anti-biofilm peptide comprises the sequence B¹-B²-B³-B⁴-B⁵-B⁶-B⁷.
 92. The non-naturally occuring anti-microbial peptide of claim 90, wherein the anti-biofilm peptide comprises the sequence B⁶-B⁷-B⁸-B⁹-B¹⁰-B¹¹.
 93. The non-naturally occuring anti-microbial peptide of claim 90, wherein the anti-biofilm peptide comprises the sequence B¹-B²-B³-B⁴-B⁵-B⁶-B⁷-B⁸-B⁹.
 94. The non-naturally occuring anti-microbial peptide of claim 90, wherein the anti-biofilm peptide comprises the sequence B⁴-B⁵-B⁶-B⁷-B⁸-B⁹-B¹⁰.
 95. The non-naturally occuring anti-microbial peptide of claims 84-94, wherein the anti-biofilm peptide is methylated.
 96. A non-naturally occuring anti-microbial peptide comprising any one of SEQ NOs: 1-4296.
 97. The non-naturally occuring anti-microbial peptide of claim 96, wherein the length of the peptide is from about 3 residues to about 17 residues.
 98. The non-naturally occuring anti-microbial peptide of claim 97, wherein the peptide is stabilized.
 99. The non-naturally occuring anti-microbial peptide of claim 98, wherein the N-terminus of the non-naturally occuring anti-microbial peptide is stabilized.
 100. The non-naturally occuring anti-microbial peptide of claim 99, wherein the stabilization comprises the addition of between 1 and 3 natural or artificial stabilizing residues.
 101. The non-naturally occuring anti-microbial peptide of claims 99-100, wherein the N-terminal stabilizing residues comprise: D-threonine, L-threonine, D-proline, L-proline, β-homo proline, D-alanine, L-alanine, β-alanine, D-valine, L-valine, β-valine, 3-methyl-β-valine, D-leucine, L-leucine, β-leucine, D-norleucine, L-norleucine, D-isoleucine, L-isoleucine, β-isoleucine, or a piperazin-2-one ring.
 102. The non-naturally occuring anti-microbial peptide of claims 96-101, wherein the N-terminus is acylated.
 103. The non-naturally occuring anti-microbial peptide of claim 98, wherein the C-terminus of the non-naturally occuring anti-microbial peptide is stabilized.
 104. The non-naturally occuring anti-microbial peptide of claim 103, wherein the stabilization comprises the addition of between 1 and 3 natural or artificial stabilizing residues.
 105. The non-naturally occuring anti-microbial peptide of claim 103-104, wherein the C-terminal stabilizing residues comprise: D-threonine, L-threonine, D-proline, L-proline, β-homo proline, D-alanine, L-alanine, D-valine, L-valine, β-valine, 3-methyl-β-valine, D-leucine, L-leucine, β-leucine, D-norleucine, L-norleucine, D-isoleucine, L-isoleucine, β-isoleucine, D-phenylalanine, L-phenylalanine, or a piperazin-2-one ring.
 106. The non-naturally occuring anti-microbial peptide of claims 96-105, wherein the C-terminus is amidated.
 107. The non-naturally occuring anti-microbial peptide of claims 103-106, wherein the C-terminal stabilization also increases the specificity of the anti-microbial peptide to target gram-negative bacteria.
 108. The non-naturally occuring anti-microbial peptide of claims 103-106, wherein the C-terminal stabilization increases the specificity of the anti-microbial peptide to target gram-positive bacteria.
 109. The non-naturally occuring anti-microbial peptide of claims 103-108, wherein the C-terminal stabilizing residues comprise: D-Pro-D-Val; D-Val-D-Pro; β-Val-β-Pro; βPro-β-Val; 3-methyl-β-Val-β-Pro; D-Pro-D-Ala; D-Ala-D-Pro; βPro-β-Ala; β-Ala-β-Pro; D-Pro-D-Leu; D-Leu-D-Pro; βPro-β-Leu; βLeu-β-Pro; D-Val-D-Ala; D-Ala-D-Val; βVal-β-Ala; βAla-β-Val; 3-methyl-β-Val-β-Ala; D-Val-D-Leu; D-Leu-D-Val; β-Val-β-Leu; β-Leu-β-Val; 3-methyl-β-Val-β-Leu; D-Phe-D-Val; or D-Val-D-Phe.
 110. The non-naturally occuring anti-microbial peptide of claims 96-109, wherein the C-terminus is amidated.
 111. The non-naturally occuring anti-microbial peptide of any one of claims 96-110, wherein the non-naturally occuring anti-microbial peptide is cyclized.
 112. The non-naturally occuring anti-microbial peptide of claim 111, wherein the non-naturally occuring anti-microbial peptide is cyclized through a lactam linkage.
 113. The non-naturally occuring anti-microbial peptide of claim 112, wherein the non-naturally occuring anti-microbial peptide is cyclized between a positive and negative residue.
 114. The non-naturally occuring anti-microbial peptide of anyone of claims 96-113, wherein an anti-biofilm peptide is covalently linked to the anti-microbial peptide.
 115. The non-naturally occuring anti-microbial peptide of claim 114, wherein the anti-biofilm peptide is covalently linked to the N-terminus of the anti-microbial peptide.
 116. The non-naturally occuring anti-microbial peptide of claim 115, wherein the anti-biofilm peptide is covalently linked to the C-terminus of the anti-microbial peptide.
 117. The non-naturally occuring anti-microbial peptide of claims 114-116, wherein the anti-biofilm peptide is covalently linked to the anti-microbial peptide through at least one linker.
 118. The non-naturally occuring anti-microbial peptide of claims 114-117, wherein the anti-biofilm peptide comprises between 1 and 12 natural, synthetic, or chemically modified residues.
 119. The non-naturally occuring anti-microbial peptide of claim 115, wherein the anti-biofilm peptide comprises the sequence according to Formula IV: B¹-B²-B³-B⁴-B⁵-B⁶-B⁷-B⁸-B⁹-B¹⁰-B¹¹-B¹², wherein: each residue corresponding to positions B¹, B³, B⁴, B⁵, B⁶, B⁷, or B⁹ comprises any hydrophobic non-aromatic natural, synthetic, or chemically modified amino acid; each residue corresponding to positions B², B⁸, B¹¹, or B¹² comprises any natural, synthetic, or chemically modified positive amino acid; and each residue corresponding to position B¹⁰ comprises any natural, synthetic, or chemically modified aromatic amino acid.
 120. The non-naturally occuring anti-microbial peptide of claim 24, wherein the anti-biofilm peptide comprises the sequence B¹-B²-B³-B⁴-B⁵-B⁶-B⁷-B⁸.
 121. The non-naturally occuring anti-microbial peptide of claim 24, wherein the anti-biofilm peptide comprises the sequence B⁷-B⁸-B⁹-B¹⁰-B¹¹-B¹².
 122. The non-naturally occuring anti-microbial peptide of claim 24, wherein the anti-biofilm peptide comprises the sequence B¹-B²-B³-B⁴-B⁵-B⁶.
 123. The non-naturally occuring anti-microbial peptide of claim 24, wherein the anti-biofilm peptide comprises the sequence B¹-B²-B³-B⁴-B⁵-B⁶-B⁷.
 124. The non-naturally occuring anti-microbial peptide of claim 115, wherein the anti-biofilm peptide comprises the sequence according to Formula IV: B¹-B²-B³-B⁴-B⁵-B⁶-B⁷-B⁸-B⁹-B¹⁰-B¹¹, wherein: each residue corresponding to positions B¹, B², B⁴, B⁵, B⁸, B⁹, or B¹¹ comprises any natural, synthetic, or chemically modified positive amino acid; each residue corresponding to positions B³, B⁶, or B⁷ comprises any natural, synthetic, or chemically modified aromatic amino acid; and each residue corresponding to position B¹⁰ comprises any hydrophobic non-aromatic natural, synthetic, or chemically modified amino acid.
 125. The non-naturally occuring anti-microbial peptide of claim 124, wherein the anti-biofilm peptide comprises residues B¹ B² B³ B⁴ B⁵ B⁶ B⁷.
 126. The non-naturally occuring anti-microbial peptide of claim 124, wherein the anti-biofilm peptide comprises residues B⁶ B⁷ B⁸ B⁹ B¹⁰ B¹¹.
 127. The non-naturally occuring anti-microbial peptide of claim 124, wherein the anti-biofilm peptide comprises residues B¹ B² B³ B⁴ B⁵ B⁶ B⁷ B⁸ B⁹.
 128. The non-naturally occuring anti-microbial peptide of claim 124, wherein the anti-biofilm peptide comprises residues B⁴ B⁵ B⁶ B⁷ B⁸ B⁹ B¹⁰.
 129. The non-naturally occuring anti-microbial peptide of claims 114-128, wherein the anti-biofilm peptide is covalently linked to the N-terminus or C-terminus of the anti-microbial peptide.
 130. The non-naturally occuring anti-microbial peptide of claim 129, wherein the anti-microbial peptide is stabilized by the addition of between 1 and 3 natural or artificial stabilizing residues to the anti-biofilm peptide.
 131. The non-naturally occuring anti-microbial peptide of claim 130, wherein the stabilizing residues comprise: D-threonine, L-threonine, D-proline, L-proline, β-homo proline, D-alanine, L-alanine, β-alanine, D-valine, L-valine, β-valine, 3-methyl-β-valine, D-leucine, L-leucine, β-leucine, D-norleucine, L-norleucine, D-isoleucine, L-isoleucine, β-isoleucine, or a piperazin-2-one ring.
 132. The non-naturally occuring anti-microbial peptide of claims 114-131, wherein the anti-biofilm peptide is methylated.
 133. A method for changing the physiology of a microbe using the non-naturally occuring anti-microbial peptide of any one of claims 1-132.
 134. The method of claim 133, wherein changing the physiology of a microbe comprises reducing the growth rate, inhibiting DNA synthesis, inhibiting protein synthesis, inhibiting structural stability, reducing cell-membrane integrity, inhibiting cell wall synthesis, reducing viability, or causing death.
 135. The method of claims 133-134, wherein the microbe comprises a pathogenic organism.
 136. The method of claim 135, wherein the pathogenic organism comprises a fungi, bacteria, virus, unicellular organism, bacterial colony, or biofilm.
 137. The method of claims 133-136, wherein the anti-microbial peptides are used in a laboratory setting.
 138. The method of claim 137, wherein the anti-microbial peptide is used as a scientific tool.
 139. The method of claims 133-136, wherein the anti-microbial peptides are used in a hospital setting.
 140. The method of claims 133-136, wherein the anti-microbial peptides are used as an animal feed additive.
 141. A method for treating, ameliorating the symptoms of, or delaying the onset of a medical condition by administering to a subject in need thereof the anti-microbial peptides of claims 1-132.
 142. The method of claim 141, wherein the medical condition comprises a microbial infection.
 143. The method of claims 141-142, wherein the anti-microbial peptide reduces the growth rate, reduces the viability, or causes death of a microbe, thereby treating, ameliorating the symptoms of, or delaying the onset of a microbial infection.
 144. The method of claims 141-143, wherein the anti-microbial peptide is administered to a subject comprising: intravenous (IV), subcutaneous (SC), intramuscular (IM), intraperitoneal (IP), intracerebroventricular (ICV), oral, topical, or nasal or a combination thereof the routes of administration. 